data_1uaw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1uaw _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.527 ' HB2' ' CB ' ' A' ' 67' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.287 0.565 . . . . 0.0 110.404 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.567 ' SD ' ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -74.2 170.82 14.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.906 . . . . 0.0 109.465 179.617 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.63 ' CG ' ' CE1' ' A' ' 65' ' ' PHE . 5.4 t80 -151.25 129.72 12.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.159 -0.963 . . . . 0.0 110.128 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.476 HD11 ' HA ' ' A' ' 92' ' ' PRO . 18.4 mm -99.39 139.84 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.206 -0.934 . . . . 0.0 109.366 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' A' ' 91' ' ' ASP . . . -122.34 120.47 4.33 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.65 -1.262 . . . . 0.0 111.154 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.523 ' CA ' HG23 ' A' ' 90' ' ' ILE . . . 112.51 41.42 1.04 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.545 ' HG ' ' CG2' ' A' ' 31' ' ' THR . 1.0 OUTLIER -51.2 120.99 5.5 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.342 -1.093 . . . . 0.0 110.624 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.463 ' HA ' ' HG3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -46.37 173.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.305 -0.872 . . . . 0.0 110.103 179.684 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.439 ' CD1' ' C ' ' A' ' 29' ' ' TRP . 0.2 OUTLIER -76.48 5.03 7.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -0.926 . . . . 0.0 110.599 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.422 ' HG2' ' CD1' ' A' ' 29' ' ' TRP . 2.5 pt20 -151.57 11.79 0.6 Allowed 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.998 -1.064 . . . . 0.0 111.058 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.545 ' CG2' ' HG ' ' A' ' 27' ' ' LEU . 1.2 m -59.25 163.01 4.09 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.987 -1.071 . . . . 0.0 109.795 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.402 ' N ' ' CG2' ' A' ' 31' ' ' THR . 12.8 t -135.59 -169.81 2.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.924 . . . . 0.0 109.748 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 36' ' ' LEU . 6.4 mt-30 -88.47 -73.82 0.48 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.035 -1.041 . . . . 0.0 110.042 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.494 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 1.3 tt0 -48.59 -43.18 35.74 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.765 -1.209 . . . . 0.0 109.642 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.522 ' O ' ' HG3' ' A' ' 38' ' ' GLU . . . -55.9 -28.76 53.77 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 107.503 -2.239 . . . . 0.0 107.503 178.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 33' ' ' GLN . 0.1 OUTLIER -81.36 -37.9 27.49 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 177.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.494 ' HG3' ' HA ' ' A' ' 34' ' ' GLU . 19.9 mtt180 -61.71 -27.27 68.59 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 122.398 1.094 . . . . 0.0 108.12 177.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.522 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -89.11 -16.38 31.64 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.966 179.338 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.68 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 16.9 t80 -80.52 -32.22 36.92 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.401 -0.812 . . . . 0.0 110.175 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.538 ' CE1' HG12 ' A' ' 77' ' ' VAL . 32.1 m-85 -110.5 -28.26 8.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.392 -0.818 . . . . 0.0 109.025 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.522 ' CA ' HG23 ' A' ' 46' ' ' VAL . . . -61.76 -15.46 48.17 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -59.8 -42.86 94.37 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.401 -1.058 . . . . 0.0 109.523 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.418 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 3.6 p90 -125.83 -6.51 6.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.423 -0.798 . . . . 0.0 109.81 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.475 ' O ' ' HA2' ' A' ' 41' ' ' GLY . . . -130.8 96.41 0.35 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 11.1 mm-40 -40.69 115.46 0.58 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.335 -1.097 . . . . 0.0 110.546 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.536 ' HA ' ' CB ' ' A' ' 68' ' ' PHE . 59.9 t -95.32 134.21 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.0 110.61 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 0.1 OUTLIER -100.33 -27.75 13.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.373 -0.83 . . . . 0.0 109.743 179.588 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 5.0 tt0 -176.84 156.63 1.39 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.472 -0.768 . . . . 0.0 109.935 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.482 ' HB2' HD23 ' A' ' 36' ' ' LEU . 8.3 p -149.72 164.72 34.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.154 -0.967 . . . . 0.0 110.347 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.577 ' CD2' ' CD2' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -133.41 126.93 32.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.203 -0.936 . . . . 0.0 110.181 179.683 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.439 ' CG1' ' CD2' ' A' ' 27' ' ' LEU . 98.1 t -117.39 127.57 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.488 -1.382 . . . . 0.0 110.434 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 63' ' ' PHE . 2.8 tpp . . . . . 0 C--N 1.302 -1.495 0 O-C-N 121.624 -0.672 . . . . 0.0 109.797 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 52' ' ' MET . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.564 ' CZ ' ' HB3' ' A' ' 52' ' ' MET . 24.8 p90 -141.72 -174.21 4.0 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.199 -1.177 . . . . 0.0 110.519 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.477 ' HA3' HD13 ' A' ' 27' ' ' LEU . . . -153.84 113.59 0.58 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.63 ' CE1' ' CG ' ' A' ' 23' ' ' PHE . 18.4 m-85 -83.98 149.91 25.99 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.365 -1.079 . . . . 0.0 109.605 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.529 ' CG1' HG12 ' A' ' 46' ' ' VAL . 3.6 t -149.8 110.2 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.163 -0.961 . . . . 0.0 110.274 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.527 ' CB ' ' HB2' ' A' ' 21' ' ' LYS . 12.8 t -90.39 53.94 2.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.249 -0.907 . . . . 0.0 110.523 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.567 ' CZ ' ' SD ' ' A' ' 22' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.124 -0.985 . . . . 0.0 110.412 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 75' ' ' ASP . . . . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.328 0.585 . . . . 0.0 110.064 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.489 ' O ' ' CG2' ' A' ' 77' ' ' VAL . . . -42.28 -85.13 0.01 OUTLIER Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.7 t -42.6 -27.02 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.308 -1.113 . . . . 0.0 110.68 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.518 ' O ' HD23 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -68.24 -82.67 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.113 -0.992 . . . . 0.0 110.192 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -40.24 -28.54 0.06 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.34 -0.85 . . . . 0.0 109.715 179.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.538 HG12 ' CE1' ' A' ' 40' ' ' PHE . 55.2 t -68.55 -43.51 83.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 O-C-N 121.459 -0.776 . . . . 0.0 110.319 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.573 ' CD2' ' N ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -59.68 -36.58 76.74 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 120.907 -1.12 . . . . 0.0 108.215 179.385 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.573 ' N ' ' CD2' ' A' ' 78' ' ' LEU . . . -48.25 -29.17 3.55 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.554 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -107.28 28.17 8.35 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.339 0.59 . . . . 0.0 109.411 179.182 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.502 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 2.9 p -49.14 -18.64 0.35 Allowed 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.143 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -107.35 -15.18 14.7 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.471 -0.768 . . . . 0.0 109.623 179.142 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.68 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 0.2 OUTLIER 56.86 -80.94 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.834 0.826 . . . . 0.0 110.321 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.561 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 3.0 tt0 54.41 123.18 0.0 OUTLIER 'General case' 0 C--N 1.288 -2.087 0 CA-C-O 122.177 0.989 . . . . 0.0 110.895 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.509 ' CD2' ' N ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -154.29 -88.55 0.05 OUTLIER 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.59 -0.694 . . . . 0.0 109.339 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.566 ' O ' ' CB ' ' A' ' 87' ' ' SER . 0.6 OUTLIER -82.01 52.31 1.94 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.111 -0.993 . . . . 0.0 108.848 178.868 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.566 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 76.72 6.8 3.32 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.231 0.539 . . . . 0.0 110.102 -179.317 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.561 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 1.6 mmtm -116.03 117.55 30.43 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.283 -0.886 . . . . 0.0 110.729 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.522 ' O ' ' CG2' ' A' ' 89' ' ' THR . 10.2 t -88.85 80.18 7.21 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.734 -0.604 . . . . 0.0 109.714 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.526 HG13 ' HB3' ' A' ' 83' ' ' HIS . 1.5 mt -52.58 -173.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.238 -0.914 . . . . 0.0 109.743 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 25' ' ' GLY . 4.6 t70 -144.54 84.2 9.3 Favored Pre-proline 0 N--CA 1.484 1.271 0 O-C-N 120.952 -1.092 . . . . 0.0 111.052 -178.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.554 ' CG ' ' O ' ' A' ' 80' ' ' GLN . 2.2 Cg_endo -56.08 113.46 1.45 Allowed 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.419 1.22 . . . . 0.0 110.962 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.616 ' HD2' ' CD2' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -132.48 109.96 10.17 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.35 -0.844 . . . . 0.0 109.451 178.264 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.491 ' CG2' ' HB2' ' A' ' 22' ' ' MET . 40.9 t -96.19 157.89 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.556 -0.715 . . . . 0.0 110.553 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 94' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.334 -0.854 . . . . 0.0 110.565 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.528 ' HB2' ' CB ' ' A' ' 67' ' ' THR . 1.3 ptpt . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.301 0.572 . . . . 0.0 110.426 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.517 ' HG3' ' CG1' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -100.81 170.81 8.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.39 -0.819 . . . . 0.0 109.698 179.648 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.625 ' HB3' ' HD2' ' A' ' 93' ' ' LYS . 19.5 t80 -147.0 155.19 42.05 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.084 -1.01 . . . . 0.0 110.353 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.506 HD13 ' CZ ' ' A' ' 40' ' ' PHE . 24.9 mm -121.26 151.79 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.321 -0.862 . . . . 0.0 109.282 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' A' ' 91' ' ' ASP . . . -133.78 138.96 10.49 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.33 -1.414 . . . . 0.0 111.341 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.474 ' O ' ' CD1' ' A' ' 90' ' ' ILE . . . 103.33 29.67 5.61 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.536 ' CD2' ' O ' ' A' ' 63' ' ' PHE . 0.8 OUTLIER -53.38 112.89 0.98 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.485 -1.009 . . . . 0.0 110.523 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.478 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -56.58 173.57 0.18 Allowed 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.411 -0.806 . . . . 0.0 110.056 179.671 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -80.33 11.54 3.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.315 -0.866 . . . . 0.0 110.493 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -133.44 -0.38 3.25 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.114 -0.991 . . . . 0.0 110.501 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.504 ' CG2' ' HG ' ' A' ' 27' ' ' LEU . 18.4 m -64.62 158.03 25.48 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.354 -0.841 . . . . 0.0 110.207 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.513 ' CG2' ' HA3' ' A' ' 35' ' ' GLY . 12.5 t -135.28 -173.15 3.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.121 -0.987 . . . . 0.0 110.069 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 36' ' ' LEU . 31.6 mt-30 -90.16 -74.76 0.48 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.198 -0.939 . . . . 0.0 110.202 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.53 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -48.72 -48.09 40.78 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.727 -1.189 . . . . 0.0 108.724 179.758 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.513 ' HA3' ' CG2' ' A' ' 32' ' ' THR . . . -48.92 -32.97 12.3 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 107.451 -2.26 . . . . 0.0 107.451 178.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.525 ' N ' ' O ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -78.88 -39.76 34.25 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.361 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.5 ' CG ' ' HA ' ' A' ' 34' ' ' GLU . 3.2 mtt180 -57.81 -25.6 60.82 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.484 1.135 . . . . 0.0 107.974 178.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.53 ' CG ' ' O ' ' A' ' 34' ' ' GLU . 1.3 mt-10 -89.09 -21.11 23.56 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.632 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.67 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 20.5 t80 -73.49 -29.99 62.86 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.916 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.572 ' HA ' ' CZ ' ' A' ' 43' ' ' PHE . 44.9 m-85 -110.89 -24.56 10.34 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.525 -0.735 . . . . 0.0 109.061 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.449 ' CA ' HG22 ' A' ' 46' ' ' VAL . . . -72.58 -9.44 74.02 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -73.78 -52.04 14.44 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.409 -1.054 . . . . 0.0 110.461 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.572 ' CZ ' ' HA ' ' A' ' 40' ' ' PHE . 3.7 p90 -104.81 8.98 35.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.295 -0.878 . . . . 0.0 110.491 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.87 175.43 32.93 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 68' ' ' PHE . 59.8 mm-40 -98.0 110.15 22.78 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.25 -1.147 . . . . 0.0 109.997 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.449 HG22 ' CA ' ' A' ' 41' ' ' GLY . 23.8 t -89.74 123.27 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 0.0 110.364 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.6 -26.2 16.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.406 -0.809 . . . . 0.0 109.75 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.446 ' HG2' ' N ' ' A' ' 49' ' ' CYS . 0.0 OUTLIER 179.95 151.89 0.43 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.438 -0.789 . . . . 0.0 110.006 179.686 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.485 ' HB3' HD21 ' A' ' 36' ' ' LEU . 9.3 m -145.34 174.72 10.87 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.331 -0.855 . . . . 0.0 110.012 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.651 ' CD2' ' CD2' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -148.36 144.41 27.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 110.375 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.499 ' HB ' ' HG2' ' A' ' 33' ' ' GLN . 86.0 t -132.33 134.88 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.624 -1.297 . . . . 0.0 110.997 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.304 -1.38 0 O-C-N 121.585 -0.697 . . . . 0.0 109.585 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.424 ' C ' ' HB2' ' A' ' 27' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.582 ' HB2' ' CE1' ' A' ' 23' ' ' PHE . 2.4 p90 -150.26 -177.94 6.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.208 -1.172 . . . . 0.0 110.598 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.523 ' N ' HD13 ' A' ' 27' ' ' LEU . . . -147.31 121.06 1.33 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.651 ' CD2' ' CD2' ' A' ' 50' ' ' LEU . 21.6 m-85 -84.04 153.25 23.92 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.4 -1.059 . . . . 0.0 110.384 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.486 ' CG2' ' C ' ' A' ' 65' ' ' PHE . 13.9 t -150.07 129.58 3.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.5 -0.75 . . . . 0.0 109.208 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.528 ' CB ' ' HB2' ' A' ' 21' ' ' LYS . 9.9 t -119.12 59.2 0.84 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.144 -0.972 . . . . 0.0 111.039 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.484 ' CZ ' HG21 ' A' ' 77' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.718 0 O-C-N 120.947 -1.096 . . . . 0.0 109.91 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 75' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.216 0.531 . . . . 0.0 110.306 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -48.11 -65.38 2.53 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.478 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 25.5 t -47.12 -52.62 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.199 -1.177 . . . . 0.0 110.39 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.468 ' HA ' HD11 ' A' ' 78' ' ' LEU . 15.7 m-20 -42.63 -52.07 4.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.145 -0.972 . . . . 0.0 110.173 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.471 ' HE3' ' N ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -59.46 -39.4 83.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.394 -0.816 . . . . 0.0 110.155 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.484 HG21 ' CZ ' ' A' ' 68' ' ' PHE . 81.7 t -55.33 -60.4 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 O-C-N 121.072 -1.017 . . . . 0.0 109.621 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.468 HD11 ' HA ' ' A' ' 75' ' ' ASP . 1.6 mp -44.12 -42.46 6.32 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.234 -0.916 . . . . 0.0 109.423 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.467 ' HB3' ' OE1' ' A' ' 80' ' ' GLN . . . -46.88 -27.9 1.4 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.176 -0.953 . . . . 0.0 109.383 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.563 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 13.9 mm100 -101.66 22.0 13.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.426 -0.796 . . . . 0.0 109.894 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.501 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 47.0 t -51.7 -16.92 0.74 Allowed 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.007 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.469 ' O ' ' C ' ' A' ' 83' ' ' HIS . 9.6 ptt180 -100.56 -10.39 21.06 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 121.369 -0.832 . . . . 0.0 109.686 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.67 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 0.5 OUTLIER 31.69 43.99 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.811 -0.555 . . . . 0.0 111.851 179.882 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 2.4 tt0 -93.4 122.58 35.96 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.795 -1.162 . . . . 0.0 110.103 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.47 HD22 ' C ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -155.0 -83.38 0.07 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.553 -0.717 . . . . 0.0 110.189 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.531 ' CB ' ' HD3' ' A' ' 88' ' ' LYS . 0.3 OUTLIER -78.4 52.74 1.18 Allowed 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.036 -1.04 . . . . 0.0 109.425 179.525 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.522 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 71.62 1.43 3.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.522 -0.736 . . . . 0.0 110.619 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.531 ' HD3' ' CB ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -112.69 126.5 55.46 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.104 -0.997 . . . . 0.0 110.249 -179.821 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.491 ' O ' HG21 ' A' ' 89' ' ' THR . 11.5 t -105.82 64.97 0.69 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.666 -0.646 . . . . 0.0 110.361 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.548 ' HB ' ' CG ' ' A' ' 83' ' ' HIS . 0.9 OUTLIER -53.0 -176.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.28 -0.888 . . . . 0.0 109.016 179.892 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' A' ' 25' ' ' GLY . 5.3 t70 -145.11 84.65 8.56 Favored Pre-proline 0 N--CA 1.485 1.28 0 O-C-N 120.653 -1.279 . . . . 0.0 111.052 -178.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.564 ' HG3' ' HD2' ' A' ' 83' ' ' HIS . 1.9 Cg_endo -57.39 112.79 1.23 Allowed 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.565 1.298 . . . . 0.0 110.634 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.625 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -111.3 107.14 16.32 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.035 -1.041 . . . . 0.0 108.983 178.237 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.517 ' CG1' ' HG3' ' A' ' 22' ' ' MET . 93.2 t -97.28 153.4 3.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.704 -0.623 . . . . 0.0 110.372 -179.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.431 ' N ' HG12 ' A' ' 94' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.206 -0.934 . . . . 0.0 110.022 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.458 ' HB2' ' OG1' ' A' ' 67' ' ' THR . 3.5 pttt . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.251 0.548 . . . . 0.0 109.996 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.532 ' HG3' ' CG1' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -76.66 162.07 28.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.249 -0.907 . . . . 0.0 110.226 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.618 ' HB3' ' HD2' ' A' ' 93' ' ' LYS . 19.9 t80 -149.54 145.96 27.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.306 -0.871 . . . . 0.0 109.935 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.566 HG12 ' CE2' ' A' ' 40' ' ' PHE . 1.1 mp -113.37 142.45 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 108.905 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 91' ' ' ASP . . . -120.42 127.16 6.94 Favored Glycine 0 N--CA 1.494 2.522 0 C-N-CA 119.478 -1.344 . . . . 0.0 111.472 -178.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.534 ' CA ' HG21 ' A' ' 90' ' ' ILE . . . 107.32 45.11 1.18 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.525 ' HB2' ' CA ' ' A' ' 63' ' ' PHE . 1.1 tp -56.47 113.97 1.82 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.103 -1.234 . . . . 0.0 110.508 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.509 ' CB ' ' HG2' ' A' ' 88' ' ' LYS . 6.1 t -45.5 170.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.471 -0.768 . . . . 0.0 110.321 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 39.9 p-90 -81.5 11.55 4.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.261 -0.899 . . . . 0.0 110.451 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -143.98 8.95 1.48 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.18 -0.95 . . . . 0.0 110.52 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.458 ' CG2' ' HG ' ' A' ' 27' ' ' LEU . 1.4 m -70.68 163.1 27.8 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.294 -0.879 . . . . 0.0 110.097 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.4 t -142.72 -175.64 4.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.125 -0.984 . . . . 0.0 109.997 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 36' ' ' LEU . 6.5 mt-30 -80.26 -73.1 0.38 Allowed 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.035 -1.041 . . . . 0.0 111.014 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.504 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -48.0 -49.59 30.39 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 118.48 -1.288 . . . . 0.0 108.765 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.458 ' HA2' ' HG3' ' A' ' 38' ' ' GLU . . . -47.73 -31.04 7.15 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 107.753 -2.139 . . . . 0.0 107.753 178.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -78.45 -39.35 38.83 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 178.283 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.489 ' N ' ' O ' ' A' ' 34' ' ' GLU . 71.7 mtt180 -59.22 -26.42 64.85 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 178.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 34' ' ' GLU . 1.3 mt-10 -88.08 -19.68 26.73 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.692 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 8.3 t80 -79.38 -43.04 24.21 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.771 -0.771 . . . . 0.0 110.735 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.566 ' CE2' HG12 ' A' ' 24' ' ' ILE . 28.4 m-85 -105.92 -28.11 10.79 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.387 -0.821 . . . . 0.0 109.217 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.488 ' CA ' HG22 ' A' ' 46' ' ' VAL . . . -67.35 -10.09 56.36 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.647 -1.781 . . . . 0.0 108.647 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -63.05 -37.14 85.99 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.379 -1.071 . . . . 0.0 109.873 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.429 ' CZ ' ' HA ' ' A' ' 40' ' ' PHE . 3.2 p90 -127.23 0.79 6.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.491 -0.756 . . . . 0.0 109.897 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.589 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -146.54 97.55 0.19 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -37.87 122.76 1.02 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.559 -0.965 . . . . 0.0 110.638 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.542 ' HA ' ' CB ' ' A' ' 68' ' ' PHE . 21.3 t -91.06 119.92 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.356 -0.84 . . . . 0.0 110.727 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -86.14 -21.56 27.5 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.358 -0.839 . . . . 0.0 109.637 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -178.75 145.16 0.29 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.366 -0.834 . . . . 0.0 110.384 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.503 ' HB2' ' CD2' ' A' ' 36' ' ' LEU . 5.5 p -148.05 170.16 18.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.287 -0.883 . . . . 0.0 109.93 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.655 ' CD2' ' CD2' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -148.97 133.66 17.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.873 -1.142 . . . . 0.0 110.927 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.493 ' CG2' ' HG2' ' A' ' 33' ' ' GLN . 61.6 t -110.51 130.19 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.808 -1.183 . . . . 0.0 109.487 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.501 ' SD ' ' CZ ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--N 1.303 -1.435 0 O-C-N 121.174 -0.954 . . . . 0.0 110.612 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.473 ' C ' ' CD2' ' A' ' 63' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 108.461 -1.856 . . . . 0.0 108.461 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.525 ' CA ' ' HB2' ' A' ' 27' ' ' LEU . 8.2 p90 -177.66 178.15 1.04 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.303 -1.116 . . . . 0.0 110.367 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.58 ' O ' ' CD1' ' A' ' 23' ' ' PHE . . . -141.67 164.36 26.71 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.655 ' CD2' ' CD2' ' A' ' 50' ' ' LEU . 13.6 m-85 -124.56 148.38 47.85 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.356 -1.085 . . . . 0.0 109.822 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.486 ' O ' ' HB2' ' A' ' 22' ' ' MET . 7.5 t -148.71 126.8 3.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.317 -0.865 . . . . 0.0 110.171 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 21' ' ' LYS . 88.4 m -106.14 19.51 20.41 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.282 -0.886 . . . . 0.0 110.079 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.589 ' CE1' ' HA3' ' A' ' 44' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.464 0 O-C-N 121.151 -0.968 . . . . 0.0 109.728 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 73' ' ' GLY . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.173 0.511 . . . . 0.0 110.348 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.478 ' O ' ' CG2' ' A' ' 77' ' ' VAL . . . -43.48 -63.75 2.04 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.1 t -54.45 -23.8 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.136 -1.214 . . . . 0.0 110.0 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.447 ' HB3' ' HE3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -75.38 -73.13 0.27 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 110.017 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.447 ' HE3' ' HB3' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -47.55 -46.47 27.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.378 -0.826 . . . . 0.0 109.818 179.807 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.508 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 79.9 t -52.59 -53.25 21.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.069 -1.02 . . . . 0.0 108.691 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -41.02 -51.81 3.23 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.659 -0.651 . . . . 0.0 110.064 179.012 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 78' ' ' LEU . . . -42.85 -27.26 0.17 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.441 -0.787 . . . . 0.0 110.19 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.562 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 9.7 mm-40 -104.58 21.85 16.06 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.265 -0.897 . . . . 0.0 110.29 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.508 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 40.3 t -51.76 -16.86 0.75 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.481 -0.762 . . . . 0.0 109.276 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.5 OUTLIER -108.33 -4.41 17.47 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 121.346 -0.846 . . . . 0.0 109.939 179.348 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.692 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 0.4 OUTLIER 34.39 31.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.786 -0.571 . . . . 0.0 111.241 179.828 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.584 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -86.24 117.78 25.27 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 118.39 -1.324 . . . . 0.0 110.205 179.502 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.504 ' CD2' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -153.78 -73.68 0.13 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.808 -0.558 . . . . 0.0 110.231 -179.249 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 87' ' ' SER . 0.4 OUTLIER -81.27 49.07 1.22 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.165 -0.96 . . . . 0.0 109.474 179.552 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 71.68 -0.11 3.29 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.539 -0.726 . . . . 0.0 110.651 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.584 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -115.35 138.66 50.74 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.182 -0.949 . . . . 0.0 110.084 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.532 ' O ' ' CG2' ' A' ' 89' ' ' THR . 14.9 t -113.11 71.27 0.74 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.544 -0.723 . . . . 0.0 110.799 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.592 ' HB ' ' CG ' ' A' ' 83' ' ' HIS . 1.2 mt -55.0 -171.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.32 -0.863 . . . . 0.0 109.534 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 25' ' ' GLY . 5.1 t70 -143.82 87.04 8.3 Favored Pre-proline 0 N--CA 1.486 1.355 0 O-C-N 120.882 -1.136 . . . . 0.0 111.192 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.562 ' CG ' ' O ' ' A' ' 80' ' ' GLN . 2.0 Cg_endo -62.49 112.23 1.53 Allowed 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.53 1.279 . . . . 0.0 111.057 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.618 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -115.43 109.32 17.69 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.115 -0.991 . . . . 0.0 109.066 178.111 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.532 ' CG1' ' HG3' ' A' ' 22' ' ' MET . 53.6 t -97.04 151.57 4.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.521 -0.737 . . . . 0.0 110.291 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.203 -0.936 . . . . 0.0 110.375 -179.871 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.251 0.548 . . . . 0.0 110.343 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.534 ' HG2' ' CG2' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -73.06 -172.12 1.01 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.349 -0.845 . . . . 0.0 109.839 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.686 ' CG ' ' CE1' ' A' ' 65' ' ' PHE . 6.5 t80 -151.01 145.38 25.5 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.015 -1.053 . . . . 0.0 110.211 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.573 HD11 ' CZ ' ' A' ' 40' ' ' PHE . 18.6 mm -118.49 126.34 75.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.299 -0.876 . . . . 0.0 108.905 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 90' ' ' ILE . . . -109.83 159.63 13.86 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.789 -1.196 . . . . 0.0 111.227 -178.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.491 ' O ' HD13 ' A' ' 90' ' ' ILE . . . 54.35 40.25 67.82 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.597 ' HA ' ' CG2' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -85.56 143.41 28.5 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.676 -0.897 . . . . 0.0 110.926 -179.135 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.489 ' O ' ' HB ' ' A' ' 31' ' ' THR . 0.5 OUTLIER -39.39 134.81 1.16 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.465 0.65 . . . . 0.0 110.942 -179.076 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.526 ' CG ' ' N ' ' A' ' 30' ' ' GLN . 31.0 p-90 -68.28 -37.97 81.22 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.361 -0.837 . . . . 0.0 109.947 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.526 ' N ' ' CG ' ' A' ' 29' ' ' TRP . 12.3 pt20 -74.76 0.21 16.07 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.396 -0.815 . . . . 0.0 110.696 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' A' ' 28' ' ' SER . 4.4 m -69.24 153.86 42.97 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.392 -0.817 . . . . 0.0 110.215 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.483 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 5.9 t -123.79 -174.18 2.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 109.625 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 36' ' ' LEU . 1.7 mt-30 -72.28 -73.15 0.2 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.044 -1.035 . . . . 0.0 110.855 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.519 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 0.1 OUTLIER -48.33 -50.01 31.97 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 118.569 -1.252 . . . . 0.0 108.845 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -49.47 -29.23 10.94 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 107.795 -2.122 . . . . 0.0 107.795 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.538 ' CD2' ' HB2' ' A' ' 49' ' ' CYS . 0.1 OUTLIER -81.72 -38.24 26.08 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 178.315 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.519 ' HG3' ' HA ' ' A' ' 34' ' ' GLU . 13.9 mtp180 -58.71 -27.31 64.75 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.478 ' HG3' ' O ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -89.25 -21.35 23.26 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.793 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.579 ' OH ' ' CG ' ' A' ' 83' ' ' HIS . 38.2 t80 -67.84 -29.17 68.24 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.568 0.699 . . . . 0.0 109.85 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.573 ' CZ ' HD11 ' A' ' 24' ' ' ILE . 38.4 m-85 -117.66 -18.72 9.6 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -70.17 -12.59 69.05 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -62.19 -47.82 82.77 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.452 -1.028 . . . . 0.0 109.691 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -119.61 7.87 11.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.519 -0.738 . . . . 0.0 109.911 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.466 ' O ' ' HA2' ' A' ' 41' ' ' GLY . . . -159.41 99.99 0.18 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 13.3 pt-20 -41.26 148.79 0.12 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.433 -1.039 . . . . 0.0 110.099 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.54 ' HA ' ' CB ' ' A' ' 68' ' ' PHE . 48.8 t -122.6 147.38 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.192 -0.943 . . . . 0.0 110.868 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -106.3 -32.7 8.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.414 -0.804 . . . . 0.0 109.887 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.469 ' O ' HG23 ' A' ' 67' ' ' THR . 0.9 OUTLIER -167.51 152.03 6.81 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.248 -0.908 . . . . 0.0 110.294 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.538 ' HB2' ' CD2' ' A' ' 36' ' ' LEU . 29.7 p -150.8 167.42 27.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.178 -0.951 . . . . 0.0 110.285 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.554 ' CD2' ' CD2' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -138.6 126.23 22.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.168 -0.957 . . . . 0.0 109.872 179.504 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.6 t -115.09 130.44 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.634 -1.292 . . . . 0.0 111.261 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.462 ' HE1' ' CE1' ' A' ' 63' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.425 0 O-C-N 121.6 -0.688 . . . . 0.0 109.292 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 7.4 p90 -151.54 -172.71 4.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.192 -1.181 . . . . 0.0 110.666 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.464 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -153.48 120.19 1.02 Allowed Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.686 ' CE1' ' CG ' ' A' ' 23' ' ' PHE . 17.3 m-85 -83.94 149.31 26.4 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.453 -1.028 . . . . 0.0 109.153 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.512 ' CG2' ' C ' ' A' ' 65' ' ' PHE . 3.5 t -150.0 114.51 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.11 -0.994 . . . . 0.0 110.845 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 48' ' ' GLU . 8.9 t -80.07 4.09 18.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.175 -0.953 . . . . 0.0 109.694 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.54 ' CB ' ' HA ' ' A' ' 46' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.3 -0.875 . . . . 0.0 110.105 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.234 0.54 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 74' ' ' VAL . . . -47.71 -77.64 0.11 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.439 ' C ' ' O ' ' A' ' 73' ' ' GLY . 51.1 t -40.95 -51.84 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.33 -1.1 . . . . 0.0 110.481 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.472 ' HA ' HD22 ' A' ' 78' ' ' LEU . 3.8 m-20 -47.1 -52.91 14.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -0.927 . . . . 0.0 110.295 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.05 -35.76 80.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.465 -0.772 . . . . 0.0 110.531 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.539 HG11 ' CE1' ' A' ' 40' ' ' PHE . 49.8 t -54.58 -72.8 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.057 -1.027 . . . . 0.0 109.753 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.472 HD22 ' HA ' ' A' ' 75' ' ' ASP . 1.1 pp -46.82 -37.42 8.67 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.909 -1.119 . . . . 0.0 109.289 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.69 -25.76 7.93 Favored 'General case' 0 C--N 1.308 -1.235 0 O-C-N 121.1 -1.0 . . . . 0.0 108.685 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.568 ' HB3' ' CE1' ' A' ' 83' ' ' HIS . 13.3 mm-40 -103.99 26.28 8.91 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.465 0.65 . . . . 0.0 109.351 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.534 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 47.4 t -54.54 -15.83 1.99 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.544 ' O ' ' C ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -113.54 8.19 17.66 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.611 -0.681 . . . . 0.0 109.66 179.099 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.62 ' CD2' ' HG3' ' A' ' 92' ' ' PRO . 2.6 m-70 -3.38 -78.01 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.613 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 4.4 tt0 59.38 122.46 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 121.467 0.651 . . . . 0.0 109.49 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.624 ' CD2' ' N ' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -157.58 -37.81 0.07 Allowed 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.274 -0.97 . . . . 0.0 110.502 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 87' ' ' SER . 1.5 t70 -121.88 48.03 1.78 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 74.44 1.33 3.82 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -177.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.613 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -117.05 119.43 35.25 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.527 ' HA ' ' CA ' ' A' ' 84' ' ' GLU . 7.3 t -92.45 77.91 5.04 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.597 ' CG2' ' HA ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -40.98 167.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 CA-C-O 121.897 0.856 . . . . 0.0 110.615 -178.8 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 25' ' ' GLY . 4.6 t70 -133.2 69.63 78.01 Favored Pre-proline 0 C--N 1.297 -1.694 0 O-C-N 121.685 -0.635 . . . . 0.0 109.448 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.62 ' HG3' ' CD2' ' A' ' 83' ' ' HIS . 1.8 Cg_endo -49.58 112.84 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.566 1.298 . . . . 0.0 109.882 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.493 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.1 OUTLIER -126.75 107.95 10.61 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.871 0.843 . . . . 0.0 110.009 179.192 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.534 ' CG2' ' HG2' ' A' ' 22' ' ' MET . 76.3 t -95.99 153.72 3.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.095 -1.003 . . . . 0.0 110.427 -179.518 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.463 ' HB2' ' HA ' ' A' ' 67' ' ' THR . 1.1 pttm . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.185 0.517 . . . . 0.0 110.105 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.597 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -55.23 155.85 4.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 110.218 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.633 ' CD2' ' CE ' ' A' ' 93' ' ' LYS . 0.5 OUTLIER -138.54 119.61 14.49 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.582 -0.699 . . . . 0.0 109.444 -179.804 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.614 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 1.2 mp -93.65 137.89 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.081 -1.012 . . . . 0.0 109.12 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.543 ' O ' ' CG2' ' A' ' 90' ' ' ILE . . . -110.62 133.05 11.32 Favored Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.823 -1.179 . . . . 0.0 112.324 -177.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.511 ' C ' HG21 ' A' ' 90' ' ' ILE . . . 62.55 36.97 93.95 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.564 ' HA ' ' CG2' ' A' ' 90' ' ' ILE . 0.4 OUTLIER -61.65 150.96 34.91 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.529 -0.983 . . . . 0.0 110.706 -179.339 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.496 ' CB ' ' HB ' ' A' ' 31' ' ' THR . 0.4 OUTLIER -39.51 123.11 1.43 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.49 0.662 . . . . 0.0 110.771 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 6.5 p-90 -63.9 -14.29 52.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.504 -0.747 . . . . 0.0 110.146 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.466 ' O ' ' O ' ' A' ' 31' ' ' THR . 4.1 pt20 -100.04 -21.74 15.5 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.373 -0.83 . . . . 0.0 110.908 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.496 ' HB ' ' CB ' ' A' ' 28' ' ' SER . 2.3 t -55.41 -161.93 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.447 0.641 . . . . 0.0 110.397 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.407 ' N ' HG21 ' A' ' 31' ' ' THR . 6.1 t -158.74 -168.99 2.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.877 . . . . 0.0 109.857 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 36' ' ' LEU . 15.1 mt-30 -79.55 -70.53 0.5 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.162 -0.961 . . . . 0.0 110.432 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.505 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -46.32 -52.29 13.01 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.959 -1.096 . . . . 0.0 109.237 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.443 ' HA2' ' HG3' ' A' ' 38' ' ' GLU . . . -48.4 -31.34 9.0 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.53 ' N ' ' O ' ' A' ' 33' ' ' GLN . 0.1 OUTLIER -79.76 -36.81 36.64 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.448 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.498 ' HG3' ' HA ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -60.76 -27.97 68.37 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 122.455 1.121 . . . . 0.0 108.052 177.728 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.505 ' HG3' ' O ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -86.02 -19.9 29.64 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.541 179.091 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.688 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 13.6 t80 -78.64 -35.29 45.66 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.988 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.583 ' HA ' ' CZ ' ' A' ' 43' ' ' PHE . 38.7 m-85 -109.14 -22.96 11.87 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.213 -0.93 . . . . 0.0 109.416 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -76.79 -3.61 80.17 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.581 -1.807 . . . . 0.0 108.581 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -73.86 -50.59 19.6 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 121.495 -1.003 . . . . 0.0 110.19 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.583 ' CZ ' ' HA ' ' A' ' 40' ' ' PHE . 2.9 p90 -103.35 13.1 34.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 110.18 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 45' ' ' GLU . . . -150.24 -111.8 0.56 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.464 ' HB3' ' O ' ' A' ' 44' ' ' GLY . 0.4 OUTLIER 176.83 104.39 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.533 -0.981 . . . . 0.0 109.408 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.53 ' CG1' HG12 ' A' ' 66' ' ' VAL . 95.1 t -90.56 137.78 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.312 -0.867 . . . . 0.0 111.04 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -101.7 -26.87 13.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.52 -0.737 . . . . 0.0 109.163 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -166.9 154.79 9.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.547 -0.721 . . . . 0.0 109.796 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.491 ' SG ' ' CD ' ' A' ' 37' ' ' ARG . 21.0 p -148.68 175.4 11.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.123 -0.986 . . . . 0.0 110.719 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.598 ' CD2' ' CD2' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -150.51 132.11 14.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -0.833 . . . . 0.0 109.902 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.2 t -129.1 147.04 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.548 -1.345 . . . . 0.0 111.298 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.458 ' O ' HD23 ' A' ' 27' ' ' LEU . . . . . . . . 0 N--CA 1.488 2.146 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.476 ' O ' HD21 ' A' ' 27' ' ' LEU . 41.4 p90 -140.5 -168.86 2.65 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.09 -1.241 . . . . 0.0 110.472 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 50' ' ' LEU . . . -155.8 179.71 31.53 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.598 ' CD2' ' CD2' ' A' ' 50' ' ' LEU . 16.8 m-85 -148.6 146.68 28.34 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.493 -1.004 . . . . 0.0 108.751 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.53 HG12 ' CG1' ' A' ' 46' ' ' VAL . 5.6 t -148.08 106.18 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 120.806 -1.184 . . . . 0.0 111.295 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.463 ' HA ' ' HB2' ' A' ' 21' ' ' LYS . 39.0 m -82.45 56.76 3.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.14 -0.975 . . . . 0.0 110.049 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.597 ' CE1' ' HB2' ' A' ' 22' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 110.74 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.511 0.672 . . . . 0.0 109.723 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.527 ' O ' ' CG2' ' A' ' 77' ' ' VAL . . . -59.14 -55.05 32.97 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.8 t -45.17 -38.93 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.124 -1.221 . . . . 0.0 110.354 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.87 -73.31 0.13 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.211 -0.931 . . . . 0.0 110.303 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.45 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -45.09 -43.06 9.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.241 -0.912 . . . . 0.0 109.469 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.583 ' CG1' ' CE ' ' A' ' 22' ' ' MET . 93.4 t -54.02 -55.61 13.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.251 -0.905 . . . . 0.0 108.886 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 81' ' ' SER . 0.1 OUTLIER -40.41 -47.27 2.55 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.716 -0.615 . . . . 0.0 109.993 178.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -43.53 -26.96 0.25 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.507 -0.746 . . . . 0.0 109.678 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.541 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 43.8 mm-40 -103.08 24.71 10.4 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.447 -0.783 . . . . 0.0 110.056 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.54 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 30.4 t -57.8 -13.74 4.76 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.556 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -99.71 -17.0 17.96 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 121.425 -0.797 . . . . 0.0 109.675 179.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.688 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 0.7 OUTLIER 31.14 32.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.613 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.556 ' N ' ' O ' ' A' ' 82' ' ' ARG . 0.8 OUTLIER -77.92 121.65 24.44 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.431 -1.418 . . . . 0.0 109.154 179.392 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -144.67 -80.88 0.17 Allowed 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.323 -178.562 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.526 ' O ' ' CD ' ' A' ' 88' ' ' LYS . 7.7 t70 -87.1 51.62 2.29 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.506 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 70.44 6.93 6.02 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -178.415 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 6.4 mmmt -108.49 120.94 43.88 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.58 -0.7 . . . . 0.0 109.964 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.491 ' O ' ' CG2' ' A' ' 89' ' ' THR . 13.4 t -100.07 67.4 1.4 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.562 -0.711 . . . . 0.0 109.589 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.629 ' HB ' ' CG ' ' A' ' 83' ' ' HIS . 1.3 mm -49.86 -179.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 119.621 -0.831 . . . . 0.0 109.544 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -141.06 79.56 17.96 Favored Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 121.163 -0.961 . . . . 0.0 110.272 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.541 ' CG ' ' O ' ' A' ' 80' ' ' GLN . 2.4 Cg_endo -51.81 113.11 1.02 Allowed 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.415 1.219 . . . . 0.0 110.201 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.633 ' CE ' ' CD2' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -135.41 113.33 11.08 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.27 -0.894 . . . . 0.0 109.965 179.221 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.518 HG22 ' CG ' ' A' ' 22' ' ' MET . 58.4 t -96.65 172.97 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.253 -0.905 . . . . 0.0 110.253 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.425 ' N ' HG13 ' A' ' 94' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.201 -0.937 . . . . 0.0 110.393 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.533 ' CB ' ' CG2' ' A' ' 67' ' ' THR . 4.6 pttt . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.229 0.538 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.586 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -75.79 174.0 10.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.186 -0.946 . . . . 0.0 109.478 179.443 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.691 ' CG ' ' CE1' ' A' ' 65' ' ' PHE . 5.9 t80 -150.6 139.4 20.8 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.204 -0.935 . . . . 0.0 109.825 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.597 HD11 ' CZ ' ' A' ' 40' ' ' PHE . 13.6 mm -106.68 152.87 8.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.49 ' O ' ' CG2' ' A' ' 90' ' ' ILE . . . -126.69 139.3 11.19 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 119.175 -1.488 . . . . 0.0 111.764 -178.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.475 ' C ' HG22 ' A' ' 90' ' ' ILE . . . 56.52 43.65 90.67 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.561 ' HA ' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -75.74 142.58 42.38 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.412 -1.052 . . . . 0.0 110.63 -179.311 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.474 ' HB2' ' HB ' ' A' ' 31' ' ' THR . 5.0 m -39.57 132.91 1.52 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.617 -0.677 . . . . 0.0 110.447 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.455 ' CZ3' ' HB3' ' A' ' 30' ' ' GLN . 47.6 p-90 -71.16 -17.95 62.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.465 -0.772 . . . . 0.0 110.624 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.455 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 10.9 pt20 -89.58 -18.12 27.19 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.184 -0.948 . . . . 0.0 110.82 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.474 ' HB ' ' HB2' ' A' ' 28' ' ' SER . 6.9 t -55.61 -173.42 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.874 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.4 t -147.85 -172.6 4.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.348 -0.845 . . . . 0.0 109.875 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 36' ' ' LEU . 3.9 mt-30 -77.79 -74.23 0.27 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.032 -1.043 . . . . 0.0 110.531 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.552 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 2.7 tt0 -48.05 -41.53 26.15 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.949 -1.094 . . . . 0.0 110.182 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.531 ' O ' ' HG3' ' A' ' 38' ' ' GLU . . . -57.47 -28.95 60.08 Favored Glycine 0 C--N 1.296 -1.684 0 N-CA-C 107.424 -2.271 . . . . 0.0 107.424 178.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.531 ' CD1' HG22 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -82.5 -38.59 23.64 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.135 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.552 ' HG3' ' HA ' ' A' ' 34' ' ' GLU . 26.4 mtt180 -61.79 -27.09 68.5 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 122.418 1.104 . . . . 0.0 108.135 178.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.531 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -87.44 -19.27 28.26 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.373 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.653 ' CE1' ' NE2' ' A' ' 83' ' ' HIS . 26.9 t80 -79.24 -30.52 43.21 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.254 -0.904 . . . . 0.0 110.205 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.597 ' CZ ' HD11 ' A' ' 24' ' ' ILE . 27.0 m-85 -108.8 -25.33 10.85 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.459 -0.776 . . . . 0.0 109.166 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -70.26 -7.84 60.98 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -63.95 -49.61 71.88 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 121.417 -1.049 . . . . 0.0 109.699 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -113.82 12.6 18.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.464 -0.772 . . . . 0.0 109.763 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 45' ' ' GLU . . . -142.85 -117.22 1.23 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 1.9 pt-20 177.09 103.47 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.406 -1.055 . . . . 0.0 109.906 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.521 ' HA ' ' CB ' ' A' ' 68' ' ' PHE . 63.3 t -89.41 126.58 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.19 -0.944 . . . . 0.0 110.702 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.95 -26.98 11.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.265 -0.897 . . . . 0.0 109.592 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -158.76 131.94 7.26 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.47 -0.769 . . . . 0.0 109.446 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 24.8 p -150.37 154.64 38.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.972 -1.08 . . . . 0.0 111.288 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.521 ' CD1' ' C ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -125.04 126.11 44.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.391 -0.818 . . . . 0.0 109.261 178.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.592 ' CG1' ' N ' ' A' ' 52' ' ' MET . 17.4 t -89.73 169.38 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.79 -1.194 . . . . 0.0 112.104 -178.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.606 ' O ' ' CE1' ' A' ' 63' ' ' PHE . 2.2 ptt? . . . . . 0 C--N 1.305 -1.332 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.733 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.601 ' HA2' ' HA ' ' A' ' 52' ' ' MET . . . . . . . . 0 N--CA 1.481 1.684 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.606 ' CE1' ' O ' ' A' ' 52' ' ' MET . 0.2 OUTLIER -136.99 -176.1 4.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.087 -1.243 . . . . 0.0 109.96 179.282 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.474 ' O ' ' HB ' ' A' ' 24' ' ' ILE . . . -135.22 100.79 0.37 Allowed Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.087 -1.53 . . . . 0.0 110.4 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.691 ' CE1' ' CG ' ' A' ' 23' ' ' PHE . 11.7 m-85 -81.23 136.02 35.79 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.119 -1.224 . . . . 0.0 108.627 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.531 HG22 ' CD1' ' A' ' 36' ' ' LEU . 3.1 t -145.99 106.6 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 118.782 -1.167 . . . . 0.0 111.16 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.533 ' CG2' ' CB ' ' A' ' 21' ' ' LYS . 1.4 m -82.63 47.21 1.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.609 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.586 ' CE1' ' HB3' ' A' ' 22' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.357 -0.84 . . . . 0.0 110.619 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.476 0.655 . . . . 0.0 109.939 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.462 ' O ' HG21 ' A' ' 77' ' ' VAL . . . -49.49 -44.63 36.96 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.528 ' O ' ' CD1' ' A' ' 78' ' ' LEU . 19.5 t -46.73 -52.27 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.352 -1.087 . . . . 0.0 109.868 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.434 ' HB3' ' HE2' ' A' ' 76' ' ' LYS . 4.6 t0 -54.08 -50.04 67.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.068 -1.02 . . . . 0.0 109.681 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.503 ' N ' ' HE2' ' A' ' 76' ' ' LYS . 6.3 mmpt? -56.26 -35.53 67.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.33 -0.856 . . . . 0.0 109.816 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.573 HG11 ' CE1' ' A' ' 40' ' ' PHE . 60.5 t -59.17 -57.07 13.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 O-C-N 121.045 -1.035 . . . . 0.0 109.477 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.528 ' CD1' ' O ' ' A' ' 74' ' ' VAL . 2.8 mp -44.84 -41.55 7.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.239 -0.913 . . . . 0.0 109.06 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -46.34 -27.99 1.2 Allowed 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.304 -0.873 . . . . 0.0 109.281 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.515 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 7.2 mm100 -101.85 25.18 8.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.533 -0.729 . . . . 0.0 109.68 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.536 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 21.4 p -56.44 -16.44 5.81 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.522 ' O ' ' C ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -97.34 -9.49 27.39 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.633 -0.667 . . . . 0.0 109.792 179.193 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.653 ' NE2' ' CE1' ' A' ' 39' ' ' TYR . 0.6 OUTLIER 19.48 48.9 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 179.81 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -91.9 125.57 36.66 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 118.493 -1.283 . . . . 0.0 109.172 178.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.539 ' CD2' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -145.34 -91.53 0.1 Allowed 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.663 -0.648 . . . . 0.0 109.655 -179.158 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.529 ' O ' ' CB ' ' A' ' 87' ' ' SER . 10.6 m-20 -79.86 52.62 1.51 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.097 -1.002 . . . . 0.0 108.74 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 72.18 9.72 5.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.618 -0.676 . . . . 0.0 109.857 -179.129 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 9.0 mmtt -111.24 120.72 43.21 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.372 -0.83 . . . . 0.0 109.608 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.496 ' O ' ' CG2' ' A' ' 89' ' ' THR . 11.9 t -101.87 69.23 1.18 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.505 -0.747 . . . . 0.0 109.726 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.599 ' HB ' ' CG ' ' A' ' 83' ' ' HIS . 0.8 OUTLIER -50.15 -178.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.389 -179.714 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -141.45 81.04 15.74 Favored Pre-proline 0 C--N 1.3 -1.558 0 O-C-N 121.189 -0.944 . . . . 0.0 109.817 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.543 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . 2.4 Cg_endo -53.96 112.58 1.01 Allowed 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 123.542 1.285 . . . . 0.0 111.275 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.576 ' HD2' ' CD2' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -128.02 104.89 8.04 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.916 0.865 . . . . 0.0 108.848 177.894 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.533 ' O ' ' CB ' ' A' ' 95' ' ' ALA . 6.2 t -96.19 -174.49 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 O-C-N 121.854 -0.529 . . . . 0.0 110.004 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.533 ' CB ' ' O ' ' A' ' 94' ' ' VAL . . . . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.181 -0.949 . . . . 0.0 110.431 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.533 ' CB ' ' OG1' ' A' ' 67' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.212 0.529 . . . . 0.0 110.236 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.577 ' SD ' ' CZ ' ' A' ' 68' ' ' PHE . 0.5 OUTLIER -83.81 178.92 7.72 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.248 -0.907 . . . . 0.0 110.528 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.616 ' HB3' ' HD2' ' A' ' 93' ' ' LYS . 0.1 OUTLIER -150.47 143.68 24.91 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.489 -0.757 . . . . 0.0 109.068 179.785 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.561 HG23 HG23 ' A' ' 90' ' ' ILE . 1.1 mp -106.85 144.62 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.069 -1.019 . . . . 0.0 109.34 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 91' ' ' ASP . . . -131.51 122.76 3.51 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 119.734 -1.222 . . . . 0.0 111.281 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.521 ' CA ' HG22 ' A' ' 90' ' ' ILE . . . 113.21 34.0 1.87 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.508 HD21 ' CG1' ' A' ' 51' ' ' VAL . 2.0 mp -39.93 137.37 0.95 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.682 -0.893 . . . . 0.0 110.715 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.482 ' N ' ' OG1' ' A' ' 31' ' ' THR . 5.0 p -56.39 -174.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 0.0 110.06 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 47.9 p-90 -77.62 5.23 9.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 0.0 110.238 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -161.67 16.17 0.1 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.111 -0.993 . . . . 0.0 111.158 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.482 ' OG1' ' N ' ' A' ' 28' ' ' SER . 98.7 m -53.6 157.54 2.16 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.055 -1.028 . . . . 0.0 110.307 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.8 t -148.23 178.55 8.47 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.101 -1.0 . . . . 0.0 110.27 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.544 ' O ' ' N ' ' A' ' 36' ' ' LEU . 7.1 mt-30 -62.61 -74.14 0.1 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.96 . . . . 0.0 111.166 -178.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.545 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 1.6 tt0 -49.68 -36.05 23.74 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.73 -1.232 . . . . 0.0 110.028 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.523 ' O ' ' HG3' ' A' ' 38' ' ' GLU . . . -61.04 -28.85 69.53 Favored Glycine 0 C--N 1.295 -1.711 0 N-CA-C 107.148 -2.381 . . . . 0.0 107.148 178.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.544 ' N ' ' O ' ' A' ' 33' ' ' GLN . 0.1 OUTLIER -80.56 -41.42 24.13 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.047 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.545 ' HG3' ' HA ' ' A' ' 34' ' ' GLU . 19.8 mtp180 -61.65 -27.77 68.91 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 122.385 1.088 . . . . 0.0 108.238 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.2 OUTLIER -87.25 -15.7 37.37 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.11 179.454 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.691 ' CE2' ' CE1' ' A' ' 83' ' ' HIS . 10.4 t80 -86.76 -43.37 12.59 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 121.345 -0.847 . . . . 0.0 110.797 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.46 ' HA ' ' CZ ' ' A' ' 43' ' ' PHE . 48.1 m-85 -101.36 -33.66 9.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.875 . . . . 0.0 109.193 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -59.76 -17.19 41.38 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -61.96 -45.72 92.44 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.474 -1.015 . . . . 0.0 109.956 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.46 ' CZ ' ' HA ' ' A' ' 40' ' ' PHE . 4.9 p90 -119.58 -2.98 10.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.445 -0.784 . . . . 0.0 109.948 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.441 ' O ' ' HA2' ' A' ' 41' ' ' GLY . . . -137.77 93.26 0.21 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.537 ' O ' ' CB ' ' A' ' 68' ' ' PHE . 1.9 mt-10 -40.03 105.91 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.411 -1.052 . . . . 0.0 110.15 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 68' ' ' PHE . 43.3 t -88.85 126.06 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 110.446 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -99.12 -31.33 11.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.278 -0.889 . . . . 0.0 110.032 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.81 135.89 17.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.29 -0.881 . . . . 0.0 110.274 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.47 ' HB2' HD23 ' A' ' 36' ' ' LEU . 31.9 p -150.48 166.66 29.48 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.876 . . . . 0.0 110.017 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.539 ' HG ' ' HB2' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -150.45 126.02 10.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.962 -1.086 . . . . 0.0 110.695 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.508 ' CG1' HD21 ' A' ' 27' ' ' LEU . 98.9 t -113.66 142.29 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.861 -1.149 . . . . 0.0 110.002 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.444 ' HG2' ' CE2' ' A' ' 63' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--N 1.304 -1.398 0 O-C-N 121.287 -0.883 . . . . 0.0 110.376 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 27' ' ' LEU . . . . . . . . 0 N--CA 1.483 1.769 0 N-CA-C 108.349 -1.9 . . . . 0.0 108.349 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 23' ' ' PHE . 50.3 p90 -132.32 -162.3 1.22 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.092 -1.24 . . . . 0.0 110.376 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 50' ' ' LEU . . . -166.53 174.85 42.0 Favored Glycine 0 N--CA 1.488 2.122 0 C-N-CA 119.319 -1.419 . . . . 0.0 110.677 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.539 ' HB2' ' HG ' ' A' ' 50' ' ' LEU . 9.8 m-85 -136.24 145.09 45.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.756 -0.849 . . . . 0.0 109.008 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.522 ' HB ' ' CE ' ' A' ' 22' ' ' MET . 16.2 t -149.98 143.4 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.981 -1.074 . . . . 0.0 110.585 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.533 ' OG1' ' CB ' ' A' ' 21' ' ' LYS . 1.5 m -137.24 58.73 1.7 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.303 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.587 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.071 -1.018 . . . . 0.0 110.557 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 75' ' ' ASP . . . . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.311 0.577 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.455 ' O ' ' CG2' ' A' ' 77' ' ' VAL . . . -51.65 -74.46 0.29 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 16.4 t -45.73 -32.54 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.22 -1.165 . . . . 0.0 110.092 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 72' ' ' ALA . 0.5 OUTLIER -62.39 -76.84 0.05 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.175 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.19 -42.72 41.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 0.0 109.797 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.455 ' CG2' ' O ' ' A' ' 73' ' ' GLY . 62.1 t -54.39 -53.81 27.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 O-C-N 121.103 -0.998 . . . . 0.0 108.916 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -42.76 -52.61 4.92 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.405 -0.809 . . . . 0.0 109.723 178.701 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 78' ' ' LEU . . . -44.89 -28.75 0.69 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.344 -0.848 . . . . 0.0 109.531 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.544 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 43.9 mm-40 -97.44 21.44 10.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.478 -0.764 . . . . 0.0 110.037 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.522 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 47.8 t -56.87 -13.09 2.32 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.506 -0.746 . . . . 0.0 109.093 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.49 ' O ' ' C ' ' A' ' 83' ' ' HIS . 7.0 ptt180 -103.07 -11.39 18.15 Favored 'General case' 0 C--N 1.31 -1.121 0 O-C-N 121.349 -0.845 . . . . 0.0 109.797 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.691 ' CE1' ' CE2' ' A' ' 39' ' ' TYR . 0.5 OUTLIER 29.63 51.65 0.08 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.877 -0.514 . . . . 0.0 112.127 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.524 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 3.6 tt0 -90.58 126.17 35.86 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.672 -1.268 . . . . 0.0 109.202 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.534 ' CD2' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -147.37 -79.73 0.15 Allowed 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.565 -179.141 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.531 ' O ' ' CD ' ' A' ' 88' ' ' LYS . 7.9 m-20 -85.33 49.89 1.84 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.502 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER 70.22 6.98 6.03 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.483 0.658 . . . . 0.0 109.557 -178.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.531 ' CD ' ' O ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -110.31 125.9 53.64 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.35 -0.844 . . . . 0.0 109.76 -179.594 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.487 ' O ' ' O ' ' A' ' 90' ' ' ILE . 9.3 t -99.77 75.45 1.9 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.577 -0.702 . . . . 0.0 109.562 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.594 ' HB ' ' CG ' ' A' ' 83' ' ' HIS . 0.9 OUTLIER -52.61 -174.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.372 -0.83 . . . . 0.0 109.181 -179.663 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 25' ' ' GLY . 20.4 t0 -142.26 85.3 10.82 Favored Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 120.565 -1.334 . . . . 0.0 111.684 -178.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.567 ' HG3' ' HD2' ' A' ' 83' ' ' HIS . 2.0 Cg_endo -59.98 113.44 1.65 Allowed 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.462 1.243 . . . . 0.0 110.757 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.616 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -123.67 108.77 12.92 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.03 -1.043 . . . . 0.0 109.774 178.073 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.534 ' CG2' ' HB2' ' A' ' 22' ' ' MET . 43.0 t -96.24 170.18 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.485 -0.76 . . . . 0.0 110.082 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.898 . . . . 0.0 110.284 -180.0 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.21 0.528 . . . . 0.0 110.088 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.643 ' CE ' ' CZ ' ' A' ' 68' ' ' PHE . 0.9 OUTLIER -86.15 -169.87 2.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.217 -0.927 . . . . 0.0 110.323 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.636 ' HB3' ' HD2' ' A' ' 93' ' ' LYS . 0.7 OUTLIER -149.97 152.1 34.4 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.355 -0.84 . . . . 0.0 109.466 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.543 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 1.1 mp -113.46 134.52 55.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.323 -0.86 . . . . 0.0 109.243 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.498 ' O ' ' CG2' ' A' ' 90' ' ' ILE . . . -102.51 136.86 13.05 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.812 -1.185 . . . . 0.0 110.699 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.466 ' C ' HG21 ' A' ' 90' ' ' ILE . . . 58.82 39.72 94.18 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.518 ' HA ' ' CG2' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -60.59 154.31 21.43 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.444 -1.033 . . . . 0.0 110.056 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.543 ' CB ' ' HB ' ' A' ' 31' ' ' THR . 0.5 OUTLIER -40.58 134.8 1.71 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.352 -0.843 . . . . 0.0 110.343 -179.673 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 11.0 p-90 -77.43 -12.26 59.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.342 -0.849 . . . . 0.0 110.63 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -110.93 -12.02 14.28 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.086 -1.009 . . . . 0.0 110.63 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.543 ' HB ' ' CB ' ' A' ' 28' ' ' SER . 13.2 t -61.42 -167.26 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.833 0 CA-C-O 121.628 0.728 . . . . 0.0 110.676 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.443 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 14.7 t -157.18 -168.1 2.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.695 -0.628 . . . . 0.0 109.751 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 36' ' ' LEU . 2.3 mt-30 -68.68 -72.46 0.18 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.082 -1.012 . . . . 0.0 110.207 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -48.33 -45.77 35.69 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.837 -1.165 . . . . 0.0 109.72 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.514 ' O ' ' HG3' ' A' ' 38' ' ' GLU . . . -55.62 -27.03 47.74 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 33' ' ' GLN . 0.1 OUTLIER -83.66 -32.68 25.5 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.082 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.467 ' HD3' ' SG ' ' A' ' 49' ' ' CYS . 18.8 mmm-85 -64.96 -28.71 69.7 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.514 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -90.55 -14.68 32.08 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.571 178.777 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.586 ' OH ' ' CG ' ' A' ' 83' ' ' HIS . 38.7 t80 -81.33 -26.34 35.68 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 121.619 -0.675 . . . . 0.0 110.171 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.521 ' HB3' ' CD2' ' A' ' 68' ' ' PHE . 14.6 m-85 -122.19 -21.51 5.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.887 . . . . 0.0 109.91 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.93 2.12 65.96 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -72.1 -55.78 6.74 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 121.426 -1.043 . . . . 0.0 109.971 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.32 12.66 26.15 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.4 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 45' ' ' GLU . . . -154.17 -116.2 0.59 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -179.74 104.39 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.532 -0.981 . . . . 0.0 109.349 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.57 ' HA ' ' CB ' ' A' ' 68' ' ' PHE . 2.7 p -90.03 149.46 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 111.266 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.77 -39.61 5.53 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.615 -0.678 . . . . 0.0 109.931 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -149.71 148.38 29.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.317 -0.864 . . . . 0.0 110.601 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.497 ' HB2' ' CD2' ' A' ' 36' ' ' LEU . 17.3 p -151.13 164.03 37.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.294 -0.879 . . . . 0.0 110.661 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.513 ' CD1' ' C ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -139.3 123.71 18.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.318 -0.864 . . . . 0.0 109.617 179.039 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.446 HG13 HD12 ' A' ' 27' ' ' LEU . 87.0 t -113.11 136.93 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.803 -1.185 . . . . 0.0 111.227 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.543 ' HG2' ' CE1' ' A' ' 63' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--N 1.302 -1.463 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 52' ' ' MET . . . . . . . . 0 N--CA 1.488 2.158 0 N-CA-C 109.346 -1.501 . . . . 0.0 109.346 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.543 ' CE1' ' HG2' ' A' ' 52' ' ' MET . 45.7 p90 -142.35 -164.32 1.79 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.293 -1.122 . . . . 0.0 110.223 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -162.54 114.09 0.59 Allowed Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.597 -1.287 . . . . 0.0 110.15 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.512 ' C ' ' CG2' ' A' ' 66' ' ' VAL . 13.4 m-85 -82.66 142.55 31.61 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.249 -1.148 . . . . 0.0 109.061 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.541 ' HB ' ' CE ' ' A' ' 22' ' ' MET . 5.7 t -150.01 114.9 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.91 -1.119 . . . . 0.0 110.582 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 7.2 t -88.17 32.31 0.77 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.388 -0.82 . . . . 0.0 109.829 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.643 ' CZ ' ' CE ' ' A' ' 22' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.868 . . . . 0.0 110.73 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.241 0.544 . . . . 0.0 110.313 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.4 -65.28 3.38 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 55.6 t -45.1 -31.0 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -1.106 . . . . 0.0 110.254 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -67.85 -61.42 1.88 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.212 -0.93 . . . . 0.0 110.413 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.403 ' O ' ' HB1' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -60.63 -46.88 88.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 110.35 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.525 HG23 ' CZ ' ' A' ' 68' ' ' PHE . 93.9 t -48.28 -62.38 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 O-C-N 121.062 -1.024 . . . . 0.0 109.255 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 81' ' ' SER . 0.1 OUTLIER -41.68 -51.31 4.1 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.338 -0.851 . . . . 0.0 109.897 179.035 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 78' ' ' LEU . . . -44.71 -25.98 0.34 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.211 -0.931 . . . . 0.0 109.548 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.613 ' HB3' ' CE1' ' A' ' 83' ' ' HIS . 7.0 mm-40 -99.91 20.0 15.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.424 -0.797 . . . . 0.0 110.386 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.535 ' HA ' ' HD2' ' A' ' 92' ' ' PRO . 25.2 p -58.07 -13.21 4.31 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.385 -0.822 . . . . 0.0 109.061 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -107.16 10.58 30.01 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.521 -0.737 . . . . 0.0 109.86 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.613 ' CE1' ' HB3' ' A' ' 80' ' ' GLN . 1.6 m-70 -21.88 83.52 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -178.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 82' ' ' ARG . 1.1 tt0 -103.69 122.74 45.67 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.465 HD23 ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -139.89 -89.83 0.18 Allowed 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.338 -0.851 . . . . 0.0 109.818 -178.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 87' ' ' SER . 53.8 t0 -78.14 53.7 1.25 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.126 -0.984 . . . . 0.0 108.356 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 70.98 9.11 6.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.627 -0.671 . . . . 0.0 109.719 -178.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 5.4 mmtt -111.7 113.99 26.71 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 121.286 -0.884 . . . . 0.0 110.25 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.526 ' O ' ' O ' ' A' ' 90' ' ' ILE . 6.8 t -90.37 68.96 6.94 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.532 HG13 ' HB3' ' A' ' 83' ' ' HIS . 1.2 mt -45.44 176.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 121.685 0.755 . . . . 0.0 109.86 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.464 ' HA ' ' O ' ' A' ' 81' ' ' SER . 5.3 t0 -144.88 77.31 13.38 Favored Pre-proline 0 C--N 1.296 -1.719 0 O-C-N 121.196 -0.94 . . . . 0.0 111.157 -178.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.569 ' HG3' ' CD2' ' A' ' 83' ' ' HIS . 2.0 Cg_endo -51.42 114.48 1.58 Allowed 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 123.446 1.235 . . . . 0.0 109.898 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.636 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -129.42 102.69 6.52 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.171 -0.956 . . . . 0.0 110.364 179.133 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.542 ' CG2' ' HB2' ' A' ' 22' ' ' MET . 95.2 t -97.31 161.61 2.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 O-C-N 121.757 -0.589 . . . . 0.0 110.063 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.175 -0.953 . . . . 0.0 110.582 -179.612 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.444 ' HE3' ' HB3' ' A' ' 65' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.287 0.565 . . . . 0.0 110.249 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.576 ' SD ' ' CD2' ' A' ' 68' ' ' PHE . 1.5 ptt? -86.31 176.97 7.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 110.197 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.593 ' HB3' ' HD2' ' A' ' 93' ' ' LYS . 3.1 t80 -150.51 154.36 37.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.167 -0.958 . . . . 0.0 110.393 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.617 ' CG2' ' CG2' ' A' ' 90' ' ' ILE . 1.3 mp -113.14 137.19 47.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.499 ' O ' HG21 ' A' ' 90' ' ' ILE . . . -112.84 140.29 16.21 Favored Glycine 0 N--CA 1.501 2.973 0 C-N-CA 119.31 -1.424 . . . . 0.0 112.951 -176.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.507 ' C ' HG21 ' A' ' 90' ' ' ILE . . . 59.66 47.06 92.79 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.567 ' HA ' ' CG2' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -79.24 146.47 33.01 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.315 -1.109 . . . . 0.0 111.506 -178.437 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.466 ' O ' HG21 ' A' ' 31' ' ' THR . 18.5 m -39.9 159.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.533 0.682 . . . . 0.0 110.763 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -92.32 -23.13 19.36 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.434 -0.791 . . . . 0.0 109.644 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.491 ' HG3' ' N ' ' A' ' 31' ' ' THR . 0.1 OUTLIER -83.78 -15.85 46.88 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.263 -0.898 . . . . 0.0 110.249 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.491 ' N ' ' HG3' ' A' ' 30' ' ' GLN . 10.5 t -55.51 -174.31 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.633 0.73 . . . . 0.0 110.598 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.5 t -161.24 -173.01 3.64 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.488 ' O ' ' N ' ' A' ' 36' ' ' LEU . 5.0 mt-30 -71.72 -74.61 0.15 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.998 -1.064 . . . . 0.0 110.781 -178.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.56 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 3.0 tt0 -49.6 -34.13 17.11 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.72 -1.237 . . . . 0.0 110.05 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.511 ' O ' ' HG3' ' A' ' 38' ' ' GLU . . . -60.72 -30.19 71.9 Favored Glycine 0 C--N 1.295 -1.719 0 N-CA-C 107.216 -2.354 . . . . 0.0 107.216 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.519 ' C ' ' CD1' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -82.51 -38.97 23.06 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.192 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.56 ' HG3' ' HA ' ' A' ' 34' ' ' GLU . 18.6 mtt180 -62.5 -27.0 68.84 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.505 1.145 . . . . 0.0 108.23 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -85.67 -21.05 28.54 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.127 179.694 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.661 ' CE1' ' NE2' ' A' ' 83' ' ' HIS . 9.9 t80 -81.94 -41.76 20.39 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.322 -0.861 . . . . 0.0 110.835 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.534 ' CE1' HG13 ' A' ' 77' ' ' VAL . 33.0 m-85 -100.3 -27.68 13.36 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.448 -0.783 . . . . 0.0 108.934 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -67.38 -9.52 55.06 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -64.64 -48.35 75.13 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.472 -1.016 . . . . 0.0 109.97 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.548 ' CG ' ' HB3' ' A' ' 76' ' ' LYS . 6.2 p90 -109.05 5.87 24.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.395 -0.815 . . . . 0.0 110.244 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.507 ' O ' ' HA2' ' A' ' 41' ' ' GLY . . . -162.76 97.74 0.15 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -38.8 124.25 1.35 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.473 -1.016 . . . . 0.0 110.745 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.548 ' HA ' ' CB ' ' A' ' 68' ' ' PHE . 47.7 t -90.07 132.16 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.384 -0.823 . . . . 0.0 110.74 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -98.67 -15.96 19.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.372 -0.83 . . . . 0.0 110.069 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -169.67 143.13 2.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.188 -0.945 . . . . 0.0 110.895 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.497 ' SG ' ' NE ' ' A' ' 37' ' ' ARG . 8.4 p -150.97 164.65 35.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.485 -0.759 . . . . 0.0 109.995 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.639 ' CD2' ' CD2' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -150.36 128.6 12.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.99 -1.069 . . . . 0.0 110.786 179.869 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.6 t -103.74 135.79 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 120.659 -1.275 . . . . 0.0 110.268 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.581 ' HG2' ' CE1' ' A' ' 63' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--N 1.306 -1.291 0 O-C-N 121.253 -0.904 . . . . 0.0 109.951 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.712 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.586 ' HB2' ' CE2' ' A' ' 23' ' ' PHE . 3.1 p90 -173.39 -174.46 1.02 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.138 -1.213 . . . . 0.0 111.05 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.417 ' O ' ' HB ' ' A' ' 24' ' ' ILE . . . -149.89 123.66 1.63 Allowed Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.639 ' CD2' ' CD2' ' A' ' 50' ' ' LEU . 18.1 m-85 -83.88 148.98 26.65 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.318 -1.107 . . . . 0.0 109.625 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 65' ' ' PHE . 3.7 t -146.44 161.92 9.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.316 -0.865 . . . . 0.0 109.621 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.442 ' CG2' ' CB ' ' A' ' 21' ' ' LYS . 1.8 m -149.56 39.6 0.81 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.198 -0.939 . . . . 0.0 110.229 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.585 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.151 -0.968 . . . . 0.0 109.858 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.142 0.496 . . . . 0.0 110.661 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.426 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -49.9 -57.24 10.07 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.462 ' O ' HD21 ' A' ' 78' ' ' LEU . 49.0 t -47.51 -43.54 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.235 -1.156 . . . . 0.0 110.32 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.533 ' HA ' ' CD2' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -59.58 -39.96 85.86 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.177 -0.952 . . . . 0.0 110.271 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.548 ' HB3' ' CG ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -71.07 -28.33 64.27 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.189 -0.944 . . . . 0.0 109.901 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.534 HG13 ' CE1' ' A' ' 40' ' ' PHE . 55.0 t -64.68 -64.42 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.139 -0.976 . . . . 0.0 109.576 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.533 ' CD2' ' HA ' ' A' ' 75' ' ' ASP . 1.5 pp -47.98 -37.98 15.88 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.109 -0.994 . . . . 0.0 109.185 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 78' ' ' LEU . . . -46.17 -30.14 1.83 Allowed 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.057 -1.027 . . . . 0.0 108.861 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.532 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 1.5 mt-30 -104.62 28.26 7.19 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.411 0.624 . . . . 0.0 109.741 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 78' ' ' LEU . 5.7 p -52.85 -18.52 1.95 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.492 ' O ' ' C ' ' A' ' 83' ' ' HIS . 4.5 ptt180 -94.49 -15.44 24.19 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.482 -0.761 . . . . 0.0 109.565 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.661 ' NE2' ' CE1' ' A' ' 39' ' ' TYR . 0.6 OUTLIER 28.72 46.31 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 179.303 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 0.8 OUTLIER -90.24 124.87 35.23 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 118.583 -1.247 . . . . 0.0 109.545 179.243 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.531 ' CD2' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -147.5 -83.63 0.11 Allowed 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 120.146 -0.621 . . . . 0.0 109.676 -179.493 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' A' ' 87' ' ' SER . 23.7 m-20 -83.18 50.73 1.8 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.11 -0.993 . . . . 0.0 108.818 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 72.63 7.19 5.54 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.472 0.653 . . . . 0.0 109.754 -179.188 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 0.6 OUTLIER -111.42 122.38 47.69 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.405 -0.809 . . . . 0.0 109.656 -179.529 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.471 ' O ' ' O ' ' A' ' 90' ' ' ILE . 9.4 t -101.9 69.43 1.18 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.062 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.617 ' CG2' ' CG2' ' A' ' 24' ' ' ILE . 0.9 OUTLIER -51.48 -176.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.346 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -143.39 84.4 10.19 Favored Pre-proline 0 C--N 1.304 -1.382 0 O-C-N 120.963 -1.086 . . . . 0.0 110.363 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.541 ' HG3' ' HD2' ' A' ' 83' ' ' HIS . 2.3 Cg_endo -56.03 113.42 1.43 Allowed 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.551 1.29 . . . . 0.0 111.167 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.593 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -127.71 104.46 7.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.233 -0.917 . . . . 0.0 109.575 178.385 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.533 ' CG1' ' HB3' ' A' ' 22' ' ' MET . 7.9 t -96.77 164.29 2.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 O-C-N 121.654 -0.654 . . . . 0.0 110.398 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.705 0 O-C-N 121.218 -0.926 . . . . 0.0 110.136 179.86 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.544 ' CB ' ' HB ' ' A' ' 67' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 120.992 0.425 . . . . 0.0 110.014 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.542 ' CG ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -71.76 -175.94 1.51 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.032 -1.042 . . . . 0.0 109.564 179.648 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.545 ' O ' ' HG2' ' A' ' 93' ' ' LYS . 2.0 t80 -149.03 119.16 7.21 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.076 -1.015 . . . . 0.0 111.487 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.522 ' CD1' ' HA ' ' A' ' 92' ' ' PRO . 17.4 mm -91.33 140.46 16.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.062 -1.024 . . . . 0.0 109.216 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 90' ' ' ILE . . . -119.23 149.42 18.08 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.669 -1.253 . . . . 0.0 111.303 -178.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.467 ' C ' HG22 ' A' ' 90' ' ' ILE . . . 55.97 43.65 87.88 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.532 ' HA ' ' CG2' ' A' ' 90' ' ' ILE . 0.2 OUTLIER -84.37 152.15 24.25 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.468 -1.019 . . . . 0.0 110.584 -179.027 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.53 ' O ' ' CG2' ' A' ' 31' ' ' THR . 14.5 m -41.73 124.66 2.6 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.459 -0.776 . . . . 0.0 110.32 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.496 ' CD2' ' N ' ' A' ' 30' ' ' GLN . 65.1 p-90 -68.2 -33.59 74.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.341 -0.85 . . . . 0.0 110.437 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.496 ' N ' ' CD2' ' A' ' 29' ' ' TRP . 17.8 pt20 -74.35 -12.56 60.56 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.324 -0.86 . . . . 0.0 111.2 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.53 ' CG2' ' O ' ' A' ' 28' ' ' SER . 5.7 t -65.05 -179.45 0.56 Allowed 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.34 -0.85 . . . . 0.0 110.37 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -148.2 -172.65 4.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.338 -0.851 . . . . 0.0 110.155 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 36' ' ' LEU . 6.5 mt-30 -66.2 -73.43 0.13 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.196 -0.94 . . . . 0.0 110.67 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.486 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 3.4 tt0 -47.46 -47.31 27.23 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.759 -1.176 . . . . 0.0 109.718 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.512 ' O ' ' HG3' ' A' ' 38' ' ' GLU . . . -53.36 -27.57 33.13 Favored Glycine 0 N--CA 1.483 1.799 0 N-CA-C 107.711 -2.156 . . . . 0.0 107.711 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.557 ' CD2' ' HB3' ' A' ' 49' ' ' CYS . 0.1 OUTLIER -83.37 -35.49 25.07 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.486 ' HG3' ' HA ' ' A' ' 34' ' ' GLU . 34.1 mtp180 -62.37 -28.34 69.7 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.512 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -90.88 -15.36 30.03 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.534 178.772 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.592 ' OH ' ' CG ' ' A' ' 83' ' ' HIS . 47.9 t80 -75.47 -29.12 59.51 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 121.55 0.69 . . . . 0.0 109.617 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.591 ' CE1' HG12 ' A' ' 77' ' ' VAL . 37.8 m-85 -116.29 -26.11 7.3 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.633 -0.667 . . . . 0.0 109.48 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -68.16 -9.27 56.94 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -71.51 -50.9 26.94 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.439 -1.036 . . . . 0.0 110.593 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 3.1 p90 -109.53 -6.85 15.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.096 -1.003 . . . . 0.0 110.747 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 40' ' ' PHE . . . -150.63 118.6 0.93 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 9.8 pt-20 -54.23 132.9 44.38 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.198 -1.178 . . . . 0.0 109.722 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.446 HG12 HG13 ' A' ' 66' ' ' VAL . 86.3 t -112.14 152.64 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.158 -0.963 . . . . 0.0 110.46 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.478 ' HB3' HG21 ' A' ' 67' ' ' THR . 0.0 OUTLIER -96.74 -29.84 13.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.355 -0.841 . . . . 0.0 109.826 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.461 ' O ' HG22 ' A' ' 67' ' ' THR . 11.6 tp10 -179.68 158.4 0.8 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.341 -0.85 . . . . 0.0 110.058 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.557 ' HB3' ' CD2' ' A' ' 36' ' ' LEU . 7.2 m -146.04 171.01 15.51 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.922 -1.112 . . . . 0.0 110.6 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.61 ' CD2' ' CD2' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -138.9 134.65 33.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.304 -0.873 . . . . 0.0 109.397 179.691 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.537 ' CG2' HD22 ' A' ' 36' ' ' LEU . 76.4 t -125.62 139.36 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.47 -1.394 . . . . 0.0 111.612 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.579 ' HG2' ' CE2' ' A' ' 63' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.485 1.323 0 O-C-N 121.347 -0.845 . . . . 0.0 109.747 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.487 ' O ' HD23 ' A' ' 27' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.579 ' CE2' ' HG2' ' A' ' 52' ' ' MET . 49.6 p90 -144.54 -167.95 2.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.139 -1.212 . . . . 0.0 110.29 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 50' ' ' LEU . . . -168.49 123.93 1.14 Allowed Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.569 -1.3 . . . . 0.0 110.199 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.61 ' CD2' ' CD2' ' A' ' 50' ' ' LEU . 27.5 m-85 -85.84 152.26 23.14 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.477 -1.013 . . . . 0.0 108.899 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.509 ' O ' ' HB2' ' A' ' 22' ' ' MET . 11.2 t -150.33 104.25 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.615 -1.303 . . . . 0.0 111.62 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.544 ' HB ' ' CB ' ' A' ' 21' ' ' LYS . 2.3 t -87.71 125.95 34.7 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.112 -0.993 . . . . 0.0 109.129 178.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.639 ' CE2' ' CG2' ' A' ' 77' ' ' VAL . 5.8 m-85 . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.027 -1.046 . . . . 0.0 109.986 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 73' ' ' GLY . . . . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.32 0.581 . . . . 0.0 110.084 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 72' ' ' ALA . . . -43.94 -42.67 6.57 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.425 HG13 HG11 ' A' ' 94' ' ' VAL . 21.3 t -64.76 -55.24 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -1.145 . . . . 0.0 110.15 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.478 ' HA ' HD23 ' A' ' 78' ' ' LEU . 10.8 m-20 -41.97 -40.97 2.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 110.206 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.441 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 33.7 mmtt -72.67 -46.6 53.06 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.422 -0.799 . . . . 0.0 110.186 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.639 ' CG2' ' CE2' ' A' ' 68' ' ' PHE . 58.0 t -53.06 -68.3 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.124 -0.985 . . . . 0.0 109.767 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.478 HD23 ' HA ' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -45.65 -39.01 7.32 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.061 -1.024 . . . . 0.0 109.209 179.123 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -48.88 -24.23 1.39 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.077 -1.014 . . . . 0.0 108.9 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.605 ' HB3' ' CE1' ' A' ' 83' ' ' HIS . 2.9 mm-40 -105.23 28.03 7.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.585 -0.697 . . . . 0.0 109.987 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.537 ' HA ' ' HD2' ' A' ' 92' ' ' PRO . 14.3 t -61.17 -10.79 7.13 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.448 -0.783 . . . . 0.0 109.123 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -108.49 11.1 27.11 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 121.418 -0.801 . . . . 0.0 109.896 179.646 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.605 ' CE1' ' HB3' ' A' ' 80' ' ' GLN . 1.7 m-70 -23.73 85.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -178.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 1.4 tt0 -106.99 121.41 44.41 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.615 ' CD1' ' N ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -142.35 -97.97 0.13 Allowed 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.991 -179.467 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.547 ' N ' HD21 ' A' ' 85' ' ' LEU . 25.4 t70 -69.73 55.64 0.13 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.834 -1.166 . . . . 0.0 108.741 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 70.42 8.37 6.59 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.445 -0.785 . . . . 0.0 110.138 -179.473 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.529 ' CD ' ' O ' ' A' ' 86' ' ' ASP . 2.3 mmmt -111.01 111.6 22.82 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.177 -0.952 . . . . 0.0 110.672 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.532 ' O ' ' O ' ' A' ' 90' ' ' ILE . 7.1 t -89.46 63.49 6.38 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.535 HG13 ' HB3' ' A' ' 83' ' ' HIS . 1.2 mt -42.65 172.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 CA-C-O 121.925 0.869 . . . . 0.0 110.277 -178.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.463 ' HA ' ' O ' ' A' ' 81' ' ' SER . 14.4 t0 -144.17 77.01 14.65 Favored Pre-proline 0 C--N 1.298 -1.637 0 O-C-N 121.32 -0.863 . . . . 0.0 110.786 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.586 ' HG3' ' CD2' ' A' ' 83' ' ' HIS . 1.9 Cg_endo -52.48 112.79 0.97 Allowed 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.514 1.27 . . . . 0.0 110.068 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.581 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 7.0 ptmt -109.43 105.56 14.96 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.627 1.203 . . . . 0.0 110.517 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.544 ' CG2' HG11 ' A' ' 77' ' ' VAL . 39.5 t -98.11 130.76 46.41 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 O-C-N 121.182 -0.949 . . . . 0.0 110.397 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.204 -0.935 . . . . 0.0 110.506 -179.697 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.549 ' CB ' ' OG1' ' A' ' 67' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.086 0.47 . . . . 0.0 110.137 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.562 ' SD ' ' CE1' ' A' ' 68' ' ' PHE . 3.1 ptm -121.1 -174.21 2.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.049 -1.032 . . . . 0.0 110.151 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.582 ' CD1' ' C ' ' A' ' 23' ' ' PHE . 0.3 OUTLIER -150.47 144.43 25.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.348 -0.845 . . . . 0.0 109.329 179.699 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.44 ' CG2' ' CG2' ' A' ' 90' ' ' ILE . 9.1 mm -108.03 129.26 62.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.122 -0.986 . . . . 0.0 109.475 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.496 ' O ' HG22 ' A' ' 90' ' ' ILE . . . -110.4 144.9 17.16 Favored Glycine 0 N--CA 1.494 2.545 0 C-N-CA 120.114 -1.041 . . . . 0.0 111.239 -178.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.442 ' C ' HG22 ' A' ' 90' ' ' ILE . . . 60.13 34.28 83.34 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.554 ' HA ' ' CG2' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -73.84 146.71 43.94 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.55 -0.971 . . . . 0.0 110.022 -179.608 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.46 ' C ' ' O ' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -39.74 132.83 1.63 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.598 -0.689 . . . . 0.0 110.3 -179.715 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.515 ' CD1' ' N ' ' A' ' 29' ' ' TRP . 0.5 OUTLIER -76.35 6.03 6.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.257 -0.902 . . . . 0.0 110.54 -179.799 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.442 ' O ' ' O ' ' A' ' 31' ' ' THR . 2.8 pt20 -124.47 -12.75 7.22 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.189 -0.944 . . . . 0.0 110.485 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.46 HG22 ' HG ' ' A' ' 27' ' ' LEU . 11.5 t -53.76 -168.7 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.603 -0.686 . . . . 0.0 110.379 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.3 t -145.16 176.15 9.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.446 -0.784 . . . . 0.0 109.748 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 36' ' ' LEU . 3.5 mt-30 -72.0 -72.58 0.22 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.111 -0.993 . . . . 0.0 111.105 -178.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.522 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -46.15 -52.85 11.49 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.672 -1.211 . . . . 0.0 109.436 -179.69 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.483 ' HA2' ' HG3' ' A' ' 38' ' ' GLU . . . -46.75 -32.69 5.99 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 107.822 -2.111 . . . . 0.0 107.822 178.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.53 ' N ' ' O ' ' A' ' 33' ' ' GLN . 0.1 OUTLIER -78.19 -39.34 40.96 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.317 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 34' ' ' GLU . 49.3 mtt180 -60.58 -26.07 66.68 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 122.316 1.055 . . . . 0.0 108.434 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -85.4 -21.28 28.88 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.787 179.513 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.694 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 29.4 t80 -79.97 -24.34 41.0 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.647 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.538 ' CE1' ' HE2' ' A' ' 22' ' ' MET . 25.4 m-85 -114.55 -19.13 11.27 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.332 -0.855 . . . . 0.0 109.104 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.17 -4.12 88.72 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 108.719 -1.753 . . . . 0.0 108.719 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -68.29 -53.05 27.04 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.352 -1.087 . . . . 0.0 110.034 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.412 ' CE1' ' HA ' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -99.41 9.39 43.38 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.277 -0.89 . . . . 0.0 110.259 179.492 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -152.68 -121.92 0.91 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.508 ' CG ' ' O ' ' A' ' 45' ' ' GLU . 5.9 pt-20 -172.08 119.44 0.42 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.385 -1.067 . . . . 0.0 109.687 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.545 ' HA ' ' CB ' ' A' ' 68' ' ' PHE . 28.1 t -93.25 124.09 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.335 -0.853 . . . . 0.0 111.124 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.86 -31.35 19.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.383 -0.823 . . . . 0.0 109.337 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -172.11 151.3 2.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.518 -0.739 . . . . 0.0 109.597 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.5 ' SG ' ' NE ' ' A' ' 37' ' ' ARG . 24.0 p -148.91 167.67 25.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.053 -1.029 . . . . 0.0 110.605 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.561 ' CD1' ' C ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -142.92 122.97 13.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.255 -0.903 . . . . 0.0 110.446 179.693 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.3 t -105.41 137.51 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.027 -1.046 . . . . 0.0 110.368 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.575 ' HG2' ' CZ ' ' A' ' 63' ' ' PHE . 1.9 ttt . . . . . 0 C--N 1.305 -1.343 0 O-C-N 121.33 -0.856 . . . . 0.0 110.064 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.483 ' C ' ' CD2' ' A' ' 27' ' ' LEU . . . . . . . . 0 N--CA 1.486 1.985 0 N-CA-C 109.149 -1.581 . . . . 0.0 109.149 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.575 ' CZ ' ' HG2' ' A' ' 52' ' ' MET . 12.4 p90 -149.82 -169.66 3.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -1.14 . . . . 0.0 110.288 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.456 ' CA ' ' O ' ' A' ' 50' ' ' LEU . . . -167.55 -161.99 18.32 Favored Glycine 0 N--CA 1.485 1.924 0 C-N-CA 119.507 -1.33 . . . . 0.0 110.303 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.49 ' O ' ' HB2' ' A' ' 49' ' ' CYS . 9.1 m-85 -146.23 143.4 29.2 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.769 -0.842 . . . . 0.0 109.074 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.519 HG23 ' CD1' ' A' ' 36' ' ' LEU . 14.1 t -147.85 97.08 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 120.805 -1.184 . . . . 0.0 110.752 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.549 ' OG1' ' CB ' ' A' ' 21' ' ' LYS . 22.7 m -80.68 58.43 3.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.368 -0.832 . . . . 0.0 109.929 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.562 ' CE1' ' SD ' ' A' ' 22' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 110.609 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.427 ' O ' ' NZ ' ' A' ' 76' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.309 0.576 . . . . 0.0 110.005 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.526 ' O ' ' CG2' ' A' ' 77' ' ' VAL . . . -53.67 -65.87 3.13 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.555 ' CG1' ' N ' ' A' ' 75' ' ' ASP . 2.2 p -39.94 -43.19 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.398 -1.06 . . . . 0.0 110.489 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.555 ' N ' ' CG1' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -58.65 -77.86 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.367 -0.833 . . . . 0.0 110.383 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.427 ' NZ ' ' O ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -48.47 -22.45 0.73 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.381 -0.824 . . . . 0.0 110.059 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 73' ' ' GLY . 55.4 t -71.72 -53.43 20.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.256 -0.903 . . . . 0.0 109.666 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.555 ' HG ' ' N ' ' A' ' 79' ' ' ALA . 1.3 pp -50.76 -28.95 10.25 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 120.918 -1.114 . . . . 0.0 108.196 178.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.555 ' N ' ' HG ' ' A' ' 78' ' ' LEU . . . -57.36 -20.03 26.61 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.525 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 1.0 OUTLIER -105.58 19.01 21.28 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.431 0.634 . . . . 0.0 109.481 179.233 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.539 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 46.3 t -53.38 -16.5 1.41 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.604 -0.839 . . . . 0.0 108.747 178.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.571 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -103.66 -2.43 26.59 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 121.358 -0.839 . . . . 0.0 109.618 178.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.694 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 0.3 OUTLIER 27.18 -85.09 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.705 0.764 . . . . 0.0 111.675 179.68 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.571 ' N ' ' O ' ' A' ' 82' ' ' ARG . 0.5 OUTLIER 54.66 122.14 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 122.205 1.002 . . . . 0.0 111.088 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.494 ' CD2' ' N ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -149.19 -92.08 0.07 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.394 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.561 ' O ' ' CB ' ' A' ' 87' ' ' SER . 7.7 t0 -82.54 54.28 2.58 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.067 -1.02 . . . . 0.0 108.495 178.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.561 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER 76.68 6.18 3.39 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.215 0.531 . . . . 0.0 109.975 -179.016 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -110.86 114.41 27.72 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.291 -0.88 . . . . 0.0 110.668 -179.351 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.475 ' O ' ' O ' ' A' ' 90' ' ' ILE . 9.7 t -89.14 76.98 7.64 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.805 -0.559 . . . . 0.0 109.805 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.6 ' HB ' ' CG ' ' A' ' 83' ' ' HIS . 1.5 mt -49.23 179.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.256 -0.903 . . . . 0.0 109.494 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 25' ' ' GLY . 8.0 t0 -140.72 79.55 19.24 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.328 -0.858 . . . . 0.0 110.1 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.539 ' HG2' ' HA ' ' A' ' 81' ' ' SER . 2.3 Cg_endo -54.61 111.94 0.87 Allowed 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.57 1.3 . . . . 0.0 110.749 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.581 ' HD2' ' CD1' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -127.59 103.12 7.15 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.866 0.841 . . . . 0.0 109.235 178.528 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.526 ' CG2' ' HB2' ' A' ' 22' ' ' MET . 15.8 t -97.11 170.48 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-O 121.349 0.595 . . . . 0.0 110.502 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.199 -0.938 . . . . 0.0 110.436 -179.801 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.401 ' HB2' ' HA ' ' A' ' 67' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.188 0.518 . . . . 0.0 110.325 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.569 ' SD ' ' CZ ' ' A' ' 68' ' ' PHE . 7.4 ttt -76.72 163.1 27.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.221 -0.924 . . . . 0.0 110.16 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.706 ' CG ' ' CE1' ' A' ' 65' ' ' PHE . 2.0 t80 -141.64 129.08 21.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.295 -0.878 . . . . 0.0 109.597 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.6 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 1.4 mp -106.48 155.87 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.115 -0.99 . . . . 0.0 109.289 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.57 ' O ' ' N ' ' A' ' 91' ' ' ASP . . . -139.21 139.08 9.8 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 119.245 -1.455 . . . . 0.0 111.42 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.466 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 105.51 27.26 5.86 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.525 ' CD2' HG12 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -50.45 118.58 3.12 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.792 -0.828 . . . . 0.0 110.864 -179.588 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.526 ' HB2' ' CB ' ' A' ' 88' ' ' LYS . 1.4 t -59.43 178.52 0.14 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.38 -0.825 . . . . 0.0 110.212 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.568 ' O ' ' CE3' ' A' ' 29' ' ' TRP . 35.1 p-90 -84.85 15.69 3.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.177 -0.952 . . . . 0.0 110.1 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -143.92 7.45 1.42 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.241 -0.912 . . . . 0.0 110.936 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.9 m -70.66 157.08 38.61 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.125 -0.984 . . . . 0.0 109.892 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.54 ' CG2' ' HA3' ' A' ' 35' ' ' GLY . 4.4 t -127.48 178.04 6.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.083 -1.01 . . . . 0.0 109.922 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.524 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 6.0 mt-30 -88.76 -73.69 0.49 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.15 -0.969 . . . . 0.0 110.734 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.55 ' HG2' ' CD ' ' A' ' 37' ' ' ARG . 0.1 OUTLIER -50.78 -49.67 57.73 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 117.967 -1.493 . . . . 0.0 108.929 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.54 ' HA3' ' CG2' ' A' ' 32' ' ' THR . . . -49.39 -27.72 8.48 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 107.603 -2.199 . . . . 0.0 107.603 178.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.503 ' C ' ' CD1' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -80.69 -32.02 36.06 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.478 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.55 ' CD ' ' HG2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -60.46 -34.79 74.52 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 177.475 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.517 ' HG2' ' HG2' ' A' ' 37' ' ' ARG . 2.0 mt-10 -76.63 -25.44 53.82 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 113.912 -1.494 . . . . 0.0 109.863 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.63 ' CE1' ' NE2' ' A' ' 83' ' ' HIS . 8.0 t80 -75.81 -25.01 55.95 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.511 -0.743 . . . . 0.0 110.82 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.481 ' O ' ' CE1' ' A' ' 43' ' ' PHE . 16.3 m-85 -113.69 -17.86 12.02 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.324 -0.86 . . . . 0.0 109.118 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -79.73 -5.53 89.37 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 108.496 -1.842 . . . . 0.0 108.496 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -63.58 -45.27 91.16 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.492 -1.005 . . . . 0.0 109.888 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.524 ' CD2' ' HB3' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -108.16 1.54 22.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.449 -0.782 . . . . 0.0 110.189 179.608 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.472 ' O ' ' HA2' ' A' ' 41' ' ' GLY . . . -149.64 179.49 26.37 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.609 -1.281 . . . . 0.0 109.933 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 0.4 OUTLIER -101.16 121.18 41.38 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.34 -1.094 . . . . 0.0 110.086 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.535 ' HA ' ' CB ' ' A' ' 68' ' ' PHE . 43.1 t -97.69 121.62 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.131 -0.981 . . . . 0.0 110.651 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . 35.8 tptt -88.91 -36.31 16.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.308 -0.87 . . . . 0.0 109.987 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -161.58 161.28 29.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 0.0 110.328 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 7.6 p -150.12 165.55 32.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.29 -0.881 . . . . 0.0 109.712 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.634 ' CD2' ' CD2' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -149.67 132.93 16.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.049 -1.032 . . . . 0.0 110.751 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.525 HG12 ' CD2' ' A' ' 27' ' ' LEU . 79.3 t -121.85 131.72 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.56 -1.338 . . . . 0.0 110.423 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 2.5 ttm . . . . . 0 C--N 1.305 -1.366 0 O-C-N 121.356 -0.84 . . . . 0.0 109.962 -179.751 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.075 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.486 ' O ' ' CD2' ' A' ' 27' ' ' LEU . 20.4 p90 -148.4 -176.9 5.48 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.277 -1.131 . . . . 0.0 110.537 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.491 ' N ' HD11 ' A' ' 27' ' ' LEU . . . -142.58 162.83 27.31 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.706 ' CE1' ' CG ' ' A' ' 23' ' ' PHE . 14.2 m-85 -128.28 154.18 46.18 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.404 -1.057 . . . . 0.0 109.41 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.497 ' CG2' ' C ' ' A' ' 65' ' ' PHE . 15.3 t -149.87 110.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.058 -1.026 . . . . 0.0 110.64 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.401 ' HA ' ' HB2' ' A' ' 21' ' ' LYS . 84.9 m -89.11 49.93 1.86 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.294 -0.879 . . . . 0.0 109.98 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.569 ' CZ ' ' SD ' ' A' ' 22' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.412 -0.805 . . . . 0.0 110.818 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 75' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.36 0.6 . . . . 0.0 109.996 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.531 ' O ' ' CG2' ' A' ' 77' ' ' VAL . . . -57.1 -70.44 0.98 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.436 ' C ' ' O ' ' A' ' 73' ' ' GLY . 98.5 t -41.9 -29.06 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.355 -1.085 . . . . 0.0 110.247 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.553 ' HA ' ' CD2' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -66.28 -80.64 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 0.0 109.898 179.744 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.524 ' HB3' ' CD2' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -47.73 -24.7 1.01 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.232 -0.917 . . . . 0.0 109.07 179.337 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.568 ' CG1' ' CE ' ' A' ' 22' ' ' MET . 78.1 t -68.74 -55.22 16.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.472 -0.767 . . . . 0.0 109.703 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.567 ' HG ' ' N ' ' A' ' 79' ' ' ALA . 1.1 pp -48.78 -28.48 3.69 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 120.835 -1.166 . . . . 0.0 108.48 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.567 ' N ' ' HG ' ' A' ' 78' ' ' LEU . . . -52.13 -32.6 36.23 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.559 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 5.4 mm-40 -99.43 24.04 8.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.781 -0.574 . . . . 0.0 109.499 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.484 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 9.8 t -49.95 -18.76 0.57 Allowed 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.092 178.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.486 ' O ' ' C ' ' A' ' 83' ' ' HIS . 0.2 OUTLIER -103.52 -7.55 20.77 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.342 -0.849 . . . . 0.0 109.841 179.45 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.63 ' NE2' ' CE1' ' A' ' 39' ' ' TYR . 0.5 OUTLIER 32.22 36.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.95 -0.469 . . . . 0.0 111.272 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 1.4 tt0 -87.14 120.26 28.22 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.594 -1.243 . . . . 0.0 110.237 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.529 ' CD2' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -151.7 -83.48 0.09 Allowed 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.679 -0.638 . . . . 0.0 110.133 -179.626 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.518 ' O ' ' CB ' ' A' ' 87' ' ' SER . 0.2 OUTLIER -79.81 53.08 1.57 Allowed 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.106 -0.996 . . . . 0.0 109.289 179.473 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 71.01 2.83 4.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.565 -0.709 . . . . 0.0 110.256 -179.796 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -110.96 124.85 52.95 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.257 -0.902 . . . . 0.0 110.246 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.498 ' O ' ' CG2' ' A' ' 89' ' ' THR . 15.1 t -104.77 63.93 0.73 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.523 -0.736 . . . . 0.0 110.133 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.582 ' HB ' ' CG ' ' A' ' 83' ' ' HIS . 0.6 OUTLIER -52.23 -176.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.35 -0.843 . . . . 0.0 108.887 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.57 ' N ' ' O ' ' A' ' 25' ' ' GLY . 13.0 t0 -143.82 87.23 8.22 Favored Pre-proline 0 N--CA 1.485 1.288 0 O-C-N 120.547 -1.346 . . . . 0.0 110.764 -178.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.559 ' CG ' ' O ' ' A' ' 80' ' ' GLN . 2.2 Cg_endo -58.42 111.79 0.98 Allowed 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.633 1.333 . . . . 0.0 111.317 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.603 ' HE2' ' CD2' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -130.41 117.51 19.81 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.383 -0.823 . . . . 0.0 109.262 178.26 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.443 HG23 ' HG3' ' A' ' 22' ' ' MET . 61.8 t -97.3 174.6 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 O-C-N 121.581 -0.699 . . . . 0.0 110.049 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.435 ' N ' HG12 ' A' ' 94' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 109.855 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.537 ' CB ' HG23 ' A' ' 67' ' ' THR . 11.6 ptmt . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.337 0.589 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.53 ' CG ' ' O ' ' A' ' 66' ' ' VAL . 12.7 ptm -123.21 175.8 6.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.441 -0.787 . . . . 0.0 110.041 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.573 ' CD2' ' O ' ' A' ' 64' ' ' GLY . 1.4 t80 -146.58 158.35 43.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.367 -0.833 . . . . 0.0 109.886 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.575 HD12 ' CZ ' ' A' ' 40' ' ' PHE . 18.3 mm -115.92 134.78 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.31 -0.868 . . . . 0.0 109.124 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.523 ' O ' HG22 ' A' ' 90' ' ' ILE . . . -113.3 141.68 17.05 Favored Glycine 0 N--CA 1.495 2.601 0 C-N-CA 119.731 -1.223 . . . . 0.0 112.285 -177.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.499 ' C ' HG22 ' A' ' 90' ' ' ILE . . . 60.28 41.91 98.54 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.59 ' HA ' ' CG2' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -77.45 153.87 33.14 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.62 -0.929 . . . . 0.0 111.163 -178.742 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.532 ' CB ' ' HB ' ' A' ' 31' ' ' THR . 0.4 OUTLIER -39.43 130.73 1.72 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.368 0.604 . . . . 0.0 110.518 -179.301 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 64.9 p-90 -68.81 -28.12 66.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.349 -0.844 . . . . 0.0 110.635 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.454 ' O ' ' O ' ' A' ' 31' ' ' THR . 2.3 pt20 -88.78 -14.76 36.33 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.083 -1.011 . . . . 0.0 110.721 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.532 ' HB ' ' CB ' ' A' ' 28' ' ' SER . 1.3 t -53.08 -169.02 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.642 -0.661 . . . . 0.0 110.364 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.496 ' N ' HG22 ' A' ' 31' ' ' THR . 15.0 t -157.62 -166.75 2.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.334 -0.854 . . . . 0.0 109.85 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 36' ' ' LEU . 3.6 mt-30 -79.9 -72.92 0.38 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.149 -0.969 . . . . 0.0 110.118 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.534 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -48.07 -44.28 31.36 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.759 -1.176 . . . . 0.0 108.551 179.302 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.492 ' HA2' ' HG3' ' A' ' 38' ' ' GLU . . . -48.14 -35.27 13.64 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 107.566 -2.214 . . . . 0.0 107.566 178.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 33' ' ' GLN . 0.1 OUTLIER -75.76 -40.07 55.98 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.301 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.481 ' CG ' ' HA ' ' A' ' 34' ' ' GLU . 50.0 mtp180 -59.42 -25.66 64.52 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 122.47 1.129 . . . . 0.0 108.421 178.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.534 ' CG ' ' O ' ' A' ' 34' ' ' GLU . 1.5 mt-10 -84.56 -21.93 30.27 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.688 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 21.0 t80 -84.56 -48.36 9.63 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.795 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.582 ' HA ' ' CZ ' ' A' ' 43' ' ' PHE . 28.1 m-85 -95.17 -33.48 12.61 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.355 -0.841 . . . . 0.0 109.321 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -65.8 -17.49 65.11 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -58.83 -45.2 90.56 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.417 -1.049 . . . . 0.0 109.276 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.582 ' CZ ' ' HA ' ' A' ' 40' ' ' PHE . 4.5 p90 -117.83 -12.82 10.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.566 -0.709 . . . . 0.0 109.493 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.471 ' O ' ' HA2' ' A' ' 41' ' ' GLY . . . -133.99 87.01 0.26 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.531 ' O ' ' CB ' ' A' ' 68' ' ' PHE . 4.0 pm0 -41.18 104.39 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.417 -1.049 . . . . 0.0 110.357 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.533 HG22 ' CG1' ' A' ' 66' ' ' VAL . 2.9 p -89.42 142.5 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.228 -0.92 . . . . 0.0 110.519 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.62 -23.68 9.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.873 . . . . 0.0 109.677 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.25 126.59 37.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.407 -0.808 . . . . 0.0 110.173 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.485 ' HB2' ' CD2' ' A' ' 36' ' ' LEU . 3.4 p -150.13 152.14 34.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.076 -1.015 . . . . 0.0 110.253 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.662 ' CD2' ' CD2' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -149.99 134.33 17.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.048 -1.033 . . . . 0.0 110.65 179.739 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 78.4 t -117.16 134.81 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.543 -1.348 . . . . 0.0 110.732 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.491 ' HE3' ' CE1' ' A' ' 63' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.303 -1.437 0 O-C-N 121.423 -0.798 . . . . 0.0 109.44 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.327 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 23' ' ' PHE . 20.8 p90 -156.35 -162.94 1.35 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.131 -1.217 . . . . 0.0 110.26 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.573 ' O ' ' CD2' ' A' ' 23' ' ' PHE . . . -166.84 -179.97 40.29 Favored Glycine 0 N--CA 1.489 2.18 0 C-N-CA 119.536 -1.316 . . . . 0.0 110.296 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.662 ' CD2' ' CD2' ' A' ' 50' ' ' LEU . 10.4 m-85 -129.28 152.98 48.26 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.833 -0.804 . . . . 0.0 109.267 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.533 ' CG1' HG22 ' A' ' 46' ' ' VAL . 3.5 t -150.05 145.1 17.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 120.986 -1.071 . . . . 0.0 110.181 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.537 HG23 ' CB ' ' A' ' 21' ' ' LYS . 3.2 m -151.1 99.23 2.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.207 -0.933 . . . . 0.0 110.717 -179.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.571 ' CZ ' HG22 ' A' ' 77' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.152 -0.967 . . . . 0.0 109.589 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.291 0.567 . . . . 0.0 110.03 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.475 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -59.36 -82.34 0.06 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.487 ' O ' HD11 ' A' ' 78' ' ' LEU . 17.9 m -41.67 -48.3 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.296 -1.12 . . . . 0.0 110.534 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 74' ' ' VAL . 21.6 m-20 -42.22 -68.15 0.21 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.036 -1.04 . . . . 0.0 110.45 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.574 ' HB3' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -59.14 -37.03 76.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.442 -0.786 . . . . 0.0 110.449 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.571 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 58.9 t -56.21 -59.71 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 121.142 -0.974 . . . . 0.0 109.911 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.564 ' CD1' ' N ' ' A' ' 78' ' ' LEU . 2.4 mp -46.03 -40.73 11.03 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.499 ' CB ' ' O ' ' A' ' 76' ' ' LYS . . . -43.18 -36.37 1.71 Allowed 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.584 0.707 . . . . 0.0 109.55 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.573 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 7.3 mm100 -102.57 27.61 6.74 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.483 -0.76 . . . . 0.0 109.505 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.561 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 65.9 p -45.56 -21.32 0.1 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.562 -0.711 . . . . 0.0 109.131 178.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.486 ' O ' ' O ' ' A' ' 83' ' ' HIS . 1.2 ptp180 -106.13 -19.66 13.65 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.463 -0.773 . . . . 0.0 110.279 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.688 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 0.2 OUTLIER 52.13 165.47 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.279 -0.888 . . . . 0.0 111.014 179.898 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.56 ' C ' ' CD1' ' A' ' 85' ' ' LEU . 1.2 tt0 175.37 119.74 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.599 0.714 . . . . 0.0 110.389 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.621 ' CD2' ' N ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -141.03 -86.49 0.18 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.575 -0.703 . . . . 0.0 109.172 178.417 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.536 ' O ' ' CB ' ' A' ' 87' ' ' SER . 0.1 OUTLIER -84.42 53.25 2.59 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.054 -1.029 . . . . 0.0 108.662 178.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 71.22 9.68 6.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.49 -0.756 . . . . 0.0 109.274 -178.769 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 10.3 mmtt -107.17 121.79 45.23 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.519 -0.738 . . . . 0.0 109.806 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 83' ' ' HIS . 15.3 t -97.31 78.42 2.72 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.393 -0.817 . . . . 0.0 109.554 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.607 ' HB ' ' CG ' ' A' ' 83' ' ' HIS . 1.1 mt -47.65 -177.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-O 121.433 0.635 . . . . 0.0 110.335 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -139.39 78.19 27.92 Favored Pre-proline 0 C--N 1.305 -1.355 0 O-C-N 121.108 -0.995 . . . . 0.0 110.566 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.613 ' HG3' ' HD2' ' A' ' 83' ' ' HIS . 2.3 Cg_endo -53.31 112.48 0.95 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.44 1.232 . . . . 0.0 110.964 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.558 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -117.06 99.78 7.29 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.287 -0.883 . . . . 0.0 109.698 178.434 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.51 ' CG1' ' HB3' ' A' ' 22' ' ' MET . 22.3 t -97.01 157.35 3.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 O-C-N 121.757 -0.589 . . . . 0.0 110.157 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.71 0 O-C-N 121.207 -0.933 . . . . 0.0 110.468 -179.711 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.476 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 5.2 pttt . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.342 0.592 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.537 ' CG ' ' N ' ' A' ' 23' ' ' PHE . 36.5 ttp -86.07 172.67 10.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.359 -0.838 . . . . 0.0 110.307 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.628 ' CZ ' ' CB ' ' A' ' 63' ' ' PHE . 1.3 t80 -148.62 139.39 22.88 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.332 -0.855 . . . . 0.0 109.268 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.573 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 1.3 mp -110.36 130.62 63.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 121.319 -0.863 . . . . 0.0 108.792 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.529 ' O ' HG21 ' A' ' 90' ' ' ILE . . . -95.73 120.53 6.58 Favored Glycine 0 N--CA 1.497 2.723 0 C-N-CA 120.028 -1.082 . . . . 0.0 113.145 -176.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.548 ' C ' HG21 ' A' ' 90' ' ' ILE . . . 76.67 28.24 59.62 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 177.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.59 ' HA ' HG23 ' A' ' 90' ' ' ILE . 1.4 pt? -49.43 142.51 7.68 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.376 -1.073 . . . . 0.0 110.383 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.539 ' O ' ' CG2' ' A' ' 31' ' ' THR . 2.3 m -39.42 121.35 1.17 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.486 0.66 . . . . 0.0 110.465 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 49.9 p-90 -58.88 -28.87 66.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.298 -0.876 . . . . 0.0 110.388 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -82.64 -13.7 56.01 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.195 -0.941 . . . . 0.0 110.642 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.539 ' CG2' ' O ' ' A' ' 28' ' ' SER . 3.0 t -63.64 -169.6 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.501 -0.749 . . . . 0.0 110.291 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.4 t -154.06 -169.92 3.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.445 -0.785 . . . . 0.0 109.922 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 36' ' ' LEU . 17.7 mt-30 -74.48 -73.05 0.25 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.121 -0.987 . . . . 0.0 110.389 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -47.84 -42.9 27.47 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.883 -1.136 . . . . 0.0 109.758 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.508 ' O ' ' HG3' ' A' ' 38' ' ' GLU . . . -55.54 -30.18 55.32 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 107.699 -2.161 . . . . 0.0 107.699 178.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.533 ' CD1' HG23 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -82.1 -37.57 26.13 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.137 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.491 ' HD2' ' CG1' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -62.86 -25.22 68.18 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 122.536 1.16 . . . . 0.0 108.503 178.487 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.508 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -90.39 -19.07 24.39 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.977 -1.011 . . . . 0.0 108.597 179.497 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.66 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 6.4 t80 -81.42 -26.61 35.25 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 121.457 -0.777 . . . . 0.0 110.334 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.523 ' CD1' ' HE3' ' A' ' 22' ' ' MET . 39.0 m-85 -118.59 -17.72 9.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.403 -0.811 . . . . 0.0 109.371 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -75.69 -21.08 77.57 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.589 ' HG3' ' CD2' ' A' ' 43' ' ' PHE . 15.9 pt20 -63.06 -32.48 73.87 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.486 -1.008 . . . . 0.0 109.421 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.589 ' CD2' ' HG3' ' A' ' 42' ' ' GLN . 4.8 p90 -130.39 1.36 4.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.37 -0.831 . . . . 0.0 109.645 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 40' ' ' PHE . . . -143.77 95.27 0.18 Allowed Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 42.3 mt-10 -40.05 110.0 0.13 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.326 -1.102 . . . . 0.0 110.774 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.54 ' HA ' ' CB ' ' A' ' 68' ' ' PHE . 70.7 t -91.16 129.43 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.389 -0.819 . . . . 0.0 110.733 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 67' ' ' THR . 0.5 OUTLIER -93.48 -33.6 13.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.406 -0.809 . . . . 0.0 109.607 179.467 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.446 ' HA ' ' OE1' ' A' ' 48' ' ' GLU . 11.3 tp10 -171.29 153.96 3.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.548 -0.72 . . . . 0.0 109.188 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.488 ' HB2' HD21 ' A' ' 36' ' ' LEU . 15.6 p -150.81 157.06 42.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.06 -1.025 . . . . 0.0 111.107 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.555 ' HG ' ' HB2' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -130.52 124.11 31.17 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.427 -0.796 . . . . 0.0 108.95 178.704 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.515 ' CG1' HD11 ' A' ' 27' ' ' LEU . 89.6 t -112.57 142.75 23.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 120.453 -1.404 . . . . 0.0 112.062 -178.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.576 ' SD ' ' CE2' ' A' ' 63' ' ' PHE . 1.9 ttm . . . . . 0 C--N 1.302 -1.458 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.47 ' O ' HD23 ' A' ' 27' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 107.827 -2.109 . . . . 0.0 107.827 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.628 ' CB ' ' CZ ' ' A' ' 23' ' ' PHE . 14.4 p90 -134.63 -167.86 2.05 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.428 -1.042 . . . . 0.0 111.428 -178.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -158.7 116.72 0.73 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.555 ' HB2' ' HG ' ' A' ' 50' ' ' LEU . 12.7 m-85 -82.99 140.97 32.44 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.483 -1.01 . . . . 0.0 108.863 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.533 HG23 ' CD1' ' A' ' 36' ' ' LEU . 2.9 t -147.34 99.36 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 120.943 -1.098 . . . . 0.0 110.239 -178.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.476 ' HB ' ' HB3' ' A' ' 21' ' ' LYS . 7.9 t -80.58 64.01 5.22 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 110.734 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.54 ' CB ' ' HA ' ' A' ' 46' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.193 -0.942 . . . . 0.0 110.745 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.455 ' O ' ' HB3' ' A' ' 75' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.329 0.585 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.472 ' O ' HG22 ' A' ' 77' ' ' VAL . . . -46.49 -61.25 4.27 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.492 ' O ' ' CD1' ' A' ' 78' ' ' LEU . 71.3 t -43.17 -48.47 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.191 -1.182 . . . . 0.0 110.197 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.455 ' HB3' ' O ' ' A' ' 72' ' ' ALA . 34.8 t70 -47.94 -56.92 6.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.971 -1.081 . . . . 0.0 110.153 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -59.73 -30.66 68.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.39 -0.819 . . . . 0.0 110.15 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.491 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 41.7 t -63.01 -58.17 8.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.113 -0.992 . . . . 0.0 109.279 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.492 ' CD1' ' O ' ' A' ' 74' ' ' VAL . 1.3 mp -45.88 -44.39 14.43 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.324 -0.86 . . . . 0.0 108.962 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.445 ' HB2' ' O ' ' A' ' 76' ' ' LYS . . . -45.96 -28.53 1.16 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.209 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.53 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 22.3 mm100 -103.76 25.53 9.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.512 -0.742 . . . . 0.0 109.898 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.5 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 23.7 t -54.43 -16.16 2.12 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.488 ' O ' ' C ' ' A' ' 83' ' ' HIS . 5.2 ptp180 -95.95 -18.15 20.49 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 121.501 -0.749 . . . . 0.0 109.533 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.66 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 0.6 OUTLIER 31.51 41.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.81 -0.556 . . . . 0.0 111.795 179.484 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 0.7 OUTLIER -86.93 122.41 30.75 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 118.619 -1.233 . . . . 0.0 110.192 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.548 ' CD2' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -144.62 -85.81 0.13 Allowed 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.626 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 87' ' ' SER . 0.6 OUTLIER -82.28 52.92 2.13 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.21 -0.931 . . . . 0.0 108.753 179.05 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 1.4 t 71.33 5.84 5.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.599 -0.688 . . . . 0.0 109.651 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.552 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 10.7 mmmt -108.02 119.54 39.76 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.357 -0.839 . . . . 0.0 109.808 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.529 ' O ' ' CG2' ' A' ' 89' ' ' THR . 15.1 t -101.41 68.62 1.21 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.608 -0.682 . . . . 0.0 109.646 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.622 ' HB ' ' CG ' ' A' ' 83' ' ' HIS . 1.2 mm -51.7 -175.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.419 -0.801 . . . . 0.0 109.803 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -143.67 83.73 10.41 Favored Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.303 -0.873 . . . . 0.0 109.877 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.53 ' CG ' ' O ' ' A' ' 80' ' ' GLN . 2.3 Cg_endo -53.22 112.32 0.9 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.553 1.291 . . . . 0.0 110.965 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.588 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -130.16 111.76 12.75 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.486 -0.759 . . . . 0.0 109.546 178.746 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.522 ' CG1' ' HB2' ' A' ' 22' ' ' MET . 3.8 t -95.66 -174.01 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.525 -0.734 . . . . 0.0 110.018 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.175 -0.953 . . . . 0.0 110.358 -179.794 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.528 ' HB2' ' CG2' ' A' ' 67' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.187 0.517 . . . . 0.0 109.841 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.512 ' HG3' ' CG2' ' A' ' 94' ' ' VAL . 5.3 tmm? -68.83 157.77 35.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.105 -0.997 . . . . 0.0 109.854 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.605 ' CG ' ' CE1' ' A' ' 65' ' ' PHE . 6.8 t80 -141.02 144.49 35.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.229 -0.919 . . . . 0.0 109.984 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.557 ' CG2' ' CG2' ' A' ' 90' ' ' ILE . 20.1 mm -108.87 137.76 39.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.314 -0.866 . . . . 0.0 109.232 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.491 ' O ' HG23 ' A' ' 90' ' ' ILE . . . -118.1 144.17 17.99 Favored Glycine 0 N--CA 1.495 2.576 0 C-N-CA 119.647 -1.263 . . . . 0.0 111.464 -177.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 90' ' ' ILE . . . 59.08 42.05 96.83 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.583 ' HA ' ' CG2' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -79.69 156.51 27.53 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.452 -1.028 . . . . 0.0 110.939 -179.072 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.485 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -39.4 142.27 0.29 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.458 0.647 . . . . 0.0 110.735 -179.097 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 47.0 p-90 -85.58 2.57 44.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.496 -0.753 . . . . 0.0 110.332 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.469 ' O ' ' O ' ' A' ' 31' ' ' THR . 14.8 pt20 -121.77 -14.41 8.12 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.212 -0.93 . . . . 0.0 110.424 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 30' ' ' GLN . 14.8 t -53.3 -168.65 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.646 -0.659 . . . . 0.0 110.26 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.0 t -153.91 -176.1 5.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.279 -0.888 . . . . 0.0 110.034 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 36' ' ' LEU . 4.9 mt-30 -69.5 -75.01 0.12 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.045 -1.034 . . . . 0.0 110.818 -179.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.469 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 7.9 tt0 -47.22 -40.46 16.31 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.817 -1.177 . . . . 0.0 110.051 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.53 ' O ' ' HG3' ' A' ' 38' ' ' GLU . . . -56.53 -32.71 61.41 Favored Glycine 0 N--CA 1.484 1.833 0 N-CA-C 107.32 -2.312 . . . . 0.0 107.32 178.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.541 ' N ' ' O ' ' A' ' 33' ' ' GLN . 0.1 OUTLIER -79.87 -38.8 31.93 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.122 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.469 ' HG3' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -61.81 -25.27 67.39 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 122.43 1.109 . . . . 0.0 108.764 178.501 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.53 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -88.66 -18.58 27.64 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.69 179.543 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.694 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 24.1 t80 -82.96 -28.02 30.09 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.348 -0.845 . . . . 0.0 110.564 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.559 ' CE1' HG12 ' A' ' 77' ' ' VAL . 39.2 m-85 -116.51 -22.53 8.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.208 -0.932 . . . . 0.0 109.457 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.52 ' CA ' HG21 ' A' ' 46' ' ' VAL . . . -72.15 -13.27 76.39 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -66.45 -36.96 84.08 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.416 -1.049 . . . . 0.0 109.713 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.575 ' CD1' ' HB3' ' A' ' 76' ' ' LYS . 9.7 p90 -125.71 7.86 7.54 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.503 -0.748 . . . . 0.0 109.828 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.479 ' O ' ' HA2' ' A' ' 41' ' ' GLY . . . -153.33 98.11 0.18 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 44' ' ' GLY . 8.5 pt-20 -39.79 124.49 1.73 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.526 -0.985 . . . . 0.0 110.26 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.52 HG21 ' CA ' ' A' ' 41' ' ' GLY . 3.3 t -98.43 126.06 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.22 -0.925 . . . . 0.0 110.453 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 1.6 mmtm -88.77 -27.6 21.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.365 -0.834 . . . . 0.0 109.498 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 12.1 pt-20 179.67 147.34 0.24 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.464 -0.772 . . . . 0.0 110.09 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 19.5 p -140.59 176.59 8.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.158 -0.964 . . . . 0.0 110.531 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.58 ' CD2' ' CD2' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -147.74 124.64 11.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.3 -0.875 . . . . 0.0 110.148 179.416 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 69.9 t -116.24 131.45 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.716 -1.24 . . . . 0.0 110.883 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 1.2 ttm . . . . . 0 N--CA 1.487 1.401 0 O-C-N 121.526 -0.734 . . . . 0.0 109.523 179.793 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.422 ' O ' HD23 ' A' ' 27' ' ' LEU . . . . . . . . 0 N--CA 1.492 2.418 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.504 ' HB2' ' CE1' ' A' ' 23' ' ' PHE . 11.7 p90 -145.78 -172.38 3.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.161 -1.199 . . . . 0.0 110.656 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.47 ' O ' ' HB ' ' A' ' 24' ' ' ILE . . . -153.7 114.16 0.61 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.605 ' CE1' ' CG ' ' A' ' 23' ' ' PHE . 19.9 m-85 -83.35 148.79 27.13 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.274 -1.133 . . . . 0.0 109.92 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 22' ' ' MET . 3.7 t -148.45 116.23 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.305 -0.872 . . . . 0.0 110.04 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.528 ' CG2' ' HB2' ' A' ' 21' ' ' LYS . 14.7 m -94.09 35.06 1.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.946 . . . . 0.0 110.511 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.585 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 O-C-N 120.936 -1.102 . . . . 0.0 109.55 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.303 0.573 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.43 ' O ' HG21 ' A' ' 77' ' ' VAL . . . -61.58 -46.16 94.86 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.571 ' CG1' ' N ' ' A' ' 75' ' ' ASP . 3.0 p -50.12 -46.17 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.205 -1.173 . . . . 0.0 109.484 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.571 ' N ' ' CG1' ' A' ' 74' ' ' VAL . 0.2 OUTLIER -59.71 -40.28 87.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.425 -0.797 . . . . 0.0 109.637 179.529 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.575 ' HB3' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -62.37 -33.51 74.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.416 -0.803 . . . . 0.0 109.389 179.378 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.559 HG12 ' CE1' ' A' ' 40' ' ' PHE . 40.5 t -62.74 -57.84 10.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.36 -0.838 . . . . 0.0 109.191 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.542 ' CD1' ' O ' ' A' ' 74' ' ' VAL . 4.0 mp -45.31 -41.91 9.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.197 -0.939 . . . . 0.0 108.852 178.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 78' ' ' LEU . . . -46.31 -28.26 1.26 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.473 -0.891 . . . . 0.0 108.747 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.524 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 33.0 mm-40 -102.62 26.78 7.55 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.668 -0.645 . . . . 0.0 109.821 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 78' ' ' LEU . 41.9 t -55.93 -16.37 4.66 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.525 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.8 OUTLIER -109.47 1.63 19.99 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 121.626 -0.671 . . . . 0.0 109.373 178.751 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.694 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 0.5 OUTLIER 28.25 -87.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.138 0.494 . . . . 0.0 112.141 179.783 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.642 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 1.6 tt0 51.01 112.35 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 122.327 1.06 . . . . 0.0 110.5 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.537 HD11 ' CG1' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -131.65 -70.06 0.59 Allowed 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.538 ' O ' ' CB ' ' A' ' 87' ' ' SER . 0.5 OUTLIER -103.71 55.33 0.74 Allowed 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.913 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 73.65 13.79 4.33 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 -178.135 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.642 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 8.6 mttt -117.86 107.2 13.82 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 121.502 -0.749 . . . . 0.0 110.997 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 90' ' ' ILE . 9.5 t -80.82 76.93 7.73 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.508 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.594 ' HB ' ' CG ' ' A' ' 83' ' ' HIS . 1.6 mt -50.72 -179.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.058 -1.026 . . . . 0.0 109.231 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 25' ' ' GLY . 11.1 t0 -139.2 75.03 34.86 Favored Pre-proline 0 C--N 1.298 -1.641 0 O-C-N 121.188 -0.945 . . . . 0.0 110.559 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.524 ' CG ' ' O ' ' A' ' 80' ' ' GLN . 2.1 Cg_endo -52.64 111.17 0.57 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.593 1.312 . . . . 0.0 110.854 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.559 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -121.66 103.91 9.24 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.098 -1.001 . . . . 0.0 109.136 178.339 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.512 ' CG2' ' HG3' ' A' ' 22' ' ' MET . 3.4 t -96.83 177.49 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 O-C-N 121.639 -0.663 . . . . 0.0 110.784 -178.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.452 -0.78 . . . . 0.0 109.776 179.899 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.203 0.525 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.527 ' HB2' ' CB ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -145.2 165.66 27.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.283 -0.886 . . . . 0.0 110.404 -179.851 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.567 ' SD ' ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -74.2 170.82 14.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.906 . . . . 0.0 109.465 179.617 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.63 ' CG ' ' CE1' ' A' ' 65' ' ' PHE . 5.4 t80 -151.25 129.72 12.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.159 -0.963 . . . . 0.0 110.128 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.476 HD11 ' HA ' ' A' ' 92' ' ' PRO . 18.4 mm -99.39 139.84 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.206 -0.934 . . . . 0.0 109.366 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' A' ' 91' ' ' ASP . . . -122.34 120.47 4.33 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.65 -1.262 . . . . 0.0 111.154 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.523 ' CA ' HG23 ' A' ' 90' ' ' ILE . . . 112.51 41.42 1.04 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.545 ' HG ' ' CG2' ' A' ' 31' ' ' THR . 1.0 OUTLIER -51.2 120.99 5.5 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.342 -1.093 . . . . 0.0 110.624 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.463 ' HA ' ' HG3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -46.37 173.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.305 -0.872 . . . . 0.0 110.103 179.684 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.439 ' CD1' ' C ' ' A' ' 29' ' ' TRP . 0.2 OUTLIER -76.48 5.03 7.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -0.926 . . . . 0.0 110.599 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.422 ' HG2' ' CD1' ' A' ' 29' ' ' TRP . 2.5 pt20 -151.57 11.79 0.6 Allowed 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.998 -1.064 . . . . 0.0 111.058 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.545 ' CG2' ' HG ' ' A' ' 27' ' ' LEU . 1.2 m -59.25 163.01 4.09 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.987 -1.071 . . . . 0.0 109.795 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.402 ' N ' ' CG2' ' A' ' 31' ' ' THR . 12.8 t -135.59 -169.81 2.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.924 . . . . 0.0 109.748 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 36' ' ' LEU . 6.4 mt-30 -88.47 -73.82 0.48 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.035 -1.041 . . . . 0.0 110.042 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.494 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 1.3 tt0 -48.59 -43.18 35.74 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.765 -1.209 . . . . 0.0 109.642 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.522 ' O ' ' HG3' ' A' ' 38' ' ' GLU . . . -55.9 -28.76 53.77 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 107.503 -2.239 . . . . 0.0 107.503 178.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 33' ' ' GLN . 0.1 OUTLIER -81.36 -37.9 27.49 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 177.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.494 ' HG3' ' HA ' ' A' ' 34' ' ' GLU . 19.9 mtt180 -61.71 -27.27 68.59 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 122.398 1.094 . . . . 0.0 108.12 177.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.522 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -89.11 -16.38 31.64 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.966 179.338 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.68 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 16.9 t80 -80.52 -32.22 36.92 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.401 -0.812 . . . . 0.0 110.175 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.538 ' CE1' HG12 ' A' ' 77' ' ' VAL . 32.1 m-85 -110.5 -28.26 8.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.392 -0.818 . . . . 0.0 109.025 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.522 ' CA ' HG23 ' A' ' 46' ' ' VAL . . . -61.76 -15.46 48.17 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -59.8 -42.86 94.37 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.401 -1.058 . . . . 0.0 109.523 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.418 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 3.6 p90 -125.83 -6.51 6.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.423 -0.798 . . . . 0.0 109.81 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.475 ' O ' ' HA2' ' A' ' 41' ' ' GLY . . . -130.8 96.41 0.35 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 11.1 mm-40 -40.69 115.46 0.58 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.335 -1.097 . . . . 0.0 110.546 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.536 ' HA ' ' CB ' ' A' ' 68' ' ' PHE . 59.9 t -95.32 134.21 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.0 110.61 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 0.1 OUTLIER -100.33 -27.75 13.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.373 -0.83 . . . . 0.0 109.743 179.588 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 5.0 tt0 -176.84 156.63 1.39 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.472 -0.768 . . . . 0.0 109.935 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.482 ' HB2' HD23 ' A' ' 36' ' ' LEU . 8.3 p -149.72 164.72 34.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.154 -0.967 . . . . 0.0 110.347 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.577 ' CD2' ' CD2' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -133.41 126.93 32.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.203 -0.936 . . . . 0.0 110.181 179.683 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.439 ' CG1' ' CD2' ' A' ' 27' ' ' LEU . 98.1 t -117.39 127.57 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.488 -1.382 . . . . 0.0 110.434 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 63' ' ' PHE . 2.8 tpp -129.3 156.17 44.44 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.624 -0.672 . . . . 0.0 109.797 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.402 ' O ' ' CB ' ' A' ' 54' ' ' ASP . 1.2 ttm180 -151.69 -171.37 3.91 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.479 -0.763 . . . . 0.0 109.97 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.402 ' CB ' ' O ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER 62.71 81.91 0.22 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.13 -0.981 . . . . 0.0 110.605 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -64.21 116.26 3.63 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.717 1.378 . . . . 0.0 110.352 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.419 HD12 ' HB ' ' A' ' 57' ' ' THR . 1.2 pp -89.34 -26.45 21.08 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.122 -0.986 . . . . 0.0 110.335 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.523 HG23 ' CG ' ' A' ' 59' ' ' ARG . 6.5 t -142.04 -148.5 0.24 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.34 -0.85 . . . . 0.0 110.081 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.39 13.86 4.07 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.215 -0.928 . . . . 0.0 110.454 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.528 ' HD3' ' N ' ' A' ' 60' ' ' SER . 0.1 OUTLIER -77.95 -161.85 0.28 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 110.271 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.528 ' N ' ' HD3' ' A' ' 59' ' ' ARG . 29.1 m -52.52 -173.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.275 -0.891 . . . . 0.0 110.687 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.17 28.12 0.75 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.268 -0.895 . . . . 0.0 110.133 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 52' ' ' MET . . . 128.2 98.36 0.94 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.564 ' CZ ' ' HB3' ' A' ' 52' ' ' MET . 24.8 p90 -141.72 -174.21 4.0 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.199 -1.177 . . . . 0.0 110.519 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.477 ' HA3' HD13 ' A' ' 27' ' ' LEU . . . -153.84 113.59 0.58 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.63 ' CE1' ' CG ' ' A' ' 23' ' ' PHE . 18.4 m-85 -83.98 149.91 25.99 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.365 -1.079 . . . . 0.0 109.605 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.529 ' CG1' HG12 ' A' ' 46' ' ' VAL . 3.6 t -149.8 110.2 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.163 -0.961 . . . . 0.0 110.274 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.527 ' CB ' ' HB2' ' A' ' 21' ' ' LYS . 12.8 t -90.39 53.94 2.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.249 -0.907 . . . . 0.0 110.523 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.567 ' CZ ' ' SD ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -77.31 -174.76 3.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.124 -0.985 . . . . 0.0 110.412 179.734 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.402 ' HE2' ' HB3' ' A' ' 69' ' ' MET . 0.0 OUTLIER -174.62 117.18 0.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.945 -1.097 . . . . 0.0 110.959 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.465 ' HB2' ' HA2' ' A' ' 44' ' ' GLY . 0.7 OUTLIER -150.57 172.85 14.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.393 -0.817 . . . . 0.0 109.994 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -53.39 -71.17 0.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.083 -1.011 . . . . 0.0 110.124 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 75' ' ' ASP . . . -90.21 24.4 2.53 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.238 -0.914 . . . . 0.0 110.064 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.489 ' O ' ' CG2' ' A' ' 77' ' ' VAL . . . -42.28 -85.13 0.01 OUTLIER Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.7 t -42.6 -27.02 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.308 -1.113 . . . . 0.0 110.68 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.518 ' O ' HD23 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -68.24 -82.67 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.113 -0.992 . . . . 0.0 110.192 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -40.24 -28.54 0.06 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.34 -0.85 . . . . 0.0 109.715 179.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.538 HG12 ' CE1' ' A' ' 40' ' ' PHE . 55.2 t -68.55 -43.51 83.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 O-C-N 121.459 -0.776 . . . . 0.0 110.319 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.573 ' CD2' ' N ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -59.68 -36.58 76.74 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 120.907 -1.12 . . . . 0.0 108.215 179.385 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.573 ' N ' ' CD2' ' A' ' 78' ' ' LEU . . . -48.25 -29.17 3.55 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.554 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -107.28 28.17 8.35 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.339 0.59 . . . . 0.0 109.411 179.182 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.502 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 2.9 p -49.14 -18.64 0.35 Allowed 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.143 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -107.35 -15.18 14.7 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.471 -0.768 . . . . 0.0 109.623 179.142 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.68 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 0.2 OUTLIER 56.86 -80.94 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.834 0.826 . . . . 0.0 110.321 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.561 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 3.0 tt0 54.41 123.18 0.0 OUTLIER 'General case' 0 C--N 1.288 -2.087 0 CA-C-O 122.177 0.989 . . . . 0.0 110.895 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.509 ' CD2' ' N ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -154.29 -88.55 0.05 OUTLIER 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.59 -0.694 . . . . 0.0 109.339 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.566 ' O ' ' CB ' ' A' ' 87' ' ' SER . 0.6 OUTLIER -82.01 52.31 1.94 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.111 -0.993 . . . . 0.0 108.848 178.868 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.566 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 76.72 6.8 3.32 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.231 0.539 . . . . 0.0 110.102 -179.317 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.561 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 1.6 mmtm -116.03 117.55 30.43 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.283 -0.886 . . . . 0.0 110.729 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.522 ' O ' ' CG2' ' A' ' 89' ' ' THR . 10.2 t -88.85 80.18 7.21 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.734 -0.604 . . . . 0.0 109.714 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.526 HG13 ' HB3' ' A' ' 83' ' ' HIS . 1.5 mt -52.58 -173.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.238 -0.914 . . . . 0.0 109.743 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 25' ' ' GLY . 4.6 t70 -144.54 84.2 9.3 Favored Pre-proline 0 N--CA 1.484 1.271 0 O-C-N 120.952 -1.092 . . . . 0.0 111.052 -178.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.554 ' CG ' ' O ' ' A' ' 80' ' ' GLN . 2.2 Cg_endo -56.08 113.46 1.45 Allowed 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.419 1.22 . . . . 0.0 110.962 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.616 ' HD2' ' CD2' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -132.48 109.96 10.17 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.35 -0.844 . . . . 0.0 109.451 178.264 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.491 ' CG2' ' HB2' ' A' ' 22' ' ' MET . 40.9 t -96.19 157.89 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.556 -0.715 . . . . 0.0 110.553 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 94' ' ' VAL . . . 42.34 -154.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.334 -0.854 . . . . 0.0 110.565 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.424 -0.798 . . . . 0.0 110.068 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.208 0.528 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.528 ' HB2' ' CB ' ' A' ' 67' ' ' THR . 1.3 ptpt -139.88 -167.53 2.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.915 . . . . 0.0 110.426 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.517 ' HG3' ' CG1' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -100.81 170.81 8.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.39 -0.819 . . . . 0.0 109.698 179.648 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.625 ' HB3' ' HD2' ' A' ' 93' ' ' LYS . 19.5 t80 -147.0 155.19 42.05 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.084 -1.01 . . . . 0.0 110.353 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.506 HD13 ' CZ ' ' A' ' 40' ' ' PHE . 24.9 mm -121.26 151.79 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.321 -0.862 . . . . 0.0 109.282 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' A' ' 91' ' ' ASP . . . -133.78 138.96 10.49 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.33 -1.414 . . . . 0.0 111.341 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.474 ' O ' ' CD1' ' A' ' 90' ' ' ILE . . . 103.33 29.67 5.61 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.536 ' CD2' ' O ' ' A' ' 63' ' ' PHE . 0.8 OUTLIER -53.38 112.89 0.98 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.485 -1.009 . . . . 0.0 110.523 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.478 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -56.58 173.57 0.18 Allowed 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.411 -0.806 . . . . 0.0 110.056 179.671 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -80.33 11.54 3.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.315 -0.866 . . . . 0.0 110.493 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -133.44 -0.38 3.25 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.114 -0.991 . . . . 0.0 110.501 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.504 ' CG2' ' HG ' ' A' ' 27' ' ' LEU . 18.4 m -64.62 158.03 25.48 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.354 -0.841 . . . . 0.0 110.207 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.513 ' CG2' ' HA3' ' A' ' 35' ' ' GLY . 12.5 t -135.28 -173.15 3.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.121 -0.987 . . . . 0.0 110.069 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 36' ' ' LEU . 31.6 mt-30 -90.16 -74.76 0.48 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.198 -0.939 . . . . 0.0 110.202 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.53 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -48.72 -48.09 40.78 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.727 -1.189 . . . . 0.0 108.724 179.758 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.513 ' HA3' ' CG2' ' A' ' 32' ' ' THR . . . -48.92 -32.97 12.3 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 107.451 -2.26 . . . . 0.0 107.451 178.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.525 ' N ' ' O ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -78.88 -39.76 34.25 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.361 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.5 ' CG ' ' HA ' ' A' ' 34' ' ' GLU . 3.2 mtt180 -57.81 -25.6 60.82 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.484 1.135 . . . . 0.0 107.974 178.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.53 ' CG ' ' O ' ' A' ' 34' ' ' GLU . 1.3 mt-10 -89.09 -21.11 23.56 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.632 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.67 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 20.5 t80 -73.49 -29.99 62.86 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.916 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.572 ' HA ' ' CZ ' ' A' ' 43' ' ' PHE . 44.9 m-85 -110.89 -24.56 10.34 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.525 -0.735 . . . . 0.0 109.061 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.449 ' CA ' HG22 ' A' ' 46' ' ' VAL . . . -72.58 -9.44 74.02 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -73.78 -52.04 14.44 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.409 -1.054 . . . . 0.0 110.461 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.572 ' CZ ' ' HA ' ' A' ' 40' ' ' PHE . 3.7 p90 -104.81 8.98 35.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.295 -0.878 . . . . 0.0 110.491 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.87 175.43 32.93 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 68' ' ' PHE . 59.8 mm-40 -98.0 110.15 22.78 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.25 -1.147 . . . . 0.0 109.997 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.449 HG22 ' CA ' ' A' ' 41' ' ' GLY . 23.8 t -89.74 123.27 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 0.0 110.364 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.6 -26.2 16.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.406 -0.809 . . . . 0.0 109.75 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.446 ' HG2' ' N ' ' A' ' 49' ' ' CYS . 0.0 OUTLIER 179.95 151.89 0.43 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.438 -0.789 . . . . 0.0 110.006 179.686 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.485 ' HB3' HD21 ' A' ' 36' ' ' LEU . 9.3 m -145.34 174.72 10.87 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.331 -0.855 . . . . 0.0 110.012 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.651 ' CD2' ' CD2' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -148.36 144.41 27.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 110.375 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.499 ' HB ' ' HG2' ' A' ' 33' ' ' GLN . 86.0 t -132.33 134.88 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.624 -1.297 . . . . 0.0 110.997 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.416 ' HG3' ' N ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -139.46 148.55 42.88 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.585 -0.697 . . . . 0.0 109.585 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.467 ' NH2' HG13 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -150.06 -47.97 0.13 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.471 -0.768 . . . . 0.0 110.255 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.534 ' N ' ' HD3' ' A' ' 55' ' ' PRO . 1.3 m-20 53.79 59.67 12.15 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.347 -0.846 . . . . 0.0 110.916 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.534 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 2.7 Cg_endo -64.62 56.81 0.25 Allowed 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.521 1.274 . . . . 0.0 110.685 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.463 ' N ' ' O ' ' A' ' 54' ' ' ASP . 8.1 mt -106.02 -52.67 2.76 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.104 -0.998 . . . . 0.0 110.03 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.618 ' C ' ' HG2' ' A' ' 58' ' ' LYS . 1.1 t -136.96 7.88 2.96 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.515 -0.74 . . . . 0.0 110.109 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.618 ' HG2' ' C ' ' A' ' 57' ' ' THR . 21.0 mmtt 75.24 -10.68 1.19 Allowed 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.549 -0.719 . . . . 0.0 110.558 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.613 ' CD ' ' N ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -46.47 -36.07 6.27 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 121.657 -0.652 . . . . 0.0 110.264 -179.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.613 ' N ' ' CD ' ' A' ' 59' ' ' ARG . 5.9 p -62.8 -152.4 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.1 -1.0 . . . . 0.0 110.4 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.419 ' HG3' ' C ' ' A' ' 60' ' ' SER . 16.0 mtt85 -134.33 -42.96 0.78 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.974 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.424 ' C ' ' HB2' ' A' ' 27' ' ' LEU . . . 91.07 90.76 1.35 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.582 ' HB2' ' CE1' ' A' ' 23' ' ' PHE . 2.4 p90 -150.26 -177.94 6.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.208 -1.172 . . . . 0.0 110.598 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.523 ' N ' HD13 ' A' ' 27' ' ' LEU . . . -147.31 121.06 1.33 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.651 ' CD2' ' CD2' ' A' ' 50' ' ' LEU . 21.6 m-85 -84.04 153.25 23.92 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.4 -1.059 . . . . 0.0 110.384 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.486 ' CG2' ' C ' ' A' ' 65' ' ' PHE . 13.9 t -150.07 129.58 3.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.5 -0.75 . . . . 0.0 109.208 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.528 ' CB ' ' HB2' ' A' ' 21' ' ' LYS . 9.9 t -119.12 59.2 0.84 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.144 -0.972 . . . . 0.0 111.039 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.484 ' CZ ' HG21 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -70.39 -161.84 0.05 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.947 -1.096 . . . . 0.0 109.91 179.546 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.431 ' HG2' ' HB2' ' A' ' 45' ' ' GLU . 9.0 ptt? -89.01 -158.3 0.49 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.132 -0.98 . . . . 0.0 110.357 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -122.03 -139.74 0.32 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.959 -1.088 . . . . 0.0 110.146 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 62.19 -148.8 0.38 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.136 -0.977 . . . . 0.0 110.239 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 75' ' ' ASP . . . -55.25 -29.37 57.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.282 -0.886 . . . . 0.0 110.306 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -48.11 -65.38 2.53 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.478 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 25.5 t -47.12 -52.62 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.199 -1.177 . . . . 0.0 110.39 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.468 ' HA ' HD11 ' A' ' 78' ' ' LEU . 15.7 m-20 -42.63 -52.07 4.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.145 -0.972 . . . . 0.0 110.173 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.471 ' HE3' ' N ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -59.46 -39.4 83.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.394 -0.816 . . . . 0.0 110.155 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.484 HG21 ' CZ ' ' A' ' 68' ' ' PHE . 81.7 t -55.33 -60.4 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 O-C-N 121.072 -1.017 . . . . 0.0 109.621 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.468 HD11 ' HA ' ' A' ' 75' ' ' ASP . 1.6 mp -44.12 -42.46 6.32 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.234 -0.916 . . . . 0.0 109.423 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.467 ' HB3' ' OE1' ' A' ' 80' ' ' GLN . . . -46.88 -27.9 1.4 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.176 -0.953 . . . . 0.0 109.383 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.563 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 13.9 mm100 -101.66 22.0 13.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.426 -0.796 . . . . 0.0 109.894 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.501 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 47.0 t -51.7 -16.92 0.74 Allowed 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.007 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.469 ' O ' ' C ' ' A' ' 83' ' ' HIS . 9.6 ptt180 -100.56 -10.39 21.06 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 121.369 -0.832 . . . . 0.0 109.686 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.67 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 0.5 OUTLIER 31.69 43.99 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.811 -0.555 . . . . 0.0 111.851 179.882 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 2.4 tt0 -93.4 122.58 35.96 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.795 -1.162 . . . . 0.0 110.103 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.47 HD22 ' C ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -155.0 -83.38 0.07 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.553 -0.717 . . . . 0.0 110.189 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.531 ' CB ' ' HD3' ' A' ' 88' ' ' LYS . 0.3 OUTLIER -78.4 52.74 1.18 Allowed 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.036 -1.04 . . . . 0.0 109.425 179.525 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.522 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 71.62 1.43 3.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.522 -0.736 . . . . 0.0 110.619 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.531 ' HD3' ' CB ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -112.69 126.5 55.46 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.104 -0.997 . . . . 0.0 110.249 -179.821 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.491 ' O ' HG21 ' A' ' 89' ' ' THR . 11.5 t -105.82 64.97 0.69 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.666 -0.646 . . . . 0.0 110.361 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.548 ' HB ' ' CG ' ' A' ' 83' ' ' HIS . 0.9 OUTLIER -53.0 -176.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.28 -0.888 . . . . 0.0 109.016 179.892 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' A' ' 25' ' ' GLY . 5.3 t70 -145.11 84.65 8.56 Favored Pre-proline 0 N--CA 1.485 1.28 0 O-C-N 120.653 -1.279 . . . . 0.0 111.052 -178.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.564 ' HG3' ' HD2' ' A' ' 83' ' ' HIS . 1.9 Cg_endo -57.39 112.79 1.23 Allowed 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.565 1.298 . . . . 0.0 110.634 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.625 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -111.3 107.14 16.32 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.035 -1.041 . . . . 0.0 108.983 178.237 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.517 ' CG1' ' HG3' ' A' ' 22' ' ' MET . 93.2 t -97.28 153.4 3.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.704 -0.623 . . . . 0.0 110.372 -179.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.431 ' N ' HG12 ' A' ' 94' ' ' VAL . . . -134.85 -156.16 0.71 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.206 -0.934 . . . . 0.0 110.022 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.1 t80 . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.234 -0.916 . . . . 0.0 110.121 179.886 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 33.4 t . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.287 0.565 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.458 ' HB2' ' OG1' ' A' ' 67' ' ' THR . 3.5 pttt -68.51 169.03 11.64 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.232 -0.917 . . . . 0.0 109.996 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.532 ' HG3' ' CG1' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -76.66 162.07 28.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.249 -0.907 . . . . 0.0 110.226 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.618 ' HB3' ' HD2' ' A' ' 93' ' ' LYS . 19.9 t80 -149.54 145.96 27.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.306 -0.871 . . . . 0.0 109.935 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.566 HG12 ' CE2' ' A' ' 40' ' ' PHE . 1.1 mp -113.37 142.45 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 108.905 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 91' ' ' ASP . . . -120.42 127.16 6.94 Favored Glycine 0 N--CA 1.494 2.522 0 C-N-CA 119.478 -1.344 . . . . 0.0 111.472 -178.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.534 ' CA ' HG21 ' A' ' 90' ' ' ILE . . . 107.32 45.11 1.18 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.525 ' HB2' ' CA ' ' A' ' 63' ' ' PHE . 1.1 tp -56.47 113.97 1.82 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.103 -1.234 . . . . 0.0 110.508 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.509 ' CB ' ' HG2' ' A' ' 88' ' ' LYS . 6.1 t -45.5 170.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.471 -0.768 . . . . 0.0 110.321 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 39.9 p-90 -81.5 11.55 4.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.261 -0.899 . . . . 0.0 110.451 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -143.98 8.95 1.48 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.18 -0.95 . . . . 0.0 110.52 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.458 ' CG2' ' HG ' ' A' ' 27' ' ' LEU . 1.4 m -70.68 163.1 27.8 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.294 -0.879 . . . . 0.0 110.097 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.4 t -142.72 -175.64 4.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.125 -0.984 . . . . 0.0 109.997 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 36' ' ' LEU . 6.5 mt-30 -80.26 -73.1 0.38 Allowed 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.035 -1.041 . . . . 0.0 111.014 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.504 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -48.0 -49.59 30.39 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 118.48 -1.288 . . . . 0.0 108.765 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.458 ' HA2' ' HG3' ' A' ' 38' ' ' GLU . . . -47.73 -31.04 7.15 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 107.753 -2.139 . . . . 0.0 107.753 178.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -78.45 -39.35 38.83 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 178.283 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.489 ' N ' ' O ' ' A' ' 34' ' ' GLU . 71.7 mtt180 -59.22 -26.42 64.85 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 178.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 34' ' ' GLU . 1.3 mt-10 -88.08 -19.68 26.73 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.692 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 8.3 t80 -79.38 -43.04 24.21 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.771 -0.771 . . . . 0.0 110.735 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.566 ' CE2' HG12 ' A' ' 24' ' ' ILE . 28.4 m-85 -105.92 -28.11 10.79 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.387 -0.821 . . . . 0.0 109.217 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.488 ' CA ' HG22 ' A' ' 46' ' ' VAL . . . -67.35 -10.09 56.36 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.647 -1.781 . . . . 0.0 108.647 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -63.05 -37.14 85.99 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.379 -1.071 . . . . 0.0 109.873 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.429 ' CZ ' ' HA ' ' A' ' 40' ' ' PHE . 3.2 p90 -127.23 0.79 6.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.491 -0.756 . . . . 0.0 109.897 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.589 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -146.54 97.55 0.19 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -37.87 122.76 1.02 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.559 -0.965 . . . . 0.0 110.638 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.542 ' HA ' ' CB ' ' A' ' 68' ' ' PHE . 21.3 t -91.06 119.92 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.356 -0.84 . . . . 0.0 110.727 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -86.14 -21.56 27.5 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.358 -0.839 . . . . 0.0 109.637 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -178.75 145.16 0.29 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.366 -0.834 . . . . 0.0 110.384 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.503 ' HB2' ' CD2' ' A' ' 36' ' ' LEU . 5.5 p -148.05 170.16 18.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.287 -0.883 . . . . 0.0 109.93 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.655 ' CD2' ' CD2' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -148.97 133.66 17.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.873 -1.142 . . . . 0.0 110.927 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.493 ' CG2' ' HG2' ' A' ' 33' ' ' GLN . 61.6 t -110.51 130.19 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.808 -1.183 . . . . 0.0 109.487 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.501 ' SD ' ' CZ ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER -142.17 168.71 19.09 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.174 -0.954 . . . . 0.0 110.612 -178.534 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 61' ' ' ARG . 13.8 ptt180 -124.95 -160.6 0.96 Allowed 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.53 -0.731 . . . . 0.0 109.582 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.579 ' CB ' ' HD3' ' A' ' 55' ' ' PRO . 0.6 OUTLIER 175.39 -58.65 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 120.897 -1.127 . . . . 0.0 111.209 179.683 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.579 ' HD3' ' CB ' ' A' ' 54' ' ' ASP . 2.9 Cg_endo -57.85 -152.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.325 1.171 . . . . 0.0 110.714 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.433 ' O ' ' HB ' ' A' ' 57' ' ' THR . 5.2 mt -93.98 -69.46 0.75 Allowed 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.15 -0.969 . . . . 0.0 110.796 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 56' ' ' LEU . 1.8 t 179.54 -30.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.339 -0.851 . . . . 0.0 110.794 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.488 ' N ' ' HD3' ' A' ' 58' ' ' LYS . 15.5 mmtp -56.99 -50.37 72.91 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.183 -0.948 . . . . 0.0 108.977 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.561 ' C ' ' CD ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -59.6 -155.5 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.243 179.434 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.479 ' HB3' ' O ' ' A' ' 27' ' ' LEU . 14.5 m -74.35 -111.91 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.13 -0.981 . . . . 0.0 109.051 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 53' ' ' ARG . 6.2 ttm180 -136.72 -42.3 0.6 Allowed 'General case' 0 N--CA 1.482 1.152 0 O-C-N 120.731 -1.231 . . . . 0.0 108.372 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.473 ' C ' ' CD2' ' A' ' 63' ' ' PHE . . . 162.94 -87.99 0.1 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.461 -1.856 . . . . 0.0 108.461 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.525 ' CA ' ' HB2' ' A' ' 27' ' ' LEU . 8.2 p90 -177.66 178.15 1.04 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.303 -1.116 . . . . 0.0 110.367 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.58 ' O ' ' CD1' ' A' ' 23' ' ' PHE . . . -141.67 164.36 26.71 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.655 ' CD2' ' CD2' ' A' ' 50' ' ' LEU . 13.6 m-85 -124.56 148.38 47.85 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.356 -1.085 . . . . 0.0 109.822 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.486 ' O ' ' HB2' ' A' ' 22' ' ' MET . 7.5 t -148.71 126.8 3.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.317 -0.865 . . . . 0.0 110.171 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 21' ' ' LYS . 88.4 m -106.14 19.51 20.41 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.282 -0.886 . . . . 0.0 110.079 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.589 ' CE1' ' HA3' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -49.83 142.44 8.84 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.151 -0.968 . . . . 0.0 109.728 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.4 ttp -136.54 123.86 21.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.261 -0.899 . . . . 0.0 110.25 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.04 -159.99 1.11 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 110.339 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -80.79 -72.36 0.42 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.23 -0.919 . . . . 0.0 110.214 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 73' ' ' GLY . . . -87.8 21.95 2.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.218 -0.927 . . . . 0.0 110.348 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.478 ' O ' ' CG2' ' A' ' 77' ' ' VAL . . . -43.48 -63.75 2.04 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.1 t -54.45 -23.8 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.136 -1.214 . . . . 0.0 110.0 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.447 ' HB3' ' HE3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -75.38 -73.13 0.27 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 110.017 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.447 ' HE3' ' HB3' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -47.55 -46.47 27.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.378 -0.826 . . . . 0.0 109.818 179.807 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.508 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 79.9 t -52.59 -53.25 21.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.069 -1.02 . . . . 0.0 108.691 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -41.02 -51.81 3.23 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.659 -0.651 . . . . 0.0 110.064 179.012 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 78' ' ' LEU . . . -42.85 -27.26 0.17 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.441 -0.787 . . . . 0.0 110.19 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.562 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 9.7 mm-40 -104.58 21.85 16.06 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.265 -0.897 . . . . 0.0 110.29 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.508 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 40.3 t -51.76 -16.86 0.75 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.481 -0.762 . . . . 0.0 109.276 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.5 OUTLIER -108.33 -4.41 17.47 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 121.346 -0.846 . . . . 0.0 109.939 179.348 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.692 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 0.4 OUTLIER 34.39 31.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.786 -0.571 . . . . 0.0 111.241 179.828 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.584 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -86.24 117.78 25.27 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 118.39 -1.324 . . . . 0.0 110.205 179.502 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.504 ' CD2' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -153.78 -73.68 0.13 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.808 -0.558 . . . . 0.0 110.231 -179.249 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 87' ' ' SER . 0.4 OUTLIER -81.27 49.07 1.22 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.165 -0.96 . . . . 0.0 109.474 179.552 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 71.68 -0.11 3.29 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.539 -0.726 . . . . 0.0 110.651 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.584 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -115.35 138.66 50.74 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.182 -0.949 . . . . 0.0 110.084 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.532 ' O ' ' CG2' ' A' ' 89' ' ' THR . 14.9 t -113.11 71.27 0.74 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.544 -0.723 . . . . 0.0 110.799 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.592 ' HB ' ' CG ' ' A' ' 83' ' ' HIS . 1.2 mt -55.0 -171.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.32 -0.863 . . . . 0.0 109.534 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 25' ' ' GLY . 5.1 t70 -143.82 87.04 8.3 Favored Pre-proline 0 N--CA 1.486 1.355 0 O-C-N 120.882 -1.136 . . . . 0.0 111.192 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.562 ' CG ' ' O ' ' A' ' 80' ' ' GLN . 2.0 Cg_endo -62.49 112.23 1.53 Allowed 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.53 1.279 . . . . 0.0 111.057 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.618 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -115.43 109.32 17.69 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.115 -0.991 . . . . 0.0 109.066 178.111 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.532 ' CG1' ' HG3' ' A' ' 22' ' ' MET . 53.6 t -97.04 151.57 4.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.521 -0.737 . . . . 0.0 110.291 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -109.02 123.32 48.95 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.203 -0.936 . . . . 0.0 110.375 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.5 t80 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.151 -0.968 . . . . 0.0 109.883 179.773 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.302 0.572 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 0.3 OUTLIER -134.83 152.77 52.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 110.343 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.534 ' HG2' ' CG2' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -73.06 -172.12 1.01 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.349 -0.845 . . . . 0.0 109.839 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.686 ' CG ' ' CE1' ' A' ' 65' ' ' PHE . 6.5 t80 -151.01 145.38 25.5 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.015 -1.053 . . . . 0.0 110.211 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.573 HD11 ' CZ ' ' A' ' 40' ' ' PHE . 18.6 mm -118.49 126.34 75.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.299 -0.876 . . . . 0.0 108.905 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 90' ' ' ILE . . . -109.83 159.63 13.86 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.789 -1.196 . . . . 0.0 111.227 -178.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.491 ' O ' HD13 ' A' ' 90' ' ' ILE . . . 54.35 40.25 67.82 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.597 ' HA ' ' CG2' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -85.56 143.41 28.5 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.676 -0.897 . . . . 0.0 110.926 -179.135 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.489 ' O ' ' HB ' ' A' ' 31' ' ' THR . 0.5 OUTLIER -39.39 134.81 1.16 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.465 0.65 . . . . 0.0 110.942 -179.076 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.526 ' CG ' ' N ' ' A' ' 30' ' ' GLN . 31.0 p-90 -68.28 -37.97 81.22 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.361 -0.837 . . . . 0.0 109.947 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.526 ' N ' ' CG ' ' A' ' 29' ' ' TRP . 12.3 pt20 -74.76 0.21 16.07 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.396 -0.815 . . . . 0.0 110.696 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' A' ' 28' ' ' SER . 4.4 m -69.24 153.86 42.97 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.392 -0.817 . . . . 0.0 110.215 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.483 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 5.9 t -123.79 -174.18 2.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 109.625 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 36' ' ' LEU . 1.7 mt-30 -72.28 -73.15 0.2 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.044 -1.035 . . . . 0.0 110.855 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.519 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 0.1 OUTLIER -48.33 -50.01 31.97 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 118.569 -1.252 . . . . 0.0 108.845 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -49.47 -29.23 10.94 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 107.795 -2.122 . . . . 0.0 107.795 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.538 ' CD2' ' HB2' ' A' ' 49' ' ' CYS . 0.1 OUTLIER -81.72 -38.24 26.08 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 178.315 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.519 ' HG3' ' HA ' ' A' ' 34' ' ' GLU . 13.9 mtp180 -58.71 -27.31 64.75 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.478 ' HG3' ' O ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -89.25 -21.35 23.26 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.793 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.579 ' OH ' ' CG ' ' A' ' 83' ' ' HIS . 38.2 t80 -67.84 -29.17 68.24 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.568 0.699 . . . . 0.0 109.85 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.573 ' CZ ' HD11 ' A' ' 24' ' ' ILE . 38.4 m-85 -117.66 -18.72 9.6 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -70.17 -12.59 69.05 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -62.19 -47.82 82.77 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.452 -1.028 . . . . 0.0 109.691 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -119.61 7.87 11.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.519 -0.738 . . . . 0.0 109.911 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.466 ' O ' ' HA2' ' A' ' 41' ' ' GLY . . . -159.41 99.99 0.18 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 13.3 pt-20 -41.26 148.79 0.12 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.433 -1.039 . . . . 0.0 110.099 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.54 ' HA ' ' CB ' ' A' ' 68' ' ' PHE . 48.8 t -122.6 147.38 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.192 -0.943 . . . . 0.0 110.868 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -106.3 -32.7 8.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.414 -0.804 . . . . 0.0 109.887 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.469 ' O ' HG23 ' A' ' 67' ' ' THR . 0.9 OUTLIER -167.51 152.03 6.81 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.248 -0.908 . . . . 0.0 110.294 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.538 ' HB2' ' CD2' ' A' ' 36' ' ' LEU . 29.7 p -150.8 167.42 27.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.178 -0.951 . . . . 0.0 110.285 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.554 ' CD2' ' CD2' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -138.6 126.23 22.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.168 -0.957 . . . . 0.0 109.872 179.504 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.6 t -115.09 130.44 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.634 -1.292 . . . . 0.0 111.261 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.462 ' HE1' ' CE1' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -132.26 148.16 52.44 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.6 -0.688 . . . . 0.0 109.292 179.317 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.512 ' NH1' ' CE3' ' A' ' 29' ' ' TRP . 4.0 ttt180 -132.06 -85.01 0.49 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.457 -0.777 . . . . 0.0 110.386 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 53' ' ' ARG . 64.6 m-20 -132.45 89.0 37.62 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 110.554 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.448 ' HD2' ' HB2' ' A' ' 60' ' ' SER . 2.9 Cg_endo -60.76 -50.72 6.0 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 O-C-N 123.633 1.333 . . . . 0.0 110.179 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.6 mt -89.96 -57.8 2.73 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.286 -0.884 . . . . 0.0 109.596 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.05 -44.87 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.507 -0.745 . . . . 0.0 110.174 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.463 ' O ' ' HD2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -175.9 23.19 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.238 -0.914 . . . . 0.0 110.816 179.8 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.528 ' CD ' ' N ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -79.26 -29.99 42.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.988 -1.07 . . . . 0.0 110.261 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.528 ' N ' ' CD ' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -58.53 -152.57 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.215 -0.928 . . . . 0.0 110.072 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.456 ' HB2' ' CE2' ' A' ' 63' ' ' PHE . 0.7 OUTLIER -134.14 -29.86 1.23 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.169 -0.957 . . . . 0.0 110.727 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.99 88.04 1.57 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 7.4 p90 -151.54 -172.71 4.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.192 -1.181 . . . . 0.0 110.666 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.464 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -153.48 120.19 1.02 Allowed Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.686 ' CE1' ' CG ' ' A' ' 23' ' ' PHE . 17.3 m-85 -83.94 149.31 26.4 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.453 -1.028 . . . . 0.0 109.153 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.512 ' CG2' ' C ' ' A' ' 65' ' ' PHE . 3.5 t -150.0 114.51 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.11 -0.994 . . . . 0.0 110.845 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 48' ' ' GLU . 8.9 t -80.07 4.09 18.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.175 -0.953 . . . . 0.0 109.694 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.54 ' CB ' ' HA ' ' A' ' 46' ' ' VAL . 1.0 OUTLIER -49.31 155.65 0.69 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.3 -0.875 . . . . 0.0 110.105 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 39.2 ttm -170.39 113.32 0.45 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.113 -0.992 . . . . 0.0 110.504 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.42 ' O ' ' C ' ' A' ' 71' ' ' GLN . 15.2 t70 -131.85 166.05 22.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.237 -0.915 . . . . 0.0 110.083 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -43.09 -71.3 0.08 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.253 -0.904 . . . . 0.0 110.214 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.23 -4.71 58.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.887 . . . . 0.0 110.186 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 74' ' ' VAL . . . -47.71 -77.64 0.11 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.439 ' C ' ' O ' ' A' ' 73' ' ' GLY . 51.1 t -40.95 -51.84 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.33 -1.1 . . . . 0.0 110.481 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.472 ' HA ' HD22 ' A' ' 78' ' ' LEU . 3.8 m-20 -47.1 -52.91 14.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -0.927 . . . . 0.0 110.295 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.05 -35.76 80.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.465 -0.772 . . . . 0.0 110.531 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.539 HG11 ' CE1' ' A' ' 40' ' ' PHE . 49.8 t -54.58 -72.8 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.057 -1.027 . . . . 0.0 109.753 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.472 HD22 ' HA ' ' A' ' 75' ' ' ASP . 1.1 pp -46.82 -37.42 8.67 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.909 -1.119 . . . . 0.0 109.289 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.69 -25.76 7.93 Favored 'General case' 0 C--N 1.308 -1.235 0 O-C-N 121.1 -1.0 . . . . 0.0 108.685 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.568 ' HB3' ' CE1' ' A' ' 83' ' ' HIS . 13.3 mm-40 -103.99 26.28 8.91 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.465 0.65 . . . . 0.0 109.351 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.534 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 47.4 t -54.54 -15.83 1.99 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.544 ' O ' ' C ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -113.54 8.19 17.66 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.611 -0.681 . . . . 0.0 109.66 179.099 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.62 ' CD2' ' HG3' ' A' ' 92' ' ' PRO . 2.6 m-70 -3.38 -78.01 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.613 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 4.4 tt0 59.38 122.46 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 121.467 0.651 . . . . 0.0 109.49 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.624 ' CD2' ' N ' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -157.58 -37.81 0.07 Allowed 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.274 -0.97 . . . . 0.0 110.502 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 87' ' ' SER . 1.5 t70 -121.88 48.03 1.78 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 74.44 1.33 3.82 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -177.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.613 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -117.05 119.43 35.25 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.527 ' HA ' ' CA ' ' A' ' 84' ' ' GLU . 7.3 t -92.45 77.91 5.04 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.597 ' CG2' ' HA ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -40.98 167.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 CA-C-O 121.897 0.856 . . . . 0.0 110.615 -178.8 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 25' ' ' GLY . 4.6 t70 -133.2 69.63 78.01 Favored Pre-proline 0 C--N 1.297 -1.694 0 O-C-N 121.685 -0.635 . . . . 0.0 109.448 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.62 ' HG3' ' CD2' ' A' ' 83' ' ' HIS . 1.8 Cg_endo -49.58 112.84 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.566 1.298 . . . . 0.0 109.882 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.493 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.1 OUTLIER -126.75 107.95 10.61 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.871 0.843 . . . . 0.0 110.009 179.192 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.534 ' CG2' ' HG2' ' A' ' 22' ' ' MET . 76.3 t -95.99 153.72 3.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.11 2.4 20.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.095 -1.003 . . . . 0.0 110.427 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.134 -0.979 . . . . 0.0 110.26 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.273 0.558 . . . . 0.0 110.223 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.463 ' HB2' ' HA ' ' A' ' 67' ' ' THR . 1.1 pttm -156.16 145.03 20.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 110.105 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.597 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -55.23 155.85 4.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 110.218 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.633 ' CD2' ' CE ' ' A' ' 93' ' ' LYS . 0.5 OUTLIER -138.54 119.61 14.49 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.582 -0.699 . . . . 0.0 109.444 -179.804 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.614 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 1.2 mp -93.65 137.89 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.081 -1.012 . . . . 0.0 109.12 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.543 ' O ' ' CG2' ' A' ' 90' ' ' ILE . . . -110.62 133.05 11.32 Favored Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.823 -1.179 . . . . 0.0 112.324 -177.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.511 ' C ' HG21 ' A' ' 90' ' ' ILE . . . 62.55 36.97 93.95 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.564 ' HA ' ' CG2' ' A' ' 90' ' ' ILE . 0.4 OUTLIER -61.65 150.96 34.91 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.529 -0.983 . . . . 0.0 110.706 -179.339 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.496 ' CB ' ' HB ' ' A' ' 31' ' ' THR . 0.4 OUTLIER -39.51 123.11 1.43 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.49 0.662 . . . . 0.0 110.771 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 6.5 p-90 -63.9 -14.29 52.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.504 -0.747 . . . . 0.0 110.146 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.466 ' O ' ' O ' ' A' ' 31' ' ' THR . 4.1 pt20 -100.04 -21.74 15.5 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.373 -0.83 . . . . 0.0 110.908 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.496 ' HB ' ' CB ' ' A' ' 28' ' ' SER . 2.3 t -55.41 -161.93 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.447 0.641 . . . . 0.0 110.397 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.407 ' N ' HG21 ' A' ' 31' ' ' THR . 6.1 t -158.74 -168.99 2.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.877 . . . . 0.0 109.857 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 36' ' ' LEU . 15.1 mt-30 -79.55 -70.53 0.5 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.162 -0.961 . . . . 0.0 110.432 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.505 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -46.32 -52.29 13.01 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.959 -1.096 . . . . 0.0 109.237 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.443 ' HA2' ' HG3' ' A' ' 38' ' ' GLU . . . -48.4 -31.34 9.0 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.53 ' N ' ' O ' ' A' ' 33' ' ' GLN . 0.1 OUTLIER -79.76 -36.81 36.64 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.448 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.498 ' HG3' ' HA ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -60.76 -27.97 68.37 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 122.455 1.121 . . . . 0.0 108.052 177.728 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.505 ' HG3' ' O ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -86.02 -19.9 29.64 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.541 179.091 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.688 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 13.6 t80 -78.64 -35.29 45.66 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.988 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.583 ' HA ' ' CZ ' ' A' ' 43' ' ' PHE . 38.7 m-85 -109.14 -22.96 11.87 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.213 -0.93 . . . . 0.0 109.416 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -76.79 -3.61 80.17 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.581 -1.807 . . . . 0.0 108.581 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -73.86 -50.59 19.6 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 121.495 -1.003 . . . . 0.0 110.19 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.583 ' CZ ' ' HA ' ' A' ' 40' ' ' PHE . 2.9 p90 -103.35 13.1 34.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 110.18 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 45' ' ' GLU . . . -150.24 -111.8 0.56 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.464 ' HB3' ' O ' ' A' ' 44' ' ' GLY . 0.4 OUTLIER 176.83 104.39 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.533 -0.981 . . . . 0.0 109.408 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.53 ' CG1' HG12 ' A' ' 66' ' ' VAL . 95.1 t -90.56 137.78 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.312 -0.867 . . . . 0.0 111.04 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -101.7 -26.87 13.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.52 -0.737 . . . . 0.0 109.163 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -166.9 154.79 9.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.547 -0.721 . . . . 0.0 109.796 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.491 ' SG ' ' CD ' ' A' ' 37' ' ' ARG . 21.0 p -148.68 175.4 11.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.123 -0.986 . . . . 0.0 110.719 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.598 ' CD2' ' CD2' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -150.51 132.11 14.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -0.833 . . . . 0.0 109.902 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.2 t -129.1 147.04 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.548 -1.345 . . . . 0.0 111.298 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.438 ' CE ' ' HB2' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -146.74 146.76 30.42 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.754 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.404 ' O ' ' NE ' ' A' ' 59' ' ' ARG . 6.7 mtp85 -118.61 -76.01 0.58 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.206 -0.934 . . . . 0.0 110.772 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.431 ' HA ' ' NE ' ' A' ' 59' ' ' ARG . 64.2 t0 -141.99 76.62 19.34 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.146 -0.971 . . . . 0.0 110.616 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.48 ' HD2' ' HG2' ' A' ' 59' ' ' ARG . 3.0 Cg_exo -55.96 -48.71 18.41 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.627 1.33 . . . . 0.0 110.644 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.476 ' O ' ' HB ' ' A' ' 57' ' ' THR . 8.0 mt -124.23 -70.12 0.77 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.168 -0.958 . . . . 0.0 110.148 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 56' ' ' LEU . 1.3 t 174.66 -50.55 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.477 -0.765 . . . . 0.0 110.253 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.4 pttt -76.59 3.17 12.05 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.256 -0.902 . . . . 0.0 110.292 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.48 ' HG2' ' HD2' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -60.08 -158.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.35 -0.844 . . . . 0.0 110.568 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.472 ' O ' ' HD2' ' A' ' 59' ' ' ARG . 59.8 m -78.84 -119.92 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.355 -0.841 . . . . 0.0 110.522 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -149.41 12.16 0.81 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.822 -1.174 . . . . 0.0 110.714 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.458 ' O ' HD23 ' A' ' 27' ' ' LEU . . . 110.8 101.67 2.65 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.476 ' O ' HD21 ' A' ' 27' ' ' LEU . 41.4 p90 -140.5 -168.86 2.65 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.09 -1.241 . . . . 0.0 110.472 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 50' ' ' LEU . . . -155.8 179.71 31.53 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.598 ' CD2' ' CD2' ' A' ' 50' ' ' LEU . 16.8 m-85 -148.6 146.68 28.34 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.493 -1.004 . . . . 0.0 108.751 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.53 HG12 ' CG1' ' A' ' 46' ' ' VAL . 5.6 t -148.08 106.18 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 120.806 -1.184 . . . . 0.0 111.295 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.463 ' HA ' ' HB2' ' A' ' 21' ' ' LYS . 39.0 m -82.45 56.76 3.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.14 -0.975 . . . . 0.0 110.049 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.597 ' CE1' ' HB2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -85.59 -144.13 0.1 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 110.74 -179.811 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.57 ' O ' ' CE1' ' A' ' 68' ' ' PHE . 5.9 tpt -79.56 167.44 20.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.179 -0.951 . . . . 0.0 110.272 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.403 ' HA ' HG21 ' A' ' 74' ' ' VAL . 52.9 m-20 -132.1 -2.9 3.56 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.175 -0.953 . . . . 0.0 110.618 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -84.12 -93.39 0.07 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.03 -1.044 . . . . 0.0 110.094 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.96 -22.35 60.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.135 -0.978 . . . . 0.0 109.723 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.527 ' O ' ' CG2' ' A' ' 77' ' ' VAL . . . -59.14 -55.05 32.97 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.403 HG21 ' HA ' ' A' ' 70' ' ' ASP . 54.8 t -45.17 -38.93 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.124 -1.221 . . . . 0.0 110.354 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.87 -73.31 0.13 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.211 -0.931 . . . . 0.0 110.303 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.45 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -45.09 -43.06 9.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.241 -0.912 . . . . 0.0 109.469 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.583 ' CG1' ' CE ' ' A' ' 22' ' ' MET . 93.4 t -54.02 -55.61 13.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.251 -0.905 . . . . 0.0 108.886 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 81' ' ' SER . 0.1 OUTLIER -40.41 -47.27 2.55 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.716 -0.615 . . . . 0.0 109.993 178.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -43.53 -26.96 0.25 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.507 -0.746 . . . . 0.0 109.678 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.541 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 43.8 mm-40 -103.08 24.71 10.4 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.447 -0.783 . . . . 0.0 110.056 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.54 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 30.4 t -57.8 -13.74 4.76 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.556 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -99.71 -17.0 17.96 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 121.425 -0.797 . . . . 0.0 109.675 179.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.688 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 0.7 OUTLIER 31.14 32.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.613 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.556 ' N ' ' O ' ' A' ' 82' ' ' ARG . 0.8 OUTLIER -77.92 121.65 24.44 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.431 -1.418 . . . . 0.0 109.154 179.392 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -144.67 -80.88 0.17 Allowed 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.323 -178.562 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.526 ' O ' ' CD ' ' A' ' 88' ' ' LYS . 7.7 t70 -87.1 51.62 2.29 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.506 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 70.44 6.93 6.02 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -178.415 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 6.4 mmmt -108.49 120.94 43.88 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.58 -0.7 . . . . 0.0 109.964 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.491 ' O ' ' CG2' ' A' ' 89' ' ' THR . 13.4 t -100.07 67.4 1.4 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.562 -0.711 . . . . 0.0 109.589 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.629 ' HB ' ' CG ' ' A' ' 83' ' ' HIS . 1.3 mm -49.86 -179.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 119.621 -0.831 . . . . 0.0 109.544 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -141.06 79.56 17.96 Favored Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 121.163 -0.961 . . . . 0.0 110.272 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.541 ' CG ' ' O ' ' A' ' 80' ' ' GLN . 2.4 Cg_endo -51.81 113.11 1.02 Allowed 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.415 1.219 . . . . 0.0 110.201 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.633 ' CE ' ' CD2' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -135.41 113.33 11.08 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.27 -0.894 . . . . 0.0 109.965 179.221 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.518 HG22 ' CG ' ' A' ' 22' ' ' MET . 58.4 t -96.65 172.97 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.253 -0.905 . . . . 0.0 110.253 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.425 ' N ' HG13 ' A' ' 94' ' ' VAL . . . 47.96 -163.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.201 -0.937 . . . . 0.0 110.393 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.516 ' CD1' ' N ' ' A' ' 96' ' ' PHE . 12.3 p90 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.305 -0.872 . . . . 0.0 110.117 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.1 m . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.256 0.551 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.533 ' CB ' ' CG2' ' A' ' 67' ' ' THR . 4.6 pttt -76.63 154.38 34.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.121 -0.987 . . . . 0.0 110.197 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.586 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -75.79 174.0 10.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.186 -0.946 . . . . 0.0 109.478 179.443 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.691 ' CG ' ' CE1' ' A' ' 65' ' ' PHE . 5.9 t80 -150.6 139.4 20.8 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.204 -0.935 . . . . 0.0 109.825 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.597 HD11 ' CZ ' ' A' ' 40' ' ' PHE . 13.6 mm -106.68 152.87 8.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.49 ' O ' ' CG2' ' A' ' 90' ' ' ILE . . . -126.69 139.3 11.19 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 119.175 -1.488 . . . . 0.0 111.764 -178.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.475 ' C ' HG22 ' A' ' 90' ' ' ILE . . . 56.52 43.65 90.67 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.561 ' HA ' ' CG2' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -75.74 142.58 42.38 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.412 -1.052 . . . . 0.0 110.63 -179.311 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.474 ' HB2' ' HB ' ' A' ' 31' ' ' THR . 5.0 m -39.57 132.91 1.52 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.617 -0.677 . . . . 0.0 110.447 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.455 ' CZ3' ' HB3' ' A' ' 30' ' ' GLN . 47.6 p-90 -71.16 -17.95 62.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.465 -0.772 . . . . 0.0 110.624 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.455 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 10.9 pt20 -89.58 -18.12 27.19 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.184 -0.948 . . . . 0.0 110.82 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.474 ' HB ' ' HB2' ' A' ' 28' ' ' SER . 6.9 t -55.61 -173.42 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.874 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.4 t -147.85 -172.6 4.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.348 -0.845 . . . . 0.0 109.875 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 36' ' ' LEU . 3.9 mt-30 -77.79 -74.23 0.27 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.032 -1.043 . . . . 0.0 110.531 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.552 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 2.7 tt0 -48.05 -41.53 26.15 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.949 -1.094 . . . . 0.0 110.182 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.531 ' O ' ' HG3' ' A' ' 38' ' ' GLU . . . -57.47 -28.95 60.08 Favored Glycine 0 C--N 1.296 -1.684 0 N-CA-C 107.424 -2.271 . . . . 0.0 107.424 178.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.531 ' CD1' HG22 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -82.5 -38.59 23.64 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.135 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.552 ' HG3' ' HA ' ' A' ' 34' ' ' GLU . 26.4 mtt180 -61.79 -27.09 68.5 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 122.418 1.104 . . . . 0.0 108.135 178.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.531 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -87.44 -19.27 28.26 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.373 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.653 ' CE1' ' NE2' ' A' ' 83' ' ' HIS . 26.9 t80 -79.24 -30.52 43.21 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.254 -0.904 . . . . 0.0 110.205 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.597 ' CZ ' HD11 ' A' ' 24' ' ' ILE . 27.0 m-85 -108.8 -25.33 10.85 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.459 -0.776 . . . . 0.0 109.166 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -70.26 -7.84 60.98 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -63.95 -49.61 71.88 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 121.417 -1.049 . . . . 0.0 109.699 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -113.82 12.6 18.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.464 -0.772 . . . . 0.0 109.763 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 45' ' ' GLU . . . -142.85 -117.22 1.23 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.515 ' OE2' ' CB ' ' A' ' 70' ' ' ASP . 1.9 pt-20 177.09 103.47 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.406 -1.055 . . . . 0.0 109.906 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.521 ' HA ' ' CB ' ' A' ' 68' ' ' PHE . 63.3 t -89.41 126.58 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.19 -0.944 . . . . 0.0 110.702 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.95 -26.98 11.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.265 -0.897 . . . . 0.0 109.592 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -158.76 131.94 7.26 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.47 -0.769 . . . . 0.0 109.446 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 24.8 p -150.37 154.64 38.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.972 -1.08 . . . . 0.0 111.288 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.521 ' CD1' ' C ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -125.04 126.11 44.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.391 -0.818 . . . . 0.0 109.261 178.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.592 ' CG1' ' N ' ' A' ' 52' ' ' MET . 17.4 t -89.73 169.38 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.79 -1.194 . . . . 0.0 112.104 -178.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.606 ' O ' ' CE1' ' A' ' 63' ' ' PHE . 2.2 ptt? 38.12 -155.92 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.733 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.591 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -150.0 124.84 9.85 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.176 0.512 . . . . 0.0 110.321 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.46 ' HB3' HD22 ' A' ' 56' ' ' LEU . 33.0 t0 -43.49 103.69 0.33 Allowed Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.229 -0.92 . . . . 0.0 110.239 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 53' ' ' ARG . 3.1 Cg_exo -61.08 96.12 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.398 1.21 . . . . 0.0 110.635 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.46 HD22 ' HB3' ' A' ' 54' ' ' ASP . 6.3 mt -90.0 -49.42 6.61 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.276 -0.89 . . . . 0.0 109.79 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 179.1 -30.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.51 -0.744 . . . . 0.0 110.141 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.452 ' O ' ' HD2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -154.29 17.13 0.48 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.321 -0.862 . . . . 0.0 110.293 179.726 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.524 ' HD3' ' CG ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -57.59 -158.64 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.242 -0.911 . . . . 0.0 110.57 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.52 ' N ' ' HD3' ' A' ' 59' ' ' ARG . 40.2 t -65.27 -132.4 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.352 -0.842 . . . . 0.0 110.64 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.24 28.74 0.73 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.019 -1.05 . . . . 0.0 110.379 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.601 ' HA2' ' HA ' ' A' ' 52' ' ' MET . . . 96.67 108.52 2.51 Favored Glycine 0 N--CA 1.481 1.684 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.606 ' CE1' ' O ' ' A' ' 52' ' ' MET . 0.2 OUTLIER -136.99 -176.1 4.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.087 -1.243 . . . . 0.0 109.96 179.282 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.474 ' O ' ' HB ' ' A' ' 24' ' ' ILE . . . -135.22 100.79 0.37 Allowed Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.087 -1.53 . . . . 0.0 110.4 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.691 ' CE1' ' CG ' ' A' ' 23' ' ' PHE . 11.7 m-85 -81.23 136.02 35.79 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.119 -1.224 . . . . 0.0 108.627 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.531 HG22 ' CD1' ' A' ' 36' ' ' LEU . 3.1 t -145.99 106.6 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 118.782 -1.167 . . . . 0.0 111.16 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.533 ' CG2' ' CB ' ' A' ' 21' ' ' LYS . 1.4 m -82.63 47.21 1.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.609 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.586 ' CE1' ' HB3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -73.94 59.46 0.7 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.357 -0.84 . . . . 0.0 110.619 -179.455 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.408 ' C ' ' O ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -42.56 122.32 2.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 110.249 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.515 ' CB ' ' OE2' ' A' ' 45' ' ' GLU . 13.6 p-10 -150.77 -163.45 1.78 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.277 -0.889 . . . . 0.0 110.141 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.61 -88.58 0.62 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.891 . . . . 0.0 110.118 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.91 -23.76 63.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.923 . . . . 0.0 109.939 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.462 ' HA3' ' OD2' ' A' ' 70' ' ' ASP . . . -49.49 -44.63 36.96 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.528 ' O ' ' CD1' ' A' ' 78' ' ' LEU . 19.5 t -46.73 -52.27 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.352 -1.087 . . . . 0.0 109.868 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.434 ' HB3' ' HE2' ' A' ' 76' ' ' LYS . 4.6 t0 -54.08 -50.04 67.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.068 -1.02 . . . . 0.0 109.681 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.503 ' N ' ' HE2' ' A' ' 76' ' ' LYS . 6.3 mmpt? -56.26 -35.53 67.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.33 -0.856 . . . . 0.0 109.816 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.573 HG11 ' CE1' ' A' ' 40' ' ' PHE . 60.5 t -59.17 -57.07 13.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 O-C-N 121.045 -1.035 . . . . 0.0 109.477 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.528 ' CD1' ' O ' ' A' ' 74' ' ' VAL . 2.8 mp -44.84 -41.55 7.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.239 -0.913 . . . . 0.0 109.06 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -46.34 -27.99 1.2 Allowed 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.304 -0.873 . . . . 0.0 109.281 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.515 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 7.2 mm100 -101.85 25.18 8.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.533 -0.729 . . . . 0.0 109.68 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.536 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 21.4 p -56.44 -16.44 5.81 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.522 ' O ' ' C ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -97.34 -9.49 27.39 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.633 -0.667 . . . . 0.0 109.792 179.193 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.653 ' NE2' ' CE1' ' A' ' 39' ' ' TYR . 0.6 OUTLIER 19.48 48.9 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 179.81 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -91.9 125.57 36.66 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 118.493 -1.283 . . . . 0.0 109.172 178.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.539 ' CD2' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -145.34 -91.53 0.1 Allowed 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.663 -0.648 . . . . 0.0 109.655 -179.158 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.529 ' O ' ' CB ' ' A' ' 87' ' ' SER . 10.6 m-20 -79.86 52.62 1.51 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.097 -1.002 . . . . 0.0 108.74 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 72.18 9.72 5.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.618 -0.676 . . . . 0.0 109.857 -179.129 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 9.0 mmtt -111.24 120.72 43.21 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.372 -0.83 . . . . 0.0 109.608 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.496 ' O ' ' CG2' ' A' ' 89' ' ' THR . 11.9 t -101.87 69.23 1.18 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.505 -0.747 . . . . 0.0 109.726 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.599 ' HB ' ' CG ' ' A' ' 83' ' ' HIS . 0.8 OUTLIER -50.15 -178.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.389 -179.714 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -141.45 81.04 15.74 Favored Pre-proline 0 C--N 1.3 -1.558 0 O-C-N 121.189 -0.944 . . . . 0.0 109.817 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.543 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . 2.4 Cg_endo -53.96 112.58 1.01 Allowed 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 123.542 1.285 . . . . 0.0 111.275 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.576 ' HD2' ' CD2' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -128.02 104.89 8.04 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.916 0.865 . . . . 0.0 108.848 177.894 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.533 ' O ' ' CB ' ' A' ' 95' ' ' ALA . 6.2 t -96.19 -174.49 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 O-C-N 121.854 -0.529 . . . . 0.0 110.004 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.533 ' CB ' ' O ' ' A' ' 94' ' ' VAL . . . 71.39 159.07 0.2 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.181 -0.949 . . . . 0.0 110.431 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.5 p90 . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.319 -0.863 . . . . 0.0 110.089 179.874 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 30.1 p . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 121.245 0.545 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.533 ' CB ' ' OG1' ' A' ' 67' ' ' THR . 0.4 OUTLIER -170.08 179.48 3.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 110.236 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.577 ' SD ' ' CZ ' ' A' ' 68' ' ' PHE . 0.5 OUTLIER -83.81 178.92 7.72 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.248 -0.907 . . . . 0.0 110.528 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.616 ' HB3' ' HD2' ' A' ' 93' ' ' LYS . 0.1 OUTLIER -150.47 143.68 24.91 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.489 -0.757 . . . . 0.0 109.068 179.785 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.561 HG23 HG23 ' A' ' 90' ' ' ILE . 1.1 mp -106.85 144.62 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.069 -1.019 . . . . 0.0 109.34 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 91' ' ' ASP . . . -131.51 122.76 3.51 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 119.734 -1.222 . . . . 0.0 111.281 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.521 ' CA ' HG22 ' A' ' 90' ' ' ILE . . . 113.21 34.0 1.87 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.508 HD21 ' CG1' ' A' ' 51' ' ' VAL . 2.0 mp -39.93 137.37 0.95 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.682 -0.893 . . . . 0.0 110.715 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.482 ' N ' ' OG1' ' A' ' 31' ' ' THR . 5.0 p -56.39 -174.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 0.0 110.06 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 47.9 p-90 -77.62 5.23 9.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 0.0 110.238 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -161.67 16.17 0.1 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.111 -0.993 . . . . 0.0 111.158 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.482 ' OG1' ' N ' ' A' ' 28' ' ' SER . 98.7 m -53.6 157.54 2.16 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.055 -1.028 . . . . 0.0 110.307 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.8 t -148.23 178.55 8.47 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.101 -1.0 . . . . 0.0 110.27 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.544 ' O ' ' N ' ' A' ' 36' ' ' LEU . 7.1 mt-30 -62.61 -74.14 0.1 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.96 . . . . 0.0 111.166 -178.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.545 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 1.6 tt0 -49.68 -36.05 23.74 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.73 -1.232 . . . . 0.0 110.028 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.523 ' O ' ' HG3' ' A' ' 38' ' ' GLU . . . -61.04 -28.85 69.53 Favored Glycine 0 C--N 1.295 -1.711 0 N-CA-C 107.148 -2.381 . . . . 0.0 107.148 178.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.544 ' N ' ' O ' ' A' ' 33' ' ' GLN . 0.1 OUTLIER -80.56 -41.42 24.13 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.047 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.545 ' HG3' ' HA ' ' A' ' 34' ' ' GLU . 19.8 mtp180 -61.65 -27.77 68.91 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 122.385 1.088 . . . . 0.0 108.238 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.2 OUTLIER -87.25 -15.7 37.37 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.11 179.454 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.691 ' CE2' ' CE1' ' A' ' 83' ' ' HIS . 10.4 t80 -86.76 -43.37 12.59 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 121.345 -0.847 . . . . 0.0 110.797 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.46 ' HA ' ' CZ ' ' A' ' 43' ' ' PHE . 48.1 m-85 -101.36 -33.66 9.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.875 . . . . 0.0 109.193 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -59.76 -17.19 41.38 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -61.96 -45.72 92.44 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.474 -1.015 . . . . 0.0 109.956 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.46 ' CZ ' ' HA ' ' A' ' 40' ' ' PHE . 4.9 p90 -119.58 -2.98 10.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.445 -0.784 . . . . 0.0 109.948 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.441 ' O ' ' HA2' ' A' ' 41' ' ' GLY . . . -137.77 93.26 0.21 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.537 ' O ' ' CB ' ' A' ' 68' ' ' PHE . 1.9 mt-10 -40.03 105.91 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.411 -1.052 . . . . 0.0 110.15 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 68' ' ' PHE . 43.3 t -88.85 126.06 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 110.446 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -99.12 -31.33 11.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.278 -0.889 . . . . 0.0 110.032 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.81 135.89 17.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.29 -0.881 . . . . 0.0 110.274 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.47 ' HB2' HD23 ' A' ' 36' ' ' LEU . 31.9 p -150.48 166.66 29.48 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.876 . . . . 0.0 110.017 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.539 ' HG ' ' HB2' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -150.45 126.02 10.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.962 -1.086 . . . . 0.0 110.695 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.508 ' CG1' HD21 ' A' ' 27' ' ' LEU . 98.9 t -113.66 142.29 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.861 -1.149 . . . . 0.0 110.002 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.481 ' HG3' ' HB3' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -144.87 143.32 30.53 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.287 -0.883 . . . . 0.0 110.376 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.437 ' O ' ' CB ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -151.53 136.73 17.51 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.68 -0.637 . . . . 0.0 110.259 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.543 ' CB ' ' HB2' ' A' ' 59' ' ' ARG . 0.3 OUTLIER 172.05 122.12 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.187 -0.946 . . . . 0.0 109.896 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.402 ' O ' ' CD2' ' A' ' 56' ' ' LEU . 3.2 Cg_exo -61.02 69.69 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.238 0 O-C-N 123.339 1.178 . . . . 0.0 110.907 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 54' ' ' ASP . 10.4 mt -130.02 -63.61 0.9 Allowed 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.238 -0.914 . . . . 0.0 109.821 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -172.41 -55.45 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.437 -0.79 . . . . 0.0 110.752 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -86.27 -42.53 13.68 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.173 -0.954 . . . . 0.0 109.362 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.543 ' HB2' ' CB ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -83.35 -29.84 27.92 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.244 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 54' ' ' ASP . 31.1 t -39.83 -27.05 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.081 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -93.75 -16.81 23.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.137 -0.977 . . . . 0.0 110.412 -179.293 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 59' ' ' ARG . . . 65.22 91.33 0.04 OUTLIER Glycine 0 N--CA 1.483 1.769 0 N-CA-C 108.349 -1.9 . . . . 0.0 108.349 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 23' ' ' PHE . 50.3 p90 -132.32 -162.3 1.22 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.092 -1.24 . . . . 0.0 110.376 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 50' ' ' LEU . . . -166.53 174.85 42.0 Favored Glycine 0 N--CA 1.488 2.122 0 C-N-CA 119.319 -1.419 . . . . 0.0 110.677 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.539 ' HB2' ' HG ' ' A' ' 50' ' ' LEU . 9.8 m-85 -136.24 145.09 45.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.756 -0.849 . . . . 0.0 109.008 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.522 ' HB ' ' CE ' ' A' ' 22' ' ' MET . 16.2 t -149.98 143.4 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.981 -1.074 . . . . 0.0 110.585 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.533 ' OG1' ' CB ' ' A' ' 21' ' ' LYS . 1.5 m -137.24 58.73 1.7 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.303 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.587 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -63.94 -177.35 0.25 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.071 -1.018 . . . . 0.0 110.557 -179.603 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.17 55.17 1.87 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.157 -0.964 . . . . 0.0 110.257 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.469 ' OD2' ' N ' ' A' ' 73' ' ' GLY . 12.1 t70 -110.26 143.45 40.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.343 -0.848 . . . . 0.0 110.044 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.94 -48.07 82.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.232 -0.918 . . . . 0.0 110.312 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 75' ' ' ASP . . . -89.93 22.32 3.23 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.255 -0.903 . . . . 0.0 110.176 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.469 ' N ' ' OD2' ' A' ' 70' ' ' ASP . . . -51.65 -74.46 0.29 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 16.4 t -45.73 -32.54 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.22 -1.165 . . . . 0.0 110.092 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 72' ' ' ALA . 0.5 OUTLIER -62.39 -76.84 0.05 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.175 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.19 -42.72 41.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 0.0 109.797 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.455 ' CG2' ' O ' ' A' ' 73' ' ' GLY . 62.1 t -54.39 -53.81 27.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 O-C-N 121.103 -0.998 . . . . 0.0 108.916 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -42.76 -52.61 4.92 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.405 -0.809 . . . . 0.0 109.723 178.701 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 78' ' ' LEU . . . -44.89 -28.75 0.69 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.344 -0.848 . . . . 0.0 109.531 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.544 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 43.9 mm-40 -97.44 21.44 10.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.478 -0.764 . . . . 0.0 110.037 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.522 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 47.8 t -56.87 -13.09 2.32 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.506 -0.746 . . . . 0.0 109.093 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.49 ' O ' ' C ' ' A' ' 83' ' ' HIS . 7.0 ptt180 -103.07 -11.39 18.15 Favored 'General case' 0 C--N 1.31 -1.121 0 O-C-N 121.349 -0.845 . . . . 0.0 109.797 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.691 ' CE1' ' CE2' ' A' ' 39' ' ' TYR . 0.5 OUTLIER 29.63 51.65 0.08 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.877 -0.514 . . . . 0.0 112.127 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.524 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 3.6 tt0 -90.58 126.17 35.86 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.672 -1.268 . . . . 0.0 109.202 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.534 ' CD2' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -147.37 -79.73 0.15 Allowed 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.565 -179.141 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.531 ' O ' ' CD ' ' A' ' 88' ' ' LYS . 7.9 m-20 -85.33 49.89 1.84 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.502 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER 70.22 6.98 6.03 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.483 0.658 . . . . 0.0 109.557 -178.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.531 ' CD ' ' O ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -110.31 125.9 53.64 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.35 -0.844 . . . . 0.0 109.76 -179.594 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.487 ' O ' ' O ' ' A' ' 90' ' ' ILE . 9.3 t -99.77 75.45 1.9 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.577 -0.702 . . . . 0.0 109.562 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.594 ' HB ' ' CG ' ' A' ' 83' ' ' HIS . 0.9 OUTLIER -52.61 -174.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.372 -0.83 . . . . 0.0 109.181 -179.663 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 25' ' ' GLY . 20.4 t0 -142.26 85.3 10.82 Favored Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 120.565 -1.334 . . . . 0.0 111.684 -178.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.567 ' HG3' ' HD2' ' A' ' 83' ' ' HIS . 2.0 Cg_endo -59.98 113.44 1.65 Allowed 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.462 1.243 . . . . 0.0 110.757 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.616 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -123.67 108.77 12.92 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.03 -1.043 . . . . 0.0 109.774 178.073 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.534 ' CG2' ' HB2' ' A' ' 22' ' ' MET . 43.0 t -96.24 170.18 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.485 -0.76 . . . . 0.0 110.082 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.26 -152.39 0.12 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.898 . . . . 0.0 110.284 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.897 . . . . 0.0 110.232 -179.882 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 14.2 t . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.303 0.573 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 0.3 OUTLIER -66.66 156.6 34.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.183 -0.948 . . . . 0.0 110.088 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.643 ' CE ' ' CZ ' ' A' ' 68' ' ' PHE . 0.9 OUTLIER -86.15 -169.87 2.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.217 -0.927 . . . . 0.0 110.323 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.636 ' HB3' ' HD2' ' A' ' 93' ' ' LYS . 0.7 OUTLIER -149.97 152.1 34.4 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.355 -0.84 . . . . 0.0 109.466 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.543 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 1.1 mp -113.46 134.52 55.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.323 -0.86 . . . . 0.0 109.243 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.498 ' O ' ' CG2' ' A' ' 90' ' ' ILE . . . -102.51 136.86 13.05 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.812 -1.185 . . . . 0.0 110.699 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.466 ' C ' HG21 ' A' ' 90' ' ' ILE . . . 58.82 39.72 94.18 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.518 ' HA ' ' CG2' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -60.59 154.31 21.43 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.444 -1.033 . . . . 0.0 110.056 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.543 ' CB ' ' HB ' ' A' ' 31' ' ' THR . 0.5 OUTLIER -40.58 134.8 1.71 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.352 -0.843 . . . . 0.0 110.343 -179.673 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 11.0 p-90 -77.43 -12.26 59.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.342 -0.849 . . . . 0.0 110.63 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -110.93 -12.02 14.28 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.086 -1.009 . . . . 0.0 110.63 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.543 ' HB ' ' CB ' ' A' ' 28' ' ' SER . 13.2 t -61.42 -167.26 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.833 0 CA-C-O 121.628 0.728 . . . . 0.0 110.676 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.443 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 14.7 t -157.18 -168.1 2.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.695 -0.628 . . . . 0.0 109.751 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 36' ' ' LEU . 2.3 mt-30 -68.68 -72.46 0.18 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.082 -1.012 . . . . 0.0 110.207 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -48.33 -45.77 35.69 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.837 -1.165 . . . . 0.0 109.72 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.514 ' O ' ' HG3' ' A' ' 38' ' ' GLU . . . -55.62 -27.03 47.74 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 33' ' ' GLN . 0.1 OUTLIER -83.66 -32.68 25.5 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.082 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.467 ' HD3' ' SG ' ' A' ' 49' ' ' CYS . 18.8 mmm-85 -64.96 -28.71 69.7 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.514 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -90.55 -14.68 32.08 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.571 178.777 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.586 ' OH ' ' CG ' ' A' ' 83' ' ' HIS . 38.7 t80 -81.33 -26.34 35.68 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 121.619 -0.675 . . . . 0.0 110.171 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.521 ' HB3' ' CD2' ' A' ' 68' ' ' PHE . 14.6 m-85 -122.19 -21.51 5.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.887 . . . . 0.0 109.91 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.93 2.12 65.96 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -72.1 -55.78 6.74 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 121.426 -1.043 . . . . 0.0 109.971 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.32 12.66 26.15 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.4 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 45' ' ' GLU . . . -154.17 -116.2 0.59 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -179.74 104.39 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.532 -0.981 . . . . 0.0 109.349 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.57 ' HA ' ' CB ' ' A' ' 68' ' ' PHE . 2.7 p -90.03 149.46 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 111.266 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.77 -39.61 5.53 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.615 -0.678 . . . . 0.0 109.931 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -149.71 148.38 29.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.317 -0.864 . . . . 0.0 110.601 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.497 ' HB2' ' CD2' ' A' ' 36' ' ' LEU . 17.3 p -151.13 164.03 37.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.294 -0.879 . . . . 0.0 110.661 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.513 ' CD1' ' C ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -139.3 123.71 18.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.318 -0.864 . . . . 0.0 109.617 179.039 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.446 HG13 HD12 ' A' ' 27' ' ' LEU . 87.0 t -113.11 136.93 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.803 -1.185 . . . . 0.0 111.227 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.543 ' HG2' ' CE1' ' A' ' 63' ' ' PHE . 1.0 OUTLIER -134.39 150.4 50.89 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.216 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -148.81 135.57 19.75 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.249 -0.907 . . . . 0.0 110.638 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.516 ' CB ' ' HD2' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -172.32 177.78 0.78 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.4 -0.812 . . . . 0.0 109.844 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.516 ' HD2' ' CB ' ' A' ' 54' ' ' ASP . 3.1 Cg_exo -60.71 169.51 5.53 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.744 1.391 . . . . 0.0 110.303 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.584 ' CD1' ' N ' ' A' ' 57' ' ' THR . 4.5 pp -88.69 -46.35 9.09 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.133 -0.979 . . . . 0.0 111.029 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.584 ' N ' ' CD1' ' A' ' 56' ' ' LEU . 0.0 OUTLIER 30.93 -95.7 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.582 -0.699 . . . . 0.0 110.833 179.832 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.47 ' N ' ' OG1' ' A' ' 57' ' ' THR . 0.3 OUTLIER -139.07 7.84 2.46 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.202 -0.937 . . . . 0.0 109.742 179.362 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.541 ' HD3' ' N ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -107.1 -164.88 1.02 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.37 -0.831 . . . . 0.0 110.298 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.541 ' N ' ' HD3' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -56.66 -166.3 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.312 -0.868 . . . . 0.0 110.007 179.754 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -150.59 28.71 0.7 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.299 -0.876 . . . . 0.0 110.371 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 52' ' ' MET . . . 100.29 104.47 2.64 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.346 -1.501 . . . . 0.0 109.346 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.543 ' CE1' ' HG2' ' A' ' 52' ' ' MET . 45.7 p90 -142.35 -164.32 1.79 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.293 -1.122 . . . . 0.0 110.223 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -162.54 114.09 0.59 Allowed Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.597 -1.287 . . . . 0.0 110.15 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.512 ' C ' ' CG2' ' A' ' 66' ' ' VAL . 13.4 m-85 -82.66 142.55 31.61 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.249 -1.148 . . . . 0.0 109.061 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.541 ' HB ' ' CE ' ' A' ' 22' ' ' MET . 5.7 t -150.01 114.9 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.91 -1.119 . . . . 0.0 110.582 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 7.2 t -88.17 32.31 0.77 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.388 -0.82 . . . . 0.0 109.829 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.643 ' CZ ' ' CE ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -66.37 176.66 1.74 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.868 . . . . 0.0 110.73 -179.698 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.464 ' HB3' ' O ' ' A' ' 68' ' ' PHE . 0.7 OUTLIER 174.28 126.31 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.052 -1.03 . . . . 0.0 110.498 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.466 ' OD1' ' HA3' ' A' ' 73' ' ' GLY . 4.1 p-10 -149.75 46.26 0.94 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.378 -0.826 . . . . 0.0 110.029 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.44 ' HB2' ' O ' ' A' ' 70' ' ' ASP . 1.5 mt-30 62.1 -86.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.3 -0.875 . . . . 0.0 110.234 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.45 -2.14 18.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.267 -0.896 . . . . 0.0 110.313 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.466 ' HA3' ' OD1' ' A' ' 70' ' ' ASP . . . -52.4 -65.28 3.38 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 55.6 t -45.1 -31.0 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -1.106 . . . . 0.0 110.254 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -67.85 -61.42 1.88 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.212 -0.93 . . . . 0.0 110.413 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.403 ' O ' ' HB1' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -60.63 -46.88 88.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 110.35 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.525 HG23 ' CZ ' ' A' ' 68' ' ' PHE . 93.9 t -48.28 -62.38 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 O-C-N 121.062 -1.024 . . . . 0.0 109.255 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 81' ' ' SER . 0.1 OUTLIER -41.68 -51.31 4.1 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.338 -0.851 . . . . 0.0 109.897 179.035 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 78' ' ' LEU . . . -44.71 -25.98 0.34 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.211 -0.931 . . . . 0.0 109.548 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.613 ' HB3' ' CE1' ' A' ' 83' ' ' HIS . 7.0 mm-40 -99.91 20.0 15.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.424 -0.797 . . . . 0.0 110.386 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.535 ' HA ' ' HD2' ' A' ' 92' ' ' PRO . 25.2 p -58.07 -13.21 4.31 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.385 -0.822 . . . . 0.0 109.061 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -107.16 10.58 30.01 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.521 -0.737 . . . . 0.0 109.86 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.613 ' CE1' ' HB3' ' A' ' 80' ' ' GLN . 1.6 m-70 -21.88 83.52 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -178.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 82' ' ' ARG . 1.1 tt0 -103.69 122.74 45.67 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.465 HD23 ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -139.89 -89.83 0.18 Allowed 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.338 -0.851 . . . . 0.0 109.818 -178.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 87' ' ' SER . 53.8 t0 -78.14 53.7 1.25 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.126 -0.984 . . . . 0.0 108.356 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 70.98 9.11 6.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.627 -0.671 . . . . 0.0 109.719 -178.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 5.4 mmtt -111.7 113.99 26.71 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 121.286 -0.884 . . . . 0.0 110.25 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.526 ' O ' ' O ' ' A' ' 90' ' ' ILE . 6.8 t -90.37 68.96 6.94 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.532 HG13 ' HB3' ' A' ' 83' ' ' HIS . 1.2 mt -45.44 176.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 121.685 0.755 . . . . 0.0 109.86 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.464 ' HA ' ' O ' ' A' ' 81' ' ' SER . 5.3 t0 -144.88 77.31 13.38 Favored Pre-proline 0 C--N 1.296 -1.719 0 O-C-N 121.196 -0.94 . . . . 0.0 111.157 -178.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.569 ' HG3' ' CD2' ' A' ' 83' ' ' HIS . 2.0 Cg_endo -51.42 114.48 1.58 Allowed 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 123.446 1.235 . . . . 0.0 109.898 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.636 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -129.42 102.69 6.52 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.171 -0.956 . . . . 0.0 110.364 179.133 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.542 ' CG2' ' HB2' ' A' ' 22' ' ' MET . 95.2 t -97.31 161.61 2.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 O-C-N 121.757 -0.589 . . . . 0.0 110.063 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.76 142.83 29.54 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.175 -0.953 . . . . 0.0 110.582 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.381 -0.824 . . . . 0.0 110.09 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 25.1 p . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.216 0.531 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.444 ' HE3' ' HB3' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -148.19 176.09 10.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.343 -0.848 . . . . 0.0 110.249 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.576 ' SD ' ' CD2' ' A' ' 68' ' ' PHE . 1.5 ptt? -86.31 176.97 7.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 110.197 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.593 ' HB3' ' HD2' ' A' ' 93' ' ' LYS . 3.1 t80 -150.51 154.36 37.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.167 -0.958 . . . . 0.0 110.393 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.617 ' CG2' ' CG2' ' A' ' 90' ' ' ILE . 1.3 mp -113.14 137.19 47.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.499 ' O ' HG21 ' A' ' 90' ' ' ILE . . . -112.84 140.29 16.21 Favored Glycine 0 N--CA 1.501 2.973 0 C-N-CA 119.31 -1.424 . . . . 0.0 112.951 -176.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.507 ' C ' HG21 ' A' ' 90' ' ' ILE . . . 59.66 47.06 92.79 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.567 ' HA ' ' CG2' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -79.24 146.47 33.01 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.315 -1.109 . . . . 0.0 111.506 -178.437 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.466 ' O ' HG21 ' A' ' 31' ' ' THR . 18.5 m -39.9 159.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.533 0.682 . . . . 0.0 110.763 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.454 ' HB3' ' HA ' ' A' ' 60' ' ' SER . 67.4 p-90 -92.32 -23.13 19.36 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.434 -0.791 . . . . 0.0 109.644 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.491 ' HG3' ' N ' ' A' ' 31' ' ' THR . 0.1 OUTLIER -83.78 -15.85 46.88 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.263 -0.898 . . . . 0.0 110.249 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.491 ' N ' ' HG3' ' A' ' 30' ' ' GLN . 10.5 t -55.51 -174.31 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.633 0.73 . . . . 0.0 110.598 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.5 t -161.24 -173.01 3.64 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.488 ' O ' ' N ' ' A' ' 36' ' ' LEU . 5.0 mt-30 -71.72 -74.61 0.15 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.998 -1.064 . . . . 0.0 110.781 -178.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.56 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 3.0 tt0 -49.6 -34.13 17.11 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.72 -1.237 . . . . 0.0 110.05 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.511 ' O ' ' HG3' ' A' ' 38' ' ' GLU . . . -60.72 -30.19 71.9 Favored Glycine 0 C--N 1.295 -1.719 0 N-CA-C 107.216 -2.354 . . . . 0.0 107.216 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.519 ' C ' ' CD1' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -82.51 -38.97 23.06 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.192 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.56 ' HG3' ' HA ' ' A' ' 34' ' ' GLU . 18.6 mtt180 -62.5 -27.0 68.84 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.505 1.145 . . . . 0.0 108.23 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -85.67 -21.05 28.54 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.127 179.694 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.661 ' CE1' ' NE2' ' A' ' 83' ' ' HIS . 9.9 t80 -81.94 -41.76 20.39 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.322 -0.861 . . . . 0.0 110.835 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.534 ' CE1' HG13 ' A' ' 77' ' ' VAL . 33.0 m-85 -100.3 -27.68 13.36 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.448 -0.783 . . . . 0.0 108.934 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -67.38 -9.52 55.06 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -64.64 -48.35 75.13 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.472 -1.016 . . . . 0.0 109.97 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.548 ' CG ' ' HB3' ' A' ' 76' ' ' LYS . 6.2 p90 -109.05 5.87 24.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.395 -0.815 . . . . 0.0 110.244 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.507 ' O ' ' HA2' ' A' ' 41' ' ' GLY . . . -162.76 97.74 0.15 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -38.8 124.25 1.35 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.473 -1.016 . . . . 0.0 110.745 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.548 ' HA ' ' CB ' ' A' ' 68' ' ' PHE . 47.7 t -90.07 132.16 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.384 -0.823 . . . . 0.0 110.74 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -98.67 -15.96 19.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.372 -0.83 . . . . 0.0 110.069 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -169.67 143.13 2.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.188 -0.945 . . . . 0.0 110.895 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.497 ' SG ' ' NE ' ' A' ' 37' ' ' ARG . 8.4 p -150.97 164.65 35.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.485 -0.759 . . . . 0.0 109.995 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.639 ' CD2' ' CD2' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -150.36 128.6 12.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.99 -1.069 . . . . 0.0 110.786 179.869 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.6 t -103.74 135.79 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 120.659 -1.275 . . . . 0.0 110.268 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.581 ' HG2' ' CE1' ' A' ' 63' ' ' PHE . 0.2 OUTLIER -141.92 157.11 45.36 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.253 -0.904 . . . . 0.0 109.951 -179.217 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.493 ' HA ' ' O ' ' A' ' 61' ' ' ARG . 7.5 ptt85 -128.11 95.3 4.14 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.32 -0.863 . . . . 0.0 110.235 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.594 ' CB ' ' CD ' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -69.38 -59.34 5.02 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.284 -0.885 . . . . 0.0 110.873 -179.728 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.594 ' CD ' ' CB ' ' A' ' 54' ' ' ASP . 3.0 Cg_exo -56.81 -164.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.375 1.197 . . . . 0.0 111.124 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.469 ' O ' ' HB ' ' A' ' 57' ' ' THR . 4.0 mt -91.0 -66.55 0.92 Allowed 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.391 -0.818 . . . . 0.0 110.655 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 56' ' ' LEU . 1.0 OUTLIER 175.83 -24.12 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.239 -0.913 . . . . 0.0 111.309 -179.611 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.2 pttp -47.83 -37.27 13.42 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.985 -1.072 . . . . 0.0 109.731 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.51 ' HD3' ' N ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -109.37 -158.89 0.66 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.661 -0.649 . . . . 0.0 109.86 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.51 ' N ' ' HD3' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -52.14 -168.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.929 . . . . 0.0 109.916 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -89.98 -48.51 7.16 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.93 -1.106 . . . . 0.0 108.719 179.275 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 165.52 -72.87 0.17 Allowed Glycine 0 N--CA 1.482 1.712 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.586 ' HB2' ' CE2' ' A' ' 23' ' ' PHE . 3.1 p90 -173.39 -174.46 1.02 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.138 -1.213 . . . . 0.0 111.05 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.417 ' O ' ' HB ' ' A' ' 24' ' ' ILE . . . -149.89 123.66 1.63 Allowed Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.639 ' CD2' ' CD2' ' A' ' 50' ' ' LEU . 18.1 m-85 -83.88 148.98 26.65 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.318 -1.107 . . . . 0.0 109.625 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 65' ' ' PHE . 3.7 t -146.44 161.92 9.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.316 -0.865 . . . . 0.0 109.621 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.442 ' CG2' ' CB ' ' A' ' 21' ' ' LYS . 1.8 m -149.56 39.6 0.81 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.198 -0.939 . . . . 0.0 110.229 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.585 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 0.9 OUTLIER -67.17 143.74 56.41 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.151 -0.968 . . . . 0.0 109.858 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 14.0 mtp -117.99 109.95 17.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.192 -0.942 . . . . 0.0 110.439 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -145.43 161.29 40.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.364 -0.835 . . . . 0.0 110.104 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.84 -70.01 0.26 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.258 -0.902 . . . . 0.0 110.159 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.29 2.12 55.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.298 -0.876 . . . . 0.0 110.661 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.426 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -49.9 -57.24 10.07 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.462 ' O ' HD21 ' A' ' 78' ' ' LEU . 49.0 t -47.51 -43.54 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.235 -1.156 . . . . 0.0 110.32 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.533 ' HA ' ' CD2' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -59.58 -39.96 85.86 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.177 -0.952 . . . . 0.0 110.271 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.548 ' HB3' ' CG ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -71.07 -28.33 64.27 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.189 -0.944 . . . . 0.0 109.901 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.534 HG13 ' CE1' ' A' ' 40' ' ' PHE . 55.0 t -64.68 -64.42 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.139 -0.976 . . . . 0.0 109.576 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.533 ' CD2' ' HA ' ' A' ' 75' ' ' ASP . 1.5 pp -47.98 -37.98 15.88 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.109 -0.994 . . . . 0.0 109.185 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 78' ' ' LEU . . . -46.17 -30.14 1.83 Allowed 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.057 -1.027 . . . . 0.0 108.861 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.532 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 1.5 mt-30 -104.62 28.26 7.19 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.411 0.624 . . . . 0.0 109.741 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 78' ' ' LEU . 5.7 p -52.85 -18.52 1.95 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.492 ' O ' ' C ' ' A' ' 83' ' ' HIS . 4.5 ptt180 -94.49 -15.44 24.19 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.482 -0.761 . . . . 0.0 109.565 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.661 ' NE2' ' CE1' ' A' ' 39' ' ' TYR . 0.6 OUTLIER 28.72 46.31 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 179.303 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 0.8 OUTLIER -90.24 124.87 35.23 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 118.583 -1.247 . . . . 0.0 109.545 179.243 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.531 ' CD2' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -147.5 -83.63 0.11 Allowed 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 120.146 -0.621 . . . . 0.0 109.676 -179.493 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' A' ' 87' ' ' SER . 23.7 m-20 -83.18 50.73 1.8 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.11 -0.993 . . . . 0.0 108.818 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 72.63 7.19 5.54 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.472 0.653 . . . . 0.0 109.754 -179.188 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 0.6 OUTLIER -111.42 122.38 47.69 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.405 -0.809 . . . . 0.0 109.656 -179.529 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.471 ' O ' ' O ' ' A' ' 90' ' ' ILE . 9.4 t -101.9 69.43 1.18 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.062 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.617 ' CG2' ' CG2' ' A' ' 24' ' ' ILE . 0.9 OUTLIER -51.48 -176.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.346 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -143.39 84.4 10.19 Favored Pre-proline 0 C--N 1.304 -1.382 0 O-C-N 120.963 -1.086 . . . . 0.0 110.363 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.541 ' HG3' ' HD2' ' A' ' 83' ' ' HIS . 2.3 Cg_endo -56.03 113.42 1.43 Allowed 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.551 1.29 . . . . 0.0 111.167 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.593 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -127.71 104.46 7.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.233 -0.917 . . . . 0.0 109.575 178.385 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.533 ' CG1' ' HB3' ' A' ' 22' ' ' MET . 7.9 t -96.77 164.29 2.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 O-C-N 121.654 -0.654 . . . . 0.0 110.398 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.59 96.63 9.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.218 -0.926 . . . . 0.0 110.136 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 58.5 t80 . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 109.909 -179.945 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.266 0.555 . . . . 0.0 110.286 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.544 ' CB ' ' HB ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -162.47 153.93 18.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.235 -0.916 . . . . 0.0 110.014 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.542 ' CG ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -71.76 -175.94 1.51 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.032 -1.042 . . . . 0.0 109.564 179.648 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.545 ' O ' ' HG2' ' A' ' 93' ' ' LYS . 2.0 t80 -149.03 119.16 7.21 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.076 -1.015 . . . . 0.0 111.487 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.522 ' CD1' ' HA ' ' A' ' 92' ' ' PRO . 17.4 mm -91.33 140.46 16.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.062 -1.024 . . . . 0.0 109.216 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 90' ' ' ILE . . . -119.23 149.42 18.08 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.669 -1.253 . . . . 0.0 111.303 -178.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.467 ' C ' HG22 ' A' ' 90' ' ' ILE . . . 55.97 43.65 87.88 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.532 ' HA ' ' CG2' ' A' ' 90' ' ' ILE . 0.2 OUTLIER -84.37 152.15 24.25 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.468 -1.019 . . . . 0.0 110.584 -179.027 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.53 ' O ' ' CG2' ' A' ' 31' ' ' THR . 14.5 m -41.73 124.66 2.6 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.459 -0.776 . . . . 0.0 110.32 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.496 ' CD2' ' N ' ' A' ' 30' ' ' GLN . 65.1 p-90 -68.2 -33.59 74.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.341 -0.85 . . . . 0.0 110.437 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.496 ' N ' ' CD2' ' A' ' 29' ' ' TRP . 17.8 pt20 -74.35 -12.56 60.56 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.324 -0.86 . . . . 0.0 111.2 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.53 ' CG2' ' O ' ' A' ' 28' ' ' SER . 5.7 t -65.05 -179.45 0.56 Allowed 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.34 -0.85 . . . . 0.0 110.37 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -148.2 -172.65 4.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.338 -0.851 . . . . 0.0 110.155 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 36' ' ' LEU . 6.5 mt-30 -66.2 -73.43 0.13 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.196 -0.94 . . . . 0.0 110.67 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.486 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 3.4 tt0 -47.46 -47.31 27.23 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.759 -1.176 . . . . 0.0 109.718 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.512 ' O ' ' HG3' ' A' ' 38' ' ' GLU . . . -53.36 -27.57 33.13 Favored Glycine 0 N--CA 1.483 1.799 0 N-CA-C 107.711 -2.156 . . . . 0.0 107.711 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.557 ' CD2' ' HB3' ' A' ' 49' ' ' CYS . 0.1 OUTLIER -83.37 -35.49 25.07 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.486 ' HG3' ' HA ' ' A' ' 34' ' ' GLU . 34.1 mtp180 -62.37 -28.34 69.7 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.512 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -90.88 -15.36 30.03 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.534 178.772 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.592 ' OH ' ' CG ' ' A' ' 83' ' ' HIS . 47.9 t80 -75.47 -29.12 59.51 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 121.55 0.69 . . . . 0.0 109.617 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.591 ' CE1' HG12 ' A' ' 77' ' ' VAL . 37.8 m-85 -116.29 -26.11 7.3 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.633 -0.667 . . . . 0.0 109.48 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -68.16 -9.27 56.94 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -71.51 -50.9 26.94 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.439 -1.036 . . . . 0.0 110.593 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 3.1 p90 -109.53 -6.85 15.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.096 -1.003 . . . . 0.0 110.747 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 40' ' ' PHE . . . -150.63 118.6 0.93 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 9.8 pt-20 -54.23 132.9 44.38 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.198 -1.178 . . . . 0.0 109.722 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.446 HG12 HG13 ' A' ' 66' ' ' VAL . 86.3 t -112.14 152.64 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.158 -0.963 . . . . 0.0 110.46 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.478 ' HB3' HG21 ' A' ' 67' ' ' THR . 0.0 OUTLIER -96.74 -29.84 13.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.355 -0.841 . . . . 0.0 109.826 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.461 ' O ' HG22 ' A' ' 67' ' ' THR . 11.6 tp10 -179.68 158.4 0.8 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.341 -0.85 . . . . 0.0 110.058 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.557 ' HB3' ' CD2' ' A' ' 36' ' ' LEU . 7.2 m -146.04 171.01 15.51 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.922 -1.112 . . . . 0.0 110.6 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.61 ' CD2' ' CD2' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -138.9 134.65 33.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.304 -0.873 . . . . 0.0 109.397 179.691 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.537 ' CG2' HD22 ' A' ' 36' ' ' LEU . 76.4 t -125.62 139.36 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.47 -1.394 . . . . 0.0 111.612 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.579 ' HG2' ' CE2' ' A' ' 63' ' ' PHE . 0.7 OUTLIER -142.62 143.6 32.46 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.347 -0.845 . . . . 0.0 109.747 179.542 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.459 ' O ' ' HD3' ' A' ' 55' ' ' PRO . 12.2 ptt180 -151.05 19.97 0.77 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.597 -0.69 . . . . 0.0 110.185 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -114.24 81.49 6.52 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.285 -0.884 . . . . 0.0 110.355 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 53' ' ' ARG . 2.9 Cg_endo -62.47 112.21 1.53 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.793 1.417 . . . . 0.0 110.621 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.455 HD12 HG22 ' A' ' 57' ' ' THR . 2.1 pp -89.39 -26.23 21.14 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.271 -0.893 . . . . 0.0 109.956 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.455 HG22 HD12 ' A' ' 56' ' ' LEU . 5.2 t -132.9 -130.77 0.18 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.575 -0.703 . . . . 0.0 109.587 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.24 31.5 6.23 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 120.97 -1.081 . . . . 0.0 110.319 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.476 ' HD3' ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -98.08 -160.87 0.83 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.276 -0.89 . . . . 0.0 110.512 -179.762 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.476 ' OG ' ' HD3' ' A' ' 59' ' ' ARG . 4.5 p -40.65 160.04 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.218 -0.926 . . . . 0.0 110.406 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.77 38.75 0.69 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.132 -0.98 . . . . 0.0 110.527 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.487 ' O ' HD23 ' A' ' 27' ' ' LEU . . . 144.66 81.94 0.05 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.579 ' CE2' ' HG2' ' A' ' 52' ' ' MET . 49.6 p90 -144.54 -167.95 2.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.139 -1.212 . . . . 0.0 110.29 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 50' ' ' LEU . . . -168.49 123.93 1.14 Allowed Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.569 -1.3 . . . . 0.0 110.199 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.61 ' CD2' ' CD2' ' A' ' 50' ' ' LEU . 27.5 m-85 -85.84 152.26 23.14 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.477 -1.013 . . . . 0.0 108.899 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.509 ' O ' ' HB2' ' A' ' 22' ' ' MET . 11.2 t -150.33 104.25 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.615 -1.303 . . . . 0.0 111.62 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.544 ' HB ' ' CB ' ' A' ' 21' ' ' LYS . 2.3 t -87.71 125.95 34.7 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.112 -0.993 . . . . 0.0 109.129 178.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.639 ' CE2' ' CG2' ' A' ' 77' ' ' VAL . 5.8 m-85 -95.79 -157.41 0.58 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.027 -1.046 . . . . 0.0 109.986 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -171.62 38.48 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.174 -0.953 . . . . 0.0 110.214 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.516 ' OD2' ' N ' ' A' ' 73' ' ' GLY . 5.6 p-10 -148.46 -143.3 0.14 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.252 -0.905 . . . . 0.0 110.112 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.404 ' O ' ' C ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -130.12 -82.61 0.55 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.199 -0.938 . . . . 0.0 110.108 179.869 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 73' ' ' GLY . . . -45.08 -33.07 1.98 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.205 -0.934 . . . . 0.0 110.084 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.516 ' N ' ' OD2' ' A' ' 70' ' ' ASP . . . -43.94 -42.67 6.57 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.425 HG13 HG11 ' A' ' 94' ' ' VAL . 21.3 t -64.76 -55.24 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -1.145 . . . . 0.0 110.15 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.478 ' HA ' HD23 ' A' ' 78' ' ' LEU . 10.8 m-20 -41.97 -40.97 2.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 110.206 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.441 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 33.7 mmtt -72.67 -46.6 53.06 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.422 -0.799 . . . . 0.0 110.186 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.639 ' CG2' ' CE2' ' A' ' 68' ' ' PHE . 58.0 t -53.06 -68.3 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.124 -0.985 . . . . 0.0 109.767 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.478 HD23 ' HA ' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -45.65 -39.01 7.32 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.061 -1.024 . . . . 0.0 109.209 179.123 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -48.88 -24.23 1.39 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.077 -1.014 . . . . 0.0 108.9 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.605 ' HB3' ' CE1' ' A' ' 83' ' ' HIS . 2.9 mm-40 -105.23 28.03 7.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.585 -0.697 . . . . 0.0 109.987 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.537 ' HA ' ' HD2' ' A' ' 92' ' ' PRO . 14.3 t -61.17 -10.79 7.13 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.448 -0.783 . . . . 0.0 109.123 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -108.49 11.1 27.11 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 121.418 -0.801 . . . . 0.0 109.896 179.646 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.605 ' CE1' ' HB3' ' A' ' 80' ' ' GLN . 1.7 m-70 -23.73 85.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -178.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 1.4 tt0 -106.99 121.41 44.41 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.615 ' CD1' ' N ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -142.35 -97.97 0.13 Allowed 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.991 -179.467 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.547 ' N ' HD21 ' A' ' 85' ' ' LEU . 25.4 t70 -69.73 55.64 0.13 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.834 -1.166 . . . . 0.0 108.741 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 70.42 8.37 6.59 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.445 -0.785 . . . . 0.0 110.138 -179.473 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.529 ' CD ' ' O ' ' A' ' 86' ' ' ASP . 2.3 mmmt -111.01 111.6 22.82 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.177 -0.952 . . . . 0.0 110.672 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.532 ' O ' ' O ' ' A' ' 90' ' ' ILE . 7.1 t -89.46 63.49 6.38 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.535 HG13 ' HB3' ' A' ' 83' ' ' HIS . 1.2 mt -42.65 172.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 CA-C-O 121.925 0.869 . . . . 0.0 110.277 -178.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.463 ' HA ' ' O ' ' A' ' 81' ' ' SER . 14.4 t0 -144.17 77.01 14.65 Favored Pre-proline 0 C--N 1.298 -1.637 0 O-C-N 121.32 -0.863 . . . . 0.0 110.786 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.586 ' HG3' ' CD2' ' A' ' 83' ' ' HIS . 1.9 Cg_endo -52.48 112.79 0.97 Allowed 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.514 1.27 . . . . 0.0 110.068 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.581 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 7.0 ptmt -109.43 105.56 14.96 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.627 1.203 . . . . 0.0 110.517 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.544 ' CG2' HG11 ' A' ' 77' ' ' VAL . 39.5 t -98.11 130.76 46.41 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 O-C-N 121.182 -0.949 . . . . 0.0 110.397 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -153.13 169.24 23.46 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.204 -0.935 . . . . 0.0 110.506 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.417 -0.802 . . . . 0.0 109.99 179.807 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.424 ' O ' ' CG2' ' A' ' 67' ' ' THR . 32.4 m . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.297 0.57 . . . . 0.0 110.306 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.549 ' CB ' ' OG1' ' A' ' 67' ' ' THR . 0.0 OUTLIER -168.82 -173.93 1.97 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.32 -0.863 . . . . 0.0 110.137 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.562 ' SD ' ' CE1' ' A' ' 68' ' ' PHE . 3.1 ptm -121.1 -174.21 2.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.049 -1.032 . . . . 0.0 110.151 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.582 ' CD1' ' C ' ' A' ' 23' ' ' PHE . 0.3 OUTLIER -150.47 144.43 25.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.348 -0.845 . . . . 0.0 109.329 179.699 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.44 ' CG2' ' CG2' ' A' ' 90' ' ' ILE . 9.1 mm -108.03 129.26 62.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.122 -0.986 . . . . 0.0 109.475 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.496 ' O ' HG22 ' A' ' 90' ' ' ILE . . . -110.4 144.9 17.16 Favored Glycine 0 N--CA 1.494 2.545 0 C-N-CA 120.114 -1.041 . . . . 0.0 111.239 -178.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.442 ' C ' HG22 ' A' ' 90' ' ' ILE . . . 60.13 34.28 83.34 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.554 ' HA ' ' CG2' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -73.84 146.71 43.94 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.55 -0.971 . . . . 0.0 110.022 -179.608 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.46 ' C ' ' O ' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -39.74 132.83 1.63 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.598 -0.689 . . . . 0.0 110.3 -179.715 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.515 ' CD1' ' N ' ' A' ' 29' ' ' TRP . 0.5 OUTLIER -76.35 6.03 6.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.257 -0.902 . . . . 0.0 110.54 -179.799 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.442 ' O ' ' O ' ' A' ' 31' ' ' THR . 2.8 pt20 -124.47 -12.75 7.22 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.189 -0.944 . . . . 0.0 110.485 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.46 HG22 ' HG ' ' A' ' 27' ' ' LEU . 11.5 t -53.76 -168.7 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.603 -0.686 . . . . 0.0 110.379 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.3 t -145.16 176.15 9.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.446 -0.784 . . . . 0.0 109.748 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 36' ' ' LEU . 3.5 mt-30 -72.0 -72.58 0.22 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.111 -0.993 . . . . 0.0 111.105 -178.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.522 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -46.15 -52.85 11.49 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.672 -1.211 . . . . 0.0 109.436 -179.69 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.483 ' HA2' ' HG3' ' A' ' 38' ' ' GLU . . . -46.75 -32.69 5.99 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 107.822 -2.111 . . . . 0.0 107.822 178.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.53 ' N ' ' O ' ' A' ' 33' ' ' GLN . 0.1 OUTLIER -78.19 -39.34 40.96 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.317 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 34' ' ' GLU . 49.3 mtt180 -60.58 -26.07 66.68 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 122.316 1.055 . . . . 0.0 108.434 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -85.4 -21.28 28.88 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.787 179.513 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.694 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 29.4 t80 -79.97 -24.34 41.0 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.647 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.538 ' CE1' ' HE2' ' A' ' 22' ' ' MET . 25.4 m-85 -114.55 -19.13 11.27 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.332 -0.855 . . . . 0.0 109.104 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.17 -4.12 88.72 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 108.719 -1.753 . . . . 0.0 108.719 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -68.29 -53.05 27.04 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.352 -1.087 . . . . 0.0 110.034 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.412 ' CE1' ' HA ' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -99.41 9.39 43.38 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.277 -0.89 . . . . 0.0 110.259 179.492 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -152.68 -121.92 0.91 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.508 ' CG ' ' O ' ' A' ' 45' ' ' GLU . 5.9 pt-20 -172.08 119.44 0.42 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.385 -1.067 . . . . 0.0 109.687 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.545 ' HA ' ' CB ' ' A' ' 68' ' ' PHE . 28.1 t -93.25 124.09 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.335 -0.853 . . . . 0.0 111.124 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.86 -31.35 19.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.383 -0.823 . . . . 0.0 109.337 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -172.11 151.3 2.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.518 -0.739 . . . . 0.0 109.597 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.5 ' SG ' ' NE ' ' A' ' 37' ' ' ARG . 24.0 p -148.91 167.67 25.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.053 -1.029 . . . . 0.0 110.605 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.561 ' CD1' ' C ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -142.92 122.97 13.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.255 -0.903 . . . . 0.0 110.446 179.693 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.3 t -105.41 137.51 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.027 -1.046 . . . . 0.0 110.368 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.575 ' HG2' ' CZ ' ' A' ' 63' ' ' PHE . 1.9 ttt -134.36 148.56 50.73 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.33 -0.856 . . . . 0.0 110.064 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.33 -40.0 0.74 Allowed 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.333 0.587 . . . . 0.0 109.94 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -49.12 154.56 1.33 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.334 -0.854 . . . . 0.0 109.902 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.9 Cg_endo -63.0 132.3 36.26 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.676 1.356 . . . . 0.0 110.982 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.447 ' HB3' ' HE1' ' A' ' 52' ' ' MET . 3.2 pp -89.69 -29.15 18.97 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.275 -0.89 . . . . 0.0 110.326 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.483 ' CG2' ' CE ' ' A' ' 58' ' ' LYS . 2.9 t -130.02 -37.27 1.5 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.273 -0.892 . . . . 0.0 110.228 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.483 ' CE ' ' CG2' ' A' ' 57' ' ' THR . 0.0 OUTLIER -168.41 -31.6 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.228 -0.92 . . . . 0.0 110.764 179.396 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.566 ' CD ' ' O ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -124.64 -179.43 4.5 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 120.993 -1.067 . . . . 0.0 109.784 179.856 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.566 ' O ' ' CD ' ' A' ' 59' ' ' ARG . 75.7 m -91.95 156.55 17.37 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.389 -0.819 . . . . 0.0 111.621 -179.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.15 -56.74 1.43 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.122 -0.986 . . . . 0.0 109.432 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.483 ' C ' ' CD2' ' A' ' 27' ' ' LEU . . . 91.89 80.83 1.43 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.149 -1.581 . . . . 0.0 109.149 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.575 ' CZ ' ' HG2' ' A' ' 52' ' ' MET . 12.4 p90 -149.82 -169.66 3.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -1.14 . . . . 0.0 110.288 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.456 ' CA ' ' O ' ' A' ' 50' ' ' LEU . . . -167.55 -161.99 18.32 Favored Glycine 0 N--CA 1.485 1.924 0 C-N-CA 119.507 -1.33 . . . . 0.0 110.303 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.49 ' O ' ' HB2' ' A' ' 49' ' ' CYS . 9.1 m-85 -146.23 143.4 29.2 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.769 -0.842 . . . . 0.0 109.074 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.519 HG23 ' CD1' ' A' ' 36' ' ' LEU . 14.1 t -147.85 97.08 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 120.805 -1.184 . . . . 0.0 110.752 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.549 ' OG1' ' CB ' ' A' ' 21' ' ' LYS . 22.7 m -80.68 58.43 3.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.368 -0.832 . . . . 0.0 109.929 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.562 ' CE1' ' SD ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -82.27 -148.19 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 110.609 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.515 ' O ' ' CE1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -61.09 163.28 6.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 110.209 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -131.09 0.45 4.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.884 . . . . 0.0 110.047 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.47 ' O ' HG12 ' A' ' 74' ' ' VAL . 2.4 mt-30 -95.23 -101.3 0.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.878 . . . . 0.0 110.19 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.427 ' O ' ' NZ ' ' A' ' 76' ' ' LYS . . . -67.52 -24.52 65.57 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.938 -1.101 . . . . 0.0 110.005 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.526 ' O ' ' CG2' ' A' ' 77' ' ' VAL . . . -53.67 -65.87 3.13 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.555 ' CG1' ' N ' ' A' ' 75' ' ' ASP . 2.2 p -39.94 -43.19 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.398 -1.06 . . . . 0.0 110.489 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.555 ' N ' ' CG1' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -58.65 -77.86 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.367 -0.833 . . . . 0.0 110.383 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.427 ' NZ ' ' O ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -48.47 -22.45 0.73 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.381 -0.824 . . . . 0.0 110.059 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 73' ' ' GLY . 55.4 t -71.72 -53.43 20.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.256 -0.903 . . . . 0.0 109.666 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.555 ' HG ' ' N ' ' A' ' 79' ' ' ALA . 1.3 pp -50.76 -28.95 10.25 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 120.918 -1.114 . . . . 0.0 108.196 178.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.555 ' N ' ' HG ' ' A' ' 78' ' ' LEU . . . -57.36 -20.03 26.61 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.525 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 1.0 OUTLIER -105.58 19.01 21.28 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.431 0.634 . . . . 0.0 109.481 179.233 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.539 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 46.3 t -53.38 -16.5 1.41 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.604 -0.839 . . . . 0.0 108.747 178.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.571 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -103.66 -2.43 26.59 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 121.358 -0.839 . . . . 0.0 109.618 178.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.694 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 0.3 OUTLIER 27.18 -85.09 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.705 0.764 . . . . 0.0 111.675 179.68 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.571 ' N ' ' O ' ' A' ' 82' ' ' ARG . 0.5 OUTLIER 54.66 122.14 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 122.205 1.002 . . . . 0.0 111.088 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.494 ' CD2' ' N ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -149.19 -92.08 0.07 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.394 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.561 ' O ' ' CB ' ' A' ' 87' ' ' SER . 7.7 t0 -82.54 54.28 2.58 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.067 -1.02 . . . . 0.0 108.495 178.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.561 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER 76.68 6.18 3.39 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.215 0.531 . . . . 0.0 109.975 -179.016 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -110.86 114.41 27.72 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.291 -0.88 . . . . 0.0 110.668 -179.351 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.475 ' O ' ' O ' ' A' ' 90' ' ' ILE . 9.7 t -89.14 76.98 7.64 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.805 -0.559 . . . . 0.0 109.805 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.6 ' HB ' ' CG ' ' A' ' 83' ' ' HIS . 1.5 mt -49.23 179.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.256 -0.903 . . . . 0.0 109.494 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 25' ' ' GLY . 8.0 t0 -140.72 79.55 19.24 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.328 -0.858 . . . . 0.0 110.1 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.539 ' HG2' ' HA ' ' A' ' 81' ' ' SER . 2.3 Cg_endo -54.61 111.94 0.87 Allowed 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.57 1.3 . . . . 0.0 110.749 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.581 ' HD2' ' CD1' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -127.59 103.12 7.15 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.866 0.841 . . . . 0.0 109.235 178.528 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.526 ' CG2' ' HB2' ' A' ' 22' ' ' MET . 15.8 t -97.11 170.48 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-O 121.349 0.595 . . . . 0.0 110.502 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.525 ' O ' ' CB ' ' A' ' 96' ' ' PHE . . . -51.48 -66.08 0.45 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.199 -0.938 . . . . 0.0 110.436 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.525 ' CB ' ' O ' ' A' ' 95' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.709 0 O-C-N 121.184 -0.947 . . . . 0.0 110.067 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.7 m . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.222 0.534 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.401 ' HB2' ' HA ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -166.71 160.13 14.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.16 -0.962 . . . . 0.0 110.325 -179.931 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.569 ' SD ' ' CZ ' ' A' ' 68' ' ' PHE . 7.4 ttt -76.72 163.1 27.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.221 -0.924 . . . . 0.0 110.16 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.706 ' CG ' ' CE1' ' A' ' 65' ' ' PHE . 2.0 t80 -141.64 129.08 21.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.295 -0.878 . . . . 0.0 109.597 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.6 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 1.4 mp -106.48 155.87 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.115 -0.99 . . . . 0.0 109.289 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.57 ' O ' ' N ' ' A' ' 91' ' ' ASP . . . -139.21 139.08 9.8 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 119.245 -1.455 . . . . 0.0 111.42 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.466 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 105.51 27.26 5.86 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.525 ' CD2' HG12 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -50.45 118.58 3.12 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.792 -0.828 . . . . 0.0 110.864 -179.588 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.526 ' HB2' ' CB ' ' A' ' 88' ' ' LYS . 1.4 t -59.43 178.52 0.14 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.38 -0.825 . . . . 0.0 110.212 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.568 ' O ' ' CE3' ' A' ' 29' ' ' TRP . 35.1 p-90 -84.85 15.69 3.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.177 -0.952 . . . . 0.0 110.1 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -143.92 7.45 1.42 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.241 -0.912 . . . . 0.0 110.936 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.9 m -70.66 157.08 38.61 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.125 -0.984 . . . . 0.0 109.892 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.54 ' CG2' ' HA3' ' A' ' 35' ' ' GLY . 4.4 t -127.48 178.04 6.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.083 -1.01 . . . . 0.0 109.922 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.524 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 6.0 mt-30 -88.76 -73.69 0.49 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.15 -0.969 . . . . 0.0 110.734 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.55 ' HG2' ' CD ' ' A' ' 37' ' ' ARG . 0.1 OUTLIER -50.78 -49.67 57.73 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 117.967 -1.493 . . . . 0.0 108.929 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.54 ' HA3' ' CG2' ' A' ' 32' ' ' THR . . . -49.39 -27.72 8.48 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 107.603 -2.199 . . . . 0.0 107.603 178.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.503 ' C ' ' CD1' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -80.69 -32.02 36.06 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.478 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.55 ' CD ' ' HG2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -60.46 -34.79 74.52 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 177.475 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.517 ' HG2' ' HG2' ' A' ' 37' ' ' ARG . 2.0 mt-10 -76.63 -25.44 53.82 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 113.912 -1.494 . . . . 0.0 109.863 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.63 ' CE1' ' NE2' ' A' ' 83' ' ' HIS . 8.0 t80 -75.81 -25.01 55.95 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.511 -0.743 . . . . 0.0 110.82 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.481 ' O ' ' CE1' ' A' ' 43' ' ' PHE . 16.3 m-85 -113.69 -17.86 12.02 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.324 -0.86 . . . . 0.0 109.118 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -79.73 -5.53 89.37 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 108.496 -1.842 . . . . 0.0 108.496 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -63.58 -45.27 91.16 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.492 -1.005 . . . . 0.0 109.888 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.524 ' CD2' ' HB3' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -108.16 1.54 22.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.449 -0.782 . . . . 0.0 110.189 179.608 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.472 ' O ' ' HA2' ' A' ' 41' ' ' GLY . . . -149.64 179.49 26.37 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.609 -1.281 . . . . 0.0 109.933 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 0.4 OUTLIER -101.16 121.18 41.38 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.34 -1.094 . . . . 0.0 110.086 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.535 ' HA ' ' CB ' ' A' ' 68' ' ' PHE . 43.1 t -97.69 121.62 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.131 -0.981 . . . . 0.0 110.651 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . 35.8 tptt -88.91 -36.31 16.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.308 -0.87 . . . . 0.0 109.987 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -161.58 161.28 29.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 0.0 110.328 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 7.6 p -150.12 165.55 32.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.29 -0.881 . . . . 0.0 109.712 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.634 ' CD2' ' CD2' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -149.67 132.93 16.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.049 -1.032 . . . . 0.0 110.751 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.525 HG12 ' CD2' ' A' ' 27' ' ' LEU . 79.3 t -121.85 131.72 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.56 -1.338 . . . . 0.0 110.423 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 2.5 ttm -131.65 151.81 51.33 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.356 -0.84 . . . . 0.0 109.962 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.503 ' O ' ' CB ' ' A' ' 54' ' ' ASP . 0.2 OUTLIER -149.78 -36.14 0.16 Allowed 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.571 -0.706 . . . . 0.0 110.273 179.76 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.503 ' CB ' ' O ' ' A' ' 53' ' ' ARG . 0.4 OUTLIER 70.99 138.38 0.06 OUTLIER Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.201 -0.937 . . . . 0.0 110.136 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -64.71 -6.69 12.86 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 123.506 1.266 . . . . 0.0 110.831 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.557 ' C ' ' CG2' ' A' ' 57' ' ' THR . 11.7 mt -89.38 -50.44 6.11 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.158 -0.964 . . . . 0.0 109.885 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.557 ' CG2' ' C ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER 61.62 -60.02 0.1 Allowed 'General case' 0 N--CA 1.505 2.275 0 CA-C-O 121.496 0.665 . . . . 0.0 110.275 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.548 ' N ' ' O ' ' A' ' 56' ' ' LEU . 1.2 pttt -45.79 -28.14 0.99 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.506 -0.746 . . . . 0.0 109.556 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.467 ' C ' ' HD3' ' A' ' 59' ' ' ARG . 0.4 OUTLIER -110.31 -35.35 6.09 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.639 -0.663 . . . . 0.0 110.232 179.809 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.429 ' N ' ' HD3' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -62.37 -155.32 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.161 -0.962 . . . . 0.0 110.202 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.01 -40.61 0.75 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.891 . . . . 0.0 109.825 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.44 89.73 0.59 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.486 ' O ' ' CD2' ' A' ' 27' ' ' LEU . 20.4 p90 -148.4 -176.9 5.48 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.277 -1.131 . . . . 0.0 110.537 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.491 ' N ' HD11 ' A' ' 27' ' ' LEU . . . -142.58 162.83 27.31 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.706 ' CE1' ' CG ' ' A' ' 23' ' ' PHE . 14.2 m-85 -128.28 154.18 46.18 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.404 -1.057 . . . . 0.0 109.41 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.497 ' CG2' ' C ' ' A' ' 65' ' ' PHE . 15.3 t -149.87 110.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.058 -1.026 . . . . 0.0 110.64 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.401 ' HA ' ' HB2' ' A' ' 21' ' ' LYS . 84.9 m -89.11 49.93 1.86 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.294 -0.879 . . . . 0.0 109.98 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.569 ' CZ ' ' SD ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -84.72 52.32 2.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.412 -0.805 . . . . 0.0 110.818 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.429 ' C ' ' O ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -42.11 119.16 1.28 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.228 -0.92 . . . . 0.0 110.471 -179.753 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -150.01 -174.36 4.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.328 -0.857 . . . . 0.0 110.008 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.5 tm0? -94.85 -71.32 0.67 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.154 -0.966 . . . . 0.0 110.22 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 75' ' ' ASP . . . -83.19 8.51 13.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 109.996 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.531 ' O ' ' CG2' ' A' ' 77' ' ' VAL . . . -57.1 -70.44 0.98 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.436 ' C ' ' O ' ' A' ' 73' ' ' GLY . 98.5 t -41.9 -29.06 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.355 -1.085 . . . . 0.0 110.247 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.553 ' HA ' ' CD2' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -66.28 -80.64 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 0.0 109.898 179.744 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.524 ' HB3' ' CD2' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -47.73 -24.7 1.01 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.232 -0.917 . . . . 0.0 109.07 179.337 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.568 ' CG1' ' CE ' ' A' ' 22' ' ' MET . 78.1 t -68.74 -55.22 16.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.472 -0.767 . . . . 0.0 109.703 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.567 ' HG ' ' N ' ' A' ' 79' ' ' ALA . 1.1 pp -48.78 -28.48 3.69 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 120.835 -1.166 . . . . 0.0 108.48 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.567 ' N ' ' HG ' ' A' ' 78' ' ' LEU . . . -52.13 -32.6 36.23 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.559 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 5.4 mm-40 -99.43 24.04 8.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.781 -0.574 . . . . 0.0 109.499 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.484 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 9.8 t -49.95 -18.76 0.57 Allowed 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.092 178.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.486 ' O ' ' C ' ' A' ' 83' ' ' HIS . 0.2 OUTLIER -103.52 -7.55 20.77 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.342 -0.849 . . . . 0.0 109.841 179.45 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.63 ' NE2' ' CE1' ' A' ' 39' ' ' TYR . 0.5 OUTLIER 32.22 36.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.95 -0.469 . . . . 0.0 111.272 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 1.4 tt0 -87.14 120.26 28.22 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.594 -1.243 . . . . 0.0 110.237 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.529 ' CD2' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -151.7 -83.48 0.09 Allowed 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.679 -0.638 . . . . 0.0 110.133 -179.626 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.518 ' O ' ' CB ' ' A' ' 87' ' ' SER . 0.2 OUTLIER -79.81 53.08 1.57 Allowed 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.106 -0.996 . . . . 0.0 109.289 179.473 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 71.01 2.83 4.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.565 -0.709 . . . . 0.0 110.256 -179.796 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -110.96 124.85 52.95 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.257 -0.902 . . . . 0.0 110.246 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.498 ' O ' ' CG2' ' A' ' 89' ' ' THR . 15.1 t -104.77 63.93 0.73 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.523 -0.736 . . . . 0.0 110.133 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.582 ' HB ' ' CG ' ' A' ' 83' ' ' HIS . 0.6 OUTLIER -52.23 -176.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.35 -0.843 . . . . 0.0 108.887 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.57 ' N ' ' O ' ' A' ' 25' ' ' GLY . 13.0 t0 -143.82 87.23 8.22 Favored Pre-proline 0 N--CA 1.485 1.288 0 O-C-N 120.547 -1.346 . . . . 0.0 110.764 -178.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.559 ' CG ' ' O ' ' A' ' 80' ' ' GLN . 2.2 Cg_endo -58.42 111.79 0.98 Allowed 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.633 1.333 . . . . 0.0 111.317 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.603 ' HE2' ' CD2' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -130.41 117.51 19.81 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.383 -0.823 . . . . 0.0 109.262 178.26 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.443 HG23 ' HG3' ' A' ' 22' ' ' MET . 61.8 t -97.3 174.6 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 O-C-N 121.581 -0.699 . . . . 0.0 110.049 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.435 ' N ' HG12 ' A' ' 94' ' ' VAL . . . -95.33 108.73 20.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 109.855 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 28.5 t80 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.937 . . . . 0.0 110.402 -179.669 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.465 ' O ' ' HB3' ' A' ' 21' ' ' LYS . 30.4 p . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.194 0.521 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.537 ' CB ' HG23 ' A' ' 67' ' ' THR . 11.6 ptmt -179.32 -171.09 0.19 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.397 -0.814 . . . . 0.0 110.252 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.53 ' CG ' ' O ' ' A' ' 66' ' ' VAL . 12.7 ptm -123.21 175.8 6.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.441 -0.787 . . . . 0.0 110.041 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.573 ' CD2' ' O ' ' A' ' 64' ' ' GLY . 1.4 t80 -146.58 158.35 43.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.367 -0.833 . . . . 0.0 109.886 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.575 HD12 ' CZ ' ' A' ' 40' ' ' PHE . 18.3 mm -115.92 134.78 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.31 -0.868 . . . . 0.0 109.124 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.523 ' O ' HG22 ' A' ' 90' ' ' ILE . . . -113.3 141.68 17.05 Favored Glycine 0 N--CA 1.495 2.601 0 C-N-CA 119.731 -1.223 . . . . 0.0 112.285 -177.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.499 ' C ' HG22 ' A' ' 90' ' ' ILE . . . 60.28 41.91 98.54 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.59 ' HA ' ' CG2' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -77.45 153.87 33.14 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.62 -0.929 . . . . 0.0 111.163 -178.742 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.532 ' CB ' ' HB ' ' A' ' 31' ' ' THR . 0.4 OUTLIER -39.43 130.73 1.72 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.368 0.604 . . . . 0.0 110.518 -179.301 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 64.9 p-90 -68.81 -28.12 66.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.349 -0.844 . . . . 0.0 110.635 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.454 ' O ' ' O ' ' A' ' 31' ' ' THR . 2.3 pt20 -88.78 -14.76 36.33 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.083 -1.011 . . . . 0.0 110.721 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.532 ' HB ' ' CB ' ' A' ' 28' ' ' SER . 1.3 t -53.08 -169.02 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.642 -0.661 . . . . 0.0 110.364 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.496 ' N ' HG22 ' A' ' 31' ' ' THR . 15.0 t -157.62 -166.75 2.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.334 -0.854 . . . . 0.0 109.85 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 36' ' ' LEU . 3.6 mt-30 -79.9 -72.92 0.38 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.149 -0.969 . . . . 0.0 110.118 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.534 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -48.07 -44.28 31.36 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.759 -1.176 . . . . 0.0 108.551 179.302 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.492 ' HA2' ' HG3' ' A' ' 38' ' ' GLU . . . -48.14 -35.27 13.64 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 107.566 -2.214 . . . . 0.0 107.566 178.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 33' ' ' GLN . 0.1 OUTLIER -75.76 -40.07 55.98 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.301 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.481 ' CG ' ' HA ' ' A' ' 34' ' ' GLU . 50.0 mtp180 -59.42 -25.66 64.52 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 122.47 1.129 . . . . 0.0 108.421 178.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.534 ' CG ' ' O ' ' A' ' 34' ' ' GLU . 1.5 mt-10 -84.56 -21.93 30.27 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.688 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 21.0 t80 -84.56 -48.36 9.63 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.795 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.582 ' HA ' ' CZ ' ' A' ' 43' ' ' PHE . 28.1 m-85 -95.17 -33.48 12.61 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.355 -0.841 . . . . 0.0 109.321 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -65.8 -17.49 65.11 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -58.83 -45.2 90.56 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.417 -1.049 . . . . 0.0 109.276 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.582 ' CZ ' ' HA ' ' A' ' 40' ' ' PHE . 4.5 p90 -117.83 -12.82 10.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.566 -0.709 . . . . 0.0 109.493 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.471 ' O ' ' HA2' ' A' ' 41' ' ' GLY . . . -133.99 87.01 0.26 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.531 ' O ' ' CB ' ' A' ' 68' ' ' PHE . 4.0 pm0 -41.18 104.39 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.417 -1.049 . . . . 0.0 110.357 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.533 HG22 ' CG1' ' A' ' 66' ' ' VAL . 2.9 p -89.42 142.5 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.228 -0.92 . . . . 0.0 110.519 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.62 -23.68 9.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.873 . . . . 0.0 109.677 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.25 126.59 37.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.407 -0.808 . . . . 0.0 110.173 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.485 ' HB2' ' CD2' ' A' ' 36' ' ' LEU . 3.4 p -150.13 152.14 34.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.076 -1.015 . . . . 0.0 110.253 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.662 ' CD2' ' CD2' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -149.99 134.33 17.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.048 -1.033 . . . . 0.0 110.65 179.739 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 78.4 t -117.16 134.81 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.543 -1.348 . . . . 0.0 110.732 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.511 ' HG3' ' N ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -129.4 152.17 49.24 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.423 -0.798 . . . . 0.0 109.44 179.746 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.511 ' N ' ' HG3' ' A' ' 52' ' ' MET . 1.7 mpp_? -147.49 -61.19 0.27 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.563 -0.711 . . . . 0.0 110.23 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -130.23 86.34 54.24 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.264 -0.898 . . . . 0.0 110.038 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.74 -76.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.706 1.371 . . . . 0.0 110.847 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.491 ' HG ' ' N ' ' A' ' 57' ' ' THR . 1.8 pp -123.16 -27.92 4.1 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.23 -0.919 . . . . 0.0 111.039 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.491 ' N ' ' HG ' ' A' ' 56' ' ' LEU . 2.5 t -131.44 -123.85 0.2 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.112 -0.993 . . . . 0.0 110.345 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.445 ' HD2' ' C ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -137.75 7.16 2.74 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 120.938 -1.101 . . . . 0.0 110.021 179.799 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.568 ' CD ' ' N ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -58.85 -38.7 79.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.254 -0.904 . . . . 0.0 110.03 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.568 ' N ' ' CD ' ' A' ' 59' ' ' ARG . 0.5 OUTLIER -48.44 170.36 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.229 -0.92 . . . . 0.0 110.106 179.808 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -129.02 -19.59 3.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.056 -1.027 . . . . 0.0 110.895 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.55 97.11 2.49 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 23' ' ' PHE . 20.8 p90 -156.35 -162.94 1.35 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.131 -1.217 . . . . 0.0 110.26 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.573 ' O ' ' CD2' ' A' ' 23' ' ' PHE . . . -166.84 -179.97 40.29 Favored Glycine 0 N--CA 1.489 2.18 0 C-N-CA 119.536 -1.316 . . . . 0.0 110.296 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.662 ' CD2' ' CD2' ' A' ' 50' ' ' LEU . 10.4 m-85 -129.28 152.98 48.26 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.833 -0.804 . . . . 0.0 109.267 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.533 ' CG1' HG22 ' A' ' 46' ' ' VAL . 3.5 t -150.05 145.1 17.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 120.986 -1.071 . . . . 0.0 110.181 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.537 HG23 ' CB ' ' A' ' 21' ' ' LYS . 3.2 m -151.1 99.23 2.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.207 -0.933 . . . . 0.0 110.717 -179.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.571 ' CZ ' HG22 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -100.57 -166.27 1.3 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.152 -0.967 . . . . 0.0 109.589 178.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.446 ' HA ' ' CE ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -151.35 74.83 1.15 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.951 . . . . 0.0 110.348 -179.878 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.431 ' OD1' ' OE2' ' A' ' 45' ' ' GLU . 0.6 OUTLIER -150.07 170.99 17.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.273 -0.892 . . . . 0.0 110.068 179.754 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.487 ' HG3' ' N ' ' A' ' 72' ' ' ALA . 27.2 pt20 -84.09 -38.92 20.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -0.936 . . . . 0.0 110.301 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.487 ' N ' ' HG3' ' A' ' 71' ' ' GLN . . . -83.77 4.24 29.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.905 . . . . 0.0 110.03 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.475 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -59.36 -82.34 0.06 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.487 ' O ' HD11 ' A' ' 78' ' ' LEU . 17.9 m -41.67 -48.3 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.296 -1.12 . . . . 0.0 110.534 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 74' ' ' VAL . 21.6 m-20 -42.22 -68.15 0.21 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.036 -1.04 . . . . 0.0 110.45 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.574 ' HB3' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -59.14 -37.03 76.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.442 -0.786 . . . . 0.0 110.449 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.571 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 58.9 t -56.21 -59.71 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 121.142 -0.974 . . . . 0.0 109.911 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.564 ' CD1' ' N ' ' A' ' 78' ' ' LEU . 2.4 mp -46.03 -40.73 11.03 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.499 ' CB ' ' O ' ' A' ' 76' ' ' LYS . . . -43.18 -36.37 1.71 Allowed 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.584 0.707 . . . . 0.0 109.55 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.573 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 7.3 mm100 -102.57 27.61 6.74 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.483 -0.76 . . . . 0.0 109.505 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.561 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 65.9 p -45.56 -21.32 0.1 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.562 -0.711 . . . . 0.0 109.131 178.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.486 ' O ' ' O ' ' A' ' 83' ' ' HIS . 1.2 ptp180 -106.13 -19.66 13.65 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.463 -0.773 . . . . 0.0 110.279 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.688 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 0.2 OUTLIER 52.13 165.47 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.279 -0.888 . . . . 0.0 111.014 179.898 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.56 ' C ' ' CD1' ' A' ' 85' ' ' LEU . 1.2 tt0 175.37 119.74 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.599 0.714 . . . . 0.0 110.389 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.621 ' CD2' ' N ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -141.03 -86.49 0.18 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.575 -0.703 . . . . 0.0 109.172 178.417 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.536 ' O ' ' CB ' ' A' ' 87' ' ' SER . 0.1 OUTLIER -84.42 53.25 2.59 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.054 -1.029 . . . . 0.0 108.662 178.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 71.22 9.68 6.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.49 -0.756 . . . . 0.0 109.274 -178.769 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 10.3 mmtt -107.17 121.79 45.23 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.519 -0.738 . . . . 0.0 109.806 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 83' ' ' HIS . 15.3 t -97.31 78.42 2.72 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.393 -0.817 . . . . 0.0 109.554 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.607 ' HB ' ' CG ' ' A' ' 83' ' ' HIS . 1.1 mt -47.65 -177.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-O 121.433 0.635 . . . . 0.0 110.335 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -139.39 78.19 27.92 Favored Pre-proline 0 C--N 1.305 -1.355 0 O-C-N 121.108 -0.995 . . . . 0.0 110.566 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.613 ' HG3' ' HD2' ' A' ' 83' ' ' HIS . 2.3 Cg_endo -53.31 112.48 0.95 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.44 1.232 . . . . 0.0 110.964 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.558 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -117.06 99.78 7.29 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.287 -0.883 . . . . 0.0 109.698 178.434 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.51 ' CG1' ' HB3' ' A' ' 22' ' ' MET . 22.3 t -97.01 157.35 3.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 O-C-N 121.757 -0.589 . . . . 0.0 110.157 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -131.49 106.44 8.22 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.207 -0.933 . . . . 0.0 110.468 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.181 -0.949 . . . . 0.0 110.923 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.214 0.53 . . . . 0.0 110.128 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.476 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 5.2 pttt -70.34 161.15 30.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 110.331 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.537 ' CG ' ' N ' ' A' ' 23' ' ' PHE . 36.5 ttp -86.07 172.67 10.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.359 -0.838 . . . . 0.0 110.307 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.628 ' CZ ' ' CB ' ' A' ' 63' ' ' PHE . 1.3 t80 -148.62 139.39 22.88 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.332 -0.855 . . . . 0.0 109.268 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.573 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 1.3 mp -110.36 130.62 63.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 121.319 -0.863 . . . . 0.0 108.792 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.529 ' O ' HG21 ' A' ' 90' ' ' ILE . . . -95.73 120.53 6.58 Favored Glycine 0 N--CA 1.497 2.723 0 C-N-CA 120.028 -1.082 . . . . 0.0 113.145 -176.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.548 ' C ' HG21 ' A' ' 90' ' ' ILE . . . 76.67 28.24 59.62 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 177.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.59 ' HA ' HG23 ' A' ' 90' ' ' ILE . 1.4 pt? -49.43 142.51 7.68 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.376 -1.073 . . . . 0.0 110.383 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.539 ' O ' ' CG2' ' A' ' 31' ' ' THR . 2.3 m -39.42 121.35 1.17 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.486 0.66 . . . . 0.0 110.465 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.459 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 49.9 p-90 -58.88 -28.87 66.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.298 -0.876 . . . . 0.0 110.388 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -82.64 -13.7 56.01 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.195 -0.941 . . . . 0.0 110.642 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.539 ' CG2' ' O ' ' A' ' 28' ' ' SER . 3.0 t -63.64 -169.6 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.501 -0.749 . . . . 0.0 110.291 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.4 t -154.06 -169.92 3.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.445 -0.785 . . . . 0.0 109.922 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 36' ' ' LEU . 17.7 mt-30 -74.48 -73.05 0.25 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.121 -0.987 . . . . 0.0 110.389 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -47.84 -42.9 27.47 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.883 -1.136 . . . . 0.0 109.758 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.508 ' O ' ' HG3' ' A' ' 38' ' ' GLU . . . -55.54 -30.18 55.32 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 107.699 -2.161 . . . . 0.0 107.699 178.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.533 ' CD1' HG23 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -82.1 -37.57 26.13 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.137 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.491 ' HD2' ' CG1' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -62.86 -25.22 68.18 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 122.536 1.16 . . . . 0.0 108.503 178.487 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.508 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -90.39 -19.07 24.39 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.977 -1.011 . . . . 0.0 108.597 179.497 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.66 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 6.4 t80 -81.42 -26.61 35.25 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 121.457 -0.777 . . . . 0.0 110.334 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.523 ' CD1' ' HE3' ' A' ' 22' ' ' MET . 39.0 m-85 -118.59 -17.72 9.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.403 -0.811 . . . . 0.0 109.371 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -75.69 -21.08 77.57 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.589 ' HG3' ' CD2' ' A' ' 43' ' ' PHE . 15.9 pt20 -63.06 -32.48 73.87 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.486 -1.008 . . . . 0.0 109.421 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.589 ' CD2' ' HG3' ' A' ' 42' ' ' GLN . 4.8 p90 -130.39 1.36 4.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.37 -0.831 . . . . 0.0 109.645 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 40' ' ' PHE . . . -143.77 95.27 0.18 Allowed Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 42.3 mt-10 -40.05 110.0 0.13 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.326 -1.102 . . . . 0.0 110.774 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.54 ' HA ' ' CB ' ' A' ' 68' ' ' PHE . 70.7 t -91.16 129.43 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.389 -0.819 . . . . 0.0 110.733 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 67' ' ' THR . 0.5 OUTLIER -93.48 -33.6 13.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.406 -0.809 . . . . 0.0 109.607 179.467 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.446 ' HA ' ' OE1' ' A' ' 48' ' ' GLU . 11.3 tp10 -171.29 153.96 3.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.548 -0.72 . . . . 0.0 109.188 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.488 ' HB2' HD21 ' A' ' 36' ' ' LEU . 15.6 p -150.81 157.06 42.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.06 -1.025 . . . . 0.0 111.107 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.555 ' HG ' ' HB2' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -130.52 124.11 31.17 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.427 -0.796 . . . . 0.0 108.95 178.704 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.515 ' CG1' HD11 ' A' ' 27' ' ' LEU . 89.6 t -112.57 142.75 23.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 120.453 -1.404 . . . . 0.0 112.062 -178.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.576 ' SD ' ' CE2' ' A' ' 63' ' ' PHE . 1.9 ttm -135.83 137.84 41.94 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.509 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 5.0 tmm_? -146.96 -34.44 0.27 Allowed 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.443 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.633 ' N ' ' HD3' ' A' ' 55' ' ' PRO . 62.0 t0 -163.18 51.75 0.31 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.008 -1.058 . . . . 0.0 111.973 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.633 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 2.4 Cg_endo -71.75 -68.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.32 -0.94 0 N-CA-C 109.337 -1.063 . . . . 0.0 109.337 178.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.434 ' CD2' ' O ' ' A' ' 55' ' ' PRO . 11.2 mt -140.64 -62.6 0.49 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.659 0.743 . . . . 0.0 109.047 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.463 ' O ' ' HD2' ' A' ' 59' ' ' ARG . 4.9 t -139.9 -28.77 0.74 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.652 -0.655 . . . . 0.0 110.733 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 60' ' ' SER . 4.4 mtmt -54.68 -37.6 65.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.113 -0.992 . . . . 0.0 109.759 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.514 ' HB3' ' CD ' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -38.93 -24.62 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.694 -0.629 . . . . 0.0 111.203 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 58' ' ' LYS . 1.6 t -38.47 -27.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.329 -0.857 . . . . 0.0 111.019 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 59' ' ' ARG . 4.6 mtt180 -99.0 -33.58 10.77 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.06 -1.025 . . . . 0.0 110.931 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.47 ' O ' HD23 ' A' ' 27' ' ' LEU . . . 56.5 77.5 0.16 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 107.827 -2.109 . . . . 0.0 107.827 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.628 ' CB ' ' CZ ' ' A' ' 23' ' ' PHE . 14.4 p90 -134.63 -167.86 2.05 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.428 -1.042 . . . . 0.0 111.428 -178.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -158.7 116.72 0.73 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.555 ' HB2' ' HG ' ' A' ' 50' ' ' LEU . 12.7 m-85 -82.99 140.97 32.44 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.483 -1.01 . . . . 0.0 108.863 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.533 HG23 ' CD1' ' A' ' 36' ' ' LEU . 2.9 t -147.34 99.36 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 120.943 -1.098 . . . . 0.0 110.239 -178.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.476 ' HB ' ' HB3' ' A' ' 21' ' ' LYS . 7.9 t -80.58 64.01 5.22 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 110.734 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.54 ' CB ' ' HA ' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -84.41 -151.18 0.12 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.193 -0.942 . . . . 0.0 110.745 179.807 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.74 173.07 10.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.233 -0.917 . . . . 0.0 110.512 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.4 2.16 5.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.306 -0.872 . . . . 0.0 110.266 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -81.26 -116.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.233 -0.917 . . . . 0.0 110.138 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.455 ' O ' ' HB3' ' A' ' 75' ' ' ASP . . . -67.9 -24.45 65.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.834 -1.166 . . . . 0.0 110.178 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.472 ' O ' HG22 ' A' ' 77' ' ' VAL . . . -46.49 -61.25 4.27 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.492 ' O ' ' CD1' ' A' ' 78' ' ' LEU . 71.3 t -43.17 -48.47 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.191 -1.182 . . . . 0.0 110.197 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.455 ' HB3' ' O ' ' A' ' 72' ' ' ALA . 34.8 t70 -47.94 -56.92 6.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.971 -1.081 . . . . 0.0 110.153 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -59.73 -30.66 68.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.39 -0.819 . . . . 0.0 110.15 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.491 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 41.7 t -63.01 -58.17 8.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.113 -0.992 . . . . 0.0 109.279 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.492 ' CD1' ' O ' ' A' ' 74' ' ' VAL . 1.3 mp -45.88 -44.39 14.43 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.324 -0.86 . . . . 0.0 108.962 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.445 ' HB2' ' O ' ' A' ' 76' ' ' LYS . . . -45.96 -28.53 1.16 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.209 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.53 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 22.3 mm100 -103.76 25.53 9.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.512 -0.742 . . . . 0.0 109.898 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.5 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 23.7 t -54.43 -16.16 2.12 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.488 ' O ' ' C ' ' A' ' 83' ' ' HIS . 5.2 ptp180 -95.95 -18.15 20.49 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 121.501 -0.749 . . . . 0.0 109.533 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.66 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 0.6 OUTLIER 31.51 41.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.81 -0.556 . . . . 0.0 111.795 179.484 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 0.7 OUTLIER -86.93 122.41 30.75 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 118.619 -1.233 . . . . 0.0 110.192 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.548 ' CD2' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -144.62 -85.81 0.13 Allowed 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.626 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 87' ' ' SER . 0.6 OUTLIER -82.28 52.92 2.13 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.21 -0.931 . . . . 0.0 108.753 179.05 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 1.4 t 71.33 5.84 5.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.599 -0.688 . . . . 0.0 109.651 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.552 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 10.7 mmmt -108.02 119.54 39.76 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.357 -0.839 . . . . 0.0 109.808 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.529 ' O ' ' CG2' ' A' ' 89' ' ' THR . 15.1 t -101.41 68.62 1.21 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.608 -0.682 . . . . 0.0 109.646 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.622 ' HB ' ' CG ' ' A' ' 83' ' ' HIS . 1.2 mm -51.7 -175.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.419 -0.801 . . . . 0.0 109.803 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -143.67 83.73 10.41 Favored Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.303 -0.873 . . . . 0.0 109.877 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.53 ' CG ' ' O ' ' A' ' 80' ' ' GLN . 2.3 Cg_endo -53.22 112.32 0.9 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.553 1.291 . . . . 0.0 110.965 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.588 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -130.16 111.76 12.75 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.486 -0.759 . . . . 0.0 109.546 178.746 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.522 ' CG1' ' HB2' ' A' ' 22' ' ' MET . 3.8 t -95.66 -174.01 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.525 -0.734 . . . . 0.0 110.018 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.6 10.38 7.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.175 -0.953 . . . . 0.0 110.358 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.418 ' CD1' HG11 ' A' ' 74' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.132 -0.98 . . . . 0.0 110.542 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.479 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 62.5 m . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.256 0.551 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.528 ' HB2' ' CG2' ' A' ' 67' ' ' THR . 0.0 OUTLIER 58.2 154.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.255 -0.903 . . . . 0.0 109.841 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.512 ' HG3' ' CG2' ' A' ' 94' ' ' VAL . 5.3 tmm? -68.83 157.77 35.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.105 -0.997 . . . . 0.0 109.854 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.605 ' CG ' ' CE1' ' A' ' 65' ' ' PHE . 6.8 t80 -141.02 144.49 35.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.229 -0.919 . . . . 0.0 109.984 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.557 ' CG2' ' CG2' ' A' ' 90' ' ' ILE . 20.1 mm -108.87 137.76 39.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.314 -0.866 . . . . 0.0 109.232 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.491 ' O ' HG23 ' A' ' 90' ' ' ILE . . . -118.1 144.17 17.99 Favored Glycine 0 N--CA 1.495 2.576 0 C-N-CA 119.647 -1.263 . . . . 0.0 111.464 -177.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 90' ' ' ILE . . . 59.08 42.05 96.83 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.583 ' HA ' ' CG2' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -79.69 156.51 27.53 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.452 -1.028 . . . . 0.0 110.939 -179.072 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.485 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -39.4 142.27 0.29 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.458 0.647 . . . . 0.0 110.735 -179.097 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.524 ' HA ' ' CD ' ' A' ' 53' ' ' ARG . 47.0 p-90 -85.58 2.57 44.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.496 -0.753 . . . . 0.0 110.332 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.469 ' O ' ' O ' ' A' ' 31' ' ' THR . 14.8 pt20 -121.77 -14.41 8.12 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.212 -0.93 . . . . 0.0 110.424 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 30' ' ' GLN . 14.8 t -53.3 -168.65 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.646 -0.659 . . . . 0.0 110.26 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.0 t -153.91 -176.1 5.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.279 -0.888 . . . . 0.0 110.034 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 36' ' ' LEU . 4.9 mt-30 -69.5 -75.01 0.12 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.045 -1.034 . . . . 0.0 110.818 -179.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.469 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 7.9 tt0 -47.22 -40.46 16.31 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.817 -1.177 . . . . 0.0 110.051 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.53 ' O ' ' HG3' ' A' ' 38' ' ' GLU . . . -56.53 -32.71 61.41 Favored Glycine 0 N--CA 1.484 1.833 0 N-CA-C 107.32 -2.312 . . . . 0.0 107.32 178.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.541 ' N ' ' O ' ' A' ' 33' ' ' GLN . 0.1 OUTLIER -79.87 -38.8 31.93 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.122 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.469 ' HG3' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -61.81 -25.27 67.39 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 122.43 1.109 . . . . 0.0 108.764 178.501 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.53 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -88.66 -18.58 27.64 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.69 179.543 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.694 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 24.1 t80 -82.96 -28.02 30.09 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.348 -0.845 . . . . 0.0 110.564 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.559 ' CE1' HG12 ' A' ' 77' ' ' VAL . 39.2 m-85 -116.51 -22.53 8.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.208 -0.932 . . . . 0.0 109.457 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.52 ' CA ' HG21 ' A' ' 46' ' ' VAL . . . -72.15 -13.27 76.39 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -66.45 -36.96 84.08 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.416 -1.049 . . . . 0.0 109.713 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.575 ' CD1' ' HB3' ' A' ' 76' ' ' LYS . 9.7 p90 -125.71 7.86 7.54 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.503 -0.748 . . . . 0.0 109.828 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.479 ' O ' ' HA2' ' A' ' 41' ' ' GLY . . . -153.33 98.11 0.18 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 44' ' ' GLY . 8.5 pt-20 -39.79 124.49 1.73 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.526 -0.985 . . . . 0.0 110.26 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.52 HG21 ' CA ' ' A' ' 41' ' ' GLY . 3.3 t -98.43 126.06 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.22 -0.925 . . . . 0.0 110.453 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 1.6 mmtm -88.77 -27.6 21.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.365 -0.834 . . . . 0.0 109.498 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 12.1 pt-20 179.67 147.34 0.24 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.464 -0.772 . . . . 0.0 110.09 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 19.5 p -140.59 176.59 8.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.158 -0.964 . . . . 0.0 110.531 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.58 ' CD2' ' CD2' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -147.74 124.64 11.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.3 -0.875 . . . . 0.0 110.148 179.416 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 69.9 t -116.24 131.45 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.716 -1.24 . . . . 0.0 110.883 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.43 ' SD ' ' CB ' ' A' ' 60' ' ' SER . 1.2 ttm -138.83 149.85 45.38 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.526 -0.734 . . . . 0.0 109.523 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.524 ' CD ' ' HA ' ' A' ' 29' ' ' TRP . 33.3 mtm180 -149.73 -59.94 0.21 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.407 -0.808 . . . . 0.0 110.273 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -144.2 74.12 15.92 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.297 -0.877 . . . . 0.0 110.331 -179.908 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -62.22 -64.6 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.686 1.361 . . . . 0.0 110.629 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.0 mt -90.87 -67.26 0.86 Allowed 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.198 -0.939 . . . . 0.0 110.138 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.478 ' O ' ' HB3' ' A' ' 58' ' ' LYS . 2.0 t -142.19 -46.13 0.34 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.439 -0.788 . . . . 0.0 110.163 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -179.89 33.9 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.541 -0.724 . . . . 0.0 109.923 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.587 ' CD ' ' N ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -76.13 -38.09 57.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 110.356 -179.886 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.587 ' N ' ' CD ' ' A' ' 59' ' ' ARG . 96.0 p -69.16 -146.06 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.1 -1.0 . . . . 0.0 110.367 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 60' ' ' SER . 1.4 mtp180 -147.66 -39.73 0.18 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 109.96 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.422 ' O ' HD23 ' A' ' 27' ' ' LEU . . . 120.45 81.87 0.69 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.504 ' HB2' ' CE1' ' A' ' 23' ' ' PHE . 11.7 p90 -145.78 -172.38 3.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.161 -1.199 . . . . 0.0 110.656 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.47 ' O ' ' HB ' ' A' ' 24' ' ' ILE . . . -153.7 114.16 0.61 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.605 ' CE1' ' CG ' ' A' ' 23' ' ' PHE . 19.9 m-85 -83.35 148.79 27.13 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.274 -1.133 . . . . 0.0 109.92 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 22' ' ' MET . 3.7 t -148.45 116.23 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.305 -0.872 . . . . 0.0 110.04 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.528 ' CG2' ' HB2' ' A' ' 21' ' ' LYS . 14.7 m -94.09 35.06 1.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.946 . . . . 0.0 110.511 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.585 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -69.14 135.26 50.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.936 -1.102 . . . . 0.0 109.55 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 4.7 ttt -143.77 122.77 12.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.1 -1.0 . . . . 0.0 110.571 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.419 ' HB2' ' HG2' ' A' ' 45' ' ' GLU . 4.6 t70 -142.86 -88.89 0.13 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.35 -0.844 . . . . 0.0 109.763 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.01 -83.67 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.339 -0.85 . . . . 0.0 109.575 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.08 -0.8 41.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.17 -0.956 . . . . 0.0 109.776 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.43 ' O ' HG21 ' A' ' 77' ' ' VAL . . . -61.58 -46.16 94.86 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.571 ' CG1' ' N ' ' A' ' 75' ' ' ASP . 3.0 p -50.12 -46.17 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.205 -1.173 . . . . 0.0 109.484 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.571 ' N ' ' CG1' ' A' ' 74' ' ' VAL . 0.2 OUTLIER -59.71 -40.28 87.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.425 -0.797 . . . . 0.0 109.637 179.529 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.575 ' HB3' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -62.37 -33.51 74.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.416 -0.803 . . . . 0.0 109.389 179.378 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.559 HG12 ' CE1' ' A' ' 40' ' ' PHE . 40.5 t -62.74 -57.84 10.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.36 -0.838 . . . . 0.0 109.191 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.542 ' CD1' ' O ' ' A' ' 74' ' ' VAL . 4.0 mp -45.31 -41.91 9.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.197 -0.939 . . . . 0.0 108.852 178.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 78' ' ' LEU . . . -46.31 -28.26 1.26 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.473 -0.891 . . . . 0.0 108.747 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.524 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 33.0 mm-40 -102.62 26.78 7.55 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.668 -0.645 . . . . 0.0 109.821 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 78' ' ' LEU . 41.9 t -55.93 -16.37 4.66 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.525 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.8 OUTLIER -109.47 1.63 19.99 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 121.626 -0.671 . . . . 0.0 109.373 178.751 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.694 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 0.5 OUTLIER 28.25 -87.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.138 0.494 . . . . 0.0 112.141 179.783 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.642 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 1.6 tt0 51.01 112.35 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 122.327 1.06 . . . . 0.0 110.5 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.537 HD11 ' CG1' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -131.65 -70.06 0.59 Allowed 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.538 ' O ' ' CB ' ' A' ' 87' ' ' SER . 0.5 OUTLIER -103.71 55.33 0.74 Allowed 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.913 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 73.65 13.79 4.33 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 -178.135 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.642 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 8.6 mttt -117.86 107.2 13.82 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 121.502 -0.749 . . . . 0.0 110.997 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 90' ' ' ILE . 9.5 t -80.82 76.93 7.73 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.508 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.594 ' HB ' ' CG ' ' A' ' 83' ' ' HIS . 1.6 mt -50.72 -179.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.058 -1.026 . . . . 0.0 109.231 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 25' ' ' GLY . 11.1 t0 -139.2 75.03 34.86 Favored Pre-proline 0 C--N 1.298 -1.641 0 O-C-N 121.188 -0.945 . . . . 0.0 110.559 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.524 ' CG ' ' O ' ' A' ' 80' ' ' GLN . 2.1 Cg_endo -52.64 111.17 0.57 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.593 1.312 . . . . 0.0 110.854 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.559 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -121.66 103.91 9.24 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.098 -1.001 . . . . 0.0 109.136 178.339 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.512 ' CG2' ' HG3' ' A' ' 22' ' ' MET . 3.4 t -96.83 177.49 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 O-C-N 121.639 -0.663 . . . . 0.0 110.784 -178.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -170.32 123.06 0.67 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.452 -0.78 . . . . 0.0 109.776 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.434 ' CD1' ' N ' ' A' ' 96' ' ' PHE . 12.3 p90 . . . . . 0 N--CA 1.495 1.775 0 O-C-N 121.225 -0.922 . . . . 0.0 110.416 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.552 ' HB2' ' CB ' ' A' ' 67' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.287 0.565 . . . . 0.0 110.404 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.956 ' HE3' HG11 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -74.2 170.82 14.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.906 . . . . 0.0 109.465 179.617 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.63 ' CG ' ' CE1' ' A' ' 65' ' ' PHE . 5.4 t80 -151.25 129.72 12.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.159 -0.963 . . . . 0.0 110.128 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.47 HG22 HG21 ' A' ' 90' ' ' ILE . 18.4 mm -99.39 139.84 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.206 -0.934 . . . . 0.0 109.366 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' A' ' 91' ' ' ASP . . . -122.34 120.47 4.33 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.65 -1.262 . . . . 0.0 111.154 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.859 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 112.51 41.42 1.04 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.043 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.975 HD21 HG13 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -51.2 120.99 5.5 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.342 -1.093 . . . . 0.0 110.624 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.607 ' HB3' HD11 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -46.37 173.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.305 -0.872 . . . . 0.0 110.103 179.684 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.439 ' CD1' ' C ' ' A' ' 29' ' ' TRP . 0.2 OUTLIER -76.48 5.03 7.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -0.926 . . . . 0.0 110.599 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.417 ' HG2' ' CD1' ' A' ' 29' ' ' TRP . 2.5 pt20 -151.57 11.79 0.6 Allowed 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.998 -1.064 . . . . 0.0 111.058 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.629 HG21 ' HG ' ' A' ' 27' ' ' LEU . 1.2 m -59.25 163.01 4.09 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.987 -1.071 . . . . 0.0 109.795 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.642 HG23 ' H ' ' A' ' 35' ' ' GLY . 12.8 t -135.59 -169.81 2.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.924 . . . . 0.0 109.748 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.536 ' O ' ' N ' ' A' ' 36' ' ' LEU . 24.0 mt-30 -88.47 -73.82 0.48 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.035 -1.041 . . . . 0.0 110.042 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.473 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 1.3 tt0 -48.59 -43.18 35.74 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.765 -1.209 . . . . 0.0 109.642 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.642 ' H ' HG23 ' A' ' 32' ' ' THR . . . -55.9 -28.76 53.77 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 107.503 -2.239 . . . . 0.0 107.503 178.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.862 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -81.36 -37.9 27.49 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 177.935 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 33' ' ' GLN . 19.9 mtt180 -61.71 -27.27 68.59 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 122.398 1.094 . . . . 0.0 108.12 177.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -89.11 -16.38 31.64 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.966 179.338 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.68 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 16.9 t80 -80.52 -32.22 36.92 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.401 -0.812 . . . . 0.0 110.175 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.848 ' HE1' HG13 ' A' ' 77' ' ' VAL . 32.1 m-85 -110.5 -28.26 8.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.392 -0.818 . . . . 0.0 109.025 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -61.76 -15.46 48.17 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -59.8 -42.86 94.37 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.401 -1.058 . . . . 0.0 109.523 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.638 ' HE1' HG22 ' A' ' 77' ' ' VAL . 3.6 p90 -125.83 -6.51 6.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.423 -0.798 . . . . 0.0 109.81 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.474 ' O ' ' HA2' ' A' ' 41' ' ' GLY . . . -130.8 96.41 0.35 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 11.1 mm-40 -40.69 115.46 0.58 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.335 -1.097 . . . . 0.0 110.546 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.513 ' HA ' ' CB ' ' A' ' 68' ' ' PHE . 59.9 t -95.32 134.21 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.0 110.61 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 0.1 OUTLIER -100.33 -27.75 13.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.373 -0.83 . . . . 0.0 109.743 179.588 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.477 ' O ' HG22 ' A' ' 67' ' ' THR . 5.0 tt0 -176.84 156.63 1.39 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.472 -0.768 . . . . 0.0 109.935 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.468 ' SG ' ' HG2' ' A' ' 37' ' ' ARG . 8.3 p -149.72 164.72 34.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.154 -0.967 . . . . 0.0 110.347 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.647 ' C ' HD12 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -133.41 126.93 32.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.203 -0.936 . . . . 0.0 110.181 179.683 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.975 HG13 HD21 ' A' ' 27' ' ' LEU . 98.1 t -117.39 127.57 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.488 -1.382 . . . . 0.0 110.434 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 63' ' ' PHE . 2.8 tpp . . . . . 0 C--N 1.302 -1.495 0 O-C-N 121.624 -0.672 . . . . 0.0 109.797 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 52' ' ' MET . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.915 ' C ' HD13 ' A' ' 27' ' ' LEU . 24.8 p90 -141.72 -174.21 4.0 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.199 -1.177 . . . . 0.0 110.519 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.674 ' N ' HD13 ' A' ' 27' ' ' LEU . . . -153.84 113.59 0.58 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.63 ' CE1' ' CG ' ' A' ' 23' ' ' PHE . 18.4 m-85 -83.98 149.91 25.99 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.365 -1.079 . . . . 0.0 109.605 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.778 HG21 HD11 ' A' ' 36' ' ' LEU . 3.6 t -149.8 110.2 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.163 -0.961 . . . . 0.0 110.274 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.562 ' O ' HG23 ' A' ' 67' ' ' THR . 12.8 t -90.39 53.94 2.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.249 -0.907 . . . . 0.0 110.523 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.567 ' CZ ' ' SD ' ' A' ' 22' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.124 -0.985 . . . . 0.0 110.412 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 75' ' ' ASP . . . . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.328 0.585 . . . . 0.0 110.064 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.809 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -42.28 -85.13 0.01 OUTLIER Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.7 t -42.6 -27.02 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.308 -1.113 . . . . 0.0 110.68 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -68.24 -82.67 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.113 -0.992 . . . . 0.0 110.192 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.466 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -40.24 -28.54 0.06 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.34 -0.85 . . . . 0.0 109.715 179.78 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.956 HG11 ' HE3' ' A' ' 22' ' ' MET . 55.2 t -68.55 -43.51 83.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 O-C-N 121.459 -0.776 . . . . 0.0 110.319 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.009 HD23 ' N ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -59.68 -36.58 76.74 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 120.907 -1.12 . . . . 0.0 108.215 179.385 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 1.009 ' N ' HD23 ' A' ' 78' ' ' LEU . . . -48.25 -29.17 3.55 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.554 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 3.3 mt-30 -107.28 28.17 8.35 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.339 0.59 . . . . 0.0 109.411 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.491 ' O ' ' HD2' ' A' ' 92' ' ' PRO . 2.9 p -49.14 -18.64 0.35 Allowed 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.143 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -107.35 -15.18 14.7 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.471 -0.768 . . . . 0.0 109.623 179.142 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.812 ' ND1' HD12 ' A' ' 90' ' ' ILE . 0.2 OUTLIER 56.86 -80.94 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.834 0.826 . . . . 0.0 110.321 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.946 ' C ' HD23 ' A' ' 85' ' ' LEU . 3.0 tt0 54.41 123.18 0.0 OUTLIER 'General case' 0 C--N 1.288 -2.087 0 CA-C-O 122.177 0.989 . . . . 0.0 110.895 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.946 HD23 ' C ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -154.29 -88.55 0.05 OUTLIER 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.59 -0.694 . . . . 0.0 109.339 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.566 ' O ' ' CB ' ' A' ' 87' ' ' SER . 0.6 OUTLIER -82.01 52.31 1.94 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.111 -0.993 . . . . 0.0 108.848 178.868 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.566 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 76.72 6.8 3.32 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.231 0.539 . . . . 0.0 110.102 -179.317 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.596 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 1.6 mmtm -116.03 117.55 30.43 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.283 -0.886 . . . . 0.0 110.729 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.787 ' O ' HG23 ' A' ' 89' ' ' THR . 10.2 t -88.85 80.18 7.21 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.734 -0.604 . . . . 0.0 109.714 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.859 HG23 ' C ' ' A' ' 26' ' ' GLY . 1.5 mt -52.58 -173.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.238 -0.914 . . . . 0.0 109.743 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.599 ' H ' HG22 ' A' ' 90' ' ' ILE . 4.6 t70 -144.54 84.2 9.3 Favored Pre-proline 0 N--CA 1.484 1.271 0 O-C-N 120.952 -1.092 . . . . 0.0 111.052 -178.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.554 ' CG ' ' O ' ' A' ' 80' ' ' GLN . 2.2 Cg_endo -56.08 113.46 1.45 Allowed 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.419 1.22 . . . . 0.0 110.962 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.618 ' HD2' ' CD2' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -132.48 109.96 10.17 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.35 -0.844 . . . . 0.0 109.451 178.264 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.745 HG22 ' HB2' ' A' ' 22' ' ' MET . 40.9 t -96.19 157.89 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.556 -0.715 . . . . 0.0 110.553 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 94' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.334 -0.854 . . . . 0.0 110.565 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.552 ' HB2' ' CB ' ' A' ' 67' ' ' THR . 1.3 ptpt . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.301 0.572 . . . . 0.0 110.426 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.973 ' CG ' HG13 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -100.81 170.81 8.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.39 -0.819 . . . . 0.0 109.698 179.648 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.65 ' HB3' ' HD2' ' A' ' 93' ' ' LYS . 19.5 t80 -147.0 155.19 42.05 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.084 -1.01 . . . . 0.0 110.353 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.494 HD13 ' HA ' ' A' ' 92' ' ' PRO . 24.9 mm -121.26 151.79 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.321 -0.862 . . . . 0.0 109.282 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.668 ' O ' HG22 ' A' ' 90' ' ' ILE . . . -133.78 138.96 10.49 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.33 -1.414 . . . . 0.0 111.341 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.879 ' O ' HD12 ' A' ' 90' ' ' ILE . . . 103.33 29.67 5.61 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.01 HD22 ' O ' ' A' ' 63' ' ' PHE . 0.8 OUTLIER -53.38 112.89 0.98 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.485 -1.009 . . . . 0.0 110.523 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.517 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -56.58 173.57 0.18 Allowed 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.411 -0.806 . . . . 0.0 110.056 179.671 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -80.33 11.54 3.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.315 -0.866 . . . . 0.0 110.493 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -133.44 -0.38 3.25 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.114 -0.991 . . . . 0.0 110.501 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.736 HG21 ' HG ' ' A' ' 27' ' ' LEU . 18.4 m -64.62 158.03 25.48 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.354 -0.841 . . . . 0.0 110.207 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.505 ' CG2' ' HA3' ' A' ' 35' ' ' GLY . 12.5 t -135.28 -173.15 3.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.121 -0.987 . . . . 0.0 110.069 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 36' ' ' LEU . 31.6 mt-30 -90.16 -74.76 0.48 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.198 -0.939 . . . . 0.0 110.202 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.53 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -48.72 -48.09 40.78 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.727 -1.189 . . . . 0.0 108.724 179.758 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.505 ' HA3' ' CG2' ' A' ' 32' ' ' THR . . . -48.92 -32.97 12.3 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 107.451 -2.26 . . . . 0.0 107.451 178.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.746 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -78.88 -39.76 34.25 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.361 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.505 ' CG ' ' HA ' ' A' ' 34' ' ' GLU . 3.2 mtt180 -57.81 -25.6 60.82 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.484 1.135 . . . . 0.0 107.974 178.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.53 ' CG ' ' O ' ' A' ' 34' ' ' GLU . 1.3 mt-10 -89.09 -21.11 23.56 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.632 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.67 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 20.5 t80 -73.49 -29.99 62.86 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.916 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.878 ' HE1' HG13 ' A' ' 77' ' ' VAL . 44.9 m-85 -110.89 -24.56 10.34 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.525 -0.735 . . . . 0.0 109.061 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.58 -9.44 74.02 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -73.78 -52.04 14.44 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.409 -1.054 . . . . 0.0 110.461 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.582 ' CZ ' ' HA ' ' A' ' 40' ' ' PHE . 3.7 p90 -104.81 8.98 35.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.295 -0.878 . . . . 0.0 110.491 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.87 175.43 32.93 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 68' ' ' PHE . 59.8 mm-40 -98.0 110.15 22.78 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.25 -1.147 . . . . 0.0 109.997 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.461 HG13 ' SG ' ' A' ' 49' ' ' CYS . 23.8 t -89.74 123.27 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 0.0 110.364 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.6 -26.2 16.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.406 -0.809 . . . . 0.0 109.75 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.944 ' O ' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER 179.95 151.89 0.43 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.438 -0.789 . . . . 0.0 110.006 179.686 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.532 ' HB3' HD21 ' A' ' 36' ' ' LEU . 9.3 m -145.34 174.72 10.87 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.331 -0.855 . . . . 0.0 110.012 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.801 HD12 ' N ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -148.36 144.41 27.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 110.375 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.891 HG13 ' CD2' ' A' ' 27' ' ' LEU . 86.0 t -132.33 134.88 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.624 -1.297 . . . . 0.0 110.997 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.304 -1.38 0 O-C-N 121.585 -0.697 . . . . 0.0 109.585 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.448 ' C ' ' HB2' ' A' ' 27' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 1.01 ' O ' HD22 ' A' ' 27' ' ' LEU . 2.4 p90 -150.26 -177.94 6.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.208 -1.172 . . . . 0.0 110.598 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.813 ' N ' HD13 ' A' ' 27' ' ' LEU . . . -147.31 121.06 1.33 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.671 ' CD2' HD21 ' A' ' 50' ' ' LEU . 21.6 m-85 -84.04 153.25 23.92 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.4 -1.059 . . . . 0.0 110.384 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.678 HG22 HD11 ' A' ' 36' ' ' LEU . 13.9 t -150.07 129.58 3.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.5 -0.75 . . . . 0.0 109.208 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.944 HG22 ' O ' ' A' ' 48' ' ' GLU . 9.9 t -119.12 59.2 0.84 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.144 -0.972 . . . . 0.0 111.039 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.683 ' CZ ' HG21 ' A' ' 77' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.718 0 O-C-N 120.947 -1.096 . . . . 0.0 109.91 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 75' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.216 0.531 . . . . 0.0 110.306 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -48.11 -65.38 2.53 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.903 ' O ' HD12 ' A' ' 78' ' ' LEU . 25.5 t -47.12 -52.62 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.199 -1.177 . . . . 0.0 110.39 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 72' ' ' ALA . 15.7 m-20 -42.63 -52.07 4.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.145 -0.972 . . . . 0.0 110.173 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.655 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -59.46 -39.4 83.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.394 -0.816 . . . . 0.0 110.155 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.878 HG13 ' HE1' ' A' ' 40' ' ' PHE . 81.7 t -55.33 -60.4 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 O-C-N 121.072 -1.017 . . . . 0.0 109.621 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.903 HD12 ' O ' ' A' ' 74' ' ' VAL . 1.6 mp -44.12 -42.46 6.32 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.234 -0.916 . . . . 0.0 109.423 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -46.88 -27.9 1.4 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.176 -0.953 . . . . 0.0 109.383 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.563 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 13.9 mm100 -101.66 22.0 13.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.426 -0.796 . . . . 0.0 109.894 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.46 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 47.0 t -51.7 -16.92 0.74 Allowed 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.007 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.469 ' O ' ' C ' ' A' ' 83' ' ' HIS . 9.6 ptt180 -100.56 -10.39 21.06 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 121.369 -0.832 . . . . 0.0 109.686 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.67 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 0.5 OUTLIER 31.69 43.99 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.811 -0.555 . . . . 0.0 111.851 179.882 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 2.4 tt0 -93.4 122.58 35.96 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.795 -1.162 . . . . 0.0 110.103 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.502 HD23 ' C ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -155.0 -83.38 0.07 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.553 -0.717 . . . . 0.0 110.189 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.559 ' CB ' ' HD3' ' A' ' 88' ' ' LYS . 0.3 OUTLIER -78.4 52.74 1.18 Allowed 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.036 -1.04 . . . . 0.0 109.425 179.525 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.522 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 71.62 1.43 3.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.522 -0.736 . . . . 0.0 110.619 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.559 ' HD3' ' CB ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -112.69 126.5 55.46 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.104 -0.997 . . . . 0.0 110.249 -179.821 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.655 ' O ' HG23 ' A' ' 89' ' ' THR . 11.5 t -105.82 64.97 0.69 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.666 -0.646 . . . . 0.0 110.361 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.879 HD12 ' O ' ' A' ' 26' ' ' GLY . 0.9 OUTLIER -53.0 -176.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.28 -0.888 . . . . 0.0 109.016 179.892 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' A' ' 25' ' ' GLY . 5.3 t70 -145.11 84.65 8.56 Favored Pre-proline 0 N--CA 1.485 1.28 0 O-C-N 120.653 -1.279 . . . . 0.0 111.052 -178.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.565 ' HG3' ' HD2' ' A' ' 83' ' ' HIS . 1.9 Cg_endo -57.39 112.79 1.23 Allowed 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.565 1.298 . . . . 0.0 110.634 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.65 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -111.3 107.14 16.32 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.035 -1.041 . . . . 0.0 108.983 178.237 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.973 HG13 ' CG ' ' A' ' 22' ' ' MET . 93.2 t -97.28 153.4 3.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.704 -0.623 . . . . 0.0 110.372 -179.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.206 -0.934 . . . . 0.0 110.022 179.826 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.473 ' HB2' ' OG1' ' A' ' 67' ' ' THR . 3.5 pttt . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.251 0.548 . . . . 0.0 109.996 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.92 ' CG ' HG22 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -76.66 162.07 28.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.249 -0.907 . . . . 0.0 110.226 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.661 ' C ' HD12 ' A' ' 24' ' ' ILE . 19.9 t80 -149.54 145.96 27.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.306 -0.871 . . . . 0.0 109.935 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.661 HD12 ' C ' ' A' ' 23' ' ' PHE . 1.1 mp -113.37 142.45 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 108.905 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.626 ' O ' HG22 ' A' ' 90' ' ' ILE . . . -120.42 127.16 6.94 Favored Glycine 0 N--CA 1.494 2.522 0 C-N-CA 119.478 -1.344 . . . . 0.0 111.472 -178.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.844 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 107.32 45.11 1.18 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.943 ' CD2' HG13 ' A' ' 51' ' ' VAL . 1.1 tp -56.47 113.97 1.82 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.103 -1.234 . . . . 0.0 110.508 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.502 ' CB ' ' HG2' ' A' ' 88' ' ' LYS . 6.1 t -45.5 170.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.471 -0.768 . . . . 0.0 110.321 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 39.9 p-90 -81.5 11.55 4.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.261 -0.899 . . . . 0.0 110.451 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -143.98 8.95 1.48 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.18 -0.95 . . . . 0.0 110.52 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.63 HG21 ' HG ' ' A' ' 27' ' ' LEU . 1.4 m -70.68 163.1 27.8 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.294 -0.879 . . . . 0.0 110.097 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.531 HG23 ' H ' ' A' ' 35' ' ' GLY . 4.4 t -142.72 -175.64 4.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.125 -0.984 . . . . 0.0 109.997 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 36' ' ' LEU . 6.5 mt-30 -80.26 -73.1 0.38 Allowed 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.035 -1.041 . . . . 0.0 111.014 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.534 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -48.0 -49.59 30.39 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 118.48 -1.288 . . . . 0.0 108.765 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.531 ' H ' HG23 ' A' ' 32' ' ' THR . . . -47.73 -31.04 7.15 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 107.753 -2.139 . . . . 0.0 107.753 178.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.905 HD21 ' HB2' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -78.45 -39.35 38.83 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 178.283 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.489 ' N ' ' O ' ' A' ' 34' ' ' GLU . 71.7 mtt180 -59.22 -26.42 64.85 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 178.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.534 ' HG3' ' O ' ' A' ' 34' ' ' GLU . 1.3 mt-10 -88.08 -19.68 26.73 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.692 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 8.3 t80 -79.38 -43.04 24.21 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.771 -0.771 . . . . 0.0 110.735 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.846 ' HE1' HG13 ' A' ' 77' ' ' VAL . 28.4 m-85 -105.92 -28.11 10.79 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.387 -0.821 . . . . 0.0 109.217 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.579 ' CA ' HG23 ' A' ' 46' ' ' VAL . . . -67.35 -10.09 56.36 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.647 -1.781 . . . . 0.0 108.647 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -63.05 -37.14 85.99 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.379 -1.071 . . . . 0.0 109.873 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.499 ' HE1' HG22 ' A' ' 77' ' ' VAL . 3.2 p90 -127.23 0.79 6.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.491 -0.756 . . . . 0.0 109.897 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.608 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -146.54 97.55 0.19 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -37.87 122.76 1.02 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.559 -0.965 . . . . 0.0 110.638 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.579 HG23 ' CA ' ' A' ' 41' ' ' GLY . 21.3 t -91.06 119.92 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.356 -0.84 . . . . 0.0 110.727 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -86.14 -21.56 27.5 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.358 -0.839 . . . . 0.0 109.637 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -178.75 145.16 0.29 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.366 -0.834 . . . . 0.0 110.384 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.905 ' HB2' HD21 ' A' ' 36' ' ' LEU . 5.5 p -148.05 170.16 18.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.287 -0.883 . . . . 0.0 109.93 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.769 HD21 ' CD2' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -148.97 133.66 17.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.873 -1.142 . . . . 0.0 110.927 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.943 HG13 ' CD2' ' A' ' 27' ' ' LEU . 61.6 t -110.51 130.19 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.808 -1.183 . . . . 0.0 109.487 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.501 ' SD ' ' CZ ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--N 1.303 -1.435 0 O-C-N 121.174 -0.954 . . . . 0.0 110.612 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.473 ' C ' ' CD2' ' A' ' 63' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 108.461 -1.856 . . . . 0.0 108.461 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.879 ' C ' HD13 ' A' ' 27' ' ' LEU . 8.2 p90 -177.66 178.15 1.04 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.303 -1.116 . . . . 0.0 110.367 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.863 ' N ' HD13 ' A' ' 27' ' ' LEU . . . -141.67 164.36 26.71 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.769 ' CD2' HD21 ' A' ' 50' ' ' LEU . 13.6 m-85 -124.56 148.38 47.85 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.356 -1.085 . . . . 0.0 109.822 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.517 HG23 ' C ' ' A' ' 65' ' ' PHE . 7.5 t -148.71 126.8 3.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.317 -0.865 . . . . 0.0 110.171 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.619 HG22 ' O ' ' A' ' 67' ' ' THR . 88.4 m -106.14 19.51 20.41 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.282 -0.886 . . . . 0.0 110.079 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.615 ' CE2' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.464 0 O-C-N 121.151 -0.968 . . . . 0.0 109.728 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 73' ' ' GLY . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.173 0.511 . . . . 0.0 110.348 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.674 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -43.48 -63.75 2.04 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.666 HG22 HG11 ' A' ' 94' ' ' VAL . 11.1 t -54.45 -23.8 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.136 -1.214 . . . . 0.0 110.0 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.486 ' HB3' ' HE3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -75.38 -73.13 0.27 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 110.017 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.486 ' HE3' ' HB3' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -47.55 -46.47 27.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.378 -0.826 . . . . 0.0 109.818 179.807 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.846 HG13 ' HE1' ' A' ' 40' ' ' PHE . 79.9 t -52.59 -53.25 21.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.069 -1.02 . . . . 0.0 108.691 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -41.02 -51.81 3.23 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.659 -0.651 . . . . 0.0 110.064 179.012 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -42.85 -27.26 0.17 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.441 -0.787 . . . . 0.0 110.19 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.562 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 9.7 mm-40 -104.58 21.85 16.06 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.265 -0.897 . . . . 0.0 110.29 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.508 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 40.3 t -51.76 -16.86 0.75 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.481 -0.762 . . . . 0.0 109.276 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.5 OUTLIER -108.33 -4.41 17.47 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 121.346 -0.846 . . . . 0.0 109.939 179.348 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.841 ' CE1' HD12 ' A' ' 90' ' ' ILE . 0.4 OUTLIER 34.39 31.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.786 -0.571 . . . . 0.0 111.241 179.828 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -86.24 117.78 25.27 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 118.39 -1.324 . . . . 0.0 110.205 179.502 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.534 HD11 ' HZ1' ' A' ' 88' ' ' LYS . 0.1 OUTLIER -153.78 -73.68 0.13 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.808 -0.558 . . . . 0.0 110.231 -179.249 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 87' ' ' SER . 0.4 OUTLIER -81.27 49.07 1.22 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.165 -0.96 . . . . 0.0 109.474 179.552 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 71.68 -0.11 3.29 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.539 -0.726 . . . . 0.0 110.651 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.673 ' HE3' HD11 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -115.35 138.66 50.74 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.182 -0.949 . . . . 0.0 110.084 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.789 ' O ' HG23 ' A' ' 89' ' ' THR . 14.9 t -113.11 71.27 0.74 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.544 -0.723 . . . . 0.0 110.799 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.844 HG23 ' C ' ' A' ' 26' ' ' GLY . 1.2 mt -55.0 -171.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.32 -0.863 . . . . 0.0 109.534 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.585 ' H ' HG22 ' A' ' 90' ' ' ILE . 5.1 t70 -143.82 87.04 8.3 Favored Pre-proline 0 N--CA 1.486 1.355 0 O-C-N 120.882 -1.136 . . . . 0.0 111.192 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.562 ' CG ' ' O ' ' A' ' 80' ' ' GLN . 2.0 Cg_endo -62.49 112.23 1.53 Allowed 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.53 1.279 . . . . 0.0 111.057 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.641 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -115.43 109.32 17.69 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.115 -0.991 . . . . 0.0 109.066 178.111 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.92 HG22 ' CG ' ' A' ' 22' ' ' MET . 53.6 t -97.04 151.57 4.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.521 -0.737 . . . . 0.0 110.291 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.203 -0.936 . . . . 0.0 110.375 -179.871 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.251 0.548 . . . . 0.0 110.343 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.981 ' CG ' HG13 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -73.06 -172.12 1.01 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.349 -0.845 . . . . 0.0 109.839 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.686 ' CG ' ' CE1' ' A' ' 65' ' ' PHE . 6.5 t80 -151.01 145.38 25.5 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.015 -1.053 . . . . 0.0 110.211 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.743 HD12 ' CZ ' ' A' ' 40' ' ' PHE . 18.6 mm -118.49 126.34 75.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.299 -0.876 . . . . 0.0 108.905 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.56 ' O ' HG22 ' A' ' 90' ' ' ILE . . . -109.83 159.63 13.86 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.789 -1.196 . . . . 0.0 111.227 -178.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 90' ' ' ILE . . . 54.35 40.25 67.82 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.006 HD22 ' CA ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -85.56 143.41 28.5 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.676 -0.897 . . . . 0.0 110.926 -179.135 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.5 ' O ' ' HB ' ' A' ' 31' ' ' THR . 0.5 OUTLIER -39.39 134.81 1.16 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.465 0.65 . . . . 0.0 110.942 -179.076 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.526 ' CG ' ' N ' ' A' ' 30' ' ' GLN . 31.0 p-90 -68.28 -37.97 81.22 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.361 -0.837 . . . . 0.0 109.947 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.526 ' N ' ' CG ' ' A' ' 29' ' ' TRP . 12.3 pt20 -74.76 0.21 16.07 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.396 -0.815 . . . . 0.0 110.696 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.5 ' HB ' ' O ' ' A' ' 28' ' ' SER . 4.4 m -69.24 153.86 42.97 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.392 -0.817 . . . . 0.0 110.215 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.552 HG23 ' H ' ' A' ' 35' ' ' GLY . 5.9 t -123.79 -174.18 2.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 109.625 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 36' ' ' LEU . 1.7 mt-30 -72.28 -73.15 0.2 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.044 -1.035 . . . . 0.0 110.855 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -48.33 -50.01 31.97 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 118.569 -1.252 . . . . 0.0 108.845 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.552 ' H ' HG23 ' A' ' 32' ' ' THR . . . -49.47 -29.23 10.94 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 107.795 -2.122 . . . . 0.0 107.795 178.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.921 HD21 ' HB2' ' A' ' 49' ' ' CYS . 0.1 OUTLIER -81.72 -38.24 26.08 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 178.315 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.491 ' HG3' ' HA ' ' A' ' 34' ' ' GLU . 13.9 mtp180 -58.71 -27.31 64.75 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.509 ' HG3' ' O ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -89.25 -21.35 23.26 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.793 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.579 ' OH ' ' CG ' ' A' ' 83' ' ' HIS . 38.2 t80 -67.84 -29.17 68.24 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.568 0.699 . . . . 0.0 109.85 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.884 ' HE1' HG13 ' A' ' 77' ' ' VAL . 38.4 m-85 -117.66 -18.72 9.6 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -70.17 -12.59 69.05 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -62.19 -47.82 82.77 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.452 -1.028 . . . . 0.0 109.691 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.582 ' HE1' HG22 ' A' ' 77' ' ' VAL . 6.0 p90 -119.61 7.87 11.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.519 -0.738 . . . . 0.0 109.911 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.464 ' O ' ' HA2' ' A' ' 41' ' ' GLY . . . -159.41 99.99 0.18 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 13.3 pt-20 -41.26 148.79 0.12 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.433 -1.039 . . . . 0.0 110.099 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.791 HG22 ' CB ' ' A' ' 68' ' ' PHE . 48.8 t -122.6 147.38 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.192 -0.943 . . . . 0.0 110.868 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -106.3 -32.7 8.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.414 -0.804 . . . . 0.0 109.887 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.765 ' O ' HG22 ' A' ' 67' ' ' THR . 0.9 OUTLIER -167.51 152.03 6.81 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.248 -0.908 . . . . 0.0 110.294 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.921 ' HB2' HD21 ' A' ' 36' ' ' LEU . 29.7 p -150.8 167.42 27.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.178 -0.951 . . . . 0.0 110.285 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.67 ' C ' HD12 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -138.6 126.23 22.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.168 -0.957 . . . . 0.0 109.872 179.504 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.488 HG23 HD23 ' A' ' 36' ' ' LEU . 61.6 t -115.09 130.44 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.634 -1.292 . . . . 0.0 111.261 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.445 ' HB3' ' HE2' ' A' ' 52' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.425 0 O-C-N 121.6 -0.688 . . . . 0.0 109.292 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 1.006 ' CA ' HD22 ' A' ' 27' ' ' LEU . 7.4 p90 -151.54 -172.71 4.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.192 -1.181 . . . . 0.0 110.666 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.564 ' N ' HD13 ' A' ' 27' ' ' LEU . . . -153.48 120.19 1.02 Allowed Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.686 ' CE1' ' CG ' ' A' ' 23' ' ' PHE . 17.3 m-85 -83.94 149.31 26.4 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.453 -1.028 . . . . 0.0 109.153 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.695 ' CG2' HD11 ' A' ' 36' ' ' LEU . 3.5 t -150.0 114.51 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.11 -0.994 . . . . 0.0 110.845 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.765 HG22 ' O ' ' A' ' 48' ' ' GLU . 8.9 t -80.07 4.09 18.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.175 -0.953 . . . . 0.0 109.694 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.791 ' CB ' HG22 ' A' ' 46' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.3 -0.875 . . . . 0.0 110.105 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.234 0.54 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.663 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -47.71 -77.64 0.11 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.569 HG22 HG11 ' A' ' 94' ' ' VAL . 51.1 t -40.95 -51.84 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.33 -1.1 . . . . 0.0 110.481 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.476 ' HA ' HD21 ' A' ' 78' ' ' LEU . 3.8 m-20 -47.1 -52.91 14.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -0.927 . . . . 0.0 110.295 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.661 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -67.05 -35.76 80.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.465 -0.772 . . . . 0.0 110.531 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.884 HG13 ' HE1' ' A' ' 40' ' ' PHE . 49.8 t -54.58 -72.8 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.057 -1.027 . . . . 0.0 109.753 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.476 HD21 ' HA ' ' A' ' 75' ' ' ASP . 1.1 pp -46.82 -37.42 8.67 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.909 -1.119 . . . . 0.0 109.289 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -51.69 -25.76 7.93 Favored 'General case' 0 C--N 1.308 -1.235 0 O-C-N 121.1 -1.0 . . . . 0.0 108.685 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.591 ' HB3' ' CE1' ' A' ' 83' ' ' HIS . 13.3 mm-40 -103.99 26.28 8.91 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.465 0.65 . . . . 0.0 109.351 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.557 ' HA ' ' HD2' ' A' ' 92' ' ' PRO . 47.4 t -54.54 -15.83 1.99 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.544 ' O ' ' C ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -113.54 8.19 17.66 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.611 -0.681 . . . . 0.0 109.66 179.099 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.638 ' CD2' ' HG3' ' A' ' 92' ' ' PRO . 2.6 m-70 -3.38 -78.01 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.736 ' C ' HD23 ' A' ' 85' ' ' LEU . 4.4 tt0 59.38 122.46 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 121.467 0.651 . . . . 0.0 109.49 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 1.083 HD21 HD11 ' A' ' 90' ' ' ILE . 0.4 OUTLIER -157.58 -37.81 0.07 Allowed 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.274 -0.97 . . . . 0.0 110.502 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 87' ' ' SER . 1.5 t70 -121.88 48.03 1.78 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 74.44 1.33 3.82 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -177.98 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -117.05 119.43 35.25 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.685 ' O ' HG23 ' A' ' 89' ' ' THR . 7.3 t -92.45 77.91 5.04 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 1.083 HD11 HD21 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -40.98 167.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 CA-C-O 121.897 0.856 . . . . 0.0 110.615 -178.8 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 25' ' ' GLY . 4.6 t70 -133.2 69.63 78.01 Favored Pre-proline 0 C--N 1.297 -1.694 0 O-C-N 121.685 -0.635 . . . . 0.0 109.448 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.638 ' HG3' ' CD2' ' A' ' 83' ' ' HIS . 1.8 Cg_endo -49.58 112.84 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.566 1.298 . . . . 0.0 109.882 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.525 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.1 OUTLIER -126.75 107.95 10.61 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.871 0.843 . . . . 0.0 110.009 179.192 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.981 HG13 ' CG ' ' A' ' 22' ' ' MET . 76.3 t -95.99 153.72 3.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.095 -1.003 . . . . 0.0 110.427 -179.518 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.468 ' HB2' ' CA ' ' A' ' 67' ' ' THR . 1.1 pttm . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.185 0.517 . . . . 0.0 110.105 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.796 ' CB ' HG22 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -55.23 155.85 4.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 110.218 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.633 ' CD2' ' CE ' ' A' ' 93' ' ' LYS . 0.5 OUTLIER -138.54 119.61 14.49 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.582 -0.699 . . . . 0.0 109.444 -179.804 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.621 ' CG2' HG21 ' A' ' 90' ' ' ILE . 1.2 mp -93.65 137.89 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.081 -1.012 . . . . 0.0 109.12 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.543 ' O ' ' CG2' ' A' ' 90' ' ' ILE . . . -110.62 133.05 11.32 Favored Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.823 -1.179 . . . . 0.0 112.324 -177.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.884 ' O ' HD12 ' A' ' 90' ' ' ILE . . . 62.55 36.97 93.95 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.902 HD22 ' CA ' ' A' ' 63' ' ' PHE . 0.4 OUTLIER -61.65 150.96 34.91 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.529 -0.983 . . . . 0.0 110.706 -179.339 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.672 ' O ' HG22 ' A' ' 31' ' ' THR . 0.4 OUTLIER -39.51 123.11 1.43 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.49 0.662 . . . . 0.0 110.771 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 6.5 p-90 -63.9 -14.29 52.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.504 -0.747 . . . . 0.0 110.146 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.466 ' O ' ' O ' ' A' ' 31' ' ' THR . 4.1 pt20 -100.04 -21.74 15.5 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.373 -0.83 . . . . 0.0 110.908 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.672 HG22 ' O ' ' A' ' 28' ' ' SER . 2.3 t -55.41 -161.93 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.447 0.641 . . . . 0.0 110.397 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.524 ' N ' HG23 ' A' ' 31' ' ' THR . 6.1 t -158.74 -168.99 2.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.877 . . . . 0.0 109.857 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 36' ' ' LEU . 15.1 mt-30 -79.55 -70.53 0.5 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.162 -0.961 . . . . 0.0 110.432 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.536 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -46.32 -52.29 13.01 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.959 -1.096 . . . . 0.0 109.237 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.458 ' H ' HG23 ' A' ' 32' ' ' THR . . . -48.4 -31.34 9.0 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.869 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -79.76 -36.81 36.64 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.448 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.511 ' HG3' ' HA ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -60.76 -27.97 68.37 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 122.455 1.121 . . . . 0.0 108.052 177.728 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.536 ' HG3' ' O ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -86.02 -19.9 29.64 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.541 179.091 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.688 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 13.6 t80 -78.64 -35.29 45.66 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.988 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.906 ' HE1' HG13 ' A' ' 77' ' ' VAL . 38.7 m-85 -109.14 -22.96 11.87 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.213 -0.93 . . . . 0.0 109.416 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -76.79 -3.61 80.17 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.581 -1.807 . . . . 0.0 108.581 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -73.86 -50.59 19.6 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 121.495 -1.003 . . . . 0.0 110.19 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.601 ' CZ ' ' HA ' ' A' ' 40' ' ' PHE . 2.9 p90 -103.35 13.1 34.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 110.18 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' A' ' 45' ' ' GLU . . . -150.24 -111.8 0.56 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.449 ' HB3' ' O ' ' A' ' 44' ' ' GLY . 0.4 OUTLIER 176.83 104.39 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.533 -0.981 . . . . 0.0 109.408 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.503 ' HA ' ' CB ' ' A' ' 68' ' ' PHE . 95.1 t -90.56 137.78 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.312 -0.867 . . . . 0.0 111.04 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -101.7 -26.87 13.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.52 -0.737 . . . . 0.0 109.163 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -166.9 154.79 9.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.547 -0.721 . . . . 0.0 109.796 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.491 ' SG ' ' CD ' ' A' ' 37' ' ' ARG . 21.0 p -148.68 175.4 11.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.123 -0.986 . . . . 0.0 110.719 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.623 HD21 ' CD2' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -150.51 132.11 14.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -0.833 . . . . 0.0 109.902 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.769 HG13 HD11 ' A' ' 27' ' ' LEU . 48.2 t -129.1 147.04 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.548 -1.345 . . . . 0.0 111.298 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.146 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.902 ' CA ' HD22 ' A' ' 27' ' ' LEU . 41.4 p90 -140.5 -168.86 2.65 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.09 -1.241 . . . . 0.0 110.472 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 50' ' ' LEU . . . -155.8 179.71 31.53 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.623 ' CD2' HD21 ' A' ' 50' ' ' LEU . 16.8 m-85 -148.6 146.68 28.34 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.493 -1.004 . . . . 0.0 108.751 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.802 HG21 HD11 ' A' ' 36' ' ' LEU . 5.6 t -148.08 106.18 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 120.806 -1.184 . . . . 0.0 111.295 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.468 ' CA ' ' HB2' ' A' ' 21' ' ' LYS . 39.0 m -82.45 56.76 3.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.14 -0.975 . . . . 0.0 110.049 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.626 ' CE1' ' HB2' ' A' ' 22' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 110.74 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.511 0.672 . . . . 0.0 109.723 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.772 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -59.14 -55.05 32.97 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.8 t -45.17 -38.93 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.124 -1.221 . . . . 0.0 110.354 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.87 -73.31 0.13 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.211 -0.931 . . . . 0.0 110.303 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.545 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -45.09 -43.06 9.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.241 -0.912 . . . . 0.0 109.469 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.906 HG13 ' HE1' ' A' ' 40' ' ' PHE . 93.4 t -54.02 -55.61 13.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.251 -0.905 . . . . 0.0 108.886 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.634 HD13 ' HB2' ' A' ' 81' ' ' SER . 0.1 OUTLIER -40.41 -47.27 2.55 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.716 -0.615 . . . . 0.0 109.993 178.947 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -43.53 -26.96 0.25 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.507 -0.746 . . . . 0.0 109.678 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.541 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 43.8 mm-40 -103.08 24.71 10.4 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.447 -0.783 . . . . 0.0 110.056 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.634 ' HB2' HD13 ' A' ' 78' ' ' LEU . 30.4 t -57.8 -13.74 4.76 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.556 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -99.71 -17.0 17.96 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 121.425 -0.797 . . . . 0.0 109.675 179.309 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.688 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 0.7 OUTLIER 31.14 32.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.613 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.556 ' N ' ' O ' ' A' ' 82' ' ' ARG . 0.8 OUTLIER -77.92 121.65 24.44 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.431 -1.418 . . . . 0.0 109.154 179.392 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.498 HD21 ' ND1' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -144.67 -80.88 0.17 Allowed 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.323 -178.562 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.526 ' O ' ' CD ' ' A' ' 88' ' ' LYS . 7.7 t70 -87.1 51.62 2.29 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.506 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 70.44 6.93 6.02 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -178.415 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.547 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 6.4 mmmt -108.49 120.94 43.88 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.58 -0.7 . . . . 0.0 109.964 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.769 ' O ' HG23 ' A' ' 89' ' ' THR . 13.4 t -100.07 67.4 1.4 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.562 -0.711 . . . . 0.0 109.589 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.884 HD12 ' O ' ' A' ' 26' ' ' GLY . 1.3 mm -49.86 -179.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 119.621 -0.831 . . . . 0.0 109.544 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.494 ' H ' HG22 ' A' ' 90' ' ' ILE . 18.8 t0 -141.06 79.56 17.96 Favored Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 121.163 -0.961 . . . . 0.0 110.272 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.541 ' CG ' ' O ' ' A' ' 80' ' ' GLN . 2.4 Cg_endo -51.81 113.11 1.02 Allowed 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.415 1.219 . . . . 0.0 110.201 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.633 ' CE ' ' CD2' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -135.41 113.33 11.08 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.27 -0.894 . . . . 0.0 109.965 179.221 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.796 HG22 ' CB ' ' A' ' 22' ' ' MET . 58.4 t -96.65 172.97 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.253 -0.905 . . . . 0.0 110.253 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.558 ' N ' HG12 ' A' ' 94' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.201 -0.937 . . . . 0.0 110.393 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.913 ' CB ' HG23 ' A' ' 67' ' ' THR . 4.6 pttt . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.229 0.538 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.899 ' CB ' HG13 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -75.79 174.0 10.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.186 -0.946 . . . . 0.0 109.478 179.443 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.691 ' CG ' ' CE1' ' A' ' 65' ' ' PHE . 5.9 t80 -150.6 139.4 20.8 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.204 -0.935 . . . . 0.0 109.825 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.731 ' CG2' HG21 ' A' ' 90' ' ' ILE . 13.6 mm -106.68 152.87 8.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.53 ' O ' HG22 ' A' ' 90' ' ' ILE . . . -126.69 139.3 11.19 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 119.175 -1.488 . . . . 0.0 111.764 -178.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.458 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 56.52 43.65 90.67 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.923 HD22 ' CA ' ' A' ' 63' ' ' PHE . 0.5 OUTLIER -75.74 142.58 42.38 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.412 -1.052 . . . . 0.0 110.63 -179.311 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.69 ' O ' HG22 ' A' ' 31' ' ' THR . 5.0 m -39.57 132.91 1.52 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.617 -0.677 . . . . 0.0 110.447 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.473 ' CZ3' ' HB3' ' A' ' 30' ' ' GLN . 47.6 p-90 -71.16 -17.95 62.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.465 -0.772 . . . . 0.0 110.624 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.473 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 10.9 pt20 -89.58 -18.12 27.19 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.184 -0.948 . . . . 0.0 110.82 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.69 HG22 ' O ' ' A' ' 28' ' ' SER . 6.9 t -55.61 -173.42 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.874 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.687 HG23 ' H ' ' A' ' 35' ' ' GLY . 7.4 t -147.85 -172.6 4.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.348 -0.845 . . . . 0.0 109.875 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 36' ' ' LEU . 3.9 mt-30 -77.79 -74.23 0.27 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.032 -1.043 . . . . 0.0 110.531 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.558 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 2.7 tt0 -48.05 -41.53 26.15 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.949 -1.094 . . . . 0.0 110.182 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.687 ' H ' HG23 ' A' ' 32' ' ' THR . . . -57.47 -28.95 60.08 Favored Glycine 0 C--N 1.296 -1.684 0 N-CA-C 107.424 -2.271 . . . . 0.0 107.424 178.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.854 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -82.5 -38.59 23.64 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.135 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.642 ' HA ' HG21 ' A' ' 46' ' ' VAL . 26.4 mtt180 -61.79 -27.09 68.5 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 122.418 1.104 . . . . 0.0 108.135 178.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.556 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -87.44 -19.27 28.26 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.373 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.653 ' CE1' ' NE2' ' A' ' 83' ' ' HIS . 26.9 t80 -79.24 -30.52 43.21 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.254 -0.904 . . . . 0.0 110.205 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.917 ' CE1' HG13 ' A' ' 77' ' ' VAL . 27.0 m-85 -108.8 -25.33 10.85 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.459 -0.776 . . . . 0.0 109.166 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -70.26 -7.84 60.98 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -63.95 -49.61 71.88 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 121.417 -1.049 . . . . 0.0 109.699 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.528 ' HE1' HG22 ' A' ' 77' ' ' VAL . 1.8 p90 -113.82 12.6 18.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.464 -0.772 . . . . 0.0 109.763 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 45' ' ' GLU . . . -142.85 -117.22 1.23 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.486 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 1.9 pt-20 177.09 103.47 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.406 -1.055 . . . . 0.0 109.906 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.642 HG21 ' HA ' ' A' ' 37' ' ' ARG . 63.3 t -89.41 126.58 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.19 -0.944 . . . . 0.0 110.702 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.95 -26.98 11.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.265 -0.897 . . . . 0.0 109.592 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -158.76 131.94 7.26 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.47 -0.769 . . . . 0.0 109.446 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 24.8 p -150.37 154.64 38.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.972 -1.08 . . . . 0.0 111.288 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.749 ' C ' HD12 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -125.04 126.11 44.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.391 -0.818 . . . . 0.0 109.261 178.958 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.592 ' CG1' ' N ' ' A' ' 52' ' ' MET . 17.4 t -89.73 169.38 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.79 -1.194 . . . . 0.0 112.104 -178.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.687 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 2.2 ptt? . . . . . 0 C--N 1.305 -1.332 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.733 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.687 ' HA2' ' HA ' ' A' ' 52' ' ' MET . . . . . . . . 0 N--CA 1.481 1.684 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.923 ' CA ' HD22 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -136.99 -176.1 4.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.087 -1.243 . . . . 0.0 109.96 179.282 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.472 ' O ' ' HB ' ' A' ' 24' ' ' ILE . . . -135.22 100.79 0.37 Allowed Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.087 -1.53 . . . . 0.0 110.4 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.691 ' CE1' ' CG ' ' A' ' 23' ' ' PHE . 11.7 m-85 -81.23 136.02 35.79 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.119 -1.224 . . . . 0.0 108.627 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.8 HG21 HD11 ' A' ' 36' ' ' LEU . 3.1 t -145.99 106.6 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 118.782 -1.167 . . . . 0.0 111.16 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.913 HG23 ' CB ' ' A' ' 21' ' ' LYS . 1.4 m -82.63 47.21 1.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.609 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.605 ' CE1' ' HB3' ' A' ' 22' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.357 -0.84 . . . . 0.0 110.619 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.476 0.655 . . . . 0.0 109.939 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.644 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -49.49 -44.63 36.96 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.937 ' O ' HD12 ' A' ' 78' ' ' LEU . 19.5 t -46.73 -52.27 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.352 -1.087 . . . . 0.0 109.868 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.56 ' HA ' HD13 ' A' ' 78' ' ' LEU . 4.6 t0 -54.08 -50.04 67.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.068 -1.02 . . . . 0.0 109.681 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.666 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 6.3 mmpt? -56.26 -35.53 67.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.33 -0.856 . . . . 0.0 109.816 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.917 HG13 ' CE1' ' A' ' 40' ' ' PHE . 60.5 t -59.17 -57.07 13.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 O-C-N 121.045 -1.035 . . . . 0.0 109.477 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.937 HD12 ' O ' ' A' ' 74' ' ' VAL . 2.8 mp -44.84 -41.55 7.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.239 -0.913 . . . . 0.0 109.06 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.666 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -46.34 -27.99 1.2 Allowed 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.304 -0.873 . . . . 0.0 109.281 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.515 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 7.2 mm100 -101.85 25.18 8.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.533 -0.729 . . . . 0.0 109.68 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.51 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 21.4 p -56.44 -16.44 5.81 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.522 ' O ' ' C ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -97.34 -9.49 27.39 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.633 -0.667 . . . . 0.0 109.792 179.193 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.863 ' CE1' HD12 ' A' ' 90' ' ' ILE . 0.6 OUTLIER 19.48 48.9 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 179.81 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.553 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -91.9 125.57 36.66 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 118.493 -1.283 . . . . 0.0 109.172 178.752 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.568 HD23 ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -145.34 -91.53 0.1 Allowed 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.663 -0.648 . . . . 0.0 109.655 -179.158 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.529 ' O ' ' CB ' ' A' ' 87' ' ' SER . 10.6 m-20 -79.86 52.62 1.51 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.097 -1.002 . . . . 0.0 108.74 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 72.18 9.72 5.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.618 -0.676 . . . . 0.0 109.857 -179.129 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 9.0 mmtt -111.24 120.72 43.21 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.372 -0.83 . . . . 0.0 109.608 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.763 ' O ' HG23 ' A' ' 89' ' ' THR . 11.9 t -101.87 69.23 1.18 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.505 -0.747 . . . . 0.0 109.726 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.863 HD12 ' CE1' ' A' ' 83' ' ' HIS . 0.8 OUTLIER -50.15 -178.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.389 -179.714 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.484 ' H ' HG22 ' A' ' 90' ' ' ILE . 14.2 t0 -141.45 81.04 15.74 Favored Pre-proline 0 C--N 1.3 -1.558 0 O-C-N 121.189 -0.944 . . . . 0.0 109.817 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.526 ' HG3' ' HD2' ' A' ' 83' ' ' HIS . 2.4 Cg_endo -53.96 112.58 1.01 Allowed 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 123.542 1.285 . . . . 0.0 111.275 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.58 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -128.02 104.89 8.04 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.916 0.865 . . . . 0.0 108.848 177.894 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.899 HG13 ' CB ' ' A' ' 22' ' ' MET . 6.2 t -96.19 -174.49 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 O-C-N 121.854 -0.529 . . . . 0.0 110.004 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.745 ' HB3' ' O ' ' A' ' 94' ' ' VAL . . . . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.181 -0.949 . . . . 0.0 110.431 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.582 ' CB ' HG23 ' A' ' 67' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.212 0.529 . . . . 0.0 110.236 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.918 ' HB2' HG22 ' A' ' 94' ' ' VAL . 0.5 OUTLIER -83.81 178.92 7.72 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.248 -0.907 . . . . 0.0 110.528 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.633 ' HB3' ' HD2' ' A' ' 93' ' ' LYS . 0.1 OUTLIER -150.47 143.68 24.91 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.489 -0.757 . . . . 0.0 109.068 179.785 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.534 HD12 ' C ' ' A' ' 23' ' ' PHE . 1.1 mp -106.85 144.62 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.069 -1.019 . . . . 0.0 109.34 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 91' ' ' ASP . . . -131.51 122.76 3.51 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 119.734 -1.222 . . . . 0.0 111.281 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 1.046 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 113.21 34.0 1.87 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.102 HD21 HG13 ' A' ' 51' ' ' VAL . 2.0 mp -39.93 137.37 0.95 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.682 -0.893 . . . . 0.0 110.715 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.537 ' CB ' ' HG1' ' A' ' 31' ' ' THR . 5.0 p -56.39 -174.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 0.0 110.06 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 47.9 p-90 -77.62 5.23 9.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 0.0 110.238 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -161.67 16.17 0.1 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.111 -0.993 . . . . 0.0 111.158 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.537 ' HG1' ' CB ' ' A' ' 28' ' ' SER . 98.7 m -53.6 157.54 2.16 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.055 -1.028 . . . . 0.0 110.307 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.607 HG23 ' H ' ' A' ' 35' ' ' GLY . 2.8 t -148.23 178.55 8.47 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.101 -1.0 . . . . 0.0 110.27 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.544 ' O ' ' N ' ' A' ' 36' ' ' LEU . 7.1 mt-30 -62.61 -74.14 0.1 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.96 . . . . 0.0 111.166 -178.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.53 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 1.6 tt0 -49.68 -36.05 23.74 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.73 -1.232 . . . . 0.0 110.028 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.607 ' H ' HG23 ' A' ' 32' ' ' THR . . . -61.04 -28.85 69.53 Favored Glycine 0 C--N 1.295 -1.711 0 N-CA-C 107.148 -2.381 . . . . 0.0 107.148 178.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.827 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -80.56 -41.42 24.13 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.047 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.53 ' HG3' ' HA ' ' A' ' 34' ' ' GLU . 19.8 mtp180 -61.65 -27.77 68.91 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 122.385 1.088 . . . . 0.0 108.238 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.547 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.2 OUTLIER -87.25 -15.7 37.37 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.11 179.454 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.691 ' CE2' ' CE1' ' A' ' 83' ' ' HIS . 10.4 t80 -86.76 -43.37 12.59 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 121.345 -0.847 . . . . 0.0 110.797 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.928 ' HE1' HG13 ' A' ' 77' ' ' VAL . 48.1 m-85 -101.36 -33.66 9.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.875 . . . . 0.0 109.193 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -59.76 -17.19 41.38 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -61.96 -45.72 92.44 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.474 -1.015 . . . . 0.0 109.956 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.59 ' HE1' HG22 ' A' ' 77' ' ' VAL . 4.9 p90 -119.58 -2.98 10.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.445 -0.784 . . . . 0.0 109.948 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.467 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -137.77 93.26 0.21 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.537 ' O ' ' CB ' ' A' ' 68' ' ' PHE . 1.9 mt-10 -40.03 105.91 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.411 -1.052 . . . . 0.0 110.15 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 68' ' ' PHE . 43.3 t -88.85 126.06 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 110.446 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -99.12 -31.33 11.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.278 -0.889 . . . . 0.0 110.032 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.81 135.89 17.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.29 -0.881 . . . . 0.0 110.274 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.788 ' HB2' HD21 ' A' ' 36' ' ' LEU . 31.9 p -150.48 166.66 29.48 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.876 . . . . 0.0 110.017 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.73 ' C ' HD12 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -150.45 126.02 10.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.962 -1.086 . . . . 0.0 110.695 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.102 HG13 HD21 ' A' ' 27' ' ' LEU . 98.9 t -113.66 142.29 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.861 -1.149 . . . . 0.0 110.002 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.437 ' HG2' ' CE2' ' A' ' 63' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--N 1.304 -1.398 0 O-C-N 121.287 -0.883 . . . . 0.0 110.376 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 27' ' ' LEU . . . . . . . . 0 N--CA 1.483 1.769 0 N-CA-C 108.349 -1.9 . . . . 0.0 108.349 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.646 ' HA ' HD13 ' A' ' 27' ' ' LEU . 50.3 p90 -132.32 -162.3 1.22 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.092 -1.24 . . . . 0.0 110.376 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 50' ' ' LEU . . . -166.53 174.85 42.0 Favored Glycine 0 N--CA 1.488 2.122 0 C-N-CA 119.319 -1.419 . . . . 0.0 110.677 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.557 ' C ' HG23 ' A' ' 66' ' ' VAL . 9.8 m-85 -136.24 145.09 45.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.756 -0.849 . . . . 0.0 109.008 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.557 HG23 ' C ' ' A' ' 65' ' ' PHE . 16.2 t -149.98 143.4 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.981 -1.074 . . . . 0.0 110.585 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.582 HG23 ' CB ' ' A' ' 21' ' ' LYS . 1.5 m -137.24 58.73 1.7 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.303 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.587 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.071 -1.018 . . . . 0.0 110.557 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 75' ' ' ASP . . . . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.311 0.577 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.729 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -51.65 -74.46 0.29 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 16.4 t -45.73 -32.54 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.22 -1.165 . . . . 0.0 110.092 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 72' ' ' ALA . 0.5 OUTLIER -62.39 -76.84 0.05 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.175 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.451 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -49.19 -42.72 41.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 0.0 109.797 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.928 HG13 ' HE1' ' A' ' 40' ' ' PHE . 62.1 t -54.39 -53.81 27.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 O-C-N 121.103 -0.998 . . . . 0.0 108.916 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -42.76 -52.61 4.92 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.405 -0.809 . . . . 0.0 109.723 178.701 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -44.89 -28.75 0.69 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.344 -0.848 . . . . 0.0 109.531 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.544 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 43.9 mm-40 -97.44 21.44 10.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.478 -0.764 . . . . 0.0 110.037 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 78' ' ' LEU . 47.8 t -56.87 -13.09 2.32 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.506 -0.746 . . . . 0.0 109.093 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.49 ' O ' ' C ' ' A' ' 83' ' ' HIS . 7.0 ptt180 -103.07 -11.39 18.15 Favored 'General case' 0 C--N 1.31 -1.121 0 O-C-N 121.349 -0.845 . . . . 0.0 109.797 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.766 ' ND1' HD12 ' A' ' 90' ' ' ILE . 0.5 OUTLIER 29.63 51.65 0.08 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.877 -0.514 . . . . 0.0 112.127 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.54 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 3.6 tt0 -90.58 126.17 35.86 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.672 -1.268 . . . . 0.0 109.202 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.534 ' CD2' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -147.37 -79.73 0.15 Allowed 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.565 -179.141 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.531 ' O ' ' CD ' ' A' ' 88' ' ' LYS . 7.9 m-20 -85.33 49.89 1.84 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.502 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER 70.22 6.98 6.03 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.483 0.658 . . . . 0.0 109.557 -178.847 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -110.31 125.9 53.64 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.35 -0.844 . . . . 0.0 109.76 -179.594 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.741 ' O ' HG23 ' A' ' 89' ' ' THR . 9.3 t -99.77 75.45 1.9 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.577 -0.702 . . . . 0.0 109.562 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 1.046 HG23 ' C ' ' A' ' 26' ' ' GLY . 0.9 OUTLIER -52.61 -174.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.372 -0.83 . . . . 0.0 109.181 -179.663 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 25' ' ' GLY . 20.4 t0 -142.26 85.3 10.82 Favored Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 120.565 -1.334 . . . . 0.0 111.684 -178.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.576 ' HG3' ' HD2' ' A' ' 83' ' ' HIS . 2.0 Cg_endo -59.98 113.44 1.65 Allowed 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.462 1.243 . . . . 0.0 110.757 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.633 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -123.67 108.77 12.92 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.03 -1.043 . . . . 0.0 109.774 178.073 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.918 HG22 ' HB2' ' A' ' 22' ' ' MET . 43.0 t -96.24 170.18 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.485 -0.76 . . . . 0.0 110.082 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.494 ' N ' HG12 ' A' ' 94' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.898 . . . . 0.0 110.284 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.21 0.528 . . . . 0.0 110.088 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' MET . . . . . 1.003 ' CB ' HG22 ' A' ' 94' ' ' VAL . 0.9 OUTLIER -86.15 -169.87 2.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.217 -0.927 . . . . 0.0 110.323 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.656 ' HB3' ' HD2' ' A' ' 93' ' ' LYS . 0.7 OUTLIER -149.97 152.1 34.4 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.355 -0.84 . . . . 0.0 109.466 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.654 HD12 ' C ' ' A' ' 23' ' ' PHE . 1.1 mp -113.46 134.52 55.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.323 -0.86 . . . . 0.0 109.243 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.498 ' O ' ' CG2' ' A' ' 90' ' ' ILE . . . -102.51 136.86 13.05 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.812 -1.185 . . . . 0.0 110.699 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.474 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 58.82 39.72 94.18 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.844 HD13 ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -60.59 154.31 21.43 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.444 -1.033 . . . . 0.0 110.056 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.773 ' O ' HG22 ' A' ' 31' ' ' THR . 0.5 OUTLIER -40.58 134.8 1.71 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.352 -0.843 . . . . 0.0 110.343 -179.673 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 11.0 p-90 -77.43 -12.26 59.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.342 -0.849 . . . . 0.0 110.63 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -110.93 -12.02 14.28 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.086 -1.009 . . . . 0.0 110.63 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.773 HG22 ' O ' ' A' ' 28' ' ' SER . 13.2 t -61.42 -167.26 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.833 0 CA-C-O 121.628 0.728 . . . . 0.0 110.676 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.589 HG23 ' H ' ' A' ' 35' ' ' GLY . 14.7 t -157.18 -168.1 2.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.695 -0.628 . . . . 0.0 109.751 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 36' ' ' LEU . 2.3 mt-30 -68.68 -72.46 0.18 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.082 -1.012 . . . . 0.0 110.207 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.406 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 3.8 tt0 -48.33 -45.77 35.69 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.837 -1.165 . . . . 0.0 109.72 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.589 ' H ' HG23 ' A' ' 32' ' ' THR . . . -55.62 -27.03 47.74 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.927 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -83.66 -32.68 25.5 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.082 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.893 ' HA ' HG11 ' A' ' 46' ' ' VAL . 18.8 mmm-85 -64.96 -28.71 69.7 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.536 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -90.55 -14.68 32.08 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.571 178.777 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.586 ' OH ' ' CG ' ' A' ' 83' ' ' HIS . 38.7 t80 -81.33 -26.34 35.68 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 121.619 -0.675 . . . . 0.0 110.171 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.798 ' HE1' HG13 ' A' ' 77' ' ' VAL . 14.6 m-85 -122.19 -21.51 5.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.887 . . . . 0.0 109.91 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.93 2.12 65.96 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.409 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 8.2 tp60 -72.1 -55.78 6.74 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 121.426 -1.043 . . . . 0.0 109.971 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.32 12.66 26.15 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.4 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 45' ' ' GLU . . . -154.17 -116.2 0.59 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -179.74 104.39 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.532 -0.981 . . . . 0.0 109.349 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.893 HG11 ' HA ' ' A' ' 37' ' ' ARG . 2.7 p -90.03 149.46 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 111.266 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.77 -39.61 5.53 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.615 -0.678 . . . . 0.0 109.931 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -149.71 148.38 29.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.317 -0.864 . . . . 0.0 110.601 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.822 ' HB2' HD21 ' A' ' 36' ' ' LEU . 17.3 p -151.13 164.03 37.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.294 -0.879 . . . . 0.0 110.661 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.732 ' C ' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -139.3 123.71 18.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.318 -0.864 . . . . 0.0 109.617 179.039 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.649 HG13 HD11 ' A' ' 27' ' ' LEU . 87.0 t -113.11 136.93 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.803 -1.185 . . . . 0.0 111.227 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.526 ' HG2' ' CE1' ' A' ' 63' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--N 1.302 -1.463 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 52' ' ' MET . . . . . . . . 0 N--CA 1.488 2.158 0 N-CA-C 109.346 -1.501 . . . . 0.0 109.346 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.844 ' O ' HD13 ' A' ' 27' ' ' LEU . 45.7 p90 -142.35 -164.32 1.79 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.293 -1.122 . . . . 0.0 110.223 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -162.54 114.09 0.59 Allowed Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.597 -1.287 . . . . 0.0 110.15 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.513 ' HB2' ' HG ' ' A' ' 50' ' ' LEU . 13.4 m-85 -82.66 142.55 31.61 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.249 -1.148 . . . . 0.0 109.061 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.646 HG21 HD11 ' A' ' 36' ' ' LEU . 5.7 t -150.01 114.9 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.91 -1.119 . . . . 0.0 110.582 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 7.2 t -88.17 32.31 0.77 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.388 -0.82 . . . . 0.0 109.829 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.652 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.868 . . . . 0.0 110.73 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.241 0.544 . . . . 0.0 110.313 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.4 -65.28 3.38 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 55.6 t -45.1 -31.0 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -1.106 . . . . 0.0 110.254 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -67.85 -61.42 1.88 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.212 -0.93 . . . . 0.0 110.413 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.578 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -60.63 -46.88 88.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 110.35 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.798 HG13 ' HE1' ' A' ' 40' ' ' PHE . 93.9 t -48.28 -62.38 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 O-C-N 121.062 -1.024 . . . . 0.0 109.255 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 81' ' ' SER . 0.1 OUTLIER -41.68 -51.31 4.1 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.338 -0.851 . . . . 0.0 109.897 179.035 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -44.71 -25.98 0.34 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.211 -0.931 . . . . 0.0 109.548 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.63 ' HB3' ' CE1' ' A' ' 83' ' ' HIS . 7.0 mm-40 -99.91 20.0 15.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.424 -0.797 . . . . 0.0 110.386 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.568 ' HA ' ' HD2' ' A' ' 92' ' ' PRO . 25.2 p -58.07 -13.21 4.31 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.385 -0.822 . . . . 0.0 109.061 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -107.16 10.58 30.01 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.521 -0.737 . . . . 0.0 109.86 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.63 ' CE1' ' HB3' ' A' ' 80' ' ' GLN . 1.6 m-70 -21.88 83.52 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -178.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 82' ' ' ARG . 1.1 tt0 -103.69 122.74 45.67 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.511 HD23 ' C ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -139.89 -89.83 0.18 Allowed 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.338 -0.851 . . . . 0.0 109.818 -178.897 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 87' ' ' SER . 53.8 t0 -78.14 53.7 1.25 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.126 -0.984 . . . . 0.0 108.356 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 70.98 9.11 6.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.627 -0.671 . . . . 0.0 109.719 -178.95 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 5.4 mmtt -111.7 113.99 26.71 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 121.286 -0.884 . . . . 0.0 110.25 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.595 ' O ' HG23 ' A' ' 89' ' ' THR . 6.8 t -90.37 68.96 6.94 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.578 HD12 ' OH ' ' A' ' 39' ' ' TYR . 1.2 mt -45.44 176.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 121.685 0.755 . . . . 0.0 109.86 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 81' ' ' SER . 5.3 t0 -144.88 77.31 13.38 Favored Pre-proline 0 C--N 1.296 -1.719 0 O-C-N 121.196 -0.94 . . . . 0.0 111.157 -178.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.583 ' HG3' ' CD2' ' A' ' 83' ' ' HIS . 2.0 Cg_endo -51.42 114.48 1.58 Allowed 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 123.446 1.235 . . . . 0.0 109.898 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.656 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -129.42 102.69 6.52 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.171 -0.956 . . . . 0.0 110.364 179.133 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 1.003 HG22 ' CB ' ' A' ' 22' ' ' MET . 95.2 t -97.31 161.61 2.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 O-C-N 121.757 -0.589 . . . . 0.0 110.063 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.175 -0.953 . . . . 0.0 110.582 -179.612 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.764 ' CB ' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.287 0.565 . . . . 0.0 110.249 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' MET . . . . . 1.067 ' HB3' HG13 ' A' ' 94' ' ' VAL . 1.5 ptt? -86.31 176.97 7.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 110.197 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.779 ' C ' HD12 ' A' ' 24' ' ' ILE . 3.1 t80 -150.51 154.36 37.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.167 -0.958 . . . . 0.0 110.393 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.851 ' CG2' HG21 ' A' ' 90' ' ' ILE . 1.3 mp -113.14 137.19 47.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.489 ' O ' HG22 ' A' ' 90' ' ' ILE . . . -112.84 140.29 16.21 Favored Glycine 0 N--CA 1.501 2.973 0 C-N-CA 119.31 -1.424 . . . . 0.0 112.951 -176.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.519 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 59.66 47.06 92.79 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.867 HD23 ' O ' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -79.24 146.47 33.01 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.315 -1.109 . . . . 0.0 111.506 -178.437 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.454 ' HB2' ' HB ' ' A' ' 31' ' ' THR . 18.5 m -39.9 159.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.533 0.682 . . . . 0.0 110.763 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -92.32 -23.13 19.36 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.434 -0.791 . . . . 0.0 109.644 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.49 ' HG3' ' N ' ' A' ' 31' ' ' THR . 0.1 OUTLIER -83.78 -15.85 46.88 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.263 -0.898 . . . . 0.0 110.249 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.577 HG21 ' HG ' ' A' ' 27' ' ' LEU . 10.5 t -55.51 -174.31 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.633 0.73 . . . . 0.0 110.598 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.701 HG23 ' H ' ' A' ' 35' ' ' GLY . 6.5 t -161.24 -173.01 3.64 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.5 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 5.0 mt-30 -71.72 -74.61 0.15 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.998 -1.064 . . . . 0.0 110.781 -178.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.559 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 3.0 tt0 -49.6 -34.13 17.11 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.72 -1.237 . . . . 0.0 110.05 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.701 ' H ' HG23 ' A' ' 32' ' ' THR . . . -60.72 -30.19 71.9 Favored Glycine 0 C--N 1.295 -1.719 0 N-CA-C 107.216 -2.354 . . . . 0.0 107.216 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.876 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -82.51 -38.97 23.06 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.192 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.559 ' HG3' ' HA ' ' A' ' 34' ' ' GLU . 18.6 mtt180 -62.5 -27.0 68.84 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.505 1.145 . . . . 0.0 108.23 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.534 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -85.67 -21.05 28.54 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.127 179.694 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.661 ' CE1' ' NE2' ' A' ' 83' ' ' HIS . 9.9 t80 -81.94 -41.76 20.39 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.322 -0.861 . . . . 0.0 110.835 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.846 ' CE1' HG13 ' A' ' 77' ' ' VAL . 33.0 m-85 -100.3 -27.68 13.36 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.448 -0.783 . . . . 0.0 108.934 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.613 ' CA ' HG23 ' A' ' 46' ' ' VAL . . . -67.38 -9.52 55.06 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -64.64 -48.35 75.13 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.472 -1.016 . . . . 0.0 109.97 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.565 ' CG ' ' HB3' ' A' ' 76' ' ' LYS . 6.2 p90 -109.05 5.87 24.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.395 -0.815 . . . . 0.0 110.244 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.515 ' O ' ' HA2' ' A' ' 41' ' ' GLY . . . -162.76 97.74 0.15 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -38.8 124.25 1.35 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.473 -1.016 . . . . 0.0 110.745 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.613 HG23 ' CA ' ' A' ' 41' ' ' GLY . 47.7 t -90.07 132.16 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.384 -0.823 . . . . 0.0 110.74 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -98.67 -15.96 19.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.372 -0.83 . . . . 0.0 110.069 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -169.67 143.13 2.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.188 -0.945 . . . . 0.0 110.895 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.497 ' SG ' ' NE ' ' A' ' 37' ' ' ARG . 8.4 p -150.97 164.65 35.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.485 -0.759 . . . . 0.0 109.995 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.719 HD21 ' CD2' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -150.36 128.6 12.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.99 -1.069 . . . . 0.0 110.786 179.869 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.6 t -103.74 135.79 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 120.659 -1.275 . . . . 0.0 110.268 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.596 ' HG2' ' CE1' ' A' ' 63' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--N 1.306 -1.291 0 O-C-N 121.253 -0.904 . . . . 0.0 109.951 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.712 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.837 ' N ' HD22 ' A' ' 27' ' ' LEU . 3.1 p90 -173.39 -174.46 1.02 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.138 -1.213 . . . . 0.0 111.05 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.43 ' O ' ' HB ' ' A' ' 24' ' ' ILE . . . -149.89 123.66 1.63 Allowed Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.719 ' CD2' HD21 ' A' ' 50' ' ' LEU . 18.1 m-85 -83.88 148.98 26.65 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.318 -1.107 . . . . 0.0 109.625 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.698 HG22 HD21 ' A' ' 36' ' ' LEU . 3.7 t -146.44 161.92 9.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.316 -0.865 . . . . 0.0 109.621 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.764 HG23 ' CB ' ' A' ' 21' ' ' LYS . 1.8 m -149.56 39.6 0.81 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.198 -0.939 . . . . 0.0 110.229 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.608 ' CE2' HG21 ' A' ' 77' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.151 -0.968 . . . . 0.0 109.858 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.142 0.496 . . . . 0.0 110.661 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.571 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -49.9 -57.24 10.07 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.414 ' H ' HG23 ' A' ' 74' ' ' VAL . 49.0 t -47.51 -43.54 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.235 -1.156 . . . . 0.0 110.32 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.959 ' HA ' HD21 ' A' ' 78' ' ' LEU . 0.5 OUTLIER -59.58 -39.96 85.86 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.177 -0.952 . . . . 0.0 110.271 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.565 ' HB3' ' CG ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -71.07 -28.33 64.27 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.189 -0.944 . . . . 0.0 109.901 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.846 HG13 ' CE1' ' A' ' 40' ' ' PHE . 55.0 t -64.68 -64.42 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.139 -0.976 . . . . 0.0 109.576 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.959 HD21 ' HA ' ' A' ' 75' ' ' ASP . 1.5 pp -47.98 -37.98 15.88 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.109 -0.994 . . . . 0.0 109.185 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -46.17 -30.14 1.83 Allowed 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.057 -1.027 . . . . 0.0 108.861 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.532 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 0.9 OUTLIER -104.62 28.26 7.19 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.411 0.624 . . . . 0.0 109.741 179.378 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.464 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 5.7 p -52.85 -18.52 1.95 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.492 ' O ' ' C ' ' A' ' 83' ' ' HIS . 4.5 ptt180 -94.49 -15.44 24.19 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.482 -0.761 . . . . 0.0 109.565 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.848 ' CE1' HD12 ' A' ' 90' ' ' ILE . 0.6 OUTLIER 28.72 46.31 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 179.303 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.578 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 0.8 OUTLIER -90.24 124.87 35.23 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 118.583 -1.247 . . . . 0.0 109.545 179.243 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.531 ' CD2' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -147.5 -83.63 0.11 Allowed 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 120.146 -0.621 . . . . 0.0 109.676 -179.493 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' A' ' 87' ' ' SER . 23.7 m-20 -83.18 50.73 1.8 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.11 -0.993 . . . . 0.0 108.818 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 72.63 7.19 5.54 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.472 0.653 . . . . 0.0 109.754 -179.188 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.578 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 0.6 OUTLIER -111.42 122.38 47.69 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.405 -0.809 . . . . 0.0 109.656 -179.529 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.718 ' O ' HG23 ' A' ' 89' ' ' THR . 9.4 t -101.9 69.43 1.18 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.062 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.851 HG21 ' CG2' ' A' ' 24' ' ' ILE . 0.9 OUTLIER -51.48 -176.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.346 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.514 ' H ' HG22 ' A' ' 90' ' ' ILE . 3.6 t70 -143.39 84.4 10.19 Favored Pre-proline 0 C--N 1.304 -1.382 0 O-C-N 120.963 -1.086 . . . . 0.0 110.363 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.543 ' HG3' ' HD2' ' A' ' 83' ' ' HIS . 2.3 Cg_endo -56.03 113.42 1.43 Allowed 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.551 1.29 . . . . 0.0 111.167 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.61 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -127.71 104.46 7.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.233 -0.917 . . . . 0.0 109.575 178.385 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 1.067 HG13 ' HB3' ' A' ' 22' ' ' MET . 7.9 t -96.77 164.29 2.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 O-C-N 121.654 -0.654 . . . . 0.0 110.398 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.705 0 O-C-N 121.218 -0.926 . . . . 0.0 110.136 179.86 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.546 ' CB ' ' HB ' ' A' ' 67' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 120.992 0.425 . . . . 0.0 110.014 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.805 ' HG2' HG13 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -71.76 -175.94 1.51 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.032 -1.042 . . . . 0.0 109.564 179.648 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.535 ' O ' ' HG2' ' A' ' 93' ' ' LYS . 2.0 t80 -149.03 119.16 7.21 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.076 -1.015 . . . . 0.0 111.487 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.706 HG22 ' CG2' ' A' ' 90' ' ' ILE . 17.4 mm -91.33 140.46 16.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.062 -1.024 . . . . 0.0 109.216 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 90' ' ' ILE . . . -119.23 149.42 18.08 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.669 -1.253 . . . . 0.0 111.303 -178.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.457 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 55.97 43.65 87.88 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.982 HD22 ' CA ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER -84.37 152.15 24.25 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.468 -1.019 . . . . 0.0 110.584 -179.027 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.8 ' O ' HG22 ' A' ' 31' ' ' THR . 14.5 m -41.73 124.66 2.6 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.459 -0.776 . . . . 0.0 110.32 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.496 ' CD2' ' N ' ' A' ' 30' ' ' GLN . 65.1 p-90 -68.2 -33.59 74.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.341 -0.85 . . . . 0.0 110.437 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.496 ' N ' ' CD2' ' A' ' 29' ' ' TRP . 17.8 pt20 -74.35 -12.56 60.56 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.324 -0.86 . . . . 0.0 111.2 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.8 HG22 ' O ' ' A' ' 28' ' ' SER . 5.7 t -65.05 -179.45 0.56 Allowed 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.34 -0.85 . . . . 0.0 110.37 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 35' ' ' GLY . 5.5 t -148.2 -172.65 4.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.338 -0.851 . . . . 0.0 110.155 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 36' ' ' LEU . 6.5 mt-30 -66.2 -73.43 0.13 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.196 -0.94 . . . . 0.0 110.67 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.472 ' HA ' ' CG ' ' A' ' 37' ' ' ARG . 3.4 tt0 -47.46 -47.31 27.23 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.759 -1.176 . . . . 0.0 109.718 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.536 ' O ' ' HG3' ' A' ' 38' ' ' GLU . . . -53.36 -27.57 33.13 Favored Glycine 0 N--CA 1.483 1.799 0 N-CA-C 107.711 -2.156 . . . . 0.0 107.711 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.999 HD21 ' HB3' ' A' ' 49' ' ' CYS . 0.1 OUTLIER -83.37 -35.49 25.07 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' A' ' 33' ' ' GLN . 34.1 mtp180 -62.37 -28.34 69.7 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.536 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -90.88 -15.36 30.03 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.534 178.772 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.601 ' HH ' ' CE1' ' A' ' 83' ' ' HIS . 47.9 t80 -75.47 -29.12 59.51 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 121.55 0.69 . . . . 0.0 109.617 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.884 ' CE1' HG13 ' A' ' 77' ' ' VAL . 37.8 m-85 -116.29 -26.11 7.3 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.633 -0.667 . . . . 0.0 109.48 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -68.16 -9.27 56.94 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -71.51 -50.9 26.94 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.439 -1.036 . . . . 0.0 110.593 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.578 ' HE1' HG22 ' A' ' 77' ' ' VAL . 3.1 p90 -109.53 -6.85 15.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.096 -1.003 . . . . 0.0 110.747 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 40' ' ' PHE . . . -150.63 118.6 0.93 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 9.8 pt-20 -54.23 132.9 44.38 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.198 -1.178 . . . . 0.0 109.722 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.752 HG11 ' SG ' ' A' ' 49' ' ' CYS . 86.3 t -112.14 152.64 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.158 -0.963 . . . . 0.0 110.46 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.45 ' HB3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -96.74 -29.84 13.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.355 -0.841 . . . . 0.0 109.826 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.502 ' O ' HG22 ' A' ' 67' ' ' THR . 11.6 tp10 -179.68 158.4 0.8 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.341 -0.85 . . . . 0.0 110.058 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.999 ' HB3' HD21 ' A' ' 36' ' ' LEU . 7.2 m -146.04 171.01 15.51 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.922 -1.112 . . . . 0.0 110.6 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.804 HD12 ' N ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -138.9 134.65 33.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.304 -0.873 . . . . 0.0 109.397 179.691 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.804 ' N ' HD12 ' A' ' 50' ' ' LEU . 76.4 t -125.62 139.36 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.47 -1.394 . . . . 0.0 111.612 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.563 ' HG2' ' CE2' ' A' ' 63' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.485 1.323 0 O-C-N 121.347 -0.845 . . . . 0.0 109.747 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.982 ' CA ' HD22 ' A' ' 27' ' ' LEU . 49.6 p90 -144.54 -167.95 2.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.139 -1.212 . . . . 0.0 110.29 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 50' ' ' LEU . . . -168.49 123.93 1.14 Allowed Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.569 -1.3 . . . . 0.0 110.199 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.61 ' CD2' ' CD2' ' A' ' 50' ' ' LEU . 27.5 m-85 -85.84 152.26 23.14 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.477 -1.013 . . . . 0.0 108.899 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.675 HG13 ' SG ' ' A' ' 49' ' ' CYS . 11.2 t -150.33 104.25 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.615 -1.303 . . . . 0.0 111.62 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.546 ' HB ' ' CB ' ' A' ' 21' ' ' LYS . 2.3 t -87.71 125.95 34.7 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.112 -0.993 . . . . 0.0 109.129 178.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.869 ' CE2' HG21 ' A' ' 77' ' ' VAL . 5.8 m-85 . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.027 -1.046 . . . . 0.0 109.986 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 73' ' ' GLY . . . . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.32 0.581 . . . . 0.0 110.084 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.764 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -43.94 -42.67 6.57 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.015 HG13 HG11 ' A' ' 94' ' ' VAL . 21.3 t -64.76 -55.24 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -1.145 . . . . 0.0 110.15 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.685 ' HA ' HD21 ' A' ' 78' ' ' LEU . 10.8 m-20 -41.97 -40.97 2.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 110.206 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.752 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 33.7 mmtt -72.67 -46.6 53.06 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.422 -0.799 . . . . 0.0 110.186 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.884 HG13 ' CE1' ' A' ' 40' ' ' PHE . 58.0 t -53.06 -68.3 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.124 -0.985 . . . . 0.0 109.767 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.685 HD21 ' HA ' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -45.65 -39.01 7.32 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.061 -1.024 . . . . 0.0 109.209 179.123 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.752 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -48.88 -24.23 1.39 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.077 -1.014 . . . . 0.0 108.9 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.631 ' HB3' ' CE1' ' A' ' 83' ' ' HIS . 8.7 mm100 -105.23 28.03 7.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.585 -0.697 . . . . 0.0 109.987 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.571 ' HA ' ' HD2' ' A' ' 92' ' ' PRO . 14.3 t -61.17 -10.79 7.13 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.448 -0.783 . . . . 0.0 109.123 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -108.49 11.1 27.11 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 121.418 -0.801 . . . . 0.0 109.896 179.646 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.631 ' CE1' ' HB3' ' A' ' 80' ' ' GLN . 1.7 m-70 -23.73 85.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -178.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.989 ' C ' HD13 ' A' ' 85' ' ' LEU . 1.4 tt0 -106.99 121.41 44.41 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.989 HD13 ' C ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -142.35 -97.97 0.13 Allowed 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.991 -179.467 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.56 ' H ' HD23 ' A' ' 85' ' ' LEU . 25.4 t70 -69.73 55.64 0.13 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.834 -1.166 . . . . 0.0 108.741 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 70.42 8.37 6.59 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.445 -0.785 . . . . 0.0 110.138 -179.473 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.529 ' CD ' ' O ' ' A' ' 86' ' ' ASP . 2.3 mmmt -111.01 111.6 22.82 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.177 -0.952 . . . . 0.0 110.672 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.558 ' O ' HG23 ' A' ' 89' ' ' THR . 7.1 t -89.46 63.49 6.38 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.706 ' CG2' HG22 ' A' ' 24' ' ' ILE . 1.2 mt -42.65 172.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 CA-C-O 121.925 0.869 . . . . 0.0 110.277 -178.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 81' ' ' SER . 14.4 t0 -144.17 77.01 14.65 Favored Pre-proline 0 C--N 1.298 -1.637 0 O-C-N 121.32 -0.863 . . . . 0.0 110.786 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.602 ' HG3' ' CD2' ' A' ' 83' ' ' HIS . 1.9 Cg_endo -52.48 112.79 0.97 Allowed 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.514 1.27 . . . . 0.0 110.068 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.581 ' O ' ' CG ' ' A' ' 93' ' ' LYS . 7.0 ptmt -109.43 105.56 14.96 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.627 1.203 . . . . 0.0 110.517 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 1.015 HG11 HG13 ' A' ' 74' ' ' VAL . 39.5 t -98.11 130.76 46.41 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 O-C-N 121.182 -0.949 . . . . 0.0 110.397 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.204 -0.935 . . . . 0.0 110.506 -179.697 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.671 ' HB3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.086 0.47 . . . . 0.0 110.137 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.831 ' CB ' HG13 ' A' ' 94' ' ' VAL . 3.1 ptm -121.1 -174.21 2.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.049 -1.032 . . . . 0.0 110.151 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.582 ' CD1' ' C ' ' A' ' 23' ' ' PHE . 0.3 OUTLIER -150.47 144.43 25.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.348 -0.845 . . . . 0.0 109.329 179.699 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.652 ' CG2' HG21 ' A' ' 90' ' ' ILE . 9.1 mm -108.03 129.26 62.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.122 -0.986 . . . . 0.0 109.475 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.513 ' O ' HG22 ' A' ' 90' ' ' ILE . . . -110.4 144.9 17.16 Favored Glycine 0 N--CA 1.494 2.545 0 C-N-CA 120.114 -1.041 . . . . 0.0 111.239 -178.197 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.435 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 60.13 34.28 83.34 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.934 HD23 ' O ' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -73.84 146.71 43.94 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.55 -0.971 . . . . 0.0 110.022 -179.608 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.625 ' O ' HG22 ' A' ' 31' ' ' THR . 0.3 OUTLIER -39.74 132.83 1.63 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.598 -0.689 . . . . 0.0 110.3 -179.715 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.515 ' CD1' ' N ' ' A' ' 29' ' ' TRP . 0.5 OUTLIER -76.35 6.03 6.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.257 -0.902 . . . . 0.0 110.54 -179.799 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.442 ' O ' ' O ' ' A' ' 31' ' ' THR . 9.7 pt20 -124.47 -12.75 7.22 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.189 -0.944 . . . . 0.0 110.485 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.625 HG22 ' O ' ' A' ' 28' ' ' SER . 11.5 t -53.76 -168.7 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.603 -0.686 . . . . 0.0 110.379 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.458 HG23 ' H ' ' A' ' 35' ' ' GLY . 1.3 t -145.16 176.15 9.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.446 -0.784 . . . . 0.0 109.748 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 36' ' ' LEU . 3.5 mt-30 -72.0 -72.58 0.22 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.111 -0.993 . . . . 0.0 111.105 -178.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.522 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -46.15 -52.85 11.49 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.672 -1.211 . . . . 0.0 109.436 -179.69 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.468 ' HA2' ' HG3' ' A' ' 38' ' ' GLU . . . -46.75 -32.69 5.99 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 107.822 -2.111 . . . . 0.0 107.822 178.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.834 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -78.19 -39.34 40.96 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.317 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.661 ' HA ' HG21 ' A' ' 46' ' ' VAL . 49.3 mtt180 -60.58 -26.07 66.68 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 122.316 1.055 . . . . 0.0 108.434 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -85.4 -21.28 28.88 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.787 179.513 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.694 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 29.4 t80 -79.97 -24.34 41.0 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.647 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.769 ' HE1' HG13 ' A' ' 77' ' ' VAL . 25.4 m-85 -114.55 -19.13 11.27 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.332 -0.855 . . . . 0.0 109.104 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.17 -4.12 88.72 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 108.719 -1.753 . . . . 0.0 108.719 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -68.29 -53.05 27.04 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.352 -1.087 . . . . 0.0 110.034 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.601 ' HE2' HE21 ' A' ' 80' ' ' GLN . 0.1 OUTLIER -99.41 9.39 43.38 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.277 -0.89 . . . . 0.0 110.259 179.492 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -152.68 -121.92 0.91 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.508 ' CG ' ' O ' ' A' ' 45' ' ' GLU . 5.9 pt-20 -172.08 119.44 0.42 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.385 -1.067 . . . . 0.0 109.687 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.661 HG21 ' HA ' ' A' ' 37' ' ' ARG . 28.1 t -93.25 124.09 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.335 -0.853 . . . . 0.0 111.124 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.86 -31.35 19.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.383 -0.823 . . . . 0.0 109.337 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -172.11 151.3 2.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.518 -0.739 . . . . 0.0 109.597 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.5 ' SG ' ' NE ' ' A' ' 37' ' ' ARG . 24.0 p -148.91 167.67 25.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.053 -1.029 . . . . 0.0 110.605 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.788 ' C ' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -142.92 122.97 13.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.255 -0.903 . . . . 0.0 110.446 179.693 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.535 ' N ' HD12 ' A' ' 50' ' ' LEU . 71.3 t -105.41 137.51 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.027 -1.046 . . . . 0.0 110.368 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.567 ' HG2' ' CZ ' ' A' ' 63' ' ' PHE . 1.9 ttt . . . . . 0 C--N 1.305 -1.343 0 O-C-N 121.33 -0.856 . . . . 0.0 110.064 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.595 ' C ' HD22 ' A' ' 27' ' ' LEU . . . . . . . . 0 N--CA 1.486 1.985 0 N-CA-C 109.149 -1.581 . . . . 0.0 109.149 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.63 ' N ' HD22 ' A' ' 27' ' ' LEU . 12.4 p90 -149.82 -169.66 3.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -1.14 . . . . 0.0 110.288 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 50' ' ' LEU . . . -167.55 -161.99 18.32 Favored Glycine 0 N--CA 1.485 1.924 0 C-N-CA 119.507 -1.33 . . . . 0.0 110.303 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.543 ' C ' HG23 ' A' ' 66' ' ' VAL . 9.1 m-85 -146.23 143.4 29.2 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.769 -0.842 . . . . 0.0 109.074 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.748 HG21 HD11 ' A' ' 36' ' ' LEU . 14.1 t -147.85 97.08 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 120.805 -1.184 . . . . 0.0 110.752 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.671 HG23 ' HB3' ' A' ' 21' ' ' LYS . 22.7 m -80.68 58.43 3.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.368 -0.832 . . . . 0.0 109.929 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.599 ' CE2' HG21 ' A' ' 77' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 110.609 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.492 ' HB1' ' NZ ' ' A' ' 76' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.309 0.576 . . . . 0.0 110.005 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.797 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -53.67 -65.87 3.13 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.555 ' CG1' ' N ' ' A' ' 75' ' ' ASP . 2.2 p -39.94 -43.19 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.398 -1.06 . . . . 0.0 110.489 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.803 ' HA ' HD23 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -58.65 -77.86 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.367 -0.833 . . . . 0.0 110.383 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.621 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -48.47 -22.45 0.73 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.381 -0.824 . . . . 0.0 110.059 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 73' ' ' GLY . 55.4 t -71.72 -53.43 20.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.256 -0.903 . . . . 0.0 109.666 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.803 HD23 ' HA ' ' A' ' 75' ' ' ASP . 1.3 pp -50.76 -28.95 10.25 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 120.918 -1.114 . . . . 0.0 108.196 178.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -57.36 -20.03 26.61 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.341 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.601 HE21 ' HE2' ' A' ' 43' ' ' PHE . 4.3 mt-30 -105.58 19.01 21.28 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.431 0.634 . . . . 0.0 109.481 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.484 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 46.3 t -53.38 -16.5 1.41 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.604 -0.839 . . . . 0.0 108.747 178.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.571 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -103.66 -2.43 26.59 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 121.358 -0.839 . . . . 0.0 109.618 178.979 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 1.014 ' CE1' HD12 ' A' ' 90' ' ' ILE . 0.3 OUTLIER 27.18 -85.09 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.705 0.764 . . . . 0.0 111.675 179.68 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.875 ' C ' HD23 ' A' ' 85' ' ' LEU . 0.5 OUTLIER 54.66 122.14 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 122.205 1.002 . . . . 0.0 111.088 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.875 HD23 ' C ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -149.19 -92.08 0.07 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.394 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.561 ' O ' ' CB ' ' A' ' 87' ' ' SER . 7.7 t0 -82.54 54.28 2.58 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.067 -1.02 . . . . 0.0 108.495 178.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.561 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER 76.68 6.18 3.39 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.215 0.531 . . . . 0.0 109.975 -179.016 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.601 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -110.86 114.41 27.72 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.291 -0.88 . . . . 0.0 110.668 -179.351 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.694 ' O ' HG23 ' A' ' 89' ' ' THR . 9.7 t -89.14 76.98 7.64 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.805 -0.559 . . . . 0.0 109.805 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 1.014 HD12 ' CE1' ' A' ' 83' ' ' HIS . 1.5 mt -49.23 179.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.256 -0.903 . . . . 0.0 109.494 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.565 ' H ' HG22 ' A' ' 90' ' ' ILE . 8.0 t0 -140.72 79.55 19.24 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.328 -0.858 . . . . 0.0 110.1 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.525 ' CG ' ' O ' ' A' ' 80' ' ' GLN . 2.3 Cg_endo -54.61 111.94 0.87 Allowed 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.57 1.3 . . . . 0.0 110.749 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.582 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -127.59 103.12 7.15 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.866 0.841 . . . . 0.0 109.235 178.528 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.831 HG13 ' CB ' ' A' ' 22' ' ' MET . 15.8 t -97.11 170.48 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-O 121.349 0.595 . . . . 0.0 110.502 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.413 ' N ' HG12 ' A' ' 94' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.199 -0.938 . . . . 0.0 110.436 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.188 0.518 . . . . 0.0 110.325 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.768 ' CG ' HG22 ' A' ' 94' ' ' VAL . 7.4 ttt -76.72 163.1 27.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.221 -0.924 . . . . 0.0 110.16 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.706 ' CG ' ' CE1' ' A' ' 65' ' ' PHE . 2.0 t80 -141.64 129.08 21.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.295 -0.878 . . . . 0.0 109.597 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.702 HD12 ' C ' ' A' ' 23' ' ' PHE . 1.4 mp -106.48 155.87 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.115 -0.99 . . . . 0.0 109.289 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.57 ' O ' ' N ' ' A' ' 91' ' ' ASP . . . -139.21 139.08 9.8 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 119.245 -1.455 . . . . 0.0 111.42 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.552 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 105.51 27.26 5.86 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.981 ' CD2' HG13 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -50.45 118.58 3.12 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.792 -0.828 . . . . 0.0 110.864 -179.588 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.523 ' HB2' ' CB ' ' A' ' 88' ' ' LYS . 1.4 t -59.43 178.52 0.14 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.38 -0.825 . . . . 0.0 110.212 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.568 ' O ' ' CE3' ' A' ' 29' ' ' TRP . 35.1 p-90 -84.85 15.69 3.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.177 -0.952 . . . . 0.0 110.1 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -143.92 7.45 1.42 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.241 -0.912 . . . . 0.0 110.936 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.595 HG21 ' HG ' ' A' ' 27' ' ' LEU . 1.9 m -70.66 157.08 38.61 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.125 -0.984 . . . . 0.0 109.892 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.531 ' CG2' ' HA3' ' A' ' 35' ' ' GLY . 4.4 t -127.48 178.04 6.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.083 -1.01 . . . . 0.0 109.922 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.516 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 6.0 mt-30 -88.76 -73.69 0.49 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.15 -0.969 . . . . 0.0 110.734 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.56 ' HA ' ' HB3' ' A' ' 37' ' ' ARG . 0.1 OUTLIER -50.78 -49.67 57.73 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 117.967 -1.493 . . . . 0.0 108.929 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.531 ' HA3' ' CG2' ' A' ' 32' ' ' THR . . . -49.39 -27.72 8.48 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 107.603 -2.199 . . . . 0.0 107.603 178.237 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.91 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -80.69 -32.02 36.06 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.478 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.581 ' HG2' ' HG2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -60.46 -34.79 74.52 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 177.475 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.581 ' HG2' ' HG2' ' A' ' 37' ' ' ARG . 2.0 mt-10 -76.63 -25.44 53.82 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 113.912 -1.494 . . . . 0.0 109.863 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.63 ' CE1' ' NE2' ' A' ' 83' ' ' HIS . 8.0 t80 -75.81 -25.01 55.95 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.511 -0.743 . . . . 0.0 110.82 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.912 ' HE1' HG13 ' A' ' 77' ' ' VAL . 16.3 m-85 -113.69 -17.86 12.02 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.324 -0.86 . . . . 0.0 109.118 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -79.73 -5.53 89.37 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 108.496 -1.842 . . . . 0.0 108.496 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -63.58 -45.27 91.16 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.492 -1.005 . . . . 0.0 109.888 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.535 ' CD2' ' HB3' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -108.16 1.54 22.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.449 -0.782 . . . . 0.0 110.189 179.608 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.478 ' O ' ' HA2' ' A' ' 41' ' ' GLY . . . -149.64 179.49 26.37 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.609 -1.281 . . . . 0.0 109.933 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 0.4 OUTLIER -101.16 121.18 41.38 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.34 -1.094 . . . . 0.0 110.086 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.645 HG22 ' HB3' ' A' ' 68' ' ' PHE . 43.1 t -97.69 121.62 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.131 -0.981 . . . . 0.0 110.651 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.419 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . 35.8 tptt -88.91 -36.31 16.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.308 -0.87 . . . . 0.0 109.987 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -161.58 161.28 29.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 0.0 110.328 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 7.6 p -150.12 165.55 32.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.29 -0.881 . . . . 0.0 109.712 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.758 HD21 ' CD2' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -149.67 132.93 16.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.049 -1.032 . . . . 0.0 110.751 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.981 HG13 ' CD2' ' A' ' 27' ' ' LEU . 79.3 t -121.85 131.72 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.56 -1.338 . . . . 0.0 110.423 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 2.5 ttm . . . . . 0 C--N 1.305 -1.366 0 O-C-N 121.356 -0.84 . . . . 0.0 109.962 -179.751 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.075 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.959 ' O ' HD22 ' A' ' 27' ' ' LEU . 20.4 p90 -148.4 -176.9 5.48 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.277 -1.131 . . . . 0.0 110.537 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.696 ' N ' HD13 ' A' ' 27' ' ' LEU . . . -142.58 162.83 27.31 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.758 ' CD2' HD21 ' A' ' 50' ' ' LEU . 14.2 m-85 -128.28 154.18 46.18 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.404 -1.057 . . . . 0.0 109.41 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.781 ' CG2' HD11 ' A' ' 36' ' ' LEU . 15.3 t -149.87 110.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.058 -1.026 . . . . 0.0 110.64 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.588 HG22 ' O ' ' A' ' 67' ' ' THR . 84.9 m -89.11 49.93 1.86 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.294 -0.879 . . . . 0.0 109.98 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.645 ' HB3' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.412 -0.805 . . . . 0.0 110.818 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 75' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.36 0.6 . . . . 0.0 109.996 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.761 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -57.1 -70.44 0.98 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.436 ' C ' ' O ' ' A' ' 73' ' ' GLY . 98.5 t -41.9 -29.06 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.355 -1.085 . . . . 0.0 110.247 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.846 ' HA ' HD23 ' A' ' 78' ' ' LEU . 0.5 OUTLIER -66.28 -80.64 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 0.0 109.898 179.744 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.704 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -47.73 -24.7 1.01 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.232 -0.917 . . . . 0.0 109.07 179.337 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.912 HG13 ' HE1' ' A' ' 40' ' ' PHE . 78.1 t -68.74 -55.22 16.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.472 -0.767 . . . . 0.0 109.703 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.846 HD23 ' HA ' ' A' ' 75' ' ' ASP . 1.1 pp -48.78 -28.48 3.69 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 120.835 -1.166 . . . . 0.0 108.48 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.704 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -52.13 -32.6 36.23 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.559 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 5.4 mm-40 -99.43 24.04 8.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.781 -0.574 . . . . 0.0 109.499 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.474 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 9.8 t -49.95 -18.76 0.57 Allowed 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.092 178.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.486 ' O ' ' C ' ' A' ' 83' ' ' HIS . 0.2 OUTLIER -103.52 -7.55 20.77 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.342 -0.849 . . . . 0.0 109.841 179.45 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.735 ' CE1' HD12 ' A' ' 90' ' ' ILE . 0.5 OUTLIER 32.22 36.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.95 -0.469 . . . . 0.0 111.272 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.551 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 1.4 tt0 -87.14 120.26 28.22 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.594 -1.243 . . . . 0.0 110.237 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.529 ' CD2' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -151.7 -83.48 0.09 Allowed 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.679 -0.638 . . . . 0.0 110.133 -179.626 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.518 ' O ' ' CB ' ' A' ' 87' ' ' SER . 0.2 OUTLIER -79.81 53.08 1.57 Allowed 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.106 -0.996 . . . . 0.0 109.289 179.473 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 71.01 2.83 4.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.565 -0.709 . . . . 0.0 110.256 -179.796 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -110.96 124.85 52.95 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.257 -0.902 . . . . 0.0 110.246 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.762 ' O ' HG23 ' A' ' 89' ' ' THR . 15.1 t -104.77 63.93 0.73 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.523 -0.736 . . . . 0.0 110.133 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.735 HD12 ' CE1' ' A' ' 83' ' ' HIS . 0.6 OUTLIER -52.23 -176.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.35 -0.843 . . . . 0.0 108.887 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.57 ' N ' ' O ' ' A' ' 25' ' ' GLY . 13.0 t0 -143.82 87.23 8.22 Favored Pre-proline 0 N--CA 1.485 1.288 0 O-C-N 120.547 -1.346 . . . . 0.0 110.764 -178.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.559 ' CG ' ' O ' ' A' ' 80' ' ' GLN . 2.2 Cg_endo -58.42 111.79 0.98 Allowed 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.633 1.333 . . . . 0.0 111.317 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.583 ' HE2' ' CD2' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -130.41 117.51 19.81 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.383 -0.823 . . . . 0.0 109.262 178.26 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.768 HG22 ' CG ' ' A' ' 22' ' ' MET . 61.8 t -97.3 174.6 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 O-C-N 121.581 -0.699 . . . . 0.0 110.049 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.579 ' N ' HG12 ' A' ' 94' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 109.855 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.717 ' CB ' HG23 ' A' ' 67' ' ' THR . 11.6 ptmt . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.337 0.589 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' MET . . . . . 1.003 ' HB3' HG13 ' A' ' 94' ' ' VAL . 12.7 ptm -123.21 175.8 6.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.441 -0.787 . . . . 0.0 110.041 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.582 ' HB3' ' HD2' ' A' ' 93' ' ' LYS . 1.4 t80 -146.58 158.35 43.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.367 -0.833 . . . . 0.0 109.886 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.962 HD11 ' CE ' ' A' ' 22' ' ' MET . 18.3 mm -115.92 134.78 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.31 -0.868 . . . . 0.0 109.124 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.513 ' O ' HG22 ' A' ' 90' ' ' ILE . . . -113.3 141.68 17.05 Favored Glycine 0 N--CA 1.495 2.601 0 C-N-CA 119.731 -1.223 . . . . 0.0 112.285 -177.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.51 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 60.28 41.91 98.54 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.007 HD22 ' CA ' ' A' ' 63' ' ' PHE . 0.3 OUTLIER -77.45 153.87 33.14 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.62 -0.929 . . . . 0.0 111.163 -178.742 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.917 ' OG ' HD23 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -39.43 130.73 1.72 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.368 0.604 . . . . 0.0 110.518 -179.301 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 64.9 p-90 -68.81 -28.12 66.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.349 -0.844 . . . . 0.0 110.635 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.454 ' O ' ' O ' ' A' ' 31' ' ' THR . 2.3 pt20 -88.78 -14.76 36.33 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.083 -1.011 . . . . 0.0 110.721 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.543 ' HB ' ' CB ' ' A' ' 28' ' ' SER . 1.3 t -53.08 -169.02 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.642 -0.661 . . . . 0.0 110.364 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.718 HG23 ' H ' ' A' ' 35' ' ' GLY . 15.0 t -157.62 -166.75 2.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.334 -0.854 . . . . 0.0 109.85 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 36' ' ' LEU . 3.6 mt-30 -79.9 -72.92 0.38 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.149 -0.969 . . . . 0.0 110.118 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.534 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -48.07 -44.28 31.36 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.759 -1.176 . . . . 0.0 108.551 179.302 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.718 ' H ' HG23 ' A' ' 32' ' ' THR . . . -48.14 -35.27 13.64 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 107.566 -2.214 . . . . 0.0 107.566 178.215 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.766 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -75.76 -40.07 55.98 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.301 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.78 ' HA ' HG11 ' A' ' 46' ' ' VAL . 50.0 mtp180 -59.42 -25.66 64.52 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 122.47 1.129 . . . . 0.0 108.421 178.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.534 ' CG ' ' O ' ' A' ' 34' ' ' GLU . 1.5 mt-10 -84.56 -21.93 30.27 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.688 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 21.0 t80 -84.56 -48.36 9.63 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.795 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.854 ' HE1' HG13 ' A' ' 77' ' ' VAL . 28.1 m-85 -95.17 -33.48 12.61 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.355 -0.841 . . . . 0.0 109.321 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -65.8 -17.49 65.11 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -58.83 -45.2 90.56 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.417 -1.049 . . . . 0.0 109.276 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.599 ' CD1' ' HB3' ' A' ' 76' ' ' LYS . 4.5 p90 -117.83 -12.82 10.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.566 -0.709 . . . . 0.0 109.493 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.469 ' O ' ' HA2' ' A' ' 41' ' ' GLY . . . -133.99 87.01 0.26 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.531 ' O ' ' CB ' ' A' ' 68' ' ' PHE . 4.0 pm0 -41.18 104.39 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.417 -1.049 . . . . 0.0 110.357 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.78 HG11 ' HA ' ' A' ' 37' ' ' ARG . 2.9 p -89.42 142.5 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.228 -0.92 . . . . 0.0 110.519 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.62 -23.68 9.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.873 . . . . 0.0 109.677 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.43 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -130.25 126.59 37.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.407 -0.808 . . . . 0.0 110.173 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.511 ' HB2' ' CD2' ' A' ' 36' ' ' LEU . 3.4 p -150.13 152.14 34.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.076 -1.015 . . . . 0.0 110.253 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.801 HD21 ' CD2' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -149.99 134.33 17.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.048 -1.033 . . . . 0.0 110.65 179.739 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 78.4 t -117.16 134.81 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.543 -1.348 . . . . 0.0 110.732 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.461 ' HG2' ' CZ ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.303 -1.437 0 O-C-N 121.423 -0.798 . . . . 0.0 109.44 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.327 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 1.007 ' CA ' HD22 ' A' ' 27' ' ' LEU . 20.8 p90 -156.35 -162.94 1.35 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.131 -1.217 . . . . 0.0 110.26 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.573 ' O ' ' CD2' ' A' ' 23' ' ' PHE . . . -166.84 -179.97 40.29 Favored Glycine 0 N--CA 1.489 2.18 0 C-N-CA 119.536 -1.316 . . . . 0.0 110.296 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.801 ' CD2' HD21 ' A' ' 50' ' ' LEU . 10.4 m-85 -129.28 152.98 48.26 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.833 -0.804 . . . . 0.0 109.267 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.58 HG22 HD21 ' A' ' 36' ' ' LEU . 3.5 t -150.05 145.1 17.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 120.986 -1.071 . . . . 0.0 110.181 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.717 HG23 ' CB ' ' A' ' 21' ' ' LYS . 3.2 m -151.1 99.23 2.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.207 -0.933 . . . . 0.0 110.717 -179.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.635 ' CE2' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.152 -0.967 . . . . 0.0 109.589 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.291 0.567 . . . . 0.0 110.03 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.703 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -59.36 -82.34 0.06 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.559 HG23 ' N ' ' A' ' 75' ' ' ASP . 17.9 m -41.67 -48.3 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.296 -1.12 . . . . 0.0 110.534 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.559 ' N ' HG23 ' A' ' 74' ' ' VAL . 21.6 m-20 -42.22 -68.15 0.21 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.036 -1.04 . . . . 0.0 110.45 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.88 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -59.14 -37.03 76.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.442 -0.786 . . . . 0.0 110.449 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.854 HG13 ' HE1' ' A' ' 40' ' ' PHE . 58.9 t -56.21 -59.71 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 121.142 -0.974 . . . . 0.0 109.911 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.564 ' CD1' ' N ' ' A' ' 78' ' ' LEU . 2.4 mp -46.03 -40.73 11.03 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.88 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -43.18 -36.37 1.71 Allowed 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.584 0.707 . . . . 0.0 109.55 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.573 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 10.3 mm-40 -102.57 27.61 6.74 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.483 -0.76 . . . . 0.0 109.505 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.562 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 65.9 p -45.56 -21.32 0.1 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.562 -0.711 . . . . 0.0 109.131 178.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.486 ' O ' ' O ' ' A' ' 83' ' ' HIS . 1.2 ptp180 -106.13 -19.66 13.65 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.463 -0.773 . . . . 0.0 110.279 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.912 ' CE1' HD12 ' A' ' 90' ' ' ILE . 0.2 OUTLIER 52.13 165.47 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.279 -0.888 . . . . 0.0 111.014 179.898 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 1.067 ' C ' HD13 ' A' ' 85' ' ' LEU . 1.2 tt0 175.37 119.74 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.599 0.714 . . . . 0.0 110.389 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 1.067 HD13 ' C ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -141.03 -86.49 0.18 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.575 -0.703 . . . . 0.0 109.172 178.417 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.536 ' O ' ' CB ' ' A' ' 87' ' ' SER . 0.1 OUTLIER -84.42 53.25 2.59 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.054 -1.029 . . . . 0.0 108.662 178.916 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 71.22 9.68 6.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.49 -0.756 . . . . 0.0 109.274 -178.769 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.586 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 10.3 mmtt -107.17 121.79 45.23 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.519 -0.738 . . . . 0.0 109.806 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.801 ' O ' HG23 ' A' ' 89' ' ' THR . 15.3 t -97.31 78.42 2.72 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.393 -0.817 . . . . 0.0 109.554 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.912 HD12 ' CE1' ' A' ' 83' ' ' HIS . 1.1 mt -47.65 -177.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-O 121.433 0.635 . . . . 0.0 110.335 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.597 ' H ' HG22 ' A' ' 90' ' ' ILE . 13.5 t0 -139.39 78.19 27.92 Favored Pre-proline 0 C--N 1.305 -1.355 0 O-C-N 121.108 -0.995 . . . . 0.0 110.566 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.631 ' HG3' ' HD2' ' A' ' 83' ' ' HIS . 2.3 Cg_endo -53.31 112.48 0.95 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.44 1.232 . . . . 0.0 110.964 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.582 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -117.06 99.78 7.29 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.287 -0.883 . . . . 0.0 109.698 178.434 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 1.003 HG13 ' HB3' ' A' ' 22' ' ' MET . 22.3 t -97.01 157.35 3.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 O-C-N 121.757 -0.589 . . . . 0.0 110.157 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.71 0 O-C-N 121.207 -0.933 . . . . 0.0 110.468 -179.711 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.514 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 5.2 pttt . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.342 0.592 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.913 ' HB2' HG13 ' A' ' 94' ' ' VAL . 36.5 ttp -86.07 172.67 10.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.359 -0.838 . . . . 0.0 110.307 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.752 ' C ' HD12 ' A' ' 24' ' ' ILE . 1.3 t80 -148.62 139.39 22.88 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.332 -0.855 . . . . 0.0 109.268 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.752 HD12 ' C ' ' A' ' 23' ' ' PHE . 1.3 mp -110.36 130.62 63.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 121.319 -0.863 . . . . 0.0 108.792 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.498 ' O ' ' CG2' ' A' ' 90' ' ' ILE . . . -95.73 120.53 6.58 Favored Glycine 0 N--CA 1.497 2.723 0 C-N-CA 120.028 -1.082 . . . . 0.0 113.145 -176.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.996 ' O ' HD12 ' A' ' 90' ' ' ILE . . . 76.67 28.24 59.62 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 177.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.024 HD11 HG13 ' A' ' 51' ' ' VAL . 1.4 pt? -49.43 142.51 7.68 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.376 -1.073 . . . . 0.0 110.383 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.839 ' O ' HG22 ' A' ' 31' ' ' THR . 2.3 m -39.42 121.35 1.17 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.486 0.66 . . . . 0.0 110.465 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 49.9 p-90 -58.88 -28.87 66.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.298 -0.876 . . . . 0.0 110.388 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -82.64 -13.7 56.01 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.195 -0.941 . . . . 0.0 110.642 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.839 HG22 ' O ' ' A' ' 28' ' ' SER . 3.0 t -63.64 -169.6 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.501 -0.749 . . . . 0.0 110.291 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.695 HG23 ' H ' ' A' ' 35' ' ' GLY . 13.4 t -154.06 -169.92 3.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.445 -0.785 . . . . 0.0 109.922 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 36' ' ' LEU . 17.7 mt-30 -74.48 -73.05 0.25 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.121 -0.987 . . . . 0.0 110.389 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.4 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 3.9 tt0 -47.84 -42.9 27.47 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.883 -1.136 . . . . 0.0 109.758 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.695 ' H ' HG23 ' A' ' 32' ' ' THR . . . -55.54 -30.18 55.32 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 107.699 -2.161 . . . . 0.0 107.699 178.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.874 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -82.1 -37.57 26.13 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.137 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.633 ' CD ' HG11 ' A' ' 46' ' ' VAL . 0.2 OUTLIER -62.86 -25.22 68.18 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 122.536 1.16 . . . . 0.0 108.503 178.487 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.53 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -90.39 -19.07 24.39 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.977 -1.011 . . . . 0.0 108.597 179.497 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.66 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 6.4 t80 -81.42 -26.61 35.25 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 121.457 -0.777 . . . . 0.0 110.334 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.895 ' HE1' HG13 ' A' ' 77' ' ' VAL . 39.0 m-85 -118.59 -17.72 9.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.403 -0.811 . . . . 0.0 109.371 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -75.69 -21.08 77.57 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.61 ' HG3' ' CD2' ' A' ' 43' ' ' PHE . 15.9 pt20 -63.06 -32.48 73.87 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.486 -1.008 . . . . 0.0 109.421 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.612 ' HE1' HG22 ' A' ' 77' ' ' VAL . 4.8 p90 -130.39 1.36 4.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.37 -0.831 . . . . 0.0 109.645 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 40' ' ' PHE . . . -143.77 95.27 0.18 Allowed Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 42.3 mt-10 -40.05 110.0 0.13 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.326 -1.102 . . . . 0.0 110.774 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.633 HG11 ' CD ' ' A' ' 37' ' ' ARG . 70.7 t -91.16 129.43 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.389 -0.819 . . . . 0.0 110.733 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 67' ' ' THR . 0.5 OUTLIER -93.48 -33.6 13.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.406 -0.809 . . . . 0.0 109.607 179.467 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.703 ' O ' HG22 ' A' ' 67' ' ' THR . 11.3 tp10 -171.29 153.96 3.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.548 -0.72 . . . . 0.0 109.188 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 15.6 p -150.81 157.06 42.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.06 -1.025 . . . . 0.0 111.107 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.733 ' C ' HD12 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -130.52 124.11 31.17 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.427 -0.796 . . . . 0.0 108.95 178.704 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.024 HG13 HD11 ' A' ' 27' ' ' LEU . 89.6 t -112.57 142.75 23.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 120.453 -1.404 . . . . 0.0 112.062 -178.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.576 ' SD ' ' CE2' ' A' ' 63' ' ' PHE . 1.9 ttm . . . . . 0 C--N 1.302 -1.458 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.46 ' C ' ' CD2' ' A' ' 27' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 107.827 -2.109 . . . . 0.0 107.827 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.83 ' CA ' HD22 ' A' ' 27' ' ' LEU . 14.4 p90 -134.63 -167.86 2.05 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.428 -1.042 . . . . 0.0 111.428 -178.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -158.7 116.72 0.73 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.554 ' HB2' ' HG ' ' A' ' 50' ' ' LEU . 12.7 m-85 -82.99 140.97 32.44 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.483 -1.01 . . . . 0.0 108.863 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.839 HG22 HD21 ' A' ' 36' ' ' LEU . 2.9 t -147.34 99.36 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 120.943 -1.098 . . . . 0.0 110.239 -178.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.703 HG22 ' O ' ' A' ' 48' ' ' GLU . 7.9 t -80.58 64.01 5.22 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 110.734 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.568 ' HB3' HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.193 -0.942 . . . . 0.0 110.745 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 75' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.329 0.585 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.671 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -46.49 -61.25 4.27 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.974 ' O ' HD12 ' A' ' 78' ' ' LEU . 71.3 t -43.17 -48.47 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.191 -1.182 . . . . 0.0 110.197 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 72' ' ' ALA . 34.8 t70 -47.94 -56.92 6.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.971 -1.081 . . . . 0.0 110.153 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.573 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -59.73 -30.66 68.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.39 -0.819 . . . . 0.0 110.15 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.895 HG13 ' HE1' ' A' ' 40' ' ' PHE . 41.7 t -63.01 -58.17 8.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.113 -0.992 . . . . 0.0 109.279 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.974 HD12 ' O ' ' A' ' 74' ' ' VAL . 1.3 mp -45.88 -44.39 14.43 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.324 -0.86 . . . . 0.0 108.962 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -45.96 -28.53 1.16 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.209 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.53 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 22.3 mm100 -103.76 25.53 9.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.512 -0.742 . . . . 0.0 109.898 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 78' ' ' LEU . 23.7 t -54.43 -16.16 2.12 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.488 ' O ' ' C ' ' A' ' 83' ' ' HIS . 5.2 ptp180 -95.95 -18.15 20.49 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 121.501 -0.749 . . . . 0.0 109.533 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.66 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 0.6 OUTLIER 31.51 41.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.81 -0.556 . . . . 0.0 111.795 179.484 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.567 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 0.7 OUTLIER -86.93 122.41 30.75 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 118.619 -1.233 . . . . 0.0 110.192 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.548 ' CD2' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -144.62 -85.81 0.13 Allowed 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.626 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 87' ' ' SER . 0.6 OUTLIER -82.28 52.92 2.13 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.21 -0.931 . . . . 0.0 108.753 179.05 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 1.4 t 71.33 5.84 5.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.599 -0.688 . . . . 0.0 109.651 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 10.7 mmmt -108.02 119.54 39.76 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.357 -0.839 . . . . 0.0 109.808 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.765 ' O ' HG23 ' A' ' 89' ' ' THR . 15.1 t -101.41 68.62 1.21 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.608 -0.682 . . . . 0.0 109.646 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.996 HD12 ' O ' ' A' ' 26' ' ' GLY . 1.2 mm -51.7 -175.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.419 -0.801 . . . . 0.0 109.803 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.503 ' H ' HG22 ' A' ' 90' ' ' ILE . 15.6 t0 -143.67 83.73 10.41 Favored Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.303 -0.873 . . . . 0.0 109.877 -179.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.53 ' CG ' ' O ' ' A' ' 80' ' ' GLN . 2.3 Cg_endo -53.22 112.32 0.9 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.553 1.291 . . . . 0.0 110.965 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.604 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -130.16 111.76 12.75 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.486 -0.759 . . . . 0.0 109.546 178.746 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.913 HG13 ' HB2' ' A' ' 22' ' ' MET . 3.8 t -95.66 -174.01 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.525 -0.734 . . . . 0.0 110.018 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.694 ' H ' HG12 ' A' ' 94' ' ' VAL . . . . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.175 -0.953 . . . . 0.0 110.358 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.746 ' HB2' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.187 0.517 . . . . 0.0 109.841 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.951 ' CG ' HG22 ' A' ' 94' ' ' VAL . 5.3 tmm? -68.83 157.77 35.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.105 -0.997 . . . . 0.0 109.854 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.605 ' CG ' ' CE1' ' A' ' 65' ' ' PHE . 6.8 t80 -141.02 144.49 35.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.229 -0.919 . . . . 0.0 109.984 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.779 ' CG2' HG21 ' A' ' 90' ' ' ILE . 20.1 mm -108.87 137.76 39.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.314 -0.866 . . . . 0.0 109.232 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 91' ' ' ASP . . . -118.1 144.17 17.99 Favored Glycine 0 N--CA 1.495 2.576 0 C-N-CA 119.647 -1.263 . . . . 0.0 111.464 -177.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 90' ' ' ILE . . . 59.08 42.05 96.83 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.992 HD22 ' CA ' ' A' ' 63' ' ' PHE . 0.3 OUTLIER -79.69 156.51 27.53 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.452 -1.028 . . . . 0.0 110.939 -179.072 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.465 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -39.4 142.27 0.29 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.458 0.647 . . . . 0.0 110.735 -179.097 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 47.0 p-90 -85.58 2.57 44.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.496 -0.753 . . . . 0.0 110.332 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.469 ' O ' ' O ' ' A' ' 31' ' ' THR . 14.8 pt20 -121.77 -14.41 8.12 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.212 -0.93 . . . . 0.0 110.424 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 30' ' ' GLN . 14.8 t -53.3 -168.65 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.646 -0.659 . . . . 0.0 110.26 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.653 HG23 ' H ' ' A' ' 35' ' ' GLY . 6.0 t -153.91 -176.1 5.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.279 -0.888 . . . . 0.0 110.034 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 36' ' ' LEU . 4.9 mt-30 -69.5 -75.01 0.12 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.045 -1.034 . . . . 0.0 110.818 -179.052 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.47 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 7.9 tt0 -47.22 -40.46 16.31 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.817 -1.177 . . . . 0.0 110.051 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.653 ' H ' HG23 ' A' ' 32' ' ' THR . . . -56.53 -32.71 61.41 Favored Glycine 0 N--CA 1.484 1.833 0 N-CA-C 107.32 -2.312 . . . . 0.0 107.32 178.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.855 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -79.87 -38.8 31.93 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.122 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.47 ' HG3' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -61.81 -25.27 67.39 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 122.43 1.109 . . . . 0.0 108.764 178.501 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.554 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -88.66 -18.58 27.64 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.69 179.543 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.694 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 24.1 t80 -82.96 -28.02 30.09 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.348 -0.845 . . . . 0.0 110.564 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.881 ' CE1' HG13 ' A' ' 77' ' ' VAL . 39.2 m-85 -116.51 -22.53 8.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.208 -0.932 . . . . 0.0 109.457 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.521 ' CA ' HG23 ' A' ' 46' ' ' VAL . . . -72.15 -13.27 76.39 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -66.45 -36.96 84.08 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.416 -1.049 . . . . 0.0 109.713 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.602 ' CD1' ' HB3' ' A' ' 76' ' ' LYS . 9.7 p90 -125.71 7.86 7.54 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.503 -0.748 . . . . 0.0 109.828 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.481 ' O ' ' HA2' ' A' ' 41' ' ' GLY . . . -153.33 98.11 0.18 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 44' ' ' GLY . 8.5 pt-20 -39.79 124.49 1.73 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.526 -0.985 . . . . 0.0 110.26 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.521 HG23 ' CA ' ' A' ' 41' ' ' GLY . 3.3 t -98.43 126.06 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.22 -0.925 . . . . 0.0 110.453 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.469 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 1.6 mmtm -88.77 -27.6 21.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.365 -0.834 . . . . 0.0 109.498 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 12.1 pt-20 179.67 147.34 0.24 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.464 -0.772 . . . . 0.0 110.09 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 19.5 p -140.59 176.59 8.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.158 -0.964 . . . . 0.0 110.531 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.682 ' C ' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -147.74 124.64 11.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.3 -0.875 . . . . 0.0 110.148 179.416 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.493 ' N ' HD12 ' A' ' 50' ' ' LEU . 69.9 t -116.24 131.45 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.716 -1.24 . . . . 0.0 110.883 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 1.2 ttm . . . . . 0 N--CA 1.487 1.401 0 O-C-N 121.526 -0.734 . . . . 0.0 109.523 179.793 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.418 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.992 ' CA ' HD22 ' A' ' 27' ' ' LEU . 11.7 p90 -145.78 -172.38 3.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.161 -1.199 . . . . 0.0 110.656 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.473 ' O ' ' HB ' ' A' ' 24' ' ' ILE . . . -153.7 114.16 0.61 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.605 ' CE1' ' CG ' ' A' ' 23' ' ' PHE . 19.9 m-85 -83.35 148.79 27.13 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.274 -1.133 . . . . 0.0 109.92 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.702 HG22 HD21 ' A' ' 36' ' ' LEU . 3.7 t -148.45 116.23 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.305 -0.872 . . . . 0.0 110.04 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.746 HG23 ' HB2' ' A' ' 21' ' ' LYS . 14.7 m -94.09 35.06 1.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.946 . . . . 0.0 110.511 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.627 ' CE2' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 O-C-N 120.936 -1.102 . . . . 0.0 109.55 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.303 0.573 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.595 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -61.58 -46.16 94.86 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.896 ' O ' HD12 ' A' ' 78' ' ' LEU . 3.0 p -50.12 -46.17 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.205 -1.173 . . . . 0.0 109.484 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.571 ' N ' ' CG1' ' A' ' 74' ' ' VAL . 0.2 OUTLIER -59.71 -40.28 87.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.425 -0.797 . . . . 0.0 109.637 179.529 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.638 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -62.37 -33.51 74.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.416 -0.803 . . . . 0.0 109.389 179.378 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.881 HG13 ' CE1' ' A' ' 40' ' ' PHE . 40.5 t -62.74 -57.84 10.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.36 -0.838 . . . . 0.0 109.191 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.896 HD12 ' O ' ' A' ' 74' ' ' VAL . 4.0 mp -45.31 -41.91 9.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.197 -0.939 . . . . 0.0 108.852 178.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -46.31 -28.26 1.26 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.473 -0.891 . . . . 0.0 108.747 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.524 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 33.0 mm-40 -102.62 26.78 7.55 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.668 -0.645 . . . . 0.0 109.821 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 78' ' ' LEU . 41.9 t -55.93 -16.37 4.66 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.525 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.8 OUTLIER -109.47 1.63 19.99 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 121.626 -0.671 . . . . 0.0 109.373 178.751 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.986 ' CE1' HD12 ' A' ' 90' ' ' ILE . 0.5 OUTLIER 28.25 -87.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.138 0.494 . . . . 0.0 112.141 179.783 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.66 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 1.6 tt0 51.01 112.35 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 122.327 1.06 . . . . 0.0 110.5 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.798 HD11 HD11 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -131.65 -70.06 0.59 Allowed 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.549 ' HB3' ' CE ' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -103.71 55.33 0.74 Allowed 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.913 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 73.65 13.79 4.33 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 -178.135 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.66 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 8.6 mttt -117.86 107.2 13.82 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 121.502 -0.749 . . . . 0.0 110.997 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.682 ' O ' HG23 ' A' ' 89' ' ' THR . 9.5 t -80.82 76.93 7.73 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.508 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.986 HD12 ' CE1' ' A' ' 83' ' ' HIS . 1.6 mt -50.72 -179.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.058 -1.026 . . . . 0.0 109.231 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.63 ' H ' HG22 ' A' ' 90' ' ' ILE . 11.1 t0 -139.2 75.03 34.86 Favored Pre-proline 0 C--N 1.298 -1.641 0 O-C-N 121.188 -0.945 . . . . 0.0 110.559 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.524 ' CG ' ' O ' ' A' ' 80' ' ' GLN . 2.1 Cg_endo -52.64 111.17 0.57 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.593 1.312 . . . . 0.0 110.854 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.588 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -121.66 103.91 9.24 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.098 -1.001 . . . . 0.0 109.136 178.339 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.951 HG22 ' CG ' ' A' ' 22' ' ' MET . 3.4 t -96.83 177.49 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 O-C-N 121.639 -0.663 . . . . 0.0 110.784 -178.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.572 ' H ' HG12 ' A' ' 94' ' ' VAL . . . . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.452 -0.78 . . . . 0.0 109.776 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.203 0.525 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.552 ' HB2' ' CB ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -145.2 165.66 27.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.283 -0.886 . . . . 0.0 110.404 -179.851 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.956 ' HE3' HG11 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -74.2 170.82 14.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.906 . . . . 0.0 109.465 179.617 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.63 ' CG ' ' CE1' ' A' ' 65' ' ' PHE . 5.4 t80 -151.25 129.72 12.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.159 -0.963 . . . . 0.0 110.128 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.47 HG22 HG21 ' A' ' 90' ' ' ILE . 18.4 mm -99.39 139.84 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.206 -0.934 . . . . 0.0 109.366 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' A' ' 91' ' ' ASP . . . -122.34 120.47 4.33 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.65 -1.262 . . . . 0.0 111.154 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.859 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 112.51 41.42 1.04 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.975 HD21 HG13 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -51.2 120.99 5.5 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.342 -1.093 . . . . 0.0 110.624 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.607 ' HB3' HD11 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -46.37 173.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.305 -0.872 . . . . 0.0 110.103 179.684 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.439 ' CD1' ' C ' ' A' ' 29' ' ' TRP . 0.2 OUTLIER -76.48 5.03 7.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -0.926 . . . . 0.0 110.599 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.417 ' HG2' ' CD1' ' A' ' 29' ' ' TRP . 2.5 pt20 -151.57 11.79 0.6 Allowed 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.998 -1.064 . . . . 0.0 111.058 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.629 HG21 ' HG ' ' A' ' 27' ' ' LEU . 1.2 m -59.25 163.01 4.09 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.987 -1.071 . . . . 0.0 109.795 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.642 HG23 ' H ' ' A' ' 35' ' ' GLY . 12.8 t -135.59 -169.81 2.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.924 . . . . 0.0 109.748 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.536 ' O ' ' N ' ' A' ' 36' ' ' LEU . 24.0 mt-30 -88.47 -73.82 0.48 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.035 -1.041 . . . . 0.0 110.042 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.473 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 1.3 tt0 -48.59 -43.18 35.74 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.765 -1.209 . . . . 0.0 109.642 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.642 ' H ' HG23 ' A' ' 32' ' ' THR . . . -55.9 -28.76 53.77 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 107.503 -2.239 . . . . 0.0 107.503 178.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.862 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -81.36 -37.9 27.49 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 177.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 33' ' ' GLN . 19.9 mtt180 -61.71 -27.27 68.59 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 122.398 1.094 . . . . 0.0 108.12 177.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -89.11 -16.38 31.64 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.966 179.338 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.68 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 16.9 t80 -80.52 -32.22 36.92 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.401 -0.812 . . . . 0.0 110.175 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.848 ' HE1' HG13 ' A' ' 77' ' ' VAL . 32.1 m-85 -110.5 -28.26 8.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.392 -0.818 . . . . 0.0 109.025 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -61.76 -15.46 48.17 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -59.8 -42.86 94.37 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.401 -1.058 . . . . 0.0 109.523 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.638 ' HE1' HG22 ' A' ' 77' ' ' VAL . 3.6 p90 -125.83 -6.51 6.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.423 -0.798 . . . . 0.0 109.81 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.496 ' HA2' ' HB2' ' A' ' 70' ' ' ASP . . . -130.8 96.41 0.35 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 11.1 mm-40 -40.69 115.46 0.58 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.335 -1.097 . . . . 0.0 110.546 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.513 ' HA ' ' CB ' ' A' ' 68' ' ' PHE . 59.9 t -95.32 134.21 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.0 110.61 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 0.1 OUTLIER -100.33 -27.75 13.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.373 -0.83 . . . . 0.0 109.743 179.588 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.477 ' O ' HG22 ' A' ' 67' ' ' THR . 5.0 tt0 -176.84 156.63 1.39 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.472 -0.768 . . . . 0.0 109.935 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.468 ' SG ' ' HG2' ' A' ' 37' ' ' ARG . 8.3 p -149.72 164.72 34.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.154 -0.967 . . . . 0.0 110.347 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.647 ' C ' HD12 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -133.41 126.93 32.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.203 -0.936 . . . . 0.0 110.181 179.683 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.975 HG13 HD21 ' A' ' 27' ' ' LEU . 98.1 t -117.39 127.57 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.488 -1.382 . . . . 0.0 110.434 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 63' ' ' PHE . 2.8 tpp -129.3 156.17 44.44 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.624 -0.672 . . . . 0.0 109.797 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.402 ' O ' ' CB ' ' A' ' 54' ' ' ASP . 1.2 ttm180 -151.69 -171.37 3.91 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.479 -0.763 . . . . 0.0 109.97 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.402 ' CB ' ' O ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER 62.71 81.91 0.22 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.13 -0.981 . . . . 0.0 110.605 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -64.21 116.26 3.63 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.717 1.378 . . . . 0.0 110.352 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.2 pp -89.34 -26.45 21.08 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.122 -0.986 . . . . 0.0 110.335 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.628 HG23 ' H ' ' A' ' 59' ' ' ARG . 6.5 t -142.04 -148.5 0.24 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.34 -0.85 . . . . 0.0 110.081 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.408 ' N ' ' OG1' ' A' ' 57' ' ' THR . 0.4 OUTLIER -83.39 13.86 4.07 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.215 -0.928 . . . . 0.0 110.454 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.628 ' H ' HG23 ' A' ' 57' ' ' THR . 0.1 OUTLIER -77.95 -161.85 0.28 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 110.271 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.508 ' N ' ' HD3' ' A' ' 59' ' ' ARG . 29.1 m -52.52 -173.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.275 -0.891 . . . . 0.0 110.687 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.17 28.12 0.75 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.268 -0.895 . . . . 0.0 110.133 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 52' ' ' MET . . . 128.2 98.36 0.94 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.915 ' C ' HD13 ' A' ' 27' ' ' LEU . 24.8 p90 -141.72 -174.21 4.0 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.199 -1.177 . . . . 0.0 110.519 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.674 ' N ' HD13 ' A' ' 27' ' ' LEU . . . -153.84 113.59 0.58 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.63 ' CE1' ' CG ' ' A' ' 23' ' ' PHE . 18.4 m-85 -83.98 149.91 25.99 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.365 -1.079 . . . . 0.0 109.605 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.778 HG21 HD11 ' A' ' 36' ' ' LEU . 3.6 t -149.8 110.2 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.163 -0.961 . . . . 0.0 110.274 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.562 ' O ' HG23 ' A' ' 67' ' ' THR . 12.8 t -90.39 53.94 2.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.249 -0.907 . . . . 0.0 110.523 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.567 ' CZ ' ' SD ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -77.31 -174.76 3.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.124 -0.985 . . . . 0.0 110.412 179.734 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.62 117.18 0.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.945 -1.097 . . . . 0.0 110.959 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.496 ' HB2' ' HA2' ' A' ' 44' ' ' GLY . 0.7 OUTLIER -150.57 172.85 14.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.393 -0.817 . . . . 0.0 109.994 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -53.39 -71.17 0.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.083 -1.011 . . . . 0.0 110.124 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 75' ' ' ASP . . . -90.21 24.4 2.53 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.238 -0.914 . . . . 0.0 110.064 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.809 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -42.28 -85.13 0.01 OUTLIER Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.7 t -42.6 -27.02 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.308 -1.113 . . . . 0.0 110.68 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -68.24 -82.67 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.113 -0.992 . . . . 0.0 110.192 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.466 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -40.24 -28.54 0.06 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.34 -0.85 . . . . 0.0 109.715 179.78 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.956 HG11 ' HE3' ' A' ' 22' ' ' MET . 55.2 t -68.55 -43.51 83.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 O-C-N 121.459 -0.776 . . . . 0.0 110.319 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.009 HD23 ' N ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -59.68 -36.58 76.74 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 120.907 -1.12 . . . . 0.0 108.215 179.385 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 1.009 ' N ' HD23 ' A' ' 78' ' ' LEU . . . -48.25 -29.17 3.55 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.554 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 3.3 mt-30 -107.28 28.17 8.35 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.339 0.59 . . . . 0.0 109.411 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.491 ' O ' ' HD2' ' A' ' 92' ' ' PRO . 2.9 p -49.14 -18.64 0.35 Allowed 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.143 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -107.35 -15.18 14.7 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.471 -0.768 . . . . 0.0 109.623 179.142 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.812 ' ND1' HD12 ' A' ' 90' ' ' ILE . 0.2 OUTLIER 56.86 -80.94 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.834 0.826 . . . . 0.0 110.321 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.946 ' C ' HD23 ' A' ' 85' ' ' LEU . 3.0 tt0 54.41 123.18 0.0 OUTLIER 'General case' 0 C--N 1.288 -2.087 0 CA-C-O 122.177 0.989 . . . . 0.0 110.895 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.946 HD23 ' C ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -154.29 -88.55 0.05 OUTLIER 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.59 -0.694 . . . . 0.0 109.339 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.566 ' O ' ' CB ' ' A' ' 87' ' ' SER . 0.6 OUTLIER -82.01 52.31 1.94 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.111 -0.993 . . . . 0.0 108.848 178.868 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.566 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 76.72 6.8 3.32 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.231 0.539 . . . . 0.0 110.102 -179.317 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.596 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 1.6 mmtm -116.03 117.55 30.43 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.283 -0.886 . . . . 0.0 110.729 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.787 ' O ' HG23 ' A' ' 89' ' ' THR . 10.2 t -88.85 80.18 7.21 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.734 -0.604 . . . . 0.0 109.714 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.859 HG23 ' C ' ' A' ' 26' ' ' GLY . 1.5 mt -52.58 -173.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.238 -0.914 . . . . 0.0 109.743 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.599 ' H ' HG22 ' A' ' 90' ' ' ILE . 4.6 t70 -144.54 84.2 9.3 Favored Pre-proline 0 N--CA 1.484 1.271 0 O-C-N 120.952 -1.092 . . . . 0.0 111.052 -178.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.554 ' CG ' ' O ' ' A' ' 80' ' ' GLN . 2.2 Cg_endo -56.08 113.46 1.45 Allowed 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.419 1.22 . . . . 0.0 110.962 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.618 ' HD2' ' CD2' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -132.48 109.96 10.17 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.35 -0.844 . . . . 0.0 109.451 178.264 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.745 HG22 ' HB2' ' A' ' 22' ' ' MET . 40.9 t -96.19 157.89 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.556 -0.715 . . . . 0.0 110.553 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 94' ' ' VAL . . . 42.34 -154.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.334 -0.854 . . . . 0.0 110.565 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.424 -0.798 . . . . 0.0 110.068 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.208 0.528 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.552 ' HB2' ' CB ' ' A' ' 67' ' ' THR . 1.3 ptpt -139.88 -167.53 2.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.915 . . . . 0.0 110.426 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.973 ' CG ' HG13 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -100.81 170.81 8.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.39 -0.819 . . . . 0.0 109.698 179.648 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.65 ' HB3' ' HD2' ' A' ' 93' ' ' LYS . 19.5 t80 -147.0 155.19 42.05 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.084 -1.01 . . . . 0.0 110.353 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.494 HD13 ' HA ' ' A' ' 92' ' ' PRO . 24.9 mm -121.26 151.79 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.321 -0.862 . . . . 0.0 109.282 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.668 ' O ' HG22 ' A' ' 90' ' ' ILE . . . -133.78 138.96 10.49 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.33 -1.414 . . . . 0.0 111.341 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.879 ' O ' HD12 ' A' ' 90' ' ' ILE . . . 103.33 29.67 5.61 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.01 HD22 ' O ' ' A' ' 63' ' ' PHE . 0.8 OUTLIER -53.38 112.89 0.98 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.485 -1.009 . . . . 0.0 110.523 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.517 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -56.58 173.57 0.18 Allowed 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.411 -0.806 . . . . 0.0 110.056 179.671 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -80.33 11.54 3.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.315 -0.866 . . . . 0.0 110.493 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -133.44 -0.38 3.25 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.114 -0.991 . . . . 0.0 110.501 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.736 HG21 ' HG ' ' A' ' 27' ' ' LEU . 18.4 m -64.62 158.03 25.48 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.354 -0.841 . . . . 0.0 110.207 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.505 ' CG2' ' HA3' ' A' ' 35' ' ' GLY . 12.5 t -135.28 -173.15 3.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.121 -0.987 . . . . 0.0 110.069 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 36' ' ' LEU . 31.6 mt-30 -90.16 -74.76 0.48 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.198 -0.939 . . . . 0.0 110.202 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.53 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -48.72 -48.09 40.78 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.727 -1.189 . . . . 0.0 108.724 179.758 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.505 ' HA3' ' CG2' ' A' ' 32' ' ' THR . . . -48.92 -32.97 12.3 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 107.451 -2.26 . . . . 0.0 107.451 178.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.746 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -78.88 -39.76 34.25 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.361 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.505 ' CG ' ' HA ' ' A' ' 34' ' ' GLU . 3.2 mtt180 -57.81 -25.6 60.82 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.484 1.135 . . . . 0.0 107.974 178.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.53 ' CG ' ' O ' ' A' ' 34' ' ' GLU . 1.3 mt-10 -89.09 -21.11 23.56 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.632 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.67 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 20.5 t80 -73.49 -29.99 62.86 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.916 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.878 ' HE1' HG13 ' A' ' 77' ' ' VAL . 44.9 m-85 -110.89 -24.56 10.34 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.525 -0.735 . . . . 0.0 109.061 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.58 -9.44 74.02 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -73.78 -52.04 14.44 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.409 -1.054 . . . . 0.0 110.461 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.582 ' CZ ' ' HA ' ' A' ' 40' ' ' PHE . 3.7 p90 -104.81 8.98 35.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.295 -0.878 . . . . 0.0 110.491 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.87 175.43 32.93 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 68' ' ' PHE . 59.8 mm-40 -98.0 110.15 22.78 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.25 -1.147 . . . . 0.0 109.997 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.461 HG13 ' SG ' ' A' ' 49' ' ' CYS . 23.8 t -89.74 123.27 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 0.0 110.364 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.6 -26.2 16.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.406 -0.809 . . . . 0.0 109.75 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.944 ' O ' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER 179.95 151.89 0.43 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.438 -0.789 . . . . 0.0 110.006 179.686 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.532 ' HB3' HD21 ' A' ' 36' ' ' LEU . 9.3 m -145.34 174.72 10.87 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.331 -0.855 . . . . 0.0 110.012 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.801 HD12 ' N ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -148.36 144.41 27.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 110.375 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.892 HG12 ' NH2' ' A' ' 53' ' ' ARG . 86.0 t -132.33 134.88 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.624 -1.297 . . . . 0.0 110.997 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.423 ' HG3' ' N ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -139.46 148.55 42.88 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.585 -0.697 . . . . 0.0 109.585 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.892 ' NH2' HG12 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -150.06 -47.97 0.13 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.471 -0.768 . . . . 0.0 110.255 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.543 ' N ' ' HD3' ' A' ' 55' ' ' PRO . 1.3 m-20 53.79 59.67 12.15 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.347 -0.846 . . . . 0.0 110.916 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.543 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 2.7 Cg_endo -64.62 56.81 0.25 Allowed 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.521 1.274 . . . . 0.0 110.685 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.463 ' N ' ' O ' ' A' ' 54' ' ' ASP . 8.1 mt -106.02 -52.67 2.76 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.104 -0.998 . . . . 0.0 110.03 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.807 HG23 ' CG ' ' A' ' 59' ' ' ARG . 1.1 t -136.96 7.88 2.96 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.515 -0.74 . . . . 0.0 110.109 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.624 ' HG2' ' C ' ' A' ' 57' ' ' THR . 21.0 mmtt 75.24 -10.68 1.19 Allowed 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.549 -0.719 . . . . 0.0 110.558 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.807 ' CG ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -46.47 -36.07 6.27 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 121.657 -0.652 . . . . 0.0 110.264 -179.871 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.613 ' N ' ' CD ' ' A' ' 59' ' ' ARG . 5.9 p -62.8 -152.4 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.1 -1.0 . . . . 0.0 110.4 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.425 ' HG3' ' C ' ' A' ' 60' ' ' SER . 16.0 mtt85 -134.33 -42.96 0.78 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.974 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.448 ' C ' ' HB2' ' A' ' 27' ' ' LEU . . . 91.07 90.76 1.35 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 1.01 ' O ' HD22 ' A' ' 27' ' ' LEU . 2.4 p90 -150.26 -177.94 6.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.208 -1.172 . . . . 0.0 110.598 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.813 ' N ' HD13 ' A' ' 27' ' ' LEU . . . -147.31 121.06 1.33 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.671 ' CD2' HD21 ' A' ' 50' ' ' LEU . 21.6 m-85 -84.04 153.25 23.92 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.4 -1.059 . . . . 0.0 110.384 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.678 HG22 HD11 ' A' ' 36' ' ' LEU . 13.9 t -150.07 129.58 3.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.5 -0.75 . . . . 0.0 109.208 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.944 HG22 ' O ' ' A' ' 48' ' ' GLU . 9.9 t -119.12 59.2 0.84 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.144 -0.972 . . . . 0.0 111.039 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.683 ' CZ ' HG21 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -70.39 -161.84 0.05 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.947 -1.096 . . . . 0.0 109.91 179.546 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.402 ' HG2' ' HB2' ' A' ' 45' ' ' GLU . 9.0 ptt? -89.01 -158.3 0.49 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.132 -0.98 . . . . 0.0 110.357 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.651 ' HA ' HG23 ' A' ' 74' ' ' VAL . 6.5 m-20 -122.03 -139.74 0.32 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.959 -1.088 . . . . 0.0 110.146 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 62.19 -148.8 0.38 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.136 -0.977 . . . . 0.0 110.239 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 75' ' ' ASP . . . -55.25 -29.37 57.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.282 -0.886 . . . . 0.0 110.306 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -48.11 -65.38 2.53 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.903 ' O ' HD12 ' A' ' 78' ' ' LEU . 25.5 t -47.12 -52.62 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.199 -1.177 . . . . 0.0 110.39 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 72' ' ' ALA . 15.7 m-20 -42.63 -52.07 4.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.145 -0.972 . . . . 0.0 110.173 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.655 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -59.46 -39.4 83.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.394 -0.816 . . . . 0.0 110.155 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.878 HG13 ' HE1' ' A' ' 40' ' ' PHE . 81.7 t -55.33 -60.4 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 O-C-N 121.072 -1.017 . . . . 0.0 109.621 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.903 HD12 ' O ' ' A' ' 74' ' ' VAL . 1.6 mp -44.12 -42.46 6.32 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.234 -0.916 . . . . 0.0 109.423 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -46.88 -27.9 1.4 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.176 -0.953 . . . . 0.0 109.383 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.563 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 13.9 mm100 -101.66 22.0 13.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.426 -0.796 . . . . 0.0 109.894 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.46 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 47.0 t -51.7 -16.92 0.74 Allowed 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.007 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.469 ' O ' ' C ' ' A' ' 83' ' ' HIS . 9.6 ptt180 -100.56 -10.39 21.06 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 121.369 -0.832 . . . . 0.0 109.686 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.67 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 0.5 OUTLIER 31.69 43.99 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.811 -0.555 . . . . 0.0 111.851 179.882 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 2.4 tt0 -93.4 122.58 35.96 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.795 -1.162 . . . . 0.0 110.103 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.502 HD23 ' C ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -155.0 -83.38 0.07 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.553 -0.717 . . . . 0.0 110.189 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.559 ' CB ' ' HD3' ' A' ' 88' ' ' LYS . 0.3 OUTLIER -78.4 52.74 1.18 Allowed 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.036 -1.04 . . . . 0.0 109.425 179.525 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.522 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 71.62 1.43 3.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.522 -0.736 . . . . 0.0 110.619 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.559 ' HD3' ' CB ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -112.69 126.5 55.46 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.104 -0.997 . . . . 0.0 110.249 -179.821 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.655 ' O ' HG23 ' A' ' 89' ' ' THR . 11.5 t -105.82 64.97 0.69 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.666 -0.646 . . . . 0.0 110.361 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.879 HD12 ' O ' ' A' ' 26' ' ' GLY . 0.9 OUTLIER -53.0 -176.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.28 -0.888 . . . . 0.0 109.016 179.892 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' A' ' 25' ' ' GLY . 5.3 t70 -145.11 84.65 8.56 Favored Pre-proline 0 N--CA 1.485 1.28 0 O-C-N 120.653 -1.279 . . . . 0.0 111.052 -178.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.565 ' HG3' ' HD2' ' A' ' 83' ' ' HIS . 1.9 Cg_endo -57.39 112.79 1.23 Allowed 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.565 1.298 . . . . 0.0 110.634 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.65 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -111.3 107.14 16.32 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.035 -1.041 . . . . 0.0 108.983 178.237 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.973 HG13 ' CG ' ' A' ' 22' ' ' MET . 93.2 t -97.28 153.4 3.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.704 -0.623 . . . . 0.0 110.372 -179.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.85 -156.16 0.71 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.206 -0.934 . . . . 0.0 110.022 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.1 t80 . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.234 -0.916 . . . . 0.0 110.121 179.886 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 33.4 t . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.287 0.565 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.473 ' HB2' ' OG1' ' A' ' 67' ' ' THR . 3.5 pttt -68.51 169.03 11.64 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.232 -0.917 . . . . 0.0 109.996 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.92 ' CG ' HG22 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -76.66 162.07 28.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.249 -0.907 . . . . 0.0 110.226 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.661 ' C ' HD12 ' A' ' 24' ' ' ILE . 19.9 t80 -149.54 145.96 27.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.306 -0.871 . . . . 0.0 109.935 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.661 HD12 ' C ' ' A' ' 23' ' ' PHE . 1.1 mp -113.37 142.45 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 108.905 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.626 ' O ' HG22 ' A' ' 90' ' ' ILE . . . -120.42 127.16 6.94 Favored Glycine 0 N--CA 1.494 2.522 0 C-N-CA 119.478 -1.344 . . . . 0.0 111.472 -178.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.844 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 107.32 45.11 1.18 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.943 ' CD2' HG13 ' A' ' 51' ' ' VAL . 1.1 tp -56.47 113.97 1.82 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.103 -1.234 . . . . 0.0 110.508 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.502 ' CB ' ' HG2' ' A' ' 88' ' ' LYS . 6.1 t -45.5 170.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.471 -0.768 . . . . 0.0 110.321 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 39.9 p-90 -81.5 11.55 4.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.261 -0.899 . . . . 0.0 110.451 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -143.98 8.95 1.48 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.18 -0.95 . . . . 0.0 110.52 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.63 HG21 ' HG ' ' A' ' 27' ' ' LEU . 1.4 m -70.68 163.1 27.8 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.294 -0.879 . . . . 0.0 110.097 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.531 HG23 ' H ' ' A' ' 35' ' ' GLY . 4.4 t -142.72 -175.64 4.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.125 -0.984 . . . . 0.0 109.997 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 36' ' ' LEU . 6.5 mt-30 -80.26 -73.1 0.38 Allowed 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.035 -1.041 . . . . 0.0 111.014 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.534 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -48.0 -49.59 30.39 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 118.48 -1.288 . . . . 0.0 108.765 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.531 ' H ' HG23 ' A' ' 32' ' ' THR . . . -47.73 -31.04 7.15 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 107.753 -2.139 . . . . 0.0 107.753 178.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.905 HD21 ' HB2' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -78.45 -39.35 38.83 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 178.283 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.489 ' N ' ' O ' ' A' ' 34' ' ' GLU . 71.7 mtt180 -59.22 -26.42 64.85 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 178.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.534 ' HG3' ' O ' ' A' ' 34' ' ' GLU . 1.3 mt-10 -88.08 -19.68 26.73 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.692 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 8.3 t80 -79.38 -43.04 24.21 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.771 -0.771 . . . . 0.0 110.735 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.846 ' HE1' HG13 ' A' ' 77' ' ' VAL . 28.4 m-85 -105.92 -28.11 10.79 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.387 -0.821 . . . . 0.0 109.217 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.579 ' CA ' HG23 ' A' ' 46' ' ' VAL . . . -67.35 -10.09 56.36 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.647 -1.781 . . . . 0.0 108.647 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -63.05 -37.14 85.99 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.379 -1.071 . . . . 0.0 109.873 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.499 ' HE1' HG22 ' A' ' 77' ' ' VAL . 3.2 p90 -127.23 0.79 6.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.491 -0.756 . . . . 0.0 109.897 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.608 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -146.54 97.55 0.19 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -37.87 122.76 1.02 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.559 -0.965 . . . . 0.0 110.638 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.579 HG23 ' CA ' ' A' ' 41' ' ' GLY . 21.3 t -91.06 119.92 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.356 -0.84 . . . . 0.0 110.727 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -86.14 -21.56 27.5 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.358 -0.839 . . . . 0.0 109.637 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -178.75 145.16 0.29 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.366 -0.834 . . . . 0.0 110.384 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.905 ' HB2' HD21 ' A' ' 36' ' ' LEU . 5.5 p -148.05 170.16 18.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.287 -0.883 . . . . 0.0 109.93 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.769 HD21 ' CD2' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -148.97 133.66 17.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.873 -1.142 . . . . 0.0 110.927 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.943 HG13 ' CD2' ' A' ' 27' ' ' LEU . 61.6 t -110.51 130.19 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.808 -1.183 . . . . 0.0 109.487 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.501 ' SD ' ' CZ ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER -142.17 168.71 19.09 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.174 -0.954 . . . . 0.0 110.612 -178.534 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.548 ' HA ' ' O ' ' A' ' 61' ' ' ARG . 13.8 ptt180 -124.95 -160.6 0.96 Allowed 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.53 -0.731 . . . . 0.0 109.582 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.599 ' CB ' ' HD3' ' A' ' 55' ' ' PRO . 0.6 OUTLIER 175.39 -58.65 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 120.897 -1.127 . . . . 0.0 111.209 179.683 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.599 ' HD3' ' CB ' ' A' ' 54' ' ' ASP . 2.9 Cg_endo -57.85 -152.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.325 1.171 . . . . 0.0 110.714 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.525 ' N ' HD23 ' A' ' 56' ' ' LEU . 5.2 mt -93.98 -69.46 0.75 Allowed 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.15 -0.969 . . . . 0.0 110.796 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.457 HG23 ' HD3' ' A' ' 58' ' ' LYS . 1.8 t 179.54 -30.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.339 -0.851 . . . . 0.0 110.794 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.48 ' HD3' ' N ' ' A' ' 58' ' ' LYS . 15.5 mmtp -56.99 -50.37 72.91 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.183 -0.948 . . . . 0.0 108.977 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.565 ' HG2' ' CB ' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -59.6 -155.5 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.243 179.434 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.495 ' HB3' ' O ' ' A' ' 27' ' ' LEU . 14.5 m -74.35 -111.91 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.13 -0.981 . . . . 0.0 109.051 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.548 ' O ' ' HA ' ' A' ' 53' ' ' ARG . 6.2 ttm180 -136.72 -42.3 0.6 Allowed 'General case' 0 N--CA 1.482 1.152 0 O-C-N 120.731 -1.231 . . . . 0.0 108.372 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 53' ' ' ARG . . . 162.94 -87.99 0.1 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.461 -1.856 . . . . 0.0 108.461 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.879 ' C ' HD13 ' A' ' 27' ' ' LEU . 8.2 p90 -177.66 178.15 1.04 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.303 -1.116 . . . . 0.0 110.367 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.863 ' N ' HD13 ' A' ' 27' ' ' LEU . . . -141.67 164.36 26.71 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.769 ' CD2' HD21 ' A' ' 50' ' ' LEU . 13.6 m-85 -124.56 148.38 47.85 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.356 -1.085 . . . . 0.0 109.822 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.517 HG23 ' C ' ' A' ' 65' ' ' PHE . 7.5 t -148.71 126.8 3.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.317 -0.865 . . . . 0.0 110.171 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.619 HG22 ' O ' ' A' ' 67' ' ' THR . 88.4 m -106.14 19.51 20.41 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.282 -0.886 . . . . 0.0 110.079 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.615 ' CE2' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -49.83 142.44 8.84 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.151 -0.968 . . . . 0.0 109.728 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.4 ttp -136.54 123.86 21.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.261 -0.899 . . . . 0.0 110.25 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.405 ' OD1' ' HG2' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -150.04 -159.99 1.11 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 110.339 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -80.79 -72.36 0.42 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.23 -0.919 . . . . 0.0 110.214 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 73' ' ' GLY . . . -87.8 21.95 2.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.218 -0.927 . . . . 0.0 110.348 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.674 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -43.48 -63.75 2.04 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.666 HG22 HG11 ' A' ' 94' ' ' VAL . 11.1 t -54.45 -23.8 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.136 -1.214 . . . . 0.0 110.0 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.486 ' HB3' ' HE3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -75.38 -73.13 0.27 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 110.017 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.486 ' HE3' ' HB3' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -47.55 -46.47 27.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.378 -0.826 . . . . 0.0 109.818 179.807 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.846 HG13 ' HE1' ' A' ' 40' ' ' PHE . 79.9 t -52.59 -53.25 21.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.069 -1.02 . . . . 0.0 108.691 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -41.02 -51.81 3.23 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.659 -0.651 . . . . 0.0 110.064 179.012 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -42.85 -27.26 0.17 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.441 -0.787 . . . . 0.0 110.19 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.562 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 9.7 mm-40 -104.58 21.85 16.06 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.265 -0.897 . . . . 0.0 110.29 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.508 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 40.3 t -51.76 -16.86 0.75 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.481 -0.762 . . . . 0.0 109.276 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.5 OUTLIER -108.33 -4.41 17.47 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 121.346 -0.846 . . . . 0.0 109.939 179.348 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.841 ' CE1' HD12 ' A' ' 90' ' ' ILE . 0.4 OUTLIER 34.39 31.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.786 -0.571 . . . . 0.0 111.241 179.828 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -86.24 117.78 25.27 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 118.39 -1.324 . . . . 0.0 110.205 179.502 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.534 HD11 ' HZ1' ' A' ' 88' ' ' LYS . 0.1 OUTLIER -153.78 -73.68 0.13 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.808 -0.558 . . . . 0.0 110.231 -179.249 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 87' ' ' SER . 0.4 OUTLIER -81.27 49.07 1.22 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.165 -0.96 . . . . 0.0 109.474 179.552 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 71.68 -0.11 3.29 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.539 -0.726 . . . . 0.0 110.651 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.673 ' HE3' HD11 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -115.35 138.66 50.74 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.182 -0.949 . . . . 0.0 110.084 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.789 ' O ' HG23 ' A' ' 89' ' ' THR . 14.9 t -113.11 71.27 0.74 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.544 -0.723 . . . . 0.0 110.799 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.844 HG23 ' C ' ' A' ' 26' ' ' GLY . 1.2 mt -55.0 -171.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.32 -0.863 . . . . 0.0 109.534 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.585 ' H ' HG22 ' A' ' 90' ' ' ILE . 5.1 t70 -143.82 87.04 8.3 Favored Pre-proline 0 N--CA 1.486 1.355 0 O-C-N 120.882 -1.136 . . . . 0.0 111.192 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.562 ' CG ' ' O ' ' A' ' 80' ' ' GLN . 2.0 Cg_endo -62.49 112.23 1.53 Allowed 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.53 1.279 . . . . 0.0 111.057 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.641 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -115.43 109.32 17.69 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.115 -0.991 . . . . 0.0 109.066 178.111 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.92 HG22 ' CG ' ' A' ' 22' ' ' MET . 53.6 t -97.04 151.57 4.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.521 -0.737 . . . . 0.0 110.291 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -109.02 123.32 48.95 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.203 -0.936 . . . . 0.0 110.375 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.5 t80 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.151 -0.968 . . . . 0.0 109.883 179.773 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.302 0.572 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 0.3 OUTLIER -134.83 152.77 52.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 110.343 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.981 ' CG ' HG13 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -73.06 -172.12 1.01 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.349 -0.845 . . . . 0.0 109.839 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.686 ' CG ' ' CE1' ' A' ' 65' ' ' PHE . 6.5 t80 -151.01 145.38 25.5 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.015 -1.053 . . . . 0.0 110.211 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.743 HD12 ' CZ ' ' A' ' 40' ' ' PHE . 18.6 mm -118.49 126.34 75.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.299 -0.876 . . . . 0.0 108.905 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.56 ' O ' HG22 ' A' ' 90' ' ' ILE . . . -109.83 159.63 13.86 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.789 -1.196 . . . . 0.0 111.227 -178.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 90' ' ' ILE . . . 54.35 40.25 67.82 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.006 HD22 ' CA ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -85.56 143.41 28.5 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.676 -0.897 . . . . 0.0 110.926 -179.135 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.5 ' O ' ' HB ' ' A' ' 31' ' ' THR . 0.5 OUTLIER -39.39 134.81 1.16 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.465 0.65 . . . . 0.0 110.942 -179.076 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.526 ' CG ' ' N ' ' A' ' 30' ' ' GLN . 31.0 p-90 -68.28 -37.97 81.22 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.361 -0.837 . . . . 0.0 109.947 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.526 ' N ' ' CG ' ' A' ' 29' ' ' TRP . 12.3 pt20 -74.76 0.21 16.07 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.396 -0.815 . . . . 0.0 110.696 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.5 ' HB ' ' O ' ' A' ' 28' ' ' SER . 4.4 m -69.24 153.86 42.97 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.392 -0.817 . . . . 0.0 110.215 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.552 HG23 ' H ' ' A' ' 35' ' ' GLY . 5.9 t -123.79 -174.18 2.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 109.625 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 36' ' ' LEU . 1.7 mt-30 -72.28 -73.15 0.2 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.044 -1.035 . . . . 0.0 110.855 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -48.33 -50.01 31.97 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 118.569 -1.252 . . . . 0.0 108.845 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.552 ' H ' HG23 ' A' ' 32' ' ' THR . . . -49.47 -29.23 10.94 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 107.795 -2.122 . . . . 0.0 107.795 178.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.921 HD21 ' HB2' ' A' ' 49' ' ' CYS . 0.1 OUTLIER -81.72 -38.24 26.08 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 178.315 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.491 ' HG3' ' HA ' ' A' ' 34' ' ' GLU . 13.9 mtp180 -58.71 -27.31 64.75 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.509 ' HG3' ' O ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -89.25 -21.35 23.26 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.793 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.579 ' OH ' ' CG ' ' A' ' 83' ' ' HIS . 38.2 t80 -67.84 -29.17 68.24 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.568 0.699 . . . . 0.0 109.85 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.884 ' HE1' HG13 ' A' ' 77' ' ' VAL . 38.4 m-85 -117.66 -18.72 9.6 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -70.17 -12.59 69.05 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -62.19 -47.82 82.77 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.452 -1.028 . . . . 0.0 109.691 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.582 ' HE1' HG22 ' A' ' 77' ' ' VAL . 6.0 p90 -119.61 7.87 11.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.519 -0.738 . . . . 0.0 109.911 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.464 ' O ' ' HA2' ' A' ' 41' ' ' GLY . . . -159.41 99.99 0.18 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 13.3 pt-20 -41.26 148.79 0.12 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.433 -1.039 . . . . 0.0 110.099 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.791 HG22 ' CB ' ' A' ' 68' ' ' PHE . 48.8 t -122.6 147.38 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.192 -0.943 . . . . 0.0 110.868 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -106.3 -32.7 8.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.414 -0.804 . . . . 0.0 109.887 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.765 ' O ' HG22 ' A' ' 67' ' ' THR . 0.9 OUTLIER -167.51 152.03 6.81 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.248 -0.908 . . . . 0.0 110.294 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.921 ' HB2' HD21 ' A' ' 36' ' ' LEU . 29.7 p -150.8 167.42 27.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.178 -0.951 . . . . 0.0 110.285 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.67 ' C ' HD12 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -138.6 126.23 22.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.168 -0.957 . . . . 0.0 109.872 179.504 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.488 HG23 HD23 ' A' ' 36' ' ' LEU . 61.6 t -115.09 130.44 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.634 -1.292 . . . . 0.0 111.261 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.445 ' HB3' ' HE2' ' A' ' 52' ' ' MET . 0.1 OUTLIER -132.26 148.16 52.44 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.6 -0.688 . . . . 0.0 109.292 179.317 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.512 ' NH1' ' CE3' ' A' ' 29' ' ' TRP . 4.0 ttt180 -132.06 -85.01 0.49 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.457 -0.777 . . . . 0.0 110.386 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 53' ' ' ARG . 64.6 m-20 -132.45 89.0 37.62 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 110.554 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 60' ' ' SER . 2.9 Cg_endo -60.76 -50.72 6.0 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 O-C-N 123.633 1.333 . . . . 0.0 110.179 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.596 HD12 ' HG2' ' A' ' 59' ' ' ARG . 9.6 mt -89.96 -57.8 2.73 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.286 -0.884 . . . . 0.0 109.596 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.05 -44.87 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.507 -0.745 . . . . 0.0 110.174 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -175.9 23.19 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.238 -0.914 . . . . 0.0 110.816 179.8 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.596 ' HG2' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -79.26 -29.99 42.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.988 -1.07 . . . . 0.0 110.261 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.528 ' N ' ' CD ' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -58.53 -152.57 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.215 -0.928 . . . . 0.0 110.072 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.462 ' HB2' ' CE2' ' A' ' 63' ' ' PHE . 0.7 OUTLIER -134.14 -29.86 1.23 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.169 -0.957 . . . . 0.0 110.727 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.99 88.04 1.57 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 1.006 ' CA ' HD22 ' A' ' 27' ' ' LEU . 7.4 p90 -151.54 -172.71 4.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.192 -1.181 . . . . 0.0 110.666 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.564 ' N ' HD13 ' A' ' 27' ' ' LEU . . . -153.48 120.19 1.02 Allowed Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.686 ' CE1' ' CG ' ' A' ' 23' ' ' PHE . 17.3 m-85 -83.94 149.31 26.4 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.453 -1.028 . . . . 0.0 109.153 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.695 ' CG2' HD11 ' A' ' 36' ' ' LEU . 3.5 t -150.0 114.51 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.11 -0.994 . . . . 0.0 110.845 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.765 HG22 ' O ' ' A' ' 48' ' ' GLU . 8.9 t -80.07 4.09 18.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.175 -0.953 . . . . 0.0 109.694 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.791 ' CB ' HG22 ' A' ' 46' ' ' VAL . 1.0 OUTLIER -49.31 155.65 0.69 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.3 -0.875 . . . . 0.0 110.105 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 39.2 ttm -170.39 113.32 0.45 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.113 -0.992 . . . . 0.0 110.504 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.42 ' O ' ' C ' ' A' ' 71' ' ' GLN . 15.2 t70 -131.85 166.05 22.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.237 -0.915 . . . . 0.0 110.083 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -43.09 -71.3 0.08 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.253 -0.904 . . . . 0.0 110.214 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.23 -4.71 58.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.887 . . . . 0.0 110.186 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.663 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -47.71 -77.64 0.11 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.569 HG22 HG11 ' A' ' 94' ' ' VAL . 51.1 t -40.95 -51.84 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.33 -1.1 . . . . 0.0 110.481 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.476 ' HA ' HD21 ' A' ' 78' ' ' LEU . 3.8 m-20 -47.1 -52.91 14.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -0.927 . . . . 0.0 110.295 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.661 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -67.05 -35.76 80.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.465 -0.772 . . . . 0.0 110.531 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.884 HG13 ' HE1' ' A' ' 40' ' ' PHE . 49.8 t -54.58 -72.8 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.057 -1.027 . . . . 0.0 109.753 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.476 HD21 ' HA ' ' A' ' 75' ' ' ASP . 1.1 pp -46.82 -37.42 8.67 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.909 -1.119 . . . . 0.0 109.289 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -51.69 -25.76 7.93 Favored 'General case' 0 C--N 1.308 -1.235 0 O-C-N 121.1 -1.0 . . . . 0.0 108.685 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.591 ' HB3' ' CE1' ' A' ' 83' ' ' HIS . 13.3 mm-40 -103.99 26.28 8.91 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.465 0.65 . . . . 0.0 109.351 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.557 ' HA ' ' HD2' ' A' ' 92' ' ' PRO . 47.4 t -54.54 -15.83 1.99 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.544 ' O ' ' C ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -113.54 8.19 17.66 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.611 -0.681 . . . . 0.0 109.66 179.099 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.638 ' CD2' ' HG3' ' A' ' 92' ' ' PRO . 2.6 m-70 -3.38 -78.01 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.736 ' C ' HD23 ' A' ' 85' ' ' LEU . 4.4 tt0 59.38 122.46 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 121.467 0.651 . . . . 0.0 109.49 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.083 HD21 HD11 ' A' ' 90' ' ' ILE . 0.4 OUTLIER -157.58 -37.81 0.07 Allowed 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.274 -0.97 . . . . 0.0 110.502 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 87' ' ' SER . 1.5 t70 -121.88 48.03 1.78 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 74.44 1.33 3.82 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -177.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -117.05 119.43 35.25 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.685 ' O ' HG23 ' A' ' 89' ' ' THR . 7.3 t -92.45 77.91 5.04 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.083 HD11 HD21 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -40.98 167.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 CA-C-O 121.897 0.856 . . . . 0.0 110.615 -178.8 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 25' ' ' GLY . 4.6 t70 -133.2 69.63 78.01 Favored Pre-proline 0 C--N 1.297 -1.694 0 O-C-N 121.685 -0.635 . . . . 0.0 109.448 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.638 ' HG3' ' CD2' ' A' ' 83' ' ' HIS . 1.8 Cg_endo -49.58 112.84 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.566 1.298 . . . . 0.0 109.882 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.525 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.1 OUTLIER -126.75 107.95 10.61 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.871 0.843 . . . . 0.0 110.009 179.192 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.981 HG13 ' CG ' ' A' ' 22' ' ' MET . 76.3 t -95.99 153.72 3.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.11 2.4 20.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.095 -1.003 . . . . 0.0 110.427 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.851 ' H ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.134 -0.979 . . . . 0.0 110.26 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.273 0.558 . . . . 0.0 110.223 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.468 ' HB2' ' CA ' ' A' ' 67' ' ' THR . 1.1 pttm -156.16 145.03 20.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 110.105 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.796 ' CB ' HG22 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -55.23 155.85 4.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 110.218 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.633 ' CD2' ' CE ' ' A' ' 93' ' ' LYS . 0.5 OUTLIER -138.54 119.61 14.49 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.582 -0.699 . . . . 0.0 109.444 -179.804 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.621 ' CG2' HG21 ' A' ' 90' ' ' ILE . 1.2 mp -93.65 137.89 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.081 -1.012 . . . . 0.0 109.12 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.543 ' O ' ' CG2' ' A' ' 90' ' ' ILE . . . -110.62 133.05 11.32 Favored Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.823 -1.179 . . . . 0.0 112.324 -177.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.884 ' O ' HD12 ' A' ' 90' ' ' ILE . . . 62.55 36.97 93.95 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.902 HD22 ' CA ' ' A' ' 63' ' ' PHE . 0.4 OUTLIER -61.65 150.96 34.91 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.529 -0.983 . . . . 0.0 110.706 -179.339 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.672 ' O ' HG22 ' A' ' 31' ' ' THR . 0.4 OUTLIER -39.51 123.11 1.43 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.49 0.662 . . . . 0.0 110.771 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 6.5 p-90 -63.9 -14.29 52.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.504 -0.747 . . . . 0.0 110.146 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.466 ' O ' ' O ' ' A' ' 31' ' ' THR . 4.1 pt20 -100.04 -21.74 15.5 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.373 -0.83 . . . . 0.0 110.908 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.672 HG22 ' O ' ' A' ' 28' ' ' SER . 2.3 t -55.41 -161.93 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.447 0.641 . . . . 0.0 110.397 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.524 ' N ' HG23 ' A' ' 31' ' ' THR . 6.1 t -158.74 -168.99 2.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.877 . . . . 0.0 109.857 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 36' ' ' LEU . 15.1 mt-30 -79.55 -70.53 0.5 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.162 -0.961 . . . . 0.0 110.432 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.536 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -46.32 -52.29 13.01 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.959 -1.096 . . . . 0.0 109.237 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.458 ' H ' HG23 ' A' ' 32' ' ' THR . . . -48.4 -31.34 9.0 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.869 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -79.76 -36.81 36.64 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.448 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.511 ' HG3' ' HA ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -60.76 -27.97 68.37 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 122.455 1.121 . . . . 0.0 108.052 177.728 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.536 ' HG3' ' O ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -86.02 -19.9 29.64 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.541 179.091 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.688 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 13.6 t80 -78.64 -35.29 45.66 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.988 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.906 ' HE1' HG13 ' A' ' 77' ' ' VAL . 38.7 m-85 -109.14 -22.96 11.87 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.213 -0.93 . . . . 0.0 109.416 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -76.79 -3.61 80.17 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.581 -1.807 . . . . 0.0 108.581 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -73.86 -50.59 19.6 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 121.495 -1.003 . . . . 0.0 110.19 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.601 ' CZ ' ' HA ' ' A' ' 40' ' ' PHE . 2.9 p90 -103.35 13.1 34.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 110.18 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' A' ' 45' ' ' GLU . . . -150.24 -111.8 0.56 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.449 ' HB3' ' O ' ' A' ' 44' ' ' GLY . 0.4 OUTLIER 176.83 104.39 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.533 -0.981 . . . . 0.0 109.408 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.503 ' HA ' ' CB ' ' A' ' 68' ' ' PHE . 95.1 t -90.56 137.78 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.312 -0.867 . . . . 0.0 111.04 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -101.7 -26.87 13.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.52 -0.737 . . . . 0.0 109.163 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -166.9 154.79 9.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.547 -0.721 . . . . 0.0 109.796 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.491 ' SG ' ' CD ' ' A' ' 37' ' ' ARG . 21.0 p -148.68 175.4 11.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.123 -0.986 . . . . 0.0 110.719 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.623 HD21 ' CD2' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -150.51 132.11 14.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -0.833 . . . . 0.0 109.902 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.769 HG13 HD11 ' A' ' 27' ' ' LEU . 48.2 t -129.1 147.04 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.548 -1.345 . . . . 0.0 111.298 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.456 ' CE ' ' HB2' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -146.74 146.76 30.42 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.754 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.404 ' O ' ' NE ' ' A' ' 59' ' ' ARG . 6.7 mtp85 -118.61 -76.01 0.58 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.206 -0.934 . . . . 0.0 110.772 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.413 ' CG ' ' NH1' ' A' ' 59' ' ' ARG . 64.2 t0 -141.99 76.62 19.34 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.146 -0.971 . . . . 0.0 110.616 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.706 ' O ' HD23 ' A' ' 56' ' ' LEU . 3.0 Cg_exo -55.96 -48.71 18.41 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.627 1.33 . . . . 0.0 110.644 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.706 HD23 ' O ' ' A' ' 55' ' ' PRO . 8.0 mt -124.23 -70.12 0.77 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.168 -0.958 . . . . 0.0 110.148 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.57 HG23 ' H ' ' A' ' 58' ' ' LYS . 1.3 t 174.66 -50.55 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.477 -0.765 . . . . 0.0 110.253 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.57 ' H ' HG23 ' A' ' 57' ' ' THR . 2.4 pttt -76.59 3.17 12.05 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.256 -0.902 . . . . 0.0 110.292 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.49 ' HD2' ' O ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -60.08 -158.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.35 -0.844 . . . . 0.0 110.568 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.49 ' O ' ' HD2' ' A' ' 59' ' ' ARG . 59.8 m -78.84 -119.92 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.355 -0.841 . . . . 0.0 110.522 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -149.41 12.16 0.81 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.822 -1.174 . . . . 0.0 110.714 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.8 101.67 2.65 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.902 ' CA ' HD22 ' A' ' 27' ' ' LEU . 41.4 p90 -140.5 -168.86 2.65 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.09 -1.241 . . . . 0.0 110.472 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 50' ' ' LEU . . . -155.8 179.71 31.53 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.623 ' CD2' HD21 ' A' ' 50' ' ' LEU . 16.8 m-85 -148.6 146.68 28.34 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.493 -1.004 . . . . 0.0 108.751 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.802 HG21 HD11 ' A' ' 36' ' ' LEU . 5.6 t -148.08 106.18 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 120.806 -1.184 . . . . 0.0 111.295 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.468 ' CA ' ' HB2' ' A' ' 21' ' ' LYS . 39.0 m -82.45 56.76 3.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.14 -0.975 . . . . 0.0 110.049 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.626 ' CE1' ' HB2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -85.59 -144.13 0.1 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 110.74 -179.811 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.57 ' O ' ' CE1' ' A' ' 68' ' ' PHE . 5.9 tpt -79.56 167.44 20.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.179 -0.951 . . . . 0.0 110.272 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.47 ' HA ' HG23 ' A' ' 74' ' ' VAL . 52.9 m-20 -132.1 -2.9 3.56 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.175 -0.953 . . . . 0.0 110.618 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -84.12 -93.39 0.07 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.03 -1.044 . . . . 0.0 110.094 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.96 -22.35 60.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.135 -0.978 . . . . 0.0 109.723 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.772 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -59.14 -55.05 32.97 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.47 HG23 ' HA ' ' A' ' 70' ' ' ASP . 54.8 t -45.17 -38.93 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.124 -1.221 . . . . 0.0 110.354 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.87 -73.31 0.13 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.211 -0.931 . . . . 0.0 110.303 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.545 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -45.09 -43.06 9.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.241 -0.912 . . . . 0.0 109.469 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.906 HG13 ' HE1' ' A' ' 40' ' ' PHE . 93.4 t -54.02 -55.61 13.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.251 -0.905 . . . . 0.0 108.886 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.634 HD13 ' HB2' ' A' ' 81' ' ' SER . 0.1 OUTLIER -40.41 -47.27 2.55 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.716 -0.615 . . . . 0.0 109.993 178.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -43.53 -26.96 0.25 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.507 -0.746 . . . . 0.0 109.678 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.541 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 43.8 mm-40 -103.08 24.71 10.4 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.447 -0.783 . . . . 0.0 110.056 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.634 ' HB2' HD13 ' A' ' 78' ' ' LEU . 30.4 t -57.8 -13.74 4.76 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.556 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -99.71 -17.0 17.96 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 121.425 -0.797 . . . . 0.0 109.675 179.309 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.688 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 0.7 OUTLIER 31.14 32.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.613 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.556 ' N ' ' O ' ' A' ' 82' ' ' ARG . 0.8 OUTLIER -77.92 121.65 24.44 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.431 -1.418 . . . . 0.0 109.154 179.392 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.498 HD21 ' ND1' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -144.67 -80.88 0.17 Allowed 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.323 -178.562 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.526 ' O ' ' CD ' ' A' ' 88' ' ' LYS . 7.7 t70 -87.1 51.62 2.29 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.506 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 70.44 6.93 6.02 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -178.415 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.547 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 6.4 mmmt -108.49 120.94 43.88 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.58 -0.7 . . . . 0.0 109.964 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.769 ' O ' HG23 ' A' ' 89' ' ' THR . 13.4 t -100.07 67.4 1.4 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.562 -0.711 . . . . 0.0 109.589 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.884 HD12 ' O ' ' A' ' 26' ' ' GLY . 1.3 mm -49.86 -179.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 119.621 -0.831 . . . . 0.0 109.544 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.494 ' H ' HG22 ' A' ' 90' ' ' ILE . 18.8 t0 -141.06 79.56 17.96 Favored Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 121.163 -0.961 . . . . 0.0 110.272 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.541 ' CG ' ' O ' ' A' ' 80' ' ' GLN . 2.4 Cg_endo -51.81 113.11 1.02 Allowed 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.415 1.219 . . . . 0.0 110.201 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.633 ' CE ' ' CD2' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -135.41 113.33 11.08 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.27 -0.894 . . . . 0.0 109.965 179.221 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.796 HG22 ' CB ' ' A' ' 22' ' ' MET . 58.4 t -96.65 172.97 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.253 -0.905 . . . . 0.0 110.253 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.558 ' N ' HG12 ' A' ' 94' ' ' VAL . . . 47.96 -163.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.201 -0.937 . . . . 0.0 110.393 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.516 ' CD1' ' N ' ' A' ' 96' ' ' PHE . 12.3 p90 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.305 -0.872 . . . . 0.0 110.117 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.1 m . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.256 0.551 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.913 ' CB ' HG23 ' A' ' 67' ' ' THR . 4.6 pttt -76.63 154.38 34.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.121 -0.987 . . . . 0.0 110.197 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.899 ' CB ' HG13 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -75.79 174.0 10.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.186 -0.946 . . . . 0.0 109.478 179.443 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.691 ' CG ' ' CE1' ' A' ' 65' ' ' PHE . 5.9 t80 -150.6 139.4 20.8 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.204 -0.935 . . . . 0.0 109.825 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.731 ' CG2' HG21 ' A' ' 90' ' ' ILE . 13.6 mm -106.68 152.87 8.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.53 ' O ' HG22 ' A' ' 90' ' ' ILE . . . -126.69 139.3 11.19 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 119.175 -1.488 . . . . 0.0 111.764 -178.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.458 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 56.52 43.65 90.67 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.923 HD22 ' CA ' ' A' ' 63' ' ' PHE . 0.5 OUTLIER -75.74 142.58 42.38 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.412 -1.052 . . . . 0.0 110.63 -179.311 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.69 ' O ' HG22 ' A' ' 31' ' ' THR . 5.0 m -39.57 132.91 1.52 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.617 -0.677 . . . . 0.0 110.447 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.473 ' CZ3' ' HB3' ' A' ' 30' ' ' GLN . 47.6 p-90 -71.16 -17.95 62.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.465 -0.772 . . . . 0.0 110.624 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.473 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 10.9 pt20 -89.58 -18.12 27.19 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.184 -0.948 . . . . 0.0 110.82 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.69 HG22 ' O ' ' A' ' 28' ' ' SER . 6.9 t -55.61 -173.42 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.874 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.687 HG23 ' H ' ' A' ' 35' ' ' GLY . 7.4 t -147.85 -172.6 4.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.348 -0.845 . . . . 0.0 109.875 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 36' ' ' LEU . 3.9 mt-30 -77.79 -74.23 0.27 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.032 -1.043 . . . . 0.0 110.531 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.558 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 2.7 tt0 -48.05 -41.53 26.15 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.949 -1.094 . . . . 0.0 110.182 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.687 ' H ' HG23 ' A' ' 32' ' ' THR . . . -57.47 -28.95 60.08 Favored Glycine 0 C--N 1.296 -1.684 0 N-CA-C 107.424 -2.271 . . . . 0.0 107.424 178.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.854 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -82.5 -38.59 23.64 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.135 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.642 ' HA ' HG21 ' A' ' 46' ' ' VAL . 26.4 mtt180 -61.79 -27.09 68.5 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 122.418 1.104 . . . . 0.0 108.135 178.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.556 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -87.44 -19.27 28.26 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.373 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.653 ' CE1' ' NE2' ' A' ' 83' ' ' HIS . 26.9 t80 -79.24 -30.52 43.21 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.254 -0.904 . . . . 0.0 110.205 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.917 ' CE1' HG13 ' A' ' 77' ' ' VAL . 27.0 m-85 -108.8 -25.33 10.85 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.459 -0.776 . . . . 0.0 109.166 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -70.26 -7.84 60.98 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -63.95 -49.61 71.88 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 121.417 -1.049 . . . . 0.0 109.699 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.528 ' HE1' HG22 ' A' ' 77' ' ' VAL . 1.8 p90 -113.82 12.6 18.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.464 -0.772 . . . . 0.0 109.763 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 45' ' ' GLU . . . -142.85 -117.22 1.23 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.515 ' OE2' ' CB ' ' A' ' 70' ' ' ASP . 1.9 pt-20 177.09 103.47 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.406 -1.055 . . . . 0.0 109.906 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.642 HG21 ' HA ' ' A' ' 37' ' ' ARG . 63.3 t -89.41 126.58 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.19 -0.944 . . . . 0.0 110.702 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.95 -26.98 11.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.265 -0.897 . . . . 0.0 109.592 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -158.76 131.94 7.26 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.47 -0.769 . . . . 0.0 109.446 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 24.8 p -150.37 154.64 38.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.972 -1.08 . . . . 0.0 111.288 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.749 HD12 ' C ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -125.04 126.11 44.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.391 -0.818 . . . . 0.0 109.261 178.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.592 ' CG1' ' N ' ' A' ' 52' ' ' MET . 17.4 t -89.73 169.38 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.79 -1.194 . . . . 0.0 112.104 -178.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.687 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 2.2 ptt? 38.12 -155.92 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.733 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -150.0 124.84 9.85 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.176 0.512 . . . . 0.0 110.321 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.461 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 33.0 t0 -43.49 103.69 0.33 Allowed Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.229 -0.92 . . . . 0.0 110.239 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 53' ' ' ARG . 3.1 Cg_exo -61.08 96.12 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.398 1.21 . . . . 0.0 110.635 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 54' ' ' ASP . 6.3 mt -90.0 -49.42 6.61 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.276 -0.89 . . . . 0.0 109.79 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.591 HG23 ' HG3' ' A' ' 58' ' ' LYS . 0.2 OUTLIER 179.1 -30.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.51 -0.744 . . . . 0.0 110.141 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.591 ' HG3' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -154.29 17.13 0.48 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.321 -0.862 . . . . 0.0 110.293 179.726 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.553 ' HD3' ' N ' ' A' ' 60' ' ' SER . 0.1 OUTLIER -57.59 -158.64 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.242 -0.911 . . . . 0.0 110.57 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.553 ' N ' ' HD3' ' A' ' 59' ' ' ARG . 40.2 t -65.27 -132.4 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.352 -0.842 . . . . 0.0 110.64 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.24 28.74 0.73 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.019 -1.05 . . . . 0.0 110.379 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.687 ' HA2' ' HA ' ' A' ' 52' ' ' MET . . . 96.67 108.52 2.51 Favored Glycine 0 N--CA 1.481 1.684 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.923 ' CA ' HD22 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -136.99 -176.1 4.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.087 -1.243 . . . . 0.0 109.96 179.282 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.472 ' O ' ' HB ' ' A' ' 24' ' ' ILE . . . -135.22 100.79 0.37 Allowed Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.087 -1.53 . . . . 0.0 110.4 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.691 ' CE1' ' CG ' ' A' ' 23' ' ' PHE . 11.7 m-85 -81.23 136.02 35.79 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.119 -1.224 . . . . 0.0 108.627 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.8 HG21 HD11 ' A' ' 36' ' ' LEU . 3.1 t -145.99 106.6 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 118.782 -1.167 . . . . 0.0 111.16 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.913 HG23 ' CB ' ' A' ' 21' ' ' LYS . 1.4 m -82.63 47.21 1.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.609 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.605 ' CE1' ' HB3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -73.94 59.46 0.7 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.357 -0.84 . . . . 0.0 110.619 -179.455 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.408 ' C ' ' O ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -42.56 122.32 2.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 110.249 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.515 ' CB ' ' OE2' ' A' ' 45' ' ' GLU . 13.6 p-10 -150.77 -163.45 1.78 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.277 -0.889 . . . . 0.0 110.141 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.61 -88.58 0.62 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.891 . . . . 0.0 110.118 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.91 -23.76 63.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.923 . . . . 0.0 109.939 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.644 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -49.49 -44.63 36.96 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.937 ' O ' HD12 ' A' ' 78' ' ' LEU . 19.5 t -46.73 -52.27 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.352 -1.087 . . . . 0.0 109.868 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.56 ' HA ' HD13 ' A' ' 78' ' ' LEU . 4.6 t0 -54.08 -50.04 67.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.068 -1.02 . . . . 0.0 109.681 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.666 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 6.3 mmpt? -56.26 -35.53 67.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.33 -0.856 . . . . 0.0 109.816 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.917 HG13 ' CE1' ' A' ' 40' ' ' PHE . 60.5 t -59.17 -57.07 13.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 O-C-N 121.045 -1.035 . . . . 0.0 109.477 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.937 HD12 ' O ' ' A' ' 74' ' ' VAL . 2.8 mp -44.84 -41.55 7.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.239 -0.913 . . . . 0.0 109.06 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.666 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -46.34 -27.99 1.2 Allowed 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.304 -0.873 . . . . 0.0 109.281 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.515 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 7.2 mm100 -101.85 25.18 8.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.533 -0.729 . . . . 0.0 109.68 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.51 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 21.4 p -56.44 -16.44 5.81 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.522 ' O ' ' C ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -97.34 -9.49 27.39 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.633 -0.667 . . . . 0.0 109.792 179.193 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.863 ' CE1' HD12 ' A' ' 90' ' ' ILE . 0.6 OUTLIER 19.48 48.9 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 179.81 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.553 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -91.9 125.57 36.66 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 118.493 -1.283 . . . . 0.0 109.172 178.752 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.568 HD23 ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -145.34 -91.53 0.1 Allowed 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.663 -0.648 . . . . 0.0 109.655 -179.158 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.529 ' O ' ' CB ' ' A' ' 87' ' ' SER . 10.6 m-20 -79.86 52.62 1.51 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.097 -1.002 . . . . 0.0 108.74 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 72.18 9.72 5.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.618 -0.676 . . . . 0.0 109.857 -179.129 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 9.0 mmtt -111.24 120.72 43.21 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.372 -0.83 . . . . 0.0 109.608 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.763 ' O ' HG23 ' A' ' 89' ' ' THR . 11.9 t -101.87 69.23 1.18 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.505 -0.747 . . . . 0.0 109.726 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.863 HD12 ' CE1' ' A' ' 83' ' ' HIS . 0.8 OUTLIER -50.15 -178.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.389 -179.714 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.484 ' H ' HG22 ' A' ' 90' ' ' ILE . 14.2 t0 -141.45 81.04 15.74 Favored Pre-proline 0 C--N 1.3 -1.558 0 O-C-N 121.189 -0.944 . . . . 0.0 109.817 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.526 ' HG3' ' HD2' ' A' ' 83' ' ' HIS . 2.4 Cg_endo -53.96 112.58 1.01 Allowed 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 123.542 1.285 . . . . 0.0 111.275 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.58 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -128.02 104.89 8.04 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.916 0.865 . . . . 0.0 108.848 177.894 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.899 HG13 ' CB ' ' A' ' 22' ' ' MET . 6.2 t -96.19 -174.49 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 O-C-N 121.854 -0.529 . . . . 0.0 110.004 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.745 ' HB3' ' O ' ' A' ' 94' ' ' VAL . . . 71.39 159.07 0.2 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.181 -0.949 . . . . 0.0 110.431 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.5 p90 . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.319 -0.863 . . . . 0.0 110.089 179.874 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 30.1 p . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 121.245 0.545 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.582 ' CB ' HG23 ' A' ' 67' ' ' THR . 0.4 OUTLIER -170.08 179.48 3.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 110.236 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.918 ' HB2' HG22 ' A' ' 94' ' ' VAL . 0.5 OUTLIER -83.81 178.92 7.72 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.248 -0.907 . . . . 0.0 110.528 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.633 ' HB3' ' HD2' ' A' ' 93' ' ' LYS . 0.1 OUTLIER -150.47 143.68 24.91 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.489 -0.757 . . . . 0.0 109.068 179.785 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.534 HD12 ' C ' ' A' ' 23' ' ' PHE . 1.1 mp -106.85 144.62 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.069 -1.019 . . . . 0.0 109.34 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 91' ' ' ASP . . . -131.51 122.76 3.51 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 119.734 -1.222 . . . . 0.0 111.281 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 1.046 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 113.21 34.0 1.87 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.102 HD21 HG13 ' A' ' 51' ' ' VAL . 2.0 mp -39.93 137.37 0.95 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.682 -0.893 . . . . 0.0 110.715 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.537 ' CB ' ' HG1' ' A' ' 31' ' ' THR . 5.0 p -56.39 -174.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 0.0 110.06 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 47.9 p-90 -77.62 5.23 9.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 0.0 110.238 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -161.67 16.17 0.1 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.111 -0.993 . . . . 0.0 111.158 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.537 ' HG1' ' CB ' ' A' ' 28' ' ' SER . 98.7 m -53.6 157.54 2.16 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.055 -1.028 . . . . 0.0 110.307 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.607 HG23 ' H ' ' A' ' 35' ' ' GLY . 2.8 t -148.23 178.55 8.47 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.101 -1.0 . . . . 0.0 110.27 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.544 ' O ' ' N ' ' A' ' 36' ' ' LEU . 7.1 mt-30 -62.61 -74.14 0.1 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.96 . . . . 0.0 111.166 -178.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.53 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 1.6 tt0 -49.68 -36.05 23.74 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.73 -1.232 . . . . 0.0 110.028 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.607 ' H ' HG23 ' A' ' 32' ' ' THR . . . -61.04 -28.85 69.53 Favored Glycine 0 C--N 1.295 -1.711 0 N-CA-C 107.148 -2.381 . . . . 0.0 107.148 178.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.827 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -80.56 -41.42 24.13 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.047 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.53 ' HG3' ' HA ' ' A' ' 34' ' ' GLU . 19.8 mtp180 -61.65 -27.77 68.91 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 122.385 1.088 . . . . 0.0 108.238 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.547 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.2 OUTLIER -87.25 -15.7 37.37 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.11 179.454 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.691 ' CE2' ' CE1' ' A' ' 83' ' ' HIS . 10.4 t80 -86.76 -43.37 12.59 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 121.345 -0.847 . . . . 0.0 110.797 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.928 ' HE1' HG13 ' A' ' 77' ' ' VAL . 48.1 m-85 -101.36 -33.66 9.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.875 . . . . 0.0 109.193 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -59.76 -17.19 41.38 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -61.96 -45.72 92.44 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.474 -1.015 . . . . 0.0 109.956 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.59 ' HE1' HG22 ' A' ' 77' ' ' VAL . 4.9 p90 -119.58 -2.98 10.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.445 -0.784 . . . . 0.0 109.948 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.467 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -137.77 93.26 0.21 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.537 ' O ' ' CB ' ' A' ' 68' ' ' PHE . 1.9 mt-10 -40.03 105.91 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.411 -1.052 . . . . 0.0 110.15 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 68' ' ' PHE . 43.3 t -88.85 126.06 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 110.446 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -99.12 -31.33 11.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.278 -0.889 . . . . 0.0 110.032 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.81 135.89 17.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.29 -0.881 . . . . 0.0 110.274 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.788 ' HB2' HD21 ' A' ' 36' ' ' LEU . 31.9 p -150.48 166.66 29.48 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.876 . . . . 0.0 110.017 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.73 ' C ' HD12 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -150.45 126.02 10.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.962 -1.086 . . . . 0.0 110.695 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.102 HG13 HD21 ' A' ' 27' ' ' LEU . 98.9 t -113.66 142.29 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.861 -1.149 . . . . 0.0 110.002 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.501 ' HG3' ' HB3' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -144.87 143.32 30.53 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.287 -0.883 . . . . 0.0 110.376 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.437 ' O ' ' CB ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -151.53 136.73 17.51 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.68 -0.637 . . . . 0.0 110.259 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.568 ' CB ' ' HB2' ' A' ' 59' ' ' ARG . 0.3 OUTLIER 172.05 122.12 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.187 -0.946 . . . . 0.0 109.896 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.934 ' O ' HD23 ' A' ' 56' ' ' LEU . 3.2 Cg_exo -61.02 69.69 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.238 0 O-C-N 123.339 1.178 . . . . 0.0 110.907 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.934 HD23 ' O ' ' A' ' 55' ' ' PRO . 10.4 mt -130.02 -63.61 0.9 Allowed 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.238 -0.914 . . . . 0.0 109.821 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.659 HG23 ' HG3' ' A' ' 58' ' ' LYS . 0.1 OUTLIER -172.41 -55.45 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.437 -0.79 . . . . 0.0 110.752 179.843 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.659 ' HG3' HG23 ' A' ' 57' ' ' THR . 11.4 mttt -86.27 -42.53 13.68 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.173 -0.954 . . . . 0.0 109.362 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.884 ' HD3' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -83.35 -29.84 27.92 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.244 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 54' ' ' ASP . 31.1 t -39.83 -27.05 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.081 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -93.75 -16.81 23.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.137 -0.977 . . . . 0.0 110.412 -179.293 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 59' ' ' ARG . . . 65.22 91.33 0.04 OUTLIER Glycine 0 N--CA 1.483 1.769 0 N-CA-C 108.349 -1.9 . . . . 0.0 108.349 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.646 ' HA ' HD13 ' A' ' 27' ' ' LEU . 50.3 p90 -132.32 -162.3 1.22 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.092 -1.24 . . . . 0.0 110.376 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 50' ' ' LEU . . . -166.53 174.85 42.0 Favored Glycine 0 N--CA 1.488 2.122 0 C-N-CA 119.319 -1.419 . . . . 0.0 110.677 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.557 ' C ' HG23 ' A' ' 66' ' ' VAL . 9.8 m-85 -136.24 145.09 45.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.756 -0.849 . . . . 0.0 109.008 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.557 HG23 ' C ' ' A' ' 65' ' ' PHE . 16.2 t -149.98 143.4 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.981 -1.074 . . . . 0.0 110.585 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.582 HG23 ' CB ' ' A' ' 21' ' ' LYS . 1.5 m -137.24 58.73 1.7 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.303 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.587 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -63.94 -177.35 0.25 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.071 -1.018 . . . . 0.0 110.557 -179.603 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.17 55.17 1.87 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.157 -0.964 . . . . 0.0 110.257 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.469 ' OD2' ' N ' ' A' ' 73' ' ' GLY . 12.1 t70 -110.26 143.45 40.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.343 -0.848 . . . . 0.0 110.044 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.94 -48.07 82.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.232 -0.918 . . . . 0.0 110.312 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 75' ' ' ASP . . . -89.93 22.32 3.23 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.255 -0.903 . . . . 0.0 110.176 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.729 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -51.65 -74.46 0.29 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 16.4 t -45.73 -32.54 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.22 -1.165 . . . . 0.0 110.092 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 72' ' ' ALA . 0.5 OUTLIER -62.39 -76.84 0.05 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.175 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.451 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -49.19 -42.72 41.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 0.0 109.797 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.928 HG13 ' HE1' ' A' ' 40' ' ' PHE . 62.1 t -54.39 -53.81 27.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 O-C-N 121.103 -0.998 . . . . 0.0 108.916 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -42.76 -52.61 4.92 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.405 -0.809 . . . . 0.0 109.723 178.701 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -44.89 -28.75 0.69 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.344 -0.848 . . . . 0.0 109.531 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.544 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 43.9 mm-40 -97.44 21.44 10.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.478 -0.764 . . . . 0.0 110.037 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 78' ' ' LEU . 47.8 t -56.87 -13.09 2.32 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.506 -0.746 . . . . 0.0 109.093 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.49 ' O ' ' C ' ' A' ' 83' ' ' HIS . 7.0 ptt180 -103.07 -11.39 18.15 Favored 'General case' 0 C--N 1.31 -1.121 0 O-C-N 121.349 -0.845 . . . . 0.0 109.797 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.766 ' ND1' HD12 ' A' ' 90' ' ' ILE . 0.5 OUTLIER 29.63 51.65 0.08 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.877 -0.514 . . . . 0.0 112.127 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.54 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 3.6 tt0 -90.58 126.17 35.86 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.672 -1.268 . . . . 0.0 109.202 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.534 ' CD2' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -147.37 -79.73 0.15 Allowed 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.565 -179.141 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.531 ' O ' ' CD ' ' A' ' 88' ' ' LYS . 7.9 m-20 -85.33 49.89 1.84 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.502 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER 70.22 6.98 6.03 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.483 0.658 . . . . 0.0 109.557 -178.847 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -110.31 125.9 53.64 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.35 -0.844 . . . . 0.0 109.76 -179.594 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.741 ' O ' HG23 ' A' ' 89' ' ' THR . 9.3 t -99.77 75.45 1.9 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.577 -0.702 . . . . 0.0 109.562 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.046 HG23 ' C ' ' A' ' 26' ' ' GLY . 0.9 OUTLIER -52.61 -174.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.372 -0.83 . . . . 0.0 109.181 -179.663 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 25' ' ' GLY . 20.4 t0 -142.26 85.3 10.82 Favored Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 120.565 -1.334 . . . . 0.0 111.684 -178.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.576 ' HG3' ' HD2' ' A' ' 83' ' ' HIS . 2.0 Cg_endo -59.98 113.44 1.65 Allowed 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.462 1.243 . . . . 0.0 110.757 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.633 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -123.67 108.77 12.92 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.03 -1.043 . . . . 0.0 109.774 178.073 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.918 HG22 ' HB2' ' A' ' 22' ' ' MET . 43.0 t -96.24 170.18 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.485 -0.76 . . . . 0.0 110.082 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.494 ' N ' HG12 ' A' ' 94' ' ' VAL . . . -83.26 -152.39 0.12 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.898 . . . . 0.0 110.284 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.897 . . . . 0.0 110.232 -179.882 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 14.2 t . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.303 0.573 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 0.3 OUTLIER -66.66 156.6 34.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.183 -0.948 . . . . 0.0 110.088 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' MET . . . . . 1.003 ' CB ' HG22 ' A' ' 94' ' ' VAL . 0.9 OUTLIER -86.15 -169.87 2.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.217 -0.927 . . . . 0.0 110.323 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.656 ' HB3' ' HD2' ' A' ' 93' ' ' LYS . 0.7 OUTLIER -149.97 152.1 34.4 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.355 -0.84 . . . . 0.0 109.466 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.654 HD12 ' C ' ' A' ' 23' ' ' PHE . 1.1 mp -113.46 134.52 55.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.323 -0.86 . . . . 0.0 109.243 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.498 ' O ' ' CG2' ' A' ' 90' ' ' ILE . . . -102.51 136.86 13.05 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.812 -1.185 . . . . 0.0 110.699 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.474 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 58.82 39.72 94.18 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.844 HD13 ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -60.59 154.31 21.43 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.444 -1.033 . . . . 0.0 110.056 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.773 ' O ' HG22 ' A' ' 31' ' ' THR . 0.5 OUTLIER -40.58 134.8 1.71 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.352 -0.843 . . . . 0.0 110.343 -179.673 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 11.0 p-90 -77.43 -12.26 59.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.342 -0.849 . . . . 0.0 110.63 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -110.93 -12.02 14.28 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.086 -1.009 . . . . 0.0 110.63 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.773 HG22 ' O ' ' A' ' 28' ' ' SER . 13.2 t -61.42 -167.26 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.833 0 CA-C-O 121.628 0.728 . . . . 0.0 110.676 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.589 HG23 ' H ' ' A' ' 35' ' ' GLY . 14.7 t -157.18 -168.1 2.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.695 -0.628 . . . . 0.0 109.751 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 36' ' ' LEU . 2.3 mt-30 -68.68 -72.46 0.18 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.082 -1.012 . . . . 0.0 110.207 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.406 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 3.8 tt0 -48.33 -45.77 35.69 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.837 -1.165 . . . . 0.0 109.72 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.589 ' H ' HG23 ' A' ' 32' ' ' THR . . . -55.62 -27.03 47.74 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.927 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -83.66 -32.68 25.5 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.082 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.893 ' HA ' HG11 ' A' ' 46' ' ' VAL . 18.8 mmm-85 -64.96 -28.71 69.7 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.536 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -90.55 -14.68 32.08 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.571 178.777 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.586 ' OH ' ' CG ' ' A' ' 83' ' ' HIS . 38.7 t80 -81.33 -26.34 35.68 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 121.619 -0.675 . . . . 0.0 110.171 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.798 ' HE1' HG13 ' A' ' 77' ' ' VAL . 14.6 m-85 -122.19 -21.51 5.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.887 . . . . 0.0 109.91 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.93 2.12 65.96 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.409 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 8.2 tp60 -72.1 -55.78 6.74 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 121.426 -1.043 . . . . 0.0 109.971 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.32 12.66 26.15 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.4 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.425 ' HA3' ' CG ' ' A' ' 70' ' ' ASP . . . -154.17 -116.2 0.59 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -179.74 104.39 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.532 -0.981 . . . . 0.0 109.349 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.893 HG11 ' HA ' ' A' ' 37' ' ' ARG . 2.7 p -90.03 149.46 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 111.266 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.77 -39.61 5.53 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.615 -0.678 . . . . 0.0 109.931 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -149.71 148.38 29.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.317 -0.864 . . . . 0.0 110.601 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.822 ' HB2' HD21 ' A' ' 36' ' ' LEU . 17.3 p -151.13 164.03 37.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.294 -0.879 . . . . 0.0 110.661 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.732 ' C ' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -139.3 123.71 18.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.318 -0.864 . . . . 0.0 109.617 179.039 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.649 HG13 HD11 ' A' ' 27' ' ' LEU . 87.0 t -113.11 136.93 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.803 -1.185 . . . . 0.0 111.227 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.526 ' HG2' ' CE1' ' A' ' 63' ' ' PHE . 1.0 OUTLIER -134.39 150.4 50.89 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.216 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -148.81 135.57 19.75 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.249 -0.907 . . . . 0.0 110.638 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.527 ' CB ' ' HD2' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -172.32 177.78 0.78 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.4 -0.812 . . . . 0.0 109.844 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.527 ' HD2' ' CB ' ' A' ' 54' ' ' ASP . 3.1 Cg_exo -60.71 169.51 5.53 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.744 1.391 . . . . 0.0 110.303 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.901 HD12 ' N ' ' A' ' 57' ' ' THR . 4.5 pp -88.69 -46.35 9.09 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.133 -0.979 . . . . 0.0 111.029 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.901 ' N ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER 30.93 -95.7 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.582 -0.699 . . . . 0.0 110.833 179.832 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.47 ' N ' ' OG1' ' A' ' 57' ' ' THR . 0.3 OUTLIER -139.07 7.84 2.46 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.202 -0.937 . . . . 0.0 109.742 179.362 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.535 ' HD3' ' N ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -107.1 -164.88 1.02 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.37 -0.831 . . . . 0.0 110.298 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.535 ' N ' ' HD3' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -56.66 -166.3 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.312 -0.868 . . . . 0.0 110.007 179.754 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -150.59 28.71 0.7 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.299 -0.876 . . . . 0.0 110.371 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 52' ' ' MET . . . 100.29 104.47 2.64 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.346 -1.501 . . . . 0.0 109.346 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.844 ' O ' HD13 ' A' ' 27' ' ' LEU . 45.7 p90 -142.35 -164.32 1.79 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.293 -1.122 . . . . 0.0 110.223 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -162.54 114.09 0.59 Allowed Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.597 -1.287 . . . . 0.0 110.15 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.513 ' HB2' ' HG ' ' A' ' 50' ' ' LEU . 13.4 m-85 -82.66 142.55 31.61 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.249 -1.148 . . . . 0.0 109.061 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.646 HG21 HD11 ' A' ' 36' ' ' LEU . 5.7 t -150.01 114.9 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.91 -1.119 . . . . 0.0 110.582 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 7.2 t -88.17 32.31 0.77 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.388 -0.82 . . . . 0.0 109.829 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.652 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -66.37 176.66 1.74 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.868 . . . . 0.0 110.73 -179.698 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.444 ' HB3' ' O ' ' A' ' 68' ' ' PHE . 0.7 OUTLIER 174.28 126.31 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.052 -1.03 . . . . 0.0 110.498 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.487 ' OD1' ' HA3' ' A' ' 73' ' ' GLY . 4.1 p-10 -149.75 46.26 0.94 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.378 -0.826 . . . . 0.0 110.029 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 70' ' ' ASP . 1.5 mt-30 62.1 -86.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.3 -0.875 . . . . 0.0 110.234 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.45 -2.14 18.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.267 -0.896 . . . . 0.0 110.313 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.487 ' HA3' ' OD1' ' A' ' 70' ' ' ASP . . . -52.4 -65.28 3.38 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 55.6 t -45.1 -31.0 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -1.106 . . . . 0.0 110.254 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -67.85 -61.42 1.88 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.212 -0.93 . . . . 0.0 110.413 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.578 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -60.63 -46.88 88.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 110.35 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.798 HG13 ' HE1' ' A' ' 40' ' ' PHE . 93.9 t -48.28 -62.38 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 O-C-N 121.062 -1.024 . . . . 0.0 109.255 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 81' ' ' SER . 0.1 OUTLIER -41.68 -51.31 4.1 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.338 -0.851 . . . . 0.0 109.897 179.035 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -44.71 -25.98 0.34 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.211 -0.931 . . . . 0.0 109.548 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.63 ' HB3' ' CE1' ' A' ' 83' ' ' HIS . 7.0 mm-40 -99.91 20.0 15.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.424 -0.797 . . . . 0.0 110.386 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.568 ' HA ' ' HD2' ' A' ' 92' ' ' PRO . 25.2 p -58.07 -13.21 4.31 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.385 -0.822 . . . . 0.0 109.061 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -107.16 10.58 30.01 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.521 -0.737 . . . . 0.0 109.86 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.63 ' CE1' ' HB3' ' A' ' 80' ' ' GLN . 1.6 m-70 -21.88 83.52 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -178.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 82' ' ' ARG . 1.1 tt0 -103.69 122.74 45.67 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.511 HD23 ' C ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -139.89 -89.83 0.18 Allowed 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.338 -0.851 . . . . 0.0 109.818 -178.897 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 87' ' ' SER . 53.8 t0 -78.14 53.7 1.25 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.126 -0.984 . . . . 0.0 108.356 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 70.98 9.11 6.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.627 -0.671 . . . . 0.0 109.719 -178.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 5.4 mmtt -111.7 113.99 26.71 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 121.286 -0.884 . . . . 0.0 110.25 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.595 ' O ' HG23 ' A' ' 89' ' ' THR . 6.8 t -90.37 68.96 6.94 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.578 HD12 ' OH ' ' A' ' 39' ' ' TYR . 1.2 mt -45.44 176.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 121.685 0.755 . . . . 0.0 109.86 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 81' ' ' SER . 5.3 t0 -144.88 77.31 13.38 Favored Pre-proline 0 C--N 1.296 -1.719 0 O-C-N 121.196 -0.94 . . . . 0.0 111.157 -178.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.583 ' HG3' ' CD2' ' A' ' 83' ' ' HIS . 2.0 Cg_endo -51.42 114.48 1.58 Allowed 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 123.446 1.235 . . . . 0.0 109.898 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.656 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -129.42 102.69 6.52 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.171 -0.956 . . . . 0.0 110.364 179.133 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 1.003 HG22 ' CB ' ' A' ' 22' ' ' MET . 95.2 t -97.31 161.61 2.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 O-C-N 121.757 -0.589 . . . . 0.0 110.063 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.76 142.83 29.54 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.175 -0.953 . . . . 0.0 110.582 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.381 -0.824 . . . . 0.0 110.09 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 25.1 p . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.216 0.531 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.764 ' CB ' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -148.19 176.09 10.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.343 -0.848 . . . . 0.0 110.249 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' MET . . . . . 1.067 ' HB3' HG13 ' A' ' 94' ' ' VAL . 1.5 ptt? -86.31 176.97 7.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 110.197 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.779 ' C ' HD12 ' A' ' 24' ' ' ILE . 3.1 t80 -150.51 154.36 37.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.167 -0.958 . . . . 0.0 110.393 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.851 ' CG2' HG21 ' A' ' 90' ' ' ILE . 1.3 mp -113.14 137.19 47.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.489 ' O ' HG22 ' A' ' 90' ' ' ILE . . . -112.84 140.29 16.21 Favored Glycine 0 N--CA 1.501 2.973 0 C-N-CA 119.31 -1.424 . . . . 0.0 112.951 -176.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.519 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 59.66 47.06 92.79 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.867 HD23 ' O ' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -79.24 146.47 33.01 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.315 -1.109 . . . . 0.0 111.506 -178.437 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.454 ' HB2' ' HB ' ' A' ' 31' ' ' THR . 18.5 m -39.9 159.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.533 0.682 . . . . 0.0 110.763 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.512 ' HB3' ' HA ' ' A' ' 60' ' ' SER . 67.4 p-90 -92.32 -23.13 19.36 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.434 -0.791 . . . . 0.0 109.644 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.49 ' HG3' ' N ' ' A' ' 31' ' ' THR . 0.1 OUTLIER -83.78 -15.85 46.88 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.263 -0.898 . . . . 0.0 110.249 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.577 HG21 ' HG ' ' A' ' 27' ' ' LEU . 10.5 t -55.51 -174.31 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.633 0.73 . . . . 0.0 110.598 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.701 HG23 ' H ' ' A' ' 35' ' ' GLY . 6.5 t -161.24 -173.01 3.64 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.5 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 5.0 mt-30 -71.72 -74.61 0.15 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.998 -1.064 . . . . 0.0 110.781 -178.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.559 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 3.0 tt0 -49.6 -34.13 17.11 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.72 -1.237 . . . . 0.0 110.05 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.701 ' H ' HG23 ' A' ' 32' ' ' THR . . . -60.72 -30.19 71.9 Favored Glycine 0 C--N 1.295 -1.719 0 N-CA-C 107.216 -2.354 . . . . 0.0 107.216 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.876 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -82.51 -38.97 23.06 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.192 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.559 ' HG3' ' HA ' ' A' ' 34' ' ' GLU . 18.6 mtt180 -62.5 -27.0 68.84 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.505 1.145 . . . . 0.0 108.23 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.534 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -85.67 -21.05 28.54 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.127 179.694 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.661 ' CE1' ' NE2' ' A' ' 83' ' ' HIS . 9.9 t80 -81.94 -41.76 20.39 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.322 -0.861 . . . . 0.0 110.835 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.846 ' CE1' HG13 ' A' ' 77' ' ' VAL . 33.0 m-85 -100.3 -27.68 13.36 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.448 -0.783 . . . . 0.0 108.934 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.613 ' CA ' HG23 ' A' ' 46' ' ' VAL . . . -67.38 -9.52 55.06 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -64.64 -48.35 75.13 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.472 -1.016 . . . . 0.0 109.97 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.565 ' CG ' ' HB3' ' A' ' 76' ' ' LYS . 6.2 p90 -109.05 5.87 24.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.395 -0.815 . . . . 0.0 110.244 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.515 ' O ' ' HA2' ' A' ' 41' ' ' GLY . . . -162.76 97.74 0.15 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -38.8 124.25 1.35 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.473 -1.016 . . . . 0.0 110.745 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.613 HG23 ' CA ' ' A' ' 41' ' ' GLY . 47.7 t -90.07 132.16 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.384 -0.823 . . . . 0.0 110.74 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -98.67 -15.96 19.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.372 -0.83 . . . . 0.0 110.069 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -169.67 143.13 2.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.188 -0.945 . . . . 0.0 110.895 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.497 ' SG ' ' NE ' ' A' ' 37' ' ' ARG . 8.4 p -150.97 164.65 35.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.485 -0.759 . . . . 0.0 109.995 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.719 HD21 ' CD2' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -150.36 128.6 12.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.99 -1.069 . . . . 0.0 110.786 179.869 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.6 t -103.74 135.79 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 120.659 -1.275 . . . . 0.0 110.268 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.596 ' HG2' ' CE1' ' A' ' 63' ' ' PHE . 0.2 OUTLIER -141.92 157.11 45.36 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.253 -0.904 . . . . 0.0 109.951 -179.217 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.543 ' HA ' ' O ' ' A' ' 61' ' ' ARG . 7.5 ptt85 -128.11 95.3 4.14 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.32 -0.863 . . . . 0.0 110.235 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.594 ' CB ' ' CD ' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -69.38 -59.34 5.02 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.284 -0.885 . . . . 0.0 110.873 -179.728 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.594 ' CD ' ' CB ' ' A' ' 54' ' ' ASP . 3.0 Cg_exo -56.81 -164.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.375 1.197 . . . . 0.0 111.124 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.61 ' N ' HD23 ' A' ' 56' ' ' LEU . 4.0 mt -91.0 -66.55 0.92 Allowed 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.391 -0.818 . . . . 0.0 110.655 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 56' ' ' LEU . 1.0 OUTLIER 175.83 -24.12 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.239 -0.913 . . . . 0.0 111.309 -179.611 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.2 pttp -47.83 -37.27 13.42 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.985 -1.072 . . . . 0.0 109.731 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.528 ' HD3' ' N ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -109.37 -158.89 0.66 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.661 -0.649 . . . . 0.0 109.86 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.528 ' N ' ' HD3' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -52.14 -168.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.929 . . . . 0.0 109.916 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -89.98 -48.51 7.16 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.93 -1.106 . . . . 0.0 108.719 179.275 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 165.52 -72.87 0.17 Allowed Glycine 0 N--CA 1.482 1.712 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.837 ' N ' HD22 ' A' ' 27' ' ' LEU . 3.1 p90 -173.39 -174.46 1.02 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.138 -1.213 . . . . 0.0 111.05 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.43 ' O ' ' HB ' ' A' ' 24' ' ' ILE . . . -149.89 123.66 1.63 Allowed Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.719 ' CD2' HD21 ' A' ' 50' ' ' LEU . 18.1 m-85 -83.88 148.98 26.65 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.318 -1.107 . . . . 0.0 109.625 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.698 HG22 HD21 ' A' ' 36' ' ' LEU . 3.7 t -146.44 161.92 9.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.316 -0.865 . . . . 0.0 109.621 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.764 HG23 ' CB ' ' A' ' 21' ' ' LYS . 1.8 m -149.56 39.6 0.81 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.198 -0.939 . . . . 0.0 110.229 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.608 ' CE2' HG21 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -67.17 143.74 56.41 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.151 -0.968 . . . . 0.0 109.858 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 14.0 mtp -117.99 109.95 17.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.192 -0.942 . . . . 0.0 110.439 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -145.43 161.29 40.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.364 -0.835 . . . . 0.0 110.104 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.84 -70.01 0.26 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.258 -0.902 . . . . 0.0 110.159 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.29 2.12 55.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.298 -0.876 . . . . 0.0 110.661 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.571 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -49.9 -57.24 10.07 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.414 ' H ' HG23 ' A' ' 74' ' ' VAL . 49.0 t -47.51 -43.54 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.235 -1.156 . . . . 0.0 110.32 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.959 ' HA ' HD21 ' A' ' 78' ' ' LEU . 0.5 OUTLIER -59.58 -39.96 85.86 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.177 -0.952 . . . . 0.0 110.271 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.565 ' HB3' ' CG ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -71.07 -28.33 64.27 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.189 -0.944 . . . . 0.0 109.901 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.846 HG13 ' CE1' ' A' ' 40' ' ' PHE . 55.0 t -64.68 -64.42 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.139 -0.976 . . . . 0.0 109.576 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.959 HD21 ' HA ' ' A' ' 75' ' ' ASP . 1.5 pp -47.98 -37.98 15.88 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.109 -0.994 . . . . 0.0 109.185 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -46.17 -30.14 1.83 Allowed 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.057 -1.027 . . . . 0.0 108.861 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.532 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 0.9 OUTLIER -104.62 28.26 7.19 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.411 0.624 . . . . 0.0 109.741 179.378 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.464 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 5.7 p -52.85 -18.52 1.95 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.492 ' O ' ' C ' ' A' ' 83' ' ' HIS . 4.5 ptt180 -94.49 -15.44 24.19 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.482 -0.761 . . . . 0.0 109.565 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.848 ' CE1' HD12 ' A' ' 90' ' ' ILE . 0.6 OUTLIER 28.72 46.31 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 179.303 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.578 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 0.8 OUTLIER -90.24 124.87 35.23 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 118.583 -1.247 . . . . 0.0 109.545 179.243 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.531 ' CD2' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -147.5 -83.63 0.11 Allowed 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 120.146 -0.621 . . . . 0.0 109.676 -179.493 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' A' ' 87' ' ' SER . 23.7 m-20 -83.18 50.73 1.8 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.11 -0.993 . . . . 0.0 108.818 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 72.63 7.19 5.54 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.472 0.653 . . . . 0.0 109.754 -179.188 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.578 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 0.6 OUTLIER -111.42 122.38 47.69 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.405 -0.809 . . . . 0.0 109.656 -179.529 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.718 ' O ' HG23 ' A' ' 89' ' ' THR . 9.4 t -101.9 69.43 1.18 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.062 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.851 HG21 ' CG2' ' A' ' 24' ' ' ILE . 0.9 OUTLIER -51.48 -176.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.346 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.514 ' H ' HG22 ' A' ' 90' ' ' ILE . 3.6 t70 -143.39 84.4 10.19 Favored Pre-proline 0 C--N 1.304 -1.382 0 O-C-N 120.963 -1.086 . . . . 0.0 110.363 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.543 ' HG3' ' HD2' ' A' ' 83' ' ' HIS . 2.3 Cg_endo -56.03 113.42 1.43 Allowed 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.551 1.29 . . . . 0.0 111.167 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.61 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -127.71 104.46 7.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.233 -0.917 . . . . 0.0 109.575 178.385 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 1.067 HG13 ' HB3' ' A' ' 22' ' ' MET . 7.9 t -96.77 164.29 2.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 O-C-N 121.654 -0.654 . . . . 0.0 110.398 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.59 96.63 9.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.218 -0.926 . . . . 0.0 110.136 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 58.5 t80 . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 109.909 -179.945 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.266 0.555 . . . . 0.0 110.286 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.546 ' CB ' ' HB ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -162.47 153.93 18.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.235 -0.916 . . . . 0.0 110.014 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.805 ' HG2' HG13 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -71.76 -175.94 1.51 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.032 -1.042 . . . . 0.0 109.564 179.648 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.535 ' O ' ' HG2' ' A' ' 93' ' ' LYS . 2.0 t80 -149.03 119.16 7.21 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.076 -1.015 . . . . 0.0 111.487 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.706 HG22 ' CG2' ' A' ' 90' ' ' ILE . 17.4 mm -91.33 140.46 16.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.062 -1.024 . . . . 0.0 109.216 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 90' ' ' ILE . . . -119.23 149.42 18.08 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.669 -1.253 . . . . 0.0 111.303 -178.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.457 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 55.97 43.65 87.88 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.982 HD22 ' CA ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER -84.37 152.15 24.25 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.468 -1.019 . . . . 0.0 110.584 -179.027 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.8 ' O ' HG22 ' A' ' 31' ' ' THR . 14.5 m -41.73 124.66 2.6 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.459 -0.776 . . . . 0.0 110.32 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.496 ' CD2' ' N ' ' A' ' 30' ' ' GLN . 65.1 p-90 -68.2 -33.59 74.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.341 -0.85 . . . . 0.0 110.437 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.496 ' N ' ' CD2' ' A' ' 29' ' ' TRP . 17.8 pt20 -74.35 -12.56 60.56 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.324 -0.86 . . . . 0.0 111.2 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.8 HG22 ' O ' ' A' ' 28' ' ' SER . 5.7 t -65.05 -179.45 0.56 Allowed 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.34 -0.85 . . . . 0.0 110.37 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 35' ' ' GLY . 5.5 t -148.2 -172.65 4.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.338 -0.851 . . . . 0.0 110.155 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 36' ' ' LEU . 6.5 mt-30 -66.2 -73.43 0.13 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.196 -0.94 . . . . 0.0 110.67 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.472 ' HA ' ' CG ' ' A' ' 37' ' ' ARG . 3.4 tt0 -47.46 -47.31 27.23 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.759 -1.176 . . . . 0.0 109.718 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.536 ' O ' ' HG3' ' A' ' 38' ' ' GLU . . . -53.36 -27.57 33.13 Favored Glycine 0 N--CA 1.483 1.799 0 N-CA-C 107.711 -2.156 . . . . 0.0 107.711 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.999 HD21 ' HB3' ' A' ' 49' ' ' CYS . 0.1 OUTLIER -83.37 -35.49 25.07 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' A' ' 33' ' ' GLN . 34.1 mtp180 -62.37 -28.34 69.7 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.536 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -90.88 -15.36 30.03 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.534 178.772 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.601 ' HH ' ' CE1' ' A' ' 83' ' ' HIS . 47.9 t80 -75.47 -29.12 59.51 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 121.55 0.69 . . . . 0.0 109.617 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.884 ' CE1' HG13 ' A' ' 77' ' ' VAL . 37.8 m-85 -116.29 -26.11 7.3 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.633 -0.667 . . . . 0.0 109.48 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -68.16 -9.27 56.94 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -71.51 -50.9 26.94 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.439 -1.036 . . . . 0.0 110.593 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.578 ' HE1' HG22 ' A' ' 77' ' ' VAL . 3.1 p90 -109.53 -6.85 15.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.096 -1.003 . . . . 0.0 110.747 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 40' ' ' PHE . . . -150.63 118.6 0.93 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 9.8 pt-20 -54.23 132.9 44.38 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.198 -1.178 . . . . 0.0 109.722 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.752 HG11 ' SG ' ' A' ' 49' ' ' CYS . 86.3 t -112.14 152.64 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.158 -0.963 . . . . 0.0 110.46 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.45 ' HB3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -96.74 -29.84 13.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.355 -0.841 . . . . 0.0 109.826 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.502 ' O ' HG22 ' A' ' 67' ' ' THR . 11.6 tp10 -179.68 158.4 0.8 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.341 -0.85 . . . . 0.0 110.058 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.999 ' HB3' HD21 ' A' ' 36' ' ' LEU . 7.2 m -146.04 171.01 15.51 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.922 -1.112 . . . . 0.0 110.6 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.804 HD12 ' N ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -138.9 134.65 33.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.304 -0.873 . . . . 0.0 109.397 179.691 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.804 ' N ' HD12 ' A' ' 50' ' ' LEU . 76.4 t -125.62 139.36 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.47 -1.394 . . . . 0.0 111.612 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.563 ' HG2' ' CE2' ' A' ' 63' ' ' PHE . 0.7 OUTLIER -142.62 143.6 32.46 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.347 -0.845 . . . . 0.0 109.747 179.542 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.497 ' O ' ' HD3' ' A' ' 55' ' ' PRO . 12.2 ptt180 -151.05 19.97 0.77 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.597 -0.69 . . . . 0.0 110.185 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -114.24 81.49 6.52 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.285 -0.884 . . . . 0.0 110.355 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 53' ' ' ARG . 2.9 Cg_endo -62.47 112.21 1.53 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.793 1.417 . . . . 0.0 110.621 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.1 pp -89.39 -26.23 21.14 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.271 -0.893 . . . . 0.0 109.956 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.452 HG23 ' N ' ' A' ' 58' ' ' LYS . 5.2 t -132.9 -130.77 0.18 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.575 -0.703 . . . . 0.0 109.587 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.452 ' N ' HG23 ' A' ' 57' ' ' THR . 0.2 OUTLIER -112.24 31.5 6.23 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 120.97 -1.081 . . . . 0.0 110.319 179.841 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.483 ' HD3' ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -98.08 -160.87 0.83 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.276 -0.89 . . . . 0.0 110.512 -179.762 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.483 ' OG ' ' HD3' ' A' ' 59' ' ' ARG . 4.5 p -40.65 160.04 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.218 -0.926 . . . . 0.0 110.406 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.77 38.75 0.69 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.132 -0.98 . . . . 0.0 110.527 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 144.66 81.94 0.05 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.982 ' CA ' HD22 ' A' ' 27' ' ' LEU . 49.6 p90 -144.54 -167.95 2.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.139 -1.212 . . . . 0.0 110.29 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 50' ' ' LEU . . . -168.49 123.93 1.14 Allowed Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.569 -1.3 . . . . 0.0 110.199 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.61 ' CD2' ' CD2' ' A' ' 50' ' ' LEU . 27.5 m-85 -85.84 152.26 23.14 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.477 -1.013 . . . . 0.0 108.899 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.675 HG13 ' SG ' ' A' ' 49' ' ' CYS . 11.2 t -150.33 104.25 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.615 -1.303 . . . . 0.0 111.62 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.546 ' HB ' ' CB ' ' A' ' 21' ' ' LYS . 2.3 t -87.71 125.95 34.7 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.112 -0.993 . . . . 0.0 109.129 178.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.869 ' CE2' HG21 ' A' ' 77' ' ' VAL . 5.8 m-85 -95.79 -157.41 0.58 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.027 -1.046 . . . . 0.0 109.986 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.414 ' HG3' ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -171.62 38.48 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.174 -0.953 . . . . 0.0 110.214 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.485 ' OD2' ' N ' ' A' ' 73' ' ' GLY . 5.6 p-10 -148.46 -143.3 0.14 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.252 -0.905 . . . . 0.0 110.112 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.404 ' O ' ' C ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -130.12 -82.61 0.55 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.199 -0.938 . . . . 0.0 110.108 179.869 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 73' ' ' GLY . . . -45.08 -33.07 1.98 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.205 -0.934 . . . . 0.0 110.084 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.764 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -43.94 -42.67 6.57 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.015 HG13 HG11 ' A' ' 94' ' ' VAL . 21.3 t -64.76 -55.24 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -1.145 . . . . 0.0 110.15 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.685 ' HA ' HD21 ' A' ' 78' ' ' LEU . 10.8 m-20 -41.97 -40.97 2.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 110.206 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.752 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 33.7 mmtt -72.67 -46.6 53.06 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.422 -0.799 . . . . 0.0 110.186 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.884 HG13 ' CE1' ' A' ' 40' ' ' PHE . 58.0 t -53.06 -68.3 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.124 -0.985 . . . . 0.0 109.767 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.685 HD21 ' HA ' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -45.65 -39.01 7.32 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.061 -1.024 . . . . 0.0 109.209 179.123 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.752 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -48.88 -24.23 1.39 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.077 -1.014 . . . . 0.0 108.9 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.631 ' HB3' ' CE1' ' A' ' 83' ' ' HIS . 8.7 mm100 -105.23 28.03 7.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.585 -0.697 . . . . 0.0 109.987 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.571 ' HA ' ' HD2' ' A' ' 92' ' ' PRO . 14.3 t -61.17 -10.79 7.13 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.448 -0.783 . . . . 0.0 109.123 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -108.49 11.1 27.11 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 121.418 -0.801 . . . . 0.0 109.896 179.646 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.631 ' CE1' ' HB3' ' A' ' 80' ' ' GLN . 1.7 m-70 -23.73 85.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -178.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.989 ' C ' HD13 ' A' ' 85' ' ' LEU . 1.4 tt0 -106.99 121.41 44.41 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.989 HD13 ' C ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -142.35 -97.97 0.13 Allowed 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.991 -179.467 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.56 ' H ' HD23 ' A' ' 85' ' ' LEU . 25.4 t70 -69.73 55.64 0.13 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.834 -1.166 . . . . 0.0 108.741 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 70.42 8.37 6.59 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.445 -0.785 . . . . 0.0 110.138 -179.473 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.529 ' CD ' ' O ' ' A' ' 86' ' ' ASP . 2.3 mmmt -111.01 111.6 22.82 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.177 -0.952 . . . . 0.0 110.672 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.558 ' O ' HG23 ' A' ' 89' ' ' THR . 7.1 t -89.46 63.49 6.38 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.706 ' CG2' HG22 ' A' ' 24' ' ' ILE . 1.2 mt -42.65 172.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 CA-C-O 121.925 0.869 . . . . 0.0 110.277 -178.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 81' ' ' SER . 14.4 t0 -144.17 77.01 14.65 Favored Pre-proline 0 C--N 1.298 -1.637 0 O-C-N 121.32 -0.863 . . . . 0.0 110.786 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.602 ' HG3' ' CD2' ' A' ' 83' ' ' HIS . 1.9 Cg_endo -52.48 112.79 0.97 Allowed 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.514 1.27 . . . . 0.0 110.068 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.581 ' O ' ' CG ' ' A' ' 93' ' ' LYS . 7.0 ptmt -109.43 105.56 14.96 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.627 1.203 . . . . 0.0 110.517 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 1.015 HG11 HG13 ' A' ' 74' ' ' VAL . 39.5 t -98.11 130.76 46.41 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 O-C-N 121.182 -0.949 . . . . 0.0 110.397 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -153.13 169.24 23.46 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.204 -0.935 . . . . 0.0 110.506 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.417 -0.802 . . . . 0.0 109.99 179.807 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.759 ' O ' HG23 ' A' ' 67' ' ' THR . 32.4 m . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.297 0.57 . . . . 0.0 110.306 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.671 ' HB3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -168.82 -173.93 1.97 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.32 -0.863 . . . . 0.0 110.137 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.831 ' CB ' HG13 ' A' ' 94' ' ' VAL . 3.1 ptm -121.1 -174.21 2.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.049 -1.032 . . . . 0.0 110.151 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.582 ' CD1' ' C ' ' A' ' 23' ' ' PHE . 0.3 OUTLIER -150.47 144.43 25.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.348 -0.845 . . . . 0.0 109.329 179.699 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.652 ' CG2' HG21 ' A' ' 90' ' ' ILE . 9.1 mm -108.03 129.26 62.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.122 -0.986 . . . . 0.0 109.475 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.513 ' O ' HG22 ' A' ' 90' ' ' ILE . . . -110.4 144.9 17.16 Favored Glycine 0 N--CA 1.494 2.545 0 C-N-CA 120.114 -1.041 . . . . 0.0 111.239 -178.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.435 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 60.13 34.28 83.34 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.934 HD23 ' O ' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -73.84 146.71 43.94 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.55 -0.971 . . . . 0.0 110.022 -179.608 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.625 ' O ' HG22 ' A' ' 31' ' ' THR . 0.3 OUTLIER -39.74 132.83 1.63 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.598 -0.689 . . . . 0.0 110.3 -179.715 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.515 ' CD1' ' N ' ' A' ' 29' ' ' TRP . 0.5 OUTLIER -76.35 6.03 6.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.257 -0.902 . . . . 0.0 110.54 -179.799 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.442 ' O ' ' O ' ' A' ' 31' ' ' THR . 9.7 pt20 -124.47 -12.75 7.22 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.189 -0.944 . . . . 0.0 110.485 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.625 HG22 ' O ' ' A' ' 28' ' ' SER . 11.5 t -53.76 -168.7 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.603 -0.686 . . . . 0.0 110.379 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.458 HG23 ' H ' ' A' ' 35' ' ' GLY . 1.3 t -145.16 176.15 9.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.446 -0.784 . . . . 0.0 109.748 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 36' ' ' LEU . 3.5 mt-30 -72.0 -72.58 0.22 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.111 -0.993 . . . . 0.0 111.105 -178.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.522 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -46.15 -52.85 11.49 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.672 -1.211 . . . . 0.0 109.436 -179.69 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.468 ' HA2' ' HG3' ' A' ' 38' ' ' GLU . . . -46.75 -32.69 5.99 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 107.822 -2.111 . . . . 0.0 107.822 178.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.834 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -78.19 -39.34 40.96 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.317 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.661 ' HA ' HG21 ' A' ' 46' ' ' VAL . 49.3 mtt180 -60.58 -26.07 66.68 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 122.316 1.055 . . . . 0.0 108.434 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -85.4 -21.28 28.88 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.787 179.513 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.694 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 29.4 t80 -79.97 -24.34 41.0 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.647 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.769 ' HE1' HG13 ' A' ' 77' ' ' VAL . 25.4 m-85 -114.55 -19.13 11.27 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.332 -0.855 . . . . 0.0 109.104 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.17 -4.12 88.72 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 108.719 -1.753 . . . . 0.0 108.719 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -68.29 -53.05 27.04 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.352 -1.087 . . . . 0.0 110.034 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.601 ' HE2' HE21 ' A' ' 80' ' ' GLN . 0.1 OUTLIER -99.41 9.39 43.38 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.277 -0.89 . . . . 0.0 110.259 179.492 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -152.68 -121.92 0.91 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.508 ' CG ' ' O ' ' A' ' 45' ' ' GLU . 5.9 pt-20 -172.08 119.44 0.42 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.385 -1.067 . . . . 0.0 109.687 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.661 HG21 ' HA ' ' A' ' 37' ' ' ARG . 28.1 t -93.25 124.09 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.335 -0.853 . . . . 0.0 111.124 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.86 -31.35 19.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.383 -0.823 . . . . 0.0 109.337 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -172.11 151.3 2.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.518 -0.739 . . . . 0.0 109.597 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.5 ' SG ' ' NE ' ' A' ' 37' ' ' ARG . 24.0 p -148.91 167.67 25.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.053 -1.029 . . . . 0.0 110.605 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.788 ' C ' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -142.92 122.97 13.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.255 -0.903 . . . . 0.0 110.446 179.693 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.535 ' N ' HD12 ' A' ' 50' ' ' LEU . 71.3 t -105.41 137.51 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.027 -1.046 . . . . 0.0 110.368 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.567 ' HG2' ' CZ ' ' A' ' 63' ' ' PHE . 1.9 ttt -134.36 148.56 50.73 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.33 -0.856 . . . . 0.0 110.064 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.33 -40.0 0.74 Allowed 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.333 0.587 . . . . 0.0 109.94 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.403 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 8.5 p-10 -49.12 154.56 1.33 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.334 -0.854 . . . . 0.0 109.902 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.9 Cg_endo -63.0 132.3 36.26 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.676 1.356 . . . . 0.0 110.982 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.552 ' HB3' ' HE1' ' A' ' 52' ' ' MET . 3.2 pp -89.69 -29.15 18.97 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.275 -0.89 . . . . 0.0 110.326 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.483 ' CG2' ' CE ' ' A' ' 58' ' ' LYS . 2.9 t -130.02 -37.27 1.5 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.273 -0.892 . . . . 0.0 110.228 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.483 ' CE ' ' CG2' ' A' ' 57' ' ' THR . 0.0 OUTLIER -168.41 -31.6 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.228 -0.92 . . . . 0.0 110.764 179.396 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.566 ' CD ' ' O ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -124.64 -179.43 4.5 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 120.993 -1.067 . . . . 0.0 109.784 179.856 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.566 ' O ' ' CD ' ' A' ' 59' ' ' ARG . 75.7 m -91.95 156.55 17.37 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.389 -0.819 . . . . 0.0 111.621 -179.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.15 -56.74 1.43 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.122 -0.986 . . . . 0.0 109.432 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.595 ' C ' HD22 ' A' ' 27' ' ' LEU . . . 91.89 80.83 1.43 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.149 -1.581 . . . . 0.0 109.149 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.63 ' N ' HD22 ' A' ' 27' ' ' LEU . 12.4 p90 -149.82 -169.66 3.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -1.14 . . . . 0.0 110.288 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 50' ' ' LEU . . . -167.55 -161.99 18.32 Favored Glycine 0 N--CA 1.485 1.924 0 C-N-CA 119.507 -1.33 . . . . 0.0 110.303 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.543 ' C ' HG23 ' A' ' 66' ' ' VAL . 9.1 m-85 -146.23 143.4 29.2 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.769 -0.842 . . . . 0.0 109.074 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.748 HG21 HD11 ' A' ' 36' ' ' LEU . 14.1 t -147.85 97.08 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 120.805 -1.184 . . . . 0.0 110.752 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.759 HG23 ' O ' ' A' ' 20' ' ' CYS . 22.7 m -80.68 58.43 3.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.368 -0.832 . . . . 0.0 109.929 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.599 ' CE2' HG21 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -82.27 -148.19 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 110.609 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.515 ' O ' ' CE1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -61.09 163.28 6.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 110.209 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -131.09 0.45 4.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.884 . . . . 0.0 110.047 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.467 ' O ' HG12 ' A' ' 74' ' ' VAL . 2.4 mt-30 -95.23 -101.3 0.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.878 . . . . 0.0 110.19 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.492 ' HB1' ' NZ ' ' A' ' 76' ' ' LYS . . . -67.52 -24.52 65.57 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.938 -1.101 . . . . 0.0 110.005 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.797 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -53.67 -65.87 3.13 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.555 ' CG1' ' N ' ' A' ' 75' ' ' ASP . 2.2 p -39.94 -43.19 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.398 -1.06 . . . . 0.0 110.489 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.803 ' HA ' HD23 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -58.65 -77.86 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.367 -0.833 . . . . 0.0 110.383 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.621 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -48.47 -22.45 0.73 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.381 -0.824 . . . . 0.0 110.059 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 73' ' ' GLY . 55.4 t -71.72 -53.43 20.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.256 -0.903 . . . . 0.0 109.666 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.803 HD23 ' HA ' ' A' ' 75' ' ' ASP . 1.3 pp -50.76 -28.95 10.25 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 120.918 -1.114 . . . . 0.0 108.196 178.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -57.36 -20.03 26.61 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.601 HE21 ' HE2' ' A' ' 43' ' ' PHE . 4.3 mt-30 -105.58 19.01 21.28 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.431 0.634 . . . . 0.0 109.481 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.484 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 46.3 t -53.38 -16.5 1.41 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.604 -0.839 . . . . 0.0 108.747 178.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.571 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -103.66 -2.43 26.59 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 121.358 -0.839 . . . . 0.0 109.618 178.979 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 1.014 ' CE1' HD12 ' A' ' 90' ' ' ILE . 0.3 OUTLIER 27.18 -85.09 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.705 0.764 . . . . 0.0 111.675 179.68 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.875 ' C ' HD23 ' A' ' 85' ' ' LEU . 0.5 OUTLIER 54.66 122.14 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 122.205 1.002 . . . . 0.0 111.088 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.875 HD23 ' C ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -149.19 -92.08 0.07 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.394 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.561 ' O ' ' CB ' ' A' ' 87' ' ' SER . 7.7 t0 -82.54 54.28 2.58 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.067 -1.02 . . . . 0.0 108.495 178.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.561 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER 76.68 6.18 3.39 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.215 0.531 . . . . 0.0 109.975 -179.016 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.601 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -110.86 114.41 27.72 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.291 -0.88 . . . . 0.0 110.668 -179.351 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.694 ' O ' HG23 ' A' ' 89' ' ' THR . 9.7 t -89.14 76.98 7.64 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.805 -0.559 . . . . 0.0 109.805 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.014 HD12 ' CE1' ' A' ' 83' ' ' HIS . 1.5 mt -49.23 179.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.256 -0.903 . . . . 0.0 109.494 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.565 ' H ' HG22 ' A' ' 90' ' ' ILE . 8.0 t0 -140.72 79.55 19.24 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.328 -0.858 . . . . 0.0 110.1 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.525 ' CG ' ' O ' ' A' ' 80' ' ' GLN . 2.3 Cg_endo -54.61 111.94 0.87 Allowed 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.57 1.3 . . . . 0.0 110.749 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.582 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -127.59 103.12 7.15 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.866 0.841 . . . . 0.0 109.235 178.528 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.831 HG13 ' CB ' ' A' ' 22' ' ' MET . 15.8 t -97.11 170.48 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-O 121.349 0.595 . . . . 0.0 110.502 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.525 ' O ' ' CB ' ' A' ' 96' ' ' PHE . . . -51.48 -66.08 0.45 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.199 -0.938 . . . . 0.0 110.436 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.525 ' CB ' ' O ' ' A' ' 95' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.709 0 O-C-N 121.184 -0.947 . . . . 0.0 110.067 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.7 m . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.222 0.534 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.71 160.13 14.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.16 -0.962 . . . . 0.0 110.325 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.768 ' CG ' HG22 ' A' ' 94' ' ' VAL . 7.4 ttt -76.72 163.1 27.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.221 -0.924 . . . . 0.0 110.16 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.706 ' CG ' ' CE1' ' A' ' 65' ' ' PHE . 2.0 t80 -141.64 129.08 21.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.295 -0.878 . . . . 0.0 109.597 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.702 HD12 ' C ' ' A' ' 23' ' ' PHE . 1.4 mp -106.48 155.87 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.115 -0.99 . . . . 0.0 109.289 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.57 ' O ' ' N ' ' A' ' 91' ' ' ASP . . . -139.21 139.08 9.8 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 119.245 -1.455 . . . . 0.0 111.42 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.552 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 105.51 27.26 5.86 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.981 ' CD2' HG13 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -50.45 118.58 3.12 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.792 -0.828 . . . . 0.0 110.864 -179.588 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.523 ' HB2' ' CB ' ' A' ' 88' ' ' LYS . 1.4 t -59.43 178.52 0.14 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.38 -0.825 . . . . 0.0 110.212 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.568 ' O ' ' CE3' ' A' ' 29' ' ' TRP . 35.1 p-90 -84.85 15.69 3.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.177 -0.952 . . . . 0.0 110.1 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -143.92 7.45 1.42 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.241 -0.912 . . . . 0.0 110.936 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.595 HG21 ' HG ' ' A' ' 27' ' ' LEU . 1.9 m -70.66 157.08 38.61 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.125 -0.984 . . . . 0.0 109.892 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.531 ' CG2' ' HA3' ' A' ' 35' ' ' GLY . 4.4 t -127.48 178.04 6.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.083 -1.01 . . . . 0.0 109.922 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.516 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 6.0 mt-30 -88.76 -73.69 0.49 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.15 -0.969 . . . . 0.0 110.734 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.56 ' HA ' ' HB3' ' A' ' 37' ' ' ARG . 0.1 OUTLIER -50.78 -49.67 57.73 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 117.967 -1.493 . . . . 0.0 108.929 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.531 ' HA3' ' CG2' ' A' ' 32' ' ' THR . . . -49.39 -27.72 8.48 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 107.603 -2.199 . . . . 0.0 107.603 178.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.91 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -80.69 -32.02 36.06 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.478 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.581 ' HG2' ' HG2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -60.46 -34.79 74.52 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 177.475 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.581 ' HG2' ' HG2' ' A' ' 37' ' ' ARG . 2.0 mt-10 -76.63 -25.44 53.82 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 113.912 -1.494 . . . . 0.0 109.863 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.63 ' CE1' ' NE2' ' A' ' 83' ' ' HIS . 8.0 t80 -75.81 -25.01 55.95 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.511 -0.743 . . . . 0.0 110.82 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.912 ' HE1' HG13 ' A' ' 77' ' ' VAL . 16.3 m-85 -113.69 -17.86 12.02 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.324 -0.86 . . . . 0.0 109.118 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -79.73 -5.53 89.37 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 108.496 -1.842 . . . . 0.0 108.496 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -63.58 -45.27 91.16 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.492 -1.005 . . . . 0.0 109.888 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.535 ' CD2' ' HB3' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -108.16 1.54 22.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.449 -0.782 . . . . 0.0 110.189 179.608 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.478 ' O ' ' HA2' ' A' ' 41' ' ' GLY . . . -149.64 179.49 26.37 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.609 -1.281 . . . . 0.0 109.933 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 0.4 OUTLIER -101.16 121.18 41.38 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.34 -1.094 . . . . 0.0 110.086 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.645 HG22 ' HB3' ' A' ' 68' ' ' PHE . 43.1 t -97.69 121.62 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.131 -0.981 . . . . 0.0 110.651 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.419 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . 35.8 tptt -88.91 -36.31 16.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.308 -0.87 . . . . 0.0 109.987 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -161.58 161.28 29.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 0.0 110.328 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 7.6 p -150.12 165.55 32.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.29 -0.881 . . . . 0.0 109.712 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.758 HD21 ' CD2' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -149.67 132.93 16.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.049 -1.032 . . . . 0.0 110.751 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.981 HG13 ' CD2' ' A' ' 27' ' ' LEU . 79.3 t -121.85 131.72 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.56 -1.338 . . . . 0.0 110.423 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 2.5 ttm -131.65 151.81 51.33 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.356 -0.84 . . . . 0.0 109.962 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.503 ' O ' ' CB ' ' A' ' 54' ' ' ASP . 0.2 OUTLIER -149.78 -36.14 0.16 Allowed 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.571 -0.706 . . . . 0.0 110.273 179.76 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.503 ' CB ' ' O ' ' A' ' 53' ' ' ARG . 0.4 OUTLIER 70.99 138.38 0.06 OUTLIER Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.201 -0.937 . . . . 0.0 110.136 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 54' ' ' ASP . 2.9 Cg_endo -64.71 -6.69 12.86 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 123.506 1.266 . . . . 0.0 110.831 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.778 ' C ' HG23 ' A' ' 57' ' ' THR . 11.7 mt -89.38 -50.44 6.11 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.158 -0.964 . . . . 0.0 109.885 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.778 HG23 ' C ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER 61.62 -60.02 0.1 Allowed 'General case' 0 N--CA 1.505 2.275 0 CA-C-O 121.496 0.665 . . . . 0.0 110.275 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.586 ' N ' ' O ' ' A' ' 56' ' ' LEU . 1.2 pttt -45.79 -28.14 0.99 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.506 -0.746 . . . . 0.0 109.556 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.465 ' HD3' ' C ' ' A' ' 59' ' ' ARG . 0.4 OUTLIER -110.31 -35.35 6.09 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.639 -0.663 . . . . 0.0 110.232 179.809 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.444 ' N ' ' HD3' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -62.37 -155.32 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.161 -0.962 . . . . 0.0 110.202 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.01 -40.61 0.75 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.891 . . . . 0.0 109.825 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.44 89.73 0.59 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.959 ' O ' HD22 ' A' ' 27' ' ' LEU . 20.4 p90 -148.4 -176.9 5.48 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.277 -1.131 . . . . 0.0 110.537 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.696 ' N ' HD13 ' A' ' 27' ' ' LEU . . . -142.58 162.83 27.31 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.758 ' CD2' HD21 ' A' ' 50' ' ' LEU . 14.2 m-85 -128.28 154.18 46.18 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.404 -1.057 . . . . 0.0 109.41 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.781 ' CG2' HD11 ' A' ' 36' ' ' LEU . 15.3 t -149.87 110.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.058 -1.026 . . . . 0.0 110.64 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.588 HG22 ' O ' ' A' ' 67' ' ' THR . 84.9 m -89.11 49.93 1.86 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.294 -0.879 . . . . 0.0 109.98 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.645 ' HB3' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -84.72 52.32 2.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.412 -0.805 . . . . 0.0 110.818 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.429 ' C ' ' O ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -42.11 119.16 1.28 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.228 -0.92 . . . . 0.0 110.471 -179.753 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -150.01 -174.36 4.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.328 -0.857 . . . . 0.0 110.008 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.5 tm0? -94.85 -71.32 0.67 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.154 -0.966 . . . . 0.0 110.22 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 75' ' ' ASP . . . -83.19 8.51 13.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 109.996 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.761 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -57.1 -70.44 0.98 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.436 ' C ' ' O ' ' A' ' 73' ' ' GLY . 98.5 t -41.9 -29.06 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.355 -1.085 . . . . 0.0 110.247 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.846 ' HA ' HD23 ' A' ' 78' ' ' LEU . 0.5 OUTLIER -66.28 -80.64 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 0.0 109.898 179.744 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.704 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -47.73 -24.7 1.01 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.232 -0.917 . . . . 0.0 109.07 179.337 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.912 HG13 ' HE1' ' A' ' 40' ' ' PHE . 78.1 t -68.74 -55.22 16.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.472 -0.767 . . . . 0.0 109.703 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.846 HD23 ' HA ' ' A' ' 75' ' ' ASP . 1.1 pp -48.78 -28.48 3.69 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 120.835 -1.166 . . . . 0.0 108.48 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.704 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -52.13 -32.6 36.23 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.559 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 5.4 mm-40 -99.43 24.04 8.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.781 -0.574 . . . . 0.0 109.499 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.474 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 9.8 t -49.95 -18.76 0.57 Allowed 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.092 178.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.486 ' O ' ' C ' ' A' ' 83' ' ' HIS . 0.2 OUTLIER -103.52 -7.55 20.77 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.342 -0.849 . . . . 0.0 109.841 179.45 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.735 ' CE1' HD12 ' A' ' 90' ' ' ILE . 0.5 OUTLIER 32.22 36.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.95 -0.469 . . . . 0.0 111.272 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.551 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 1.4 tt0 -87.14 120.26 28.22 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.594 -1.243 . . . . 0.0 110.237 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.529 ' CD2' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -151.7 -83.48 0.09 Allowed 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.679 -0.638 . . . . 0.0 110.133 -179.626 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.518 ' O ' ' CB ' ' A' ' 87' ' ' SER . 0.2 OUTLIER -79.81 53.08 1.57 Allowed 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.106 -0.996 . . . . 0.0 109.289 179.473 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 71.01 2.83 4.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.565 -0.709 . . . . 0.0 110.256 -179.796 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -110.96 124.85 52.95 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.257 -0.902 . . . . 0.0 110.246 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.762 ' O ' HG23 ' A' ' 89' ' ' THR . 15.1 t -104.77 63.93 0.73 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.523 -0.736 . . . . 0.0 110.133 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.735 HD12 ' CE1' ' A' ' 83' ' ' HIS . 0.6 OUTLIER -52.23 -176.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.35 -0.843 . . . . 0.0 108.887 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.57 ' N ' ' O ' ' A' ' 25' ' ' GLY . 13.0 t0 -143.82 87.23 8.22 Favored Pre-proline 0 N--CA 1.485 1.288 0 O-C-N 120.547 -1.346 . . . . 0.0 110.764 -178.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.559 ' CG ' ' O ' ' A' ' 80' ' ' GLN . 2.2 Cg_endo -58.42 111.79 0.98 Allowed 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.633 1.333 . . . . 0.0 111.317 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.583 ' HE2' ' CD2' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -130.41 117.51 19.81 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.383 -0.823 . . . . 0.0 109.262 178.26 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.768 HG22 ' CG ' ' A' ' 22' ' ' MET . 61.8 t -97.3 174.6 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 O-C-N 121.581 -0.699 . . . . 0.0 110.049 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.579 ' N ' HG12 ' A' ' 94' ' ' VAL . . . -95.33 108.73 20.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 109.855 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 28.5 t80 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.937 . . . . 0.0 110.402 -179.669 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.455 ' O ' ' HB3' ' A' ' 21' ' ' LYS . 30.4 p . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.194 0.521 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.717 ' CB ' HG23 ' A' ' 67' ' ' THR . 11.6 ptmt -179.32 -171.09 0.19 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.397 -0.814 . . . . 0.0 110.252 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' MET . . . . . 1.003 ' HB3' HG13 ' A' ' 94' ' ' VAL . 12.7 ptm -123.21 175.8 6.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.441 -0.787 . . . . 0.0 110.041 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.582 ' HB3' ' HD2' ' A' ' 93' ' ' LYS . 1.4 t80 -146.58 158.35 43.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.367 -0.833 . . . . 0.0 109.886 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.962 HD11 ' CE ' ' A' ' 22' ' ' MET . 18.3 mm -115.92 134.78 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.31 -0.868 . . . . 0.0 109.124 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.513 ' O ' HG22 ' A' ' 90' ' ' ILE . . . -113.3 141.68 17.05 Favored Glycine 0 N--CA 1.495 2.601 0 C-N-CA 119.731 -1.223 . . . . 0.0 112.285 -177.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.51 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 60.28 41.91 98.54 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.007 HD22 ' CA ' ' A' ' 63' ' ' PHE . 0.3 OUTLIER -77.45 153.87 33.14 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.62 -0.929 . . . . 0.0 111.163 -178.742 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.917 ' OG ' HD23 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -39.43 130.73 1.72 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.368 0.604 . . . . 0.0 110.518 -179.301 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 64.9 p-90 -68.81 -28.12 66.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.349 -0.844 . . . . 0.0 110.635 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.454 ' O ' ' O ' ' A' ' 31' ' ' THR . 2.3 pt20 -88.78 -14.76 36.33 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.083 -1.011 . . . . 0.0 110.721 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.543 ' HB ' ' CB ' ' A' ' 28' ' ' SER . 1.3 t -53.08 -169.02 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.642 -0.661 . . . . 0.0 110.364 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.718 HG23 ' H ' ' A' ' 35' ' ' GLY . 15.0 t -157.62 -166.75 2.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.334 -0.854 . . . . 0.0 109.85 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 36' ' ' LEU . 3.6 mt-30 -79.9 -72.92 0.38 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.149 -0.969 . . . . 0.0 110.118 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.534 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -48.07 -44.28 31.36 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.759 -1.176 . . . . 0.0 108.551 179.302 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.718 ' H ' HG23 ' A' ' 32' ' ' THR . . . -48.14 -35.27 13.64 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 107.566 -2.214 . . . . 0.0 107.566 178.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.766 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -75.76 -40.07 55.98 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.301 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.78 ' HA ' HG11 ' A' ' 46' ' ' VAL . 50.0 mtp180 -59.42 -25.66 64.52 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 122.47 1.129 . . . . 0.0 108.421 178.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.534 ' CG ' ' O ' ' A' ' 34' ' ' GLU . 1.5 mt-10 -84.56 -21.93 30.27 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.688 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 21.0 t80 -84.56 -48.36 9.63 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.795 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.854 ' HE1' HG13 ' A' ' 77' ' ' VAL . 28.1 m-85 -95.17 -33.48 12.61 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.355 -0.841 . . . . 0.0 109.321 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -65.8 -17.49 65.11 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -58.83 -45.2 90.56 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.417 -1.049 . . . . 0.0 109.276 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.599 ' CD1' ' HB3' ' A' ' 76' ' ' LYS . 4.5 p90 -117.83 -12.82 10.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.566 -0.709 . . . . 0.0 109.493 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.469 ' O ' ' HA2' ' A' ' 41' ' ' GLY . . . -133.99 87.01 0.26 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.531 ' O ' ' CB ' ' A' ' 68' ' ' PHE . 4.0 pm0 -41.18 104.39 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.417 -1.049 . . . . 0.0 110.357 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.78 HG11 ' HA ' ' A' ' 37' ' ' ARG . 2.9 p -89.42 142.5 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.228 -0.92 . . . . 0.0 110.519 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.62 -23.68 9.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.873 . . . . 0.0 109.677 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.43 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -130.25 126.59 37.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.407 -0.808 . . . . 0.0 110.173 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.511 ' HB2' ' CD2' ' A' ' 36' ' ' LEU . 3.4 p -150.13 152.14 34.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.076 -1.015 . . . . 0.0 110.253 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.801 HD21 ' CD2' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -149.99 134.33 17.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.048 -1.033 . . . . 0.0 110.65 179.739 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 78.4 t -117.16 134.81 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.543 -1.348 . . . . 0.0 110.732 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.524 ' HG3' ' N ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -129.4 152.17 49.24 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.423 -0.798 . . . . 0.0 109.44 179.746 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.524 ' N ' ' HG3' ' A' ' 52' ' ' MET . 1.7 mpp_? -147.49 -61.19 0.27 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.563 -0.711 . . . . 0.0 110.23 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -130.23 86.34 54.24 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.264 -0.898 . . . . 0.0 110.038 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.74 -76.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.706 1.371 . . . . 0.0 110.847 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.615 ' HG ' HG22 ' A' ' 57' ' ' THR . 1.8 pp -123.16 -27.92 4.1 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.23 -0.919 . . . . 0.0 111.039 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.615 HG22 ' HG ' ' A' ' 56' ' ' LEU . 2.5 t -131.44 -123.85 0.2 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.112 -0.993 . . . . 0.0 110.345 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.438 ' N ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -137.75 7.16 2.74 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 120.938 -1.101 . . . . 0.0 110.021 179.799 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.574 ' H ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -58.85 -38.7 79.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.254 -0.904 . . . . 0.0 110.03 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.568 ' N ' ' CD ' ' A' ' 59' ' ' ARG . 0.5 OUTLIER -48.44 170.36 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.229 -0.92 . . . . 0.0 110.106 179.808 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -129.02 -19.59 3.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.056 -1.027 . . . . 0.0 110.895 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.55 97.11 2.49 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 1.007 ' CA ' HD22 ' A' ' 27' ' ' LEU . 20.8 p90 -156.35 -162.94 1.35 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.131 -1.217 . . . . 0.0 110.26 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.573 ' O ' ' CD2' ' A' ' 23' ' ' PHE . . . -166.84 -179.97 40.29 Favored Glycine 0 N--CA 1.489 2.18 0 C-N-CA 119.536 -1.316 . . . . 0.0 110.296 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.801 ' CD2' HD21 ' A' ' 50' ' ' LEU . 10.4 m-85 -129.28 152.98 48.26 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.833 -0.804 . . . . 0.0 109.267 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.58 HG22 HD21 ' A' ' 36' ' ' LEU . 3.5 t -150.05 145.1 17.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 120.986 -1.071 . . . . 0.0 110.181 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.717 HG23 ' CB ' ' A' ' 21' ' ' LYS . 3.2 m -151.1 99.23 2.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.207 -0.933 . . . . 0.0 110.717 -179.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.635 ' CE2' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -100.57 -166.27 1.3 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.152 -0.967 . . . . 0.0 109.589 178.854 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.462 ' HA ' ' CE ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -151.35 74.83 1.15 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.951 . . . . 0.0 110.348 -179.878 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.431 ' OD1' ' OE2' ' A' ' 45' ' ' GLU . 0.6 OUTLIER -150.07 170.99 17.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.273 -0.892 . . . . 0.0 110.068 179.754 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.505 ' HG3' ' N ' ' A' ' 72' ' ' ALA . 27.2 pt20 -84.09 -38.92 20.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -0.936 . . . . 0.0 110.301 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.505 ' N ' ' HG3' ' A' ' 71' ' ' GLN . . . -83.77 4.24 29.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.905 . . . . 0.0 110.03 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.703 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -59.36 -82.34 0.06 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.559 HG23 ' N ' ' A' ' 75' ' ' ASP . 17.9 m -41.67 -48.3 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.296 -1.12 . . . . 0.0 110.534 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.559 ' N ' HG23 ' A' ' 74' ' ' VAL . 21.6 m-20 -42.22 -68.15 0.21 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.036 -1.04 . . . . 0.0 110.45 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.88 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -59.14 -37.03 76.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.442 -0.786 . . . . 0.0 110.449 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.854 HG13 ' HE1' ' A' ' 40' ' ' PHE . 58.9 t -56.21 -59.71 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 121.142 -0.974 . . . . 0.0 109.911 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.564 ' CD1' ' N ' ' A' ' 78' ' ' LEU . 2.4 mp -46.03 -40.73 11.03 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.88 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -43.18 -36.37 1.71 Allowed 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.584 0.707 . . . . 0.0 109.55 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.573 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 10.3 mm-40 -102.57 27.61 6.74 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.483 -0.76 . . . . 0.0 109.505 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.562 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 65.9 p -45.56 -21.32 0.1 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.562 -0.711 . . . . 0.0 109.131 178.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.486 ' O ' ' O ' ' A' ' 83' ' ' HIS . 1.2 ptp180 -106.13 -19.66 13.65 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.463 -0.773 . . . . 0.0 110.279 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.912 ' CE1' HD12 ' A' ' 90' ' ' ILE . 0.2 OUTLIER 52.13 165.47 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.279 -0.888 . . . . 0.0 111.014 179.898 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 1.067 ' C ' HD13 ' A' ' 85' ' ' LEU . 1.2 tt0 175.37 119.74 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.599 0.714 . . . . 0.0 110.389 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.067 HD13 ' C ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -141.03 -86.49 0.18 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.575 -0.703 . . . . 0.0 109.172 178.417 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.536 ' O ' ' CB ' ' A' ' 87' ' ' SER . 0.1 OUTLIER -84.42 53.25 2.59 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.054 -1.029 . . . . 0.0 108.662 178.916 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 71.22 9.68 6.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.49 -0.756 . . . . 0.0 109.274 -178.769 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.586 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 10.3 mmtt -107.17 121.79 45.23 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.519 -0.738 . . . . 0.0 109.806 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.801 ' O ' HG23 ' A' ' 89' ' ' THR . 15.3 t -97.31 78.42 2.72 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.393 -0.817 . . . . 0.0 109.554 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.912 HD12 ' CE1' ' A' ' 83' ' ' HIS . 1.1 mt -47.65 -177.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-O 121.433 0.635 . . . . 0.0 110.335 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.597 ' H ' HG22 ' A' ' 90' ' ' ILE . 13.5 t0 -139.39 78.19 27.92 Favored Pre-proline 0 C--N 1.305 -1.355 0 O-C-N 121.108 -0.995 . . . . 0.0 110.566 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.631 ' HG3' ' HD2' ' A' ' 83' ' ' HIS . 2.3 Cg_endo -53.31 112.48 0.95 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.44 1.232 . . . . 0.0 110.964 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.582 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -117.06 99.78 7.29 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.287 -0.883 . . . . 0.0 109.698 178.434 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 1.003 HG13 ' HB3' ' A' ' 22' ' ' MET . 22.3 t -97.01 157.35 3.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 O-C-N 121.757 -0.589 . . . . 0.0 110.157 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -131.49 106.44 8.22 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.207 -0.933 . . . . 0.0 110.468 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.181 -0.949 . . . . 0.0 110.923 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.214 0.53 . . . . 0.0 110.128 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.514 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 5.2 pttt -70.34 161.15 30.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 110.331 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.913 ' HB2' HG13 ' A' ' 94' ' ' VAL . 36.5 ttp -86.07 172.67 10.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.359 -0.838 . . . . 0.0 110.307 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.752 ' C ' HD12 ' A' ' 24' ' ' ILE . 1.3 t80 -148.62 139.39 22.88 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.332 -0.855 . . . . 0.0 109.268 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.752 HD12 ' C ' ' A' ' 23' ' ' PHE . 1.3 mp -110.36 130.62 63.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 121.319 -0.863 . . . . 0.0 108.792 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.498 ' O ' ' CG2' ' A' ' 90' ' ' ILE . . . -95.73 120.53 6.58 Favored Glycine 0 N--CA 1.497 2.723 0 C-N-CA 120.028 -1.082 . . . . 0.0 113.145 -176.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.996 ' O ' HD12 ' A' ' 90' ' ' ILE . . . 76.67 28.24 59.62 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 177.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.024 HD11 HG13 ' A' ' 51' ' ' VAL . 1.4 pt? -49.43 142.51 7.68 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.376 -1.073 . . . . 0.0 110.383 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.839 ' O ' HG22 ' A' ' 31' ' ' THR . 2.3 m -39.42 121.35 1.17 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.486 0.66 . . . . 0.0 110.465 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.493 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 49.9 p-90 -58.88 -28.87 66.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.298 -0.876 . . . . 0.0 110.388 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -82.64 -13.7 56.01 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.195 -0.941 . . . . 0.0 110.642 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.839 HG22 ' O ' ' A' ' 28' ' ' SER . 3.0 t -63.64 -169.6 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.501 -0.749 . . . . 0.0 110.291 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.695 HG23 ' H ' ' A' ' 35' ' ' GLY . 13.4 t -154.06 -169.92 3.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.445 -0.785 . . . . 0.0 109.922 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 36' ' ' LEU . 17.7 mt-30 -74.48 -73.05 0.25 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.121 -0.987 . . . . 0.0 110.389 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.4 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 3.9 tt0 -47.84 -42.9 27.47 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.883 -1.136 . . . . 0.0 109.758 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.695 ' H ' HG23 ' A' ' 32' ' ' THR . . . -55.54 -30.18 55.32 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 107.699 -2.161 . . . . 0.0 107.699 178.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.874 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -82.1 -37.57 26.13 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.137 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.633 ' CD ' HG11 ' A' ' 46' ' ' VAL . 0.2 OUTLIER -62.86 -25.22 68.18 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 122.536 1.16 . . . . 0.0 108.503 178.487 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.53 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -90.39 -19.07 24.39 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.977 -1.011 . . . . 0.0 108.597 179.497 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.66 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 6.4 t80 -81.42 -26.61 35.25 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 121.457 -0.777 . . . . 0.0 110.334 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.895 ' HE1' HG13 ' A' ' 77' ' ' VAL . 39.0 m-85 -118.59 -17.72 9.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.403 -0.811 . . . . 0.0 109.371 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -75.69 -21.08 77.57 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.61 ' HG3' ' CD2' ' A' ' 43' ' ' PHE . 15.9 pt20 -63.06 -32.48 73.87 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.486 -1.008 . . . . 0.0 109.421 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.612 ' HE1' HG22 ' A' ' 77' ' ' VAL . 4.8 p90 -130.39 1.36 4.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.37 -0.831 . . . . 0.0 109.645 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 40' ' ' PHE . . . -143.77 95.27 0.18 Allowed Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 42.3 mt-10 -40.05 110.0 0.13 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.326 -1.102 . . . . 0.0 110.774 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.633 HG11 ' CD ' ' A' ' 37' ' ' ARG . 70.7 t -91.16 129.43 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.389 -0.819 . . . . 0.0 110.733 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 67' ' ' THR . 0.5 OUTLIER -93.48 -33.6 13.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.406 -0.809 . . . . 0.0 109.607 179.467 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.703 ' O ' HG22 ' A' ' 67' ' ' THR . 11.3 tp10 -171.29 153.96 3.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.548 -0.72 . . . . 0.0 109.188 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 15.6 p -150.81 157.06 42.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.06 -1.025 . . . . 0.0 111.107 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.733 ' C ' HD12 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -130.52 124.11 31.17 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.427 -0.796 . . . . 0.0 108.95 178.704 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.024 HG13 HD11 ' A' ' 27' ' ' LEU . 89.6 t -112.57 142.75 23.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 120.453 -1.404 . . . . 0.0 112.062 -178.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.576 ' SD ' ' CE2' ' A' ' 63' ' ' PHE . 1.9 ttm -135.83 137.84 41.94 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.543 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 5.0 tmm_? -146.96 -34.44 0.27 Allowed 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.443 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.653 ' N ' ' HD3' ' A' ' 55' ' ' PRO . 62.0 t0 -163.18 51.75 0.31 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.008 -1.058 . . . . 0.0 111.973 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.847 ' O ' HD23 ' A' ' 56' ' ' LEU . 2.4 Cg_endo -71.75 -68.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.32 -0.94 0 N-CA-C 109.337 -1.063 . . . . 0.0 109.337 178.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.847 HD23 ' O ' ' A' ' 55' ' ' PRO . 11.2 mt -140.64 -62.6 0.49 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.659 0.743 . . . . 0.0 109.047 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.471 ' O ' ' HD2' ' A' ' 59' ' ' ARG . 4.9 t -139.9 -28.77 0.74 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.652 -0.655 . . . . 0.0 110.733 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 60' ' ' SER . 4.4 mtmt -54.68 -37.6 65.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.113 -0.992 . . . . 0.0 109.759 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.551 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -38.93 -24.62 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.694 -0.629 . . . . 0.0 111.203 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 58' ' ' LYS . 1.6 t -38.47 -27.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.329 -0.857 . . . . 0.0 111.019 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 59' ' ' ARG . 4.6 mtt180 -99.0 -33.58 10.77 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.06 -1.025 . . . . 0.0 110.931 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.46 ' C ' ' CD2' ' A' ' 27' ' ' LEU . . . 56.5 77.5 0.16 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 107.827 -2.109 . . . . 0.0 107.827 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.83 ' CA ' HD22 ' A' ' 27' ' ' LEU . 14.4 p90 -134.63 -167.86 2.05 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.428 -1.042 . . . . 0.0 111.428 -178.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -158.7 116.72 0.73 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.554 ' HB2' ' HG ' ' A' ' 50' ' ' LEU . 12.7 m-85 -82.99 140.97 32.44 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.483 -1.01 . . . . 0.0 108.863 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.839 HG22 HD21 ' A' ' 36' ' ' LEU . 2.9 t -147.34 99.36 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 120.943 -1.098 . . . . 0.0 110.239 -178.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.703 HG22 ' O ' ' A' ' 48' ' ' GLU . 7.9 t -80.58 64.01 5.22 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 110.734 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.568 ' HB3' HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -84.41 -151.18 0.12 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.193 -0.942 . . . . 0.0 110.745 179.807 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.74 173.07 10.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.233 -0.917 . . . . 0.0 110.512 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.4 2.16 5.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.306 -0.872 . . . . 0.0 110.266 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -81.26 -116.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.233 -0.917 . . . . 0.0 110.138 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 75' ' ' ASP . . . -67.9 -24.45 65.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.834 -1.166 . . . . 0.0 110.178 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.671 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -46.49 -61.25 4.27 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.974 ' O ' HD12 ' A' ' 78' ' ' LEU . 71.3 t -43.17 -48.47 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.191 -1.182 . . . . 0.0 110.197 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 72' ' ' ALA . 34.8 t70 -47.94 -56.92 6.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.971 -1.081 . . . . 0.0 110.153 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.573 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -59.73 -30.66 68.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.39 -0.819 . . . . 0.0 110.15 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.895 HG13 ' HE1' ' A' ' 40' ' ' PHE . 41.7 t -63.01 -58.17 8.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.113 -0.992 . . . . 0.0 109.279 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.974 HD12 ' O ' ' A' ' 74' ' ' VAL . 1.3 mp -45.88 -44.39 14.43 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.324 -0.86 . . . . 0.0 108.962 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -45.96 -28.53 1.16 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.209 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.53 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 22.3 mm100 -103.76 25.53 9.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.512 -0.742 . . . . 0.0 109.898 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 78' ' ' LEU . 23.7 t -54.43 -16.16 2.12 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.488 ' O ' ' C ' ' A' ' 83' ' ' HIS . 5.2 ptp180 -95.95 -18.15 20.49 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 121.501 -0.749 . . . . 0.0 109.533 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.66 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 0.6 OUTLIER 31.51 41.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.81 -0.556 . . . . 0.0 111.795 179.484 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.567 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 0.7 OUTLIER -86.93 122.41 30.75 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 118.619 -1.233 . . . . 0.0 110.192 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.548 ' CD2' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -144.62 -85.81 0.13 Allowed 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.626 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 87' ' ' SER . 0.6 OUTLIER -82.28 52.92 2.13 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.21 -0.931 . . . . 0.0 108.753 179.05 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 1.4 t 71.33 5.84 5.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.599 -0.688 . . . . 0.0 109.651 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 10.7 mmmt -108.02 119.54 39.76 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.357 -0.839 . . . . 0.0 109.808 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.765 ' O ' HG23 ' A' ' 89' ' ' THR . 15.1 t -101.41 68.62 1.21 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.608 -0.682 . . . . 0.0 109.646 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.996 HD12 ' O ' ' A' ' 26' ' ' GLY . 1.2 mm -51.7 -175.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.419 -0.801 . . . . 0.0 109.803 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.503 ' H ' HG22 ' A' ' 90' ' ' ILE . 15.6 t0 -143.67 83.73 10.41 Favored Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.303 -0.873 . . . . 0.0 109.877 -179.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.53 ' CG ' ' O ' ' A' ' 80' ' ' GLN . 2.3 Cg_endo -53.22 112.32 0.9 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.553 1.291 . . . . 0.0 110.965 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.604 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -130.16 111.76 12.75 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.486 -0.759 . . . . 0.0 109.546 178.746 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.913 HG13 ' HB2' ' A' ' 22' ' ' MET . 3.8 t -95.66 -174.01 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.525 -0.734 . . . . 0.0 110.018 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.694 ' H ' HG12 ' A' ' 94' ' ' VAL . . . -82.6 10.38 7.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.175 -0.953 . . . . 0.0 110.358 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.441 ' CE1' HG21 ' A' ' 74' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.132 -0.98 . . . . 0.0 110.542 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 62.5 m . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.256 0.551 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.746 ' HB2' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER 58.2 154.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.255 -0.903 . . . . 0.0 109.841 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.951 ' CG ' HG22 ' A' ' 94' ' ' VAL . 5.3 tmm? -68.83 157.77 35.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.105 -0.997 . . . . 0.0 109.854 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.605 ' CG ' ' CE1' ' A' ' 65' ' ' PHE . 6.8 t80 -141.02 144.49 35.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.229 -0.919 . . . . 0.0 109.984 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.779 ' CG2' HG21 ' A' ' 90' ' ' ILE . 20.1 mm -108.87 137.76 39.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.314 -0.866 . . . . 0.0 109.232 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 91' ' ' ASP . . . -118.1 144.17 17.99 Favored Glycine 0 N--CA 1.495 2.576 0 C-N-CA 119.647 -1.263 . . . . 0.0 111.464 -177.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 90' ' ' ILE . . . 59.08 42.05 96.83 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.992 HD22 ' CA ' ' A' ' 63' ' ' PHE . 0.3 OUTLIER -79.69 156.51 27.53 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.452 -1.028 . . . . 0.0 110.939 -179.072 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.465 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -39.4 142.27 0.29 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.458 0.647 . . . . 0.0 110.735 -179.097 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.585 ' HA ' ' CD ' ' A' ' 53' ' ' ARG . 47.0 p-90 -85.58 2.57 44.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.496 -0.753 . . . . 0.0 110.332 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.469 ' O ' ' O ' ' A' ' 31' ' ' THR . 14.8 pt20 -121.77 -14.41 8.12 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.212 -0.93 . . . . 0.0 110.424 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 30' ' ' GLN . 14.8 t -53.3 -168.65 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.646 -0.659 . . . . 0.0 110.26 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.653 HG23 ' H ' ' A' ' 35' ' ' GLY . 6.0 t -153.91 -176.1 5.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.279 -0.888 . . . . 0.0 110.034 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 36' ' ' LEU . 4.9 mt-30 -69.5 -75.01 0.12 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.045 -1.034 . . . . 0.0 110.818 -179.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.47 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 7.9 tt0 -47.22 -40.46 16.31 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.817 -1.177 . . . . 0.0 110.051 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.653 ' H ' HG23 ' A' ' 32' ' ' THR . . . -56.53 -32.71 61.41 Favored Glycine 0 N--CA 1.484 1.833 0 N-CA-C 107.32 -2.312 . . . . 0.0 107.32 178.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.855 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -79.87 -38.8 31.93 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.122 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.47 ' HG3' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -61.81 -25.27 67.39 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 122.43 1.109 . . . . 0.0 108.764 178.501 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.554 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -88.66 -18.58 27.64 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.69 179.543 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.694 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 24.1 t80 -82.96 -28.02 30.09 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.348 -0.845 . . . . 0.0 110.564 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.881 ' CE1' HG13 ' A' ' 77' ' ' VAL . 39.2 m-85 -116.51 -22.53 8.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.208 -0.932 . . . . 0.0 109.457 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.521 ' CA ' HG23 ' A' ' 46' ' ' VAL . . . -72.15 -13.27 76.39 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -66.45 -36.96 84.08 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.416 -1.049 . . . . 0.0 109.713 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.602 ' CD1' ' HB3' ' A' ' 76' ' ' LYS . 9.7 p90 -125.71 7.86 7.54 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.503 -0.748 . . . . 0.0 109.828 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.481 ' O ' ' HA2' ' A' ' 41' ' ' GLY . . . -153.33 98.11 0.18 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 44' ' ' GLY . 8.5 pt-20 -39.79 124.49 1.73 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.526 -0.985 . . . . 0.0 110.26 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.521 HG23 ' CA ' ' A' ' 41' ' ' GLY . 3.3 t -98.43 126.06 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.22 -0.925 . . . . 0.0 110.453 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.469 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 1.6 mmtm -88.77 -27.6 21.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.365 -0.834 . . . . 0.0 109.498 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 12.1 pt-20 179.67 147.34 0.24 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.464 -0.772 . . . . 0.0 110.09 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 19.5 p -140.59 176.59 8.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.158 -0.964 . . . . 0.0 110.531 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.682 ' C ' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -147.74 124.64 11.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.3 -0.875 . . . . 0.0 110.148 179.416 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.493 ' N ' HD12 ' A' ' 50' ' ' LEU . 69.9 t -116.24 131.45 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.716 -1.24 . . . . 0.0 110.883 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.435 ' SD ' ' HB2' ' A' ' 60' ' ' SER . 1.2 ttm -138.83 149.85 45.38 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.526 -0.734 . . . . 0.0 109.523 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.585 ' CD ' ' HA ' ' A' ' 29' ' ' TRP . 33.3 mtm180 -149.73 -59.94 0.21 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.407 -0.808 . . . . 0.0 110.273 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -144.2 74.12 15.92 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.297 -0.877 . . . . 0.0 110.331 -179.908 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -62.22 -64.6 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.686 1.361 . . . . 0.0 110.629 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.0 mt -90.87 -67.26 0.86 Allowed 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.198 -0.939 . . . . 0.0 110.138 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.542 HG23 ' N ' ' A' ' 58' ' ' LYS . 2.0 t -142.19 -46.13 0.34 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.439 -0.788 . . . . 0.0 110.163 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.542 ' N ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -179.89 33.9 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.541 -0.724 . . . . 0.0 109.923 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.587 ' CD ' ' N ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -76.13 -38.09 57.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 110.356 -179.886 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.587 ' N ' ' CD ' ' A' ' 59' ' ' ARG . 96.0 p -69.16 -146.06 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.1 -1.0 . . . . 0.0 110.367 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 60' ' ' SER . 1.4 mtp180 -147.66 -39.73 0.18 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 109.96 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 120.45 81.87 0.69 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.992 ' CA ' HD22 ' A' ' 27' ' ' LEU . 11.7 p90 -145.78 -172.38 3.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.161 -1.199 . . . . 0.0 110.656 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.473 ' O ' ' HB ' ' A' ' 24' ' ' ILE . . . -153.7 114.16 0.61 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.605 ' CE1' ' CG ' ' A' ' 23' ' ' PHE . 19.9 m-85 -83.35 148.79 27.13 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.274 -1.133 . . . . 0.0 109.92 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.702 HG22 HD21 ' A' ' 36' ' ' LEU . 3.7 t -148.45 116.23 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.305 -0.872 . . . . 0.0 110.04 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.746 HG23 ' HB2' ' A' ' 21' ' ' LYS . 14.7 m -94.09 35.06 1.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.946 . . . . 0.0 110.511 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.627 ' CE2' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -69.14 135.26 50.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.936 -1.102 . . . . 0.0 109.55 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 4.7 ttt -143.77 122.77 12.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.1 -1.0 . . . . 0.0 110.571 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.43 ' HB2' ' HG2' ' A' ' 45' ' ' GLU . 4.6 t70 -142.86 -88.89 0.13 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.35 -0.844 . . . . 0.0 109.763 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.01 -83.67 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.339 -0.85 . . . . 0.0 109.575 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.08 -0.8 41.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.17 -0.956 . . . . 0.0 109.776 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.595 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -61.58 -46.16 94.86 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.896 ' O ' HD12 ' A' ' 78' ' ' LEU . 3.0 p -50.12 -46.17 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.205 -1.173 . . . . 0.0 109.484 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.571 ' N ' ' CG1' ' A' ' 74' ' ' VAL . 0.2 OUTLIER -59.71 -40.28 87.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.425 -0.797 . . . . 0.0 109.637 179.529 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.638 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -62.37 -33.51 74.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.416 -0.803 . . . . 0.0 109.389 179.378 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.881 HG13 ' CE1' ' A' ' 40' ' ' PHE . 40.5 t -62.74 -57.84 10.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.36 -0.838 . . . . 0.0 109.191 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.896 HD12 ' O ' ' A' ' 74' ' ' VAL . 4.0 mp -45.31 -41.91 9.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.197 -0.939 . . . . 0.0 108.852 178.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -46.31 -28.26 1.26 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.473 -0.891 . . . . 0.0 108.747 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.524 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 33.0 mm-40 -102.62 26.78 7.55 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.668 -0.645 . . . . 0.0 109.821 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 78' ' ' LEU . 41.9 t -55.93 -16.37 4.66 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.525 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.8 OUTLIER -109.47 1.63 19.99 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 121.626 -0.671 . . . . 0.0 109.373 178.751 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.986 ' CE1' HD12 ' A' ' 90' ' ' ILE . 0.5 OUTLIER 28.25 -87.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.138 0.494 . . . . 0.0 112.141 179.783 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.66 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 1.6 tt0 51.01 112.35 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 122.327 1.06 . . . . 0.0 110.5 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.798 HD11 HD11 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -131.65 -70.06 0.59 Allowed 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.549 ' HB3' ' CE ' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -103.71 55.33 0.74 Allowed 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.913 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 73.65 13.79 4.33 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 -178.135 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.66 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 8.6 mttt -117.86 107.2 13.82 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 121.502 -0.749 . . . . 0.0 110.997 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.682 ' O ' HG23 ' A' ' 89' ' ' THR . 9.5 t -80.82 76.93 7.73 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.508 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.986 HD12 ' CE1' ' A' ' 83' ' ' HIS . 1.6 mt -50.72 -179.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.058 -1.026 . . . . 0.0 109.231 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.63 ' H ' HG22 ' A' ' 90' ' ' ILE . 11.1 t0 -139.2 75.03 34.86 Favored Pre-proline 0 C--N 1.298 -1.641 0 O-C-N 121.188 -0.945 . . . . 0.0 110.559 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.524 ' CG ' ' O ' ' A' ' 80' ' ' GLN . 2.1 Cg_endo -52.64 111.17 0.57 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.593 1.312 . . . . 0.0 110.854 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.588 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -121.66 103.91 9.24 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.098 -1.001 . . . . 0.0 109.136 178.339 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.951 HG22 ' CG ' ' A' ' 22' ' ' MET . 3.4 t -96.83 177.49 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 O-C-N 121.639 -0.663 . . . . 0.0 110.784 -178.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.572 ' H ' HG12 ' A' ' 94' ' ' VAL . . . -170.32 123.06 0.67 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.452 -0.78 . . . . 0.0 109.776 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.434 ' CD1' ' N ' ' A' ' 96' ' ' PHE . 12.3 p90 . . . . . 0 N--CA 1.495 1.775 0 O-C-N 121.225 -0.922 . . . . 0.0 110.416 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.552 ' HB2' ' CB ' ' A' ' 67' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.287 0.565 . . . . 0.0 110.404 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.956 ' HE3' HG11 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -74.2 170.82 14.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.906 . . . . 0.0 109.465 179.617 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.63 ' CG ' ' CE1' ' A' ' 65' ' ' PHE . 5.4 t80 -151.25 129.72 12.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.159 -0.963 . . . . 0.0 110.128 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.47 HG22 HG21 ' A' ' 90' ' ' ILE . 18.4 mm -99.39 139.84 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.206 -0.934 . . . . 0.0 109.366 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' A' ' 91' ' ' ASP . . . -122.34 120.47 4.33 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.65 -1.262 . . . . 0.0 111.154 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.859 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 112.51 41.42 1.04 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.975 HD21 HG13 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -51.2 120.99 5.5 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.342 -1.093 . . . . 0.0 110.624 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.607 ' HB3' HD11 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -46.37 173.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.305 -0.872 . . . . 0.0 110.103 179.684 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.439 ' CD1' ' C ' ' A' ' 29' ' ' TRP . 0.2 OUTLIER -76.48 5.03 7.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -0.926 . . . . 0.0 110.599 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.417 ' HG2' ' CD1' ' A' ' 29' ' ' TRP . 2.5 pt20 -151.57 11.79 0.6 Allowed 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.998 -1.064 . . . . 0.0 111.058 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.629 HG21 ' HG ' ' A' ' 27' ' ' LEU . 1.2 m -59.25 163.01 4.09 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.987 -1.071 . . . . 0.0 109.795 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.642 HG23 ' H ' ' A' ' 35' ' ' GLY . 12.8 t -135.59 -169.81 2.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.924 . . . . 0.0 109.748 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.536 ' O ' ' N ' ' A' ' 36' ' ' LEU . 6.4 mt-30 -88.47 -73.82 0.48 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.035 -1.041 . . . . 0.0 110.042 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.473 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 1.3 tt0 -48.59 -43.18 35.74 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.765 -1.209 . . . . 0.0 109.642 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.642 ' H ' HG23 ' A' ' 32' ' ' THR . . . -55.9 -28.76 53.77 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 107.503 -2.239 . . . . 0.0 107.503 178.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.862 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -81.36 -37.9 27.49 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 177.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 33' ' ' GLN . 19.9 mtt180 -61.71 -27.27 68.59 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 122.398 1.094 . . . . 0.0 108.12 177.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -89.11 -16.38 31.64 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.966 179.338 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.68 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 16.9 t80 -80.52 -32.22 36.92 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.401 -0.812 . . . . 0.0 110.175 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.848 ' HE1' HG13 ' A' ' 77' ' ' VAL . 32.1 m-85 -110.5 -28.26 8.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.392 -0.818 . . . . 0.0 109.025 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -61.76 -15.46 48.17 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -59.8 -42.86 94.37 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.401 -1.058 . . . . 0.0 109.523 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.638 ' HE1' HG22 ' A' ' 77' ' ' VAL . 3.6 p90 -125.83 -6.51 6.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.423 -0.798 . . . . 0.0 109.81 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.474 ' O ' ' HA2' ' A' ' 41' ' ' GLY . . . -130.8 96.41 0.35 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 11.1 mm-40 -40.69 115.46 0.58 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.335 -1.097 . . . . 0.0 110.546 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.513 ' HA ' ' CB ' ' A' ' 68' ' ' PHE . 59.9 t -95.32 134.21 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.0 110.61 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 0.1 OUTLIER -100.33 -27.75 13.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.373 -0.83 . . . . 0.0 109.743 179.588 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.477 ' O ' HG22 ' A' ' 67' ' ' THR . 5.0 tt0 -176.84 156.63 1.39 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.472 -0.768 . . . . 0.0 109.935 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.468 ' SG ' ' HG2' ' A' ' 37' ' ' ARG . 8.3 p -149.72 164.72 34.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.154 -0.967 . . . . 0.0 110.347 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.647 ' C ' HD12 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -133.41 126.93 32.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.203 -0.936 . . . . 0.0 110.181 179.683 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.975 HG13 HD21 ' A' ' 27' ' ' LEU . 98.1 t -117.39 127.57 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.488 -1.382 . . . . 0.0 110.434 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 63' ' ' PHE . 2.8 tpp . . . . . 0 C--N 1.302 -1.495 0 O-C-N 121.624 -0.672 . . . . 0.0 109.797 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 52' ' ' MET . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.915 ' C ' HD13 ' A' ' 27' ' ' LEU . 24.8 p90 -141.72 -174.21 4.0 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.199 -1.177 . . . . 0.0 110.519 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.674 ' N ' HD13 ' A' ' 27' ' ' LEU . . . -153.84 113.59 0.58 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.63 ' CE1' ' CG ' ' A' ' 23' ' ' PHE . 18.4 m-85 -83.98 149.91 25.99 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.365 -1.079 . . . . 0.0 109.605 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.778 HG21 HD11 ' A' ' 36' ' ' LEU . 3.6 t -149.8 110.2 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.163 -0.961 . . . . 0.0 110.274 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.562 ' O ' HG23 ' A' ' 67' ' ' THR . 12.8 t -90.39 53.94 2.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.249 -0.907 . . . . 0.0 110.523 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.567 ' CZ ' ' SD ' ' A' ' 22' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.124 -0.985 . . . . 0.0 110.412 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 75' ' ' ASP . . . . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.328 0.585 . . . . 0.0 110.064 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.809 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -42.28 -85.13 0.01 OUTLIER Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.7 t -42.6 -27.02 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.308 -1.113 . . . . 0.0 110.68 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -68.24 -82.67 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.113 -0.992 . . . . 0.0 110.192 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.466 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -40.24 -28.54 0.06 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.34 -0.85 . . . . 0.0 109.715 179.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.956 HG11 ' HE3' ' A' ' 22' ' ' MET . 55.2 t -68.55 -43.51 83.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 O-C-N 121.459 -0.776 . . . . 0.0 110.319 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.009 HD23 ' N ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -59.68 -36.58 76.74 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 120.907 -1.12 . . . . 0.0 108.215 179.385 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 1.009 ' N ' HD23 ' A' ' 78' ' ' LEU . . . -48.25 -29.17 3.55 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.554 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -107.28 28.17 8.35 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.339 0.59 . . . . 0.0 109.411 179.182 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.491 ' O ' ' HD2' ' A' ' 92' ' ' PRO . 2.9 p -49.14 -18.64 0.35 Allowed 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.143 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -107.35 -15.18 14.7 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.471 -0.768 . . . . 0.0 109.623 179.142 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.812 ' ND1' HD12 ' A' ' 90' ' ' ILE . 0.2 OUTLIER 56.86 -80.94 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.834 0.826 . . . . 0.0 110.321 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.946 ' C ' HD23 ' A' ' 85' ' ' LEU . 3.0 tt0 54.41 123.18 0.0 OUTLIER 'General case' 0 C--N 1.288 -2.087 0 CA-C-O 122.177 0.989 . . . . 0.0 110.895 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.946 HD23 ' C ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -154.29 -88.55 0.05 OUTLIER 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.59 -0.694 . . . . 0.0 109.339 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.566 ' O ' ' CB ' ' A' ' 87' ' ' SER . 0.6 OUTLIER -82.01 52.31 1.94 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.111 -0.993 . . . . 0.0 108.848 178.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.566 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 76.72 6.8 3.32 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.231 0.539 . . . . 0.0 110.102 -179.317 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.596 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 1.6 mmtm -116.03 117.55 30.43 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.283 -0.886 . . . . 0.0 110.729 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.787 ' O ' HG23 ' A' ' 89' ' ' THR . 10.2 t -88.85 80.18 7.21 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.734 -0.604 . . . . 0.0 109.714 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.859 HG23 ' C ' ' A' ' 26' ' ' GLY . 1.5 mt -52.58 -173.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.238 -0.914 . . . . 0.0 109.743 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.599 ' H ' HG22 ' A' ' 90' ' ' ILE . 4.6 t70 -144.54 84.2 9.3 Favored Pre-proline 0 N--CA 1.484 1.271 0 O-C-N 120.952 -1.092 . . . . 0.0 111.052 -178.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.554 ' CG ' ' O ' ' A' ' 80' ' ' GLN . 2.2 Cg_endo -56.08 113.46 1.45 Allowed 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.419 1.22 . . . . 0.0 110.962 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.618 ' HD2' ' CD2' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -132.48 109.96 10.17 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.35 -0.844 . . . . 0.0 109.451 178.264 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.745 HG22 ' HB2' ' A' ' 22' ' ' MET . 40.9 t -96.19 157.89 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.556 -0.715 . . . . 0.0 110.553 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 94' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.334 -0.854 . . . . 0.0 110.565 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.552 ' HB2' ' CB ' ' A' ' 67' ' ' THR . 1.3 ptpt . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.301 0.572 . . . . 0.0 110.426 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.973 ' CG ' HG13 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -100.81 170.81 8.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.39 -0.819 . . . . 0.0 109.698 179.648 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.65 ' HB3' ' HD2' ' A' ' 93' ' ' LYS . 19.5 t80 -147.0 155.19 42.05 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.084 -1.01 . . . . 0.0 110.353 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.494 HD13 ' HA ' ' A' ' 92' ' ' PRO . 24.9 mm -121.26 151.79 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.321 -0.862 . . . . 0.0 109.282 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.668 ' O ' HG22 ' A' ' 90' ' ' ILE . . . -133.78 138.96 10.49 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.33 -1.414 . . . . 0.0 111.341 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.879 ' O ' HD12 ' A' ' 90' ' ' ILE . . . 103.33 29.67 5.61 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.01 HD22 ' O ' ' A' ' 63' ' ' PHE . 0.8 OUTLIER -53.38 112.89 0.98 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.485 -1.009 . . . . 0.0 110.523 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.517 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -56.58 173.57 0.18 Allowed 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.411 -0.806 . . . . 0.0 110.056 179.671 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -80.33 11.54 3.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.315 -0.866 . . . . 0.0 110.493 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -133.44 -0.38 3.25 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.114 -0.991 . . . . 0.0 110.501 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.736 HG21 ' HG ' ' A' ' 27' ' ' LEU . 18.4 m -64.62 158.03 25.48 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.354 -0.841 . . . . 0.0 110.207 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.505 ' CG2' ' HA3' ' A' ' 35' ' ' GLY . 12.5 t -135.28 -173.15 3.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.121 -0.987 . . . . 0.0 110.069 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 36' ' ' LEU . 31.6 mt-30 -90.16 -74.76 0.48 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.198 -0.939 . . . . 0.0 110.202 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.53 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -48.72 -48.09 40.78 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.727 -1.189 . . . . 0.0 108.724 179.758 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.505 ' HA3' ' CG2' ' A' ' 32' ' ' THR . . . -48.92 -32.97 12.3 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 107.451 -2.26 . . . . 0.0 107.451 178.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.746 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -78.88 -39.76 34.25 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.361 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.505 ' CG ' ' HA ' ' A' ' 34' ' ' GLU . 3.2 mtt180 -57.81 -25.6 60.82 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.484 1.135 . . . . 0.0 107.974 178.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.53 ' CG ' ' O ' ' A' ' 34' ' ' GLU . 1.3 mt-10 -89.09 -21.11 23.56 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.632 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.67 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 20.5 t80 -73.49 -29.99 62.86 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.916 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.878 ' HE1' HG13 ' A' ' 77' ' ' VAL . 44.9 m-85 -110.89 -24.56 10.34 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.525 -0.735 . . . . 0.0 109.061 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.58 -9.44 74.02 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -73.78 -52.04 14.44 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.409 -1.054 . . . . 0.0 110.461 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.582 ' CZ ' ' HA ' ' A' ' 40' ' ' PHE . 3.7 p90 -104.81 8.98 35.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.295 -0.878 . . . . 0.0 110.491 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.87 175.43 32.93 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 68' ' ' PHE . 59.8 mm-40 -98.0 110.15 22.78 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.25 -1.147 . . . . 0.0 109.997 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.461 HG13 ' SG ' ' A' ' 49' ' ' CYS . 23.8 t -89.74 123.27 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 0.0 110.364 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.6 -26.2 16.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.406 -0.809 . . . . 0.0 109.75 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.944 ' O ' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER 179.95 151.89 0.43 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.438 -0.789 . . . . 0.0 110.006 179.686 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.532 ' HB3' HD21 ' A' ' 36' ' ' LEU . 9.3 m -145.34 174.72 10.87 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.331 -0.855 . . . . 0.0 110.012 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.801 HD12 ' N ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -148.36 144.41 27.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 110.375 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.891 HG13 ' CD2' ' A' ' 27' ' ' LEU . 86.0 t -132.33 134.88 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.624 -1.297 . . . . 0.0 110.997 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.304 -1.38 0 O-C-N 121.585 -0.697 . . . . 0.0 109.585 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.448 ' C ' ' HB2' ' A' ' 27' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 1.01 ' O ' HD22 ' A' ' 27' ' ' LEU . 2.4 p90 -150.26 -177.94 6.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.208 -1.172 . . . . 0.0 110.598 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.813 ' N ' HD13 ' A' ' 27' ' ' LEU . . . -147.31 121.06 1.33 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.671 ' CD2' HD21 ' A' ' 50' ' ' LEU . 21.6 m-85 -84.04 153.25 23.92 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.4 -1.059 . . . . 0.0 110.384 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.678 HG22 HD11 ' A' ' 36' ' ' LEU . 13.9 t -150.07 129.58 3.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.5 -0.75 . . . . 0.0 109.208 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.944 HG22 ' O ' ' A' ' 48' ' ' GLU . 9.9 t -119.12 59.2 0.84 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.144 -0.972 . . . . 0.0 111.039 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.683 ' CZ ' HG21 ' A' ' 77' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.718 0 O-C-N 120.947 -1.096 . . . . 0.0 109.91 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 75' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.216 0.531 . . . . 0.0 110.306 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -48.11 -65.38 2.53 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.903 ' O ' HD12 ' A' ' 78' ' ' LEU . 25.5 t -47.12 -52.62 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.199 -1.177 . . . . 0.0 110.39 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 72' ' ' ALA . 15.7 m-20 -42.63 -52.07 4.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.145 -0.972 . . . . 0.0 110.173 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.655 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -59.46 -39.4 83.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.394 -0.816 . . . . 0.0 110.155 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.878 HG13 ' HE1' ' A' ' 40' ' ' PHE . 81.7 t -55.33 -60.4 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 O-C-N 121.072 -1.017 . . . . 0.0 109.621 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.903 HD12 ' O ' ' A' ' 74' ' ' VAL . 1.6 mp -44.12 -42.46 6.32 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.234 -0.916 . . . . 0.0 109.423 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -46.88 -27.9 1.4 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.176 -0.953 . . . . 0.0 109.383 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.563 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 13.9 mm100 -101.66 22.0 13.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.426 -0.796 . . . . 0.0 109.894 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.46 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 47.0 t -51.7 -16.92 0.74 Allowed 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.007 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.469 ' O ' ' C ' ' A' ' 83' ' ' HIS . 9.6 ptt180 -100.56 -10.39 21.06 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 121.369 -0.832 . . . . 0.0 109.686 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.67 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 0.5 OUTLIER 31.69 43.99 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.811 -0.555 . . . . 0.0 111.851 179.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 2.4 tt0 -93.4 122.58 35.96 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.795 -1.162 . . . . 0.0 110.103 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.502 HD23 ' C ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -155.0 -83.38 0.07 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.553 -0.717 . . . . 0.0 110.189 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.559 ' CB ' ' HD3' ' A' ' 88' ' ' LYS . 0.3 OUTLIER -78.4 52.74 1.18 Allowed 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.036 -1.04 . . . . 0.0 109.425 179.525 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.522 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 71.62 1.43 3.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.522 -0.736 . . . . 0.0 110.619 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.559 ' HD3' ' CB ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -112.69 126.5 55.46 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.104 -0.997 . . . . 0.0 110.249 -179.821 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.655 ' O ' HG23 ' A' ' 89' ' ' THR . 11.5 t -105.82 64.97 0.69 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.666 -0.646 . . . . 0.0 110.361 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.879 HD12 ' O ' ' A' ' 26' ' ' GLY . 0.9 OUTLIER -53.0 -176.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.28 -0.888 . . . . 0.0 109.016 179.892 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' A' ' 25' ' ' GLY . 5.3 t70 -145.11 84.65 8.56 Favored Pre-proline 0 N--CA 1.485 1.28 0 O-C-N 120.653 -1.279 . . . . 0.0 111.052 -178.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.565 ' HG3' ' HD2' ' A' ' 83' ' ' HIS . 1.9 Cg_endo -57.39 112.79 1.23 Allowed 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.565 1.298 . . . . 0.0 110.634 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.65 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -111.3 107.14 16.32 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.035 -1.041 . . . . 0.0 108.983 178.237 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.973 HG13 ' CG ' ' A' ' 22' ' ' MET . 93.2 t -97.28 153.4 3.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.704 -0.623 . . . . 0.0 110.372 -179.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.206 -0.934 . . . . 0.0 110.022 179.826 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.473 ' HB2' ' OG1' ' A' ' 67' ' ' THR . 3.5 pttt . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.251 0.548 . . . . 0.0 109.996 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.92 ' CG ' HG22 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -76.66 162.07 28.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.249 -0.907 . . . . 0.0 110.226 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.661 ' C ' HD12 ' A' ' 24' ' ' ILE . 19.9 t80 -149.54 145.96 27.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.306 -0.871 . . . . 0.0 109.935 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.661 HD12 ' C ' ' A' ' 23' ' ' PHE . 1.1 mp -113.37 142.45 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 108.905 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.626 ' O ' HG22 ' A' ' 90' ' ' ILE . . . -120.42 127.16 6.94 Favored Glycine 0 N--CA 1.494 2.522 0 C-N-CA 119.478 -1.344 . . . . 0.0 111.472 -178.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.844 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 107.32 45.11 1.18 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.943 ' CD2' HG13 ' A' ' 51' ' ' VAL . 1.1 tp -56.47 113.97 1.82 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.103 -1.234 . . . . 0.0 110.508 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.502 ' CB ' ' HG2' ' A' ' 88' ' ' LYS . 6.1 t -45.5 170.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.471 -0.768 . . . . 0.0 110.321 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 39.9 p-90 -81.5 11.55 4.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.261 -0.899 . . . . 0.0 110.451 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -143.98 8.95 1.48 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.18 -0.95 . . . . 0.0 110.52 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.63 HG21 ' HG ' ' A' ' 27' ' ' LEU . 1.4 m -70.68 163.1 27.8 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.294 -0.879 . . . . 0.0 110.097 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.531 HG23 ' H ' ' A' ' 35' ' ' GLY . 4.4 t -142.72 -175.64 4.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.125 -0.984 . . . . 0.0 109.997 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 36' ' ' LEU . 6.5 mt-30 -80.26 -73.1 0.38 Allowed 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.035 -1.041 . . . . 0.0 111.014 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.534 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -48.0 -49.59 30.39 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 118.48 -1.288 . . . . 0.0 108.765 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.531 ' H ' HG23 ' A' ' 32' ' ' THR . . . -47.73 -31.04 7.15 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 107.753 -2.139 . . . . 0.0 107.753 178.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.905 HD21 ' HB2' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -78.45 -39.35 38.83 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 178.283 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.489 ' N ' ' O ' ' A' ' 34' ' ' GLU . 71.7 mtt180 -59.22 -26.42 64.85 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 178.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.534 ' HG3' ' O ' ' A' ' 34' ' ' GLU . 1.3 mt-10 -88.08 -19.68 26.73 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.692 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 8.3 t80 -79.38 -43.04 24.21 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.771 -0.771 . . . . 0.0 110.735 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.846 ' HE1' HG13 ' A' ' 77' ' ' VAL . 28.4 m-85 -105.92 -28.11 10.79 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.387 -0.821 . . . . 0.0 109.217 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.579 ' CA ' HG23 ' A' ' 46' ' ' VAL . . . -67.35 -10.09 56.36 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.647 -1.781 . . . . 0.0 108.647 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -63.05 -37.14 85.99 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.379 -1.071 . . . . 0.0 109.873 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.499 ' HE1' HG22 ' A' ' 77' ' ' VAL . 3.2 p90 -127.23 0.79 6.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.491 -0.756 . . . . 0.0 109.897 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.608 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -146.54 97.55 0.19 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -37.87 122.76 1.02 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.559 -0.965 . . . . 0.0 110.638 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.579 HG23 ' CA ' ' A' ' 41' ' ' GLY . 21.3 t -91.06 119.92 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.356 -0.84 . . . . 0.0 110.727 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -86.14 -21.56 27.5 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.358 -0.839 . . . . 0.0 109.637 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -178.75 145.16 0.29 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.366 -0.834 . . . . 0.0 110.384 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.905 ' HB2' HD21 ' A' ' 36' ' ' LEU . 5.5 p -148.05 170.16 18.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.287 -0.883 . . . . 0.0 109.93 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.769 HD21 ' CD2' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -148.97 133.66 17.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.873 -1.142 . . . . 0.0 110.927 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.943 HG13 ' CD2' ' A' ' 27' ' ' LEU . 61.6 t -110.51 130.19 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.808 -1.183 . . . . 0.0 109.487 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.501 ' SD ' ' CZ ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--N 1.303 -1.435 0 O-C-N 121.174 -0.954 . . . . 0.0 110.612 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.473 ' C ' ' CD2' ' A' ' 63' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 108.461 -1.856 . . . . 0.0 108.461 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.879 ' C ' HD13 ' A' ' 27' ' ' LEU . 8.2 p90 -177.66 178.15 1.04 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.303 -1.116 . . . . 0.0 110.367 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.863 ' N ' HD13 ' A' ' 27' ' ' LEU . . . -141.67 164.36 26.71 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.769 ' CD2' HD21 ' A' ' 50' ' ' LEU . 13.6 m-85 -124.56 148.38 47.85 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.356 -1.085 . . . . 0.0 109.822 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.517 HG23 ' C ' ' A' ' 65' ' ' PHE . 7.5 t -148.71 126.8 3.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.317 -0.865 . . . . 0.0 110.171 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.619 HG22 ' O ' ' A' ' 67' ' ' THR . 88.4 m -106.14 19.51 20.41 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.282 -0.886 . . . . 0.0 110.079 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.615 ' CE2' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.464 0 O-C-N 121.151 -0.968 . . . . 0.0 109.728 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 73' ' ' GLY . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.173 0.511 . . . . 0.0 110.348 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.674 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -43.48 -63.75 2.04 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.666 HG22 HG11 ' A' ' 94' ' ' VAL . 11.1 t -54.45 -23.8 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.136 -1.214 . . . . 0.0 110.0 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.486 ' HB3' ' HE3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -75.38 -73.13 0.27 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 110.017 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.486 ' HE3' ' HB3' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -47.55 -46.47 27.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.378 -0.826 . . . . 0.0 109.818 179.807 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.846 HG13 ' HE1' ' A' ' 40' ' ' PHE . 79.9 t -52.59 -53.25 21.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.069 -1.02 . . . . 0.0 108.691 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -41.02 -51.81 3.23 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.659 -0.651 . . . . 0.0 110.064 179.012 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -42.85 -27.26 0.17 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.441 -0.787 . . . . 0.0 110.19 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.562 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 9.7 mm-40 -104.58 21.85 16.06 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.265 -0.897 . . . . 0.0 110.29 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.508 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 40.3 t -51.76 -16.86 0.75 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.481 -0.762 . . . . 0.0 109.276 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.5 OUTLIER -108.33 -4.41 17.47 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 121.346 -0.846 . . . . 0.0 109.939 179.348 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.841 ' CE1' HD12 ' A' ' 90' ' ' ILE . 0.4 OUTLIER 34.39 31.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.786 -0.571 . . . . 0.0 111.241 179.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -86.24 117.78 25.27 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 118.39 -1.324 . . . . 0.0 110.205 179.502 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.534 HD11 ' HZ1' ' A' ' 88' ' ' LYS . 0.1 OUTLIER -153.78 -73.68 0.13 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.808 -0.558 . . . . 0.0 110.231 -179.249 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 87' ' ' SER . 0.4 OUTLIER -81.27 49.07 1.22 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.165 -0.96 . . . . 0.0 109.474 179.552 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 71.68 -0.11 3.29 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.539 -0.726 . . . . 0.0 110.651 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.673 ' HE3' HD11 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -115.35 138.66 50.74 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.182 -0.949 . . . . 0.0 110.084 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.789 ' O ' HG23 ' A' ' 89' ' ' THR . 14.9 t -113.11 71.27 0.74 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.544 -0.723 . . . . 0.0 110.799 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.844 HG23 ' C ' ' A' ' 26' ' ' GLY . 1.2 mt -55.0 -171.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.32 -0.863 . . . . 0.0 109.534 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.585 ' H ' HG22 ' A' ' 90' ' ' ILE . 5.1 t70 -143.82 87.04 8.3 Favored Pre-proline 0 N--CA 1.486 1.355 0 O-C-N 120.882 -1.136 . . . . 0.0 111.192 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.562 ' CG ' ' O ' ' A' ' 80' ' ' GLN . 2.0 Cg_endo -62.49 112.23 1.53 Allowed 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.53 1.279 . . . . 0.0 111.057 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.641 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -115.43 109.32 17.69 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.115 -0.991 . . . . 0.0 109.066 178.111 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.92 HG22 ' CG ' ' A' ' 22' ' ' MET . 53.6 t -97.04 151.57 4.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.521 -0.737 . . . . 0.0 110.291 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.203 -0.936 . . . . 0.0 110.375 -179.871 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.251 0.548 . . . . 0.0 110.343 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.981 ' CG ' HG13 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -73.06 -172.12 1.01 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.349 -0.845 . . . . 0.0 109.839 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.686 ' CG ' ' CE1' ' A' ' 65' ' ' PHE . 6.5 t80 -151.01 145.38 25.5 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.015 -1.053 . . . . 0.0 110.211 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.743 HD12 ' CZ ' ' A' ' 40' ' ' PHE . 18.6 mm -118.49 126.34 75.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.299 -0.876 . . . . 0.0 108.905 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.56 ' O ' HG22 ' A' ' 90' ' ' ILE . . . -109.83 159.63 13.86 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.789 -1.196 . . . . 0.0 111.227 -178.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 90' ' ' ILE . . . 54.35 40.25 67.82 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.006 HD22 ' CA ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -85.56 143.41 28.5 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.676 -0.897 . . . . 0.0 110.926 -179.135 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.5 ' O ' ' HB ' ' A' ' 31' ' ' THR . 0.5 OUTLIER -39.39 134.81 1.16 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.465 0.65 . . . . 0.0 110.942 -179.076 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.526 ' CG ' ' N ' ' A' ' 30' ' ' GLN . 31.0 p-90 -68.28 -37.97 81.22 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.361 -0.837 . . . . 0.0 109.947 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.526 ' N ' ' CG ' ' A' ' 29' ' ' TRP . 12.3 pt20 -74.76 0.21 16.07 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.396 -0.815 . . . . 0.0 110.696 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.5 ' HB ' ' O ' ' A' ' 28' ' ' SER . 4.4 m -69.24 153.86 42.97 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.392 -0.817 . . . . 0.0 110.215 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.552 HG23 ' H ' ' A' ' 35' ' ' GLY . 5.9 t -123.79 -174.18 2.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 109.625 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 36' ' ' LEU . 1.7 mt-30 -72.28 -73.15 0.2 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.044 -1.035 . . . . 0.0 110.855 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -48.33 -50.01 31.97 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 118.569 -1.252 . . . . 0.0 108.845 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.552 ' H ' HG23 ' A' ' 32' ' ' THR . . . -49.47 -29.23 10.94 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 107.795 -2.122 . . . . 0.0 107.795 178.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.921 HD21 ' HB2' ' A' ' 49' ' ' CYS . 0.1 OUTLIER -81.72 -38.24 26.08 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 178.315 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.491 ' HG3' ' HA ' ' A' ' 34' ' ' GLU . 13.9 mtp180 -58.71 -27.31 64.75 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.509 ' HG3' ' O ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -89.25 -21.35 23.26 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.793 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.579 ' OH ' ' CG ' ' A' ' 83' ' ' HIS . 38.2 t80 -67.84 -29.17 68.24 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.568 0.699 . . . . 0.0 109.85 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.884 ' HE1' HG13 ' A' ' 77' ' ' VAL . 38.4 m-85 -117.66 -18.72 9.6 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -70.17 -12.59 69.05 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -62.19 -47.82 82.77 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.452 -1.028 . . . . 0.0 109.691 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.582 ' HE1' HG22 ' A' ' 77' ' ' VAL . 6.0 p90 -119.61 7.87 11.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.519 -0.738 . . . . 0.0 109.911 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.464 ' O ' ' HA2' ' A' ' 41' ' ' GLY . . . -159.41 99.99 0.18 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 13.3 pt-20 -41.26 148.79 0.12 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.433 -1.039 . . . . 0.0 110.099 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.791 HG22 ' CB ' ' A' ' 68' ' ' PHE . 48.8 t -122.6 147.38 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.192 -0.943 . . . . 0.0 110.868 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -106.3 -32.7 8.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.414 -0.804 . . . . 0.0 109.887 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.765 ' O ' HG22 ' A' ' 67' ' ' THR . 0.9 OUTLIER -167.51 152.03 6.81 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.248 -0.908 . . . . 0.0 110.294 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.921 ' HB2' HD21 ' A' ' 36' ' ' LEU . 29.7 p -150.8 167.42 27.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.178 -0.951 . . . . 0.0 110.285 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.67 ' C ' HD12 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -138.6 126.23 22.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.168 -0.957 . . . . 0.0 109.872 179.504 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.488 HG23 HD23 ' A' ' 36' ' ' LEU . 61.6 t -115.09 130.44 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.634 -1.292 . . . . 0.0 111.261 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.445 ' HB3' ' HE2' ' A' ' 52' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.425 0 O-C-N 121.6 -0.688 . . . . 0.0 109.292 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 1.006 ' CA ' HD22 ' A' ' 27' ' ' LEU . 7.4 p90 -151.54 -172.71 4.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.192 -1.181 . . . . 0.0 110.666 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.564 ' N ' HD13 ' A' ' 27' ' ' LEU . . . -153.48 120.19 1.02 Allowed Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.686 ' CE1' ' CG ' ' A' ' 23' ' ' PHE . 17.3 m-85 -83.94 149.31 26.4 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.453 -1.028 . . . . 0.0 109.153 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.695 ' CG2' HD11 ' A' ' 36' ' ' LEU . 3.5 t -150.0 114.51 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.11 -0.994 . . . . 0.0 110.845 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.765 HG22 ' O ' ' A' ' 48' ' ' GLU . 8.9 t -80.07 4.09 18.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.175 -0.953 . . . . 0.0 109.694 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.791 ' CB ' HG22 ' A' ' 46' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.3 -0.875 . . . . 0.0 110.105 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.234 0.54 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.663 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -47.71 -77.64 0.11 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.569 HG22 HG11 ' A' ' 94' ' ' VAL . 51.1 t -40.95 -51.84 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.33 -1.1 . . . . 0.0 110.481 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.476 ' HA ' HD21 ' A' ' 78' ' ' LEU . 3.8 m-20 -47.1 -52.91 14.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -0.927 . . . . 0.0 110.295 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.661 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -67.05 -35.76 80.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.465 -0.772 . . . . 0.0 110.531 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.884 HG13 ' HE1' ' A' ' 40' ' ' PHE . 49.8 t -54.58 -72.8 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.057 -1.027 . . . . 0.0 109.753 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.476 HD21 ' HA ' ' A' ' 75' ' ' ASP . 1.1 pp -46.82 -37.42 8.67 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.909 -1.119 . . . . 0.0 109.289 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -51.69 -25.76 7.93 Favored 'General case' 0 C--N 1.308 -1.235 0 O-C-N 121.1 -1.0 . . . . 0.0 108.685 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.591 ' HB3' ' CE1' ' A' ' 83' ' ' HIS . 13.3 mm-40 -103.99 26.28 8.91 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.465 0.65 . . . . 0.0 109.351 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.557 ' HA ' ' HD2' ' A' ' 92' ' ' PRO . 47.4 t -54.54 -15.83 1.99 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.544 ' O ' ' C ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -113.54 8.19 17.66 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.611 -0.681 . . . . 0.0 109.66 179.099 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.638 ' CD2' ' HG3' ' A' ' 92' ' ' PRO . 2.6 m-70 -3.38 -78.01 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.736 ' C ' HD23 ' A' ' 85' ' ' LEU . 4.4 tt0 59.38 122.46 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 121.467 0.651 . . . . 0.0 109.49 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 1.083 HD21 HD11 ' A' ' 90' ' ' ILE . 0.4 OUTLIER -157.58 -37.81 0.07 Allowed 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.274 -0.97 . . . . 0.0 110.502 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 87' ' ' SER . 1.5 t70 -121.88 48.03 1.78 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 74.44 1.33 3.82 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -177.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -117.05 119.43 35.25 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.685 ' O ' HG23 ' A' ' 89' ' ' THR . 7.3 t -92.45 77.91 5.04 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 1.083 HD11 HD21 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -40.98 167.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 CA-C-O 121.897 0.856 . . . . 0.0 110.615 -178.8 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 25' ' ' GLY . 4.6 t70 -133.2 69.63 78.01 Favored Pre-proline 0 C--N 1.297 -1.694 0 O-C-N 121.685 -0.635 . . . . 0.0 109.448 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.638 ' HG3' ' CD2' ' A' ' 83' ' ' HIS . 1.8 Cg_endo -49.58 112.84 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.566 1.298 . . . . 0.0 109.882 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.525 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.1 OUTLIER -126.75 107.95 10.61 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.871 0.843 . . . . 0.0 110.009 179.192 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.981 HG13 ' CG ' ' A' ' 22' ' ' MET . 76.3 t -95.99 153.72 3.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.095 -1.003 . . . . 0.0 110.427 -179.518 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.468 ' HB2' ' CA ' ' A' ' 67' ' ' THR . 1.1 pttm . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.185 0.517 . . . . 0.0 110.105 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.796 ' CB ' HG22 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -55.23 155.85 4.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 110.218 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.633 ' CD2' ' CE ' ' A' ' 93' ' ' LYS . 0.5 OUTLIER -138.54 119.61 14.49 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.582 -0.699 . . . . 0.0 109.444 -179.804 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.621 ' CG2' HG21 ' A' ' 90' ' ' ILE . 1.2 mp -93.65 137.89 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.081 -1.012 . . . . 0.0 109.12 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.543 ' O ' ' CG2' ' A' ' 90' ' ' ILE . . . -110.62 133.05 11.32 Favored Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.823 -1.179 . . . . 0.0 112.324 -177.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.884 ' O ' HD12 ' A' ' 90' ' ' ILE . . . 62.55 36.97 93.95 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.902 HD22 ' CA ' ' A' ' 63' ' ' PHE . 0.4 OUTLIER -61.65 150.96 34.91 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.529 -0.983 . . . . 0.0 110.706 -179.339 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.672 ' O ' HG22 ' A' ' 31' ' ' THR . 0.4 OUTLIER -39.51 123.11 1.43 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.49 0.662 . . . . 0.0 110.771 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 6.5 p-90 -63.9 -14.29 52.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.504 -0.747 . . . . 0.0 110.146 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.466 ' O ' ' O ' ' A' ' 31' ' ' THR . 4.1 pt20 -100.04 -21.74 15.5 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.373 -0.83 . . . . 0.0 110.908 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.672 HG22 ' O ' ' A' ' 28' ' ' SER . 2.3 t -55.41 -161.93 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.447 0.641 . . . . 0.0 110.397 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.524 ' N ' HG23 ' A' ' 31' ' ' THR . 6.1 t -158.74 -168.99 2.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.877 . . . . 0.0 109.857 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 36' ' ' LEU . 15.1 mt-30 -79.55 -70.53 0.5 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.162 -0.961 . . . . 0.0 110.432 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.536 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -46.32 -52.29 13.01 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.959 -1.096 . . . . 0.0 109.237 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.458 ' H ' HG23 ' A' ' 32' ' ' THR . . . -48.4 -31.34 9.0 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.869 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -79.76 -36.81 36.64 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.448 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.511 ' HG3' ' HA ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -60.76 -27.97 68.37 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 122.455 1.121 . . . . 0.0 108.052 177.728 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.536 ' HG3' ' O ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -86.02 -19.9 29.64 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.541 179.091 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.688 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 13.6 t80 -78.64 -35.29 45.66 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.988 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.906 ' HE1' HG13 ' A' ' 77' ' ' VAL . 38.7 m-85 -109.14 -22.96 11.87 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.213 -0.93 . . . . 0.0 109.416 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -76.79 -3.61 80.17 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.581 -1.807 . . . . 0.0 108.581 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -73.86 -50.59 19.6 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 121.495 -1.003 . . . . 0.0 110.19 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.601 ' CZ ' ' HA ' ' A' ' 40' ' ' PHE . 2.9 p90 -103.35 13.1 34.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 110.18 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' A' ' 45' ' ' GLU . . . -150.24 -111.8 0.56 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.449 ' HB3' ' O ' ' A' ' 44' ' ' GLY . 0.4 OUTLIER 176.83 104.39 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.533 -0.981 . . . . 0.0 109.408 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.503 ' HA ' ' CB ' ' A' ' 68' ' ' PHE . 95.1 t -90.56 137.78 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.312 -0.867 . . . . 0.0 111.04 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -101.7 -26.87 13.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.52 -0.737 . . . . 0.0 109.163 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -166.9 154.79 9.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.547 -0.721 . . . . 0.0 109.796 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.491 ' SG ' ' CD ' ' A' ' 37' ' ' ARG . 21.0 p -148.68 175.4 11.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.123 -0.986 . . . . 0.0 110.719 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.623 HD21 ' CD2' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -150.51 132.11 14.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -0.833 . . . . 0.0 109.902 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.769 HG13 HD11 ' A' ' 27' ' ' LEU . 48.2 t -129.1 147.04 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.548 -1.345 . . . . 0.0 111.298 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.146 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.902 ' CA ' HD22 ' A' ' 27' ' ' LEU . 41.4 p90 -140.5 -168.86 2.65 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.09 -1.241 . . . . 0.0 110.472 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 50' ' ' LEU . . . -155.8 179.71 31.53 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.623 ' CD2' HD21 ' A' ' 50' ' ' LEU . 16.8 m-85 -148.6 146.68 28.34 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.493 -1.004 . . . . 0.0 108.751 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.802 HG21 HD11 ' A' ' 36' ' ' LEU . 5.6 t -148.08 106.18 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 120.806 -1.184 . . . . 0.0 111.295 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.468 ' CA ' ' HB2' ' A' ' 21' ' ' LYS . 39.0 m -82.45 56.76 3.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.14 -0.975 . . . . 0.0 110.049 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.626 ' CE1' ' HB2' ' A' ' 22' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 110.74 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.511 0.672 . . . . 0.0 109.723 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.772 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -59.14 -55.05 32.97 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.8 t -45.17 -38.93 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.124 -1.221 . . . . 0.0 110.354 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.87 -73.31 0.13 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.211 -0.931 . . . . 0.0 110.303 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.545 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -45.09 -43.06 9.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.241 -0.912 . . . . 0.0 109.469 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.906 HG13 ' HE1' ' A' ' 40' ' ' PHE . 93.4 t -54.02 -55.61 13.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.251 -0.905 . . . . 0.0 108.886 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.634 HD13 ' HB2' ' A' ' 81' ' ' SER . 0.1 OUTLIER -40.41 -47.27 2.55 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.716 -0.615 . . . . 0.0 109.993 178.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -43.53 -26.96 0.25 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.507 -0.746 . . . . 0.0 109.678 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.541 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 43.8 mm-40 -103.08 24.71 10.4 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.447 -0.783 . . . . 0.0 110.056 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.634 ' HB2' HD13 ' A' ' 78' ' ' LEU . 30.4 t -57.8 -13.74 4.76 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.556 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -99.71 -17.0 17.96 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 121.425 -0.797 . . . . 0.0 109.675 179.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.688 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 0.7 OUTLIER 31.14 32.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.613 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.556 ' N ' ' O ' ' A' ' 82' ' ' ARG . 0.8 OUTLIER -77.92 121.65 24.44 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.431 -1.418 . . . . 0.0 109.154 179.392 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.498 HD21 ' ND1' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -144.67 -80.88 0.17 Allowed 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.323 -178.562 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.526 ' O ' ' CD ' ' A' ' 88' ' ' LYS . 7.7 t70 -87.1 51.62 2.29 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.506 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 70.44 6.93 6.02 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -178.415 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.547 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 6.4 mmmt -108.49 120.94 43.88 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.58 -0.7 . . . . 0.0 109.964 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.769 ' O ' HG23 ' A' ' 89' ' ' THR . 13.4 t -100.07 67.4 1.4 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.562 -0.711 . . . . 0.0 109.589 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.884 HD12 ' O ' ' A' ' 26' ' ' GLY . 1.3 mm -49.86 -179.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 119.621 -0.831 . . . . 0.0 109.544 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.494 ' H ' HG22 ' A' ' 90' ' ' ILE . 18.8 t0 -141.06 79.56 17.96 Favored Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 121.163 -0.961 . . . . 0.0 110.272 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.541 ' CG ' ' O ' ' A' ' 80' ' ' GLN . 2.4 Cg_endo -51.81 113.11 1.02 Allowed 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.415 1.219 . . . . 0.0 110.201 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.633 ' CE ' ' CD2' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -135.41 113.33 11.08 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.27 -0.894 . . . . 0.0 109.965 179.221 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.796 HG22 ' CB ' ' A' ' 22' ' ' MET . 58.4 t -96.65 172.97 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.253 -0.905 . . . . 0.0 110.253 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.558 ' N ' HG12 ' A' ' 94' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.201 -0.937 . . . . 0.0 110.393 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.913 ' CB ' HG23 ' A' ' 67' ' ' THR . 4.6 pttt . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.229 0.538 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.899 ' CB ' HG13 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -75.79 174.0 10.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.186 -0.946 . . . . 0.0 109.478 179.443 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.691 ' CG ' ' CE1' ' A' ' 65' ' ' PHE . 5.9 t80 -150.6 139.4 20.8 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.204 -0.935 . . . . 0.0 109.825 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.731 ' CG2' HG21 ' A' ' 90' ' ' ILE . 13.6 mm -106.68 152.87 8.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.53 ' O ' HG22 ' A' ' 90' ' ' ILE . . . -126.69 139.3 11.19 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 119.175 -1.488 . . . . 0.0 111.764 -178.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.458 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 56.52 43.65 90.67 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.923 HD22 ' CA ' ' A' ' 63' ' ' PHE . 0.5 OUTLIER -75.74 142.58 42.38 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.412 -1.052 . . . . 0.0 110.63 -179.311 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.69 ' O ' HG22 ' A' ' 31' ' ' THR . 5.0 m -39.57 132.91 1.52 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.617 -0.677 . . . . 0.0 110.447 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.473 ' CZ3' ' HB3' ' A' ' 30' ' ' GLN . 47.6 p-90 -71.16 -17.95 62.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.465 -0.772 . . . . 0.0 110.624 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.473 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 10.9 pt20 -89.58 -18.12 27.19 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.184 -0.948 . . . . 0.0 110.82 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.69 HG22 ' O ' ' A' ' 28' ' ' SER . 6.9 t -55.61 -173.42 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.874 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.687 HG23 ' H ' ' A' ' 35' ' ' GLY . 7.4 t -147.85 -172.6 4.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.348 -0.845 . . . . 0.0 109.875 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 36' ' ' LEU . 3.9 mt-30 -77.79 -74.23 0.27 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.032 -1.043 . . . . 0.0 110.531 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.558 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 2.7 tt0 -48.05 -41.53 26.15 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.949 -1.094 . . . . 0.0 110.182 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.687 ' H ' HG23 ' A' ' 32' ' ' THR . . . -57.47 -28.95 60.08 Favored Glycine 0 C--N 1.296 -1.684 0 N-CA-C 107.424 -2.271 . . . . 0.0 107.424 178.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.854 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -82.5 -38.59 23.64 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.135 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.642 ' HA ' HG21 ' A' ' 46' ' ' VAL . 26.4 mtt180 -61.79 -27.09 68.5 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 122.418 1.104 . . . . 0.0 108.135 178.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.556 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -87.44 -19.27 28.26 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.373 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.653 ' CE1' ' NE2' ' A' ' 83' ' ' HIS . 26.9 t80 -79.24 -30.52 43.21 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.254 -0.904 . . . . 0.0 110.205 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.917 ' CE1' HG13 ' A' ' 77' ' ' VAL . 27.0 m-85 -108.8 -25.33 10.85 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.459 -0.776 . . . . 0.0 109.166 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -70.26 -7.84 60.98 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -63.95 -49.61 71.88 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 121.417 -1.049 . . . . 0.0 109.699 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.528 ' HE1' HG22 ' A' ' 77' ' ' VAL . 1.8 p90 -113.82 12.6 18.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.464 -0.772 . . . . 0.0 109.763 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 45' ' ' GLU . . . -142.85 -117.22 1.23 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.486 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 1.9 pt-20 177.09 103.47 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.406 -1.055 . . . . 0.0 109.906 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.642 HG21 ' HA ' ' A' ' 37' ' ' ARG . 63.3 t -89.41 126.58 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.19 -0.944 . . . . 0.0 110.702 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.95 -26.98 11.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.265 -0.897 . . . . 0.0 109.592 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -158.76 131.94 7.26 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.47 -0.769 . . . . 0.0 109.446 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 24.8 p -150.37 154.64 38.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.972 -1.08 . . . . 0.0 111.288 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.749 ' C ' HD12 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -125.04 126.11 44.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.391 -0.818 . . . . 0.0 109.261 178.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.592 ' CG1' ' N ' ' A' ' 52' ' ' MET . 17.4 t -89.73 169.38 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.79 -1.194 . . . . 0.0 112.104 -178.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.687 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 2.2 ptt? . . . . . 0 C--N 1.305 -1.332 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.733 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.687 ' HA2' ' HA ' ' A' ' 52' ' ' MET . . . . . . . . 0 N--CA 1.481 1.684 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.923 ' CA ' HD22 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -136.99 -176.1 4.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.087 -1.243 . . . . 0.0 109.96 179.282 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.472 ' O ' ' HB ' ' A' ' 24' ' ' ILE . . . -135.22 100.79 0.37 Allowed Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.087 -1.53 . . . . 0.0 110.4 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.691 ' CE1' ' CG ' ' A' ' 23' ' ' PHE . 11.7 m-85 -81.23 136.02 35.79 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.119 -1.224 . . . . 0.0 108.627 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.8 HG21 HD11 ' A' ' 36' ' ' LEU . 3.1 t -145.99 106.6 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 118.782 -1.167 . . . . 0.0 111.16 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.913 HG23 ' CB ' ' A' ' 21' ' ' LYS . 1.4 m -82.63 47.21 1.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.609 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.605 ' CE1' ' HB3' ' A' ' 22' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.357 -0.84 . . . . 0.0 110.619 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.476 0.655 . . . . 0.0 109.939 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.644 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -49.49 -44.63 36.96 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.937 ' O ' HD12 ' A' ' 78' ' ' LEU . 19.5 t -46.73 -52.27 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.352 -1.087 . . . . 0.0 109.868 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.56 ' HA ' HD13 ' A' ' 78' ' ' LEU . 4.6 t0 -54.08 -50.04 67.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.068 -1.02 . . . . 0.0 109.681 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.666 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 6.3 mmpt? -56.26 -35.53 67.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.33 -0.856 . . . . 0.0 109.816 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.917 HG13 ' CE1' ' A' ' 40' ' ' PHE . 60.5 t -59.17 -57.07 13.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 O-C-N 121.045 -1.035 . . . . 0.0 109.477 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.937 HD12 ' O ' ' A' ' 74' ' ' VAL . 2.8 mp -44.84 -41.55 7.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.239 -0.913 . . . . 0.0 109.06 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.666 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -46.34 -27.99 1.2 Allowed 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.304 -0.873 . . . . 0.0 109.281 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.515 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 7.2 mm100 -101.85 25.18 8.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.533 -0.729 . . . . 0.0 109.68 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.51 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 21.4 p -56.44 -16.44 5.81 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.522 ' O ' ' C ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -97.34 -9.49 27.39 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.633 -0.667 . . . . 0.0 109.792 179.193 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.863 ' CE1' HD12 ' A' ' 90' ' ' ILE . 0.6 OUTLIER 19.48 48.9 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 179.81 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.553 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -91.9 125.57 36.66 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 118.493 -1.283 . . . . 0.0 109.172 178.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.568 HD23 ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -145.34 -91.53 0.1 Allowed 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.663 -0.648 . . . . 0.0 109.655 -179.158 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.529 ' O ' ' CB ' ' A' ' 87' ' ' SER . 10.6 m-20 -79.86 52.62 1.51 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.097 -1.002 . . . . 0.0 108.74 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 72.18 9.72 5.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.618 -0.676 . . . . 0.0 109.857 -179.129 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 9.0 mmtt -111.24 120.72 43.21 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.372 -0.83 . . . . 0.0 109.608 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.763 ' O ' HG23 ' A' ' 89' ' ' THR . 11.9 t -101.87 69.23 1.18 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.505 -0.747 . . . . 0.0 109.726 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.863 HD12 ' CE1' ' A' ' 83' ' ' HIS . 0.8 OUTLIER -50.15 -178.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.389 -179.714 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.484 ' H ' HG22 ' A' ' 90' ' ' ILE . 14.2 t0 -141.45 81.04 15.74 Favored Pre-proline 0 C--N 1.3 -1.558 0 O-C-N 121.189 -0.944 . . . . 0.0 109.817 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.526 ' HG3' ' HD2' ' A' ' 83' ' ' HIS . 2.4 Cg_endo -53.96 112.58 1.01 Allowed 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 123.542 1.285 . . . . 0.0 111.275 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.58 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -128.02 104.89 8.04 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.916 0.865 . . . . 0.0 108.848 177.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.899 HG13 ' CB ' ' A' ' 22' ' ' MET . 6.2 t -96.19 -174.49 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 O-C-N 121.854 -0.529 . . . . 0.0 110.004 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.745 ' HB3' ' O ' ' A' ' 94' ' ' VAL . . . . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.181 -0.949 . . . . 0.0 110.431 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.582 ' CB ' HG23 ' A' ' 67' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.212 0.529 . . . . 0.0 110.236 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.918 ' HB2' HG22 ' A' ' 94' ' ' VAL . 0.5 OUTLIER -83.81 178.92 7.72 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.248 -0.907 . . . . 0.0 110.528 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.633 ' HB3' ' HD2' ' A' ' 93' ' ' LYS . 0.1 OUTLIER -150.47 143.68 24.91 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.489 -0.757 . . . . 0.0 109.068 179.785 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.534 HD12 ' C ' ' A' ' 23' ' ' PHE . 1.1 mp -106.85 144.62 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.069 -1.019 . . . . 0.0 109.34 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 91' ' ' ASP . . . -131.51 122.76 3.51 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 119.734 -1.222 . . . . 0.0 111.281 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 1.046 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 113.21 34.0 1.87 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.102 HD21 HG13 ' A' ' 51' ' ' VAL . 2.0 mp -39.93 137.37 0.95 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.682 -0.893 . . . . 0.0 110.715 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.537 ' CB ' ' HG1' ' A' ' 31' ' ' THR . 5.0 p -56.39 -174.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 0.0 110.06 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 47.9 p-90 -77.62 5.23 9.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 0.0 110.238 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -161.67 16.17 0.1 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.111 -0.993 . . . . 0.0 111.158 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.537 ' HG1' ' CB ' ' A' ' 28' ' ' SER . 98.7 m -53.6 157.54 2.16 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.055 -1.028 . . . . 0.0 110.307 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.607 HG23 ' H ' ' A' ' 35' ' ' GLY . 2.8 t -148.23 178.55 8.47 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.101 -1.0 . . . . 0.0 110.27 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.544 ' O ' ' N ' ' A' ' 36' ' ' LEU . 7.1 mt-30 -62.61 -74.14 0.1 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.96 . . . . 0.0 111.166 -178.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.53 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 1.6 tt0 -49.68 -36.05 23.74 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.73 -1.232 . . . . 0.0 110.028 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.607 ' H ' HG23 ' A' ' 32' ' ' THR . . . -61.04 -28.85 69.53 Favored Glycine 0 C--N 1.295 -1.711 0 N-CA-C 107.148 -2.381 . . . . 0.0 107.148 178.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.827 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -80.56 -41.42 24.13 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.047 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.53 ' HG3' ' HA ' ' A' ' 34' ' ' GLU . 19.8 mtp180 -61.65 -27.77 68.91 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 122.385 1.088 . . . . 0.0 108.238 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.547 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.2 OUTLIER -87.25 -15.7 37.37 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.11 179.454 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.691 ' CE2' ' CE1' ' A' ' 83' ' ' HIS . 10.4 t80 -86.76 -43.37 12.59 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 121.345 -0.847 . . . . 0.0 110.797 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.928 ' HE1' HG13 ' A' ' 77' ' ' VAL . 48.1 m-85 -101.36 -33.66 9.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.875 . . . . 0.0 109.193 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -59.76 -17.19 41.38 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -61.96 -45.72 92.44 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.474 -1.015 . . . . 0.0 109.956 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.59 ' HE1' HG22 ' A' ' 77' ' ' VAL . 4.9 p90 -119.58 -2.98 10.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.445 -0.784 . . . . 0.0 109.948 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.467 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -137.77 93.26 0.21 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.537 ' O ' ' CB ' ' A' ' 68' ' ' PHE . 1.9 mt-10 -40.03 105.91 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.411 -1.052 . . . . 0.0 110.15 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 68' ' ' PHE . 43.3 t -88.85 126.06 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 110.446 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -99.12 -31.33 11.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.278 -0.889 . . . . 0.0 110.032 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.81 135.89 17.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.29 -0.881 . . . . 0.0 110.274 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.788 ' HB2' HD21 ' A' ' 36' ' ' LEU . 31.9 p -150.48 166.66 29.48 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.876 . . . . 0.0 110.017 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.73 ' C ' HD12 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -150.45 126.02 10.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.962 -1.086 . . . . 0.0 110.695 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.102 HG13 HD21 ' A' ' 27' ' ' LEU . 98.9 t -113.66 142.29 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.861 -1.149 . . . . 0.0 110.002 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.437 ' HG2' ' CE2' ' A' ' 63' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--N 1.304 -1.398 0 O-C-N 121.287 -0.883 . . . . 0.0 110.376 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 27' ' ' LEU . . . . . . . . 0 N--CA 1.483 1.769 0 N-CA-C 108.349 -1.9 . . . . 0.0 108.349 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.646 ' HA ' HD13 ' A' ' 27' ' ' LEU . 50.3 p90 -132.32 -162.3 1.22 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.092 -1.24 . . . . 0.0 110.376 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 50' ' ' LEU . . . -166.53 174.85 42.0 Favored Glycine 0 N--CA 1.488 2.122 0 C-N-CA 119.319 -1.419 . . . . 0.0 110.677 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.557 ' C ' HG23 ' A' ' 66' ' ' VAL . 9.8 m-85 -136.24 145.09 45.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.756 -0.849 . . . . 0.0 109.008 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.557 HG23 ' C ' ' A' ' 65' ' ' PHE . 16.2 t -149.98 143.4 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.981 -1.074 . . . . 0.0 110.585 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.582 HG23 ' CB ' ' A' ' 21' ' ' LYS . 1.5 m -137.24 58.73 1.7 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.303 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.587 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.071 -1.018 . . . . 0.0 110.557 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 75' ' ' ASP . . . . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.311 0.577 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.729 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -51.65 -74.46 0.29 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 16.4 t -45.73 -32.54 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.22 -1.165 . . . . 0.0 110.092 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 72' ' ' ALA . 0.5 OUTLIER -62.39 -76.84 0.05 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.175 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.451 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -49.19 -42.72 41.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 0.0 109.797 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.928 HG13 ' HE1' ' A' ' 40' ' ' PHE . 62.1 t -54.39 -53.81 27.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 O-C-N 121.103 -0.998 . . . . 0.0 108.916 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -42.76 -52.61 4.92 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.405 -0.809 . . . . 0.0 109.723 178.701 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -44.89 -28.75 0.69 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.344 -0.848 . . . . 0.0 109.531 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.544 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 43.9 mm-40 -97.44 21.44 10.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.478 -0.764 . . . . 0.0 110.037 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 78' ' ' LEU . 47.8 t -56.87 -13.09 2.32 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.506 -0.746 . . . . 0.0 109.093 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.49 ' O ' ' C ' ' A' ' 83' ' ' HIS . 7.0 ptt180 -103.07 -11.39 18.15 Favored 'General case' 0 C--N 1.31 -1.121 0 O-C-N 121.349 -0.845 . . . . 0.0 109.797 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.766 ' ND1' HD12 ' A' ' 90' ' ' ILE . 0.5 OUTLIER 29.63 51.65 0.08 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.877 -0.514 . . . . 0.0 112.127 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.54 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 3.6 tt0 -90.58 126.17 35.86 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.672 -1.268 . . . . 0.0 109.202 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.534 ' CD2' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -147.37 -79.73 0.15 Allowed 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.565 -179.141 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.531 ' O ' ' CD ' ' A' ' 88' ' ' LYS . 7.9 m-20 -85.33 49.89 1.84 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.502 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER 70.22 6.98 6.03 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.483 0.658 . . . . 0.0 109.557 -178.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -110.31 125.9 53.64 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.35 -0.844 . . . . 0.0 109.76 -179.594 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.741 ' O ' HG23 ' A' ' 89' ' ' THR . 9.3 t -99.77 75.45 1.9 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.577 -0.702 . . . . 0.0 109.562 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 1.046 HG23 ' C ' ' A' ' 26' ' ' GLY . 0.9 OUTLIER -52.61 -174.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.372 -0.83 . . . . 0.0 109.181 -179.663 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 25' ' ' GLY . 20.4 t0 -142.26 85.3 10.82 Favored Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 120.565 -1.334 . . . . 0.0 111.684 -178.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.576 ' HG3' ' HD2' ' A' ' 83' ' ' HIS . 2.0 Cg_endo -59.98 113.44 1.65 Allowed 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.462 1.243 . . . . 0.0 110.757 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.633 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -123.67 108.77 12.92 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.03 -1.043 . . . . 0.0 109.774 178.073 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.918 HG22 ' HB2' ' A' ' 22' ' ' MET . 43.0 t -96.24 170.18 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.485 -0.76 . . . . 0.0 110.082 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.494 ' N ' HG12 ' A' ' 94' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.898 . . . . 0.0 110.284 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.21 0.528 . . . . 0.0 110.088 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 1.003 ' CB ' HG22 ' A' ' 94' ' ' VAL . 0.9 OUTLIER -86.15 -169.87 2.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.217 -0.927 . . . . 0.0 110.323 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.656 ' HB3' ' HD2' ' A' ' 93' ' ' LYS . 0.7 OUTLIER -149.97 152.1 34.4 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.355 -0.84 . . . . 0.0 109.466 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.654 HD12 ' C ' ' A' ' 23' ' ' PHE . 1.1 mp -113.46 134.52 55.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.323 -0.86 . . . . 0.0 109.243 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.498 ' O ' ' CG2' ' A' ' 90' ' ' ILE . . . -102.51 136.86 13.05 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.812 -1.185 . . . . 0.0 110.699 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.474 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 58.82 39.72 94.18 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.844 HD13 ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -60.59 154.31 21.43 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.444 -1.033 . . . . 0.0 110.056 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.773 ' O ' HG22 ' A' ' 31' ' ' THR . 0.5 OUTLIER -40.58 134.8 1.71 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.352 -0.843 . . . . 0.0 110.343 -179.673 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 11.0 p-90 -77.43 -12.26 59.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.342 -0.849 . . . . 0.0 110.63 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -110.93 -12.02 14.28 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.086 -1.009 . . . . 0.0 110.63 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.773 HG22 ' O ' ' A' ' 28' ' ' SER . 13.2 t -61.42 -167.26 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.833 0 CA-C-O 121.628 0.728 . . . . 0.0 110.676 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.589 HG23 ' H ' ' A' ' 35' ' ' GLY . 14.7 t -157.18 -168.1 2.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.695 -0.628 . . . . 0.0 109.751 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 36' ' ' LEU . 2.3 mt-30 -68.68 -72.46 0.18 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.082 -1.012 . . . . 0.0 110.207 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.406 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 3.8 tt0 -48.33 -45.77 35.69 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.837 -1.165 . . . . 0.0 109.72 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.589 ' H ' HG23 ' A' ' 32' ' ' THR . . . -55.62 -27.03 47.74 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.927 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -83.66 -32.68 25.5 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.082 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.893 ' HA ' HG11 ' A' ' 46' ' ' VAL . 18.8 mmm-85 -64.96 -28.71 69.7 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.536 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -90.55 -14.68 32.08 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.571 178.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.586 ' OH ' ' CG ' ' A' ' 83' ' ' HIS . 38.7 t80 -81.33 -26.34 35.68 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 121.619 -0.675 . . . . 0.0 110.171 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.798 ' HE1' HG13 ' A' ' 77' ' ' VAL . 14.6 m-85 -122.19 -21.51 5.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.887 . . . . 0.0 109.91 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.93 2.12 65.96 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.409 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 8.2 tp60 -72.1 -55.78 6.74 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 121.426 -1.043 . . . . 0.0 109.971 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.32 12.66 26.15 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.4 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 45' ' ' GLU . . . -154.17 -116.2 0.59 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -179.74 104.39 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.532 -0.981 . . . . 0.0 109.349 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.893 HG11 ' HA ' ' A' ' 37' ' ' ARG . 2.7 p -90.03 149.46 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 111.266 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.77 -39.61 5.53 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.615 -0.678 . . . . 0.0 109.931 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -149.71 148.38 29.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.317 -0.864 . . . . 0.0 110.601 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.822 ' HB2' HD21 ' A' ' 36' ' ' LEU . 17.3 p -151.13 164.03 37.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.294 -0.879 . . . . 0.0 110.661 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.732 ' C ' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -139.3 123.71 18.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.318 -0.864 . . . . 0.0 109.617 179.039 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.649 HG13 HD11 ' A' ' 27' ' ' LEU . 87.0 t -113.11 136.93 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.803 -1.185 . . . . 0.0 111.227 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.526 ' HG2' ' CE1' ' A' ' 63' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--N 1.302 -1.463 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 52' ' ' MET . . . . . . . . 0 N--CA 1.488 2.158 0 N-CA-C 109.346 -1.501 . . . . 0.0 109.346 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.844 ' O ' HD13 ' A' ' 27' ' ' LEU . 45.7 p90 -142.35 -164.32 1.79 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.293 -1.122 . . . . 0.0 110.223 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -162.54 114.09 0.59 Allowed Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.597 -1.287 . . . . 0.0 110.15 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.513 ' HB2' ' HG ' ' A' ' 50' ' ' LEU . 13.4 m-85 -82.66 142.55 31.61 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.249 -1.148 . . . . 0.0 109.061 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.646 HG21 HD11 ' A' ' 36' ' ' LEU . 5.7 t -150.01 114.9 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.91 -1.119 . . . . 0.0 110.582 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 7.2 t -88.17 32.31 0.77 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.388 -0.82 . . . . 0.0 109.829 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.652 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.868 . . . . 0.0 110.73 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.241 0.544 . . . . 0.0 110.313 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.4 -65.28 3.38 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 55.6 t -45.1 -31.0 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -1.106 . . . . 0.0 110.254 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -67.85 -61.42 1.88 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.212 -0.93 . . . . 0.0 110.413 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.578 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -60.63 -46.88 88.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 110.35 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.798 HG13 ' HE1' ' A' ' 40' ' ' PHE . 93.9 t -48.28 -62.38 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 O-C-N 121.062 -1.024 . . . . 0.0 109.255 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 81' ' ' SER . 0.1 OUTLIER -41.68 -51.31 4.1 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.338 -0.851 . . . . 0.0 109.897 179.035 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -44.71 -25.98 0.34 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.211 -0.931 . . . . 0.0 109.548 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.63 ' HB3' ' CE1' ' A' ' 83' ' ' HIS . 7.0 mm-40 -99.91 20.0 15.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.424 -0.797 . . . . 0.0 110.386 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.568 ' HA ' ' HD2' ' A' ' 92' ' ' PRO . 25.2 p -58.07 -13.21 4.31 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.385 -0.822 . . . . 0.0 109.061 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -107.16 10.58 30.01 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.521 -0.737 . . . . 0.0 109.86 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.63 ' CE1' ' HB3' ' A' ' 80' ' ' GLN . 1.6 m-70 -21.88 83.52 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -178.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 82' ' ' ARG . 1.1 tt0 -103.69 122.74 45.67 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.511 HD23 ' C ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -139.89 -89.83 0.18 Allowed 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.338 -0.851 . . . . 0.0 109.818 -178.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 87' ' ' SER . 53.8 t0 -78.14 53.7 1.25 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.126 -0.984 . . . . 0.0 108.356 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 70.98 9.11 6.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.627 -0.671 . . . . 0.0 109.719 -178.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 5.4 mmtt -111.7 113.99 26.71 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 121.286 -0.884 . . . . 0.0 110.25 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.595 ' O ' HG23 ' A' ' 89' ' ' THR . 6.8 t -90.37 68.96 6.94 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.578 HD12 ' OH ' ' A' ' 39' ' ' TYR . 1.2 mt -45.44 176.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 121.685 0.755 . . . . 0.0 109.86 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 81' ' ' SER . 5.3 t0 -144.88 77.31 13.38 Favored Pre-proline 0 C--N 1.296 -1.719 0 O-C-N 121.196 -0.94 . . . . 0.0 111.157 -178.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.583 ' HG3' ' CD2' ' A' ' 83' ' ' HIS . 2.0 Cg_endo -51.42 114.48 1.58 Allowed 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 123.446 1.235 . . . . 0.0 109.898 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.656 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -129.42 102.69 6.52 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.171 -0.956 . . . . 0.0 110.364 179.133 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 1.003 HG22 ' CB ' ' A' ' 22' ' ' MET . 95.2 t -97.31 161.61 2.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 O-C-N 121.757 -0.589 . . . . 0.0 110.063 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.175 -0.953 . . . . 0.0 110.582 -179.612 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.764 ' CB ' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.287 0.565 . . . . 0.0 110.249 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 1.067 ' HB3' HG13 ' A' ' 94' ' ' VAL . 1.5 ptt? -86.31 176.97 7.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 110.197 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.779 ' C ' HD12 ' A' ' 24' ' ' ILE . 3.1 t80 -150.51 154.36 37.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.167 -0.958 . . . . 0.0 110.393 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.851 ' CG2' HG21 ' A' ' 90' ' ' ILE . 1.3 mp -113.14 137.19 47.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.489 ' O ' HG22 ' A' ' 90' ' ' ILE . . . -112.84 140.29 16.21 Favored Glycine 0 N--CA 1.501 2.973 0 C-N-CA 119.31 -1.424 . . . . 0.0 112.951 -176.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.519 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 59.66 47.06 92.79 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.867 ' O ' HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -79.24 146.47 33.01 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.315 -1.109 . . . . 0.0 111.506 -178.437 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.454 ' HB2' ' HB ' ' A' ' 31' ' ' THR . 18.5 m -39.9 159.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.533 0.682 . . . . 0.0 110.763 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -92.32 -23.13 19.36 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.434 -0.791 . . . . 0.0 109.644 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.49 ' HG3' ' N ' ' A' ' 31' ' ' THR . 0.1 OUTLIER -83.78 -15.85 46.88 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.263 -0.898 . . . . 0.0 110.249 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.577 HG21 ' HG ' ' A' ' 27' ' ' LEU . 10.5 t -55.51 -174.31 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.633 0.73 . . . . 0.0 110.598 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.701 HG23 ' H ' ' A' ' 35' ' ' GLY . 6.5 t -161.24 -173.01 3.64 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.5 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 5.0 mt-30 -71.72 -74.61 0.15 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.998 -1.064 . . . . 0.0 110.781 -178.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.559 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 3.0 tt0 -49.6 -34.13 17.11 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.72 -1.237 . . . . 0.0 110.05 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.701 ' H ' HG23 ' A' ' 32' ' ' THR . . . -60.72 -30.19 71.9 Favored Glycine 0 C--N 1.295 -1.719 0 N-CA-C 107.216 -2.354 . . . . 0.0 107.216 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.876 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -82.51 -38.97 23.06 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.192 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.559 ' HG3' ' HA ' ' A' ' 34' ' ' GLU . 18.6 mtt180 -62.5 -27.0 68.84 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.505 1.145 . . . . 0.0 108.23 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.534 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -85.67 -21.05 28.54 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.127 179.694 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.661 ' CE1' ' NE2' ' A' ' 83' ' ' HIS . 9.9 t80 -81.94 -41.76 20.39 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.322 -0.861 . . . . 0.0 110.835 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.846 ' CE1' HG13 ' A' ' 77' ' ' VAL . 33.0 m-85 -100.3 -27.68 13.36 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.448 -0.783 . . . . 0.0 108.934 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.613 ' CA ' HG23 ' A' ' 46' ' ' VAL . . . -67.38 -9.52 55.06 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -64.64 -48.35 75.13 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.472 -1.016 . . . . 0.0 109.97 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.565 ' CG ' ' HB3' ' A' ' 76' ' ' LYS . 6.2 p90 -109.05 5.87 24.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.395 -0.815 . . . . 0.0 110.244 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.515 ' O ' ' HA2' ' A' ' 41' ' ' GLY . . . -162.76 97.74 0.15 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -38.8 124.25 1.35 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.473 -1.016 . . . . 0.0 110.745 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.613 HG23 ' CA ' ' A' ' 41' ' ' GLY . 47.7 t -90.07 132.16 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.384 -0.823 . . . . 0.0 110.74 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -98.67 -15.96 19.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.372 -0.83 . . . . 0.0 110.069 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -169.67 143.13 2.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.188 -0.945 . . . . 0.0 110.895 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.497 ' SG ' ' NE ' ' A' ' 37' ' ' ARG . 8.4 p -150.97 164.65 35.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.485 -0.759 . . . . 0.0 109.995 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.719 HD21 ' CD2' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -150.36 128.6 12.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.99 -1.069 . . . . 0.0 110.786 179.869 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.6 t -103.74 135.79 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 120.659 -1.275 . . . . 0.0 110.268 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.596 ' HG2' ' CE1' ' A' ' 63' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--N 1.306 -1.291 0 O-C-N 121.253 -0.904 . . . . 0.0 109.951 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.712 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.837 ' N ' HD22 ' A' ' 27' ' ' LEU . 3.1 p90 -173.39 -174.46 1.02 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.138 -1.213 . . . . 0.0 111.05 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.43 ' O ' ' HB ' ' A' ' 24' ' ' ILE . . . -149.89 123.66 1.63 Allowed Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.719 ' CD2' HD21 ' A' ' 50' ' ' LEU . 18.1 m-85 -83.88 148.98 26.65 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.318 -1.107 . . . . 0.0 109.625 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.698 HG22 HD21 ' A' ' 36' ' ' LEU . 3.7 t -146.44 161.92 9.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.316 -0.865 . . . . 0.0 109.621 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.764 HG23 ' CB ' ' A' ' 21' ' ' LYS . 1.8 m -149.56 39.6 0.81 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.198 -0.939 . . . . 0.0 110.229 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.608 ' CE2' HG21 ' A' ' 77' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.151 -0.968 . . . . 0.0 109.858 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.142 0.496 . . . . 0.0 110.661 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.571 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -49.9 -57.24 10.07 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.414 ' H ' HG23 ' A' ' 74' ' ' VAL . 49.0 t -47.51 -43.54 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.235 -1.156 . . . . 0.0 110.32 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.959 ' HA ' HD21 ' A' ' 78' ' ' LEU . 0.5 OUTLIER -59.58 -39.96 85.86 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.177 -0.952 . . . . 0.0 110.271 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.565 ' HB3' ' CG ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -71.07 -28.33 64.27 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.189 -0.944 . . . . 0.0 109.901 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.846 HG13 ' CE1' ' A' ' 40' ' ' PHE . 55.0 t -64.68 -64.42 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.139 -0.976 . . . . 0.0 109.576 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.959 HD21 ' HA ' ' A' ' 75' ' ' ASP . 1.5 pp -47.98 -37.98 15.88 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.109 -0.994 . . . . 0.0 109.185 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -46.17 -30.14 1.83 Allowed 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.057 -1.027 . . . . 0.0 108.861 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.532 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 1.5 mt-30 -104.62 28.26 7.19 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.411 0.624 . . . . 0.0 109.741 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.464 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 5.7 p -52.85 -18.52 1.95 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.492 ' O ' ' C ' ' A' ' 83' ' ' HIS . 4.5 ptt180 -94.49 -15.44 24.19 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.482 -0.761 . . . . 0.0 109.565 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.848 ' CE1' HD12 ' A' ' 90' ' ' ILE . 0.6 OUTLIER 28.72 46.31 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 179.303 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.578 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 0.8 OUTLIER -90.24 124.87 35.23 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 118.583 -1.247 . . . . 0.0 109.545 179.243 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.531 ' CD2' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -147.5 -83.63 0.11 Allowed 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 120.146 -0.621 . . . . 0.0 109.676 -179.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' A' ' 87' ' ' SER . 23.7 m-20 -83.18 50.73 1.8 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.11 -0.993 . . . . 0.0 108.818 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 72.63 7.19 5.54 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.472 0.653 . . . . 0.0 109.754 -179.188 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.578 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 0.6 OUTLIER -111.42 122.38 47.69 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.405 -0.809 . . . . 0.0 109.656 -179.529 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.718 ' O ' HG23 ' A' ' 89' ' ' THR . 9.4 t -101.9 69.43 1.18 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.062 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.851 HG21 ' CG2' ' A' ' 24' ' ' ILE . 0.9 OUTLIER -51.48 -176.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.346 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.514 ' H ' HG22 ' A' ' 90' ' ' ILE . 3.6 t70 -143.39 84.4 10.19 Favored Pre-proline 0 C--N 1.304 -1.382 0 O-C-N 120.963 -1.086 . . . . 0.0 110.363 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.543 ' HG3' ' HD2' ' A' ' 83' ' ' HIS . 2.3 Cg_endo -56.03 113.42 1.43 Allowed 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.551 1.29 . . . . 0.0 111.167 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.61 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -127.71 104.46 7.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.233 -0.917 . . . . 0.0 109.575 178.385 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 1.067 HG13 ' HB3' ' A' ' 22' ' ' MET . 7.9 t -96.77 164.29 2.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 O-C-N 121.654 -0.654 . . . . 0.0 110.398 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.705 0 O-C-N 121.218 -0.926 . . . . 0.0 110.136 179.86 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.546 ' CB ' ' HB ' ' A' ' 67' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 120.992 0.425 . . . . 0.0 110.014 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.805 ' HG2' HG13 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -71.76 -175.94 1.51 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.032 -1.042 . . . . 0.0 109.564 179.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.535 ' O ' ' HG2' ' A' ' 93' ' ' LYS . 2.0 t80 -149.03 119.16 7.21 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.076 -1.015 . . . . 0.0 111.487 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.706 HG22 ' CG2' ' A' ' 90' ' ' ILE . 17.4 mm -91.33 140.46 16.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.062 -1.024 . . . . 0.0 109.216 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 90' ' ' ILE . . . -119.23 149.42 18.08 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.669 -1.253 . . . . 0.0 111.303 -178.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.457 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 55.97 43.65 87.88 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.982 HD22 ' CA ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER -84.37 152.15 24.25 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.468 -1.019 . . . . 0.0 110.584 -179.027 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.8 ' O ' HG22 ' A' ' 31' ' ' THR . 14.5 m -41.73 124.66 2.6 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.459 -0.776 . . . . 0.0 110.32 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.496 ' CD2' ' N ' ' A' ' 30' ' ' GLN . 65.1 p-90 -68.2 -33.59 74.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.341 -0.85 . . . . 0.0 110.437 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.496 ' N ' ' CD2' ' A' ' 29' ' ' TRP . 17.8 pt20 -74.35 -12.56 60.56 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.324 -0.86 . . . . 0.0 111.2 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.8 HG22 ' O ' ' A' ' 28' ' ' SER . 5.7 t -65.05 -179.45 0.56 Allowed 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.34 -0.85 . . . . 0.0 110.37 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 35' ' ' GLY . 5.5 t -148.2 -172.65 4.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.338 -0.851 . . . . 0.0 110.155 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 36' ' ' LEU . 6.5 mt-30 -66.2 -73.43 0.13 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.196 -0.94 . . . . 0.0 110.67 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.472 ' HA ' ' CG ' ' A' ' 37' ' ' ARG . 3.4 tt0 -47.46 -47.31 27.23 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.759 -1.176 . . . . 0.0 109.718 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.536 ' O ' ' HG3' ' A' ' 38' ' ' GLU . . . -53.36 -27.57 33.13 Favored Glycine 0 N--CA 1.483 1.799 0 N-CA-C 107.711 -2.156 . . . . 0.0 107.711 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.999 HD21 ' HB3' ' A' ' 49' ' ' CYS . 0.1 OUTLIER -83.37 -35.49 25.07 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' A' ' 33' ' ' GLN . 34.1 mtp180 -62.37 -28.34 69.7 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.536 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -90.88 -15.36 30.03 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.534 178.772 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.601 ' HH ' ' CE1' ' A' ' 83' ' ' HIS . 47.9 t80 -75.47 -29.12 59.51 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 121.55 0.69 . . . . 0.0 109.617 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.884 ' CE1' HG13 ' A' ' 77' ' ' VAL . 37.8 m-85 -116.29 -26.11 7.3 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.633 -0.667 . . . . 0.0 109.48 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -68.16 -9.27 56.94 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -71.51 -50.9 26.94 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.439 -1.036 . . . . 0.0 110.593 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.578 ' HE1' HG22 ' A' ' 77' ' ' VAL . 3.1 p90 -109.53 -6.85 15.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.096 -1.003 . . . . 0.0 110.747 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 40' ' ' PHE . . . -150.63 118.6 0.93 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 9.8 pt-20 -54.23 132.9 44.38 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.198 -1.178 . . . . 0.0 109.722 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.752 HG11 ' SG ' ' A' ' 49' ' ' CYS . 86.3 t -112.14 152.64 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.158 -0.963 . . . . 0.0 110.46 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.45 ' HB3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -96.74 -29.84 13.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.355 -0.841 . . . . 0.0 109.826 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.502 ' O ' HG22 ' A' ' 67' ' ' THR . 11.6 tp10 -179.68 158.4 0.8 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.341 -0.85 . . . . 0.0 110.058 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.999 ' HB3' HD21 ' A' ' 36' ' ' LEU . 7.2 m -146.04 171.01 15.51 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.922 -1.112 . . . . 0.0 110.6 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.804 HD12 ' N ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -138.9 134.65 33.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.304 -0.873 . . . . 0.0 109.397 179.691 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.804 ' N ' HD12 ' A' ' 50' ' ' LEU . 76.4 t -125.62 139.36 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.47 -1.394 . . . . 0.0 111.612 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.563 ' HG2' ' CE2' ' A' ' 63' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.485 1.323 0 O-C-N 121.347 -0.845 . . . . 0.0 109.747 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.982 ' CA ' HD22 ' A' ' 27' ' ' LEU . 49.6 p90 -144.54 -167.95 2.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.139 -1.212 . . . . 0.0 110.29 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 50' ' ' LEU . . . -168.49 123.93 1.14 Allowed Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.569 -1.3 . . . . 0.0 110.199 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.61 ' CD2' ' CD2' ' A' ' 50' ' ' LEU . 27.5 m-85 -85.84 152.26 23.14 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.477 -1.013 . . . . 0.0 108.899 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.675 HG13 ' SG ' ' A' ' 49' ' ' CYS . 11.2 t -150.33 104.25 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.615 -1.303 . . . . 0.0 111.62 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.546 ' HB ' ' CB ' ' A' ' 21' ' ' LYS . 2.3 t -87.71 125.95 34.7 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.112 -0.993 . . . . 0.0 109.129 178.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.869 ' CE2' HG21 ' A' ' 77' ' ' VAL . 5.8 m-85 . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.027 -1.046 . . . . 0.0 109.986 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 73' ' ' GLY . . . . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.32 0.581 . . . . 0.0 110.084 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.764 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -43.94 -42.67 6.57 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.015 HG13 HG11 ' A' ' 94' ' ' VAL . 21.3 t -64.76 -55.24 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -1.145 . . . . 0.0 110.15 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.685 ' HA ' HD21 ' A' ' 78' ' ' LEU . 10.8 m-20 -41.97 -40.97 2.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 110.206 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.752 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 33.7 mmtt -72.67 -46.6 53.06 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.422 -0.799 . . . . 0.0 110.186 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.884 HG13 ' CE1' ' A' ' 40' ' ' PHE . 58.0 t -53.06 -68.3 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.124 -0.985 . . . . 0.0 109.767 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.685 HD21 ' HA ' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -45.65 -39.01 7.32 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.061 -1.024 . . . . 0.0 109.209 179.123 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.752 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -48.88 -24.23 1.39 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.077 -1.014 . . . . 0.0 108.9 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.631 ' HB3' ' CE1' ' A' ' 83' ' ' HIS . 2.9 mm-40 -105.23 28.03 7.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.585 -0.697 . . . . 0.0 109.987 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.571 ' HA ' ' HD2' ' A' ' 92' ' ' PRO . 14.3 t -61.17 -10.79 7.13 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.448 -0.783 . . . . 0.0 109.123 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -108.49 11.1 27.11 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 121.418 -0.801 . . . . 0.0 109.896 179.646 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.631 ' CE1' ' HB3' ' A' ' 80' ' ' GLN . 1.7 m-70 -23.73 85.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -178.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.989 ' C ' HD13 ' A' ' 85' ' ' LEU . 1.4 tt0 -106.99 121.41 44.41 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.989 HD13 ' C ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -142.35 -97.97 0.13 Allowed 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.991 -179.467 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.56 ' H ' HD23 ' A' ' 85' ' ' LEU . 25.4 t70 -69.73 55.64 0.13 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.834 -1.166 . . . . 0.0 108.741 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 70.42 8.37 6.59 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.445 -0.785 . . . . 0.0 110.138 -179.473 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.529 ' CD ' ' O ' ' A' ' 86' ' ' ASP . 2.3 mmmt -111.01 111.6 22.82 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.177 -0.952 . . . . 0.0 110.672 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.558 ' O ' HG23 ' A' ' 89' ' ' THR . 7.1 t -89.46 63.49 6.38 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.706 ' CG2' HG22 ' A' ' 24' ' ' ILE . 1.2 mt -42.65 172.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 CA-C-O 121.925 0.869 . . . . 0.0 110.277 -178.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 81' ' ' SER . 14.4 t0 -144.17 77.01 14.65 Favored Pre-proline 0 C--N 1.298 -1.637 0 O-C-N 121.32 -0.863 . . . . 0.0 110.786 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.602 ' HG3' ' CD2' ' A' ' 83' ' ' HIS . 1.9 Cg_endo -52.48 112.79 0.97 Allowed 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.514 1.27 . . . . 0.0 110.068 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.581 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 7.0 ptmt -109.43 105.56 14.96 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.627 1.203 . . . . 0.0 110.517 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 1.015 HG11 HG13 ' A' ' 74' ' ' VAL . 39.5 t -98.11 130.76 46.41 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 O-C-N 121.182 -0.949 . . . . 0.0 110.397 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.204 -0.935 . . . . 0.0 110.506 -179.697 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.671 ' HB3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.086 0.47 . . . . 0.0 110.137 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.831 ' CB ' HG13 ' A' ' 94' ' ' VAL . 3.1 ptm -121.1 -174.21 2.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.049 -1.032 . . . . 0.0 110.151 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.582 ' CD1' ' C ' ' A' ' 23' ' ' PHE . 0.3 OUTLIER -150.47 144.43 25.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.348 -0.845 . . . . 0.0 109.329 179.699 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.652 ' CG2' HG21 ' A' ' 90' ' ' ILE . 9.1 mm -108.03 129.26 62.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.122 -0.986 . . . . 0.0 109.475 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.513 ' O ' HG22 ' A' ' 90' ' ' ILE . . . -110.4 144.9 17.16 Favored Glycine 0 N--CA 1.494 2.545 0 C-N-CA 120.114 -1.041 . . . . 0.0 111.239 -178.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.435 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 60.13 34.28 83.34 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.934 ' O ' HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -73.84 146.71 43.94 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.55 -0.971 . . . . 0.0 110.022 -179.608 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.625 ' O ' HG22 ' A' ' 31' ' ' THR . 0.3 OUTLIER -39.74 132.83 1.63 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.598 -0.689 . . . . 0.0 110.3 -179.715 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.515 ' CD1' ' N ' ' A' ' 29' ' ' TRP . 0.5 OUTLIER -76.35 6.03 6.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.257 -0.902 . . . . 0.0 110.54 -179.799 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.442 ' O ' ' O ' ' A' ' 31' ' ' THR . 2.8 pt20 -124.47 -12.75 7.22 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.189 -0.944 . . . . 0.0 110.485 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.625 HG22 ' O ' ' A' ' 28' ' ' SER . 11.5 t -53.76 -168.7 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.603 -0.686 . . . . 0.0 110.379 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.458 HG23 ' H ' ' A' ' 35' ' ' GLY . 1.3 t -145.16 176.15 9.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.446 -0.784 . . . . 0.0 109.748 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 36' ' ' LEU . 3.5 mt-30 -72.0 -72.58 0.22 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.111 -0.993 . . . . 0.0 111.105 -178.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.522 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -46.15 -52.85 11.49 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.672 -1.211 . . . . 0.0 109.436 -179.69 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.468 ' HA2' ' HG3' ' A' ' 38' ' ' GLU . . . -46.75 -32.69 5.99 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 107.822 -2.111 . . . . 0.0 107.822 178.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.834 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -78.19 -39.34 40.96 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.317 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.661 ' HA ' HG21 ' A' ' 46' ' ' VAL . 49.3 mtt180 -60.58 -26.07 66.68 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 122.316 1.055 . . . . 0.0 108.434 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -85.4 -21.28 28.88 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.787 179.513 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.694 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 29.4 t80 -79.97 -24.34 41.0 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.647 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.769 ' HE1' HG13 ' A' ' 77' ' ' VAL . 25.4 m-85 -114.55 -19.13 11.27 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.332 -0.855 . . . . 0.0 109.104 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.17 -4.12 88.72 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 108.719 -1.753 . . . . 0.0 108.719 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -68.29 -53.05 27.04 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.352 -1.087 . . . . 0.0 110.034 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.467 ' CE1' ' HA ' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -99.41 9.39 43.38 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.277 -0.89 . . . . 0.0 110.259 179.492 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -152.68 -121.92 0.91 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.508 ' CG ' ' O ' ' A' ' 45' ' ' GLU . 5.9 pt-20 -172.08 119.44 0.42 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.385 -1.067 . . . . 0.0 109.687 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.661 HG21 ' HA ' ' A' ' 37' ' ' ARG . 28.1 t -93.25 124.09 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.335 -0.853 . . . . 0.0 111.124 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.86 -31.35 19.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.383 -0.823 . . . . 0.0 109.337 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -172.11 151.3 2.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.518 -0.739 . . . . 0.0 109.597 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.5 ' SG ' ' NE ' ' A' ' 37' ' ' ARG . 24.0 p -148.91 167.67 25.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.053 -1.029 . . . . 0.0 110.605 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.788 ' C ' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -142.92 122.97 13.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.255 -0.903 . . . . 0.0 110.446 179.693 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.535 ' N ' HD12 ' A' ' 50' ' ' LEU . 71.3 t -105.41 137.51 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.027 -1.046 . . . . 0.0 110.368 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.567 ' HG2' ' CZ ' ' A' ' 63' ' ' PHE . 1.9 ttt . . . . . 0 C--N 1.305 -1.343 0 O-C-N 121.33 -0.856 . . . . 0.0 110.064 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.595 ' C ' HD22 ' A' ' 27' ' ' LEU . . . . . . . . 0 N--CA 1.486 1.985 0 N-CA-C 109.149 -1.581 . . . . 0.0 109.149 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.63 ' N ' HD22 ' A' ' 27' ' ' LEU . 12.4 p90 -149.82 -169.66 3.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -1.14 . . . . 0.0 110.288 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 50' ' ' LEU . . . -167.55 -161.99 18.32 Favored Glycine 0 N--CA 1.485 1.924 0 C-N-CA 119.507 -1.33 . . . . 0.0 110.303 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.543 ' C ' HG23 ' A' ' 66' ' ' VAL . 9.1 m-85 -146.23 143.4 29.2 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.769 -0.842 . . . . 0.0 109.074 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.748 HG21 HD11 ' A' ' 36' ' ' LEU . 14.1 t -147.85 97.08 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 120.805 -1.184 . . . . 0.0 110.752 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.671 HG23 ' HB3' ' A' ' 21' ' ' LYS . 22.7 m -80.68 58.43 3.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.368 -0.832 . . . . 0.0 109.929 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.599 ' CE2' HG21 ' A' ' 77' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 110.609 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.492 ' HB1' ' NZ ' ' A' ' 76' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.309 0.576 . . . . 0.0 110.005 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.797 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -53.67 -65.87 3.13 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.555 ' CG1' ' N ' ' A' ' 75' ' ' ASP . 2.2 p -39.94 -43.19 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.398 -1.06 . . . . 0.0 110.489 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.803 ' HA ' HD23 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -58.65 -77.86 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.367 -0.833 . . . . 0.0 110.383 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.621 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -48.47 -22.45 0.73 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.381 -0.824 . . . . 0.0 110.059 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 73' ' ' GLY . 55.4 t -71.72 -53.43 20.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.256 -0.903 . . . . 0.0 109.666 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.803 HD23 ' HA ' ' A' ' 75' ' ' ASP . 1.3 pp -50.76 -28.95 10.25 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 120.918 -1.114 . . . . 0.0 108.196 178.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -57.36 -20.03 26.61 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.525 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 1.0 OUTLIER -105.58 19.01 21.28 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.431 0.634 . . . . 0.0 109.481 179.233 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.484 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 46.3 t -53.38 -16.5 1.41 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.604 -0.839 . . . . 0.0 108.747 178.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.571 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -103.66 -2.43 26.59 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 121.358 -0.839 . . . . 0.0 109.618 178.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 1.014 ' CE1' HD12 ' A' ' 90' ' ' ILE . 0.3 OUTLIER 27.18 -85.09 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.705 0.764 . . . . 0.0 111.675 179.68 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.875 ' C ' HD23 ' A' ' 85' ' ' LEU . 0.5 OUTLIER 54.66 122.14 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 122.205 1.002 . . . . 0.0 111.088 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.875 HD23 ' C ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -149.19 -92.08 0.07 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.394 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.561 ' O ' ' CB ' ' A' ' 87' ' ' SER . 7.7 t0 -82.54 54.28 2.58 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.067 -1.02 . . . . 0.0 108.495 178.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.561 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER 76.68 6.18 3.39 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.215 0.531 . . . . 0.0 109.975 -179.016 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.601 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -110.86 114.41 27.72 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.291 -0.88 . . . . 0.0 110.668 -179.351 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.694 ' O ' HG23 ' A' ' 89' ' ' THR . 9.7 t -89.14 76.98 7.64 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.805 -0.559 . . . . 0.0 109.805 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 1.014 HD12 ' CE1' ' A' ' 83' ' ' HIS . 1.5 mt -49.23 179.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.256 -0.903 . . . . 0.0 109.494 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.565 ' H ' HG22 ' A' ' 90' ' ' ILE . 8.0 t0 -140.72 79.55 19.24 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.328 -0.858 . . . . 0.0 110.1 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.525 ' CG ' ' O ' ' A' ' 80' ' ' GLN . 2.3 Cg_endo -54.61 111.94 0.87 Allowed 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.57 1.3 . . . . 0.0 110.749 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.582 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -127.59 103.12 7.15 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.866 0.841 . . . . 0.0 109.235 178.528 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.831 HG13 ' CB ' ' A' ' 22' ' ' MET . 15.8 t -97.11 170.48 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-O 121.349 0.595 . . . . 0.0 110.502 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.413 ' N ' HG12 ' A' ' 94' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.199 -0.938 . . . . 0.0 110.436 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.188 0.518 . . . . 0.0 110.325 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.768 ' CG ' HG22 ' A' ' 94' ' ' VAL . 7.4 ttt -76.72 163.1 27.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.221 -0.924 . . . . 0.0 110.16 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.706 ' CG ' ' CE1' ' A' ' 65' ' ' PHE . 2.0 t80 -141.64 129.08 21.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.295 -0.878 . . . . 0.0 109.597 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.702 HD12 ' C ' ' A' ' 23' ' ' PHE . 1.4 mp -106.48 155.87 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.115 -0.99 . . . . 0.0 109.289 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.57 ' O ' ' N ' ' A' ' 91' ' ' ASP . . . -139.21 139.08 9.8 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 119.245 -1.455 . . . . 0.0 111.42 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.552 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 105.51 27.26 5.86 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.981 ' CD2' HG13 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -50.45 118.58 3.12 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.792 -0.828 . . . . 0.0 110.864 -179.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.523 ' HB2' ' CB ' ' A' ' 88' ' ' LYS . 1.4 t -59.43 178.52 0.14 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.38 -0.825 . . . . 0.0 110.212 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.568 ' O ' ' CE3' ' A' ' 29' ' ' TRP . 35.1 p-90 -84.85 15.69 3.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.177 -0.952 . . . . 0.0 110.1 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -143.92 7.45 1.42 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.241 -0.912 . . . . 0.0 110.936 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.595 HG21 ' HG ' ' A' ' 27' ' ' LEU . 1.9 m -70.66 157.08 38.61 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.125 -0.984 . . . . 0.0 109.892 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.531 ' CG2' ' HA3' ' A' ' 35' ' ' GLY . 4.4 t -127.48 178.04 6.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.083 -1.01 . . . . 0.0 109.922 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.516 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 6.0 mt-30 -88.76 -73.69 0.49 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.15 -0.969 . . . . 0.0 110.734 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.56 ' HA ' ' HB3' ' A' ' 37' ' ' ARG . 0.1 OUTLIER -50.78 -49.67 57.73 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 117.967 -1.493 . . . . 0.0 108.929 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.531 ' HA3' ' CG2' ' A' ' 32' ' ' THR . . . -49.39 -27.72 8.48 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 107.603 -2.199 . . . . 0.0 107.603 178.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.91 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -80.69 -32.02 36.06 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.478 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.581 ' HG2' ' HG2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -60.46 -34.79 74.52 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 177.475 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.581 ' HG2' ' HG2' ' A' ' 37' ' ' ARG . 2.0 mt-10 -76.63 -25.44 53.82 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 113.912 -1.494 . . . . 0.0 109.863 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.63 ' CE1' ' NE2' ' A' ' 83' ' ' HIS . 8.0 t80 -75.81 -25.01 55.95 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.511 -0.743 . . . . 0.0 110.82 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.912 ' HE1' HG13 ' A' ' 77' ' ' VAL . 16.3 m-85 -113.69 -17.86 12.02 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.324 -0.86 . . . . 0.0 109.118 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -79.73 -5.53 89.37 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 108.496 -1.842 . . . . 0.0 108.496 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -63.58 -45.27 91.16 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.492 -1.005 . . . . 0.0 109.888 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.535 ' CD2' ' HB3' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -108.16 1.54 22.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.449 -0.782 . . . . 0.0 110.189 179.608 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.478 ' O ' ' HA2' ' A' ' 41' ' ' GLY . . . -149.64 179.49 26.37 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.609 -1.281 . . . . 0.0 109.933 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 0.4 OUTLIER -101.16 121.18 41.38 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.34 -1.094 . . . . 0.0 110.086 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.645 HG22 ' HB3' ' A' ' 68' ' ' PHE . 43.1 t -97.69 121.62 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.131 -0.981 . . . . 0.0 110.651 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.419 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . 35.8 tptt -88.91 -36.31 16.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.308 -0.87 . . . . 0.0 109.987 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -161.58 161.28 29.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 0.0 110.328 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 7.6 p -150.12 165.55 32.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.29 -0.881 . . . . 0.0 109.712 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.758 HD21 ' CD2' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -149.67 132.93 16.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.049 -1.032 . . . . 0.0 110.751 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.981 HG13 ' CD2' ' A' ' 27' ' ' LEU . 79.3 t -121.85 131.72 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.56 -1.338 . . . . 0.0 110.423 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 2.5 ttm . . . . . 0 C--N 1.305 -1.366 0 O-C-N 121.356 -0.84 . . . . 0.0 109.962 -179.751 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.075 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.959 ' O ' HD22 ' A' ' 27' ' ' LEU . 20.4 p90 -148.4 -176.9 5.48 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.277 -1.131 . . . . 0.0 110.537 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.696 ' N ' HD13 ' A' ' 27' ' ' LEU . . . -142.58 162.83 27.31 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.758 ' CD2' HD21 ' A' ' 50' ' ' LEU . 14.2 m-85 -128.28 154.18 46.18 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.404 -1.057 . . . . 0.0 109.41 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.781 ' CG2' HD11 ' A' ' 36' ' ' LEU . 15.3 t -149.87 110.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.058 -1.026 . . . . 0.0 110.64 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.588 HG22 ' O ' ' A' ' 67' ' ' THR . 84.9 m -89.11 49.93 1.86 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.294 -0.879 . . . . 0.0 109.98 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.645 ' HB3' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.412 -0.805 . . . . 0.0 110.818 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 75' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.36 0.6 . . . . 0.0 109.996 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.761 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -57.1 -70.44 0.98 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.436 ' C ' ' O ' ' A' ' 73' ' ' GLY . 98.5 t -41.9 -29.06 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.355 -1.085 . . . . 0.0 110.247 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.846 ' HA ' HD23 ' A' ' 78' ' ' LEU . 0.5 OUTLIER -66.28 -80.64 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 0.0 109.898 179.744 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.704 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -47.73 -24.7 1.01 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.232 -0.917 . . . . 0.0 109.07 179.337 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.912 HG13 ' HE1' ' A' ' 40' ' ' PHE . 78.1 t -68.74 -55.22 16.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.472 -0.767 . . . . 0.0 109.703 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.846 HD23 ' HA ' ' A' ' 75' ' ' ASP . 1.1 pp -48.78 -28.48 3.69 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 120.835 -1.166 . . . . 0.0 108.48 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.704 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -52.13 -32.6 36.23 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.559 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 5.4 mm-40 -99.43 24.04 8.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.781 -0.574 . . . . 0.0 109.499 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.474 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 9.8 t -49.95 -18.76 0.57 Allowed 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.092 178.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.486 ' O ' ' C ' ' A' ' 83' ' ' HIS . 0.2 OUTLIER -103.52 -7.55 20.77 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.342 -0.849 . . . . 0.0 109.841 179.45 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.735 ' CE1' HD12 ' A' ' 90' ' ' ILE . 0.5 OUTLIER 32.22 36.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.95 -0.469 . . . . 0.0 111.272 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.551 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 1.4 tt0 -87.14 120.26 28.22 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.594 -1.243 . . . . 0.0 110.237 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.529 ' CD2' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -151.7 -83.48 0.09 Allowed 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.679 -0.638 . . . . 0.0 110.133 -179.626 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.518 ' O ' ' CB ' ' A' ' 87' ' ' SER . 0.2 OUTLIER -79.81 53.08 1.57 Allowed 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.106 -0.996 . . . . 0.0 109.289 179.473 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 71.01 2.83 4.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.565 -0.709 . . . . 0.0 110.256 -179.796 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -110.96 124.85 52.95 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.257 -0.902 . . . . 0.0 110.246 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.762 ' O ' HG23 ' A' ' 89' ' ' THR . 15.1 t -104.77 63.93 0.73 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.523 -0.736 . . . . 0.0 110.133 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.735 HD12 ' CE1' ' A' ' 83' ' ' HIS . 0.6 OUTLIER -52.23 -176.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.35 -0.843 . . . . 0.0 108.887 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.57 ' N ' ' O ' ' A' ' 25' ' ' GLY . 13.0 t0 -143.82 87.23 8.22 Favored Pre-proline 0 N--CA 1.485 1.288 0 O-C-N 120.547 -1.346 . . . . 0.0 110.764 -178.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.559 ' CG ' ' O ' ' A' ' 80' ' ' GLN . 2.2 Cg_endo -58.42 111.79 0.98 Allowed 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.633 1.333 . . . . 0.0 111.317 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.583 ' HE2' ' CD2' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -130.41 117.51 19.81 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.383 -0.823 . . . . 0.0 109.262 178.26 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.768 HG22 ' CG ' ' A' ' 22' ' ' MET . 61.8 t -97.3 174.6 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 O-C-N 121.581 -0.699 . . . . 0.0 110.049 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.579 ' N ' HG12 ' A' ' 94' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 109.855 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.717 ' CB ' HG23 ' A' ' 67' ' ' THR . 11.6 ptmt . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.337 0.589 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 1.003 ' HB3' HG13 ' A' ' 94' ' ' VAL . 12.7 ptm -123.21 175.8 6.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.441 -0.787 . . . . 0.0 110.041 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.582 ' HB3' ' HD2' ' A' ' 93' ' ' LYS . 1.4 t80 -146.58 158.35 43.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.367 -0.833 . . . . 0.0 109.886 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.962 HD11 ' CE ' ' A' ' 22' ' ' MET . 18.3 mm -115.92 134.78 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.31 -0.868 . . . . 0.0 109.124 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.513 ' O ' HG22 ' A' ' 90' ' ' ILE . . . -113.3 141.68 17.05 Favored Glycine 0 N--CA 1.495 2.601 0 C-N-CA 119.731 -1.223 . . . . 0.0 112.285 -177.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.51 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 60.28 41.91 98.54 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.007 HD22 ' CA ' ' A' ' 63' ' ' PHE . 0.3 OUTLIER -77.45 153.87 33.14 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.62 -0.929 . . . . 0.0 111.163 -178.742 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.917 ' OG ' HD23 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -39.43 130.73 1.72 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.368 0.604 . . . . 0.0 110.518 -179.301 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 64.9 p-90 -68.81 -28.12 66.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.349 -0.844 . . . . 0.0 110.635 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.454 ' O ' ' O ' ' A' ' 31' ' ' THR . 2.3 pt20 -88.78 -14.76 36.33 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.083 -1.011 . . . . 0.0 110.721 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.543 ' HB ' ' CB ' ' A' ' 28' ' ' SER . 1.3 t -53.08 -169.02 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.642 -0.661 . . . . 0.0 110.364 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.718 HG23 ' H ' ' A' ' 35' ' ' GLY . 15.0 t -157.62 -166.75 2.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.334 -0.854 . . . . 0.0 109.85 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 36' ' ' LEU . 3.6 mt-30 -79.9 -72.92 0.38 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.149 -0.969 . . . . 0.0 110.118 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.534 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -48.07 -44.28 31.36 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.759 -1.176 . . . . 0.0 108.551 179.302 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.718 ' H ' HG23 ' A' ' 32' ' ' THR . . . -48.14 -35.27 13.64 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 107.566 -2.214 . . . . 0.0 107.566 178.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.766 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -75.76 -40.07 55.98 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.301 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.78 ' HA ' HG11 ' A' ' 46' ' ' VAL . 50.0 mtp180 -59.42 -25.66 64.52 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 122.47 1.129 . . . . 0.0 108.421 178.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.534 ' CG ' ' O ' ' A' ' 34' ' ' GLU . 1.5 mt-10 -84.56 -21.93 30.27 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.688 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 21.0 t80 -84.56 -48.36 9.63 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.795 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.854 ' HE1' HG13 ' A' ' 77' ' ' VAL . 28.1 m-85 -95.17 -33.48 12.61 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.355 -0.841 . . . . 0.0 109.321 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -65.8 -17.49 65.11 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -58.83 -45.2 90.56 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.417 -1.049 . . . . 0.0 109.276 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.599 ' CD1' ' HB3' ' A' ' 76' ' ' LYS . 4.5 p90 -117.83 -12.82 10.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.566 -0.709 . . . . 0.0 109.493 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.469 ' O ' ' HA2' ' A' ' 41' ' ' GLY . . . -133.99 87.01 0.26 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.531 ' O ' ' CB ' ' A' ' 68' ' ' PHE . 4.0 pm0 -41.18 104.39 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.417 -1.049 . . . . 0.0 110.357 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.78 HG11 ' HA ' ' A' ' 37' ' ' ARG . 2.9 p -89.42 142.5 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.228 -0.92 . . . . 0.0 110.519 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.62 -23.68 9.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.873 . . . . 0.0 109.677 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.43 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -130.25 126.59 37.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.407 -0.808 . . . . 0.0 110.173 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.511 ' HB2' ' CD2' ' A' ' 36' ' ' LEU . 3.4 p -150.13 152.14 34.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.076 -1.015 . . . . 0.0 110.253 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.801 HD21 ' CD2' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -149.99 134.33 17.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.048 -1.033 . . . . 0.0 110.65 179.739 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 78.4 t -117.16 134.81 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.543 -1.348 . . . . 0.0 110.732 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.461 ' HG2' ' CZ ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.303 -1.437 0 O-C-N 121.423 -0.798 . . . . 0.0 109.44 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.327 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 1.007 ' CA ' HD22 ' A' ' 27' ' ' LEU . 20.8 p90 -156.35 -162.94 1.35 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.131 -1.217 . . . . 0.0 110.26 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.573 ' O ' ' CD2' ' A' ' 23' ' ' PHE . . . -166.84 -179.97 40.29 Favored Glycine 0 N--CA 1.489 2.18 0 C-N-CA 119.536 -1.316 . . . . 0.0 110.296 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.801 ' CD2' HD21 ' A' ' 50' ' ' LEU . 10.4 m-85 -129.28 152.98 48.26 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.833 -0.804 . . . . 0.0 109.267 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.58 HG22 HD21 ' A' ' 36' ' ' LEU . 3.5 t -150.05 145.1 17.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 120.986 -1.071 . . . . 0.0 110.181 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.717 HG23 ' CB ' ' A' ' 21' ' ' LYS . 3.2 m -151.1 99.23 2.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.207 -0.933 . . . . 0.0 110.717 -179.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.635 ' CE2' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.152 -0.967 . . . . 0.0 109.589 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.291 0.567 . . . . 0.0 110.03 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.703 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -59.36 -82.34 0.06 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.559 HG23 ' N ' ' A' ' 75' ' ' ASP . 17.9 m -41.67 -48.3 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.296 -1.12 . . . . 0.0 110.534 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.559 ' N ' HG23 ' A' ' 74' ' ' VAL . 21.6 m-20 -42.22 -68.15 0.21 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.036 -1.04 . . . . 0.0 110.45 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.88 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -59.14 -37.03 76.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.442 -0.786 . . . . 0.0 110.449 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.854 HG13 ' HE1' ' A' ' 40' ' ' PHE . 58.9 t -56.21 -59.71 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 121.142 -0.974 . . . . 0.0 109.911 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.564 ' CD1' ' N ' ' A' ' 78' ' ' LEU . 2.4 mp -46.03 -40.73 11.03 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.88 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -43.18 -36.37 1.71 Allowed 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.584 0.707 . . . . 0.0 109.55 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.573 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 7.3 mm100 -102.57 27.61 6.74 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.483 -0.76 . . . . 0.0 109.505 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.562 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 65.9 p -45.56 -21.32 0.1 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.562 -0.711 . . . . 0.0 109.131 178.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.486 ' O ' ' O ' ' A' ' 83' ' ' HIS . 1.2 ptp180 -106.13 -19.66 13.65 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.463 -0.773 . . . . 0.0 110.279 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.912 ' CE1' HD12 ' A' ' 90' ' ' ILE . 0.2 OUTLIER 52.13 165.47 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.279 -0.888 . . . . 0.0 111.014 179.898 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 1.067 ' C ' HD13 ' A' ' 85' ' ' LEU . 1.2 tt0 175.37 119.74 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.599 0.714 . . . . 0.0 110.389 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 1.067 HD13 ' C ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -141.03 -86.49 0.18 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.575 -0.703 . . . . 0.0 109.172 178.417 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.536 ' O ' ' CB ' ' A' ' 87' ' ' SER . 0.1 OUTLIER -84.42 53.25 2.59 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.054 -1.029 . . . . 0.0 108.662 178.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 71.22 9.68 6.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.49 -0.756 . . . . 0.0 109.274 -178.769 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.586 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 10.3 mmtt -107.17 121.79 45.23 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.519 -0.738 . . . . 0.0 109.806 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.801 ' O ' HG23 ' A' ' 89' ' ' THR . 15.3 t -97.31 78.42 2.72 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.393 -0.817 . . . . 0.0 109.554 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.912 HD12 ' CE1' ' A' ' 83' ' ' HIS . 1.1 mt -47.65 -177.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-O 121.433 0.635 . . . . 0.0 110.335 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.597 ' H ' HG22 ' A' ' 90' ' ' ILE . 13.5 t0 -139.39 78.19 27.92 Favored Pre-proline 0 C--N 1.305 -1.355 0 O-C-N 121.108 -0.995 . . . . 0.0 110.566 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.631 ' HG3' ' HD2' ' A' ' 83' ' ' HIS . 2.3 Cg_endo -53.31 112.48 0.95 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.44 1.232 . . . . 0.0 110.964 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.582 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -117.06 99.78 7.29 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.287 -0.883 . . . . 0.0 109.698 178.434 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 1.003 HG13 ' HB3' ' A' ' 22' ' ' MET . 22.3 t -97.01 157.35 3.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 O-C-N 121.757 -0.589 . . . . 0.0 110.157 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.71 0 O-C-N 121.207 -0.933 . . . . 0.0 110.468 -179.711 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.514 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 5.2 pttt . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.342 0.592 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.913 ' HB2' HG13 ' A' ' 94' ' ' VAL . 36.5 ttp -86.07 172.67 10.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.359 -0.838 . . . . 0.0 110.307 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.752 ' C ' HD12 ' A' ' 24' ' ' ILE . 1.3 t80 -148.62 139.39 22.88 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.332 -0.855 . . . . 0.0 109.268 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.752 HD12 ' C ' ' A' ' 23' ' ' PHE . 1.3 mp -110.36 130.62 63.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 121.319 -0.863 . . . . 0.0 108.792 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.498 ' O ' ' CG2' ' A' ' 90' ' ' ILE . . . -95.73 120.53 6.58 Favored Glycine 0 N--CA 1.497 2.723 0 C-N-CA 120.028 -1.082 . . . . 0.0 113.145 -176.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.996 ' O ' HD12 ' A' ' 90' ' ' ILE . . . 76.67 28.24 59.62 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 177.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.024 HD11 HG13 ' A' ' 51' ' ' VAL . 1.4 pt? -49.43 142.51 7.68 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.376 -1.073 . . . . 0.0 110.383 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.839 ' O ' HG22 ' A' ' 31' ' ' THR . 2.3 m -39.42 121.35 1.17 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.486 0.66 . . . . 0.0 110.465 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 49.9 p-90 -58.88 -28.87 66.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.298 -0.876 . . . . 0.0 110.388 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -82.64 -13.7 56.01 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.195 -0.941 . . . . 0.0 110.642 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.839 HG22 ' O ' ' A' ' 28' ' ' SER . 3.0 t -63.64 -169.6 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.501 -0.749 . . . . 0.0 110.291 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.695 HG23 ' H ' ' A' ' 35' ' ' GLY . 13.4 t -154.06 -169.92 3.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.445 -0.785 . . . . 0.0 109.922 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 36' ' ' LEU . 17.7 mt-30 -74.48 -73.05 0.25 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.121 -0.987 . . . . 0.0 110.389 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.4 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 3.9 tt0 -47.84 -42.9 27.47 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.883 -1.136 . . . . 0.0 109.758 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.695 ' H ' HG23 ' A' ' 32' ' ' THR . . . -55.54 -30.18 55.32 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 107.699 -2.161 . . . . 0.0 107.699 178.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.874 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -82.1 -37.57 26.13 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.137 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.633 ' CD ' HG11 ' A' ' 46' ' ' VAL . 0.2 OUTLIER -62.86 -25.22 68.18 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 122.536 1.16 . . . . 0.0 108.503 178.487 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.53 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -90.39 -19.07 24.39 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.977 -1.011 . . . . 0.0 108.597 179.497 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.66 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 6.4 t80 -81.42 -26.61 35.25 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 121.457 -0.777 . . . . 0.0 110.334 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.895 ' HE1' HG13 ' A' ' 77' ' ' VAL . 39.0 m-85 -118.59 -17.72 9.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.403 -0.811 . . . . 0.0 109.371 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -75.69 -21.08 77.57 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.61 ' HG3' ' CD2' ' A' ' 43' ' ' PHE . 15.9 pt20 -63.06 -32.48 73.87 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.486 -1.008 . . . . 0.0 109.421 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.612 ' HE1' HG22 ' A' ' 77' ' ' VAL . 4.8 p90 -130.39 1.36 4.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.37 -0.831 . . . . 0.0 109.645 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 40' ' ' PHE . . . -143.77 95.27 0.18 Allowed Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 42.3 mt-10 -40.05 110.0 0.13 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.326 -1.102 . . . . 0.0 110.774 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.633 HG11 ' CD ' ' A' ' 37' ' ' ARG . 70.7 t -91.16 129.43 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.389 -0.819 . . . . 0.0 110.733 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 67' ' ' THR . 0.5 OUTLIER -93.48 -33.6 13.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.406 -0.809 . . . . 0.0 109.607 179.467 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.703 ' O ' HG22 ' A' ' 67' ' ' THR . 11.3 tp10 -171.29 153.96 3.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.548 -0.72 . . . . 0.0 109.188 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 15.6 p -150.81 157.06 42.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.06 -1.025 . . . . 0.0 111.107 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.733 ' C ' HD12 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -130.52 124.11 31.17 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.427 -0.796 . . . . 0.0 108.95 178.704 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.024 HG13 HD11 ' A' ' 27' ' ' LEU . 89.6 t -112.57 142.75 23.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 120.453 -1.404 . . . . 0.0 112.062 -178.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.576 ' SD ' ' CE2' ' A' ' 63' ' ' PHE . 1.9 ttm . . . . . 0 C--N 1.302 -1.458 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.46 ' C ' ' CD2' ' A' ' 27' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 107.827 -2.109 . . . . 0.0 107.827 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.83 ' CA ' HD22 ' A' ' 27' ' ' LEU . 14.4 p90 -134.63 -167.86 2.05 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.428 -1.042 . . . . 0.0 111.428 -178.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -158.7 116.72 0.73 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.554 ' HB2' ' HG ' ' A' ' 50' ' ' LEU . 12.7 m-85 -82.99 140.97 32.44 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.483 -1.01 . . . . 0.0 108.863 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.839 HG22 HD21 ' A' ' 36' ' ' LEU . 2.9 t -147.34 99.36 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 120.943 -1.098 . . . . 0.0 110.239 -178.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.703 HG22 ' O ' ' A' ' 48' ' ' GLU . 7.9 t -80.58 64.01 5.22 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 110.734 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.568 ' HB3' HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.193 -0.942 . . . . 0.0 110.745 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 75' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.329 0.585 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.671 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -46.49 -61.25 4.27 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.974 ' O ' HD12 ' A' ' 78' ' ' LEU . 71.3 t -43.17 -48.47 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.191 -1.182 . . . . 0.0 110.197 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 72' ' ' ALA . 34.8 t70 -47.94 -56.92 6.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.971 -1.081 . . . . 0.0 110.153 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.573 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -59.73 -30.66 68.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.39 -0.819 . . . . 0.0 110.15 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.895 HG13 ' HE1' ' A' ' 40' ' ' PHE . 41.7 t -63.01 -58.17 8.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.113 -0.992 . . . . 0.0 109.279 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.974 HD12 ' O ' ' A' ' 74' ' ' VAL . 1.3 mp -45.88 -44.39 14.43 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.324 -0.86 . . . . 0.0 108.962 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -45.96 -28.53 1.16 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.209 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.53 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 22.3 mm100 -103.76 25.53 9.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.512 -0.742 . . . . 0.0 109.898 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 78' ' ' LEU . 23.7 t -54.43 -16.16 2.12 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.488 ' O ' ' C ' ' A' ' 83' ' ' HIS . 5.2 ptp180 -95.95 -18.15 20.49 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 121.501 -0.749 . . . . 0.0 109.533 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.66 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 0.6 OUTLIER 31.51 41.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.81 -0.556 . . . . 0.0 111.795 179.484 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.567 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 0.7 OUTLIER -86.93 122.41 30.75 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 118.619 -1.233 . . . . 0.0 110.192 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.548 ' CD2' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -144.62 -85.81 0.13 Allowed 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.626 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 87' ' ' SER . 0.6 OUTLIER -82.28 52.92 2.13 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.21 -0.931 . . . . 0.0 108.753 179.05 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 1.4 t 71.33 5.84 5.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.599 -0.688 . . . . 0.0 109.651 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 10.7 mmmt -108.02 119.54 39.76 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.357 -0.839 . . . . 0.0 109.808 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.765 ' O ' HG23 ' A' ' 89' ' ' THR . 15.1 t -101.41 68.62 1.21 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.608 -0.682 . . . . 0.0 109.646 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.996 HD12 ' O ' ' A' ' 26' ' ' GLY . 1.2 mm -51.7 -175.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.419 -0.801 . . . . 0.0 109.803 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.503 ' H ' HG22 ' A' ' 90' ' ' ILE . 15.6 t0 -143.67 83.73 10.41 Favored Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.303 -0.873 . . . . 0.0 109.877 -179.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.53 ' CG ' ' O ' ' A' ' 80' ' ' GLN . 2.3 Cg_endo -53.22 112.32 0.9 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.553 1.291 . . . . 0.0 110.965 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.604 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -130.16 111.76 12.75 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.486 -0.759 . . . . 0.0 109.546 178.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.913 HG13 ' HB2' ' A' ' 22' ' ' MET . 3.8 t -95.66 -174.01 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.525 -0.734 . . . . 0.0 110.018 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.694 ' H ' HG12 ' A' ' 94' ' ' VAL . . . . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.175 -0.953 . . . . 0.0 110.358 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.746 ' HB2' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.187 0.517 . . . . 0.0 109.841 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.951 ' CG ' HG22 ' A' ' 94' ' ' VAL . 5.3 tmm? -68.83 157.77 35.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.105 -0.997 . . . . 0.0 109.854 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.605 ' CG ' ' CE1' ' A' ' 65' ' ' PHE . 6.8 t80 -141.02 144.49 35.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.229 -0.919 . . . . 0.0 109.984 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.779 ' CG2' HG21 ' A' ' 90' ' ' ILE . 20.1 mm -108.87 137.76 39.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.314 -0.866 . . . . 0.0 109.232 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 91' ' ' ASP . . . -118.1 144.17 17.99 Favored Glycine 0 N--CA 1.495 2.576 0 C-N-CA 119.647 -1.263 . . . . 0.0 111.464 -177.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 90' ' ' ILE . . . 59.08 42.05 96.83 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.992 HD22 ' CA ' ' A' ' 63' ' ' PHE . 0.3 OUTLIER -79.69 156.51 27.53 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.452 -1.028 . . . . 0.0 110.939 -179.072 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.465 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -39.4 142.27 0.29 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.458 0.647 . . . . 0.0 110.735 -179.097 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 47.0 p-90 -85.58 2.57 44.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.496 -0.753 . . . . 0.0 110.332 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.469 ' O ' ' O ' ' A' ' 31' ' ' THR . 14.8 pt20 -121.77 -14.41 8.12 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.212 -0.93 . . . . 0.0 110.424 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 30' ' ' GLN . 14.8 t -53.3 -168.65 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.646 -0.659 . . . . 0.0 110.26 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.653 HG23 ' H ' ' A' ' 35' ' ' GLY . 6.0 t -153.91 -176.1 5.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.279 -0.888 . . . . 0.0 110.034 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 36' ' ' LEU . 4.9 mt-30 -69.5 -75.01 0.12 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.045 -1.034 . . . . 0.0 110.818 -179.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.47 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 7.9 tt0 -47.22 -40.46 16.31 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.817 -1.177 . . . . 0.0 110.051 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.653 ' H ' HG23 ' A' ' 32' ' ' THR . . . -56.53 -32.71 61.41 Favored Glycine 0 N--CA 1.484 1.833 0 N-CA-C 107.32 -2.312 . . . . 0.0 107.32 178.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.855 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -79.87 -38.8 31.93 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.122 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.47 ' HG3' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -61.81 -25.27 67.39 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 122.43 1.109 . . . . 0.0 108.764 178.501 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.554 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -88.66 -18.58 27.64 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.69 179.543 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.694 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 24.1 t80 -82.96 -28.02 30.09 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.348 -0.845 . . . . 0.0 110.564 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.881 ' CE1' HG13 ' A' ' 77' ' ' VAL . 39.2 m-85 -116.51 -22.53 8.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.208 -0.932 . . . . 0.0 109.457 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.521 ' CA ' HG23 ' A' ' 46' ' ' VAL . . . -72.15 -13.27 76.39 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -66.45 -36.96 84.08 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.416 -1.049 . . . . 0.0 109.713 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.602 ' CD1' ' HB3' ' A' ' 76' ' ' LYS . 9.7 p90 -125.71 7.86 7.54 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.503 -0.748 . . . . 0.0 109.828 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.481 ' O ' ' HA2' ' A' ' 41' ' ' GLY . . . -153.33 98.11 0.18 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 44' ' ' GLY . 8.5 pt-20 -39.79 124.49 1.73 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.526 -0.985 . . . . 0.0 110.26 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.521 HG23 ' CA ' ' A' ' 41' ' ' GLY . 3.3 t -98.43 126.06 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.22 -0.925 . . . . 0.0 110.453 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.469 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 1.6 mmtm -88.77 -27.6 21.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.365 -0.834 . . . . 0.0 109.498 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 12.1 pt-20 179.67 147.34 0.24 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.464 -0.772 . . . . 0.0 110.09 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 19.5 p -140.59 176.59 8.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.158 -0.964 . . . . 0.0 110.531 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.682 ' C ' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -147.74 124.64 11.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.3 -0.875 . . . . 0.0 110.148 179.416 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.493 ' N ' HD12 ' A' ' 50' ' ' LEU . 69.9 t -116.24 131.45 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.716 -1.24 . . . . 0.0 110.883 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 1.2 ttm . . . . . 0 N--CA 1.487 1.401 0 O-C-N 121.526 -0.734 . . . . 0.0 109.523 179.793 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.418 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.992 ' CA ' HD22 ' A' ' 27' ' ' LEU . 11.7 p90 -145.78 -172.38 3.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.161 -1.199 . . . . 0.0 110.656 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.473 ' O ' ' HB ' ' A' ' 24' ' ' ILE . . . -153.7 114.16 0.61 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.605 ' CE1' ' CG ' ' A' ' 23' ' ' PHE . 19.9 m-85 -83.35 148.79 27.13 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.274 -1.133 . . . . 0.0 109.92 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.702 HG22 HD21 ' A' ' 36' ' ' LEU . 3.7 t -148.45 116.23 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.305 -0.872 . . . . 0.0 110.04 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.746 HG23 ' HB2' ' A' ' 21' ' ' LYS . 14.7 m -94.09 35.06 1.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.946 . . . . 0.0 110.511 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.627 ' CE2' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 O-C-N 120.936 -1.102 . . . . 0.0 109.55 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.303 0.573 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.595 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -61.58 -46.16 94.86 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.896 ' O ' HD12 ' A' ' 78' ' ' LEU . 3.0 p -50.12 -46.17 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.205 -1.173 . . . . 0.0 109.484 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.571 ' N ' ' CG1' ' A' ' 74' ' ' VAL . 0.2 OUTLIER -59.71 -40.28 87.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.425 -0.797 . . . . 0.0 109.637 179.529 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.638 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -62.37 -33.51 74.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.416 -0.803 . . . . 0.0 109.389 179.378 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.881 HG13 ' CE1' ' A' ' 40' ' ' PHE . 40.5 t -62.74 -57.84 10.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.36 -0.838 . . . . 0.0 109.191 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.896 HD12 ' O ' ' A' ' 74' ' ' VAL . 4.0 mp -45.31 -41.91 9.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.197 -0.939 . . . . 0.0 108.852 178.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -46.31 -28.26 1.26 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.473 -0.891 . . . . 0.0 108.747 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.524 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 33.0 mm-40 -102.62 26.78 7.55 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.668 -0.645 . . . . 0.0 109.821 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 78' ' ' LEU . 41.9 t -55.93 -16.37 4.66 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.525 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.8 OUTLIER -109.47 1.63 19.99 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 121.626 -0.671 . . . . 0.0 109.373 178.751 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.986 ' CE1' HD12 ' A' ' 90' ' ' ILE . 0.5 OUTLIER 28.25 -87.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.138 0.494 . . . . 0.0 112.141 179.783 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.66 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 1.6 tt0 51.01 112.35 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 122.327 1.06 . . . . 0.0 110.5 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.798 HD11 HD11 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -131.65 -70.06 0.59 Allowed 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.549 ' HB3' ' CE ' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -103.71 55.33 0.74 Allowed 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.913 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 73.65 13.79 4.33 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 -178.135 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.66 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 8.6 mttt -117.86 107.2 13.82 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 121.502 -0.749 . . . . 0.0 110.997 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.682 ' O ' HG23 ' A' ' 89' ' ' THR . 9.5 t -80.82 76.93 7.73 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.508 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.986 HD12 ' CE1' ' A' ' 83' ' ' HIS . 1.6 mt -50.72 -179.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.058 -1.026 . . . . 0.0 109.231 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.63 ' H ' HG22 ' A' ' 90' ' ' ILE . 11.1 t0 -139.2 75.03 34.86 Favored Pre-proline 0 C--N 1.298 -1.641 0 O-C-N 121.188 -0.945 . . . . 0.0 110.559 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.524 ' CG ' ' O ' ' A' ' 80' ' ' GLN . 2.1 Cg_endo -52.64 111.17 0.57 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.593 1.312 . . . . 0.0 110.854 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.588 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -121.66 103.91 9.24 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.098 -1.001 . . . . 0.0 109.136 178.339 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.951 HG22 ' CG ' ' A' ' 22' ' ' MET . 3.4 t -96.83 177.49 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 O-C-N 121.639 -0.663 . . . . 0.0 110.784 -178.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.572 ' H ' HG12 ' A' ' 94' ' ' VAL . . . . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.452 -0.78 . . . . 0.0 109.776 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.203 0.525 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.552 ' HB2' ' CB ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -145.2 165.66 27.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.283 -0.886 . . . . 0.0 110.404 -179.851 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.956 ' HE3' HG11 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -74.2 170.82 14.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.906 . . . . 0.0 109.465 179.617 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.63 ' CG ' ' CE1' ' A' ' 65' ' ' PHE . 5.4 t80 -151.25 129.72 12.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.159 -0.963 . . . . 0.0 110.128 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.47 HG22 HG21 ' A' ' 90' ' ' ILE . 18.4 mm -99.39 139.84 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.206 -0.934 . . . . 0.0 109.366 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' A' ' 91' ' ' ASP . . . -122.34 120.47 4.33 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.65 -1.262 . . . . 0.0 111.154 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.859 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 112.51 41.42 1.04 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.975 HD21 HG13 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -51.2 120.99 5.5 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.342 -1.093 . . . . 0.0 110.624 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.607 ' HB3' HD11 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -46.37 173.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.305 -0.872 . . . . 0.0 110.103 179.684 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.439 ' CD1' ' C ' ' A' ' 29' ' ' TRP . 0.2 OUTLIER -76.48 5.03 7.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -0.926 . . . . 0.0 110.599 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.417 ' HG2' ' CD1' ' A' ' 29' ' ' TRP . 2.5 pt20 -151.57 11.79 0.6 Allowed 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.998 -1.064 . . . . 0.0 111.058 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.629 HG21 ' HG ' ' A' ' 27' ' ' LEU . 1.2 m -59.25 163.01 4.09 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.987 -1.071 . . . . 0.0 109.795 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.642 HG23 ' H ' ' A' ' 35' ' ' GLY . 12.8 t -135.59 -169.81 2.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.924 . . . . 0.0 109.748 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.536 ' O ' ' N ' ' A' ' 36' ' ' LEU . 6.4 mt-30 -88.47 -73.82 0.48 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.035 -1.041 . . . . 0.0 110.042 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.473 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 1.3 tt0 -48.59 -43.18 35.74 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.765 -1.209 . . . . 0.0 109.642 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.642 ' H ' HG23 ' A' ' 32' ' ' THR . . . -55.9 -28.76 53.77 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 107.503 -2.239 . . . . 0.0 107.503 178.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.862 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -81.36 -37.9 27.49 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 177.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 33' ' ' GLN . 19.9 mtt180 -61.71 -27.27 68.59 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 122.398 1.094 . . . . 0.0 108.12 177.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -89.11 -16.38 31.64 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.966 179.338 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.68 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 16.9 t80 -80.52 -32.22 36.92 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.401 -0.812 . . . . 0.0 110.175 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.848 ' HE1' HG13 ' A' ' 77' ' ' VAL . 32.1 m-85 -110.5 -28.26 8.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.392 -0.818 . . . . 0.0 109.025 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -61.76 -15.46 48.17 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -59.8 -42.86 94.37 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.401 -1.058 . . . . 0.0 109.523 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.638 ' HE1' HG22 ' A' ' 77' ' ' VAL . 3.6 p90 -125.83 -6.51 6.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.423 -0.798 . . . . 0.0 109.81 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.496 ' HA2' ' HB2' ' A' ' 70' ' ' ASP . . . -130.8 96.41 0.35 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 11.1 mm-40 -40.69 115.46 0.58 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.335 -1.097 . . . . 0.0 110.546 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.513 ' HA ' ' CB ' ' A' ' 68' ' ' PHE . 59.9 t -95.32 134.21 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.0 110.61 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 0.1 OUTLIER -100.33 -27.75 13.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.373 -0.83 . . . . 0.0 109.743 179.588 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.477 ' O ' HG22 ' A' ' 67' ' ' THR . 5.0 tt0 -176.84 156.63 1.39 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.472 -0.768 . . . . 0.0 109.935 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.468 ' SG ' ' HG2' ' A' ' 37' ' ' ARG . 8.3 p -149.72 164.72 34.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.154 -0.967 . . . . 0.0 110.347 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.647 ' C ' HD12 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -133.41 126.93 32.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.203 -0.936 . . . . 0.0 110.181 179.683 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.975 HG13 HD21 ' A' ' 27' ' ' LEU . 98.1 t -117.39 127.57 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.488 -1.382 . . . . 0.0 110.434 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 63' ' ' PHE . 2.8 tpp -129.3 156.17 44.44 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.624 -0.672 . . . . 0.0 109.797 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.402 ' O ' ' CB ' ' A' ' 54' ' ' ASP . 1.2 ttm180 -151.69 -171.37 3.91 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.479 -0.763 . . . . 0.0 109.97 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.402 ' CB ' ' O ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER 62.71 81.91 0.22 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.13 -0.981 . . . . 0.0 110.605 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -64.21 116.26 3.63 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.717 1.378 . . . . 0.0 110.352 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.2 pp -89.34 -26.45 21.08 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.122 -0.986 . . . . 0.0 110.335 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.628 HG23 ' H ' ' A' ' 59' ' ' ARG . 6.5 t -142.04 -148.5 0.24 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.34 -0.85 . . . . 0.0 110.081 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.408 ' N ' ' OG1' ' A' ' 57' ' ' THR . 0.4 OUTLIER -83.39 13.86 4.07 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.215 -0.928 . . . . 0.0 110.454 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.628 ' H ' HG23 ' A' ' 57' ' ' THR . 0.1 OUTLIER -77.95 -161.85 0.28 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 110.271 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.508 ' N ' ' HD3' ' A' ' 59' ' ' ARG . 29.1 m -52.52 -173.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.275 -0.891 . . . . 0.0 110.687 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.17 28.12 0.75 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.268 -0.895 . . . . 0.0 110.133 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 52' ' ' MET . . . 128.2 98.36 0.94 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.915 ' C ' HD13 ' A' ' 27' ' ' LEU . 24.8 p90 -141.72 -174.21 4.0 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.199 -1.177 . . . . 0.0 110.519 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.674 ' N ' HD13 ' A' ' 27' ' ' LEU . . . -153.84 113.59 0.58 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.63 ' CE1' ' CG ' ' A' ' 23' ' ' PHE . 18.4 m-85 -83.98 149.91 25.99 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.365 -1.079 . . . . 0.0 109.605 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.778 HG21 HD11 ' A' ' 36' ' ' LEU . 3.6 t -149.8 110.2 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.163 -0.961 . . . . 0.0 110.274 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.562 ' O ' HG23 ' A' ' 67' ' ' THR . 12.8 t -90.39 53.94 2.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.249 -0.907 . . . . 0.0 110.523 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.567 ' CZ ' ' SD ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -77.31 -174.76 3.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.124 -0.985 . . . . 0.0 110.412 179.734 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.62 117.18 0.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.945 -1.097 . . . . 0.0 110.959 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.496 ' HB2' ' HA2' ' A' ' 44' ' ' GLY . 0.7 OUTLIER -150.57 172.85 14.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.393 -0.817 . . . . 0.0 109.994 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -53.39 -71.17 0.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.083 -1.011 . . . . 0.0 110.124 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 75' ' ' ASP . . . -90.21 24.4 2.53 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.238 -0.914 . . . . 0.0 110.064 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.809 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -42.28 -85.13 0.01 OUTLIER Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.7 t -42.6 -27.02 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.308 -1.113 . . . . 0.0 110.68 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -68.24 -82.67 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.113 -0.992 . . . . 0.0 110.192 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.466 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -40.24 -28.54 0.06 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.34 -0.85 . . . . 0.0 109.715 179.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.956 HG11 ' HE3' ' A' ' 22' ' ' MET . 55.2 t -68.55 -43.51 83.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 O-C-N 121.459 -0.776 . . . . 0.0 110.319 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.009 HD23 ' N ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -59.68 -36.58 76.74 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 120.907 -1.12 . . . . 0.0 108.215 179.385 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 1.009 ' N ' HD23 ' A' ' 78' ' ' LEU . . . -48.25 -29.17 3.55 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.554 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -107.28 28.17 8.35 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.339 0.59 . . . . 0.0 109.411 179.182 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.491 ' O ' ' HD2' ' A' ' 92' ' ' PRO . 2.9 p -49.14 -18.64 0.35 Allowed 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.143 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -107.35 -15.18 14.7 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.471 -0.768 . . . . 0.0 109.623 179.142 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.812 ' ND1' HD12 ' A' ' 90' ' ' ILE . 0.2 OUTLIER 56.86 -80.94 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.834 0.826 . . . . 0.0 110.321 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.946 ' C ' HD23 ' A' ' 85' ' ' LEU . 3.0 tt0 54.41 123.18 0.0 OUTLIER 'General case' 0 C--N 1.288 -2.087 0 CA-C-O 122.177 0.989 . . . . 0.0 110.895 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.946 HD23 ' C ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -154.29 -88.55 0.05 OUTLIER 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.59 -0.694 . . . . 0.0 109.339 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.566 ' O ' ' CB ' ' A' ' 87' ' ' SER . 0.6 OUTLIER -82.01 52.31 1.94 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.111 -0.993 . . . . 0.0 108.848 178.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.566 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 76.72 6.8 3.32 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.231 0.539 . . . . 0.0 110.102 -179.317 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.596 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 1.6 mmtm -116.03 117.55 30.43 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.283 -0.886 . . . . 0.0 110.729 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.787 ' O ' HG23 ' A' ' 89' ' ' THR . 10.2 t -88.85 80.18 7.21 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.734 -0.604 . . . . 0.0 109.714 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.859 HG23 ' C ' ' A' ' 26' ' ' GLY . 1.5 mt -52.58 -173.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.238 -0.914 . . . . 0.0 109.743 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.599 ' H ' HG22 ' A' ' 90' ' ' ILE . 4.6 t70 -144.54 84.2 9.3 Favored Pre-proline 0 N--CA 1.484 1.271 0 O-C-N 120.952 -1.092 . . . . 0.0 111.052 -178.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.554 ' CG ' ' O ' ' A' ' 80' ' ' GLN . 2.2 Cg_endo -56.08 113.46 1.45 Allowed 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.419 1.22 . . . . 0.0 110.962 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.618 ' HD2' ' CD2' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -132.48 109.96 10.17 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.35 -0.844 . . . . 0.0 109.451 178.264 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.745 HG22 ' HB2' ' A' ' 22' ' ' MET . 40.9 t -96.19 157.89 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.556 -0.715 . . . . 0.0 110.553 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 94' ' ' VAL . . . 42.34 -154.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.334 -0.854 . . . . 0.0 110.565 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.424 -0.798 . . . . 0.0 110.068 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.208 0.528 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.552 ' HB2' ' CB ' ' A' ' 67' ' ' THR . 1.3 ptpt -139.88 -167.53 2.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.915 . . . . 0.0 110.426 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.973 ' CG ' HG13 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -100.81 170.81 8.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.39 -0.819 . . . . 0.0 109.698 179.648 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.65 ' HB3' ' HD2' ' A' ' 93' ' ' LYS . 19.5 t80 -147.0 155.19 42.05 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.084 -1.01 . . . . 0.0 110.353 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.494 HD13 ' HA ' ' A' ' 92' ' ' PRO . 24.9 mm -121.26 151.79 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.321 -0.862 . . . . 0.0 109.282 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.668 ' O ' HG22 ' A' ' 90' ' ' ILE . . . -133.78 138.96 10.49 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.33 -1.414 . . . . 0.0 111.341 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.879 ' O ' HD12 ' A' ' 90' ' ' ILE . . . 103.33 29.67 5.61 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.01 HD22 ' O ' ' A' ' 63' ' ' PHE . 0.8 OUTLIER -53.38 112.89 0.98 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.485 -1.009 . . . . 0.0 110.523 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.517 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -56.58 173.57 0.18 Allowed 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.411 -0.806 . . . . 0.0 110.056 179.671 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -80.33 11.54 3.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.315 -0.866 . . . . 0.0 110.493 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -133.44 -0.38 3.25 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.114 -0.991 . . . . 0.0 110.501 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.736 HG21 ' HG ' ' A' ' 27' ' ' LEU . 18.4 m -64.62 158.03 25.48 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.354 -0.841 . . . . 0.0 110.207 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.505 ' CG2' ' HA3' ' A' ' 35' ' ' GLY . 12.5 t -135.28 -173.15 3.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.121 -0.987 . . . . 0.0 110.069 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 36' ' ' LEU . 31.6 mt-30 -90.16 -74.76 0.48 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.198 -0.939 . . . . 0.0 110.202 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.53 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -48.72 -48.09 40.78 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.727 -1.189 . . . . 0.0 108.724 179.758 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.505 ' HA3' ' CG2' ' A' ' 32' ' ' THR . . . -48.92 -32.97 12.3 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 107.451 -2.26 . . . . 0.0 107.451 178.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.746 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -78.88 -39.76 34.25 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.361 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.505 ' CG ' ' HA ' ' A' ' 34' ' ' GLU . 3.2 mtt180 -57.81 -25.6 60.82 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.484 1.135 . . . . 0.0 107.974 178.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.53 ' CG ' ' O ' ' A' ' 34' ' ' GLU . 1.3 mt-10 -89.09 -21.11 23.56 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.632 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.67 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 20.5 t80 -73.49 -29.99 62.86 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.916 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.878 ' HE1' HG13 ' A' ' 77' ' ' VAL . 44.9 m-85 -110.89 -24.56 10.34 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.525 -0.735 . . . . 0.0 109.061 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.58 -9.44 74.02 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -73.78 -52.04 14.44 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.409 -1.054 . . . . 0.0 110.461 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.582 ' CZ ' ' HA ' ' A' ' 40' ' ' PHE . 3.7 p90 -104.81 8.98 35.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.295 -0.878 . . . . 0.0 110.491 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.87 175.43 32.93 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 68' ' ' PHE . 59.8 mm-40 -98.0 110.15 22.78 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.25 -1.147 . . . . 0.0 109.997 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.461 HG13 ' SG ' ' A' ' 49' ' ' CYS . 23.8 t -89.74 123.27 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 0.0 110.364 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.6 -26.2 16.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.406 -0.809 . . . . 0.0 109.75 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.944 ' O ' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER 179.95 151.89 0.43 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.438 -0.789 . . . . 0.0 110.006 179.686 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.532 ' HB3' HD21 ' A' ' 36' ' ' LEU . 9.3 m -145.34 174.72 10.87 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.331 -0.855 . . . . 0.0 110.012 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.801 HD12 ' N ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -148.36 144.41 27.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 110.375 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.892 HG12 ' NH2' ' A' ' 53' ' ' ARG . 86.0 t -132.33 134.88 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.624 -1.297 . . . . 0.0 110.997 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.423 ' HG3' ' N ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -139.46 148.55 42.88 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.585 -0.697 . . . . 0.0 109.585 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.892 ' NH2' HG12 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -150.06 -47.97 0.13 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.471 -0.768 . . . . 0.0 110.255 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.543 ' N ' ' HD3' ' A' ' 55' ' ' PRO . 1.3 m-20 53.79 59.67 12.15 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.347 -0.846 . . . . 0.0 110.916 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.543 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 2.7 Cg_endo -64.62 56.81 0.25 Allowed 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.521 1.274 . . . . 0.0 110.685 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.463 ' N ' ' O ' ' A' ' 54' ' ' ASP . 8.1 mt -106.02 -52.67 2.76 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.104 -0.998 . . . . 0.0 110.03 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.807 HG23 ' CG ' ' A' ' 59' ' ' ARG . 1.1 t -136.96 7.88 2.96 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.515 -0.74 . . . . 0.0 110.109 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.624 ' HG2' ' C ' ' A' ' 57' ' ' THR . 21.0 mmtt 75.24 -10.68 1.19 Allowed 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.549 -0.719 . . . . 0.0 110.558 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.807 ' CG ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -46.47 -36.07 6.27 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 121.657 -0.652 . . . . 0.0 110.264 -179.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.613 ' N ' ' CD ' ' A' ' 59' ' ' ARG . 5.9 p -62.8 -152.4 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.1 -1.0 . . . . 0.0 110.4 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.425 ' HG3' ' C ' ' A' ' 60' ' ' SER . 16.0 mtt85 -134.33 -42.96 0.78 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.974 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.448 ' C ' ' HB2' ' A' ' 27' ' ' LEU . . . 91.07 90.76 1.35 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 1.01 ' O ' HD22 ' A' ' 27' ' ' LEU . 2.4 p90 -150.26 -177.94 6.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.208 -1.172 . . . . 0.0 110.598 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.813 ' N ' HD13 ' A' ' 27' ' ' LEU . . . -147.31 121.06 1.33 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.671 ' CD2' HD21 ' A' ' 50' ' ' LEU . 21.6 m-85 -84.04 153.25 23.92 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.4 -1.059 . . . . 0.0 110.384 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.678 HG22 HD11 ' A' ' 36' ' ' LEU . 13.9 t -150.07 129.58 3.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.5 -0.75 . . . . 0.0 109.208 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.944 HG22 ' O ' ' A' ' 48' ' ' GLU . 9.9 t -119.12 59.2 0.84 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.144 -0.972 . . . . 0.0 111.039 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.683 ' CZ ' HG21 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -70.39 -161.84 0.05 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.947 -1.096 . . . . 0.0 109.91 179.546 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.402 ' HG2' ' HB2' ' A' ' 45' ' ' GLU . 9.0 ptt? -89.01 -158.3 0.49 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.132 -0.98 . . . . 0.0 110.357 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.651 ' HA ' HG23 ' A' ' 74' ' ' VAL . 6.5 m-20 -122.03 -139.74 0.32 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.959 -1.088 . . . . 0.0 110.146 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 62.19 -148.8 0.38 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.136 -0.977 . . . . 0.0 110.239 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 75' ' ' ASP . . . -55.25 -29.37 57.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.282 -0.886 . . . . 0.0 110.306 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -48.11 -65.38 2.53 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.903 ' O ' HD12 ' A' ' 78' ' ' LEU . 25.5 t -47.12 -52.62 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.199 -1.177 . . . . 0.0 110.39 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 72' ' ' ALA . 15.7 m-20 -42.63 -52.07 4.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.145 -0.972 . . . . 0.0 110.173 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.655 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -59.46 -39.4 83.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.394 -0.816 . . . . 0.0 110.155 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.878 HG13 ' HE1' ' A' ' 40' ' ' PHE . 81.7 t -55.33 -60.4 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 O-C-N 121.072 -1.017 . . . . 0.0 109.621 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.903 HD12 ' O ' ' A' ' 74' ' ' VAL . 1.6 mp -44.12 -42.46 6.32 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.234 -0.916 . . . . 0.0 109.423 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -46.88 -27.9 1.4 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.176 -0.953 . . . . 0.0 109.383 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.563 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 13.9 mm100 -101.66 22.0 13.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.426 -0.796 . . . . 0.0 109.894 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.46 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 47.0 t -51.7 -16.92 0.74 Allowed 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.007 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.469 ' O ' ' C ' ' A' ' 83' ' ' HIS . 9.6 ptt180 -100.56 -10.39 21.06 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 121.369 -0.832 . . . . 0.0 109.686 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.67 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 0.5 OUTLIER 31.69 43.99 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.811 -0.555 . . . . 0.0 111.851 179.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 2.4 tt0 -93.4 122.58 35.96 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.795 -1.162 . . . . 0.0 110.103 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.502 HD23 ' C ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -155.0 -83.38 0.07 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.553 -0.717 . . . . 0.0 110.189 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.559 ' CB ' ' HD3' ' A' ' 88' ' ' LYS . 0.3 OUTLIER -78.4 52.74 1.18 Allowed 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.036 -1.04 . . . . 0.0 109.425 179.525 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.522 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 71.62 1.43 3.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.522 -0.736 . . . . 0.0 110.619 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.559 ' HD3' ' CB ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -112.69 126.5 55.46 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.104 -0.997 . . . . 0.0 110.249 -179.821 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.655 ' O ' HG23 ' A' ' 89' ' ' THR . 11.5 t -105.82 64.97 0.69 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.666 -0.646 . . . . 0.0 110.361 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.879 HD12 ' O ' ' A' ' 26' ' ' GLY . 0.9 OUTLIER -53.0 -176.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.28 -0.888 . . . . 0.0 109.016 179.892 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' A' ' 25' ' ' GLY . 5.3 t70 -145.11 84.65 8.56 Favored Pre-proline 0 N--CA 1.485 1.28 0 O-C-N 120.653 -1.279 . . . . 0.0 111.052 -178.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.565 ' HG3' ' HD2' ' A' ' 83' ' ' HIS . 1.9 Cg_endo -57.39 112.79 1.23 Allowed 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.565 1.298 . . . . 0.0 110.634 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.65 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -111.3 107.14 16.32 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.035 -1.041 . . . . 0.0 108.983 178.237 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.973 HG13 ' CG ' ' A' ' 22' ' ' MET . 93.2 t -97.28 153.4 3.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.704 -0.623 . . . . 0.0 110.372 -179.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.85 -156.16 0.71 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.206 -0.934 . . . . 0.0 110.022 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.1 t80 . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.234 -0.916 . . . . 0.0 110.121 179.886 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 33.4 t . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.287 0.565 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.473 ' HB2' ' OG1' ' A' ' 67' ' ' THR . 3.5 pttt -68.51 169.03 11.64 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.232 -0.917 . . . . 0.0 109.996 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.92 ' CG ' HG22 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -76.66 162.07 28.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.249 -0.907 . . . . 0.0 110.226 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.661 ' C ' HD12 ' A' ' 24' ' ' ILE . 19.9 t80 -149.54 145.96 27.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.306 -0.871 . . . . 0.0 109.935 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.661 HD12 ' C ' ' A' ' 23' ' ' PHE . 1.1 mp -113.37 142.45 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 108.905 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.626 ' O ' HG22 ' A' ' 90' ' ' ILE . . . -120.42 127.16 6.94 Favored Glycine 0 N--CA 1.494 2.522 0 C-N-CA 119.478 -1.344 . . . . 0.0 111.472 -178.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.844 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 107.32 45.11 1.18 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.943 ' CD2' HG13 ' A' ' 51' ' ' VAL . 1.1 tp -56.47 113.97 1.82 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.103 -1.234 . . . . 0.0 110.508 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.502 ' CB ' ' HG2' ' A' ' 88' ' ' LYS . 6.1 t -45.5 170.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.471 -0.768 . . . . 0.0 110.321 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 39.9 p-90 -81.5 11.55 4.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.261 -0.899 . . . . 0.0 110.451 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -143.98 8.95 1.48 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.18 -0.95 . . . . 0.0 110.52 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.63 HG21 ' HG ' ' A' ' 27' ' ' LEU . 1.4 m -70.68 163.1 27.8 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.294 -0.879 . . . . 0.0 110.097 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.531 HG23 ' H ' ' A' ' 35' ' ' GLY . 4.4 t -142.72 -175.64 4.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.125 -0.984 . . . . 0.0 109.997 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 36' ' ' LEU . 6.5 mt-30 -80.26 -73.1 0.38 Allowed 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.035 -1.041 . . . . 0.0 111.014 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.534 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -48.0 -49.59 30.39 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 118.48 -1.288 . . . . 0.0 108.765 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.531 ' H ' HG23 ' A' ' 32' ' ' THR . . . -47.73 -31.04 7.15 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 107.753 -2.139 . . . . 0.0 107.753 178.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.905 HD21 ' HB2' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -78.45 -39.35 38.83 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 178.283 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.489 ' N ' ' O ' ' A' ' 34' ' ' GLU . 71.7 mtt180 -59.22 -26.42 64.85 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 178.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.534 ' HG3' ' O ' ' A' ' 34' ' ' GLU . 1.3 mt-10 -88.08 -19.68 26.73 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.692 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 8.3 t80 -79.38 -43.04 24.21 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.771 -0.771 . . . . 0.0 110.735 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.846 ' HE1' HG13 ' A' ' 77' ' ' VAL . 28.4 m-85 -105.92 -28.11 10.79 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.387 -0.821 . . . . 0.0 109.217 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.579 ' CA ' HG23 ' A' ' 46' ' ' VAL . . . -67.35 -10.09 56.36 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.647 -1.781 . . . . 0.0 108.647 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -63.05 -37.14 85.99 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.379 -1.071 . . . . 0.0 109.873 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.499 ' HE1' HG22 ' A' ' 77' ' ' VAL . 3.2 p90 -127.23 0.79 6.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.491 -0.756 . . . . 0.0 109.897 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.608 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -146.54 97.55 0.19 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -37.87 122.76 1.02 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.559 -0.965 . . . . 0.0 110.638 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.579 HG23 ' CA ' ' A' ' 41' ' ' GLY . 21.3 t -91.06 119.92 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.356 -0.84 . . . . 0.0 110.727 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -86.14 -21.56 27.5 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.358 -0.839 . . . . 0.0 109.637 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -178.75 145.16 0.29 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.366 -0.834 . . . . 0.0 110.384 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.905 ' HB2' HD21 ' A' ' 36' ' ' LEU . 5.5 p -148.05 170.16 18.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.287 -0.883 . . . . 0.0 109.93 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.769 HD21 ' CD2' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -148.97 133.66 17.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.873 -1.142 . . . . 0.0 110.927 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.943 HG13 ' CD2' ' A' ' 27' ' ' LEU . 61.6 t -110.51 130.19 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.808 -1.183 . . . . 0.0 109.487 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.501 ' SD ' ' CZ ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER -142.17 168.71 19.09 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.174 -0.954 . . . . 0.0 110.612 -178.534 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.548 ' HA ' ' O ' ' A' ' 61' ' ' ARG . 13.8 ptt180 -124.95 -160.6 0.96 Allowed 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.53 -0.731 . . . . 0.0 109.582 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.599 ' CB ' ' HD3' ' A' ' 55' ' ' PRO . 0.6 OUTLIER 175.39 -58.65 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 120.897 -1.127 . . . . 0.0 111.209 179.683 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.599 ' HD3' ' CB ' ' A' ' 54' ' ' ASP . 2.9 Cg_endo -57.85 -152.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.325 1.171 . . . . 0.0 110.714 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.525 HD23 ' N ' ' A' ' 56' ' ' LEU . 5.2 mt -93.98 -69.46 0.75 Allowed 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.15 -0.969 . . . . 0.0 110.796 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.457 HG23 ' HD3' ' A' ' 58' ' ' LYS . 1.8 t 179.54 -30.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.339 -0.851 . . . . 0.0 110.794 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.48 ' N ' ' HD3' ' A' ' 58' ' ' LYS . 15.5 mmtp -56.99 -50.37 72.91 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.183 -0.948 . . . . 0.0 108.977 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.565 ' HG2' ' CB ' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -59.6 -155.5 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.243 179.434 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.495 ' HB3' ' O ' ' A' ' 27' ' ' LEU . 14.5 m -74.35 -111.91 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.13 -0.981 . . . . 0.0 109.051 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.548 ' O ' ' HA ' ' A' ' 53' ' ' ARG . 6.2 ttm180 -136.72 -42.3 0.6 Allowed 'General case' 0 N--CA 1.482 1.152 0 O-C-N 120.731 -1.231 . . . . 0.0 108.372 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 53' ' ' ARG . . . 162.94 -87.99 0.1 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.461 -1.856 . . . . 0.0 108.461 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.879 ' C ' HD13 ' A' ' 27' ' ' LEU . 8.2 p90 -177.66 178.15 1.04 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.303 -1.116 . . . . 0.0 110.367 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.863 ' N ' HD13 ' A' ' 27' ' ' LEU . . . -141.67 164.36 26.71 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.769 ' CD2' HD21 ' A' ' 50' ' ' LEU . 13.6 m-85 -124.56 148.38 47.85 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.356 -1.085 . . . . 0.0 109.822 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.517 HG23 ' C ' ' A' ' 65' ' ' PHE . 7.5 t -148.71 126.8 3.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.317 -0.865 . . . . 0.0 110.171 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.619 HG22 ' O ' ' A' ' 67' ' ' THR . 88.4 m -106.14 19.51 20.41 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.282 -0.886 . . . . 0.0 110.079 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.615 ' CE2' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -49.83 142.44 8.84 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.151 -0.968 . . . . 0.0 109.728 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.4 ttp -136.54 123.86 21.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.261 -0.899 . . . . 0.0 110.25 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.405 ' OD1' ' HG2' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -150.04 -159.99 1.11 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 110.339 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -80.79 -72.36 0.42 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.23 -0.919 . . . . 0.0 110.214 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 73' ' ' GLY . . . -87.8 21.95 2.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.218 -0.927 . . . . 0.0 110.348 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.674 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -43.48 -63.75 2.04 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.666 HG22 HG11 ' A' ' 94' ' ' VAL . 11.1 t -54.45 -23.8 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.136 -1.214 . . . . 0.0 110.0 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.486 ' HB3' ' HE3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -75.38 -73.13 0.27 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 110.017 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.486 ' HE3' ' HB3' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -47.55 -46.47 27.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.378 -0.826 . . . . 0.0 109.818 179.807 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.846 HG13 ' HE1' ' A' ' 40' ' ' PHE . 79.9 t -52.59 -53.25 21.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.069 -1.02 . . . . 0.0 108.691 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -41.02 -51.81 3.23 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.659 -0.651 . . . . 0.0 110.064 179.012 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -42.85 -27.26 0.17 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.441 -0.787 . . . . 0.0 110.19 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.562 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 9.7 mm-40 -104.58 21.85 16.06 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.265 -0.897 . . . . 0.0 110.29 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.508 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 40.3 t -51.76 -16.86 0.75 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.481 -0.762 . . . . 0.0 109.276 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.5 OUTLIER -108.33 -4.41 17.47 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 121.346 -0.846 . . . . 0.0 109.939 179.348 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.841 ' CE1' HD12 ' A' ' 90' ' ' ILE . 0.4 OUTLIER 34.39 31.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.786 -0.571 . . . . 0.0 111.241 179.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -86.24 117.78 25.27 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 118.39 -1.324 . . . . 0.0 110.205 179.502 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.534 HD11 ' HZ1' ' A' ' 88' ' ' LYS . 0.1 OUTLIER -153.78 -73.68 0.13 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.808 -0.558 . . . . 0.0 110.231 -179.249 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 87' ' ' SER . 0.4 OUTLIER -81.27 49.07 1.22 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.165 -0.96 . . . . 0.0 109.474 179.552 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 71.68 -0.11 3.29 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.539 -0.726 . . . . 0.0 110.651 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.673 ' HE3' HD11 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -115.35 138.66 50.74 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.182 -0.949 . . . . 0.0 110.084 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.789 ' O ' HG23 ' A' ' 89' ' ' THR . 14.9 t -113.11 71.27 0.74 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.544 -0.723 . . . . 0.0 110.799 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.844 HG23 ' C ' ' A' ' 26' ' ' GLY . 1.2 mt -55.0 -171.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.32 -0.863 . . . . 0.0 109.534 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.585 ' H ' HG22 ' A' ' 90' ' ' ILE . 5.1 t70 -143.82 87.04 8.3 Favored Pre-proline 0 N--CA 1.486 1.355 0 O-C-N 120.882 -1.136 . . . . 0.0 111.192 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.562 ' CG ' ' O ' ' A' ' 80' ' ' GLN . 2.0 Cg_endo -62.49 112.23 1.53 Allowed 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.53 1.279 . . . . 0.0 111.057 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.641 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -115.43 109.32 17.69 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.115 -0.991 . . . . 0.0 109.066 178.111 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.92 HG22 ' CG ' ' A' ' 22' ' ' MET . 53.6 t -97.04 151.57 4.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.521 -0.737 . . . . 0.0 110.291 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -109.02 123.32 48.95 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.203 -0.936 . . . . 0.0 110.375 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.5 t80 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.151 -0.968 . . . . 0.0 109.883 179.773 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.302 0.572 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 0.3 OUTLIER -134.83 152.77 52.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 110.343 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.981 ' CG ' HG13 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -73.06 -172.12 1.01 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.349 -0.845 . . . . 0.0 109.839 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.686 ' CG ' ' CE1' ' A' ' 65' ' ' PHE . 6.5 t80 -151.01 145.38 25.5 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.015 -1.053 . . . . 0.0 110.211 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.743 HD12 ' CZ ' ' A' ' 40' ' ' PHE . 18.6 mm -118.49 126.34 75.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.299 -0.876 . . . . 0.0 108.905 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.56 ' O ' HG22 ' A' ' 90' ' ' ILE . . . -109.83 159.63 13.86 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.789 -1.196 . . . . 0.0 111.227 -178.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 90' ' ' ILE . . . 54.35 40.25 67.82 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.006 HD22 ' CA ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -85.56 143.41 28.5 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.676 -0.897 . . . . 0.0 110.926 -179.135 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.5 ' O ' ' HB ' ' A' ' 31' ' ' THR . 0.5 OUTLIER -39.39 134.81 1.16 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.465 0.65 . . . . 0.0 110.942 -179.076 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.526 ' CG ' ' N ' ' A' ' 30' ' ' GLN . 31.0 p-90 -68.28 -37.97 81.22 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.361 -0.837 . . . . 0.0 109.947 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.526 ' N ' ' CG ' ' A' ' 29' ' ' TRP . 12.3 pt20 -74.76 0.21 16.07 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.396 -0.815 . . . . 0.0 110.696 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.5 ' HB ' ' O ' ' A' ' 28' ' ' SER . 4.4 m -69.24 153.86 42.97 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.392 -0.817 . . . . 0.0 110.215 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.552 HG23 ' H ' ' A' ' 35' ' ' GLY . 5.9 t -123.79 -174.18 2.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 109.625 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 36' ' ' LEU . 1.7 mt-30 -72.28 -73.15 0.2 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.044 -1.035 . . . . 0.0 110.855 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -48.33 -50.01 31.97 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 118.569 -1.252 . . . . 0.0 108.845 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.552 ' H ' HG23 ' A' ' 32' ' ' THR . . . -49.47 -29.23 10.94 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 107.795 -2.122 . . . . 0.0 107.795 178.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.921 HD21 ' HB2' ' A' ' 49' ' ' CYS . 0.1 OUTLIER -81.72 -38.24 26.08 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 178.315 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.491 ' HG3' ' HA ' ' A' ' 34' ' ' GLU . 13.9 mtp180 -58.71 -27.31 64.75 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.509 ' HG3' ' O ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -89.25 -21.35 23.26 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.793 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.579 ' OH ' ' CG ' ' A' ' 83' ' ' HIS . 38.2 t80 -67.84 -29.17 68.24 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.568 0.699 . . . . 0.0 109.85 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.884 ' HE1' HG13 ' A' ' 77' ' ' VAL . 38.4 m-85 -117.66 -18.72 9.6 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -70.17 -12.59 69.05 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -62.19 -47.82 82.77 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.452 -1.028 . . . . 0.0 109.691 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.582 ' HE1' HG22 ' A' ' 77' ' ' VAL . 6.0 p90 -119.61 7.87 11.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.519 -0.738 . . . . 0.0 109.911 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.464 ' O ' ' HA2' ' A' ' 41' ' ' GLY . . . -159.41 99.99 0.18 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 13.3 pt-20 -41.26 148.79 0.12 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.433 -1.039 . . . . 0.0 110.099 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.791 HG22 ' CB ' ' A' ' 68' ' ' PHE . 48.8 t -122.6 147.38 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.192 -0.943 . . . . 0.0 110.868 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -106.3 -32.7 8.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.414 -0.804 . . . . 0.0 109.887 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.765 ' O ' HG22 ' A' ' 67' ' ' THR . 0.9 OUTLIER -167.51 152.03 6.81 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.248 -0.908 . . . . 0.0 110.294 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.921 ' HB2' HD21 ' A' ' 36' ' ' LEU . 29.7 p -150.8 167.42 27.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.178 -0.951 . . . . 0.0 110.285 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.67 ' C ' HD12 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -138.6 126.23 22.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.168 -0.957 . . . . 0.0 109.872 179.504 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.488 HG23 HD23 ' A' ' 36' ' ' LEU . 61.6 t -115.09 130.44 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.634 -1.292 . . . . 0.0 111.261 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.445 ' HB3' ' HE2' ' A' ' 52' ' ' MET . 0.1 OUTLIER -132.26 148.16 52.44 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.6 -0.688 . . . . 0.0 109.292 179.317 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.512 ' NH1' ' CE3' ' A' ' 29' ' ' TRP . 4.0 ttt180 -132.06 -85.01 0.49 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.457 -0.777 . . . . 0.0 110.386 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 53' ' ' ARG . 64.6 m-20 -132.45 89.0 37.62 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 110.554 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 60' ' ' SER . 2.9 Cg_endo -60.76 -50.72 6.0 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 O-C-N 123.633 1.333 . . . . 0.0 110.179 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.596 HD12 ' HG2' ' A' ' 59' ' ' ARG . 9.6 mt -89.96 -57.8 2.73 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.286 -0.884 . . . . 0.0 109.596 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.05 -44.87 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.507 -0.745 . . . . 0.0 110.174 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.472 ' O ' ' HD2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -175.9 23.19 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.238 -0.914 . . . . 0.0 110.816 179.8 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.596 ' HG2' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -79.26 -29.99 42.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.988 -1.07 . . . . 0.0 110.261 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.528 ' N ' ' CD ' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -58.53 -152.57 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.215 -0.928 . . . . 0.0 110.072 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.462 ' HB2' ' CE2' ' A' ' 63' ' ' PHE . 0.7 OUTLIER -134.14 -29.86 1.23 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.169 -0.957 . . . . 0.0 110.727 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.99 88.04 1.57 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 1.006 ' CA ' HD22 ' A' ' 27' ' ' LEU . 7.4 p90 -151.54 -172.71 4.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.192 -1.181 . . . . 0.0 110.666 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.564 ' N ' HD13 ' A' ' 27' ' ' LEU . . . -153.48 120.19 1.02 Allowed Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.686 ' CE1' ' CG ' ' A' ' 23' ' ' PHE . 17.3 m-85 -83.94 149.31 26.4 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.453 -1.028 . . . . 0.0 109.153 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.695 ' CG2' HD11 ' A' ' 36' ' ' LEU . 3.5 t -150.0 114.51 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.11 -0.994 . . . . 0.0 110.845 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.765 HG22 ' O ' ' A' ' 48' ' ' GLU . 8.9 t -80.07 4.09 18.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.175 -0.953 . . . . 0.0 109.694 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.791 ' CB ' HG22 ' A' ' 46' ' ' VAL . 1.0 OUTLIER -49.31 155.65 0.69 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.3 -0.875 . . . . 0.0 110.105 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 39.2 ttm -170.39 113.32 0.45 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.113 -0.992 . . . . 0.0 110.504 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.42 ' O ' ' C ' ' A' ' 71' ' ' GLN . 15.2 t70 -131.85 166.05 22.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.237 -0.915 . . . . 0.0 110.083 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -43.09 -71.3 0.08 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.253 -0.904 . . . . 0.0 110.214 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.23 -4.71 58.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.887 . . . . 0.0 110.186 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.663 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -47.71 -77.64 0.11 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.569 HG22 HG11 ' A' ' 94' ' ' VAL . 51.1 t -40.95 -51.84 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.33 -1.1 . . . . 0.0 110.481 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.476 ' HA ' HD21 ' A' ' 78' ' ' LEU . 3.8 m-20 -47.1 -52.91 14.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -0.927 . . . . 0.0 110.295 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.661 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -67.05 -35.76 80.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.465 -0.772 . . . . 0.0 110.531 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.884 HG13 ' HE1' ' A' ' 40' ' ' PHE . 49.8 t -54.58 -72.8 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.057 -1.027 . . . . 0.0 109.753 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.476 HD21 ' HA ' ' A' ' 75' ' ' ASP . 1.1 pp -46.82 -37.42 8.67 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.909 -1.119 . . . . 0.0 109.289 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -51.69 -25.76 7.93 Favored 'General case' 0 C--N 1.308 -1.235 0 O-C-N 121.1 -1.0 . . . . 0.0 108.685 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.591 ' HB3' ' CE1' ' A' ' 83' ' ' HIS . 13.3 mm-40 -103.99 26.28 8.91 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.465 0.65 . . . . 0.0 109.351 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.557 ' HA ' ' HD2' ' A' ' 92' ' ' PRO . 47.4 t -54.54 -15.83 1.99 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.544 ' O ' ' C ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -113.54 8.19 17.66 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.611 -0.681 . . . . 0.0 109.66 179.099 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.638 ' CD2' ' HG3' ' A' ' 92' ' ' PRO . 2.6 m-70 -3.38 -78.01 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.736 ' C ' HD23 ' A' ' 85' ' ' LEU . 4.4 tt0 59.38 122.46 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 121.467 0.651 . . . . 0.0 109.49 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.083 HD21 HD11 ' A' ' 90' ' ' ILE . 0.4 OUTLIER -157.58 -37.81 0.07 Allowed 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.274 -0.97 . . . . 0.0 110.502 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 87' ' ' SER . 1.5 t70 -121.88 48.03 1.78 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 74.44 1.33 3.82 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -177.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -117.05 119.43 35.25 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.685 ' O ' HG23 ' A' ' 89' ' ' THR . 7.3 t -92.45 77.91 5.04 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.083 HD11 HD21 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -40.98 167.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 CA-C-O 121.897 0.856 . . . . 0.0 110.615 -178.8 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 25' ' ' GLY . 4.6 t70 -133.2 69.63 78.01 Favored Pre-proline 0 C--N 1.297 -1.694 0 O-C-N 121.685 -0.635 . . . . 0.0 109.448 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.638 ' HG3' ' CD2' ' A' ' 83' ' ' HIS . 1.8 Cg_endo -49.58 112.84 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.566 1.298 . . . . 0.0 109.882 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.525 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.1 OUTLIER -126.75 107.95 10.61 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.871 0.843 . . . . 0.0 110.009 179.192 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.981 HG13 ' CG ' ' A' ' 22' ' ' MET . 76.3 t -95.99 153.72 3.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.11 2.4 20.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.095 -1.003 . . . . 0.0 110.427 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.851 ' H ' HG12 ' A' ' 94' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.134 -0.979 . . . . 0.0 110.26 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.273 0.558 . . . . 0.0 110.223 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.468 ' HB2' ' CA ' ' A' ' 67' ' ' THR . 1.1 pttm -156.16 145.03 20.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 110.105 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.796 ' CB ' HG22 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -55.23 155.85 4.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 110.218 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.633 ' CD2' ' CE ' ' A' ' 93' ' ' LYS . 0.5 OUTLIER -138.54 119.61 14.49 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.582 -0.699 . . . . 0.0 109.444 -179.804 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.621 ' CG2' HG21 ' A' ' 90' ' ' ILE . 1.2 mp -93.65 137.89 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.081 -1.012 . . . . 0.0 109.12 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.543 ' O ' ' CG2' ' A' ' 90' ' ' ILE . . . -110.62 133.05 11.32 Favored Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.823 -1.179 . . . . 0.0 112.324 -177.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.884 ' O ' HD12 ' A' ' 90' ' ' ILE . . . 62.55 36.97 93.95 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.902 HD22 ' CA ' ' A' ' 63' ' ' PHE . 0.4 OUTLIER -61.65 150.96 34.91 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.529 -0.983 . . . . 0.0 110.706 -179.339 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.672 ' O ' HG22 ' A' ' 31' ' ' THR . 0.4 OUTLIER -39.51 123.11 1.43 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.49 0.662 . . . . 0.0 110.771 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 6.5 p-90 -63.9 -14.29 52.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.504 -0.747 . . . . 0.0 110.146 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.466 ' O ' ' O ' ' A' ' 31' ' ' THR . 4.1 pt20 -100.04 -21.74 15.5 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.373 -0.83 . . . . 0.0 110.908 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.672 HG22 ' O ' ' A' ' 28' ' ' SER . 2.3 t -55.41 -161.93 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.447 0.641 . . . . 0.0 110.397 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.524 ' N ' HG23 ' A' ' 31' ' ' THR . 6.1 t -158.74 -168.99 2.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.877 . . . . 0.0 109.857 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 36' ' ' LEU . 15.1 mt-30 -79.55 -70.53 0.5 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.162 -0.961 . . . . 0.0 110.432 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.536 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -46.32 -52.29 13.01 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.959 -1.096 . . . . 0.0 109.237 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.458 ' H ' HG23 ' A' ' 32' ' ' THR . . . -48.4 -31.34 9.0 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.869 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -79.76 -36.81 36.64 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.448 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.511 ' HG3' ' HA ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -60.76 -27.97 68.37 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 122.455 1.121 . . . . 0.0 108.052 177.728 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.536 ' HG3' ' O ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -86.02 -19.9 29.64 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.541 179.091 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.688 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 13.6 t80 -78.64 -35.29 45.66 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.988 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.906 ' HE1' HG13 ' A' ' 77' ' ' VAL . 38.7 m-85 -109.14 -22.96 11.87 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.213 -0.93 . . . . 0.0 109.416 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -76.79 -3.61 80.17 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.581 -1.807 . . . . 0.0 108.581 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -73.86 -50.59 19.6 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 121.495 -1.003 . . . . 0.0 110.19 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.601 ' CZ ' ' HA ' ' A' ' 40' ' ' PHE . 2.9 p90 -103.35 13.1 34.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 110.18 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' A' ' 45' ' ' GLU . . . -150.24 -111.8 0.56 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.449 ' HB3' ' O ' ' A' ' 44' ' ' GLY . 0.4 OUTLIER 176.83 104.39 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.533 -0.981 . . . . 0.0 109.408 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.503 ' HA ' ' CB ' ' A' ' 68' ' ' PHE . 95.1 t -90.56 137.78 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.312 -0.867 . . . . 0.0 111.04 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -101.7 -26.87 13.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.52 -0.737 . . . . 0.0 109.163 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -166.9 154.79 9.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.547 -0.721 . . . . 0.0 109.796 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.491 ' SG ' ' CD ' ' A' ' 37' ' ' ARG . 21.0 p -148.68 175.4 11.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.123 -0.986 . . . . 0.0 110.719 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.623 HD21 ' CD2' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -150.51 132.11 14.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -0.833 . . . . 0.0 109.902 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.769 HG13 HD11 ' A' ' 27' ' ' LEU . 48.2 t -129.1 147.04 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.548 -1.345 . . . . 0.0 111.298 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.456 ' CE ' ' HB2' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -146.74 146.76 30.42 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.754 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.404 ' O ' ' NE ' ' A' ' 59' ' ' ARG . 6.7 mtp85 -118.61 -76.01 0.58 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.206 -0.934 . . . . 0.0 110.772 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.413 ' CG ' ' NH1' ' A' ' 59' ' ' ARG . 64.2 t0 -141.99 76.62 19.34 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.146 -0.971 . . . . 0.0 110.616 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.706 ' O ' HD23 ' A' ' 56' ' ' LEU . 3.0 Cg_exo -55.96 -48.71 18.41 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.627 1.33 . . . . 0.0 110.644 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.706 HD23 ' O ' ' A' ' 55' ' ' PRO . 8.0 mt -124.23 -70.12 0.77 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.168 -0.958 . . . . 0.0 110.148 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.57 HG23 ' H ' ' A' ' 58' ' ' LYS . 1.3 t 174.66 -50.55 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.477 -0.765 . . . . 0.0 110.253 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.57 ' H ' HG23 ' A' ' 57' ' ' THR . 2.4 pttt -76.59 3.17 12.05 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.256 -0.902 . . . . 0.0 110.292 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.49 ' HD2' ' O ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -60.08 -158.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.35 -0.844 . . . . 0.0 110.568 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.49 ' O ' ' HD2' ' A' ' 59' ' ' ARG . 59.8 m -78.84 -119.92 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.355 -0.841 . . . . 0.0 110.522 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -149.41 12.16 0.81 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.822 -1.174 . . . . 0.0 110.714 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.8 101.67 2.65 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.902 ' CA ' HD22 ' A' ' 27' ' ' LEU . 41.4 p90 -140.5 -168.86 2.65 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.09 -1.241 . . . . 0.0 110.472 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 50' ' ' LEU . . . -155.8 179.71 31.53 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.623 ' CD2' HD21 ' A' ' 50' ' ' LEU . 16.8 m-85 -148.6 146.68 28.34 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.493 -1.004 . . . . 0.0 108.751 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.802 HG21 HD11 ' A' ' 36' ' ' LEU . 5.6 t -148.08 106.18 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 120.806 -1.184 . . . . 0.0 111.295 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.468 ' CA ' ' HB2' ' A' ' 21' ' ' LYS . 39.0 m -82.45 56.76 3.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.14 -0.975 . . . . 0.0 110.049 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.626 ' CE1' ' HB2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -85.59 -144.13 0.1 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 110.74 -179.811 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.57 ' O ' ' CE1' ' A' ' 68' ' ' PHE . 5.9 tpt -79.56 167.44 20.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.179 -0.951 . . . . 0.0 110.272 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.47 ' HA ' HG23 ' A' ' 74' ' ' VAL . 52.9 m-20 -132.1 -2.9 3.56 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.175 -0.953 . . . . 0.0 110.618 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -84.12 -93.39 0.07 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.03 -1.044 . . . . 0.0 110.094 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.96 -22.35 60.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.135 -0.978 . . . . 0.0 109.723 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.772 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -59.14 -55.05 32.97 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.47 HG23 ' HA ' ' A' ' 70' ' ' ASP . 54.8 t -45.17 -38.93 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.124 -1.221 . . . . 0.0 110.354 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.87 -73.31 0.13 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.211 -0.931 . . . . 0.0 110.303 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.545 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -45.09 -43.06 9.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.241 -0.912 . . . . 0.0 109.469 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.906 HG13 ' HE1' ' A' ' 40' ' ' PHE . 93.4 t -54.02 -55.61 13.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.251 -0.905 . . . . 0.0 108.886 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.634 HD13 ' HB2' ' A' ' 81' ' ' SER . 0.1 OUTLIER -40.41 -47.27 2.55 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.716 -0.615 . . . . 0.0 109.993 178.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -43.53 -26.96 0.25 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.507 -0.746 . . . . 0.0 109.678 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.541 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 43.8 mm-40 -103.08 24.71 10.4 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.447 -0.783 . . . . 0.0 110.056 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.634 ' HB2' HD13 ' A' ' 78' ' ' LEU . 30.4 t -57.8 -13.74 4.76 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.556 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -99.71 -17.0 17.96 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 121.425 -0.797 . . . . 0.0 109.675 179.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.688 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 0.7 OUTLIER 31.14 32.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.613 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.556 ' N ' ' O ' ' A' ' 82' ' ' ARG . 0.8 OUTLIER -77.92 121.65 24.44 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.431 -1.418 . . . . 0.0 109.154 179.392 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.498 HD21 ' ND1' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -144.67 -80.88 0.17 Allowed 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.323 -178.562 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.526 ' O ' ' CD ' ' A' ' 88' ' ' LYS . 7.7 t70 -87.1 51.62 2.29 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.506 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 70.44 6.93 6.02 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -178.415 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.547 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 6.4 mmmt -108.49 120.94 43.88 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.58 -0.7 . . . . 0.0 109.964 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.769 ' O ' HG23 ' A' ' 89' ' ' THR . 13.4 t -100.07 67.4 1.4 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.562 -0.711 . . . . 0.0 109.589 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.884 HD12 ' O ' ' A' ' 26' ' ' GLY . 1.3 mm -49.86 -179.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 119.621 -0.831 . . . . 0.0 109.544 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.494 ' H ' HG22 ' A' ' 90' ' ' ILE . 18.8 t0 -141.06 79.56 17.96 Favored Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 121.163 -0.961 . . . . 0.0 110.272 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.541 ' CG ' ' O ' ' A' ' 80' ' ' GLN . 2.4 Cg_endo -51.81 113.11 1.02 Allowed 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.415 1.219 . . . . 0.0 110.201 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.633 ' CE ' ' CD2' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -135.41 113.33 11.08 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.27 -0.894 . . . . 0.0 109.965 179.221 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.796 HG22 ' CB ' ' A' ' 22' ' ' MET . 58.4 t -96.65 172.97 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.253 -0.905 . . . . 0.0 110.253 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.558 ' N ' HG12 ' A' ' 94' ' ' VAL . . . 47.96 -163.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.201 -0.937 . . . . 0.0 110.393 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.516 ' CD1' ' N ' ' A' ' 96' ' ' PHE . 12.3 p90 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.305 -0.872 . . . . 0.0 110.117 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.1 m . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.256 0.551 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.913 ' CB ' HG23 ' A' ' 67' ' ' THR . 4.6 pttt -76.63 154.38 34.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.121 -0.987 . . . . 0.0 110.197 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.899 ' CB ' HG13 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -75.79 174.0 10.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.186 -0.946 . . . . 0.0 109.478 179.443 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.691 ' CG ' ' CE1' ' A' ' 65' ' ' PHE . 5.9 t80 -150.6 139.4 20.8 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.204 -0.935 . . . . 0.0 109.825 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.731 ' CG2' HG21 ' A' ' 90' ' ' ILE . 13.6 mm -106.68 152.87 8.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.53 ' O ' HG22 ' A' ' 90' ' ' ILE . . . -126.69 139.3 11.19 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 119.175 -1.488 . . . . 0.0 111.764 -178.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.458 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 56.52 43.65 90.67 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.923 HD22 ' CA ' ' A' ' 63' ' ' PHE . 0.5 OUTLIER -75.74 142.58 42.38 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.412 -1.052 . . . . 0.0 110.63 -179.311 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.69 ' O ' HG22 ' A' ' 31' ' ' THR . 5.0 m -39.57 132.91 1.52 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.617 -0.677 . . . . 0.0 110.447 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.473 ' CZ3' ' HB3' ' A' ' 30' ' ' GLN . 47.6 p-90 -71.16 -17.95 62.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.465 -0.772 . . . . 0.0 110.624 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.473 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 10.9 pt20 -89.58 -18.12 27.19 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.184 -0.948 . . . . 0.0 110.82 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.69 HG22 ' O ' ' A' ' 28' ' ' SER . 6.9 t -55.61 -173.42 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.874 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.687 HG23 ' H ' ' A' ' 35' ' ' GLY . 7.4 t -147.85 -172.6 4.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.348 -0.845 . . . . 0.0 109.875 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 36' ' ' LEU . 3.9 mt-30 -77.79 -74.23 0.27 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.032 -1.043 . . . . 0.0 110.531 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.558 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 2.7 tt0 -48.05 -41.53 26.15 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.949 -1.094 . . . . 0.0 110.182 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.687 ' H ' HG23 ' A' ' 32' ' ' THR . . . -57.47 -28.95 60.08 Favored Glycine 0 C--N 1.296 -1.684 0 N-CA-C 107.424 -2.271 . . . . 0.0 107.424 178.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.854 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -82.5 -38.59 23.64 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.135 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.642 ' HA ' HG21 ' A' ' 46' ' ' VAL . 26.4 mtt180 -61.79 -27.09 68.5 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 122.418 1.104 . . . . 0.0 108.135 178.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.556 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -87.44 -19.27 28.26 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.373 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.653 ' CE1' ' NE2' ' A' ' 83' ' ' HIS . 26.9 t80 -79.24 -30.52 43.21 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.254 -0.904 . . . . 0.0 110.205 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.917 ' CE1' HG13 ' A' ' 77' ' ' VAL . 27.0 m-85 -108.8 -25.33 10.85 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.459 -0.776 . . . . 0.0 109.166 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -70.26 -7.84 60.98 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -63.95 -49.61 71.88 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 121.417 -1.049 . . . . 0.0 109.699 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.528 ' HE1' HG22 ' A' ' 77' ' ' VAL . 1.8 p90 -113.82 12.6 18.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.464 -0.772 . . . . 0.0 109.763 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 45' ' ' GLU . . . -142.85 -117.22 1.23 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.515 ' OE2' ' CB ' ' A' ' 70' ' ' ASP . 1.9 pt-20 177.09 103.47 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.406 -1.055 . . . . 0.0 109.906 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.642 HG21 ' HA ' ' A' ' 37' ' ' ARG . 63.3 t -89.41 126.58 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.19 -0.944 . . . . 0.0 110.702 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.95 -26.98 11.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.265 -0.897 . . . . 0.0 109.592 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -158.76 131.94 7.26 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.47 -0.769 . . . . 0.0 109.446 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 24.8 p -150.37 154.64 38.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.972 -1.08 . . . . 0.0 111.288 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.749 HD12 ' C ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -125.04 126.11 44.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.391 -0.818 . . . . 0.0 109.261 178.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.592 ' CG1' ' N ' ' A' ' 52' ' ' MET . 17.4 t -89.73 169.38 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.79 -1.194 . . . . 0.0 112.104 -178.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.687 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 2.2 ptt? 38.12 -155.92 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.733 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -150.0 124.84 9.85 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.176 0.512 . . . . 0.0 110.321 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.461 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 33.0 t0 -43.49 103.69 0.33 Allowed Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.229 -0.92 . . . . 0.0 110.239 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 53' ' ' ARG . 3.1 Cg_exo -61.08 96.12 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.398 1.21 . . . . 0.0 110.635 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 54' ' ' ASP . 6.3 mt -90.0 -49.42 6.61 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.276 -0.89 . . . . 0.0 109.79 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.591 HG23 ' HG3' ' A' ' 58' ' ' LYS . 0.2 OUTLIER 179.1 -30.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.51 -0.744 . . . . 0.0 110.141 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.591 ' HG3' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -154.29 17.13 0.48 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.321 -0.862 . . . . 0.0 110.293 179.726 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.553 ' HD3' ' N ' ' A' ' 60' ' ' SER . 0.1 OUTLIER -57.59 -158.64 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.242 -0.911 . . . . 0.0 110.57 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.553 ' N ' ' HD3' ' A' ' 59' ' ' ARG . 40.2 t -65.27 -132.4 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.352 -0.842 . . . . 0.0 110.64 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.24 28.74 0.73 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.019 -1.05 . . . . 0.0 110.379 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.687 ' HA2' ' HA ' ' A' ' 52' ' ' MET . . . 96.67 108.52 2.51 Favored Glycine 0 N--CA 1.481 1.684 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.923 ' CA ' HD22 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -136.99 -176.1 4.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.087 -1.243 . . . . 0.0 109.96 179.282 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.472 ' O ' ' HB ' ' A' ' 24' ' ' ILE . . . -135.22 100.79 0.37 Allowed Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.087 -1.53 . . . . 0.0 110.4 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.691 ' CE1' ' CG ' ' A' ' 23' ' ' PHE . 11.7 m-85 -81.23 136.02 35.79 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.119 -1.224 . . . . 0.0 108.627 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.8 HG21 HD11 ' A' ' 36' ' ' LEU . 3.1 t -145.99 106.6 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 118.782 -1.167 . . . . 0.0 111.16 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.913 HG23 ' CB ' ' A' ' 21' ' ' LYS . 1.4 m -82.63 47.21 1.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.609 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.605 ' CE1' ' HB3' ' A' ' 22' ' ' MET . 0.0 OUTLIER -73.94 59.46 0.7 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.357 -0.84 . . . . 0.0 110.619 -179.455 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.408 ' C ' ' O ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -42.56 122.32 2.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 110.249 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.515 ' CB ' ' OE2' ' A' ' 45' ' ' GLU . 13.6 p-10 -150.77 -163.45 1.78 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.277 -0.889 . . . . 0.0 110.141 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.61 -88.58 0.62 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.891 . . . . 0.0 110.118 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.91 -23.76 63.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.923 . . . . 0.0 109.939 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.644 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -49.49 -44.63 36.96 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.937 ' O ' HD12 ' A' ' 78' ' ' LEU . 19.5 t -46.73 -52.27 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.352 -1.087 . . . . 0.0 109.868 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.56 ' HA ' HD13 ' A' ' 78' ' ' LEU . 4.6 t0 -54.08 -50.04 67.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.068 -1.02 . . . . 0.0 109.681 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.666 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 6.3 mmpt? -56.26 -35.53 67.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.33 -0.856 . . . . 0.0 109.816 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.917 HG13 ' CE1' ' A' ' 40' ' ' PHE . 60.5 t -59.17 -57.07 13.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 O-C-N 121.045 -1.035 . . . . 0.0 109.477 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.937 HD12 ' O ' ' A' ' 74' ' ' VAL . 2.8 mp -44.84 -41.55 7.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.239 -0.913 . . . . 0.0 109.06 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.666 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -46.34 -27.99 1.2 Allowed 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.304 -0.873 . . . . 0.0 109.281 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.515 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 7.2 mm100 -101.85 25.18 8.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.533 -0.729 . . . . 0.0 109.68 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.51 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 21.4 p -56.44 -16.44 5.81 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.522 ' O ' ' C ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -97.34 -9.49 27.39 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.633 -0.667 . . . . 0.0 109.792 179.193 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.863 ' CE1' HD12 ' A' ' 90' ' ' ILE . 0.6 OUTLIER 19.48 48.9 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 179.81 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.553 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -91.9 125.57 36.66 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 118.493 -1.283 . . . . 0.0 109.172 178.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.568 HD23 ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -145.34 -91.53 0.1 Allowed 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.663 -0.648 . . . . 0.0 109.655 -179.158 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.529 ' O ' ' CB ' ' A' ' 87' ' ' SER . 10.6 m-20 -79.86 52.62 1.51 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.097 -1.002 . . . . 0.0 108.74 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 72.18 9.72 5.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.618 -0.676 . . . . 0.0 109.857 -179.129 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 9.0 mmtt -111.24 120.72 43.21 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.372 -0.83 . . . . 0.0 109.608 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.763 HG23 ' O ' ' A' ' 89' ' ' THR . 11.9 t -101.87 69.23 1.18 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.505 -0.747 . . . . 0.0 109.726 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.863 HD12 ' CE1' ' A' ' 83' ' ' HIS . 0.8 OUTLIER -50.15 -178.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.389 -179.714 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.484 ' H ' HG22 ' A' ' 90' ' ' ILE . 14.2 t0 -141.45 81.04 15.74 Favored Pre-proline 0 C--N 1.3 -1.558 0 O-C-N 121.189 -0.944 . . . . 0.0 109.817 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.526 ' HG3' ' HD2' ' A' ' 83' ' ' HIS . 2.4 Cg_endo -53.96 112.58 1.01 Allowed 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 123.542 1.285 . . . . 0.0 111.275 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.58 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -128.02 104.89 8.04 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.916 0.865 . . . . 0.0 108.848 177.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.899 HG13 ' CB ' ' A' ' 22' ' ' MET . 6.2 t -96.19 -174.49 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 O-C-N 121.854 -0.529 . . . . 0.0 110.004 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.745 ' HB3' ' O ' ' A' ' 94' ' ' VAL . . . 71.39 159.07 0.2 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.181 -0.949 . . . . 0.0 110.431 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.5 p90 . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.319 -0.863 . . . . 0.0 110.089 179.874 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 30.1 p . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 121.245 0.545 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.582 ' CB ' HG23 ' A' ' 67' ' ' THR . 0.4 OUTLIER -170.08 179.48 3.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 110.236 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.918 ' HB2' HG22 ' A' ' 94' ' ' VAL . 0.5 OUTLIER -83.81 178.92 7.72 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.248 -0.907 . . . . 0.0 110.528 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.633 ' HB3' ' HD2' ' A' ' 93' ' ' LYS . 0.1 OUTLIER -150.47 143.68 24.91 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.489 -0.757 . . . . 0.0 109.068 179.785 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.534 HD12 ' C ' ' A' ' 23' ' ' PHE . 1.1 mp -106.85 144.62 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.069 -1.019 . . . . 0.0 109.34 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 91' ' ' ASP . . . -131.51 122.76 3.51 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 119.734 -1.222 . . . . 0.0 111.281 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 1.046 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 113.21 34.0 1.87 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.102 HD21 HG13 ' A' ' 51' ' ' VAL . 2.0 mp -39.93 137.37 0.95 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.682 -0.893 . . . . 0.0 110.715 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.537 ' CB ' ' HG1' ' A' ' 31' ' ' THR . 5.0 p -56.39 -174.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 0.0 110.06 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 47.9 p-90 -77.62 5.23 9.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 0.0 110.238 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -161.67 16.17 0.1 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.111 -0.993 . . . . 0.0 111.158 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.537 ' HG1' ' CB ' ' A' ' 28' ' ' SER . 98.7 m -53.6 157.54 2.16 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.055 -1.028 . . . . 0.0 110.307 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.607 HG23 ' H ' ' A' ' 35' ' ' GLY . 2.8 t -148.23 178.55 8.47 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.101 -1.0 . . . . 0.0 110.27 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.544 ' O ' ' N ' ' A' ' 36' ' ' LEU . 7.1 mt-30 -62.61 -74.14 0.1 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.96 . . . . 0.0 111.166 -178.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.53 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 1.6 tt0 -49.68 -36.05 23.74 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.73 -1.232 . . . . 0.0 110.028 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.607 ' H ' HG23 ' A' ' 32' ' ' THR . . . -61.04 -28.85 69.53 Favored Glycine 0 C--N 1.295 -1.711 0 N-CA-C 107.148 -2.381 . . . . 0.0 107.148 178.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.827 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -80.56 -41.42 24.13 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.047 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.53 ' HG3' ' HA ' ' A' ' 34' ' ' GLU . 19.8 mtp180 -61.65 -27.77 68.91 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 122.385 1.088 . . . . 0.0 108.238 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.547 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.2 OUTLIER -87.25 -15.7 37.37 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.11 179.454 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.691 ' CE2' ' CE1' ' A' ' 83' ' ' HIS . 10.4 t80 -86.76 -43.37 12.59 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 121.345 -0.847 . . . . 0.0 110.797 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.928 ' HE1' HG13 ' A' ' 77' ' ' VAL . 48.1 m-85 -101.36 -33.66 9.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.875 . . . . 0.0 109.193 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -59.76 -17.19 41.38 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -61.96 -45.72 92.44 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.474 -1.015 . . . . 0.0 109.956 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.59 ' HE1' HG22 ' A' ' 77' ' ' VAL . 4.9 p90 -119.58 -2.98 10.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.445 -0.784 . . . . 0.0 109.948 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.467 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -137.77 93.26 0.21 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.537 ' O ' ' CB ' ' A' ' 68' ' ' PHE . 1.9 mt-10 -40.03 105.91 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.411 -1.052 . . . . 0.0 110.15 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 68' ' ' PHE . 43.3 t -88.85 126.06 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 110.446 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -99.12 -31.33 11.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.278 -0.889 . . . . 0.0 110.032 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.81 135.89 17.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.29 -0.881 . . . . 0.0 110.274 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.788 ' HB2' HD21 ' A' ' 36' ' ' LEU . 31.9 p -150.48 166.66 29.48 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.876 . . . . 0.0 110.017 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.73 ' C ' HD12 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -150.45 126.02 10.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.962 -1.086 . . . . 0.0 110.695 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.102 HG13 HD21 ' A' ' 27' ' ' LEU . 98.9 t -113.66 142.29 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.861 -1.149 . . . . 0.0 110.002 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.501 ' HG3' ' HB3' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -144.87 143.32 30.53 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.287 -0.883 . . . . 0.0 110.376 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.437 ' O ' ' CB ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -151.53 136.73 17.51 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.68 -0.637 . . . . 0.0 110.259 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.568 ' CB ' ' HB2' ' A' ' 59' ' ' ARG . 0.3 OUTLIER 172.05 122.12 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.187 -0.946 . . . . 0.0 109.896 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.934 ' O ' HD23 ' A' ' 56' ' ' LEU . 3.2 Cg_exo -61.02 69.69 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.238 0 O-C-N 123.339 1.178 . . . . 0.0 110.907 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.934 HD23 ' O ' ' A' ' 55' ' ' PRO . 10.4 mt -130.02 -63.61 0.9 Allowed 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.238 -0.914 . . . . 0.0 109.821 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.659 HG23 ' HG3' ' A' ' 58' ' ' LYS . 0.1 OUTLIER -172.41 -55.45 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.437 -0.79 . . . . 0.0 110.752 179.843 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.659 ' HG3' HG23 ' A' ' 57' ' ' THR . 11.4 mttt -86.27 -42.53 13.68 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.173 -0.954 . . . . 0.0 109.362 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.884 ' HD3' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -83.35 -29.84 27.92 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.244 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 54' ' ' ASP . 31.1 t -39.83 -27.05 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.081 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -93.75 -16.81 23.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.137 -0.977 . . . . 0.0 110.412 -179.293 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 59' ' ' ARG . . . 65.22 91.33 0.04 OUTLIER Glycine 0 N--CA 1.483 1.769 0 N-CA-C 108.349 -1.9 . . . . 0.0 108.349 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.646 ' HA ' HD13 ' A' ' 27' ' ' LEU . 50.3 p90 -132.32 -162.3 1.22 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.092 -1.24 . . . . 0.0 110.376 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 50' ' ' LEU . . . -166.53 174.85 42.0 Favored Glycine 0 N--CA 1.488 2.122 0 C-N-CA 119.319 -1.419 . . . . 0.0 110.677 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.557 ' C ' HG23 ' A' ' 66' ' ' VAL . 9.8 m-85 -136.24 145.09 45.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.756 -0.849 . . . . 0.0 109.008 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.557 HG23 ' C ' ' A' ' 65' ' ' PHE . 16.2 t -149.98 143.4 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.981 -1.074 . . . . 0.0 110.585 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.582 HG23 ' CB ' ' A' ' 21' ' ' LYS . 1.5 m -137.24 58.73 1.7 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.303 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.587 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -63.94 -177.35 0.25 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.071 -1.018 . . . . 0.0 110.557 -179.603 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.17 55.17 1.87 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.157 -0.964 . . . . 0.0 110.257 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.469 ' OD2' ' N ' ' A' ' 73' ' ' GLY . 12.1 t70 -110.26 143.45 40.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.343 -0.848 . . . . 0.0 110.044 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.94 -48.07 82.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.232 -0.918 . . . . 0.0 110.312 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 75' ' ' ASP . . . -89.93 22.32 3.23 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.255 -0.903 . . . . 0.0 110.176 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.729 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -51.65 -74.46 0.29 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 16.4 t -45.73 -32.54 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.22 -1.165 . . . . 0.0 110.092 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 72' ' ' ALA . 0.5 OUTLIER -62.39 -76.84 0.05 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.175 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.451 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -49.19 -42.72 41.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 0.0 109.797 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.928 HG13 ' HE1' ' A' ' 40' ' ' PHE . 62.1 t -54.39 -53.81 27.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 O-C-N 121.103 -0.998 . . . . 0.0 108.916 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -42.76 -52.61 4.92 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.405 -0.809 . . . . 0.0 109.723 178.701 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -44.89 -28.75 0.69 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.344 -0.848 . . . . 0.0 109.531 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.544 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 43.9 mm-40 -97.44 21.44 10.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.478 -0.764 . . . . 0.0 110.037 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 78' ' ' LEU . 47.8 t -56.87 -13.09 2.32 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.506 -0.746 . . . . 0.0 109.093 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.49 ' O ' ' C ' ' A' ' 83' ' ' HIS . 7.0 ptt180 -103.07 -11.39 18.15 Favored 'General case' 0 C--N 1.31 -1.121 0 O-C-N 121.349 -0.845 . . . . 0.0 109.797 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.766 ' ND1' HD12 ' A' ' 90' ' ' ILE . 0.5 OUTLIER 29.63 51.65 0.08 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.877 -0.514 . . . . 0.0 112.127 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.54 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 3.6 tt0 -90.58 126.17 35.86 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.672 -1.268 . . . . 0.0 109.202 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.534 ' CD2' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -147.37 -79.73 0.15 Allowed 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.565 -179.141 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.531 ' O ' ' CD ' ' A' ' 88' ' ' LYS . 7.9 m-20 -85.33 49.89 1.84 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.502 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER 70.22 6.98 6.03 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.483 0.658 . . . . 0.0 109.557 -178.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -110.31 125.9 53.64 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.35 -0.844 . . . . 0.0 109.76 -179.594 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.741 ' O ' HG23 ' A' ' 89' ' ' THR . 9.3 t -99.77 75.45 1.9 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.577 -0.702 . . . . 0.0 109.562 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.046 HG23 ' C ' ' A' ' 26' ' ' GLY . 0.9 OUTLIER -52.61 -174.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.372 -0.83 . . . . 0.0 109.181 -179.663 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 25' ' ' GLY . 20.4 t0 -142.26 85.3 10.82 Favored Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 120.565 -1.334 . . . . 0.0 111.684 -178.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.576 ' HG3' ' HD2' ' A' ' 83' ' ' HIS . 2.0 Cg_endo -59.98 113.44 1.65 Allowed 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.462 1.243 . . . . 0.0 110.757 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.633 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -123.67 108.77 12.92 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.03 -1.043 . . . . 0.0 109.774 178.073 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.918 HG22 ' HB2' ' A' ' 22' ' ' MET . 43.0 t -96.24 170.18 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.485 -0.76 . . . . 0.0 110.082 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.494 ' N ' HG12 ' A' ' 94' ' ' VAL . . . -83.26 -152.39 0.12 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.898 . . . . 0.0 110.284 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.897 . . . . 0.0 110.232 -179.882 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 14.2 t . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.303 0.573 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 0.3 OUTLIER -66.66 156.6 34.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.183 -0.948 . . . . 0.0 110.088 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 1.003 ' CB ' HG22 ' A' ' 94' ' ' VAL . 0.9 OUTLIER -86.15 -169.87 2.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.217 -0.927 . . . . 0.0 110.323 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.656 ' HB3' ' HD2' ' A' ' 93' ' ' LYS . 0.7 OUTLIER -149.97 152.1 34.4 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.355 -0.84 . . . . 0.0 109.466 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.654 HD12 ' C ' ' A' ' 23' ' ' PHE . 1.1 mp -113.46 134.52 55.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.323 -0.86 . . . . 0.0 109.243 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.498 ' O ' ' CG2' ' A' ' 90' ' ' ILE . . . -102.51 136.86 13.05 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.812 -1.185 . . . . 0.0 110.699 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.474 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 58.82 39.72 94.18 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.844 HD13 ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -60.59 154.31 21.43 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.444 -1.033 . . . . 0.0 110.056 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.773 ' O ' HG22 ' A' ' 31' ' ' THR . 0.5 OUTLIER -40.58 134.8 1.71 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.352 -0.843 . . . . 0.0 110.343 -179.673 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 11.0 p-90 -77.43 -12.26 59.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.342 -0.849 . . . . 0.0 110.63 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -110.93 -12.02 14.28 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.086 -1.009 . . . . 0.0 110.63 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.773 HG22 ' O ' ' A' ' 28' ' ' SER . 13.2 t -61.42 -167.26 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.833 0 CA-C-O 121.628 0.728 . . . . 0.0 110.676 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.589 HG23 ' H ' ' A' ' 35' ' ' GLY . 14.7 t -157.18 -168.1 2.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.695 -0.628 . . . . 0.0 109.751 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 36' ' ' LEU . 2.3 mt-30 -68.68 -72.46 0.18 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.082 -1.012 . . . . 0.0 110.207 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.406 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 3.8 tt0 -48.33 -45.77 35.69 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.837 -1.165 . . . . 0.0 109.72 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.589 ' H ' HG23 ' A' ' 32' ' ' THR . . . -55.62 -27.03 47.74 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.927 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -83.66 -32.68 25.5 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.082 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.893 ' HA ' HG11 ' A' ' 46' ' ' VAL . 18.8 mmm-85 -64.96 -28.71 69.7 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.536 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -90.55 -14.68 32.08 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.571 178.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.586 ' OH ' ' CG ' ' A' ' 83' ' ' HIS . 38.7 t80 -81.33 -26.34 35.68 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 121.619 -0.675 . . . . 0.0 110.171 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.798 ' HE1' HG13 ' A' ' 77' ' ' VAL . 14.6 m-85 -122.19 -21.51 5.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.887 . . . . 0.0 109.91 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.93 2.12 65.96 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.409 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 8.2 tp60 -72.1 -55.78 6.74 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 121.426 -1.043 . . . . 0.0 109.971 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.32 12.66 26.15 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.4 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.425 ' HA3' ' CG ' ' A' ' 70' ' ' ASP . . . -154.17 -116.2 0.59 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -179.74 104.39 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.532 -0.981 . . . . 0.0 109.349 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.893 HG11 ' HA ' ' A' ' 37' ' ' ARG . 2.7 p -90.03 149.46 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 111.266 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.77 -39.61 5.53 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.615 -0.678 . . . . 0.0 109.931 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -149.71 148.38 29.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.317 -0.864 . . . . 0.0 110.601 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.822 ' HB2' HD21 ' A' ' 36' ' ' LEU . 17.3 p -151.13 164.03 37.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.294 -0.879 . . . . 0.0 110.661 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.732 ' C ' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -139.3 123.71 18.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.318 -0.864 . . . . 0.0 109.617 179.039 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.649 HG13 HD11 ' A' ' 27' ' ' LEU . 87.0 t -113.11 136.93 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.803 -1.185 . . . . 0.0 111.227 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.526 ' HG2' ' CE1' ' A' ' 63' ' ' PHE . 1.0 OUTLIER -134.39 150.4 50.89 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.216 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -148.81 135.57 19.75 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.249 -0.907 . . . . 0.0 110.638 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.527 ' CB ' ' HD2' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -172.32 177.78 0.78 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.4 -0.812 . . . . 0.0 109.844 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.527 ' HD2' ' CB ' ' A' ' 54' ' ' ASP . 3.1 Cg_exo -60.71 169.51 5.53 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.744 1.391 . . . . 0.0 110.303 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.901 HD12 ' N ' ' A' ' 57' ' ' THR . 4.5 pp -88.69 -46.35 9.09 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.133 -0.979 . . . . 0.0 111.029 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.901 ' N ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER 30.93 -95.7 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.582 -0.699 . . . . 0.0 110.833 179.832 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.47 ' N ' ' OG1' ' A' ' 57' ' ' THR . 0.3 OUTLIER -139.07 7.84 2.46 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.202 -0.937 . . . . 0.0 109.742 179.362 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.535 ' HD3' ' N ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -107.1 -164.88 1.02 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.37 -0.831 . . . . 0.0 110.298 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.535 ' N ' ' HD3' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -56.66 -166.3 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.312 -0.868 . . . . 0.0 110.007 179.754 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -150.59 28.71 0.7 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.299 -0.876 . . . . 0.0 110.371 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 52' ' ' MET . . . 100.29 104.47 2.64 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.346 -1.501 . . . . 0.0 109.346 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.844 ' O ' HD13 ' A' ' 27' ' ' LEU . 45.7 p90 -142.35 -164.32 1.79 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.293 -1.122 . . . . 0.0 110.223 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -162.54 114.09 0.59 Allowed Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.597 -1.287 . . . . 0.0 110.15 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.513 ' HB2' ' HG ' ' A' ' 50' ' ' LEU . 13.4 m-85 -82.66 142.55 31.61 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.249 -1.148 . . . . 0.0 109.061 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.646 HG21 HD11 ' A' ' 36' ' ' LEU . 5.7 t -150.01 114.9 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.91 -1.119 . . . . 0.0 110.582 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 7.2 t -88.17 32.31 0.77 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.388 -0.82 . . . . 0.0 109.829 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.652 ' CE2' ' HE1' ' A' ' 22' ' ' MET . 0.0 OUTLIER -66.37 176.66 1.74 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.868 . . . . 0.0 110.73 -179.698 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.444 ' HB3' ' O ' ' A' ' 68' ' ' PHE . 0.7 OUTLIER 174.28 126.31 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.052 -1.03 . . . . 0.0 110.498 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.487 ' OD1' ' HA3' ' A' ' 73' ' ' GLY . 4.1 p-10 -149.75 46.26 0.94 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.378 -0.826 . . . . 0.0 110.029 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 70' ' ' ASP . 1.5 mt-30 62.1 -86.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.3 -0.875 . . . . 0.0 110.234 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.45 -2.14 18.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.267 -0.896 . . . . 0.0 110.313 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.487 ' HA3' ' OD1' ' A' ' 70' ' ' ASP . . . -52.4 -65.28 3.38 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 55.6 t -45.1 -31.0 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -1.106 . . . . 0.0 110.254 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -67.85 -61.42 1.88 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.212 -0.93 . . . . 0.0 110.413 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.578 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -60.63 -46.88 88.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 110.35 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.798 HG13 ' HE1' ' A' ' 40' ' ' PHE . 93.9 t -48.28 -62.38 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 O-C-N 121.062 -1.024 . . . . 0.0 109.255 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 81' ' ' SER . 0.1 OUTLIER -41.68 -51.31 4.1 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.338 -0.851 . . . . 0.0 109.897 179.035 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -44.71 -25.98 0.34 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.211 -0.931 . . . . 0.0 109.548 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.63 ' HB3' ' CE1' ' A' ' 83' ' ' HIS . 7.0 mm-40 -99.91 20.0 15.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.424 -0.797 . . . . 0.0 110.386 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.568 ' HA ' ' HD2' ' A' ' 92' ' ' PRO . 25.2 p -58.07 -13.21 4.31 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.385 -0.822 . . . . 0.0 109.061 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -107.16 10.58 30.01 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.521 -0.737 . . . . 0.0 109.86 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.63 ' CE1' ' HB3' ' A' ' 80' ' ' GLN . 1.6 m-70 -21.88 83.52 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -178.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 82' ' ' ARG . 1.1 tt0 -103.69 122.74 45.67 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.511 HD23 ' C ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -139.89 -89.83 0.18 Allowed 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.338 -0.851 . . . . 0.0 109.818 -178.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 87' ' ' SER . 53.8 t0 -78.14 53.7 1.25 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.126 -0.984 . . . . 0.0 108.356 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 70.98 9.11 6.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.627 -0.671 . . . . 0.0 109.719 -178.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 5.4 mmtt -111.7 113.99 26.71 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 121.286 -0.884 . . . . 0.0 110.25 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.595 ' O ' HG23 ' A' ' 89' ' ' THR . 6.8 t -90.37 68.96 6.94 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.578 HD12 ' OH ' ' A' ' 39' ' ' TYR . 1.2 mt -45.44 176.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 121.685 0.755 . . . . 0.0 109.86 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 81' ' ' SER . 5.3 t0 -144.88 77.31 13.38 Favored Pre-proline 0 C--N 1.296 -1.719 0 O-C-N 121.196 -0.94 . . . . 0.0 111.157 -178.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.583 ' HG3' ' CD2' ' A' ' 83' ' ' HIS . 2.0 Cg_endo -51.42 114.48 1.58 Allowed 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 123.446 1.235 . . . . 0.0 109.898 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.656 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -129.42 102.69 6.52 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.171 -0.956 . . . . 0.0 110.364 179.133 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 1.003 HG22 ' CB ' ' A' ' 22' ' ' MET . 95.2 t -97.31 161.61 2.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 O-C-N 121.757 -0.589 . . . . 0.0 110.063 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.76 142.83 29.54 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.175 -0.953 . . . . 0.0 110.582 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.381 -0.824 . . . . 0.0 110.09 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 25.1 p . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.216 0.531 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.764 ' CB ' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -148.19 176.09 10.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.343 -0.848 . . . . 0.0 110.249 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 1.067 ' HB3' HG13 ' A' ' 94' ' ' VAL . 1.5 ptt? -86.31 176.97 7.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 110.197 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.779 ' C ' HD12 ' A' ' 24' ' ' ILE . 3.1 t80 -150.51 154.36 37.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.167 -0.958 . . . . 0.0 110.393 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.851 ' CG2' HG21 ' A' ' 90' ' ' ILE . 1.3 mp -113.14 137.19 47.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.489 ' O ' HG22 ' A' ' 90' ' ' ILE . . . -112.84 140.29 16.21 Favored Glycine 0 N--CA 1.501 2.973 0 C-N-CA 119.31 -1.424 . . . . 0.0 112.951 -176.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.519 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 59.66 47.06 92.79 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.867 ' O ' HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -79.24 146.47 33.01 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.315 -1.109 . . . . 0.0 111.506 -178.437 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.454 ' HB2' ' HB ' ' A' ' 31' ' ' THR . 18.5 m -39.9 159.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.533 0.682 . . . . 0.0 110.763 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.512 ' HB3' ' HA ' ' A' ' 60' ' ' SER . 67.4 p-90 -92.32 -23.13 19.36 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.434 -0.791 . . . . 0.0 109.644 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.49 ' HG3' ' N ' ' A' ' 31' ' ' THR . 0.1 OUTLIER -83.78 -15.85 46.88 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.263 -0.898 . . . . 0.0 110.249 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.577 HG21 ' HG ' ' A' ' 27' ' ' LEU . 10.5 t -55.51 -174.31 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.633 0.73 . . . . 0.0 110.598 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.701 HG23 ' H ' ' A' ' 35' ' ' GLY . 6.5 t -161.24 -173.01 3.64 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.5 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 5.0 mt-30 -71.72 -74.61 0.15 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.998 -1.064 . . . . 0.0 110.781 -178.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.559 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 3.0 tt0 -49.6 -34.13 17.11 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.72 -1.237 . . . . 0.0 110.05 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.701 ' H ' HG23 ' A' ' 32' ' ' THR . . . -60.72 -30.19 71.9 Favored Glycine 0 C--N 1.295 -1.719 0 N-CA-C 107.216 -2.354 . . . . 0.0 107.216 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.876 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -82.51 -38.97 23.06 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.192 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.559 ' HG3' ' HA ' ' A' ' 34' ' ' GLU . 18.6 mtt180 -62.5 -27.0 68.84 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.505 1.145 . . . . 0.0 108.23 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.534 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -85.67 -21.05 28.54 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.127 179.694 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.661 ' CE1' ' NE2' ' A' ' 83' ' ' HIS . 9.9 t80 -81.94 -41.76 20.39 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.322 -0.861 . . . . 0.0 110.835 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.846 ' CE1' HG13 ' A' ' 77' ' ' VAL . 33.0 m-85 -100.3 -27.68 13.36 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.448 -0.783 . . . . 0.0 108.934 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.613 ' CA ' HG23 ' A' ' 46' ' ' VAL . . . -67.38 -9.52 55.06 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -64.64 -48.35 75.13 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.472 -1.016 . . . . 0.0 109.97 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.565 ' CG ' ' HB3' ' A' ' 76' ' ' LYS . 6.2 p90 -109.05 5.87 24.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.395 -0.815 . . . . 0.0 110.244 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.515 ' O ' ' HA2' ' A' ' 41' ' ' GLY . . . -162.76 97.74 0.15 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -38.8 124.25 1.35 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.473 -1.016 . . . . 0.0 110.745 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.613 HG23 ' CA ' ' A' ' 41' ' ' GLY . 47.7 t -90.07 132.16 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.384 -0.823 . . . . 0.0 110.74 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -98.67 -15.96 19.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.372 -0.83 . . . . 0.0 110.069 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -169.67 143.13 2.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.188 -0.945 . . . . 0.0 110.895 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.497 ' SG ' ' NE ' ' A' ' 37' ' ' ARG . 8.4 p -150.97 164.65 35.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.485 -0.759 . . . . 0.0 109.995 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.719 HD21 ' CD2' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -150.36 128.6 12.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.99 -1.069 . . . . 0.0 110.786 179.869 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.6 t -103.74 135.79 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 120.659 -1.275 . . . . 0.0 110.268 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.596 ' HG2' ' CE1' ' A' ' 63' ' ' PHE . 0.2 OUTLIER -141.92 157.11 45.36 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.253 -0.904 . . . . 0.0 109.951 -179.217 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.543 ' HA ' ' O ' ' A' ' 61' ' ' ARG . 7.5 ptt85 -128.11 95.3 4.14 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.32 -0.863 . . . . 0.0 110.235 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.594 ' CB ' ' CD ' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -69.38 -59.34 5.02 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.284 -0.885 . . . . 0.0 110.873 -179.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.594 ' CD ' ' CB ' ' A' ' 54' ' ' ASP . 3.0 Cg_exo -56.81 -164.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.375 1.197 . . . . 0.0 111.124 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.61 HD23 ' N ' ' A' ' 56' ' ' LEU . 4.0 mt -91.0 -66.55 0.92 Allowed 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.391 -0.818 . . . . 0.0 110.655 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 56' ' ' LEU . 1.0 OUTLIER 175.83 -24.12 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.239 -0.913 . . . . 0.0 111.309 -179.611 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.2 pttp -47.83 -37.27 13.42 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.985 -1.072 . . . . 0.0 109.731 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.528 ' HD3' ' N ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -109.37 -158.89 0.66 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.661 -0.649 . . . . 0.0 109.86 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.528 ' N ' ' HD3' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -52.14 -168.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.929 . . . . 0.0 109.916 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -89.98 -48.51 7.16 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.93 -1.106 . . . . 0.0 108.719 179.275 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 165.52 -72.87 0.17 Allowed Glycine 0 N--CA 1.482 1.712 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.837 ' N ' HD22 ' A' ' 27' ' ' LEU . 3.1 p90 -173.39 -174.46 1.02 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.138 -1.213 . . . . 0.0 111.05 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.43 ' O ' ' HB ' ' A' ' 24' ' ' ILE . . . -149.89 123.66 1.63 Allowed Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.719 ' CD2' HD21 ' A' ' 50' ' ' LEU . 18.1 m-85 -83.88 148.98 26.65 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.318 -1.107 . . . . 0.0 109.625 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.698 HG22 HD21 ' A' ' 36' ' ' LEU . 3.7 t -146.44 161.92 9.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.316 -0.865 . . . . 0.0 109.621 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.764 HG23 ' CB ' ' A' ' 21' ' ' LYS . 1.8 m -149.56 39.6 0.81 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.198 -0.939 . . . . 0.0 110.229 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.608 ' CE2' HG21 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -67.17 143.74 56.41 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.151 -0.968 . . . . 0.0 109.858 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 14.0 mtp -117.99 109.95 17.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.192 -0.942 . . . . 0.0 110.439 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -145.43 161.29 40.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.364 -0.835 . . . . 0.0 110.104 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.84 -70.01 0.26 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.258 -0.902 . . . . 0.0 110.159 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.29 2.12 55.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.298 -0.876 . . . . 0.0 110.661 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.571 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -49.9 -57.24 10.07 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.414 ' H ' HG23 ' A' ' 74' ' ' VAL . 49.0 t -47.51 -43.54 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.235 -1.156 . . . . 0.0 110.32 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.959 ' HA ' HD21 ' A' ' 78' ' ' LEU . 0.5 OUTLIER -59.58 -39.96 85.86 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.177 -0.952 . . . . 0.0 110.271 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.565 ' HB3' ' CG ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -71.07 -28.33 64.27 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.189 -0.944 . . . . 0.0 109.901 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.846 HG13 ' CE1' ' A' ' 40' ' ' PHE . 55.0 t -64.68 -64.42 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.139 -0.976 . . . . 0.0 109.576 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.959 HD21 ' HA ' ' A' ' 75' ' ' ASP . 1.5 pp -47.98 -37.98 15.88 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.109 -0.994 . . . . 0.0 109.185 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -46.17 -30.14 1.83 Allowed 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.057 -1.027 . . . . 0.0 108.861 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.532 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 1.5 mt-30 -104.62 28.26 7.19 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.411 0.624 . . . . 0.0 109.741 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.464 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 5.7 p -52.85 -18.52 1.95 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.492 ' O ' ' C ' ' A' ' 83' ' ' HIS . 4.5 ptt180 -94.49 -15.44 24.19 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.482 -0.761 . . . . 0.0 109.565 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.848 ' CE1' HD12 ' A' ' 90' ' ' ILE . 0.6 OUTLIER 28.72 46.31 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 179.303 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.578 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 0.8 OUTLIER -90.24 124.87 35.23 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 118.583 -1.247 . . . . 0.0 109.545 179.243 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.531 ' CD2' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -147.5 -83.63 0.11 Allowed 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 120.146 -0.621 . . . . 0.0 109.676 -179.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' A' ' 87' ' ' SER . 23.7 m-20 -83.18 50.73 1.8 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.11 -0.993 . . . . 0.0 108.818 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 72.63 7.19 5.54 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.472 0.653 . . . . 0.0 109.754 -179.188 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.578 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 0.6 OUTLIER -111.42 122.38 47.69 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.405 -0.809 . . . . 0.0 109.656 -179.529 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.718 ' O ' HG23 ' A' ' 89' ' ' THR . 9.4 t -101.9 69.43 1.18 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.062 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.851 HG21 ' CG2' ' A' ' 24' ' ' ILE . 0.9 OUTLIER -51.48 -176.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.346 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.514 ' H ' HG22 ' A' ' 90' ' ' ILE . 3.6 t70 -143.39 84.4 10.19 Favored Pre-proline 0 C--N 1.304 -1.382 0 O-C-N 120.963 -1.086 . . . . 0.0 110.363 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.543 ' HG3' ' HD2' ' A' ' 83' ' ' HIS . 2.3 Cg_endo -56.03 113.42 1.43 Allowed 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.551 1.29 . . . . 0.0 111.167 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.61 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -127.71 104.46 7.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.233 -0.917 . . . . 0.0 109.575 178.385 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 1.067 HG13 ' HB3' ' A' ' 22' ' ' MET . 7.9 t -96.77 164.29 2.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 O-C-N 121.654 -0.654 . . . . 0.0 110.398 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.59 96.63 9.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.218 -0.926 . . . . 0.0 110.136 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 58.5 t80 . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 109.909 -179.945 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.266 0.555 . . . . 0.0 110.286 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.546 ' CB ' ' HB ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -162.47 153.93 18.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.235 -0.916 . . . . 0.0 110.014 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.805 ' HG2' HG13 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -71.76 -175.94 1.51 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.032 -1.042 . . . . 0.0 109.564 179.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.535 ' O ' ' HG2' ' A' ' 93' ' ' LYS . 2.0 t80 -149.03 119.16 7.21 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.076 -1.015 . . . . 0.0 111.487 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.706 HG22 ' CG2' ' A' ' 90' ' ' ILE . 17.4 mm -91.33 140.46 16.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.062 -1.024 . . . . 0.0 109.216 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 90' ' ' ILE . . . -119.23 149.42 18.08 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.669 -1.253 . . . . 0.0 111.303 -178.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.457 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 55.97 43.65 87.88 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.982 HD22 ' CA ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER -84.37 152.15 24.25 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.468 -1.019 . . . . 0.0 110.584 -179.027 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.8 ' O ' HG22 ' A' ' 31' ' ' THR . 14.5 m -41.73 124.66 2.6 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.459 -0.776 . . . . 0.0 110.32 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.496 ' CD2' ' N ' ' A' ' 30' ' ' GLN . 65.1 p-90 -68.2 -33.59 74.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.341 -0.85 . . . . 0.0 110.437 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.496 ' N ' ' CD2' ' A' ' 29' ' ' TRP . 17.8 pt20 -74.35 -12.56 60.56 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.324 -0.86 . . . . 0.0 111.2 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.8 HG22 ' O ' ' A' ' 28' ' ' SER . 5.7 t -65.05 -179.45 0.56 Allowed 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.34 -0.85 . . . . 0.0 110.37 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 35' ' ' GLY . 5.5 t -148.2 -172.65 4.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.338 -0.851 . . . . 0.0 110.155 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 36' ' ' LEU . 6.5 mt-30 -66.2 -73.43 0.13 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.196 -0.94 . . . . 0.0 110.67 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.472 ' HA ' ' CG ' ' A' ' 37' ' ' ARG . 3.4 tt0 -47.46 -47.31 27.23 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.759 -1.176 . . . . 0.0 109.718 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.536 ' O ' ' HG3' ' A' ' 38' ' ' GLU . . . -53.36 -27.57 33.13 Favored Glycine 0 N--CA 1.483 1.799 0 N-CA-C 107.711 -2.156 . . . . 0.0 107.711 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.999 HD21 ' HB3' ' A' ' 49' ' ' CYS . 0.1 OUTLIER -83.37 -35.49 25.07 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' A' ' 33' ' ' GLN . 34.1 mtp180 -62.37 -28.34 69.7 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.536 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -90.88 -15.36 30.03 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.534 178.772 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.601 ' HH ' ' CE1' ' A' ' 83' ' ' HIS . 47.9 t80 -75.47 -29.12 59.51 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 121.55 0.69 . . . . 0.0 109.617 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.884 ' CE1' HG13 ' A' ' 77' ' ' VAL . 37.8 m-85 -116.29 -26.11 7.3 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.633 -0.667 . . . . 0.0 109.48 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -68.16 -9.27 56.94 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -71.51 -50.9 26.94 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.439 -1.036 . . . . 0.0 110.593 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.578 ' HE1' HG22 ' A' ' 77' ' ' VAL . 3.1 p90 -109.53 -6.85 15.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.096 -1.003 . . . . 0.0 110.747 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 40' ' ' PHE . . . -150.63 118.6 0.93 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 9.8 pt-20 -54.23 132.9 44.38 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.198 -1.178 . . . . 0.0 109.722 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.752 HG11 ' SG ' ' A' ' 49' ' ' CYS . 86.3 t -112.14 152.64 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.158 -0.963 . . . . 0.0 110.46 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.45 ' HB3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -96.74 -29.84 13.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.355 -0.841 . . . . 0.0 109.826 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.502 ' O ' HG22 ' A' ' 67' ' ' THR . 11.6 tp10 -179.68 158.4 0.8 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.341 -0.85 . . . . 0.0 110.058 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.999 ' HB3' HD21 ' A' ' 36' ' ' LEU . 7.2 m -146.04 171.01 15.51 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.922 -1.112 . . . . 0.0 110.6 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.804 HD12 ' N ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -138.9 134.65 33.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.304 -0.873 . . . . 0.0 109.397 179.691 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.804 ' N ' HD12 ' A' ' 50' ' ' LEU . 76.4 t -125.62 139.36 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.47 -1.394 . . . . 0.0 111.612 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.563 ' HG2' ' CE2' ' A' ' 63' ' ' PHE . 0.7 OUTLIER -142.62 143.6 32.46 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.347 -0.845 . . . . 0.0 109.747 179.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.497 ' O ' ' HD3' ' A' ' 55' ' ' PRO . 12.2 ptt180 -151.05 19.97 0.77 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.597 -0.69 . . . . 0.0 110.185 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -114.24 81.49 6.52 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.285 -0.884 . . . . 0.0 110.355 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 53' ' ' ARG . 2.9 Cg_endo -62.47 112.21 1.53 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.793 1.417 . . . . 0.0 110.621 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.1 pp -89.39 -26.23 21.14 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.271 -0.893 . . . . 0.0 109.956 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.452 HG23 ' N ' ' A' ' 58' ' ' LYS . 5.2 t -132.9 -130.77 0.18 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.575 -0.703 . . . . 0.0 109.587 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.452 ' N ' HG23 ' A' ' 57' ' ' THR . 0.2 OUTLIER -112.24 31.5 6.23 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 120.97 -1.081 . . . . 0.0 110.319 179.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.483 ' HD3' ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -98.08 -160.87 0.83 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.276 -0.89 . . . . 0.0 110.512 -179.762 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.483 ' OG ' ' HD3' ' A' ' 59' ' ' ARG . 4.5 p -40.65 160.04 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.218 -0.926 . . . . 0.0 110.406 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.77 38.75 0.69 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.132 -0.98 . . . . 0.0 110.527 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 144.66 81.94 0.05 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.982 ' CA ' HD22 ' A' ' 27' ' ' LEU . 49.6 p90 -144.54 -167.95 2.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.139 -1.212 . . . . 0.0 110.29 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 50' ' ' LEU . . . -168.49 123.93 1.14 Allowed Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.569 -1.3 . . . . 0.0 110.199 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.61 ' CD2' ' CD2' ' A' ' 50' ' ' LEU . 27.5 m-85 -85.84 152.26 23.14 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.477 -1.013 . . . . 0.0 108.899 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.675 HG13 ' SG ' ' A' ' 49' ' ' CYS . 11.2 t -150.33 104.25 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.615 -1.303 . . . . 0.0 111.62 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.546 ' HB ' ' CB ' ' A' ' 21' ' ' LYS . 2.3 t -87.71 125.95 34.7 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.112 -0.993 . . . . 0.0 109.129 178.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.869 ' CE2' HG21 ' A' ' 77' ' ' VAL . 5.8 m-85 -95.79 -157.41 0.58 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.027 -1.046 . . . . 0.0 109.986 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.414 ' HG3' ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -171.62 38.48 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.174 -0.953 . . . . 0.0 110.214 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.485 ' OD2' ' N ' ' A' ' 73' ' ' GLY . 5.6 p-10 -148.46 -143.3 0.14 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.252 -0.905 . . . . 0.0 110.112 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.404 ' O ' ' C ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -130.12 -82.61 0.55 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.199 -0.938 . . . . 0.0 110.108 179.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 73' ' ' GLY . . . -45.08 -33.07 1.98 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.205 -0.934 . . . . 0.0 110.084 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.764 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -43.94 -42.67 6.57 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.015 HG13 HG11 ' A' ' 94' ' ' VAL . 21.3 t -64.76 -55.24 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -1.145 . . . . 0.0 110.15 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.685 ' HA ' HD21 ' A' ' 78' ' ' LEU . 10.8 m-20 -41.97 -40.97 2.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 110.206 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.752 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 33.7 mmtt -72.67 -46.6 53.06 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.422 -0.799 . . . . 0.0 110.186 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.884 HG13 ' CE1' ' A' ' 40' ' ' PHE . 58.0 t -53.06 -68.3 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.124 -0.985 . . . . 0.0 109.767 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.685 HD21 ' HA ' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -45.65 -39.01 7.32 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.061 -1.024 . . . . 0.0 109.209 179.123 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.752 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -48.88 -24.23 1.39 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.077 -1.014 . . . . 0.0 108.9 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.631 ' HB3' ' CE1' ' A' ' 83' ' ' HIS . 2.9 mm-40 -105.23 28.03 7.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.585 -0.697 . . . . 0.0 109.987 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.571 ' HA ' ' HD2' ' A' ' 92' ' ' PRO . 14.3 t -61.17 -10.79 7.13 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.448 -0.783 . . . . 0.0 109.123 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -108.49 11.1 27.11 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 121.418 -0.801 . . . . 0.0 109.896 179.646 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.631 ' CE1' ' HB3' ' A' ' 80' ' ' GLN . 1.7 m-70 -23.73 85.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -178.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.989 ' C ' HD13 ' A' ' 85' ' ' LEU . 1.4 tt0 -106.99 121.41 44.41 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.989 HD13 ' C ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -142.35 -97.97 0.13 Allowed 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.991 -179.467 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.56 ' H ' HD23 ' A' ' 85' ' ' LEU . 25.4 t70 -69.73 55.64 0.13 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.834 -1.166 . . . . 0.0 108.741 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 70.42 8.37 6.59 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.445 -0.785 . . . . 0.0 110.138 -179.473 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.529 ' CD ' ' O ' ' A' ' 86' ' ' ASP . 2.3 mmmt -111.01 111.6 22.82 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.177 -0.952 . . . . 0.0 110.672 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.558 ' O ' HG23 ' A' ' 89' ' ' THR . 7.1 t -89.46 63.49 6.38 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.706 ' CG2' HG22 ' A' ' 24' ' ' ILE . 1.2 mt -42.65 172.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 CA-C-O 121.925 0.869 . . . . 0.0 110.277 -178.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 81' ' ' SER . 14.4 t0 -144.17 77.01 14.65 Favored Pre-proline 0 C--N 1.298 -1.637 0 O-C-N 121.32 -0.863 . . . . 0.0 110.786 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.602 ' HG3' ' CD2' ' A' ' 83' ' ' HIS . 1.9 Cg_endo -52.48 112.79 0.97 Allowed 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.514 1.27 . . . . 0.0 110.068 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.581 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 7.0 ptmt -109.43 105.56 14.96 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.627 1.203 . . . . 0.0 110.517 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 1.015 HG11 HG13 ' A' ' 74' ' ' VAL . 39.5 t -98.11 130.76 46.41 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 O-C-N 121.182 -0.949 . . . . 0.0 110.397 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -153.13 169.24 23.46 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.204 -0.935 . . . . 0.0 110.506 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.417 -0.802 . . . . 0.0 109.99 179.807 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.759 ' O ' HG23 ' A' ' 67' ' ' THR . 32.4 m . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.297 0.57 . . . . 0.0 110.306 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.671 ' HB3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -168.82 -173.93 1.97 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.32 -0.863 . . . . 0.0 110.137 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.831 ' CB ' HG13 ' A' ' 94' ' ' VAL . 3.1 ptm -121.1 -174.21 2.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.049 -1.032 . . . . 0.0 110.151 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.582 ' CD1' ' C ' ' A' ' 23' ' ' PHE . 0.3 OUTLIER -150.47 144.43 25.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.348 -0.845 . . . . 0.0 109.329 179.699 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.652 ' CG2' HG21 ' A' ' 90' ' ' ILE . 9.1 mm -108.03 129.26 62.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.122 -0.986 . . . . 0.0 109.475 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.513 ' O ' HG22 ' A' ' 90' ' ' ILE . . . -110.4 144.9 17.16 Favored Glycine 0 N--CA 1.494 2.545 0 C-N-CA 120.114 -1.041 . . . . 0.0 111.239 -178.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.435 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 60.13 34.28 83.34 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.934 ' O ' HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -73.84 146.71 43.94 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.55 -0.971 . . . . 0.0 110.022 -179.608 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.625 ' O ' HG22 ' A' ' 31' ' ' THR . 0.3 OUTLIER -39.74 132.83 1.63 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.598 -0.689 . . . . 0.0 110.3 -179.715 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.515 ' CD1' ' N ' ' A' ' 29' ' ' TRP . 0.5 OUTLIER -76.35 6.03 6.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.257 -0.902 . . . . 0.0 110.54 -179.799 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.442 ' O ' ' O ' ' A' ' 31' ' ' THR . 2.8 pt20 -124.47 -12.75 7.22 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.189 -0.944 . . . . 0.0 110.485 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.625 HG22 ' O ' ' A' ' 28' ' ' SER . 11.5 t -53.76 -168.7 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.603 -0.686 . . . . 0.0 110.379 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.458 HG23 ' H ' ' A' ' 35' ' ' GLY . 1.3 t -145.16 176.15 9.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.446 -0.784 . . . . 0.0 109.748 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 36' ' ' LEU . 3.5 mt-30 -72.0 -72.58 0.22 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.111 -0.993 . . . . 0.0 111.105 -178.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.522 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -46.15 -52.85 11.49 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.672 -1.211 . . . . 0.0 109.436 -179.69 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.468 ' HA2' ' HG3' ' A' ' 38' ' ' GLU . . . -46.75 -32.69 5.99 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 107.822 -2.111 . . . . 0.0 107.822 178.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.834 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -78.19 -39.34 40.96 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.317 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.661 ' HA ' HG21 ' A' ' 46' ' ' VAL . 49.3 mtt180 -60.58 -26.07 66.68 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 122.316 1.055 . . . . 0.0 108.434 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -85.4 -21.28 28.88 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.787 179.513 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.694 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 29.4 t80 -79.97 -24.34 41.0 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.647 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.769 ' HE1' HG13 ' A' ' 77' ' ' VAL . 25.4 m-85 -114.55 -19.13 11.27 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.332 -0.855 . . . . 0.0 109.104 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.17 -4.12 88.72 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 108.719 -1.753 . . . . 0.0 108.719 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -68.29 -53.05 27.04 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.352 -1.087 . . . . 0.0 110.034 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.467 ' CE1' ' HA ' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -99.41 9.39 43.38 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.277 -0.89 . . . . 0.0 110.259 179.492 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -152.68 -121.92 0.91 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.508 ' CG ' ' O ' ' A' ' 45' ' ' GLU . 5.9 pt-20 -172.08 119.44 0.42 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.385 -1.067 . . . . 0.0 109.687 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.661 HG21 ' HA ' ' A' ' 37' ' ' ARG . 28.1 t -93.25 124.09 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.335 -0.853 . . . . 0.0 111.124 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.86 -31.35 19.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.383 -0.823 . . . . 0.0 109.337 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -172.11 151.3 2.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.518 -0.739 . . . . 0.0 109.597 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.5 ' SG ' ' NE ' ' A' ' 37' ' ' ARG . 24.0 p -148.91 167.67 25.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.053 -1.029 . . . . 0.0 110.605 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.788 ' C ' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -142.92 122.97 13.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.255 -0.903 . . . . 0.0 110.446 179.693 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.535 ' N ' HD12 ' A' ' 50' ' ' LEU . 71.3 t -105.41 137.51 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.027 -1.046 . . . . 0.0 110.368 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.567 ' HG2' ' CZ ' ' A' ' 63' ' ' PHE . 1.9 ttt -134.36 148.56 50.73 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.33 -0.856 . . . . 0.0 110.064 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.33 -40.0 0.74 Allowed 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.333 0.587 . . . . 0.0 109.94 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.403 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 8.5 p-10 -49.12 154.56 1.33 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.334 -0.854 . . . . 0.0 109.902 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.9 Cg_endo -63.0 132.3 36.26 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.676 1.356 . . . . 0.0 110.982 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.552 ' HB3' ' HE1' ' A' ' 52' ' ' MET . 3.2 pp -89.69 -29.15 18.97 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.275 -0.89 . . . . 0.0 110.326 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.483 ' CG2' ' CE ' ' A' ' 58' ' ' LYS . 2.9 t -130.02 -37.27 1.5 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.273 -0.892 . . . . 0.0 110.228 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.483 ' CE ' ' CG2' ' A' ' 57' ' ' THR . 0.0 OUTLIER -168.41 -31.6 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.228 -0.92 . . . . 0.0 110.764 179.396 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.566 ' CD ' ' O ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -124.64 -179.43 4.5 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 120.993 -1.067 . . . . 0.0 109.784 179.856 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.566 ' O ' ' CD ' ' A' ' 59' ' ' ARG . 75.7 m -91.95 156.55 17.37 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.389 -0.819 . . . . 0.0 111.621 -179.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.15 -56.74 1.43 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.122 -0.986 . . . . 0.0 109.432 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.595 ' C ' HD22 ' A' ' 27' ' ' LEU . . . 91.89 80.83 1.43 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.149 -1.581 . . . . 0.0 109.149 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.63 ' N ' HD22 ' A' ' 27' ' ' LEU . 12.4 p90 -149.82 -169.66 3.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -1.14 . . . . 0.0 110.288 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 50' ' ' LEU . . . -167.55 -161.99 18.32 Favored Glycine 0 N--CA 1.485 1.924 0 C-N-CA 119.507 -1.33 . . . . 0.0 110.303 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.543 ' C ' HG23 ' A' ' 66' ' ' VAL . 9.1 m-85 -146.23 143.4 29.2 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.769 -0.842 . . . . 0.0 109.074 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.748 HG21 HD11 ' A' ' 36' ' ' LEU . 14.1 t -147.85 97.08 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 120.805 -1.184 . . . . 0.0 110.752 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.759 HG23 ' O ' ' A' ' 20' ' ' CYS . 22.7 m -80.68 58.43 3.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.368 -0.832 . . . . 0.0 109.929 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.599 ' CE2' HG21 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -82.27 -148.19 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 110.609 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.515 ' O ' ' CE1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -61.09 163.28 6.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 110.209 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -131.09 0.45 4.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.884 . . . . 0.0 110.047 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.467 ' O ' HG12 ' A' ' 74' ' ' VAL . 2.4 mt-30 -95.23 -101.3 0.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.878 . . . . 0.0 110.19 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.492 ' HB1' ' NZ ' ' A' ' 76' ' ' LYS . . . -67.52 -24.52 65.57 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.938 -1.101 . . . . 0.0 110.005 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.797 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -53.67 -65.87 3.13 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.555 ' CG1' ' N ' ' A' ' 75' ' ' ASP . 2.2 p -39.94 -43.19 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.398 -1.06 . . . . 0.0 110.489 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.803 ' HA ' HD23 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -58.65 -77.86 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.367 -0.833 . . . . 0.0 110.383 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.621 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -48.47 -22.45 0.73 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.381 -0.824 . . . . 0.0 110.059 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 73' ' ' GLY . 55.4 t -71.72 -53.43 20.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.256 -0.903 . . . . 0.0 109.666 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.803 HD23 ' HA ' ' A' ' 75' ' ' ASP . 1.3 pp -50.76 -28.95 10.25 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 120.918 -1.114 . . . . 0.0 108.196 178.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -57.36 -20.03 26.61 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.525 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 1.0 OUTLIER -105.58 19.01 21.28 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.431 0.634 . . . . 0.0 109.481 179.233 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.484 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 46.3 t -53.38 -16.5 1.41 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.604 -0.839 . . . . 0.0 108.747 178.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.571 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -103.66 -2.43 26.59 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 121.358 -0.839 . . . . 0.0 109.618 178.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 1.014 ' CE1' HD12 ' A' ' 90' ' ' ILE . 0.3 OUTLIER 27.18 -85.09 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.705 0.764 . . . . 0.0 111.675 179.68 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.875 ' C ' HD23 ' A' ' 85' ' ' LEU . 0.5 OUTLIER 54.66 122.14 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 122.205 1.002 . . . . 0.0 111.088 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.875 HD23 ' C ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -149.19 -92.08 0.07 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.394 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.561 ' O ' ' CB ' ' A' ' 87' ' ' SER . 7.7 t0 -82.54 54.28 2.58 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.067 -1.02 . . . . 0.0 108.495 178.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.561 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER 76.68 6.18 3.39 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.215 0.531 . . . . 0.0 109.975 -179.016 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.601 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -110.86 114.41 27.72 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.291 -0.88 . . . . 0.0 110.668 -179.351 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.694 ' O ' HG23 ' A' ' 89' ' ' THR . 9.7 t -89.14 76.98 7.64 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.805 -0.559 . . . . 0.0 109.805 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.014 HD12 ' CE1' ' A' ' 83' ' ' HIS . 1.5 mt -49.23 179.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.256 -0.903 . . . . 0.0 109.494 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.565 ' H ' HG22 ' A' ' 90' ' ' ILE . 8.0 t0 -140.72 79.55 19.24 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.328 -0.858 . . . . 0.0 110.1 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.525 ' CG ' ' O ' ' A' ' 80' ' ' GLN . 2.3 Cg_endo -54.61 111.94 0.87 Allowed 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.57 1.3 . . . . 0.0 110.749 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.582 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -127.59 103.12 7.15 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.866 0.841 . . . . 0.0 109.235 178.528 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.831 HG13 ' CB ' ' A' ' 22' ' ' MET . 15.8 t -97.11 170.48 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-O 121.349 0.595 . . . . 0.0 110.502 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.525 ' O ' ' CB ' ' A' ' 96' ' ' PHE . . . -51.48 -66.08 0.45 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.199 -0.938 . . . . 0.0 110.436 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.525 ' CB ' ' O ' ' A' ' 95' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.709 0 O-C-N 121.184 -0.947 . . . . 0.0 110.067 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.7 m . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.222 0.534 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.71 160.13 14.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.16 -0.962 . . . . 0.0 110.325 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.768 ' CG ' HG22 ' A' ' 94' ' ' VAL . 7.4 ttt -76.72 163.1 27.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.221 -0.924 . . . . 0.0 110.16 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.706 ' CG ' ' CE1' ' A' ' 65' ' ' PHE . 2.0 t80 -141.64 129.08 21.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.295 -0.878 . . . . 0.0 109.597 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.702 HD12 ' C ' ' A' ' 23' ' ' PHE . 1.4 mp -106.48 155.87 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.115 -0.99 . . . . 0.0 109.289 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.57 ' O ' ' N ' ' A' ' 91' ' ' ASP . . . -139.21 139.08 9.8 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 119.245 -1.455 . . . . 0.0 111.42 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.552 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 105.51 27.26 5.86 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.981 ' CD2' HG13 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -50.45 118.58 3.12 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.792 -0.828 . . . . 0.0 110.864 -179.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.523 ' HB2' ' CB ' ' A' ' 88' ' ' LYS . 1.4 t -59.43 178.52 0.14 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.38 -0.825 . . . . 0.0 110.212 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.568 ' O ' ' CE3' ' A' ' 29' ' ' TRP . 35.1 p-90 -84.85 15.69 3.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.177 -0.952 . . . . 0.0 110.1 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -143.92 7.45 1.42 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.241 -0.912 . . . . 0.0 110.936 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.595 HG21 ' HG ' ' A' ' 27' ' ' LEU . 1.9 m -70.66 157.08 38.61 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.125 -0.984 . . . . 0.0 109.892 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.531 ' CG2' ' HA3' ' A' ' 35' ' ' GLY . 4.4 t -127.48 178.04 6.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.083 -1.01 . . . . 0.0 109.922 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.516 ' HG2' ' CG2' ' A' ' 51' ' ' VAL . 6.0 mt-30 -88.76 -73.69 0.49 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.15 -0.969 . . . . 0.0 110.734 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.56 ' HA ' ' HB3' ' A' ' 37' ' ' ARG . 0.1 OUTLIER -50.78 -49.67 57.73 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 117.967 -1.493 . . . . 0.0 108.929 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.531 ' HA3' ' CG2' ' A' ' 32' ' ' THR . . . -49.39 -27.72 8.48 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 107.603 -2.199 . . . . 0.0 107.603 178.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.91 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -80.69 -32.02 36.06 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.478 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.581 ' HG2' ' HG2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -60.46 -34.79 74.52 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 177.475 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.581 ' HG2' ' HG2' ' A' ' 37' ' ' ARG . 2.0 mt-10 -76.63 -25.44 53.82 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 113.912 -1.494 . . . . 0.0 109.863 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.63 ' CE1' ' NE2' ' A' ' 83' ' ' HIS . 8.0 t80 -75.81 -25.01 55.95 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.511 -0.743 . . . . 0.0 110.82 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.912 ' HE1' HG13 ' A' ' 77' ' ' VAL . 16.3 m-85 -113.69 -17.86 12.02 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.324 -0.86 . . . . 0.0 109.118 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -79.73 -5.53 89.37 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 108.496 -1.842 . . . . 0.0 108.496 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -63.58 -45.27 91.16 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.492 -1.005 . . . . 0.0 109.888 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.535 ' CD2' ' HB3' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -108.16 1.54 22.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.449 -0.782 . . . . 0.0 110.189 179.608 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.478 ' O ' ' HA2' ' A' ' 41' ' ' GLY . . . -149.64 179.49 26.37 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.609 -1.281 . . . . 0.0 109.933 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 0.4 OUTLIER -101.16 121.18 41.38 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.34 -1.094 . . . . 0.0 110.086 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.645 HG22 ' HB3' ' A' ' 68' ' ' PHE . 43.1 t -97.69 121.62 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.131 -0.981 . . . . 0.0 110.651 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.419 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . 35.8 tptt -88.91 -36.31 16.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.308 -0.87 . . . . 0.0 109.987 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -161.58 161.28 29.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 0.0 110.328 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 7.6 p -150.12 165.55 32.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.29 -0.881 . . . . 0.0 109.712 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.758 HD21 ' CD2' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -149.67 132.93 16.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.049 -1.032 . . . . 0.0 110.751 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.981 HG13 ' CD2' ' A' ' 27' ' ' LEU . 79.3 t -121.85 131.72 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.56 -1.338 . . . . 0.0 110.423 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 2.5 ttm -131.65 151.81 51.33 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.356 -0.84 . . . . 0.0 109.962 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.503 ' O ' ' CB ' ' A' ' 54' ' ' ASP . 0.2 OUTLIER -149.78 -36.14 0.16 Allowed 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.571 -0.706 . . . . 0.0 110.273 179.76 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.503 ' CB ' ' O ' ' A' ' 53' ' ' ARG . 0.4 OUTLIER 70.99 138.38 0.06 OUTLIER Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.201 -0.937 . . . . 0.0 110.136 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 54' ' ' ASP . 2.9 Cg_endo -64.71 -6.69 12.86 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 123.506 1.266 . . . . 0.0 110.831 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.778 ' C ' HG23 ' A' ' 57' ' ' THR . 11.7 mt -89.38 -50.44 6.11 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.158 -0.964 . . . . 0.0 109.885 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.778 HG23 ' C ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER 61.62 -60.02 0.1 Allowed 'General case' 0 N--CA 1.505 2.275 0 CA-C-O 121.496 0.665 . . . . 0.0 110.275 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.586 ' N ' ' O ' ' A' ' 56' ' ' LEU . 1.2 pttt -45.79 -28.14 0.99 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.506 -0.746 . . . . 0.0 109.556 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.465 ' C ' ' HD3' ' A' ' 59' ' ' ARG . 0.4 OUTLIER -110.31 -35.35 6.09 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.639 -0.663 . . . . 0.0 110.232 179.809 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.444 ' N ' ' HD3' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -62.37 -155.32 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.161 -0.962 . . . . 0.0 110.202 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.01 -40.61 0.75 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.891 . . . . 0.0 109.825 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.44 89.73 0.59 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.959 ' O ' HD22 ' A' ' 27' ' ' LEU . 20.4 p90 -148.4 -176.9 5.48 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.277 -1.131 . . . . 0.0 110.537 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.696 ' N ' HD13 ' A' ' 27' ' ' LEU . . . -142.58 162.83 27.31 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.758 ' CD2' HD21 ' A' ' 50' ' ' LEU . 14.2 m-85 -128.28 154.18 46.18 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.404 -1.057 . . . . 0.0 109.41 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.781 ' CG2' HD11 ' A' ' 36' ' ' LEU . 15.3 t -149.87 110.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.058 -1.026 . . . . 0.0 110.64 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.588 HG22 ' O ' ' A' ' 67' ' ' THR . 84.9 m -89.11 49.93 1.86 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.294 -0.879 . . . . 0.0 109.98 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.645 ' HB3' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -84.72 52.32 2.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.412 -0.805 . . . . 0.0 110.818 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.429 ' C ' ' O ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -42.11 119.16 1.28 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.228 -0.92 . . . . 0.0 110.471 -179.753 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -150.01 -174.36 4.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.328 -0.857 . . . . 0.0 110.008 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.5 tm0? -94.85 -71.32 0.67 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.154 -0.966 . . . . 0.0 110.22 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 75' ' ' ASP . . . -83.19 8.51 13.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 109.996 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.761 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -57.1 -70.44 0.98 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.436 ' C ' ' O ' ' A' ' 73' ' ' GLY . 98.5 t -41.9 -29.06 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.355 -1.085 . . . . 0.0 110.247 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.846 ' HA ' HD23 ' A' ' 78' ' ' LEU . 0.5 OUTLIER -66.28 -80.64 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 0.0 109.898 179.744 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.704 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -47.73 -24.7 1.01 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.232 -0.917 . . . . 0.0 109.07 179.337 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.912 HG13 ' HE1' ' A' ' 40' ' ' PHE . 78.1 t -68.74 -55.22 16.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.472 -0.767 . . . . 0.0 109.703 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.846 HD23 ' HA ' ' A' ' 75' ' ' ASP . 1.1 pp -48.78 -28.48 3.69 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 120.835 -1.166 . . . . 0.0 108.48 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.704 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -52.13 -32.6 36.23 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.559 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 5.4 mm-40 -99.43 24.04 8.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.781 -0.574 . . . . 0.0 109.499 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.474 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 9.8 t -49.95 -18.76 0.57 Allowed 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.092 178.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.486 ' O ' ' C ' ' A' ' 83' ' ' HIS . 0.2 OUTLIER -103.52 -7.55 20.77 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.342 -0.849 . . . . 0.0 109.841 179.45 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.735 ' CE1' HD12 ' A' ' 90' ' ' ILE . 0.5 OUTLIER 32.22 36.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.95 -0.469 . . . . 0.0 111.272 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.551 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 1.4 tt0 -87.14 120.26 28.22 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.594 -1.243 . . . . 0.0 110.237 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.529 ' CD2' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -151.7 -83.48 0.09 Allowed 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.679 -0.638 . . . . 0.0 110.133 -179.626 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.518 ' O ' ' CB ' ' A' ' 87' ' ' SER . 0.2 OUTLIER -79.81 53.08 1.57 Allowed 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.106 -0.996 . . . . 0.0 109.289 179.473 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 71.01 2.83 4.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.565 -0.709 . . . . 0.0 110.256 -179.796 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -110.96 124.85 52.95 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.257 -0.902 . . . . 0.0 110.246 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.762 ' O ' HG23 ' A' ' 89' ' ' THR . 15.1 t -104.77 63.93 0.73 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.523 -0.736 . . . . 0.0 110.133 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.735 HD12 ' CE1' ' A' ' 83' ' ' HIS . 0.6 OUTLIER -52.23 -176.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.35 -0.843 . . . . 0.0 108.887 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.57 ' N ' ' O ' ' A' ' 25' ' ' GLY . 13.0 t0 -143.82 87.23 8.22 Favored Pre-proline 0 N--CA 1.485 1.288 0 O-C-N 120.547 -1.346 . . . . 0.0 110.764 -178.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.559 ' CG ' ' O ' ' A' ' 80' ' ' GLN . 2.2 Cg_endo -58.42 111.79 0.98 Allowed 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.633 1.333 . . . . 0.0 111.317 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.583 ' HE2' ' CD2' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -130.41 117.51 19.81 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.383 -0.823 . . . . 0.0 109.262 178.26 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.768 HG22 ' CG ' ' A' ' 22' ' ' MET . 61.8 t -97.3 174.6 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 O-C-N 121.581 -0.699 . . . . 0.0 110.049 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.579 ' N ' HG12 ' A' ' 94' ' ' VAL . . . -95.33 108.73 20.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 109.855 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 28.5 t80 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.937 . . . . 0.0 110.402 -179.669 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.455 ' O ' ' HB3' ' A' ' 21' ' ' LYS . 30.4 p . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.194 0.521 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.717 ' CB ' HG23 ' A' ' 67' ' ' THR . 11.6 ptmt -179.32 -171.09 0.19 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.397 -0.814 . . . . 0.0 110.252 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 1.003 ' HB3' HG13 ' A' ' 94' ' ' VAL . 12.7 ptm -123.21 175.8 6.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.441 -0.787 . . . . 0.0 110.041 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.582 ' HB3' ' HD2' ' A' ' 93' ' ' LYS . 1.4 t80 -146.58 158.35 43.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.367 -0.833 . . . . 0.0 109.886 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.962 HD11 ' CE ' ' A' ' 22' ' ' MET . 18.3 mm -115.92 134.78 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.31 -0.868 . . . . 0.0 109.124 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.513 ' O ' HG22 ' A' ' 90' ' ' ILE . . . -113.3 141.68 17.05 Favored Glycine 0 N--CA 1.495 2.601 0 C-N-CA 119.731 -1.223 . . . . 0.0 112.285 -177.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.51 ' C ' HG23 ' A' ' 90' ' ' ILE . . . 60.28 41.91 98.54 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.007 HD22 ' CA ' ' A' ' 63' ' ' PHE . 0.3 OUTLIER -77.45 153.87 33.14 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.62 -0.929 . . . . 0.0 111.163 -178.742 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.917 ' OG ' HD23 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -39.43 130.73 1.72 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.368 0.604 . . . . 0.0 110.518 -179.301 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 64.9 p-90 -68.81 -28.12 66.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.349 -0.844 . . . . 0.0 110.635 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.454 ' O ' ' O ' ' A' ' 31' ' ' THR . 2.3 pt20 -88.78 -14.76 36.33 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.083 -1.011 . . . . 0.0 110.721 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.543 ' HB ' ' CB ' ' A' ' 28' ' ' SER . 1.3 t -53.08 -169.02 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.642 -0.661 . . . . 0.0 110.364 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.718 HG23 ' H ' ' A' ' 35' ' ' GLY . 15.0 t -157.62 -166.75 2.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.334 -0.854 . . . . 0.0 109.85 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 36' ' ' LEU . 3.6 mt-30 -79.9 -72.92 0.38 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.149 -0.969 . . . . 0.0 110.118 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.534 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -48.07 -44.28 31.36 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.759 -1.176 . . . . 0.0 108.551 179.302 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.718 ' H ' HG23 ' A' ' 32' ' ' THR . . . -48.14 -35.27 13.64 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 107.566 -2.214 . . . . 0.0 107.566 178.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.766 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -75.76 -40.07 55.98 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.301 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.78 ' HA ' HG11 ' A' ' 46' ' ' VAL . 50.0 mtp180 -59.42 -25.66 64.52 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 122.47 1.129 . . . . 0.0 108.421 178.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.534 ' CG ' ' O ' ' A' ' 34' ' ' GLU . 1.5 mt-10 -84.56 -21.93 30.27 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.688 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 21.0 t80 -84.56 -48.36 9.63 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.795 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.854 ' HE1' HG13 ' A' ' 77' ' ' VAL . 28.1 m-85 -95.17 -33.48 12.61 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.355 -0.841 . . . . 0.0 109.321 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -65.8 -17.49 65.11 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -58.83 -45.2 90.56 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.417 -1.049 . . . . 0.0 109.276 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.599 ' CD1' ' HB3' ' A' ' 76' ' ' LYS . 4.5 p90 -117.83 -12.82 10.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.566 -0.709 . . . . 0.0 109.493 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.469 ' O ' ' HA2' ' A' ' 41' ' ' GLY . . . -133.99 87.01 0.26 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.531 ' O ' ' CB ' ' A' ' 68' ' ' PHE . 4.0 pm0 -41.18 104.39 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.417 -1.049 . . . . 0.0 110.357 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.78 HG11 ' HA ' ' A' ' 37' ' ' ARG . 2.9 p -89.42 142.5 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.228 -0.92 . . . . 0.0 110.519 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.62 -23.68 9.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.873 . . . . 0.0 109.677 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.43 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -130.25 126.59 37.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.407 -0.808 . . . . 0.0 110.173 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.511 ' HB2' ' CD2' ' A' ' 36' ' ' LEU . 3.4 p -150.13 152.14 34.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.076 -1.015 . . . . 0.0 110.253 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.801 HD21 ' CD2' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -149.99 134.33 17.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.048 -1.033 . . . . 0.0 110.65 179.739 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 78.4 t -117.16 134.81 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.543 -1.348 . . . . 0.0 110.732 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.524 ' HG3' ' N ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -129.4 152.17 49.24 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.423 -0.798 . . . . 0.0 109.44 179.746 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.524 ' N ' ' HG3' ' A' ' 52' ' ' MET . 1.7 mpp_? -147.49 -61.19 0.27 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.563 -0.711 . . . . 0.0 110.23 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -130.23 86.34 54.24 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.264 -0.898 . . . . 0.0 110.038 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.74 -76.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.706 1.371 . . . . 0.0 110.847 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.615 ' HG ' HG22 ' A' ' 57' ' ' THR . 1.8 pp -123.16 -27.92 4.1 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.23 -0.919 . . . . 0.0 111.039 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.615 HG22 ' HG ' ' A' ' 56' ' ' LEU . 2.5 t -131.44 -123.85 0.2 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.112 -0.993 . . . . 0.0 110.345 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.438 ' N ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -137.75 7.16 2.74 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 120.938 -1.101 . . . . 0.0 110.021 179.799 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.574 ' H ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -58.85 -38.7 79.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.254 -0.904 . . . . 0.0 110.03 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.568 ' N ' ' CD ' ' A' ' 59' ' ' ARG . 0.5 OUTLIER -48.44 170.36 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.229 -0.92 . . . . 0.0 110.106 179.808 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -129.02 -19.59 3.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.056 -1.027 . . . . 0.0 110.895 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.55 97.11 2.49 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 1.007 ' CA ' HD22 ' A' ' 27' ' ' LEU . 20.8 p90 -156.35 -162.94 1.35 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.131 -1.217 . . . . 0.0 110.26 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.573 ' O ' ' CD2' ' A' ' 23' ' ' PHE . . . -166.84 -179.97 40.29 Favored Glycine 0 N--CA 1.489 2.18 0 C-N-CA 119.536 -1.316 . . . . 0.0 110.296 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.801 ' CD2' HD21 ' A' ' 50' ' ' LEU . 10.4 m-85 -129.28 152.98 48.26 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.833 -0.804 . . . . 0.0 109.267 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.58 HG22 HD21 ' A' ' 36' ' ' LEU . 3.5 t -150.05 145.1 17.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 120.986 -1.071 . . . . 0.0 110.181 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.717 HG23 ' CB ' ' A' ' 21' ' ' LYS . 3.2 m -151.1 99.23 2.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.207 -0.933 . . . . 0.0 110.717 -179.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.635 ' CE2' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -100.57 -166.27 1.3 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.152 -0.967 . . . . 0.0 109.589 178.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.462 ' HA ' ' CE ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -151.35 74.83 1.15 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.951 . . . . 0.0 110.348 -179.878 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.431 ' OD1' ' OE2' ' A' ' 45' ' ' GLU . 0.6 OUTLIER -150.07 170.99 17.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.273 -0.892 . . . . 0.0 110.068 179.754 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.505 ' HG3' ' N ' ' A' ' 72' ' ' ALA . 27.2 pt20 -84.09 -38.92 20.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -0.936 . . . . 0.0 110.301 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.505 ' N ' ' HG3' ' A' ' 71' ' ' GLN . . . -83.77 4.24 29.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.905 . . . . 0.0 110.03 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.703 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -59.36 -82.34 0.06 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.559 HG23 ' N ' ' A' ' 75' ' ' ASP . 17.9 m -41.67 -48.3 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.296 -1.12 . . . . 0.0 110.534 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.559 ' N ' HG23 ' A' ' 74' ' ' VAL . 21.6 m-20 -42.22 -68.15 0.21 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.036 -1.04 . . . . 0.0 110.45 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.88 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -59.14 -37.03 76.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.442 -0.786 . . . . 0.0 110.449 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.854 HG13 ' HE1' ' A' ' 40' ' ' PHE . 58.9 t -56.21 -59.71 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 121.142 -0.974 . . . . 0.0 109.911 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.564 ' CD1' ' N ' ' A' ' 78' ' ' LEU . 2.4 mp -46.03 -40.73 11.03 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.88 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -43.18 -36.37 1.71 Allowed 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.584 0.707 . . . . 0.0 109.55 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.573 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 7.3 mm100 -102.57 27.61 6.74 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.483 -0.76 . . . . 0.0 109.505 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.562 ' HA ' ' HG2' ' A' ' 92' ' ' PRO . 65.9 p -45.56 -21.32 0.1 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.562 -0.711 . . . . 0.0 109.131 178.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.486 ' O ' ' O ' ' A' ' 83' ' ' HIS . 1.2 ptp180 -106.13 -19.66 13.65 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.463 -0.773 . . . . 0.0 110.279 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.912 ' CE1' HD12 ' A' ' 90' ' ' ILE . 0.2 OUTLIER 52.13 165.47 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.279 -0.888 . . . . 0.0 111.014 179.898 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 1.067 ' C ' HD13 ' A' ' 85' ' ' LEU . 1.2 tt0 175.37 119.74 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.599 0.714 . . . . 0.0 110.389 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.067 HD13 ' C ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -141.03 -86.49 0.18 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.575 -0.703 . . . . 0.0 109.172 178.417 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.536 ' O ' ' CB ' ' A' ' 87' ' ' SER . 0.1 OUTLIER -84.42 53.25 2.59 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.054 -1.029 . . . . 0.0 108.662 178.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 71.22 9.68 6.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.49 -0.756 . . . . 0.0 109.274 -178.769 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.586 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 10.3 mmtt -107.17 121.79 45.23 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.519 -0.738 . . . . 0.0 109.806 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.801 ' O ' HG23 ' A' ' 89' ' ' THR . 15.3 t -97.31 78.42 2.72 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.393 -0.817 . . . . 0.0 109.554 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.912 HD12 ' CE1' ' A' ' 83' ' ' HIS . 1.1 mt -47.65 -177.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-O 121.433 0.635 . . . . 0.0 110.335 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.597 ' H ' HG22 ' A' ' 90' ' ' ILE . 13.5 t0 -139.39 78.19 27.92 Favored Pre-proline 0 C--N 1.305 -1.355 0 O-C-N 121.108 -0.995 . . . . 0.0 110.566 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.631 ' HG3' ' HD2' ' A' ' 83' ' ' HIS . 2.3 Cg_endo -53.31 112.48 0.95 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.44 1.232 . . . . 0.0 110.964 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.582 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -117.06 99.78 7.29 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.287 -0.883 . . . . 0.0 109.698 178.434 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 1.003 HG13 ' HB3' ' A' ' 22' ' ' MET . 22.3 t -97.01 157.35 3.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 O-C-N 121.757 -0.589 . . . . 0.0 110.157 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -131.49 106.44 8.22 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.207 -0.933 . . . . 0.0 110.468 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.181 -0.949 . . . . 0.0 110.923 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.214 0.53 . . . . 0.0 110.128 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.514 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 5.2 pttt -70.34 161.15 30.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 110.331 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.913 ' HB2' HG13 ' A' ' 94' ' ' VAL . 36.5 ttp -86.07 172.67 10.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.359 -0.838 . . . . 0.0 110.307 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.752 ' C ' HD12 ' A' ' 24' ' ' ILE . 1.3 t80 -148.62 139.39 22.88 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.332 -0.855 . . . . 0.0 109.268 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.752 HD12 ' C ' ' A' ' 23' ' ' PHE . 1.3 mp -110.36 130.62 63.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 121.319 -0.863 . . . . 0.0 108.792 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.498 ' O ' ' CG2' ' A' ' 90' ' ' ILE . . . -95.73 120.53 6.58 Favored Glycine 0 N--CA 1.497 2.723 0 C-N-CA 120.028 -1.082 . . . . 0.0 113.145 -176.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.996 ' O ' HD12 ' A' ' 90' ' ' ILE . . . 76.67 28.24 59.62 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 177.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.024 HD11 HG13 ' A' ' 51' ' ' VAL . 1.4 pt? -49.43 142.51 7.68 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.376 -1.073 . . . . 0.0 110.383 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.839 ' O ' HG22 ' A' ' 31' ' ' THR . 2.3 m -39.42 121.35 1.17 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.486 0.66 . . . . 0.0 110.465 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.493 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 49.9 p-90 -58.88 -28.87 66.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.298 -0.876 . . . . 0.0 110.388 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -82.64 -13.7 56.01 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.195 -0.941 . . . . 0.0 110.642 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.839 HG22 ' O ' ' A' ' 28' ' ' SER . 3.0 t -63.64 -169.6 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.501 -0.749 . . . . 0.0 110.291 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.695 HG23 ' H ' ' A' ' 35' ' ' GLY . 13.4 t -154.06 -169.92 3.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.445 -0.785 . . . . 0.0 109.922 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 36' ' ' LEU . 17.7 mt-30 -74.48 -73.05 0.25 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.121 -0.987 . . . . 0.0 110.389 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.4 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 3.9 tt0 -47.84 -42.9 27.47 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.883 -1.136 . . . . 0.0 109.758 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.695 ' H ' HG23 ' A' ' 32' ' ' THR . . . -55.54 -30.18 55.32 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 107.699 -2.161 . . . . 0.0 107.699 178.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.874 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -82.1 -37.57 26.13 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.137 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.633 ' CD ' HG11 ' A' ' 46' ' ' VAL . 0.2 OUTLIER -62.86 -25.22 68.18 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 122.536 1.16 . . . . 0.0 108.503 178.487 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.53 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -90.39 -19.07 24.39 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.977 -1.011 . . . . 0.0 108.597 179.497 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.66 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 6.4 t80 -81.42 -26.61 35.25 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 121.457 -0.777 . . . . 0.0 110.334 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.895 ' HE1' HG13 ' A' ' 77' ' ' VAL . 39.0 m-85 -118.59 -17.72 9.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.403 -0.811 . . . . 0.0 109.371 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -75.69 -21.08 77.57 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.61 ' HG3' ' CD2' ' A' ' 43' ' ' PHE . 15.9 pt20 -63.06 -32.48 73.87 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.486 -1.008 . . . . 0.0 109.421 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.612 ' HE1' HG22 ' A' ' 77' ' ' VAL . 4.8 p90 -130.39 1.36 4.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.37 -0.831 . . . . 0.0 109.645 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 40' ' ' PHE . . . -143.77 95.27 0.18 Allowed Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 42.3 mt-10 -40.05 110.0 0.13 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.326 -1.102 . . . . 0.0 110.774 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.633 HG11 ' CD ' ' A' ' 37' ' ' ARG . 70.7 t -91.16 129.43 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.389 -0.819 . . . . 0.0 110.733 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 67' ' ' THR . 0.5 OUTLIER -93.48 -33.6 13.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.406 -0.809 . . . . 0.0 109.607 179.467 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.703 ' O ' HG22 ' A' ' 67' ' ' THR . 11.3 tp10 -171.29 153.96 3.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.548 -0.72 . . . . 0.0 109.188 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 15.6 p -150.81 157.06 42.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.06 -1.025 . . . . 0.0 111.107 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.733 ' C ' HD12 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -130.52 124.11 31.17 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.427 -0.796 . . . . 0.0 108.95 178.704 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.024 HG13 HD11 ' A' ' 27' ' ' LEU . 89.6 t -112.57 142.75 23.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 120.453 -1.404 . . . . 0.0 112.062 -178.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.576 ' SD ' ' CE2' ' A' ' 63' ' ' PHE . 1.9 ttm -135.83 137.84 41.94 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.543 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 5.0 tmm_? -146.96 -34.44 0.27 Allowed 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.443 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.653 ' N ' ' HD3' ' A' ' 55' ' ' PRO . 62.0 t0 -163.18 51.75 0.31 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.008 -1.058 . . . . 0.0 111.973 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.847 ' O ' HD23 ' A' ' 56' ' ' LEU . 2.4 Cg_endo -71.75 -68.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.32 -0.94 0 N-CA-C 109.337 -1.063 . . . . 0.0 109.337 178.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.847 HD23 ' O ' ' A' ' 55' ' ' PRO . 11.2 mt -140.64 -62.6 0.49 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.659 0.743 . . . . 0.0 109.047 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.471 ' O ' ' HD2' ' A' ' 59' ' ' ARG . 4.9 t -139.9 -28.77 0.74 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.652 -0.655 . . . . 0.0 110.733 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 60' ' ' SER . 4.4 mtmt -54.68 -37.6 65.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.113 -0.992 . . . . 0.0 109.759 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.551 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -38.93 -24.62 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.694 -0.629 . . . . 0.0 111.203 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 58' ' ' LYS . 1.6 t -38.47 -27.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.329 -0.857 . . . . 0.0 111.019 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 59' ' ' ARG . 4.6 mtt180 -99.0 -33.58 10.77 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.06 -1.025 . . . . 0.0 110.931 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.46 ' C ' ' CD2' ' A' ' 27' ' ' LEU . . . 56.5 77.5 0.16 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 107.827 -2.109 . . . . 0.0 107.827 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.83 ' CA ' HD22 ' A' ' 27' ' ' LEU . 14.4 p90 -134.63 -167.86 2.05 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.428 -1.042 . . . . 0.0 111.428 -178.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -158.7 116.72 0.73 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.554 ' HB2' ' HG ' ' A' ' 50' ' ' LEU . 12.7 m-85 -82.99 140.97 32.44 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.483 -1.01 . . . . 0.0 108.863 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.839 HG22 HD21 ' A' ' 36' ' ' LEU . 2.9 t -147.34 99.36 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 120.943 -1.098 . . . . 0.0 110.239 -178.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.703 HG22 ' O ' ' A' ' 48' ' ' GLU . 7.9 t -80.58 64.01 5.22 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 110.734 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.568 ' HB3' HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -84.41 -151.18 0.12 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.193 -0.942 . . . . 0.0 110.745 179.807 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.74 173.07 10.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.233 -0.917 . . . . 0.0 110.512 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.4 2.16 5.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.306 -0.872 . . . . 0.0 110.266 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -81.26 -116.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.233 -0.917 . . . . 0.0 110.138 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 75' ' ' ASP . . . -67.9 -24.45 65.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.834 -1.166 . . . . 0.0 110.178 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.671 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -46.49 -61.25 4.27 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.974 ' O ' HD12 ' A' ' 78' ' ' LEU . 71.3 t -43.17 -48.47 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.191 -1.182 . . . . 0.0 110.197 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 72' ' ' ALA . 34.8 t70 -47.94 -56.92 6.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.971 -1.081 . . . . 0.0 110.153 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.573 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -59.73 -30.66 68.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.39 -0.819 . . . . 0.0 110.15 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.895 HG13 ' HE1' ' A' ' 40' ' ' PHE . 41.7 t -63.01 -58.17 8.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.113 -0.992 . . . . 0.0 109.279 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.974 HD12 ' O ' ' A' ' 74' ' ' VAL . 1.3 mp -45.88 -44.39 14.43 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.324 -0.86 . . . . 0.0 108.962 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -45.96 -28.53 1.16 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.209 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.53 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 22.3 mm100 -103.76 25.53 9.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.512 -0.742 . . . . 0.0 109.898 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 78' ' ' LEU . 23.7 t -54.43 -16.16 2.12 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.488 ' O ' ' C ' ' A' ' 83' ' ' HIS . 5.2 ptp180 -95.95 -18.15 20.49 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 121.501 -0.749 . . . . 0.0 109.533 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.66 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 0.6 OUTLIER 31.51 41.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.81 -0.556 . . . . 0.0 111.795 179.484 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.567 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 0.7 OUTLIER -86.93 122.41 30.75 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 118.619 -1.233 . . . . 0.0 110.192 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.548 ' CD2' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -144.62 -85.81 0.13 Allowed 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.626 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 87' ' ' SER . 0.6 OUTLIER -82.28 52.92 2.13 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.21 -0.931 . . . . 0.0 108.753 179.05 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 1.4 t 71.33 5.84 5.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.599 -0.688 . . . . 0.0 109.651 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 10.7 mmmt -108.02 119.54 39.76 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.357 -0.839 . . . . 0.0 109.808 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.765 ' O ' HG23 ' A' ' 89' ' ' THR . 15.1 t -101.41 68.62 1.21 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.608 -0.682 . . . . 0.0 109.646 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.996 HD12 ' O ' ' A' ' 26' ' ' GLY . 1.2 mm -51.7 -175.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.419 -0.801 . . . . 0.0 109.803 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.503 ' H ' HG22 ' A' ' 90' ' ' ILE . 15.6 t0 -143.67 83.73 10.41 Favored Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.303 -0.873 . . . . 0.0 109.877 -179.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.53 ' CG ' ' O ' ' A' ' 80' ' ' GLN . 2.3 Cg_endo -53.22 112.32 0.9 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.553 1.291 . . . . 0.0 110.965 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.604 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -130.16 111.76 12.75 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.486 -0.759 . . . . 0.0 109.546 178.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.913 HG13 ' HB2' ' A' ' 22' ' ' MET . 3.8 t -95.66 -174.01 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.525 -0.734 . . . . 0.0 110.018 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.694 ' H ' HG12 ' A' ' 94' ' ' VAL . . . -82.6 10.38 7.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.175 -0.953 . . . . 0.0 110.358 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.441 ' CE1' HG21 ' A' ' 74' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.132 -0.98 . . . . 0.0 110.542 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 62.5 m . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.256 0.551 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.746 ' HB2' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER 58.2 154.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.255 -0.903 . . . . 0.0 109.841 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.951 ' CG ' HG22 ' A' ' 94' ' ' VAL . 5.3 tmm? -68.83 157.77 35.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.105 -0.997 . . . . 0.0 109.854 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.605 ' CG ' ' CE1' ' A' ' 65' ' ' PHE . 6.8 t80 -141.02 144.49 35.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.229 -0.919 . . . . 0.0 109.984 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.779 ' CG2' HG21 ' A' ' 90' ' ' ILE . 20.1 mm -108.87 137.76 39.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.314 -0.866 . . . . 0.0 109.232 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 91' ' ' ASP . . . -118.1 144.17 17.99 Favored Glycine 0 N--CA 1.495 2.576 0 C-N-CA 119.647 -1.263 . . . . 0.0 111.464 -177.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 90' ' ' ILE . . . 59.08 42.05 96.83 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.992 HD22 ' CA ' ' A' ' 63' ' ' PHE . 0.3 OUTLIER -79.69 156.51 27.53 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.452 -1.028 . . . . 0.0 110.939 -179.072 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.465 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -39.4 142.27 0.29 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.458 0.647 . . . . 0.0 110.735 -179.097 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.585 ' HA ' ' CD ' ' A' ' 53' ' ' ARG . 47.0 p-90 -85.58 2.57 44.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.496 -0.753 . . . . 0.0 110.332 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.469 ' O ' ' O ' ' A' ' 31' ' ' THR . 14.8 pt20 -121.77 -14.41 8.12 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.212 -0.93 . . . . 0.0 110.424 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 30' ' ' GLN . 14.8 t -53.3 -168.65 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.646 -0.659 . . . . 0.0 110.26 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.653 HG23 ' H ' ' A' ' 35' ' ' GLY . 6.0 t -153.91 -176.1 5.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.279 -0.888 . . . . 0.0 110.034 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 36' ' ' LEU . 4.9 mt-30 -69.5 -75.01 0.12 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.045 -1.034 . . . . 0.0 110.818 -179.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.47 ' HA ' ' HG3' ' A' ' 37' ' ' ARG . 7.9 tt0 -47.22 -40.46 16.31 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.817 -1.177 . . . . 0.0 110.051 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.653 ' H ' HG23 ' A' ' 32' ' ' THR . . . -56.53 -32.71 61.41 Favored Glycine 0 N--CA 1.484 1.833 0 N-CA-C 107.32 -2.312 . . . . 0.0 107.32 178.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.855 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -79.87 -38.8 31.93 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.122 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.47 ' HG3' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -61.81 -25.27 67.39 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 122.43 1.109 . . . . 0.0 108.764 178.501 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.554 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -88.66 -18.58 27.64 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.69 179.543 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.694 ' CZ ' ' CE1' ' A' ' 83' ' ' HIS . 24.1 t80 -82.96 -28.02 30.09 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.348 -0.845 . . . . 0.0 110.564 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.881 ' CE1' HG13 ' A' ' 77' ' ' VAL . 39.2 m-85 -116.51 -22.53 8.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.208 -0.932 . . . . 0.0 109.457 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.521 ' CA ' HG23 ' A' ' 46' ' ' VAL . . . -72.15 -13.27 76.39 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -66.45 -36.96 84.08 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.416 -1.049 . . . . 0.0 109.713 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.602 ' CD1' ' HB3' ' A' ' 76' ' ' LYS . 9.7 p90 -125.71 7.86 7.54 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.503 -0.748 . . . . 0.0 109.828 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.481 ' O ' ' HA2' ' A' ' 41' ' ' GLY . . . -153.33 98.11 0.18 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 44' ' ' GLY . 8.5 pt-20 -39.79 124.49 1.73 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.526 -0.985 . . . . 0.0 110.26 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.521 HG23 ' CA ' ' A' ' 41' ' ' GLY . 3.3 t -98.43 126.06 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.22 -0.925 . . . . 0.0 110.453 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.469 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 1.6 mmtm -88.77 -27.6 21.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.365 -0.834 . . . . 0.0 109.498 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 12.1 pt-20 179.67 147.34 0.24 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.464 -0.772 . . . . 0.0 110.09 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 19.5 p -140.59 176.59 8.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.158 -0.964 . . . . 0.0 110.531 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.682 ' C ' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -147.74 124.64 11.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.3 -0.875 . . . . 0.0 110.148 179.416 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.493 ' N ' HD12 ' A' ' 50' ' ' LEU . 69.9 t -116.24 131.45 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.716 -1.24 . . . . 0.0 110.883 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.435 ' SD ' ' HB2' ' A' ' 60' ' ' SER . 1.2 ttm -138.83 149.85 45.38 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.526 -0.734 . . . . 0.0 109.523 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.585 ' CD ' ' HA ' ' A' ' 29' ' ' TRP . 33.3 mtm180 -149.73 -59.94 0.21 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.407 -0.808 . . . . 0.0 110.273 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -144.2 74.12 15.92 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.297 -0.877 . . . . 0.0 110.331 -179.908 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -62.22 -64.6 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.686 1.361 . . . . 0.0 110.629 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.0 mt -90.87 -67.26 0.86 Allowed 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.198 -0.939 . . . . 0.0 110.138 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.542 HG23 ' N ' ' A' ' 58' ' ' LYS . 2.0 t -142.19 -46.13 0.34 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.439 -0.788 . . . . 0.0 110.163 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.542 ' N ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -179.89 33.9 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.541 -0.724 . . . . 0.0 109.923 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.587 ' CD ' ' N ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -76.13 -38.09 57.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 110.356 -179.886 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.587 ' N ' ' CD ' ' A' ' 59' ' ' ARG . 96.0 p -69.16 -146.06 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.1 -1.0 . . . . 0.0 110.367 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 60' ' ' SER . 1.4 mtp180 -147.66 -39.73 0.18 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 109.96 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 120.45 81.87 0.69 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.992 ' CA ' HD22 ' A' ' 27' ' ' LEU . 11.7 p90 -145.78 -172.38 3.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.161 -1.199 . . . . 0.0 110.656 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.473 ' O ' ' HB ' ' A' ' 24' ' ' ILE . . . -153.7 114.16 0.61 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.605 ' CE1' ' CG ' ' A' ' 23' ' ' PHE . 19.9 m-85 -83.35 148.79 27.13 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.274 -1.133 . . . . 0.0 109.92 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.702 HG22 HD21 ' A' ' 36' ' ' LEU . 3.7 t -148.45 116.23 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.305 -0.872 . . . . 0.0 110.04 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.746 HG23 ' HB2' ' A' ' 21' ' ' LYS . 14.7 m -94.09 35.06 1.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.946 . . . . 0.0 110.511 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.627 ' CE2' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -69.14 135.26 50.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.936 -1.102 . . . . 0.0 109.55 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 4.7 ttt -143.77 122.77 12.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.1 -1.0 . . . . 0.0 110.571 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.43 ' HB2' ' HG2' ' A' ' 45' ' ' GLU . 4.6 t70 -142.86 -88.89 0.13 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.35 -0.844 . . . . 0.0 109.763 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.01 -83.67 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.339 -0.85 . . . . 0.0 109.575 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.08 -0.8 41.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.17 -0.956 . . . . 0.0 109.776 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.595 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -61.58 -46.16 94.86 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.896 ' O ' HD12 ' A' ' 78' ' ' LEU . 3.0 p -50.12 -46.17 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.205 -1.173 . . . . 0.0 109.484 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.571 ' N ' ' CG1' ' A' ' 74' ' ' VAL . 0.2 OUTLIER -59.71 -40.28 87.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.425 -0.797 . . . . 0.0 109.637 179.529 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.638 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -62.37 -33.51 74.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.416 -0.803 . . . . 0.0 109.389 179.378 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.881 HG13 ' CE1' ' A' ' 40' ' ' PHE . 40.5 t -62.74 -57.84 10.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.36 -0.838 . . . . 0.0 109.191 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.896 HD12 ' O ' ' A' ' 74' ' ' VAL . 4.0 mp -45.31 -41.91 9.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.197 -0.939 . . . . 0.0 108.852 178.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -46.31 -28.26 1.26 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.473 -0.891 . . . . 0.0 108.747 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.524 ' O ' ' CG ' ' A' ' 92' ' ' PRO . 33.0 mm-40 -102.62 26.78 7.55 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.668 -0.645 . . . . 0.0 109.821 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 78' ' ' LEU . 41.9 t -55.93 -16.37 4.66 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.525 ' O ' ' N ' ' A' ' 84' ' ' GLU . 0.8 OUTLIER -109.47 1.63 19.99 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 121.626 -0.671 . . . . 0.0 109.373 178.751 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.986 ' CE1' HD12 ' A' ' 90' ' ' ILE . 0.5 OUTLIER 28.25 -87.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.138 0.494 . . . . 0.0 112.141 179.783 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.66 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 1.6 tt0 51.01 112.35 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 122.327 1.06 . . . . 0.0 110.5 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.798 HD11 HD11 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -131.65 -70.06 0.59 Allowed 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.549 ' HB3' ' CE ' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -103.71 55.33 0.74 Allowed 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.913 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER 73.65 13.79 4.33 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 -178.135 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.66 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 8.6 mttt -117.86 107.2 13.82 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 121.502 -0.749 . . . . 0.0 110.997 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.682 ' O ' HG23 ' A' ' 89' ' ' THR . 9.5 t -80.82 76.93 7.73 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.508 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.986 HD12 ' CE1' ' A' ' 83' ' ' HIS . 1.6 mt -50.72 -179.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.058 -1.026 . . . . 0.0 109.231 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.63 ' H ' HG22 ' A' ' 90' ' ' ILE . 11.1 t0 -139.2 75.03 34.86 Favored Pre-proline 0 C--N 1.298 -1.641 0 O-C-N 121.188 -0.945 . . . . 0.0 110.559 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.524 ' CG ' ' O ' ' A' ' 80' ' ' GLN . 2.1 Cg_endo -52.64 111.17 0.57 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.593 1.312 . . . . 0.0 110.854 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.588 ' HD2' ' HB3' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -121.66 103.91 9.24 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.098 -1.001 . . . . 0.0 109.136 178.339 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.951 HG22 ' CG ' ' A' ' 22' ' ' MET . 3.4 t -96.83 177.49 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 O-C-N 121.639 -0.663 . . . . 0.0 110.784 -178.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.572 ' H ' HG12 ' A' ' 94' ' ' VAL . . . -170.32 123.06 0.67 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.452 -0.78 . . . . 0.0 109.776 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.434 ' CD1' ' N ' ' A' ' 96' ' ' PHE . 12.3 p90 . . . . . 0 N--CA 1.495 1.775 0 O-C-N 121.225 -0.922 . . . . 0.0 110.416 -179.522 . . . . . . . . 1 1 . 1 stop_ save_